{
  "3": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs3745274",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2242446",
        "gene": "SLC6A2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs36029",
        "gene": "SLC6A2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1861647",
        "gene": "SLC6A2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*17",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*17",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "antiinflammatory and antirheumatic products, non-steroids": {
    "genes": [
      "NQO1",
      "PTGS2",
      "SOD2",
      "PTGS1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "imatinib": {
    "genes": [
      "NQO1",
      "POR",
      "ABCC4",
      "KIT",
      "SLC22A1",
      "KDR",
      "ABCB1",
      "EGFR",
      "CYP2B6",
      "FIP1L1",
      "CYP1A1",
      "GSTT1",
      "ATIC",
      "MAPK1",
      "SLCO1B3",
      "FLT3",
      "CXCL14",
      "BCR",
      "SLC22A4",
      "PDGFRB",
      "VEGFA",
      "PDGFRA",
      "ULK3",
      "ABCC2",
      "NR1I2",
      "CCL5",
      "ABCA3",
      "SLC19A1",
      "ABCG2",
      "RUNDC3B",
      "GSTM1",
      "CYP3A4",
      "SLCO1A2",
      "FLT4",
      "CYP2C8",
      "CYP2F1",
      "UGT2A1",
      "FLT1",
      "SHC1",
      "CYP3A5",
      "BCL2L11",
      "SLC22A5",
      "CHST1",
      "RET",
      "ABL1",
      "ABCB4",
      "ARID5B",
      "CYP1A2",
      "GSTP1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs9561765",
        "gene": "ABCC4",
        "level": "3",
        "phenotypes": "Gastrointestinal Stromal Tumors"
      },
      {
        "variant": "rs2631372",
        "gene": "SLC22A5",
        "level": "3",
        "phenotypes": "Gastrointestinal Stromal Tumors"
      },
      {
        "variant": "rs724710",
        "gene": "BCL2L11",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1050152",
        "gene": "SLC22A4",
        "level": "3",
        "phenotypes": "Chronic myelogenous leukemia, BCR-ABL1 positive,Gastrointestinal Stromal Tumors"
      },
      {
        "variant": "GSTT1 non-null, GSTT1 null",
        "gene": "GSTT1",
        "level": "3",
        "phenotypes": "Chronic myelogenous leukemia, BCR-ABL1 positive"
      },
      {
        "variant": "rs2631367",
        "gene": "SLC22A5",
        "level": "3",
        "phenotypes": "Gastrointestinal Stromal Tumors"
      },
      {
        "variant": "rs12505410",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Chronic myelogenous leukemia, BCR-ABL1 positive"
      },
      {
        "variant": "rs13120400",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Chronic myelogenous leukemia, BCR-ABL1 positive"
      },
      {
        "variant": "rs2725252",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Chronic myelogenous leukemia, BCR-ABL1 positive"
      },
      {
        "variant": "rs3745274",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Chronic myelogenous leukemia, BCR-ABL1 positive"
      },
      {
        "variant": "rs683369",
        "gene": "SLC22A1",
        "level": "3",
        "phenotypes": "Chronic myelogenous leukemia, BCR-ABL1 positive"
      },
      {
        "variant": "rs45605536",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs58818712",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs41282401",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1061018",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2231137",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3764043",
        "gene": "SLCO1A2",
        "level": "3",
        "phenotypes": "Chronic myelogenous leukemia, BCR-ABL1 positive"
      },
      {
        "variant": "rs2290573",
        "gene": "ULK3",
        "level": "3",
        "phenotypes": "Chronic myelogenous leukemia, BCR-ABL1 positive"
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Chronic myelogenous leukemia, BCR-ABL1 positive"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Chronic myelogenous leukemia, BCR-ABL1 positive"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Chronic myelogenous leukemia, BCR-ABL1 positive"
      },
      {
        "variant": "rs683369",
        "gene": "SLC22A1",
        "level": "3",
        "phenotypes": "Gastrointestinal Stromal Tumors"
      },
      {
        "variant": "rs274558",
        "gene": "SLC22A5",
        "level": "3",
        "phenotypes": "Gastrointestinal Stromal Tumors"
      },
      {
        "variant": "rs10258429",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Gastrointestinal Stromal Tumors"
      },
      {
        "variant": "rs2235040",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Gastrointestinal Stromal Tumors"
      },
      {
        "variant": "rs11249454",
        "gene": "UGT2A1",
        "level": "3",
        "phenotypes": "Gastrointestinal Stromal Tumors"
      },
      {
        "variant": "rs1202283",
        "gene": "ABCB4",
        "level": "3",
        "phenotypes": "Gastrointestinal Stromal Tumors"
      },
      {
        "variant": "rs2273697",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Gastrointestinal Stromal Tumors"
      },
      {
        "variant": "rs9787901",
        "gene": "CHST1",
        "level": "3",
        "phenotypes": "Gastrointestinal Stromal Tumors"
      },
      {
        "variant": "rs10517",
        "gene": "NQO1",
        "level": "3",
        "phenotypes": "Gastrointestinal Stromal Tumors"
      },
      {
        "variant": "rs305968",
        "gene": "CYP2F1",
        "level": "3",
        "phenotypes": "Gastrointestinal Stromal Tumors"
      },
      {
        "variant": "rs12659",
        "gene": "SLC19A1",
        "level": "3",
        "phenotypes": "Gastrointestinal Stromal Tumors"
      },
      {
        "variant": "rs1051266",
        "gene": "SLC19A1",
        "level": "3",
        "phenotypes": "Gastrointestinal Stromal Tumors"
      },
      {
        "variant": "rs628031",
        "gene": "SLC22A1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs762551",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": "Gastrointestinal Stromal Tumors"
      },
      {
        "variant": "rs2231137",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Drug Toxicity,Gastrointestinal Stromal Tumors"
      },
      {
        "variant": "rs28656907",
        "gene": "ABCB1,RUNDC3B",
        "level": "3",
        "phenotypes": "Drug Toxicity,Gastrointestinal Stromal Tumors"
      },
      {
        "variant": "CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for imatinib and ABL1, BCR, FIP1L1, KIT, PDGFRA, PDGFRB"
      },
      {
        "source": "PMDA",
        "level": "Testing Required",
        "name": "Annotation of PMDA Label for imatinib and ABL1, BCR"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for imatinib and ABL1, BCR, FIP1L1, KIT, PDGFRA, PDGFRB"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for imatinib and ABL1, BCR, FIP1L1, KIT, PDGFRA, PDGFRB"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "corticosteroids": {
    "genes": [
      "NQO1",
      "ST13",
      "ZNF432",
      "HDAC1",
      "DTNBP1",
      "CTLA4",
      "NR3C1",
      "LHX2",
      "DCAF4",
      "ITPA",
      "TRDN",
      "GSTT1",
      "KCNN1",
      "STIP1",
      "APOBEC3B",
      "LHFPL3",
      "FCER2",
      "FKBP5",
      "ADORA2A",
      "ACP1",
      "ANKS1B",
      "GLCCI1",
      "SERPINE1",
      "ABCC2",
      "FAM240C",
      "NR1I2",
      "GGH",
      "GSTM1",
      "ZNF37A",
      "ADRB2",
      "POGK",
      "ADAM33",
      "NEU3",
      "CYP2C8",
      "ME3",
      "SUMF1",
      "IL10",
      "CYP3A5",
      "NRP2",
      "KANSL1",
      "BCL2L11",
      "TAAR6",
      "MAPT",
      "ACOT7",
      "TBX21",
      "ABCC1",
      "ANKRD30B",
      "KL",
      "CRHR1",
      "GSTP1",
      "WNT7B"
    ],
    "clinicalVariants": [
      {
        "variant": "rs7160796",
        "gene": "DCAF4",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs4713916",
        "gene": "FKBP5",
        "level": "3",
        "phenotypes": "Crohn Disease"
      },
      {
        "variant": "rs1741981",
        "gene": "HDAC1",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs138335",
        "gene": "ST13",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs138337",
        "gene": "ST13",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs2240017",
        "gene": "TBX21",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs7772821",
        "gene": "TAAR6",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs724710",
        "gene": "BCL2L11",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs2241843",
        "gene": "BCL2L11",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs1876828",
        "gene": "CRHR1",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Asthma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fluorouracil": {
    "genes": [
      "NQO1",
      "ABCC4",
      "PARD3B",
      "ERCC1",
      "LGR5",
      "HNF4A",
      "NT5C1A",
      "PSMB3P",
      "RAB27A",
      "RRM2B",
      "IL6",
      "RBX1",
      "HLA-DQA1",
      "KDR",
      "ABCB1",
      "REV3L",
      "MIR24-2",
      "KLC3",
      "ENOSF1",
      "HMMR",
      "MECP2",
      "KHDRBS3",
      "TOP2A",
      "PPARA",
      "EGFR",
      "ERCC4",
      "MTHFR",
      "OR10AE3P",
      "CSPG4",
      "WNT5B",
      "PON1",
      "GSTT1",
      "MTHFD1",
      "VENTXP7",
      "APEX1",
      "ALDH1A1",
      "CYP2C19",
      "NOS1",
      "WDR7",
      "TNFSF13B",
      "COLEC10",
      "KRAS",
      "OGG1",
      "HLA-DQB1",
      "PERP",
      "SPARC",
      "GALNT14",
      "STAT3",
      "DPYD",
      "MSH6",
      "IMPDH2",
      "CYP4X1",
      "ATM",
      "ALDH3A1",
      "TYMP",
      "ERCC2",
      "PPARD",
      "SHMT1",
      "TWIST1",
      "TPMT",
      "PIK3R2",
      "CBR1",
      "PPP2R5D",
      "FGFR4",
      "XRCC1",
      "FOXO1",
      "PDGFRB",
      "VEGFA",
      "SELE",
      "SOD2",
      "TK1",
      "COL6A3",
      "UGT2B7",
      "GCKR",
      "CDA",
      "WRN",
      "ABCC2",
      "NR1I2",
      "SLC19A1",
      "ABCG2",
      "PTEN",
      "WWOX",
      "ABCG1",
      "FEN1",
      "CCND1",
      "TP53",
      "ERCC5",
      "IRS1",
      "NFKB1",
      "TP53AIP1",
      "UMPS",
      "GSTM1",
      "IGF2BP2",
      "ABCC5",
      "MTR",
      "RAD51",
      "CCL2",
      "CYP19A1",
      "ABCC11",
      "KLC1",
      "VDR",
      "CYP3A4",
      "C18orf56",
      "RXRG",
      "XPC",
      "SCN1A",
      "RGS5",
      "XRCC3",
      "NLGN1",
      "HLA-DRB1",
      "FLT4",
      "RALBP1",
      "TNF",
      "MUTYH",
      "IL8",
      "CYP2C8",
      "OSGEP",
      "SOD3",
      "CYP1B1",
      "FLT1",
      "TMEM167A",
      "UGT1A1",
      "CHN2",
      "MSH2",
      "PIGB",
      "SLCO1B1",
      "IGFBP3",
      "CYP2A6",
      "DPYS",
      "XRCC4",
      "ETFRF1",
      "NEIL1",
      "SLC22A16",
      "PROM1",
      "CCNK",
      "SMAD7",
      "IFNG",
      "DLG5",
      "ABCA2",
      "INSR",
      "AGXT",
      "MIR27A",
      "KCNQ1",
      "UPB1",
      "GNAS",
      "MSH3",
      "ABCC1",
      "EXO1",
      "TYMS",
      "ZNF215",
      "MEGF11",
      "NR1I3",
      "PPARG",
      "GSTP1",
      "NOS3",
      "CBR3",
      "HLA-G",
      "MIR23A",
      "GNL3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs17376848",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1801158",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1801159",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1801265",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1801160",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs78060119",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs59086055",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs115232898",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1801160",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs72549306",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs72549303",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs115232898",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs78060119",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs1801268",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs1801266",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs72549309",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs59086055",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs2297595",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs67376798",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs67376798",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs3918290",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs3918290",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs55886062",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs148994843",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs56005131",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs56038477",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs75017182",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs75017182",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs55886062",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs13181",
        "gene": "ERCC2",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs2070744",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2010851",
        "gene": "WNT5B",
        "level": "3",
        "phenotypes": "Colonic Neoplasms"
      },
      {
        "variant": "rs1979277",
        "gene": "SHMT1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs12659",
        "gene": "SLC19A1",
        "level": "3",
        "phenotypes": "Uterine Cervical Neoplasm"
      },
      {
        "variant": "rs17626122",
        "gene": "PARD3B",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms,Drug Toxicity"
      },
      {
        "variant": "rs7194667",
        "gene": "ABCC11",
        "level": "3",
        "phenotypes": "Leukopenia,Neoplasms"
      },
      {
        "variant": "rs25648",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Stomach Neoplasms"
      },
      {
        "variant": "rs7325568",
        "gene": "",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs2293347",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Stomach Neoplasms"
      },
      {
        "variant": "rs1047840",
        "gene": "EXO1",
        "level": "3",
        "phenotypes": "Metastatic neoplasm"
      },
      {
        "variant": "rs2291078",
        "gene": "UMPS",
        "level": "3",
        "phenotypes": "Metastatic neoplasm"
      },
      {
        "variant": "rs3772809",
        "gene": "UMPS",
        "level": "3",
        "phenotypes": "Metastatic neoplasm"
      },
      {
        "variant": "rs3772810",
        "gene": "UMPS",
        "level": "3",
        "phenotypes": "Metastatic neoplasm"
      },
      {
        "variant": "rs3218592",
        "gene": "REV3L",
        "level": "3",
        "phenotypes": "Metastatic neoplasm"
      },
      {
        "variant": "rs17160359",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Metastatic neoplasm"
      },
      {
        "variant": "rs2289310",
        "gene": "DLG5",
        "level": "3",
        "phenotypes": "Metastatic neoplasm"
      },
      {
        "variant": "rs17431184",
        "gene": "PTEN",
        "level": "3",
        "phenotypes": "Metastatic neoplasm"
      },
      {
        "variant": "rs2236722",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Metastatic neoplasm"
      },
      {
        "variant": "rs662",
        "gene": "PON1",
        "level": "3",
        "phenotypes": "Neoplasms,Stomach Neoplasms"
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Neoplasms,Ovarian Neoplasms,Stomach Neoplasms"
      },
      {
        "variant": "rs699947",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs17109924",
        "gene": "LGR5",
        "level": "3",
        "phenotypes": "Colonic Neoplasms"
      },
      {
        "variant": "rs10937158",
        "gene": "ABCC5",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs2292997",
        "gene": "",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs225440",
        "gene": "ABCG1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs3749438",
        "gene": "ABCC5",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs371194629",
        "gene": "HLA-G",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs9380142",
        "gene": "HLA-G",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs17179108",
        "gene": "HLA-G",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs3917412",
        "gene": "SELE",
        "level": "3",
        "phenotypes": "Colonic Neoplasms"
      },
      {
        "variant": "rs183205964",
        "gene": "TYMS",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs2854744",
        "gene": "IGFBP3",
        "level": "3",
        "phenotypes": "Stomach Neoplasms"
      },
      {
        "variant": "rs201045130",
        "gene": "NT5C1A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs374150125",
        "gene": "NT5C1A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs370457585",
        "gene": "NT5C1A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs115632870",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs72728438",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2847153",
        "gene": "TYMS",
        "level": "3",
        "phenotypes": "Pancreatic Neoplasms"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Colonic Neoplasms"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1056836",
        "gene": "CYP1B1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1056515",
        "gene": "RGS5",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs12613732",
        "gene": "GALNT14",
        "level": "3",
        "phenotypes": "Hepatocellular Carcinoma"
      },
      {
        "variant": "rs351855",
        "gene": "FGFR4",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Colonic Neoplasms"
      },
      {
        "variant": "rs12050587",
        "gene": "PIGB",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Leukopenia,Neutropenia"
      },
      {
        "variant": "rs11636687",
        "gene": "",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Leukopenia,Neutropenia"
      },
      {
        "variant": "TPMT*1, TPMT*3B, TPMT*3C",
        "gene": "TPMT",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs2298881",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Stomach Neoplasms"
      },
      {
        "variant": "rs10040363",
        "gene": "XRCC4",
        "level": "3",
        "phenotypes": "Stomach Neoplasms"
      },
      {
        "variant": "rs11479",
        "gene": "TYMP",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs2075685",
        "gene": "TMEM167A,XRCC4",
        "level": "3",
        "phenotypes": "Stomach Neoplasms"
      },
      {
        "variant": "rs115457081",
        "gene": "IRS1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs112242273",
        "gene": "GNL3",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs299293",
        "gene": "HMMR",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs299313",
        "gene": "HMMR",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs117101815",
        "gene": "PERP",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs78428806",
        "gene": "PERP",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs3805945",
        "gene": "PPP2R5D",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs299314",
        "gene": "HMMR",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs9402944",
        "gene": "PERP",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs9389568",
        "gene": "PERP",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs117458836",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs118088833",
        "gene": "TP53AIP1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs149212925",
        "gene": "NOS1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs144991623",
        "gene": "FOXO1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs77769901",
        "gene": "CCNK",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs4968187",
        "gene": "TP53",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs181501757",
        "gene": "TOP2A",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs142244113",
        "gene": "INSR",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs41412545",
        "gene": "INSR",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs118129530",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs56022120",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs117341846",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs117951771",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs148235907",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs138602176",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs150688309",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs79430272",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs55633228",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs148013902",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs145623321",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs58695150",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs8110364",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs74743371",
        "gene": "CBR3",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs141084494",
        "gene": "RBX1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs188052243",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1335150891",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs748620513",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1184321568",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs143879757",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1212037891",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs7699188",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1056836",
        "gene": "CYP1B1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs6907567",
        "gene": "SLC22A16",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs714368",
        "gene": "SLC22A16",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs12248560",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs4244285",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2273697",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs3740066",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1801516",
        "gene": "ATM",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2228100",
        "gene": "ALDH3A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs3212986",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs20572",
        "gene": "CBR1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs25487",
        "gene": "XRCC1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs25487",
        "gene": "XRCC1",
        "level": "3",
        "phenotypes": "Colonic Neoplasms,Colorectal Neoplasms,Neoplasms,Rectal Neoplasms,Uterine Cervical Neoplasm"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs11280056",
        "gene": "TYMS",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Colonic Neoplasms"
      },
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs861539",
        "gene": "KLC1,XRCC3",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs112783657",
        "gene": "CBR3",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs6025211",
        "gene": "",
        "level": "3",
        "phenotypes": "Liver cancer"
      },
      {
        "variant": "rs9679162",
        "gene": "GALNT14",
        "level": "3",
        "phenotypes": "Liver cancer"
      },
      {
        "variant": "rs11280056",
        "gene": "TYMS",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs45445694",
        "gene": "TYMS",
        "level": "3",
        "phenotypes": "Overall survival,Progression-free survival"
      },
      {
        "variant": "rs45445694",
        "gene": "TYMS",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs9679162",
        "gene": "GALNT14",
        "level": "3",
        "phenotypes": "Hepatocellular Carcinoma,Liver cancer"
      },
      {
        "variant": "rs1800566",
        "gene": "NQO1",
        "level": "3",
        "phenotypes": "Metastatic neoplasm,Stomach Neoplasms"
      },
      {
        "variant": "rs1800566",
        "gene": "NQO1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1760944",
        "gene": "APEX1,OSGEP",
        "level": "3",
        "phenotypes": "Carcinoma, Squamous Cell,Overall survival"
      },
      {
        "variant": "rs1799782",
        "gene": "XRCC1",
        "level": "3",
        "phenotypes": "Carcinoma, Squamous Cell,Overall survival"
      },
      {
        "variant": "rs3219489",
        "gene": "MUTYH",
        "level": "3",
        "phenotypes": "Carcinoma, Squamous Cell,Progression-free survival"
      },
      {
        "variant": "rs9344",
        "gene": "CCND1",
        "level": "3",
        "phenotypes": "Colonic Neoplasms"
      },
      {
        "variant": "rs9561778",
        "gene": "ABCC4",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neoplasms"
      },
      {
        "variant": "rs568367673",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs187713395",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs527580106",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs570122671",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs367619008",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs376073289",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs140039091",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs369103276",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs758649719",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs372307932",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs201268750",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs528152707",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs536577604",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs558354142",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs538703919",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs538336580",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs140989814",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs374527058",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs371258350",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs368146607",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs548783838",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs575853463",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs569661196",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs374825099",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs755416212",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs143004875",
        "gene": "DPYS",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs2016520",
        "gene": "PPARD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs895819",
        "gene": "MIR27A",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Rectal Neoplasms"
      },
      {
        "variant": "rs2960436",
        "gene": "",
        "level": "3",
        "phenotypes": "Stomach Neoplasms"
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "4",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Neoplasm of esophagus"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "4",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs3918290",
        "gene": "DPYD",
        "level": "4",
        "phenotypes": "Neoplasms"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Testing Required",
        "name": "Annotation of Swissmedic Label for fluorouracil and DPYD"
      },
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for fluorouracil and TYMS"
      },
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for fluorouracil and DPYD"
      },
      {
        "source": "HCSC",
        "level": "Testing Recommended",
        "name": "Annotation of HCSC Label for fluorouracil and DPYD"
      },
      {
        "source": "FDA",
        "level": "Testing Recommended",
        "name": "Annotation of FDA Label for fluorouracil and DPYD"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for fluorouracil"
      }
    ],
    "guidelines": {
      "advice": "An Italian working group comprising the Italian Association of Medical Oncology (AIOM) and the Italian Society of Pharmacology (SIF) has published recommendations for the use of DPYD genotype when prescribing fluoropyrimidines (5-fluorouracil, capecitabine and tegafur).\n",
      "source": "AIOM"
    }
  },
  "anthracyclines and related substances": {
    "genes": [
      "NQO1",
      "SLC28A1",
      "CAT",
      "UGT1A10",
      "SLC28A3",
      "HPR",
      "ABCB1",
      "ADCY2",
      "CYP2D6",
      "EGLN3",
      "FMO2",
      "SLC22A2",
      "CYP4F2",
      "SPG7",
      "CYP4X1",
      "HNMT",
      "UGT1A9",
      "SLC22A17",
      "CBR1",
      "UGT1A8",
      "GPR35",
      "FMO3",
      "SLC10A2",
      "VEGFA",
      "SOD2",
      "ABCC2",
      "ADH7",
      "GSTM1",
      "RARG",
      "HAS3",
      "FLT1",
      "CELF4",
      "SULT2B1",
      "CYP3A5",
      "UGT1A6",
      "ABCB4",
      "UGT1A7",
      "ABCC1",
      "HCG22",
      "ECT2L",
      "EPAS1",
      "GSTP1",
      "NOS3",
      "CBR3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs7853758",
        "gene": "SLC28A3",
        "level": "2B",
        "phenotypes": "Cardiotoxicity"
      },
      {
        "variant": "rs10836235",
        "gene": "CAT",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Neoplasms,Ovarian Neoplasms,Stomach Neoplasms"
      },
      {
        "variant": "rs11155012",
        "gene": "ECT2L",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1056892",
        "gene": "CBR3",
        "level": "3",
        "phenotypes": "Heart Failure,Neoplasms"
      },
      {
        "variant": "rs9024",
        "gene": "CBR1",
        "level": "3",
        "phenotypes": "Cardiomyopathies,Neoplasms"
      },
      {
        "variant": "rs2232228",
        "gene": "HAS3",
        "level": "3",
        "phenotypes": "Cardiomyopathies"
      },
      {
        "variant": "rs885004",
        "gene": "SLC28A3",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs2229774",
        "gene": "RARG",
        "level": "3",
        "phenotypes": "Cardiotoxicity,Neoplasms"
      },
      {
        "variant": "rs1736557",
        "gene": "FMO3",
        "level": "4",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs17583889",
        "gene": "HNMT",
        "level": "4",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs17645700",
        "gene": "",
        "level": "4",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs4261716",
        "gene": "UGT1A6",
        "level": "4",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs6759892",
        "gene": "UGT1A6",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs17863783",
        "gene": "UGT1A6",
        "level": "4",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs729147",
        "gene": "ADH7",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs316019",
        "gene": "SLC22A2",
        "level": "4",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1149222",
        "gene": "ABCB4",
        "level": "4",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs4148808",
        "gene": "ABCB4",
        "level": "4",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs2235047",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs4877847",
        "gene": "SLC28A3",
        "level": "4",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs9514091",
        "gene": "SLC10A2",
        "level": "4",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs7319981",
        "gene": "SLC10A2",
        "level": "4",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs2290271",
        "gene": "SLC28A1",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs4148350",
        "gene": "ABCC1",
        "level": "4",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs2305364",
        "gene": "SLC28A1",
        "level": "4",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs2019604",
        "gene": "SPG7",
        "level": "4",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs2108623",
        "gene": "CYP4F2",
        "level": "4",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs10426377",
        "gene": "SULT2B1",
        "level": "4",
        "phenotypes": "Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "oxaliplatin": {
    "genes": [
      "NQO1",
      "PARD3B",
      "ERCC1",
      "MT1A",
      "KCNE1",
      "KDR",
      "ABCB1",
      "KLC3",
      "ENOSF1",
      "KCNE2",
      "MTHFR",
      "PON1",
      "GSTT1",
      "PTGS2",
      "KRAS",
      "DPYD",
      "MSH6",
      "FARS2",
      "TAC1",
      "CAMK2N1",
      "TYMP",
      "ERCC2",
      "APOBEC2",
      "XRCC1",
      "VEGFA",
      "SELE",
      "SOD2",
      "GCKR",
      "CDA",
      "ABCC2",
      "ARHGEF4",
      "ABCG2",
      "TP53",
      "GSTM1",
      "IGF2BP2",
      "ABCC5",
      "CYP3A4",
      "CCNH",
      "XRCC3",
      "CSMD1",
      "HLA-DRB1",
      "FLT4",
      "FOXC1",
      "SOD3",
      "FLT1",
      "UGT1A1",
      "GNA13",
      "CYP3A5",
      "PIN1",
      "ITGA1",
      "UGT1A6",
      "MGAT4A",
      "CYP2A6",
      "PROM1",
      "SMAD7",
      "AGXT",
      "UGT1A7",
      "KCNQ1",
      "ABCC1",
      "TYMS",
      "ACYP2",
      "BTG4",
      "GSTP1",
      "NOS3",
      "DLEU7"
    ],
    "clinicalVariants": [
      {
        "variant": "rs13181",
        "gene": "ERCC2",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs17626122",
        "gene": "PARD3B",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms,Drug Toxicity"
      },
      {
        "variant": "rs25648",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Stomach Neoplasms"
      },
      {
        "variant": "rs7325568",
        "gene": "",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs662",
        "gene": "PON1",
        "level": "3",
        "phenotypes": "Neoplasms,Stomach Neoplasms"
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Neoplasms,Ovarian Neoplasms,Stomach Neoplasms"
      },
      {
        "variant": "rs699947",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs3917412",
        "gene": "SELE",
        "level": "3",
        "phenotypes": "Colonic Neoplasms"
      },
      {
        "variant": "rs885036",
        "gene": "MGAT4A",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs885036",
        "gene": "MGAT4A",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Colonic Neoplasms"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "UGT1A7*3",
        "gene": "UGT1A7",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "UGT1A6*2a",
        "gene": "UGT1A6",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs5275",
        "gene": "PTGS2",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs2010963",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Colonic Neoplasms"
      },
      {
        "variant": "rs2233678",
        "gene": "PIN1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Colonic Neoplasms"
      },
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs13181",
        "gene": "ERCC2,KLC3",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms,Neoplasm of esophagus,Osteosarcoma,Ovarian Neoplasms,Pancreatic Neoplasms"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms,Gastrointestinal Neoplasms,Non-Small Cell Lung Carcinoma,Ovarian Neoplasms"
      },
      {
        "variant": "GSTM1 non-null, GSTM1 null",
        "gene": "GSTM1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1800566",
        "gene": "NQO1",
        "level": "3",
        "phenotypes": "Metastatic neoplasm,Stomach Neoplasms"
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "4",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "4",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "antiepileptics": {
    "genes": [
      "NQO1",
      "ALDH5A1",
      "CYP2C9",
      "ABCB1",
      "NR3C1",
      "DDX12P",
      "OPRD1",
      "CYP1A1",
      "OPRM1",
      "CPS1",
      "HLA-A",
      "SOD2",
      "CACNA1C",
      "ABCC2",
      "CACNA1H",
      "ABCG2",
      "SCN2A",
      "ABCC5",
      "HLA-B",
      "SCN1A",
      "NANOGP6",
      "NIPAL2",
      "ACE",
      "KCNT1",
      "CACNA1A"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-B*15:02",
        "gene": "HLA-B",
        "level": "2A",
        "phenotypes": "Maculopapular Exanthema,Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Headache Disorders,Migraine with Aura,Migraine without Aura"
      },
      {
        "variant": "HLA-B*58:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs3789243",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs16935279",
        "gene": "",
        "level": "3",
        "phenotypes": "Psychotic Disorder,Schizophrenia"
      },
      {
        "variant": "rs2304016",
        "gene": "SCN2A",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs17183814",
        "gene": "SCN2A",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs3740066",
        "gene": "ABCC2",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2273697",
        "gene": "ABCC2",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Epilepsies, Partial,Epilepsy,Epilepsy, idiopathic generalized"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Epilepsy"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "analgesics and anesthetics": {
    "genes": [
      "NQO1",
      "SOD2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "antibiotics": {
    "genes": [
      "NQO1",
      "KCNE1",
      "ABCB1",
      "LGALS3",
      "SOD2",
      "CACNA1C"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1805128",
        "gene": "KCNE1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11125",
        "gene": "LGALS3",
        "level": "3",
        "phenotypes": "Hypersensitivity"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "antifungals for systemic use": {
    "genes": [
      "NQO1",
      "SOD2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "antimycobacterials": {
    "genes": [
      "NQO1",
      "SOD2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "antithyroid preparations": {
    "genes": [
      "NQO1",
      "HLA-DQA1",
      "HLA-DQB1",
      "FOXF2",
      "KLRC4",
      "SOD2",
      "HLA-B",
      "HLA-DRB1",
      "EHMT2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs199564443",
        "gene": "FOXF2",
        "level": "3",
        "phenotypes": "Agranulocytosis"
      },
      {
        "variant": "rs1071816",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Agranulocytosis"
      },
      {
        "variant": "rs652888",
        "gene": "EHMT2",
        "level": "3",
        "phenotypes": "Agranulocytosis"
      },
      {
        "variant": "HLA-B*08:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Agranulocytosis"
      },
      {
        "variant": "HLA-B*27:05",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Agranulocytosis"
      },
      {
        "variant": "rs111618861",
        "gene": "",
        "level": "3",
        "phenotypes": "Agranulocytosis"
      },
      {
        "variant": "HLA-DRB1*08:03",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Agranulocytosis,Graves Disease"
      },
      {
        "variant": "HLA-B*39:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Agranulocytosis,Graves Disease"
      },
      {
        "variant": "HLA-DQB1*06:01",
        "gene": "HLA-DQB1",
        "level": "3",
        "phenotypes": "Agranulocytosis,Graves Disease"
      },
      {
        "variant": "HLA-DQA1*01:03",
        "gene": "HLA-DQA1",
        "level": "3",
        "phenotypes": "Agranulocytosis,Graves Disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "drugs for treatment of tuberculosis": {
    "genes": [
      "NQO1",
      "ABCC3",
      "ABCC4",
      "HLA-DQA1",
      "CFTR",
      "ABCB1",
      "HPX",
      "CYP2B6",
      "GSTT1",
      "HLA-DQB1",
      "ABCC8",
      "HLA-A",
      "XPO1",
      "SOD2",
      "RIPOR2",
      "UGT2B7",
      "ABCC2",
      "ABCC9",
      "GSTM1",
      "ABCC5",
      "CYP2E1",
      "METTL3",
      "ABCC6",
      "HLA-C",
      "UGT1A1",
      "SLCO1B1",
      "NAT2",
      "METTL14",
      "ABCC10",
      "HMOX1",
      "ABCC13",
      "ABCC1"
    ],
    "clinicalVariants": [
      {
        "variant": "NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16",
        "gene": "NAT2",
        "level": "1B",
        "phenotypes": "Drug-induced liver injury,Toxic liver disease,Tuberculosis"
      },
      {
        "variant": "CYP2E1*1A, CYP2E1*5B",
        "gene": "CYP2E1",
        "level": "3",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "rs3745274",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "HIV infectious disease,Tuberculosis"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "HIV infectious disease,Tuberculosis"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "rs1799929",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "rs10946737",
        "gene": "RIPOR2",
        "level": "3",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "rs4430924",
        "gene": "XPO1",
        "level": "3",
        "phenotypes": "Drug Toxicity,Tuberculosis"
      },
      {
        "variant": "rs3740065",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Toxic liver disease,Tuberculosis"
      },
      {
        "variant": "rs1495741",
        "gene": "",
        "level": "3",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "NAT2*1, NAT2*4, NAT2*6, NAT2*7, NAT2*16",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Drug-induced liver injury,HIV infectious disease,Tuberculosis"
      },
      {
        "variant": "GSTM1 non-null, GSTM1 null",
        "gene": "GSTM1",
        "level": "4",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "GSTT1 non-null, GSTT1 null",
        "gene": "GSTT1",
        "level": "4",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "rs2031920",
        "gene": "CYP2E1",
        "level": "4",
        "phenotypes": "Tuberculosis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "platinum compounds": {
    "genes": [
      "NQO1",
      "ABCC3",
      "ERCC1",
      "ABCB1",
      "KLC3",
      "MLH1",
      "ERCC4",
      "ATP7A",
      "ERCC3",
      "MTHFR",
      "WNT5B",
      "CYP1A1",
      "GSTT1",
      "WIF1",
      "APEX1",
      "YAP1",
      "CDKN2B-AS1",
      "OGG1",
      "SLC22A2",
      "EIF3A",
      "DPYD",
      "POLR1G",
      "PPP1R13L",
      "IGF2",
      "APLF",
      "ERCC2",
      "XPA",
      "XRCC1",
      "DYNC2H1",
      "H19",
      "CDA",
      "WRN",
      "ABCC2",
      "SLC19A1",
      "ABCG2",
      "INS-IGF2",
      "FEN1",
      "CCND1",
      "TP53",
      "HOTTIP",
      "ERCC5",
      "NUP107",
      "HMGB1",
      "GSTM1",
      "AXIN2",
      "HMGB2",
      "MTR",
      "RAD51",
      "XBP1",
      "HLA-DOB",
      "XPC",
      "MALAT1",
      "XRCC3",
      "MDM2",
      "ATP7B",
      "HSPA5",
      "TMEM167A",
      "IL16",
      "HOTAIR",
      "MSH2",
      "IL1B",
      "FASLG",
      "NAT2",
      "CCN4",
      "IGF2-AS",
      "XRCC4",
      "NEIL1",
      "SLC31A1",
      "SLC47A1",
      "MEG3",
      "FAS",
      "RETN",
      "CXXC4",
      "CASP7",
      "MSH3",
      "RRM1",
      "GSTP1",
      "NOS3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs25487",
        "gene": "XRCC1",
        "level": "2B",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs3212986",
        "gene": "ERCC1,POLR1G,PPP1R13L",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs7921977",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2227310",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs12415607",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs4353229",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1127687",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1127687",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs9535828",
        "gene": "ATP7B",
        "level": "3",
        "phenotypes": "Lung Neoplasms"
      },
      {
        "variant": "rs9535826",
        "gene": "ATP7B",
        "level": "3",
        "phenotypes": "Lung Neoplasms"
      },
      {
        "variant": "rs2269577",
        "gene": "XBP1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs3738948",
        "gene": "ERCC3",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1800975",
        "gene": "XPA",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1799801",
        "gene": "ERCC4",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs3213239",
        "gene": "APLF",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs13181",
        "gene": "ERCC2",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs4413407",
        "gene": "CXXC4",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs12819505",
        "gene": "WNT5B",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs10878232",
        "gene": "WIF1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs11868547",
        "gene": "AXIN2",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs4541111",
        "gene": "AXIN2",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1052555",
        "gene": "ERCC2",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs11030918",
        "gene": "RRM1",
        "level": "3",
        "phenotypes": "Mesothelioma"
      },
      {
        "variant": "rs12806698",
        "gene": "RRM1",
        "level": "3",
        "phenotypes": "Mesothelioma"
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Neoplasms,Ovarian Neoplasms,Stomach Neoplasms"
      },
      {
        "variant": "rs7958904",
        "gene": "HOTAIR",
        "level": "3",
        "phenotypes": "Lung Neoplasms"
      },
      {
        "variant": "rs619586",
        "gene": "MALAT1",
        "level": "3",
        "phenotypes": "Lung Neoplasms"
      },
      {
        "variant": "rs2839698",
        "gene": "H19",
        "level": "3",
        "phenotypes": "Lung Neoplasms"
      },
      {
        "variant": "rs6983267",
        "gene": "",
        "level": "3",
        "phenotypes": "Lung Neoplasms"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs7091672",
        "gene": "EIF3A",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs4752219",
        "gene": "EIF3A",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs4752220",
        "gene": "EIF3A",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1409314",
        "gene": "EIF3A",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs10510050",
        "gene": "EIF3A",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1799793",
        "gene": "ERCC2",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs50872",
        "gene": "ERCC2",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs7170924",
        "gene": "IL16",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs12621220",
        "gene": "IL1B",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1143623",
        "gene": "IL1B",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1042927",
        "gene": "RRM1",
        "level": "3",
        "phenotypes": "Mesothelioma"
      },
      {
        "variant": "rs73594404",
        "gene": "",
        "level": "3",
        "phenotypes": "Anemia,Dermatitis,Leukopenia,Mucositis,Myelosuppression,Neutropenia,Thrombocytopenia"
      },
      {
        "variant": "rs2027701",
        "gene": "",
        "level": "3",
        "phenotypes": "Anemia,Dermatitis,Leukopenia,Mucositis,Myelosuppression,Neutropenia,Thrombocytopenia"
      },
      {
        "variant": "rs2298881",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Stomach Neoplasms"
      },
      {
        "variant": "rs2228000",
        "gene": "XPC",
        "level": "3",
        "phenotypes": "Gastrointestinal toxicity,Hematologic Disorder,Leukopenia,Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs10040363",
        "gene": "XRCC4",
        "level": "3",
        "phenotypes": "Stomach Neoplasms"
      },
      {
        "variant": "rs12806698",
        "gene": "RRM1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1829346",
        "gene": "",
        "level": "3",
        "phenotypes": "Nasopharyngeal Neoplasms"
      },
      {
        "variant": "rs2075685",
        "gene": "TMEM167A,XRCC4",
        "level": "3",
        "phenotypes": "Stomach Neoplasms"
      },
      {
        "variant": "rs36080650",
        "gene": "",
        "level": "3",
        "phenotypes": "Nasopharyngeal Neoplasms"
      },
      {
        "variant": "rs861539",
        "gene": "XRCC3",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs4979223",
        "gene": "SLC31A1",
        "level": "3",
        "phenotypes": "Overall survival,Thrombocytopenia"
      },
      {
        "variant": "rs4978536",
        "gene": "SLC31A1",
        "level": "3",
        "phenotypes": "Thrombocytopenia"
      },
      {
        "variant": "rs2233914",
        "gene": "SLC31A1",
        "level": "3",
        "phenotypes": "Drug Toxicity,Overall survival"
      },
      {
        "variant": "rs10817464",
        "gene": "SLC31A1",
        "level": "3",
        "phenotypes": "Anemia,Leukopenia,Nausea,Neutropenia,Thrombocytopenia,Vomiting"
      },
      {
        "variant": "rs1690924",
        "gene": "MDM2",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1051266",
        "gene": "SLC19A1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1799793",
        "gene": "ERCC2",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Pneumonitis"
      },
      {
        "variant": "rs1799793",
        "gene": "ERCC2",
        "level": "3",
        "phenotypes": "adverse events,Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs316019",
        "gene": "SLC22A2",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs10759637",
        "gene": "SLC31A1",
        "level": "3",
        "phenotypes": "Overall survival,Thrombocytopenia"
      },
      {
        "variant": "rs13181",
        "gene": "ERCC2,KLC3",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms,Neoplasm of esophagus,Osteosarcoma,Ovarian Neoplasms,Pancreatic Neoplasms"
      },
      {
        "variant": "rs1042522",
        "gene": "TP53",
        "level": "3",
        "phenotypes": "Overall survival"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms,Gastrointestinal Neoplasms,Non-Small Cell Lung Carcinoma,Ovarian Neoplasms"
      },
      {
        "variant": "rs716274",
        "gene": "DYNC2H1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "GSTM1 non-null, GSTM1 null",
        "gene": "GSTM1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1800566",
        "gene": "NQO1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs430397",
        "gene": "HSPA5",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1059698",
        "gene": "",
        "level": "3",
        "phenotypes": "Anemia,Dermatitis,Mucositis,Myelosuppression,Nasopharyngeal Neoplasms,Neutropenia,Thrombocytopenia"
      },
      {
        "variant": "rs10132552",
        "gene": "MEG3",
        "level": "3",
        "phenotypes": "Anemia,Dermatitis,Leukopenia,Mucositis,Myelosuppression,Neutropenia,Thrombocytopenia"
      },
      {
        "variant": "rs1799782",
        "gene": "XRCC1",
        "level": "3",
        "phenotypes": "Lung Neoplasms,Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1799793",
        "gene": "ERCC2",
        "level": "4",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs3212986",
        "gene": "ERCC1",
        "level": "4",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Ovarian Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fec100": {
    "genes": [
      "NQO1",
      "ALDH1A1",
      "DPYD",
      "PPCDC"
    ],
    "clinicalVariants": [
      {
        "variant": "rs147451859",
        "gene": "PPCDC",
        "level": "3",
        "phenotypes": "Amenorrhea"
      },
      {
        "variant": "rs17587029",
        "gene": "",
        "level": "3",
        "phenotypes": "Amenorrhea"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cisplatin": {
    "genes": [
      "NQO1",
      "ABCC3",
      "ABCC4",
      "ERCC1",
      "REV1",
      "CSNK2A3",
      "GSTA1",
      "SLC22A1",
      "IL6",
      "KDR",
      "ABCB1",
      "REV3L",
      "WFS1",
      "KLC3",
      "ENOSF1",
      "SYNE3",
      "MECP2",
      "ACSS2",
      "CYBA",
      "NRAS",
      "LARP1B",
      "MTHFR",
      "GSTT1",
      "MTHFD1",
      "MAP3K1",
      "APEX1",
      "PIK3CA",
      "OGG1",
      "SEMA6A",
      "SLC22A2",
      "SPTAN1",
      "EIF3A",
      "GALNT14",
      "DPYD",
      "POLR1G",
      "PPP1R13L",
      "BLMH",
      "DCBLD1",
      "RARS1",
      "NHLH1",
      "UGT1A9",
      "EPO",
      "TYMP",
      "ERCC2",
      "PPARD",
      "GALNT18",
      "TPMT",
      "CERS6",
      "DDX25",
      "AQP1",
      "XRCC1",
      "LIG3",
      "ABCB5",
      "EPHX1",
      "VEGFA",
      "SOD2",
      "UGT2B7",
      "DUX1",
      "TRPA1",
      "RAF1",
      "CDA",
      "ABCC2",
      "CLCN6",
      "SLC19A1",
      "PTEN",
      "WWOX",
      "AKT1",
      "CCND1",
      "TP53",
      "ERCC5",
      "GSTM1",
      "ABCC5",
      "MTR",
      "MYO1H",
      "CCL2",
      "GSTM3",
      "CYP2E1",
      "CYP3A4",
      "C18orf56",
      "XPC",
      "TLR4",
      "MIR335",
      "XRCC3",
      "LRP2",
      "CYP24A1",
      "FLT4",
      "TNF",
      "CD274",
      "MUTYH",
      "CDH13",
      "HIF1A",
      "TRAF3IP2-AS1",
      "CYP2C8",
      "OSGEP",
      "OTOS",
      "SLC16A5",
      "CYP1B1",
      "FLT1",
      "CASP3",
      "TMEM43",
      "UGT1A1",
      "MSH2",
      "CMPK1",
      "CYP3A5",
      "AKT2",
      "FASLG",
      "NAT2",
      "GSTM4",
      "UBE2I",
      "SLC31A1",
      "GPX5",
      "MTOR",
      "TRAF3IP2",
      "GNAS",
      "MLLT3",
      "RRM1",
      "TYMS",
      "GGT1",
      "NFE2L2",
      "COMT",
      "ACYP2",
      "RAD52",
      "ADH1C",
      "ALDH2",
      "GSTP1",
      "ESR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs1799735",
        "gene": "GSTM3",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs4148416",
        "gene": "ABCC3",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs6413432",
        "gene": "CYP2E1",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs2070676",
        "gene": "CYP2E1",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs1130214",
        "gene": "AKT1",
        "level": "3",
        "phenotypes": "Lung Neoplasms"
      },
      {
        "variant": "rs12659",
        "gene": "SLC19A1",
        "level": "3",
        "phenotypes": "Uterine Cervical Neoplasm"
      },
      {
        "variant": "GSTM1 non-null, GSTM1 null",
        "gene": "GSTM1",
        "level": "3",
        "phenotypes": "Deafness,Ototoxicity,Testicular Neoplasms"
      },
      {
        "variant": "rs3740556",
        "gene": "EIF3A",
        "level": "3",
        "phenotypes": "Lung Neoplasms"
      },
      {
        "variant": "rs17574269",
        "gene": "DCBLD1",
        "level": "3",
        "phenotypes": "Small cell carcinoma"
      },
      {
        "variant": "rs16950650",
        "gene": "ABCC4",
        "level": "3",
        "phenotypes": "Small cell carcinoma"
      },
      {
        "variant": "rs2494752",
        "gene": "AKT1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs25648",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Stomach Neoplasms"
      },
      {
        "variant": "rs7851395",
        "gene": "SLC31A1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs726501",
        "gene": "MAP3K1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7186128",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1051740",
        "gene": "EPHX1",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs698",
        "gene": "ADH1C",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs1142345",
        "gene": "TPMT",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs3219484",
        "gene": "MUTYH",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs1801280",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs1052536",
        "gene": "LIG3",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs1138272",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs462779",
        "gene": "REV3L",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs3087403",
        "gene": "REV1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs1065634",
        "gene": "NRAS",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs11710163",
        "gene": "RAF1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs12118636",
        "gene": "",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs16886403",
        "gene": "MAP3K1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs17309872",
        "gene": "ACSS2",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs17661089",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs451774",
        "gene": "GPX5",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs4492666",
        "gene": "CMPK1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2284449",
        "gene": "RRM1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs720106",
        "gene": "RRM1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs232043",
        "gene": "RRM1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2228171",
        "gene": "LRP2",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs2699887",
        "gene": "PIK3CA",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2299939",
        "gene": "PTEN",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2498804",
        "gene": "",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs12613732",
        "gene": "GALNT14",
        "level": "3",
        "phenotypes": "Hepatocellular Carcinoma"
      },
      {
        "variant": "rs3957357",
        "gene": "GSTA1",
        "level": "3",
        "phenotypes": "Anemia,Ovarian Neoplasms"
      },
      {
        "variant": "rs9597",
        "gene": "UBE2I",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs7937567",
        "gene": "CSNK2A3,GALNT18",
        "level": "3",
        "phenotypes": "Urinary Bladder Neoplasms"
      },
      {
        "variant": "rs10964552",
        "gene": "MLLT3",
        "level": "3",
        "phenotypes": "Urinary Bladder Neoplasms"
      },
      {
        "variant": "rs244898",
        "gene": "RARS1",
        "level": "3",
        "phenotypes": "Urinary Bladder Neoplasms"
      },
      {
        "variant": "TPMT*1, TPMT*3A",
        "gene": "TPMT",
        "level": "3",
        "phenotypes": "Ototoxicity"
      },
      {
        "variant": "rs1800460",
        "gene": "TPMT",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs10981694",
        "gene": "SLC31A1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs4646316",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Drug Toxicity,Neoplasms,Ototoxicity"
      },
      {
        "variant": "rs9332377",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Drug Toxicity,Neoplasms,Ototoxicity"
      },
      {
        "variant": "rs4646316",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Neoplasms,Nephrotoxicity"
      },
      {
        "variant": "rs9332377",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Neoplasms,Nephrotoxicity"
      },
      {
        "variant": "rs3212986",
        "gene": "ERCC1,POLR1G,PPP1R13L",
        "level": "3",
        "phenotypes": "Mesothelioma"
      },
      {
        "variant": "rs2273697",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Mesothelioma"
      },
      {
        "variant": "rs13181",
        "gene": "ERCC2,KLC3",
        "level": "3",
        "phenotypes": "Mesothelioma"
      },
      {
        "variant": "rs4148737",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1805087",
        "gene": "MTR",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Testicular Neoplasms,Vomiting"
      },
      {
        "variant": "rs2740574",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Alopecia,Testicular Neoplasms"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Infectious disease,Nausea,Testicular Neoplasms"
      },
      {
        "variant": "rs1050565",
        "gene": "BLMH",
        "level": "3",
        "phenotypes": "Alopecia,Pain,Testicular Neoplasms"
      },
      {
        "variant": "rs13181",
        "gene": "ERCC2",
        "level": "3",
        "phenotypes": "Alopecia,Testicular Neoplasms"
      },
      {
        "variant": "rs1799793",
        "gene": "ERCC2",
        "level": "3",
        "phenotypes": "Anemia,Testicular Neoplasms"
      },
      {
        "variant": "rs238406",
        "gene": "ERCC2",
        "level": "3",
        "phenotypes": "Leukopenia,Testicular Neoplasms"
      },
      {
        "variant": "rs3212986",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Testicular Neoplasms,Vomiting"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Febrile neutropenia,Testicular Neoplasms"
      },
      {
        "variant": "rs28362731",
        "gene": "AQP1",
        "level": "3",
        "phenotypes": "Thrombocytopenia"
      },
      {
        "variant": "rs1049305",
        "gene": "AQP1",
        "level": "3",
        "phenotypes": "Alopecia,Mesothelioma"
      },
      {
        "variant": "rs1049305",
        "gene": "AQP1",
        "level": "3",
        "phenotypes": "Anemia,Mesothelioma"
      },
      {
        "variant": "rs1049305",
        "gene": "AQP1",
        "level": "3",
        "phenotypes": "Leukopenia,Mesothelioma"
      },
      {
        "variant": "rs316019",
        "gene": "SLC22A2",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs6025211",
        "gene": "",
        "level": "3",
        "phenotypes": "Liver cancer"
      },
      {
        "variant": "rs9679162",
        "gene": "GALNT14",
        "level": "3",
        "phenotypes": "Liver cancer"
      },
      {
        "variant": "rs2291767",
        "gene": "OTOS",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs12201199",
        "gene": "TPMT",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs316019",
        "gene": "SLC22A2",
        "level": "3",
        "phenotypes": "Ototoxicity"
      },
      {
        "variant": "rs1051640",
        "gene": "ABCC3",
        "level": "3",
        "phenotypes": "Drug Toxicity,Neoplasms,Ototoxicity"
      },
      {
        "variant": "rs4788863",
        "gene": "SLC16A5",
        "level": "3",
        "phenotypes": "Neoplasms,Ototoxicity,Testicular Neoplasms"
      },
      {
        "variant": "rs3212986",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs36120609",
        "gene": "GSTM3",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs13181",
        "gene": "ERCC2,KLC3",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms,Neoplasm of esophagus,Osteosarcoma,Ovarian Neoplasms,Pancreatic Neoplasms"
      },
      {
        "variant": "rs2228001",
        "gene": "XPC",
        "level": "3",
        "phenotypes": "Neoplasms,Osteosarcoma,Ototoxicity,Testicular Neoplasms"
      },
      {
        "variant": "rs2228001",
        "gene": "TMEM43,XPC",
        "level": "3",
        "phenotypes": "Neutropenia,Urinary Bladder Neoplasms"
      },
      {
        "variant": "rs2228001",
        "gene": "TMEM43,XPC",
        "level": "3",
        "phenotypes": "Drug Toxicity,Urinary Bladder Neoplasms"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms,Gastrointestinal Neoplasms,Non-Small Cell Lung Carcinoma,Ovarian Neoplasms"
      },
      {
        "variant": "GSTM1 non-null, GSTM1 null",
        "gene": "GSTM1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Medulloblastoma,Neoplasms,Ototoxicity,Testicular Neoplasms"
      },
      {
        "variant": "rs9679162",
        "gene": "GALNT14",
        "level": "3",
        "phenotypes": "Hepatocellular Carcinoma,Liver cancer"
      },
      {
        "variant": "rs1760944",
        "gene": "APEX1,OSGEP",
        "level": "3",
        "phenotypes": "Carcinoma, Squamous Cell,Overall survival"
      },
      {
        "variant": "rs1799782",
        "gene": "XRCC1",
        "level": "3",
        "phenotypes": "Carcinoma, Squamous Cell,Overall survival"
      },
      {
        "variant": "rs3219489",
        "gene": "MUTYH",
        "level": "3",
        "phenotypes": "Carcinoma, Squamous Cell,Progression-free survival"
      },
      {
        "variant": "rs2236225",
        "gene": "MTHFD1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "GSTT1 non-null, GSTT1 null",
        "gene": "GSTT1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs9344",
        "gene": "CCND1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Mucositis,Osteosarcoma"
      },
      {
        "variant": "rs4673",
        "gene": "CYBA",
        "level": "3",
        "phenotypes": "Anemia,Mucositis,Osteosarcoma"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Cardiotoxicity,Osteosarcoma"
      },
      {
        "variant": "rs1801133",
        "gene": "CLCN6,MTHFR",
        "level": "3",
        "phenotypes": "Nephrotoxicity,Osteosarcoma"
      },
      {
        "variant": "rs13181",
        "gene": "ERCC2",
        "level": "3",
        "phenotypes": "Nephrotoxicity,Osteosarcoma"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Neoplasm of esophagus,Ovarian Neoplasms,Stomach Neoplasms"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Pancreatic Neoplasms"
      },
      {
        "variant": "rs3212980",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs2336219",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs9344",
        "gene": "CCND1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs1142345",
        "gene": "TPMT",
        "level": "3",
        "phenotypes": "Drug Toxicity,Neoplasms,Ototoxicity"
      },
      {
        "variant": "rs2207396",
        "gene": "ESR1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1049305",
        "gene": "AQP1",
        "level": "3",
        "phenotypes": "Mesothelioma,Thrombocytopenia"
      },
      {
        "variant": "rs1872328",
        "gene": "ACYP2",
        "level": "3",
        "phenotypes": "Brain Neoplasms,Hearing Loss,Ototoxicity"
      },
      {
        "variant": "rs11226",
        "gene": "RAD52",
        "level": "4",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "GSTT1 non-null, GSTT1 null",
        "gene": "GSTT1",
        "level": "4",
        "phenotypes": "Deafness,Neoplasms,Ototoxicity"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Neoplasm of esophagus"
      },
      {
        "variant": "rs2075252",
        "gene": "LRP2",
        "level": "4",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs3212986",
        "gene": "ERCC1",
        "level": "4",
        "phenotypes": "Neoplasm of esophagus,Ovarian Neoplasms,Stomach Neoplasms"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for cisplatin and TPMT"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for cisplatin"
      }
    ],
    "guidelines": {
      "advice": "The Canadian Pharmacogenomics Network for Drug Safety (CPNDS) clinical recommendation group has published guidelines for the use of pharmacogenetic testing for TPMT gene variants when prescribing cisplatin in pediatric cancer patients. They recommend testing for the TPMT alleles *2, *3A, *3B or *3C in all pediatric cancer patients due to the association of these alleles with an increased risk of cisplatin-induced ototoxicity.\n",
      "source": "CPNDS"
    }
  },
  "clozapine": {
    "genes": [
      "NQO1",
      "INSIG2",
      "POR",
      "LEPR",
      "CYP3A43",
      "ITIH3",
      "DRD2",
      "DTNBP1",
      "ABCB1",
      "HTR1A",
      "HTR2C",
      "ELAVL2",
      "SH2B1",
      "PPARA",
      "PRKAB2",
      "AOC1",
      "CYP2D6",
      "MTHFR",
      "DRD1",
      "CYP1A1",
      "MIR1912",
      "GSTT1",
      "MC4R",
      "CYP2C19",
      "C3",
      "HLA-DQB1",
      "CYP2C18",
      "UGT1A4",
      "PRKAA2",
      "SLC6A3",
      "HNMT",
      "GRIN2B",
      "FKBP5",
      "HLA-DRB5",
      "TRAT1",
      "SLC6A4",
      "GPX1",
      "EPM2A",
      "CHRM1",
      "HTR2A",
      "GLP1R",
      "SOD2",
      "UGT2B7",
      "TRAC",
      "APOE",
      "CNR1",
      "ABCG2",
      "GRIN1",
      "MIR1264",
      "GCG",
      "AGT",
      "ANKK1",
      "TACR1",
      "GSTM1",
      "LEP",
      "FAAH",
      "NFIB",
      "CYP3A4",
      "ACKR1",
      "DRD4",
      "CCKBR",
      "HLA-B",
      "OXT",
      "LEPROT",
      "HRH1",
      "HLA-DRB1",
      "TNF",
      "HLA-DPB1",
      "HLA-DRB3",
      "HTR3A",
      "ERBB4",
      "GFRA2",
      "HLA-C",
      "UGT1A1",
      "CYP3A5",
      "NTRK2",
      "DRD3",
      "NQO2",
      "ACE",
      "CYP1A2",
      "ABCC1",
      "COMT",
      "MPO",
      "SLC1A1",
      "RABEP1",
      "UGT2B10",
      "PPARG",
      "GSTP1",
      "TBC1D1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs6280",
        "gene": "DRD3",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs742105",
        "gene": "DTNBP1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1079598",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs6277",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1150226",
        "gene": "HTR3A",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs7787082",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs10248420",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1062613",
        "gene": "HTR3A",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2276302",
        "gene": "HTR3A",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs13429709",
        "gene": "GCG",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs9852",
        "gene": "TBC1D1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs10465180",
        "gene": "NTRK2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1778929",
        "gene": "NTRK2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1360780",
        "gene": "FKBP5",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs4436578",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "HLA-DRB3*02:02",
        "gene": "HLA-DRB3",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Schizoaffective disorder,Schizophrenia"
      },
      {
        "variant": "rs6295",
        "gene": "HTR1A",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs324420",
        "gene": "FAAH",
        "level": "3",
        "phenotypes": "Psychotic Disorder"
      },
      {
        "variant": "rs806378",
        "gene": "CNR1",
        "level": "3",
        "phenotypes": "Autism Spectrum Disorder,Schizophrenia"
      },
      {
        "variant": "rs1072388",
        "gene": "GRIN2B",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs265976",
        "gene": "DRD1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1415744",
        "gene": "EPM2A",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2975226",
        "gene": "SLC6A3",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2535629",
        "gene": "ITIH3",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "GSTM1 non-null, GSTM1 null",
        "gene": "GSTM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "GSTT1 non-null, GSTT1 null",
        "gene": "GSTT1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs149104283",
        "gene": "",
        "level": "3",
        "phenotypes": "Neutropenia"
      },
      {
        "variant": "rs2277984",
        "gene": "C3",
        "level": "3",
        "phenotypes": "Metabolic Syndrome"
      },
      {
        "variant": "rs3888190",
        "gene": "SH2B1",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depressive Disorder,Psychotic Disorder,Schizoaffective disorder"
      },
      {
        "variant": "rs1000940",
        "gene": "RABEP1",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depressive Disorder,Psychotic Disorder,Schizoaffective disorder"
      },
      {
        "variant": "UGT1A1*1, UGT1A1*28",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3813929",
        "gene": "HTR2C",
        "level": "3",
        "phenotypes": "Mental Disorders,Schizophrenia"
      },
      {
        "variant": "rs1414334",
        "gene": "HTR2C",
        "level": "3",
        "phenotypes": "Metabolic Syndrome,Schizophrenia"
      },
      {
        "variant": "rs28379954",
        "gene": "NFIB",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs11872992",
        "gene": "MC4R",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2268639",
        "gene": "GLP1R",
        "level": "3",
        "phenotypes": "Schizophrenia,Weight gain"
      },
      {
        "variant": "HLA-DRB1*04:02",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Agranulocytosis"
      },
      {
        "variant": "rs72547516",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs762551",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs762551",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": "Schizophrenia,Seizures"
      },
      {
        "variant": "CYP1A2*1, CYP1A2*8",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for clozapine"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for clozapine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "There is no gene-drug interaction between CYP1A2 and clozapine.\n",
      "source": "DPWG"
    }
  },
  "cyclophosphamide": {
    "genes": [
      "NQO1",
      "FBXO21",
      "ABCC3",
      "ABCC4",
      "ERCC1",
      "TUBB2A",
      "SLC28A3",
      "CYP2C9",
      "GSTA1",
      "RAB27A",
      "RRM2B",
      "RBX1",
      "HLA-DQA1",
      "MIR146A",
      "ABCB1",
      "KLC3",
      "HMMR",
      "CYBA",
      "GATA3",
      "TOP2A",
      "CYP2B6",
      "MCPH1",
      "MTHFR",
      "EGLN3",
      "CYP1A1",
      "GSTT1",
      "ALDH1A1",
      "CYP2C19",
      "NOS1",
      "TNRC6B",
      "TNFSF13B",
      "HLA-DQB1",
      "PERP",
      "FCGR3A",
      "DOP1B",
      "DPYD",
      "BMP7",
      "CYP4X1",
      "MIR423",
      "MIR577",
      "ATM",
      "ALDH3A1",
      "ERCC2",
      "CXCL12",
      "TPMT",
      "PIK3R2",
      "CBR1",
      "PPP2R5D",
      "PNPLA3",
      "FGFR4",
      "MIR449B",
      "XRCC1",
      "FOXO1",
      "LIG3",
      "GEMIN4",
      "EPHX1",
      "VEGFA",
      "SOD2",
      "UGT2B7",
      "DUX1",
      "MIR2053",
      "ABCC2",
      "NR1I2",
      "XPO5",
      "ABCG2",
      "TP53",
      "ERCC5",
      "CXCR2",
      "IRS1",
      "TP53AIP1",
      "GSTM1",
      "MTR",
      "CYP2A7P1",
      "GSTM3",
      "ATF5",
      "CYP2E1",
      "CYP3A4",
      "C18orf56",
      "MIR1206",
      "MIR1307",
      "CPT1A",
      "HLA-DRB1",
      "METTL3",
      "MIR3117",
      "EPHA6",
      "SPIDR",
      "TNRC6A",
      "MIR4268",
      "RAC2",
      "MUTYH",
      "MISP",
      "IL8",
      "MIR604",
      "FCGR2A",
      "AGO1",
      "CYP2C8",
      "CTH",
      "DOK5",
      "IKZF3",
      "CYP1B1",
      "FLT1",
      "IL10",
      "LINC00251",
      "MIR492",
      "UGT1A1",
      "MIR300",
      "CYP3A5",
      "C5orf22",
      "PIGB",
      "SLCO1B1",
      "NAT2",
      "CYP2A6",
      "DDX20",
      "SLC22A16",
      "CCNK",
      "MIR618",
      "INSR",
      "CTNNB1",
      "NQO2",
      "ABCC1",
      "TYMS",
      "IGHMBP2",
      "CNOT1",
      "ZNF215",
      "RAD52",
      "ADH1C",
      "EPAS1",
      "GSTP1",
      "DROSHA",
      "NOS3",
      "CBR3",
      "GNL3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs2279343",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Transplantation"
      },
      {
        "variant": "rs2740574",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs8192709",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Cystitis,Transplantation"
      },
      {
        "variant": "rs2070744",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs3745274",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs3745274",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Hepatic Veno-Occlusive Disease,Transplantation"
      },
      {
        "variant": "rs1799735",
        "gene": "GSTM3",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs4148416",
        "gene": "ABCC3",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs3211371",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs6413432",
        "gene": "CYP2E1",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs2070676",
        "gene": "CYP2E1",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs2010963",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs723685",
        "gene": "SLC22A16",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6151031",
        "gene": "ALDH1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1051740",
        "gene": "EPHX1",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs698",
        "gene": "ADH1C",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs1142345",
        "gene": "TPMT",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs3219484",
        "gene": "MUTYH",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs1801280",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs1052536",
        "gene": "LIG3",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs3824662",
        "gene": "GATA3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2B6*1, CYP2B6*6",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Leukemia, Lymphocytic, Chronic, B-Cell"
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Neoplasms,Ovarian Neoplasms,Stomach Neoplasms"
      },
      {
        "variant": "rs4244285",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Systemic lupus erythematosus"
      },
      {
        "variant": "rs4802101",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Lupus erythematosus"
      },
      {
        "variant": "CYP2B6*1, CYP2B6*6",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Lymphoma, B-Cell"
      },
      {
        "variant": "rs3957356",
        "gene": "GSTA1",
        "level": "3",
        "phenotypes": "Lupus Nephritis"
      },
      {
        "variant": "rs4135385",
        "gene": "CTNNB1",
        "level": "3",
        "phenotypes": "Multiple Myeloma"
      },
      {
        "variant": "rs639174",
        "gene": "DROSHA",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs17021408",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs1891059",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs80223967",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs1801157",
        "gene": "CXCL12",
        "level": "3",
        "phenotypes": "Leukemia, Lymphocytic, Chronic, B-Cell"
      },
      {
        "variant": "rs1056836",
        "gene": "CYP1B1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1570360",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs1056836",
        "gene": "CYP1B1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2229109",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Non-Hodgkin Lymphoma"
      },
      {
        "variant": "rs351855",
        "gene": "FGFR4",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs7254579",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Lupus erythematosus"
      },
      {
        "variant": "rs117532069",
        "gene": "DOK5",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs79085477",
        "gene": "BMP7",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs141059755",
        "gene": "LINC00251",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs3957357",
        "gene": "GSTA1",
        "level": "3",
        "phenotypes": "Anemia,Ovarian Neoplasms"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs12050587",
        "gene": "PIGB",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Leukopenia,Neutropenia"
      },
      {
        "variant": "rs11636687",
        "gene": "",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Leukopenia,Neutropenia"
      },
      {
        "variant": "rs12210538",
        "gene": "SLC22A16",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs115457081",
        "gene": "IRS1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs112242273",
        "gene": "GNL3",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs299293",
        "gene": "HMMR",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs299313",
        "gene": "HMMR",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs117101815",
        "gene": "PERP",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs78428806",
        "gene": "PERP",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs3805945",
        "gene": "PPP2R5D",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs299314",
        "gene": "HMMR",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs9402944",
        "gene": "PERP",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs9389568",
        "gene": "PERP",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs117458836",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs118088833",
        "gene": "TP53AIP1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs149212925",
        "gene": "NOS1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs144991623",
        "gene": "FOXO1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs77769901",
        "gene": "CCNK",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs4968187",
        "gene": "TP53",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs181501757",
        "gene": "TOP2A",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs142244113",
        "gene": "INSR",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs41412545",
        "gene": "INSR",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs118129530",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs56022120",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs117341846",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs117951771",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs148235907",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs138602176",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs150688309",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs79430272",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs55633228",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs148013902",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs145623321",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs58695150",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs8110364",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs74743371",
        "gene": "CBR3",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs141084494",
        "gene": "RBX1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs1143684",
        "gene": "NQO2",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs3957357",
        "gene": "GSTA1",
        "level": "3",
        "phenotypes": "Lymphoma, Large B-Cell, Diffuse"
      },
      {
        "variant": "rs4148737",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs6151031",
        "gene": "ALDH1A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs4244285",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs12721655",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1056836",
        "gene": "CYP1B1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs6907567",
        "gene": "SLC22A16",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs714368",
        "gene": "SLC22A16",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs12248560",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs4244285",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2273697",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs3740066",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1801516",
        "gene": "ATM",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2228100",
        "gene": "ALDH3A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs3212986",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs20572",
        "gene": "CBR1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs25487",
        "gene": "XRCC1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs112783657",
        "gene": "CBR3",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs36120609",
        "gene": "GSTM3",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs4880",
        "gene": "SOD2",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs738409",
        "gene": "PNPLA3",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs9561778",
        "gene": "ABCC4",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Drug Toxicity"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Drug Toxicity"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1800566",
        "gene": "NQO1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs9561778",
        "gene": "ABCC4",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neoplasms"
      },
      {
        "variant": "rs3745274",
        "gene": "CYP2A7P1,CYP2B6",
        "level": "3",
        "phenotypes": "Lupus Nephritis"
      },
      {
        "variant": "rs1021737",
        "gene": "CTH",
        "level": "3",
        "phenotypes": "Hematopoietic stem cell transplantation"
      },
      {
        "variant": "rs25487",
        "gene": "XRCC1",
        "level": "4",
        "phenotypes": "Neoplasms,Ovarian Neoplasms"
      },
      {
        "variant": "rs11226",
        "gene": "RAD52",
        "level": "4",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs3745274",
        "gene": "CYP2A7P1,CYP2B6",
        "level": "4",
        "phenotypes": "Diarrhea,Drug Toxicity,Infectious disease,Lupus Nephritis,Toxic liver disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cytarabine": {
    "genes": [
      "NQO1",
      "ABCC3",
      "ABCC4",
      "SLC28A3",
      "RRM2B",
      "CTPS1",
      "MIR146A",
      "ABCB1",
      "GATA3",
      "CYP1A1",
      "GSTT1",
      "TNRC6B",
      "DCK",
      "RRM2",
      "BMP7",
      "MIR423",
      "MIR577",
      "P2RY12",
      "NT5C2",
      "RAD50",
      "GLI1",
      "TPMT",
      "PNPLA3",
      "MIR449B",
      "XRCC1",
      "GEMIN4",
      "MIR2053",
      "CDA",
      "XPO5",
      "NME4",
      "GSTM1",
      "ATF5",
      "ARHGAP9",
      "CYP2E1",
      "C18orf56",
      "MIR1206",
      "MIR1307",
      "CPT1A",
      "MIR3117",
      "TNRC6A",
      "MIR4268",
      "NT5C3A",
      "MIR604",
      "AGO1",
      "DOK5",
      "IL10",
      "LINC00251",
      "SULT2B1",
      "MIR492",
      "UGT1A1",
      "MIR300",
      "CMPK1",
      "C5orf22",
      "SLCO1B1",
      "MED12L",
      "DDX20",
      "MIR618",
      "SLC22A12",
      "NQO2",
      "ADH1A",
      "RRM1",
      "TYMS",
      "IGHMBP2",
      "CNOT1",
      "GSTP1",
      "DROSHA",
      "NOS3",
      "CBR3",
      "SLC29A1",
      "BRD10"
    ],
    "clinicalVariants": [
      {
        "variant": "rs532545",
        "gene": "CDA",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute,Neoplasms"
      },
      {
        "variant": "rs532545",
        "gene": "CDA",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid"
      },
      {
        "variant": "rs602950",
        "gene": "CDA",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3215400",
        "gene": "CDA",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs60369023",
        "gene": "CDA",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11231825",
        "gene": "SLC22A12",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs2070673",
        "gene": "CYP2E1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs2302948",
        "gene": "SULT2B1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs2515641",
        "gene": "CYP2E1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs5030743",
        "gene": "RRM2",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs1265138",
        "gene": "RRM2B",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs2898950",
        "gene": "RRM1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs1561876",
        "gene": "RRM1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs1042919",
        "gene": "RRM1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs80143932",
        "gene": "DCK",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs3824662",
        "gene": "GATA3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3750117",
        "gene": "NT5C3A",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs639174",
        "gene": "DROSHA",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs17021408",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs1891059",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs80223967",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs2291075",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs2291075",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs2072671",
        "gene": "CDA",
        "level": "3",
        "phenotypes": "Leukemia,Lymphoma"
      },
      {
        "variant": "rs117532069",
        "gene": "DOK5",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs79085477",
        "gene": "BMP7",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs141059755",
        "gene": "LINC00251",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs2306744",
        "gene": "DCK",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs1130609",
        "gene": "RRM2",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "doxorubicin": {
    "genes": [
      "NQO1",
      "FBXO21",
      "ERBB2",
      "ABCC3",
      "ABCC4",
      "ERCC1",
      "CYP2J2",
      "SLC28A1",
      "SETD4",
      "SLC28A3",
      "GPX3",
      "GSTA1",
      "AKR7A2",
      "ABCB1",
      "KLC3",
      "CYBA",
      "GATA3",
      "TOP2A",
      "CYP2B6",
      "MTHFR",
      "CYP1A1",
      "GSTT1",
      "MTHFD1",
      "ALDH1A1",
      "CYP2C19",
      "SLC22A2",
      "FCGR3A",
      "ETFB",
      "GALNT14",
      "DOP1B",
      "DPYD",
      "G6PD",
      "BMP7",
      "POLR1G",
      "CYP4F2",
      "PPP1R13L",
      "SPG7",
      "COL1A2",
      "HNMT",
      "ATM",
      "ALDH3A1",
      "SLC22A17",
      "AKR1C3",
      "ERCC2",
      "TPMT",
      "CBR1",
      "PNPLA3",
      "GPR35",
      "XRCC1",
      "SLCO6A1",
      "FMO3",
      "SLC10A2",
      "HFE",
      "SOD2",
      "ABCC2",
      "ABCC9",
      "NR1I2",
      "CLCN6",
      "ADH7",
      "ABCG2",
      "CCND1",
      "TP53",
      "SERPINA6",
      "GSTM1",
      "GSTA2",
      "ABCB11",
      "ABCC5",
      "MTR",
      "XDH",
      "GSTM3",
      "CYP3A4",
      "C18orf56",
      "XPC",
      "CPT1A",
      "RARG",
      "SLC13A3",
      "RAC2",
      "FCGR2A",
      "HAS3",
      "CYP2C8",
      "DOK5",
      "CYP1B1",
      "LINC00251",
      "CASP3",
      "TMEM43",
      "SULT2B1",
      "UGT1A1",
      "MSH2",
      "ABCA1",
      "FASLG",
      "SLCO1B1",
      "UGT1A6",
      "ABCC10",
      "SLC22A16",
      "SLC22A7",
      "ABCB4",
      "NQO2",
      "NCF4",
      "ABCC1",
      "TYMS",
      "IGHMBP2",
      "TOP2B",
      "GSTP1",
      "SLCO4C1",
      "NOS3",
      "CBR3",
      "SLC15A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs7853758",
        "gene": "SLC28A3",
        "level": "2B",
        "phenotypes": "Cardiotoxicity"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Multiple Myeloma"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Multiple Myeloma"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs8133052",
        "gene": "CBR3",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs8187710",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Non-Hodgkin Lymphoma"
      },
      {
        "variant": "rs17222723",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Cardiac rhythm disease,Drug Toxicity,Non-Hodgkin Lymphoma"
      },
      {
        "variant": "rs2070744",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs3745274",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs4148416",
        "gene": "ABCC3",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs3211371",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs723685",
        "gene": "SLC22A16",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3824662",
        "gene": "GATA3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3957357",
        "gene": "GSTA1",
        "level": "3",
        "phenotypes": "Sarcoma"
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Neoplasms,Ovarian Neoplasms,Stomach Neoplasms"
      },
      {
        "variant": "rs17021408",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs1891059",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs80223967",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs714368",
        "gene": "SLC22A16",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "GSTM1 non-null, GSTM1 null",
        "gene": "GSTM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2229109",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs2229109",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Non-Hodgkin Lymphoma"
      },
      {
        "variant": "rs20572",
        "gene": "CBR1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs9024",
        "gene": "CBR1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs117532069",
        "gene": "DOK5",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs79085477",
        "gene": "BMP7",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs141059755",
        "gene": "LINC00251",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs12210538",
        "gene": "SLC22A16",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs4673",
        "gene": "CYBA",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs4673",
        "gene": "CYBA",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1883112",
        "gene": "NCF4",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs13058338",
        "gene": "RAC2",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1143684",
        "gene": "NQO2",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs3957357",
        "gene": "GSTA1",
        "level": "3",
        "phenotypes": "Lymphoma, Large B-Cell, Diffuse"
      },
      {
        "variant": "rs4148737",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs6151031",
        "gene": "ALDH1A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs4244285",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs12721655",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1056836",
        "gene": "CYP1B1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs6907567",
        "gene": "SLC22A16",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs714368",
        "gene": "SLC22A16",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs12248560",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs4244285",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2273697",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs3740066",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1801516",
        "gene": "ATM",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2228100",
        "gene": "ALDH3A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs3212986",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs20572",
        "gene": "CBR1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs25487",
        "gene": "XRCC1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2236225",
        "gene": "MTHFD1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "GSTT1 non-null, GSTT1 null",
        "gene": "GSTT1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs9344",
        "gene": "CCND1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Mucositis,Osteosarcoma"
      },
      {
        "variant": "rs4673",
        "gene": "CYBA",
        "level": "3",
        "phenotypes": "Anemia,Mucositis,Osteosarcoma"
      },
      {
        "variant": "rs2228001",
        "gene": "TMEM43,XPC",
        "level": "3",
        "phenotypes": "Infectious disease,Osteosarcoma"
      },
      {
        "variant": "rs3212986",
        "gene": "ERCC1,POLR1G,PPP1R13L",
        "level": "3",
        "phenotypes": "Infectious disease,Leukopenia,Osteosarcoma"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Cardiotoxicity,Osteosarcoma"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Leukopenia,Osteosarcoma"
      },
      {
        "variant": "rs1801133",
        "gene": "CLCN6,MTHFR",
        "level": "3",
        "phenotypes": "Nephrotoxicity,Osteosarcoma"
      },
      {
        "variant": "rs13181",
        "gene": "ERCC2",
        "level": "3",
        "phenotypes": "Nephrotoxicity,Osteosarcoma"
      },
      {
        "variant": "rs1937840",
        "gene": "AKR1C3",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1937840",
        "gene": "AKR1C3",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs9561778",
        "gene": "ABCC4",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neoplasms"
      },
      {
        "variant": "rs9344",
        "gene": "CCND1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs45511401",
        "gene": "ABCC1",
        "level": "3",
        "phenotypes": "Cardiac rhythm disease,Drug Toxicity,Non-Hodgkin Lymphoma"
      },
      {
        "variant": "rs2229774",
        "gene": "RARG",
        "level": "3",
        "phenotypes": "Cardiotoxicity,Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "epirubicin": {
    "genes": [
      "NQO1",
      "ERCC1",
      "TUBB2A",
      "SLC28A3",
      "RAB27A",
      "RRM2B",
      "RBX1",
      "HLA-DQA1",
      "ABCB1",
      "ENOSF1",
      "HMMR",
      "TOP2A",
      "MCPH1",
      "MTHFR",
      "EGLN3",
      "PON1",
      "GSTT1",
      "MDM4",
      "NOS1",
      "TNFSF13B",
      "HLA-DQB1",
      "PERP",
      "DPYD",
      "TYMP",
      "ERCC2",
      "PIK3R2",
      "PPP2R5D",
      "XRCC1",
      "FOXO1",
      "VEGFA",
      "SOD2",
      "UGT2B7",
      "GCKR",
      "CDA",
      "ABCC2",
      "ABCG2",
      "TP53",
      "IRS1",
      "TP53AIP1",
      "GSTM1",
      "IGF2BP2",
      "CYP3A4",
      "C18orf56",
      "HLA-DRB1",
      "RARG",
      "EPHA6",
      "SPIDR",
      "MISP",
      "CYP2C8",
      "SOD3",
      "CYP1B1",
      "FLT1",
      "UGT1A1",
      "CYP3A5",
      "PIGB",
      "SLCO1B1",
      "UGT1A6",
      "CCNK",
      "INSR",
      "KCNQ1",
      "ABCC1",
      "RRM1",
      "TYMS",
      "ZNF215",
      "EPAS1",
      "GSTP1",
      "NOS3",
      "CBR3",
      "GNL3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs662",
        "gene": "PON1",
        "level": "3",
        "phenotypes": "Neoplasms,Stomach Neoplasms"
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Neoplasms,Ovarian Neoplasms,Stomach Neoplasms"
      },
      {
        "variant": "rs1563828",
        "gene": "MDM4",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1056836",
        "gene": "CYP1B1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1056836",
        "gene": "CYP1B1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs12050587",
        "gene": "PIGB",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Leukopenia,Neutropenia"
      },
      {
        "variant": "rs11636687",
        "gene": "",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Leukopenia,Neutropenia"
      },
      {
        "variant": "rs115457081",
        "gene": "IRS1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs112242273",
        "gene": "GNL3",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs299293",
        "gene": "HMMR",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs299313",
        "gene": "HMMR",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs117101815",
        "gene": "PERP",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs78428806",
        "gene": "PERP",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs3805945",
        "gene": "PPP2R5D",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs299314",
        "gene": "HMMR",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs9402944",
        "gene": "PERP",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs9389568",
        "gene": "PERP",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs117458836",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs118088833",
        "gene": "TP53AIP1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs149212925",
        "gene": "NOS1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs144991623",
        "gene": "FOXO1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs77769901",
        "gene": "CCNK",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs4968187",
        "gene": "TP53",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs181501757",
        "gene": "TOP2A",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs142244113",
        "gene": "INSR",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs41412545",
        "gene": "INSR",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs118129530",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs56022120",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs117341846",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs117951771",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs148235907",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs138602176",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs150688309",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs79430272",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs55633228",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs148013902",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs145623321",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs58695150",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs8110364",
        "gene": "PIK3R2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs74743371",
        "gene": "CBR3",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs141084494",
        "gene": "RBX1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs112783657",
        "gene": "CBR3",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Drug Toxicity"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Neutropenia"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1800566",
        "gene": "NQO1",
        "level": "3",
        "phenotypes": "Metastatic neoplasm,Stomach Neoplasms"
      },
      {
        "variant": "rs1800566",
        "gene": "NQO1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "etoposide": {
    "genes": [
      "NQO1",
      "ABCC3",
      "ERCC1",
      "ABCB1",
      "YAP1",
      "BLMH",
      "SLIT1",
      "ERCC2",
      "DYNC2H1",
      "ABCG2",
      "GSTM1",
      "CYP3A4",
      "C18orf56",
      "METTL3",
      "PLA2G6",
      "UGT1A1",
      "SLCO1B1",
      "TYMS",
      "GSTP1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs6539870",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs446112",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs2291075",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs2291075",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Testicular Neoplasms,Vomiting"
      },
      {
        "variant": "rs2740574",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Alopecia,Testicular Neoplasms"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Infectious disease,Nausea,Testicular Neoplasms"
      },
      {
        "variant": "rs1050565",
        "gene": "BLMH",
        "level": "3",
        "phenotypes": "Alopecia,Pain,Testicular Neoplasms"
      },
      {
        "variant": "rs13181",
        "gene": "ERCC2",
        "level": "3",
        "phenotypes": "Alopecia,Testicular Neoplasms"
      },
      {
        "variant": "rs1799793",
        "gene": "ERCC2",
        "level": "3",
        "phenotypes": "Anemia,Testicular Neoplasms"
      },
      {
        "variant": "rs238406",
        "gene": "ERCC2",
        "level": "3",
        "phenotypes": "Leukopenia,Testicular Neoplasms"
      },
      {
        "variant": "rs3212986",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Testicular Neoplasms,Vomiting"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Febrile neutropenia,Testicular Neoplasms"
      },
      {
        "variant": "rs716274",
        "gene": "DYNC2H1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2784917",
        "gene": "SLIT1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "idarubicin": {
    "genes": [
      "NQO1",
      "ABCB1",
      "CYBA",
      "DCK",
      "CYP2E1",
      "RAC2",
      "NT5C3A",
      "SULT2B1",
      "SLCO1B1",
      "SLC22A12",
      "NQO2",
      "NCF4",
      "ADH1A",
      "CBR3",
      "BRD10"
    ],
    "clinicalVariants": [
      {
        "variant": "rs11231825",
        "gene": "SLC22A12",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs2070673",
        "gene": "CYP2E1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs2302948",
        "gene": "SULT2B1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs2515641",
        "gene": "CYP2E1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs80143932",
        "gene": "DCK",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs3750117",
        "gene": "NT5C3A",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs2306744",
        "gene": "DCK",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs4673",
        "gene": "CYBA",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs4673",
        "gene": "CYBA",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1883112",
        "gene": "NCF4",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs13058338",
        "gene": "RAC2",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1883112",
        "gene": "NCF4",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs13058338",
        "gene": "RAC2",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "methotrexate": {
    "genes": [
      "NQO1",
      "ABCC3",
      "ABCC4",
      "BIRC5",
      "UGT1A10",
      "SLC28A3",
      "AMPD1",
      "MIR146A",
      "CNOT4",
      "ABCB1",
      "UGT1A3",
      "KLC3",
      "ENOSF1",
      "GATA3",
      "ADA",
      "FGF14",
      "ENG",
      "C1orf167",
      "CYP2B6",
      "SLC16A7",
      "RFC1",
      "ITPA",
      "MTHFR",
      "GSTT1",
      "MTHFD1",
      "ATIC",
      "TNRC6B",
      "HLA-E",
      "IL12B",
      "HLA-DQB1",
      "FOXP3",
      "TNFAIP3",
      "UGT1A4",
      "FOLH1",
      "RBMS3",
      "DPYD",
      "BMP7",
      "RAVER2",
      "FASTKD3",
      "IMPDH2",
      "KLRC1",
      "GSK3B",
      "MIR423",
      "MIR577",
      "SPECC1L",
      "UGT1A9",
      "SLC22A8",
      "ADORA2A",
      "ERCC2",
      "MTRR",
      "SHMT1",
      "SLCO1B3",
      "TPMT",
      "ADORA3",
      "PNPLA3",
      "UGT1A8",
      "NALCN",
      "FTCDNL1",
      "FGFR4",
      "MIR449B",
      "UGT1A5",
      "PTPRM",
      "NFATC1",
      "GEMIN4",
      "MROH2A",
      "PKD1L2",
      "SOD2",
      "PTPN22",
      "MIR2053",
      "ABCC2",
      "NR1I2",
      "CLCN6",
      "XPO5",
      "SLC19A1",
      "ABCG2",
      "PFDN4",
      "KLRD1",
      "SLC22A11",
      "ATP5F1E",
      "COL18A1",
      "CCND1",
      "FOLR1",
      "GGH",
      "MTR",
      "AHRR",
      "ATF5",
      "FPGS",
      "CYP3A4",
      "C18orf56",
      "UGT1A",
      "DHFR",
      "SLCO1A2",
      "TLR4",
      "SLC22A6",
      "MIR1206",
      "ADORA2A-AS1",
      "MIR1307",
      "CPT1A",
      "SPATA9",
      "HLA-DRB1",
      "NFATC2",
      "METTL3",
      "MIR3117",
      "MIR5189",
      "TNRC6A",
      "MIR4268",
      "HTR3A",
      "MIR604",
      "DDRGK1",
      "SLC46A1",
      "AGO1",
      "SLC22A9",
      "PACSIN2",
      "KIR2DS4",
      "DOK5",
      "HLA-C",
      "IL10",
      "LINC00251",
      "BCOR",
      "MIR492",
      "UGT1A1",
      "MIR300",
      "IMPDH1",
      "C5orf22",
      "CDH2",
      "SLCO1B1",
      "MIR595",
      "POLG",
      "UGT1A6",
      "PYGL",
      "DDX20",
      "JAK1",
      "MIR618",
      "SLC28A2",
      "UGT1A7",
      "HTR3B",
      "ARID5B",
      "MSH3",
      "ABCC1",
      "TYMS",
      "IGHMBP2",
      "CNOT1",
      "PLCG2",
      "GSTP1",
      "DROSHA",
      "NOS3",
      "HLA-G",
      "SLC29A1",
      "CDK9"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1051266",
        "gene": "SLC19A1",
        "level": "2A",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "2A",
        "phenotypes": "Arthritis, Psoriatic,Drug Toxicity,Juvenile Rheumatoid Arthritis,Rheumatoid arthritis"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "2A",
        "phenotypes": "Acute lymphoblastic leukemia,Drug Toxicity,Leukopenia,Lymphoma,Mucositis,Myelosuppression,Neoplasms,Neutropenia,Osteosarcoma,Primary central nervous system lymphoma,Thrombocytopenia,Toxic liver disease"
      },
      {
        "variant": "rs4673993",
        "gene": "ATIC",
        "level": "2B",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs9977268",
        "gene": "SLC19A1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs9345389",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Residual Neoplasm"
      },
      {
        "variant": "rs4888024",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Residual Neoplasm"
      },
      {
        "variant": "rs5760410",
        "gene": "ADORA2A,SPECC1L",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs11545078",
        "gene": "GGH",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs2853539",
        "gene": "TYMS",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs28364006",
        "gene": "ABCC1",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs2238476",
        "gene": "ABCC1",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs17731538",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs246240",
        "gene": "ABCC1",
        "level": "3",
        "phenotypes": "Drug Toxicity,Psoriasis"
      },
      {
        "variant": "rs13120400",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs1544105",
        "gene": "FPGS",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs7992226",
        "gene": "NALCN",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs10821936",
        "gene": "ARID5B",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs4846051",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Drug Toxicity,Rheumatoid arthritis"
      },
      {
        "variant": "rs1800909",
        "gene": "GGH",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs3761422",
        "gene": "ADORA2A",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs2267076",
        "gene": "ADORA2A",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs2070744",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs3758149",
        "gene": "GGH",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1979277",
        "gene": "SHMT1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs4148416",
        "gene": "ABCC3",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs4986790",
        "gene": "TLR4",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1105525",
        "gene": "DHFR",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs6920220",
        "gene": "TNFAIP3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3824662",
        "gene": "GATA3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1476413",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs17421511",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs16853826",
        "gene": "ATIC",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs10197559",
        "gene": "ATIC",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1643650",
        "gene": "DHFR",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs3768142",
        "gene": "MTR",
        "level": "3",
        "phenotypes": "Agranulocytosis"
      },
      {
        "variant": "rs3763980",
        "gene": "SLC16A7",
        "level": "3",
        "phenotypes": "Juvenile Rheumatoid Arthritis"
      },
      {
        "variant": "rs11045872",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs11045821",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs11231809",
        "gene": "SLC22A11",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs246240",
        "gene": "ABCC1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs3784864",
        "gene": "ABCC1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs7317112",
        "gene": "ABCC4",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Neoplasms,Ovarian Neoplasms,Stomach Neoplasms"
      },
      {
        "variant": "rs2231135",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs1650723",
        "gene": "DHFR",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs1053129",
        "gene": "DHFR",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs1059150",
        "gene": "ATP5F1E",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1264457",
        "gene": "HLA-E",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs719235",
        "gene": "GGH",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs7142143",
        "gene": "PYGL",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs639174",
        "gene": "DROSHA",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs17021408",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs1891059",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs80223967",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs10994982",
        "gene": "ARID5B",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs2229109",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs2413739",
        "gene": "PACSIN2",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs61886492",
        "gene": "FOLH1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs351855",
        "gene": "FGFR4",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs117532069",
        "gene": "DOK5",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs79085477",
        "gene": "BMP7",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs141059755",
        "gene": "LINC00251",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs2298383",
        "gene": "ADORA2A,ADORA2A-AS1",
        "level": "3",
        "phenotypes": "Hematologic Neoplasms"
      },
      {
        "variant": "rs2302489",
        "gene": "KLRD1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs7301582",
        "gene": "KLRC1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs3761548",
        "gene": "FOXP3",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs2838958",
        "gene": "SLC19A1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs408626",
        "gene": "DHFR",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs442767",
        "gene": "DHFR",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs7270101",
        "gene": "ITPA",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Leukopenia,Neutropenia"
      },
      {
        "variant": "rs35592",
        "gene": "ABCC1",
        "level": "3",
        "phenotypes": "Psoriasis,Rheumatoid arthritis"
      },
      {
        "variant": "rs4148737",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1127354",
        "gene": "ITPA",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Rheumatoid arthritis"
      },
      {
        "variant": "rs4148324",
        "gene": "UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A5,UGT1A6,UGT1A7,UGT1A8,UGT1A9",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs12505410",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs13120400",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs13137622",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs2838956",
        "gene": "SLC19A1",
        "level": "3",
        "phenotypes": "adverse events,Rheumatoid arthritis"
      },
      {
        "variant": "rs371194629",
        "gene": "HLA-G",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs9895420",
        "gene": "ABCC3",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs1801394",
        "gene": "MTRR",
        "level": "3",
        "phenotypes": "Juvenile Rheumatoid Arthritis,Rheumatoid arthritis"
      },
      {
        "variant": "rs45445694",
        "gene": "C18orf56,TYMS",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs4149081",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs2236624",
        "gene": "ADORA2A",
        "level": "3",
        "phenotypes": "adverse events,Rheumatoid arthritis"
      },
      {
        "variant": "rs2298383",
        "gene": "ADORA2A",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs17004921",
        "gene": "ADORA2A-AS1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs4948496",
        "gene": "ARID5B",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs4948496",
        "gene": "ARID5B",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Leukopenia"
      },
      {
        "variant": "rs11045879",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs2236225",
        "gene": "MTHFD1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "GSTT1 non-null, GSTT1 null",
        "gene": "GSTT1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs9344",
        "gene": "CCND1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs17222723",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Leukopenia,Osteosarcoma"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Cardiotoxicity,Osteosarcoma"
      },
      {
        "variant": "rs1801133",
        "gene": "CLCN6,MTHFR",
        "level": "3",
        "phenotypes": "Nephrotoxicity,Osteosarcoma"
      },
      {
        "variant": "rs13181",
        "gene": "ERCC2",
        "level": "3",
        "phenotypes": "Nephrotoxicity,Osteosarcoma"
      },
      {
        "variant": "rs4880",
        "gene": "SOD2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2236225",
        "gene": "MTHFD1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Mesothelioma"
      },
      {
        "variant": "rs45445694",
        "gene": "TYMS",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Neoplasms"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs3758149",
        "gene": "GGH",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs1051296",
        "gene": "SLC19A1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs1544105",
        "gene": "FPGS",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs70991108",
        "gene": "DHFR",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Drug-induced liver injury,Leukopenia,Thrombocytopenia"
      },
      {
        "variant": "rs11280056",
        "gene": "ENOSF1,TYMS",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Gastrointestinal toxicity,Mucositis,Neutropenia"
      },
      {
        "variant": "rs11280056",
        "gene": "ENOSF1,TYMS",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Rheumatoid arthritis"
      },
      {
        "variant": "rs3758149",
        "gene": "GGH",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs11545077",
        "gene": "GGH",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs11545076",
        "gene": "GGH",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs45445694",
        "gene": "TYMS",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Non-Hodgkin Lymphoma"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Burkitt Lymphoma,Lymphoma, T-Cell"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteosarcoma"
      },
      {
        "variant": "rs4149081",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteosarcoma"
      },
      {
        "variant": "rs2306283",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs4149009",
        "gene": "SLCO1A2",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs1544105",
        "gene": "FPGS",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1051266",
        "gene": "SLC19A1",
        "level": "3",
        "phenotypes": "Drug Toxicity,Rheumatoid arthritis"
      },
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Lymphoma,Mucositis,Osteosarcoma"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Burkitt Lymphoma,Drug Toxicity,Lymphoma, T-Cell"
      },
      {
        "variant": "rs1805087",
        "gene": "MTR",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1805087",
        "gene": "MTR",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1805087",
        "gene": "MTR",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Leukemia,Lymphoma,Osteosarcoma"
      },
      {
        "variant": "rs9344",
        "gene": "CCND1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Lymphoma,Osteosarcoma"
      },
      {
        "variant": "rs9344",
        "gene": "CCND1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs9344",
        "gene": "CCND1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs2236225",
        "gene": "MTHFD1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Anemia,Leukopenia,Mucositis,Non-Hodgkin Lymphoma,Osteosarcoma,Thrombocytopenia,Toxic liver disease"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Drug Toxicity"
      },
      {
        "variant": "rs1801394",
        "gene": "MTRR",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Drug Toxicity,Lymphoma,Osteosarcoma"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Burkitt Lymphoma,Leukemia,Lymphoma,Lymphoma, T-Cell"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Chronic myelogenous leukemia, BCR-ABL1 positive,Graft vs Host Disease,Leukemia"
      },
      {
        "variant": "rs2292596",
        "gene": "AHRR",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "HLA-C*06:02",
        "gene": "HLA-C",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs3740065",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Burkitt Lymphoma,Drug Toxicity,Lymphoma,Mucositis,Non-Small Cell Lung Carcinoma,Osteosarcoma"
      },
      {
        "variant": "rs9516519",
        "gene": "ABCC4",
        "level": "3",
        "phenotypes": "Burkitt Lymphoma"
      },
      {
        "variant": "rs10841753",
        "gene": "SLCO1B1",
        "level": "4",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs7624766",
        "gene": "",
        "level": "4",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1901633",
        "gene": "",
        "level": "4",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs4982133",
        "gene": "",
        "level": "4",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1703794",
        "gene": "",
        "level": "4",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs6506569",
        "gene": "PTPRM",
        "level": "4",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs2650972",
        "gene": "",
        "level": "4",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs6064463",
        "gene": "",
        "level": "4",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs17602729",
        "gene": "AMPD1",
        "level": "4",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "4",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs1051266",
        "gene": "SLC19A1",
        "level": "4",
        "phenotypes": "Acute lymphoblastic leukemia,Neoplasms"
      },
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "4",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs45445694",
        "gene": "C18orf56,TYMS",
        "level": "4",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs1051266",
        "gene": "SLC19A1",
        "level": "4",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs11280056",
        "gene": "TYMS",
        "level": "4",
        "phenotypes": "Drug Toxicity,Hematopoietic stem cell transplantation,Psoriasis,Rheumatoid arthritis,Toxic liver disease"
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "4",
        "phenotypes": "Acute lymphoblastic leukemia,Burkitt Lymphoma,Lymphoma, T-Cell,Osteosarcoma"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "4",
        "phenotypes": "Acute lymphoblastic leukemia,Lymphoid Leukemia"
      },
      {
        "variant": "rs1051266",
        "gene": "SLC19A1",
        "level": "4",
        "phenotypes": "Acute lymphoblastic leukemia,Burkitt Lymphoma,Leukemia,Lymphoma, T-Cell,Neoplasms,Osteosarcoma"
      },
      {
        "variant": "rs2273697",
        "gene": "ABCC2",
        "level": "4",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Juvenile Rheumatoid Arthritis,Rheumatoid arthritis"
      },
      {
        "variant": "rs1805087",
        "gene": "MTR",
        "level": "4",
        "phenotypes": "Acute lymphoblastic leukemia,Brain Diseases,Drug Toxicity,Osteosarcoma"
      },
      {
        "variant": "rs1801394",
        "gene": "FASTKD3,MTRR",
        "level": "4",
        "phenotypes": "Juvenile Rheumatoid Arthritis,Rheumatoid arthritis"
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "4",
        "phenotypes": "Acute lymphoblastic leukemia,Burkitt Lymphoma,Drug Toxicity,Lymphoma, T-Cell,Osteosarcoma"
      },
      {
        "variant": "rs11045879",
        "gene": "SLCO1B1",
        "level": "4",
        "phenotypes": "Acute lymphoblastic leukemia,Lymphoma,Osteosarcoma"
      },
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "4",
        "phenotypes": "Acute lymphoblastic leukemia,Burkitt Lymphoma,Lymphoma, T-Cell,Non-Hodgkin Lymphoma"
      },
      {
        "variant": "rs2372536",
        "gene": "ATIC",
        "level": "4",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs3740065",
        "gene": "ABCC2",
        "level": "4",
        "phenotypes": "Acute lymphoblastic leukemia,Burkitt Lymphoma,Osteosarcoma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for methotrexate dosing based on MTHFR rs1801133 genotypes.\n",
      "source": "DPWG"
    }
  },
  "valproic acid": {
    "genes": [
      "NQO1",
      "ALDH5A1",
      "ABAT",
      "LEPR",
      "UGT1A10",
      "CYP2C9",
      "ACOT1",
      "GABRB2",
      "HDAC1",
      "DRD2",
      "FABP2",
      "ABCB1",
      "UGT1A3",
      "HTR2C",
      "GABPA",
      "SH2B1",
      "PPARA",
      "CYP2B6",
      "CYP2D6",
      "CYP1A1",
      "GSTT1",
      "CYP2C19",
      "UGT1A4",
      "PRKAA2",
      "GRIN2B",
      "UGT1A9",
      "GABRG2",
      "CPS1",
      "SLC6A4",
      "UGT1A8",
      "MOBP",
      "HLA-A",
      "UGT1A5",
      "HTR2A",
      "APEH",
      "SOD2",
      "CACNA1C",
      "UGT2B7",
      "OTC",
      "CACNA1H",
      "SLC16A1",
      "COL1A1",
      "OGDH",
      "SCN2A",
      "CACNA1F",
      "ANKK1",
      "GSTM1",
      "XBP1",
      "CYP3A4",
      "HLA-B",
      "SCN1A",
      "UNC13A",
      "CACNA1D",
      "HDAC9",
      "GABRA1",
      "GABRA3",
      "HLA-C",
      "CYP3A5",
      "POLG",
      "UGT1A6",
      "CYP2A6",
      "GABRA6",
      "NTRK2",
      "HDAC11",
      "UGT1A7",
      "CYP1A2",
      "RABEP1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs6759892",
        "gene": "UGT1A10,UGT1A6,UGT1A7,UGT1A8,UGT1A9",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2070959",
        "gene": "UGT1A10,UGT1A6,UGT1A7,UGT1A8,UGT1A9",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2769605",
        "gene": "",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs4880",
        "gene": "SOD2",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs1137101",
        "gene": "LEPR",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs1800497",
        "gene": "ANKK1",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs3087374",
        "gene": "POLG",
        "level": "3",
        "phenotypes": "Toxic liver disease"
      },
      {
        "variant": "rs1019385",
        "gene": "GRIN2B",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs1800012",
        "gene": "COL1A1",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs1105879",
        "gene": "UGT1A6",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2606345",
        "gene": "CYP1A1",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "UGT1A6*1a, UGT1A6*2a, UGT1A6*3a, UGT1A6*4a, UGT1A6*8",
        "gene": "UGT1A6",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Psychotic Disorder"
      },
      {
        "variant": "rs28898617",
        "gene": "UGT1A10,UGT1A3,UGT1A4,UGT1A5,UGT1A6,UGT1A7,UGT1A8,UGT1A9",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs3888190",
        "gene": "SH2B1",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depressive Disorder,Psychotic Disorder,Schizoaffective disorder"
      },
      {
        "variant": "rs1000940",
        "gene": "RABEP1",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depressive Disorder,Psychotic Disorder,Schizoaffective disorder"
      },
      {
        "variant": "rs2279020",
        "gene": "GABRA1",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs7668258",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs12233719",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs17183814",
        "gene": "SCN2A",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2298771",
        "gene": "SCN1A",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3",
        "gene": "CYP2C19",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs7439366",
        "gene": "UGT2B7",
        "level": "4",
        "phenotypes": "Epilepsy"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for valproic acid and OTC"
      },
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for valproic acid and CPS1, OTC"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for valproic acid and OTC, POLG"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for valproic acid and POLG"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for valproic acid"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "warfarin": {
    "genes": [
      "NQO1",
      "POR",
      "CYP2C9",
      "HNF4A",
      "ABCB1",
      "DNMT3A",
      "ORM2",
      "STX4",
      "FRAS1",
      "CYP1A1",
      "F5",
      "CYP2C19",
      "NEDD4",
      "CYP2C18",
      "CYP4F2",
      "MIR133B",
      "PROCR",
      "APOB",
      "FGFBP2",
      "SLCO1B3",
      "SLC15A2",
      "ORM1",
      "MPZ",
      "EPHX1",
      "VEGFA",
      "CRP",
      "FAM201A",
      "CACNA1C",
      "VKORC1",
      "APOE",
      "NR1I2",
      "PRSS53",
      "GATA4",
      "STX1B",
      "APOC1",
      "FPGS",
      "VDR",
      "CYP3A4",
      "LRP1",
      "CALU",
      "F13A1",
      "NKX2-6",
      "F2",
      "F11",
      "PROC",
      "OPN1SW",
      "ASPH",
      "MYC",
      "EPHA7",
      "UGT1A1",
      "CYP4F11",
      "SLCO1B1",
      "DDHD1",
      "CYP2A6",
      "PROS1",
      "F7",
      "THBD",
      "CYP1A2",
      "NR1I3",
      "VKORC1L1",
      "GGCX"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11",
        "gene": "CYP2C9",
        "level": "1A",
        "phenotypes": "over-anticoagulation"
      },
      {
        "variant": "rs2108622",
        "gene": "CYP4F2",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11",
        "gene": "CYP2C9",
        "level": "1A",
        "phenotypes": "Hemorrhage"
      },
      {
        "variant": "rs12777823",
        "gene": "",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*4, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*11",
        "gene": "CYP2C9",
        "level": "1A",
        "phenotypes": "Cardiovascular Disease"
      },
      {
        "variant": "rs9923231",
        "gene": "VKORC1",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs9923231",
        "gene": "VKORC1",
        "level": "1B",
        "phenotypes": "over-anticoagulation"
      },
      {
        "variant": "rs8050894",
        "gene": "VKORC1",
        "level": "1B",
        "phenotypes": ""
      },
      {
        "variant": "rs9934438",
        "gene": "VKORC1",
        "level": "1B",
        "phenotypes": ""
      },
      {
        "variant": "rs2359612",
        "gene": "VKORC1",
        "level": "1B",
        "phenotypes": ""
      },
      {
        "variant": "rs7294",
        "gene": "VKORC1",
        "level": "1B",
        "phenotypes": ""
      },
      {
        "variant": "rs9923231",
        "gene": "VKORC1",
        "level": "2A",
        "phenotypes": "time to therapeutic inr"
      },
      {
        "variant": "rs9923231",
        "gene": "VKORC1",
        "level": "2A",
        "phenotypes": "time in therapeutic range"
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*13, CYP2C9*14",
        "gene": "CYP2C9",
        "level": "2A",
        "phenotypes": "Atrial Fibrillation,Heart valve replacement"
      },
      {
        "variant": "rs9923231",
        "gene": "VKORC1",
        "level": "2A",
        "phenotypes": "Hemorrhage"
      },
      {
        "variant": "rs2884737",
        "gene": "VKORC1",
        "level": "2A",
        "phenotypes": ""
      },
      {
        "variant": "rs61742245",
        "gene": "VKORC1",
        "level": "2A",
        "phenotypes": ""
      },
      {
        "variant": "rs10871454",
        "gene": "STX4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs104894539",
        "gene": "VKORC1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs104894540",
        "gene": "VKORC1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs104894541",
        "gene": "VKORC1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs104894542",
        "gene": "VKORC1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs17880887",
        "gene": "VKORC1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs9332096",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10509680",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs17886199",
        "gene": "PRSS53,VKORC1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs61162043",
        "gene": "VKORC1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7856096",
        "gene": "FPGS",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7200749",
        "gene": "VKORC1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2592551",
        "gene": "GGCX",
        "level": "3",
        "phenotypes": "Atrial Fibrillation"
      },
      {
        "variant": "rs1042580",
        "gene": "THBD",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1877724",
        "gene": "EPHX1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3212198",
        "gene": "HNF4A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C9*1, CYP2C9*59",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs9934438",
        "gene": "VKORC1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1800566",
        "gene": "NQO1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs9934438",
        "gene": "VKORC1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Atrial Fibrillation"
      },
      {
        "variant": "rs41301394",
        "gene": "POR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs17126068",
        "gene": "DDHD1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2288344",
        "gene": "NEDD4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4379440",
        "gene": "ASPH",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2108622",
        "gene": "CYP4F2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11676382",
        "gene": "GGCX",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs699664",
        "gene": "GGCX",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11676382",
        "gene": "GGCX",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10517",
        "gene": "NQO1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs72800847",
        "gene": "STX1B",
        "level": "3",
        "phenotypes": "Heart valve replacement"
      },
      {
        "variant": "rs3826041",
        "gene": "CYP1A1",
        "level": "3",
        "phenotypes": "Heart valve replacement"
      },
      {
        "variant": "rs2304429",
        "gene": "DNMT3A",
        "level": "3",
        "phenotypes": "Heart valve replacement"
      },
      {
        "variant": "rs4889606",
        "gene": "STX1B",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2189784",
        "gene": "CYP4F2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1060467",
        "gene": "CYP4F11",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4072879",
        "gene": "VKORC1L1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2645400",
        "gene": "GATA4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4841588",
        "gene": "GATA4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11168292",
        "gene": "VDR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11168293",
        "gene": "VDR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4760658",
        "gene": "VDR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs429358",
        "gene": "APOE",
        "level": "3",
        "phenotypes": "Hemorrhage,Venous thromboembolism"
      },
      {
        "variant": "rs887829",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "Heart valve replacement"
      },
      {
        "variant": "rs7412",
        "gene": "APOE",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs429358",
        "gene": "APOE",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs679899",
        "gene": "APOB",
        "level": "3",
        "phenotypes": "Heart valve replacement,Hemorrhage"
      },
      {
        "variant": "rs1367117",
        "gene": "APOB",
        "level": "3",
        "phenotypes": "Heart valve replacement,Hemorrhage"
      },
      {
        "variant": "rs780801862",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C9*1, CYP2C9*29",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs339097",
        "gene": "CALU",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7196161",
        "gene": "VKORC1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs78132896",
        "gene": "EPHA7",
        "level": "3",
        "phenotypes": "Hemorrhage"
      },
      {
        "variant": "rs7089580",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3814637",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3814637",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4917639",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs72547529",
        "gene": "VKORC1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11150606",
        "gene": "VKORC1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1800566",
        "gene": "NQO1",
        "level": "3",
        "phenotypes": "Hemorrhage"
      },
      {
        "variant": "rs1800566",
        "gene": "NQO1",
        "level": "3",
        "phenotypes": "Thrombotic disease"
      },
      {
        "variant": "rs4918758",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11676382",
        "gene": "GGCX",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1131873",
        "gene": "EPHX1",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs2501873",
        "gene": "NR1I3",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs12714145",
        "gene": "GGCX",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs699664",
        "gene": "GGCX",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs2108622",
        "gene": "CYP4F2",
        "level": "4",
        "phenotypes": "over-anticoagulation"
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs17708472",
        "gene": "VKORC1",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs1800566",
        "gene": "NQO1",
        "level": "4",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for warfarin and CYP2C9, VKORC1"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for warfarin and CYP2C9, VKORC1"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for warfarin and PROC, PROS1"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for warfarin and PROC, PROS1"
      }
    ],
    "guidelines": {
      "advice": "Testing for VKORC1/CYP2C9 genotype is advisable to determine the optimal dose and to orient the prescription to an alternative therapeutic option such as a direct-action oral anticoagulant before initiating vitamin K antagonists (VKA) treatment. Testing is also advisable to explain an hemorrhagic event or VKA resistance after treatment initiation.\n",
      "source": "RNPGx"
    }
  },
  "benzene": {
    "genes": [
      "NQO1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "antineoplastic agents": {
    "genes": [
      "NQO1",
      "ABCC4",
      "SLC28A3",
      "CTPS1",
      "ABCB1",
      "NR3C1",
      "CYP2B6",
      "ZNF100",
      "CYP2D6",
      "ITPA",
      "MTHFR",
      "GSTT1",
      "CYP2C19",
      "SPARC",
      "DPYD",
      "AKR1C3",
      "ADORA2A",
      "ANKS1B",
      "SERPINE1",
      "ABCC2",
      "CLCN6",
      "ABCG2",
      "WWOX",
      "TP53",
      "SERPINA3",
      "GGH",
      "GSTM1",
      "FPGS",
      "CYP3A4",
      "UGT1A",
      "RBFOX1",
      "UGT2B15",
      "DCTD",
      "NEU3",
      "GSTM5",
      "CTH",
      "IL10",
      "CYP3A5",
      "NRP2",
      "BCL2L11",
      "HTR3B",
      "ABCC1",
      "TYMS",
      "GSTP1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1760217",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Pancreatic Neoplasms"
      },
      {
        "variant": "rs17091162",
        "gene": "SERPINA3",
        "level": "3",
        "phenotypes": "Pancreatic Neoplasms"
      },
      {
        "variant": "rs6500843",
        "gene": "RBFOX1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1042522",
        "gene": "TP53",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "muraglitazar": {
    "genes": [
      "REN",
      "EDN1",
      "ADRB1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1801253",
        "gene": "ADRB1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus,Edema,Hyperlipidemias"
      },
      {
        "variant": "rs2368564",
        "gene": "REN",
        "level": "3",
        "phenotypes": "Diabetes Mellitus,Edema,Hyperlipidemias"
      },
      {
        "variant": "rs5370",
        "gene": "EDN1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus,Edema,Hyperlipidemias"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "hydrochlorothiazide": {
    "genes": [
      "REN",
      "ADO",
      "NELFCD",
      "SLC22A1",
      "CSK",
      "ADRB1",
      "ABCB1",
      "HMGCS2",
      "NEDD4L",
      "STK39",
      "GNB3",
      "HS3ST4",
      "ERCC6L2",
      "BEST3",
      "PDE3A",
      "YEATS4",
      "CYP11B2",
      "TXNDC11",
      "TET2",
      "ACE2",
      "CAMK1D",
      "SLIT1",
      "FBXL17",
      "PLCE1",
      "NELL1",
      "KCNJ1",
      "WNK1",
      "CSMD3",
      "VASP",
      "ANKFN1",
      "USP5",
      "CDCA3",
      "NUCB2",
      "TCF7L2",
      "C5orf56",
      "LRRC15",
      "AGT",
      "ADD1",
      "GPR83",
      "SH2B3",
      "EBF1",
      "AGTR1",
      "ADRB2",
      "PRKCA",
      "CSMD1",
      "GRK5",
      "SCNN1G",
      "ALDH1A2",
      "DIAPH3",
      "PRKAG2",
      "LUC7L2",
      "FTO",
      "CNTNAP2",
      "ILKAP",
      "TTC6",
      "ACE",
      "UGGT2",
      "HSD3B1",
      "DOT1L",
      "RAD52",
      "SLC25A31",
      "NOS3",
      "FGF5"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4961",
        "gene": "ADD1",
        "level": "2B",
        "phenotypes": "Essential hypertension,Hypertension"
      },
      {
        "variant": "rs12795437",
        "gene": "KCNJ1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus,Hypertension"
      },
      {
        "variant": "rs880054",
        "gene": "WNK1",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs238",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs4791040",
        "gene": "PRKCA",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs4815273",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs2776546",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs11600347",
        "gene": "KCNJ1",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs658903",
        "gene": "KCNJ1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus,Hypertension"
      },
      {
        "variant": "rs10792367",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs4132670",
        "gene": "TCF7L2",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs4506565",
        "gene": "TCF7L2",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs3758785",
        "gene": "GPR83",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs7917983",
        "gene": "TCF7L2",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs113095083",
        "gene": "ILKAP",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs12505746",
        "gene": "TET2",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs7706429",
        "gene": "FBXL17",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs4431329",
        "gene": "FBXL17",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs9285669",
        "gene": "",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs11993031",
        "gene": "CSMD1",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs7387065",
        "gene": "CSMD1",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs11189015",
        "gene": "SLIT1",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs77876672",
        "gene": "DIAPH3",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs9590353",
        "gene": "UGGT2",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs9915451",
        "gene": "ANKFN1",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs12346562",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs11313667",
        "gene": "LRRC15",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs292449",
        "gene": "NEDD4L",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2269879",
        "gene": "DOT1L",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs10995",
        "gene": "VASP",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs9943291",
        "gene": "HMGCS2",
        "level": "3",
        "phenotypes": "Hyperglycemia,Hypertension"
      },
      {
        "variant": "rs61824877",
        "gene": "",
        "level": "3",
        "phenotypes": "Hyperglycemia,Hypertension"
      },
      {
        "variant": "rs2273359",
        "gene": "NELFCD",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs11065987",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs35123024",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs261316",
        "gene": "ALDH1A2",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs4149601",
        "gene": "NEDD4L",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs3784921",
        "gene": "TXNDC11",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs201279313",
        "gene": "SLC25A31",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs757081",
        "gene": "NUCB2",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs12521868",
        "gene": "C5orf56",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1378942",
        "gene": "CSK",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs12579720",
        "gene": "PDE3A",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs932764",
        "gene": "PLCE1",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs10995311",
        "gene": "ADO",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs10224002",
        "gene": "PRKAG2",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs4149601",
        "gene": "NEDD4L",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs16960228",
        "gene": "PRKCA",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs7297610",
        "gene": "YEATS4",
        "level": "3",
        "phenotypes": "Essential hypertension,Hypertension"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vitamin d and analogues": {
    "genes": [
      "REN",
      "UGT1A3",
      "UGT1A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "amisulpride": {
    "genes": [
      "INSIG2",
      "DRD2",
      "ABCB1",
      "HTR1A",
      "HTR2C",
      "SH2B1",
      "CYP2D6",
      "MC4R",
      "ANKS1B",
      "ANKK1",
      "LEP",
      "SNAP25",
      "RABEP1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs10042486",
        "gene": "HTR1A",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1079597",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs7968606",
        "gene": "ANKS1B",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs3888190",
        "gene": "SH2B1",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depressive Disorder,Psychotic Disorder,Schizoaffective disorder"
      },
      {
        "variant": "rs1000940",
        "gene": "RABEP1",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depressive Disorder,Psychotic Disorder,Schizoaffective disorder"
      },
      {
        "variant": "rs489693",
        "gene": "MC4R",
        "level": "3",
        "phenotypes": "Hypertriglyceridemia,Weight gain"
      },
      {
        "variant": "rs17782313",
        "gene": "MC4R",
        "level": "3",
        "phenotypes": "Weight gain"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "olanzapine": {
    "genes": [
      "INSIG2",
      "ADRB3",
      "LEPR",
      "APOC3",
      "CYP3A43",
      "CYP2C9",
      "SLC22A1",
      "DRD2",
      "ABCB1",
      "HTR1A",
      "HTR2C",
      "RGS4",
      "AHR",
      "SH2B1",
      "GNB3",
      "PMCH",
      "PRKAB2",
      "CYP2B6",
      "CYP2D6",
      "MTHFR",
      "CYP1A1",
      "MIR1912",
      "MC4R",
      "CYP2C19",
      "UGT1A4",
      "BDNF",
      "CYP4F2",
      "PRKAA2",
      "PLAGL1",
      "SV2C",
      "SLC6A4",
      "ATP1A2",
      "CHAT",
      "TPMT",
      "RELN",
      "EPM2A",
      "HLA-A",
      "FMO3",
      "FMO1",
      "HTR2A",
      "GLP1R",
      "CACNA1C",
      "IL1A",
      "ABCC2",
      "GIPR",
      "APOE",
      "SPOPL",
      "CNR1",
      "MIR1264",
      "GCG",
      "AGT",
      "ANKK1",
      "LEP",
      "FAAH",
      "GSTM3",
      "CYP3A4",
      "CCKBR",
      "HLA-B",
      "LEPROT",
      "HRH1",
      "CSMD1",
      "EIF2AK4",
      "SLC26A9",
      "CYP2C8",
      "HTR3C",
      "PTPRN2",
      "UGT1A1",
      "CYP3A5",
      "POLG",
      "DRD3",
      "HTR3B",
      "ACE",
      "CYP1A2",
      "COMT",
      "SLC1A1",
      "RABEP1",
      "UGT2B10",
      "PPARG",
      "GSTP1",
      "TBC1D1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs6313",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "Alzheimer Disease"
      },
      {
        "variant": "rs4994",
        "gene": "ADRB3",
        "level": "3",
        "phenotypes": "Schizophrenia,Weight gain"
      },
      {
        "variant": "rs2842030",
        "gene": "RGS4",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs4731426",
        "gene": "LEP",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs951439",
        "gene": "RGS4",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1079598",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs5443",
        "gene": "GNB3",
        "level": "3",
        "phenotypes": "Schizophrenia,Weight gain"
      },
      {
        "variant": "rs6313",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "Schizophrenia,Weight gain"
      },
      {
        "variant": "rs6280",
        "gene": "DRD3",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs762551",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7997012",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6277",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs12720462",
        "gene": "FMO1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2266780",
        "gene": "FMO3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7877",
        "gene": "FMO1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2440390",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Mental Disorders"
      },
      {
        "variant": "rs1414334",
        "gene": "HTR2C",
        "level": "3",
        "phenotypes": "Mental Disorders"
      },
      {
        "variant": "rs10042486",
        "gene": "HTR1A",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs11960832",
        "gene": "SV2C",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1124493",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs13429709",
        "gene": "GCG",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1799735",
        "gene": "GSTM3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1800497",
        "gene": "ANKK1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*6",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": "Hypotensive disorder"
      },
      {
        "variant": "TPMT*1, TPMT*3A, TPMT*3C",
        "gene": "TPMT",
        "level": "3",
        "phenotypes": "Fatigue"
      },
      {
        "variant": "UGT1A1*1, UGT1A1*28",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "Fatigue"
      },
      {
        "variant": "rs9852",
        "gene": "TBC1D1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Psychotic Disorder"
      },
      {
        "variant": "rs7912580",
        "gene": "",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2412459",
        "gene": "EIF2AK4",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs4410790",
        "gene": "AHR",
        "level": "3",
        "phenotypes": "Psychotic Disorder"
      },
      {
        "variant": "rs1880676",
        "gene": "CHAT",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2734841",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2734842",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3810950",
        "gene": "CHAT",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs4436578",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs472660",
        "gene": "CYP3A43",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Schizoaffective disorder,Schizophrenia"
      },
      {
        "variant": "rs6265",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs324420",
        "gene": "FAAH",
        "level": "3",
        "phenotypes": "Psychotic Disorder"
      },
      {
        "variant": "rs806378",
        "gene": "CNR1",
        "level": "3",
        "phenotypes": "Autism Spectrum Disorder,Schizophrenia"
      },
      {
        "variant": "rs1076560",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs10423928",
        "gene": "GIPR",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs6314",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1801282",
        "gene": "PPARG",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1415744",
        "gene": "EPM2A",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs6279",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depression"
      },
      {
        "variant": "rs6275",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depression"
      },
      {
        "variant": "rs7973796",
        "gene": "PMCH",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2472297",
        "gene": "CYP1A1",
        "level": "3",
        "phenotypes": "Psychotic Disorder"
      },
      {
        "variant": "rs11677416",
        "gene": "IL1A",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs3888190",
        "gene": "SH2B1",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depressive Disorder,Psychotic Disorder,Schizoaffective disorder"
      },
      {
        "variant": "rs1000940",
        "gene": "RABEP1",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depressive Disorder,Psychotic Disorder,Schizoaffective disorder"
      },
      {
        "variant": "rs6688363",
        "gene": "ATP1A2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs10170310",
        "gene": "SPOPL",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs6313",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs36120609",
        "gene": "GSTM3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3813929",
        "gene": "HTR2C",
        "level": "3",
        "phenotypes": "Mental Disorders,Schizophrenia"
      },
      {
        "variant": "rs518147",
        "gene": "HTR2C",
        "level": "3",
        "phenotypes": "Schizophrenia,Weight gain"
      },
      {
        "variant": "rs2497538",
        "gene": "HTR2C",
        "level": "3",
        "phenotypes": "Weight gain"
      },
      {
        "variant": "rs34059508",
        "gene": "SLC22A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3842",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10248420",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Somnolence"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Somnolence"
      },
      {
        "variant": "rs5128",
        "gene": "APOC3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4728709",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Asthenia"
      },
      {
        "variant": "rs3842",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Cardiac rhythm disease"
      },
      {
        "variant": "rs11872992",
        "gene": "MC4R",
        "level": "3",
        "phenotypes": "Schizophrenia,Weight gain"
      },
      {
        "variant": "rs2268639",
        "gene": "GLP1R",
        "level": "3",
        "phenotypes": "Schizophrenia,Weight gain"
      },
      {
        "variant": "rs1799978",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1799732",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*3, CYP2D6*4",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Schizophrenia,Weight gain"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "4",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for olanzapine and CYP1A2, CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for olanzapine dosing based on CYP1A2 genotypes.\n",
      "source": "DPWG"
    }
  },
  "quetiapine": {
    "genes": [
      "INSIG2",
      "LEPR",
      "CYP3A43",
      "CYP2C9",
      "DRD2",
      "ABCB1",
      "HTR1A",
      "RIMS1",
      "HTR2C",
      "RGS4",
      "SH2B1",
      "CYP2B6",
      "CYP2D6",
      "MTHFR",
      "MIR1912",
      "MC4R",
      "CYP2C19",
      "UGT1A4",
      "MIR582",
      "GRIN2B",
      "KCNMA1",
      "SV2C",
      "SLC6A4",
      "RELN",
      "EPM2A",
      "HLA-A",
      "HTR2A",
      "CACNA1C",
      "APOE",
      "CNR1",
      "MIR1264",
      "AGT",
      "ANKK1",
      "LEP",
      "FAAH",
      "CYP3A4",
      "HLA-B",
      "LEPROT",
      "EIF2AK4",
      "CYP3A5",
      "POLG",
      "DRD3",
      "ACE",
      "PDE4D",
      "CYP1A2",
      "COMT",
      "RABEP1"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP3A4*1, CYP3A4*20, CYP3A4*22",
        "gene": "CYP3A4",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs951439",
        "gene": "RGS4",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1806201",
        "gene": "GRIN2B",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs10042486",
        "gene": "HTR1A",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs7912580",
        "gene": "",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2412459",
        "gene": "EIF2AK4",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs324420",
        "gene": "FAAH",
        "level": "3",
        "phenotypes": "Psychotic Disorder"
      },
      {
        "variant": "rs6280",
        "gene": "DRD3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1415744",
        "gene": "EPM2A",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs5993883",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs6269",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs4818",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs3888190",
        "gene": "SH2B1",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depressive Disorder,Psychotic Disorder,Schizoaffective disorder"
      },
      {
        "variant": "rs1000940",
        "gene": "RABEP1",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depressive Disorder,Psychotic Disorder,Schizoaffective disorder"
      },
      {
        "variant": "rs17382202",
        "gene": "PDE4D",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs17742120",
        "gene": "MIR582,PDE4D",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2164660",
        "gene": "PDE4D",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs17782313",
        "gene": "MC4R",
        "level": "3",
        "phenotypes": "Weight gain"
      },
      {
        "variant": "CYP3A4*1, CYP3A4*3",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs489693",
        "gene": "MC4R",
        "level": "3",
        "phenotypes": "Hypertriglyceridemia,Schizoaffective disorder,Schizophrenia,Weight gain"
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Patients who are CYP3A4 poor metabolizers and being treated for depression should be given an alternative drug. Patients being treated for other indications and who are CYP3A4 poor metabolizers should be given a reduced dose of quetiapine. No action is needed for patients who are CYP3A4 intermediate metabolizers.\nClinPGx uses CYP3A4 allele nomenclature as defined by PharmVar, while the current version of this guideline issued by the DPWG uses retired allele names. Further details are given on the DPWG curation page.\n",
      "source": "DPWG"
    }
  },
  "risperidone": {
    "genes": [
      "INSIG2",
      "POR",
      "LEPR",
      "CYP3A43",
      "UGT1A10",
      "CYP2C9",
      "DRD2",
      "ABCB1",
      "HTR1A",
      "UGT1A3",
      "HTR2C",
      "RGS4",
      "GRM3",
      "SH2B1",
      "GNB3",
      "PPARA",
      "CYP2B6",
      "CYP2D6",
      "MTHFR",
      "DRD1",
      "MIR1912",
      "MC4R",
      "CYP2C19",
      "MSANTD1",
      "UGT1A4",
      "BDNF",
      "GRIN2B",
      "UGT1A9",
      "SLC22A8",
      "TMEFF2",
      "SV2C",
      "SLC6A4",
      "UGT1A8",
      "RELN",
      "EPM2A",
      "HLA-A",
      "UGT1A5",
      "GRID2",
      "HTR2A",
      "PPA2",
      "GRM7",
      "CACNA1C",
      "TNFRSF11A",
      "PSMD14",
      "APOE",
      "NR1I2",
      "CNR1",
      "ABCG2",
      "MIR1264",
      "AKT1",
      "AGT",
      "TNIK",
      "ANKK1",
      "HRH3",
      "LEP",
      "FAAH",
      "SLC44A3",
      "CCL2",
      "NFIB",
      "CYP2E1",
      "HTR6",
      "CYP3A4",
      "HLA-B",
      "LEPROT",
      "ADRB2",
      "EIF2AK4",
      "LRP1B",
      "HTR3A",
      "CYP1B1",
      "UGT1A1",
      "CYP3A5",
      "HRH4",
      "FTO",
      "POLG",
      "UGT1A6",
      "AGAP1",
      "WBP2NL",
      "DRD3",
      "HTT",
      "NPAS3",
      "UGT1A7",
      "ACE",
      "CYP1A2",
      "TYMS",
      "COMT",
      "SLC1A1",
      "CYP3A7",
      "RABEP1",
      "TJP1"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*14",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Psychotic Disorder,Schizophrenia"
      },
      {
        "variant": "rs6313",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "Alzheimer Disease"
      },
      {
        "variant": "rs2842030",
        "gene": "RGS4",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Autism"
      },
      {
        "variant": "rs951439",
        "gene": "RGS4",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs6280",
        "gene": "DRD3",
        "level": "3",
        "phenotypes": "Autism"
      },
      {
        "variant": "rs6311",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "Autism"
      },
      {
        "variant": "rs167771",
        "gene": "DRD3",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Schizophrenia"
      },
      {
        "variant": "rs165599",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs724226",
        "gene": "GRM3",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1806201",
        "gene": "GRIN2B",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs6313",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs10042486",
        "gene": "HTR1A",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs7643645",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": "Psychotic Disorder"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs3787430",
        "gene": "HRH3",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2857657",
        "gene": "CCL2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs7912580",
        "gene": "",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2412459",
        "gene": "EIF2AK4",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs4436578",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs324420",
        "gene": "FAAH",
        "level": "3",
        "phenotypes": "Psychotic Disorder"
      },
      {
        "variant": "rs806378",
        "gene": "CNR1",
        "level": "3",
        "phenotypes": "Autism Spectrum Disorder,Schizophrenia"
      },
      {
        "variant": "rs4586",
        "gene": "CCL2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs7799039",
        "gene": "LEP",
        "level": "3",
        "phenotypes": "Autism Spectrum Disorder,Mood Disorder"
      },
      {
        "variant": "rs1875705",
        "gene": "GRID2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2069062",
        "gene": "GRM7",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1805054",
        "gene": "",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2661319",
        "gene": "RGS4",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1415744",
        "gene": "EPM2A",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs4795893",
        "gene": "CCL2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1523130",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depression,Substance-Related Disorders"
      },
      {
        "variant": "rs2276707",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depression,Substance-Related Disorders"
      },
      {
        "variant": "rs3888190",
        "gene": "SH2B1",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depressive Disorder,Psychotic Disorder,Schizoaffective disorder"
      },
      {
        "variant": "rs1000940",
        "gene": "RABEP1",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depressive Disorder,Psychotic Disorder,Schizoaffective disorder"
      },
      {
        "variant": "rs10929302",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "Hyperprolactinemia"
      },
      {
        "variant": "rs1976391",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "Hyperprolactinemia"
      },
      {
        "variant": "rs887829",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "Hyperprolactinemia"
      },
      {
        "variant": "rs2636697",
        "gene": "PPA2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs813676",
        "gene": "TJP1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs8050896",
        "gene": "",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2980976",
        "gene": "TNFRSF11A",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs711355",
        "gene": "TJP1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs785423",
        "gene": "TJP1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs7395555",
        "gene": "",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2636719",
        "gene": "PPA2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2514218",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Psychotic Disorder,Schizoaffective disorder,Schizophrenia"
      },
      {
        "variant": "rs362306",
        "gene": "HTT,MSANTD1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs3787429",
        "gene": "HRH3",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1056827",
        "gene": "CYP1B1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs6706232",
        "gene": "UGT1A10,UGT1A3,UGT1A4,UGT1A5,UGT1A6,UGT1A7,UGT1A8,UGT1A9",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs10012",
        "gene": "CYP1B1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs362267",
        "gene": "HTT,MSANTD1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2515641",
        "gene": "CYP2E1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs4818",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs3803300",
        "gene": "AKT1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs4483927",
        "gene": "HRH4",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs6280",
        "gene": "DRD3",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2494732",
        "gene": "AKT1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs6313",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",
        "gene": "SLC6A4",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs3813929",
        "gene": "HTR2C",
        "level": "3",
        "phenotypes": "Mental Disorders,Schizophrenia"
      },
      {
        "variant": "rs1414334",
        "gene": "HTR2C",
        "level": "3",
        "phenotypes": "Metabolic Syndrome"
      },
      {
        "variant": "rs6318",
        "gene": "HTR2C",
        "level": "3",
        "phenotypes": "Schizophrenia,Weight gain"
      },
      {
        "variant": "rs3813928",
        "gene": "HTR2C",
        "level": "3",
        "phenotypes": "Autism"
      },
      {
        "variant": "rs489693",
        "gene": "MC4R",
        "level": "3",
        "phenotypes": "Weight gain"
      },
      {
        "variant": "rs17782313",
        "gene": "MC4R",
        "level": "3",
        "phenotypes": "Weight gain"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs9606186",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1049353",
        "gene": "CNR1",
        "level": "3",
        "phenotypes": "Autism Spectrum Disorder,Psychotic Disorder"
      },
      {
        "variant": "rs1800497",
        "gene": "ANKK1,DRD2",
        "level": "3",
        "phenotypes": "Autism,Hyperprolactinemia,Schizophrenia"
      },
      {
        "variant": "rs1799978",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Hyperprolactinemia"
      },
      {
        "variant": "rs1799732",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Bipolar Disorder,Depression,Psychotic Disorder,Schizophrenia,Substance-Related Disorders"
      },
      {
        "variant": "rs4633",
        "gene": "COMT",
        "level": "4",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "4",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1799978",
        "gene": "DRD2",
        "level": "4",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1800497",
        "gene": "ANKK1,DRD2",
        "level": "4",
        "phenotypes": "Autism,Schizophrenia"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for risperidone and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for risperidone and CYP2D6"
      },
      {
        "source": "EMA",
        "level": "No Clinical PGx",
        "name": "Annotation of EMA Label for risperidone and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for risperidone and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "The Dutch Pharmacogenetics Working Group Guideline for risperidone recommends decreasing the dose for CYP2D6 poor metabolizers and using an alternative drug or titrate the dose according to the maximum dose for the active metabolite for CYP2D6 ultrarapid metabolizers.\n",
      "source": "DPWG"
    }
  },
  "antipsychotics": {
    "genes": [
      "INSIG2",
      "LEPR",
      "CYP3A43",
      "KCNE1",
      "DRD2",
      "ABCB1",
      "HTR1A",
      "HTR2C",
      "RGS4",
      "SMYD3",
      "GRM3",
      "SLC1A3",
      "GNB3",
      "PRKAB2",
      "ADCY2",
      "CYP2D6",
      "ADRA2A",
      "CACNG3",
      "MTHFR",
      "DRD1",
      "SLC25A14",
      "CACNA1E",
      "MC4R",
      "OPRM1",
      "CYP2C19",
      "UCP3",
      "NRG1",
      "PI4KA",
      "BDNF",
      "PRKAA2",
      "SLC6A4",
      "NEFM",
      "HTR2A",
      "BDNF-AS",
      "CACNA1C",
      "GABRB1",
      "CLCN6",
      "CNR1",
      "ZNF804A",
      "DNAJB13",
      "GCG",
      "ANKK1",
      "LEP",
      "NRXN1",
      "FAAH",
      "CCL2",
      "CACNA2D3",
      "GRIK3",
      "SNAP25",
      "CYP3A4",
      "CACNB2",
      "UCP2",
      "CACNA1B",
      "DGKB",
      "TDRD6",
      "CHRM4",
      "HSPG2",
      "IL1B",
      "SLC1A4",
      "SLC18A2",
      "ADIPOQ",
      "FTO",
      "SLC25A27",
      "RGS2",
      "CYP39A1",
      "DRD3",
      "CACNB4",
      "CYP1A2",
      "ANGPTL4",
      "COMT",
      "IBA57",
      "PPARG",
      "NOS3",
      "TBC1D1",
      "GABRG3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs951439",
        "gene": "RGS4",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1801133",
        "gene": "CLCN6,MTHFR",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1079598",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Tardive Dyskinesia"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs6277",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs5030655",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4606",
        "gene": "RGS2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs10042486",
        "gene": "HTR1A",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1344706",
        "gene": "ZNF804A",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs878949",
        "gene": "HSPG2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2445142",
        "gene": "HSPG2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2061051",
        "gene": "GABRG3",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs10501087",
        "gene": "BDNF-AS",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs6265",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs11030104",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs6311",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "Tardive Dyskinesia"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs16944",
        "gene": "IL1B",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1143634",
        "gene": "IL1B",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs6265",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs9346455",
        "gene": "",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1544938",
        "gene": "ADCY2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs17716295",
        "gene": "NRG1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs6465084",
        "gene": "GRM3",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1468412",
        "gene": "GRM3",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs12467557",
        "gene": "NRXN1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs10490162",
        "gene": "NRXN1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2513265",
        "gene": "",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs7799039",
        "gene": "LEP",
        "level": "3",
        "phenotypes": "Autism Spectrum Disorder,Mood Disorder"
      },
      {
        "variant": "rs1137101",
        "gene": "LEPR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1799732",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Psychotic Disorder"
      },
      {
        "variant": "rs1805128",
        "gene": "KCNE1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4849127",
        "gene": "IL1B",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs17587100",
        "gene": "INSIG2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1334802",
        "gene": "GRIK3",
        "level": "3",
        "phenotypes": "Psychotic Disorder"
      },
      {
        "variant": "rs363341",
        "gene": "SLC18A2",
        "level": "3",
        "phenotypes": "Psychotic Disorder"
      },
      {
        "variant": "rs1124491",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Psychotic Disorder"
      },
      {
        "variant": "rs9567733",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "Psychotic Disorder"
      },
      {
        "variant": "CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*14",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Dystonia"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Cardiac Arrest,Overdose,Respiratory Insufficiency"
      },
      {
        "variant": "rs13250975",
        "gene": "NRG1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs7720513",
        "gene": "",
        "level": "3",
        "phenotypes": "Weight gain"
      },
      {
        "variant": "rs1525085",
        "gene": "DGKB",
        "level": "3",
        "phenotypes": "Weight gain"
      },
      {
        "variant": "rs6977820",
        "gene": "",
        "level": "3",
        "phenotypes": "Schizophrenia,Tardive Dyskinesia"
      },
      {
        "variant": "rs3813929",
        "gene": "HTR2C",
        "level": "3",
        "phenotypes": "Mental Disorders"
      },
      {
        "variant": "rs17782313",
        "gene": "MC4R",
        "level": "3",
        "phenotypes": "Weight gain"
      },
      {
        "variant": "rs489693",
        "gene": "MC4R",
        "level": "3",
        "phenotypes": "Weight gain"
      },
      {
        "variant": "rs62097526",
        "gene": "",
        "level": "3",
        "phenotypes": "Weight gain"
      },
      {
        "variant": "rs762551",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2069514",
        "gene": "CYP1A2",
        "level": "4",
        "phenotypes": "Schizophrenia"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pemetrexed": {
    "genes": [
      "CAMKK2",
      "ERCC1",
      "EGFR",
      "MTHFR",
      "MTHFD1",
      "ATIC",
      "FOLR3",
      "SLC22A8",
      "ALK",
      "VEGFA",
      "ABCC2",
      "SLC19A1",
      "CCND1",
      "GGH",
      "C18orf56",
      "DHFR",
      "CD274",
      "HIF1A",
      "EXO1",
      "TYMS"
    ],
    "clinicalVariants": [
      {
        "variant": "rs442767",
        "gene": "DHFR",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1650697",
        "gene": "DHFR",
        "level": "3",
        "phenotypes": "Mesothelioma,Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs11545078",
        "gene": "GGH",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs61734430",
        "gene": "FOLR3",
        "level": "3",
        "phenotypes": "Mesothelioma,Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs3788189",
        "gene": "SLC19A1",
        "level": "3",
        "phenotypes": "Mesothelioma,Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs914232",
        "gene": "SLC19A1",
        "level": "3",
        "phenotypes": "Mesothelioma,Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1051298",
        "gene": "SLC19A1",
        "level": "3",
        "phenotypes": "Mesothelioma,Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs3780126",
        "gene": "GGH",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2273697",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Mesothelioma"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Mesothelioma,Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs11280056",
        "gene": "TYMS",
        "level": "3",
        "phenotypes": "Mesothelioma"
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for pemetrexed"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for pemetrexed and ALK, EGFR"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for pemetrexed and CD274"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for pemetrexed"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "drugs used in nicotine dependence": {
    "genes": [
      "CHRNA3",
      "OPRM1",
      "ANKK1",
      "CYP2A6",
      "CHRNA5",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "rs588765",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs4803381",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1051730",
        "gene": "CHRNA3",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs16969968",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1051730",
        "gene": "CHRNA3",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1051730",
        "gene": "CHRNA3",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "4",
        "phenotypes": "Tobacco Use Disorder"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "opium alkaloids and derivatives": {
    "genes": [
      "CHRNA3",
      "CHRNA5"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1051730",
        "gene": "CHRNA3",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs16969968",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs660652",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Pain,Tobacco Use Disorder"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "eculizumab": {
    "genes": [
      "CHRNA3",
      "C3",
      "CHRNB1",
      "AQP4",
      "CHRNA1",
      "CHRNA6",
      "CHRNE",
      "CHRNA4",
      "CR1",
      "CFH",
      "CHRNA7",
      "C5",
      "CHRNA5"
    ],
    "clinicalVariants": [
      {
        "variant": "rs56040400",
        "gene": "C5",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2274567",
        "gene": "CR1",
        "level": "3",
        "phenotypes": "Paroxysmal nocturnal hemoglobinuria"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for eculizumab and AQP4, CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for eculizumab and AQP4, CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for eculizumab and AQP4, CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "varenicline": {
    "genes": [
      "CHRNA3",
      "PPARGC1A",
      "CHRFAM7A",
      "CYP2B6",
      "ICAM5",
      "SLC22A2",
      "ZBTB4",
      "CHRNB1",
      "HYKK",
      "NR1H4",
      "HNF1A",
      "NR1I2",
      "CHRNA4",
      "CHRNB3",
      "CHRNB2",
      "RXRA",
      "CYP2A6",
      "CHRNA5",
      "CHRNA2",
      "NR1I3",
      "PPARG",
      "ESR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs588765",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1044396",
        "gene": "CHRNA4",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs503464",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs7164594",
        "gene": "HYKK",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs2036527",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs16969968",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cotinine": {
    "genes": [
      "CHRNA3",
      "CYP2B6",
      "NAT1",
      "OPRM1",
      "EGLN2",
      "FMO3",
      "PSMA4",
      "CHRNB4",
      "CYP2A6",
      "CHRNA5",
      "UGT2B10"
    ],
    "clinicalVariants": [
      {
        "variant": "rs13253389",
        "gene": "NAT1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs77107237",
        "gene": "",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs57064725",
        "gene": "PSMA4",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs7170068",
        "gene": "CHRNA3",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs16969968",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs10851907",
        "gene": "CHRNB4",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs2942857",
        "gene": "UGT2B10",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs6912029",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1074287",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs12209447",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs510769",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3798676",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs553202",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7748401",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs495491",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10457090",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs589046",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3778152",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs563649",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2075572",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2B6*1, CYP2B6*6",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "3-hydroxycotinine": {
    "genes": [
      "CHRNA3",
      "EGLN2",
      "CYP2A6",
      "CHRNA5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "efgartigimod alfa": {
    "genes": [
      "CHRNA3",
      "CHRNB1",
      "CHRNA1",
      "CHRNA6",
      "CHRNE",
      "CHRNA4",
      "CHRNA7",
      "CHRNA5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for efgartigimod alfa and CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for efgartigimod alfa and CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for efgartigimod alfa and CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ravulizumab": {
    "genes": [
      "CHRNA3",
      "CHRNB1",
      "AQP4",
      "CHRNA1",
      "CHRNA6",
      "CHRNE",
      "CHRNA4",
      "CHRNA7",
      "CHRNA5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for ravulizumab and AQP4, CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "rozanolixizumab": {
    "genes": [
      "CHRNA3",
      "CHRNB1",
      "CHRNA1",
      "CHRNA6",
      "CHRNE",
      "MUSK",
      "CHRNA4",
      "CHRNA7",
      "CHRNA5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for rozanolixizumab and CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE, MUSK"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "zilucoplan": {
    "genes": [
      "CHRNA3",
      "CHRNB1",
      "CHRNA1",
      "CHRNA6",
      "CHRNE",
      "CHRNA4",
      "CHRNA7",
      "CHRNA5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for zilucoplan and CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for zilucoplan and CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for zilucoplan and CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ethanol": {
    "genes": [
      "CHRNA3",
      "CAT",
      "DRD2",
      "FUT2",
      "MED19",
      "CARTPT",
      "ACSS2",
      "GHSR",
      "CYP2D6",
      "SRPRB",
      "OPRD1",
      "DRD1",
      "PDYN",
      "SLC39A8",
      "POMC",
      "TMX2",
      "OPRM1",
      "GRIK1",
      "SLC4A8",
      "MBOAT7",
      "SUGP1",
      "ADH1B",
      "BDNF",
      "SLC6A3",
      "TAS2R16",
      "OPRK1",
      "PDE4B",
      "ANKS1B",
      "SLC6A4",
      "PNPLA3",
      "DPP6",
      "CACNA1C",
      "GCKR",
      "CRHBP",
      "ADH7",
      "CHRNA4",
      "GATA4",
      "ANKK1",
      "CYP2E1",
      "DRD4",
      "CHRNB3",
      "PGM1",
      "PIP5K1C",
      "DBH",
      "TNRC6A",
      "THSD7B",
      "CADM2",
      "ARID4A",
      "FTO",
      "KLB",
      "DRD3",
      "HTR3B",
      "MAP2K4",
      "CHRNA5",
      "ADH1A",
      "CYP1A2",
      "ADH1C",
      "TM6SF2",
      "RABGAP1L",
      "ALDH2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs671",
        "gene": "ALDH2",
        "level": "2B",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs1229984",
        "gene": "ADH1B",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1001179",
        "gene": "CAT",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs846664",
        "gene": "TAS2R16",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs1051730",
        "gene": "CHRNA3",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs578776",
        "gene": "CHRNA3",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs615470",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs16969968",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs6350",
        "gene": "SLC6A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1800497",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Alcohol abuse,Death"
      },
      {
        "variant": "rs11940694",
        "gene": "KLB",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs1799972",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Substance-Related Disorders"
      },
      {
        "variant": "rs1800497",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Alcohol abuse,Substance-Related Disorders"
      },
      {
        "variant": "rs511435",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs524731",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs3823010",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs3778156",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs2031920",
        "gene": "CYP2E1",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs1044394",
        "gene": "CHRNA4",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs553202",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs524731",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs548646",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs648007",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3778148",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1461773",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2075572",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs681243",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10055255",
        "gene": "CRHBP",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs1800497",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10485057",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10485057",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs3778150",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3778150",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs28363170",
        "gene": "SLC6A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs28363170",
        "gene": "SLC6A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6088638",
        "gene": "ACSS2",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2074957",
        "gene": "PIP5K1C",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs4807493",
        "gene": "PIP5K1C",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs10432303",
        "gene": "PIP5K1C",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs8109485",
        "gene": "PIP5K1C",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs4432372",
        "gene": "PIP5K1C",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs10405681",
        "gene": "PIP5K1C",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs1476592",
        "gene": "PIP5K1C",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs10419980",
        "gene": "PIP5K1C",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs738409",
        "gene": "PNPLA3",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs10516440",
        "gene": "",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs2159140",
        "gene": "MAP2K4",
        "level": "3",
        "phenotypes": "Alcohol abuse,Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs17376019",
        "gene": "SRPRB",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799732",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs6473797",
        "gene": "OPRK1",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs495491",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs61826952",
        "gene": "RABGAP1L",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs2133896",
        "gene": "ANKS1B",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",
        "gene": "SLC6A4",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs2066713",
        "gene": "SLC6A4",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs25531",
        "gene": "SLC6A4",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs4251417",
        "gene": "SLC6A4",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs1034936",
        "gene": "CACNA1C",
        "level": "3",
        "phenotypes": "Alcohol abuse,Bipolar Disorder"
      },
      {
        "variant": "rs1800497",
        "gene": "ANKK1,DRD2",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs6421482",
        "gene": "PDE4B",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs61767420",
        "gene": "",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs1260326",
        "gene": "GCKR",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs494904",
        "gene": "",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs1402398",
        "gene": "",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs9679319",
        "gene": "",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs13382553",
        "gene": "THSD7B",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs2673136",
        "gene": "",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs62250713",
        "gene": "CADM2",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs75967634",
        "gene": "ADH1B",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs1229984",
        "gene": "ADH1B",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs13129401",
        "gene": "",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs13125415",
        "gene": "ADH1C",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs13135092",
        "gene": "SLC39A8",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs2533200",
        "gene": "DPP6",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs2582405",
        "gene": "",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs7900002",
        "gene": "",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs56722963",
        "gene": "",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs576859",
        "gene": "MED19,TMX2",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs1783835",
        "gene": "",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs12296477",
        "gene": "SLC4A8",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs6589386",
        "gene": "",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs61974485",
        "gene": "ARID4A",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs8008020",
        "gene": "",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs72768626",
        "gene": "TNRC6A",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs9937709",
        "gene": "FTO",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs492602",
        "gene": "FUT2",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs671",
        "gene": "ALDH2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1381376",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs28363170",
        "gene": "SLC6A3",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "4",
        "phenotypes": "Substance-Related Disorders"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "4",
        "phenotypes": "Alcohol abuse"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "bupropion": {
    "genes": [
      "CHRNA3",
      "POR",
      "CYP2C9",
      "DRD2",
      "HTR2C",
      "AKR7A3",
      "CYP2B6",
      "CYP2D6",
      "DRD1",
      "SACM1L",
      "CYP2C19",
      "UGT1A4",
      "SLC6A3",
      "FKBP5",
      "SLC6A4",
      "HLA-A",
      "HTR2A",
      "APOE",
      "CHRNA4",
      "ANKK1",
      "CYP3A4",
      "CHRNB3",
      "HLA-B",
      "DBH",
      "CHRNB2",
      "CYP3A5",
      "SLC18A2",
      "POLG",
      "CYP2A6",
      "CHRNA5",
      "ACE",
      "CHRNA2",
      "CYP1A2",
      "EPB41",
      "COMT",
      "GALR1"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*18, CYP2B6*22, CYP2B6*30",
        "gene": "CYP2B6",
        "level": "2A",
        "phenotypes": ""
      },
      {
        "variant": "rs2168631",
        "gene": "DRD1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11749035",
        "gene": "DRD1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11746641",
        "gene": "DRD1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2742435",
        "gene": "SACM1L",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2742423",
        "gene": "SACM1L",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2742421",
        "gene": "SACM1L",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2742417",
        "gene": "SACM1L",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2742390",
        "gene": "SACM1L",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2251954",
        "gene": "SACM1L",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2245705",
        "gene": "SACM1L",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1969624",
        "gene": "SACM1L",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs6702335",
        "gene": "EPB41",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3211371",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1799732",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs4803381",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs2717162",
        "gene": "GALR1",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs165599",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs2279343",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs503464",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1800497",
        "gene": "ANKK1",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "CYP2B6*1, CYP2B6*6",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",
        "gene": "SLC6A4",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs8109525",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs8075924",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2770296",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2873804",
        "gene": "DBH",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs363225",
        "gene": "SLC18A2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs363226",
        "gene": "SLC18A2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs17614642",
        "gene": "FKBP5",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2036527",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs16969968",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1800497",
        "gene": "ANKK1,DRD2",
        "level": "3",
        "phenotypes": "Obesity"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for bupropion and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cocaine": {
    "genes": [
      "CHRNA3",
      "DRD2",
      "OPRD1",
      "OPRM1",
      "SLC6A3",
      "OPRK1",
      "ARRB2",
      "CNR1",
      "KAT2B",
      "ANKK1",
      "BCHE",
      "SYT1",
      "GABRA2",
      "HTR3B",
      "CHRNA5"
    ],
    "clinicalVariants": [
      {
        "variant": "rs6454674",
        "gene": "CNR1",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs806368",
        "gene": "CNR1",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs2283265",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs684513",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs1125394",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs1803274",
        "gene": "BCHE",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs62638690",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Cocaine dependence,Heroin Dependence"
      },
      {
        "variant": "rs1799972",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Substance-Related Disorders"
      },
      {
        "variant": "rs524731",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs3823010",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs495491",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs2236256",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs11503014",
        "gene": "GABRA2",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs678849",
        "gene": "OPRD1",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs9829896",
        "gene": "KAT2B",
        "level": "3",
        "phenotypes": "Substance-Related Disorders"
      },
      {
        "variant": "rs2251214",
        "gene": "SYT1",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs588765",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs16969968",
        "gene": "CHRNA3,CHRNA5",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs1076560",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs3778156",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs997917",
        "gene": "OPRK1",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs10111937",
        "gene": "OPRK1",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "4",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "4",
        "phenotypes": "Substance-Related Disorders"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nicotine": {
    "genes": [
      "CHRNA3",
      "POR",
      "DRD2",
      "CARTPT",
      "CYP2B6",
      "CYP2D6",
      "DRD1",
      "PON1",
      "MAOB",
      "OPRM1",
      "CHRNA10",
      "ADGRL3",
      "BDNF",
      "SLC6A3",
      "MAOA",
      "ARRB2",
      "CHAT",
      "DDC",
      "CHRNA6",
      "EGLN2",
      "FMO3",
      "FMO1",
      "HTR2A",
      "ZNF536",
      "APOE",
      "CNR1",
      "CHRNA4",
      "ANKK1",
      "NRXN1",
      "DRD4",
      "CHRNB3",
      "TH",
      "DBH",
      "CHRNB2",
      "CHRM2",
      "HINT1",
      "CYP2A13",
      "GRIN3A",
      "CYP3A5",
      "CHRNB4",
      "CYP2A6",
      "CHRNA7",
      "HTR3B",
      "CHRNA5",
      "CHRNA2",
      "CYP1A2",
      "EPB41",
      "COMT",
      "GALR1",
      "UGT2B10"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2A6*1, CYP2A6*1x2, CYP2A6*2, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10, CYP2A6*11, CYP2A6*12, CYP2A6*13, CYP2A6*14, CYP2A6*15, CYP2A6*17, CYP2A6*19, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*38, CYP2A6*39, CYP2A6*41, CYP2A6*46, CYP2A6*55",
        "gene": "CYP2A6",
        "level": "1B",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs16969968",
        "gene": "CHRNA5",
        "level": "2B",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs28399433",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs28399468",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2236196",
        "gene": "CHRNA4",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1044396",
        "gene": "CHRNA4",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs2168631",
        "gene": "DRD1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11749035",
        "gene": "DRD1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11746641",
        "gene": "DRD1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6702335",
        "gene": "EPB41",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs10912675",
        "gene": "FMO1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7877",
        "gene": "FMO1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs112561475",
        "gene": "UGT2B10",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs376817657",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10121600",
        "gene": "GRIN3A",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1044397",
        "gene": "CHRNA4",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs588765",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs12461964",
        "gene": "",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs113288603",
        "gene": "",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1799732",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs2056527",
        "gene": "",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1057868",
        "gene": "POR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs12718541",
        "gene": "DDC",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs4532",
        "gene": "DRD1",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs686",
        "gene": "DRD1",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs2717162",
        "gene": "GALR1",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs324650",
        "gene": "CHRM2",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs660652",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Pain,Tobacco Use Disorder"
      },
      {
        "variant": "rs2072660",
        "gene": "CHRNB2",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs2072658",
        "gene": "CHRNB2",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs2229959",
        "gene": "CHRNA4",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs3813567",
        "gene": "CHRNB4",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs3743078",
        "gene": "CHRNA3",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs637137",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs684513",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs11788456",
        "gene": "GRIN3A",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs2869950",
        "gene": "CHRNB4",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs12459249",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs503464",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs2236196",
        "gene": "CHRNA4",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs55781567",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs2266780",
        "gene": "FMO3",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs4803381",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs56113850",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs6912029",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1074287",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs12209447",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs510769",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3798676",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs553202",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7748401",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs495491",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10457090",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs589046",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3778152",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs563649",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2075572",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799972",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Substance-Related Disorders"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1800497",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs2279343",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "CYP2B6*1, CYP2B6*6",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs6277",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2337980",
        "gene": "CHRNA7",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1800497",
        "gene": "ANKK1,DRD2",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1709083",
        "gene": "CYP2A13",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs72552266",
        "gene": "CYP2A13",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs28399433",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "CYP2B6*1, CYP2B6*4",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs3758987",
        "gene": "HTR3B",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs11606194",
        "gene": "HTR3B",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs6090378",
        "gene": "CHRNA4",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs3787138",
        "gene": "CHRNA4",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs3787140",
        "gene": "CHRNA4",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs3852209",
        "gene": "HINT1",
        "level": "3",
        "phenotypes": "Smoking Cessation,Tobacco Use Disorder"
      },
      {
        "variant": "rs3852209",
        "gene": "HINT1",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1051730",
        "gene": "CHRNA3",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs10485057",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs10485057",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs16969968",
        "gene": "CHRNA3,CHRNA5",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1800497",
        "gene": "ANKK1,DRD2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1800497",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs2036527",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs16969968",
        "gene": "CHRNA5",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1051730",
        "gene": "CHRNA3",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1051730",
        "gene": "CHRNA3",
        "level": "3",
        "phenotypes": "Pregnancy"
      },
      {
        "variant": "rs1051730",
        "gene": "CHRNA3",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1051730",
        "gene": "CHRNA3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3743075",
        "gene": "CHRNA3",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs7178270",
        "gene": "CHRNB4",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1948",
        "gene": "CHRNB4",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs2271339",
        "gene": "ADGRL3",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1456862",
        "gene": "ADGRL3",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs578776",
        "gene": "CHRNA3,CHRNA5",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1044396",
        "gene": "CHRNA4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2229959",
        "gene": "CHRNA4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1800497",
        "gene": "ANKK1",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs2072661",
        "gene": "CHRNB2",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs61750900",
        "gene": "UGT2B10",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1051730",
        "gene": "CHRNA3",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1051730",
        "gene": "CHRNA3",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs578776",
        "gene": "CHRNA3",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs145014075",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs72549435",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs199515342",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs571335587",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs61605570",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs768416963",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1302192284",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs111869995",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs137904044",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs200554095",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs772964366",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs758479488",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs145157460",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs148693084",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1303839356",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs374515279",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs777098658",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs145308399",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5031016",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*46",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "CYP2A6*1, CYP2A6*1x2, CYP2A6*2",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "CYP2A6*1, CYP2A6*1x2, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs778019189",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "4",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "4",
        "phenotypes": "Tobacco Use Disorder"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "4",
        "phenotypes": "Substance-Related Disorders"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "4",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "interferon beta-1a": {
    "genes": [
      "IRF6",
      "HLA-DQA1",
      "FHIT",
      "CD58",
      "GAPVD1",
      "RORA",
      "HLA-B",
      "HLA-DRB1",
      "ZNF697",
      "ACE"
    ],
    "clinicalVariants": [
      {
        "variant": "rs9272105",
        "gene": "HLA-DQA1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs12044852",
        "gene": "CD58",
        "level": "3",
        "phenotypes": "Multiple Sclerosis"
      },
      {
        "variant": "rs4278350",
        "gene": "",
        "level": "3",
        "phenotypes": "Multiple Sclerosis"
      },
      {
        "variant": "rs760316",
        "gene": "FHIT",
        "level": "3",
        "phenotypes": "Multiple Sclerosis"
      },
      {
        "variant": "rs1448673",
        "gene": "",
        "level": "3",
        "phenotypes": "Multiple Sclerosis"
      },
      {
        "variant": "rs10819043",
        "gene": "GAPVD1",
        "level": "3",
        "phenotypes": "Multiple Sclerosis"
      },
      {
        "variant": "rs3133084",
        "gene": "",
        "level": "3",
        "phenotypes": "Multiple Sclerosis"
      },
      {
        "variant": "rs10494227",
        "gene": "ZNF697",
        "level": "3",
        "phenotypes": "Multiple Sclerosis"
      },
      {
        "variant": "rs2291858",
        "gene": "GAPVD1",
        "level": "3",
        "phenotypes": "Multiple Sclerosis"
      },
      {
        "variant": "rs10760397",
        "gene": "GAPVD1",
        "level": "3",
        "phenotypes": "Multiple Sclerosis"
      },
      {
        "variant": "HLA-DRB1*04:01",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Multiple Sclerosis"
      },
      {
        "variant": "HLA-B*15:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Multiple Sclerosis"
      },
      {
        "variant": "rs2205986",
        "gene": "IRF6",
        "level": "3",
        "phenotypes": "Drug-induced liver injury,Multiple Sclerosis"
      },
      {
        "variant": "rs4774388",
        "gene": "RORA",
        "level": "3",
        "phenotypes": "Multiple Sclerosis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "interferon beta-1b": {
    "genes": [
      "IRF6",
      "HLA-DQA1",
      "FHIT",
      "CD58",
      "GAPVD1",
      "ZNF697"
    ],
    "clinicalVariants": [
      {
        "variant": "rs9272105",
        "gene": "HLA-DQA1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs12044852",
        "gene": "CD58",
        "level": "3",
        "phenotypes": "Multiple Sclerosis"
      },
      {
        "variant": "rs4278350",
        "gene": "",
        "level": "3",
        "phenotypes": "Multiple Sclerosis"
      },
      {
        "variant": "rs760316",
        "gene": "FHIT",
        "level": "3",
        "phenotypes": "Multiple Sclerosis"
      },
      {
        "variant": "rs1448673",
        "gene": "",
        "level": "3",
        "phenotypes": "Multiple Sclerosis"
      },
      {
        "variant": "rs10819043",
        "gene": "GAPVD1",
        "level": "3",
        "phenotypes": "Multiple Sclerosis"
      },
      {
        "variant": "rs3133084",
        "gene": "",
        "level": "3",
        "phenotypes": "Multiple Sclerosis"
      },
      {
        "variant": "rs10494227",
        "gene": "ZNF697",
        "level": "3",
        "phenotypes": "Multiple Sclerosis"
      },
      {
        "variant": "rs2291858",
        "gene": "GAPVD1",
        "level": "3",
        "phenotypes": "Multiple Sclerosis"
      },
      {
        "variant": "rs10760397",
        "gene": "GAPVD1",
        "level": "3",
        "phenotypes": "Multiple Sclerosis"
      },
      {
        "variant": "rs2205986",
        "gene": "IRF6",
        "level": "3",
        "phenotypes": "Drug-induced liver injury,Multiple Sclerosis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "gefitinib": {
    "genes": [
      "ERBB2",
      "CYP2C9",
      "ABCB1",
      "REL",
      "UHRF1",
      "EGFR",
      "CYP2D6",
      "IKBKE",
      "ARF1",
      "NR1H2",
      "MAP3K1",
      "TAGAP",
      "TNFAIP3",
      "TAB2",
      "SIRT2",
      "USP36",
      "NUP62",
      "DVL2",
      "NFKB2",
      "RELA",
      "ERBB3",
      "DPT",
      "NFKBIA",
      "ABCG2",
      "AKT1",
      "NFKB1",
      "CYP3A4",
      "HLA-DRB1",
      "SUMO4",
      "ERBB4",
      "CYP3A5",
      "NFKBIB",
      "IKBKB",
      "ARFGEF3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs121434568",
        "gene": "EGFR",
        "level": "1A",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs121434569",
        "gene": "EGFR",
        "level": "2B",
        "phenotypes": "Drug Resistance,Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs726501",
        "gene": "MAP3K1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2293347",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs712829",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs11227247",
        "gene": "RELA",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Toxic liver disease"
      },
      {
        "variant": "rs2272733",
        "gene": "IKBKB",
        "level": "3",
        "phenotypes": "Exanthema,Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2151222",
        "gene": "IKBKE",
        "level": "3",
        "phenotypes": "Diarrhea,Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs12142086",
        "gene": "IKBKE",
        "level": "3",
        "phenotypes": "Exanthema,Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2233406",
        "gene": "NFKBIA",
        "level": "3",
        "phenotypes": "Diarrhea,Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2233407",
        "gene": "NFKBIA",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Toxic liver disease"
      },
      {
        "variant": "rs9694958",
        "gene": "IKBKB",
        "level": "3",
        "phenotypes": "Exanthema,Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs3748022",
        "gene": "IKBKE",
        "level": "3",
        "phenotypes": "Exanthema,Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2233409",
        "gene": "NFKBIA",
        "level": "3",
        "phenotypes": "Diarrhea,Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2053071",
        "gene": "NFKBIB,SIRT2",
        "level": "3",
        "phenotypes": "Toxic liver disease"
      },
      {
        "variant": "rs2695121",
        "gene": "NR1H2",
        "level": "3",
        "phenotypes": "Diarrhea,Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs577001",
        "gene": "TAB2",
        "level": "3",
        "phenotypes": "Diarrhea"
      },
      {
        "variant": "rs8904",
        "gene": "NFKBIA",
        "level": "3",
        "phenotypes": "Exanthema,Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs11568315",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Adenocarcinoma,Drug Toxicity,Exanthema,Non-Small Cell Lung Carcinoma,Toxic liver disease"
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "4",
        "phenotypes": "Lung Neoplasms"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for gefitinib and CYP2D6"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for gefitinib and EGFR"
      },
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for gefitinib and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for gefitinib and EGFR"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for gefitinib and EGFR"
      },
      {
        "source": "PMDA",
        "level": "Testing Required",
        "name": "Annotation of PMDA Label for gefitinib and CYP2D6, EGFR"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for gefitinib and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for gefitinib and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "There are currently no dosing recommendations for gefitinib based on CYP2D6 genotype.\n",
      "source": "DPWG"
    }
  },
  "erlotinib": {
    "genes": [
      "ERBB2",
      "ABCB1",
      "UHRF1",
      "EGFR",
      "MET",
      "CYP2D6",
      "ARF1",
      "MAP3K1",
      "USP36",
      "NUP62",
      "DVL2",
      "ERBB3",
      "ABCG2",
      "AKT1",
      "CYP3A4",
      "HLA-DRB1",
      "ERBB4",
      "UGT1A1",
      "CYP3A5",
      "CYP1A2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs121434569",
        "gene": "EGFR",
        "level": "2B",
        "phenotypes": "Adenocarcinoma,Drug Resistance,Lung Neoplasms,Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs712829",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs712829",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs726501",
        "gene": "MAP3K1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2472304",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for erlotinib and EGFR"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for erlotinib and EGFR"
      },
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for erlotinib and UGT1A1"
      },
      {
        "source": "PMDA",
        "level": "Testing Required",
        "name": "Annotation of PMDA Label for erlotinib and EGFR"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for erlotinib and EGFR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lapatinib": {
    "genes": [
      "ERBB2",
      "HLA-DQA1",
      "EGFR",
      "PIK3CA",
      "ESR2",
      "HLA-A",
      "ERBB3",
      "CCND1",
      "ABCB11",
      "HLA-B",
      "PGR",
      "HLA-DRB1",
      "ERBB4",
      "HLA-C",
      "ESR1"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-DQA1*02:01",
        "gene": "HLA-DQA1",
        "level": "3",
        "phenotypes": "Toxic liver disease"
      },
      {
        "variant": "HLA-DRB1*07:01",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Toxic liver disease"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for lapatinib and HLA-DQA1, HLA-DRB1"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for lapatinib and ERBB2, ESR1, ESR2, PGR"
      },
      {
        "source": "EMA",
        "level": "Informative PGx",
        "name": "Annotation of EMA Label for lapatinib and HLA-DQA1, HLA-DRB1"
      },
      {
        "source": "PMDA",
        "level": "Testing Required",
        "name": "Annotation of PMDA Label for lapatinib and ERBB2, HLA-DQA1, HLA-DRB1"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for lapatinib and ERBB2"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for lapatinib and ERBB2, ESR1, ESR2"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for lapatinib and HLA-DQA1, HLA-DRB1"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for lapatinib and HLA-DQA1, HLA-DRB1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "everolimus": {
    "genes": [
      "ERBB2",
      "ABCB1",
      "RPTOR",
      "ESR2",
      "FGFR4",
      "CYP3A4",
      "HLA-DRB1",
      "PIK3R1",
      "CYP2C8",
      "CYP3A5",
      "MTOR",
      "ESR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Lymphopenia"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Mucositis"
      },
      {
        "variant": "rs351855",
        "gene": "FGFR4",
        "level": "3",
        "phenotypes": "Discontinuation"
      },
      {
        "variant": "rs10515074",
        "gene": "PIK3R1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Hyperglycemia,Leukopenia"
      },
      {
        "variant": "rs9906827",
        "gene": "RPTOR",
        "level": "3",
        "phenotypes": "Pneumonitis,Progression-free survival"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Heart transplantation,Kidney Neoplasms,Kidney Transplantation,Lung transplantation,Neuroendocrine Tumors"
      },
      {
        "variant": "rs2024627",
        "gene": "MTOR",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Kidney Neoplasms,Neuroendocrine Tumors"
      },
      {
        "variant": "CYP3A4*1, CYP3A4*22",
        "gene": "CYP3A4",
        "level": "4",
        "phenotypes": "Breast Neoplasms,Kidney Neoplasms,Kidney Transplantation,Neuroendocrine Tumors"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for everolimus and ERBB2, ESR1, ESR2"
      },
      {
        "source": "PMDA",
        "level": "Testing Required",
        "name": "Annotation of PMDA Label for everolimus and ERBB2, ESR1, ESR2"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for everolimus and ERBB2, ESR1, ESR2"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for everolimus and ERBB2, ESR1, ESR2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fulvestrant": {
    "genes": [
      "ERBB2",
      "CYP2C9",
      "ESR2",
      "PGR",
      "ESR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for fulvestrant and ERBB2, ESR1, ESR2"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for fulvestrant and ERBB2, ESR1, ESR2, PGR"
      },
      {
        "source": "PMDA",
        "level": "Testing Required",
        "name": "Annotation of PMDA Label for fulvestrant and ESR1, ESR2"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for fulvestrant and ERBB2, ESR1, ESR2, PGR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "olaparib": {
    "genes": [
      "ERBB2",
      "BRCA1",
      "PPP2R2A",
      "ESR2",
      "PGR",
      "BRCA2",
      "ESR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for olaparib and ESR1, ESR2, PGR, PPP2R2A"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for olaparib and BRCA1, BRCA2, ERBB2"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for olaparib and BRCA1, BRCA2, ERBB2"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for olaparib and BRCA1, BRCA2, ERBB2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ixabepilone": {
    "genes": [
      "ERBB2",
      "ESR2",
      "PGR",
      "ESR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for ixabepilone and ERBB2, ESR1, ESR2, PGR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pertuzumab": {
    "genes": [
      "ERBB2",
      "ESR2",
      "PGR",
      "ESR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for pertuzumab and ERBB2"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for pertuzumab and ERBB2"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for pertuzumab and ERBB2"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for pertuzumab and ESR1, ESR2, PGR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "neratinib": {
    "genes": [
      "ERBB2",
      "ESR2",
      "PGR",
      "ESR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for neratinib and ERBB2"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for neratinib and ERBB2, ESR1, ESR2, PGR"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for neratinib and ESR1, ESR2, PGR"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for neratinib and ERBB2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "trastuzumab emtansine": {
    "genes": [
      "ERBB2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for trastuzumab emtansine and ERBB2"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for trastuzumab emtansine and ERBB2"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for trastuzumab emtansine and ERBB2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pembrolizumab": {
    "genes": [
      "ERBB2",
      "EGFR",
      "IL7",
      "SMAD3",
      "KRAS",
      "SEMA5A",
      "HLA-A",
      "ALK",
      "GABRP",
      "BRAF",
      "HLA-DRB1",
      "CD274",
      "HLA-DPB1",
      "SLCO1B1",
      "EDIL3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for pembrolizumab and BRAF"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for pembrolizumab and ALK, CD274, EGFR, ERBB2"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for pembrolizumab and ALK, CD274, EGFR, ERBB2"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for pembrolizumab and BRAF"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for pembrolizumab and BRAF"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for pembrolizumab and ALK, CD274, EGFR, ERBB2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nivolumab": {
    "genes": [
      "ERBB2",
      "EGFR",
      "IL7",
      "SMAD3",
      "KRAS",
      "G6PD",
      "SEMA5A",
      "HLA-A",
      "ALK",
      "GABRP",
      "BRAF",
      "CD274",
      "SLCO1B1",
      "EDIL3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for nivolumab and ALK, CD274, EGFR, ERBB2"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for nivolumab and BRAF"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for nivolumab and BRAF, ERBB2"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for nivolumab and ALK, CD274, EGFR"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for nivolumab and BRAF"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for nivolumab and ALK, CD274, EGFR, ERBB2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "palbociclib": {
    "genes": [
      "ERBB2",
      "ABCB1",
      "SULT2A1",
      "ESR2",
      "CDKN2A",
      "ABCG2",
      "CYP3A4",
      "PGR",
      "ESR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for palbociclib and ERBB2, ESR1, ESR2, PGR"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for palbociclib and ERBB2, ESR1, ESR2, PGR"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for palbociclib and ERBB2, ESR1, ESR2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ribociclib": {
    "genes": [
      "ERBB2",
      "ABCB1",
      "ESR2",
      "CYP3A4",
      "PGR",
      "ESR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for ribociclib and ERBB2, ESR1, ESR2, PGR"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for ribociclib and ERBB2, ESR1, ESR2, PGR"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for ribociclib and ERBB2, ESR1, ESR2, PGR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "abemaciclib": {
    "genes": [
      "ERBB2",
      "ABCB1",
      "ESR2",
      "CYP3A4",
      "PGR",
      "MKI67",
      "ESR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for abemaciclib and ERBB2, ESR1, ESR2"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for abemaciclib and ERBB2, ESR1, ESR2, PGR"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for abemaciclib and ERBB2, ESR1, ESR2, PGR"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for abemaciclib and MKI67"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "eribulin": {
    "genes": [
      "ERBB2",
      "ESR2",
      "PGR",
      "ESR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for eribulin and ERBB2, ESR1, ESR2, PGR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "talazoparib": {
    "genes": [
      "ERBB2",
      "ATR",
      "MLH1",
      "BRCA1",
      "RAD51C",
      "CHEK2",
      "ATM",
      "CDK12",
      "MRE11",
      "PALB2",
      "FANCA",
      "NBN",
      "BRCA2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for talazoparib and ERBB2"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for talazoparib and ATM, ATR, BRCA1, BRCA2, CDK12, CHEK2, FANCA, MLH1, MRE11, NBN, PALB2, RAD51C"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for talazoparib and ATM, ATR, BRCA1, BRCA2, CDK12, CHEK2, ERBB2, FANCA, MLH1, MRE11, NBN, PALB2, RAD51C"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for talazoparib and BRCA1, BRCA2, ERBB2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "alpelisib": {
    "genes": [
      "ERBB2",
      "PIK3CA",
      "ESR2",
      "ESR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for alpelisib and ERBB2, ESR1, ESR2, PIK3CA"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for alpelisib and ERBB2, ESR1, ESR2, PIK3CA"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for alpelisib and ERBB2, ESR1, ESR2, PIK3CA"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tipiracil / trifluridine": {
    "genes": [
      "ERBB2",
      "KRAS"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for tipiracil / trifluridine and ERBB2, KRAS"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for tipiracil / trifluridine and ERBB2, KRAS"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for tipiracil / trifluridine and ERBB2, KRAS"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "trastuzumab deruxtecan": {
    "genes": [
      "ERBB2",
      "ESR2",
      "ESR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for trastuzumab deruxtecan and ERBB2"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for trastuzumab deruxtecan and ESR1, ESR2"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for trastuzumab deruxtecan and ERBB2"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for trastuzumab deruxtecan and ERBB2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sacituzumab govitecan": {
    "genes": [
      "ERBB2",
      "BRCA1",
      "ESR2",
      "UGT1A1",
      "BRCA2",
      "ESR1"
    ],
    "clinicalVariants": [
      {
        "variant": "UGT1A1*1, UGT1A1*28",
        "gene": "UGT1A1",
        "level": "1A",
        "phenotypes": "adverse events,Discontinuation,Neutropenia"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for sacituzumab govitecan and UGT1A1"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for sacituzumab govitecan and UGT1A1"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for sacituzumab govitecan and UGT1A1"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for sacituzumab govitecan and BRCA1, BRCA2"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for sacituzumab govitecan and ERBB2, ESR1, ESR2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tucatinib": {
    "genes": [
      "ERBB2",
      "NRAS",
      "HRAS",
      "KRAS"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for tucatinib and ERBB2, HRAS, KRAS, NRAS"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for tucatinib and ERBB2"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for tucatinib and ERBB2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "margetuximab": {
    "genes": [
      "ERBB2",
      "FCGR2B",
      "FCGR3A",
      "FCGR2A"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for margetuximab and ERBB2"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for margetuximab"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for margetuximab and FCGR2A, FCGR2B, FCGR3A"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for margetuximab"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "elacestrant": {
    "genes": [
      "ERBB2",
      "ESR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for elacestrant and ERBB2, ESR1"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for elacestrant"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for elacestrant and ESR1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "capivasertib": {
    "genes": [
      "ERBB2",
      "PIK3CA",
      "PIK3CD",
      "ESR2",
      "PTEN",
      "AKT1",
      "ESR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for capivasertib and AKT1, ERBB2, ESR1, ESR2, PIK3CD, PTEN"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for capivasertib and AKT1, ERBB2, ESR1, ESR2, PIK3CA, PTEN"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for capivasertib and AKT1, ERBB2, ESR1, ESR2, PIK3CA, PTEN"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "zolbetuximab": {
    "genes": [
      "ERBB2",
      "CLDN18"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for zolbetuximab and CLDN18, ERBB2"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for zolbetuximab and CLDN18, ERBB2"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for zolbetuximab and CLDN18, ERBB2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "inavolisib": {
    "genes": [
      "ERBB2",
      "PIK3CA",
      "ESR2",
      "ESR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for inavolisib and ERBB2, ESR1, ESR2, PIK3CA"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for inavolisib and ERBB2, ESR1, ESR2, PIK3CA"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for inavolisib and ERBB2, ESR1, ESR2, PIK3CA"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "zanidatamab": {
    "genes": [
      "ERBB2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for zanidatamab and ERBB2"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for zanidatamab and ERBB2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "capecitabine": {
    "genes": [
      "ERBB2",
      "ERCC1",
      "SLC28A1",
      "PHC1",
      "SMARCAD1",
      "ABCB1",
      "REV3L",
      "VPS13D",
      "MIR24-2",
      "ENOSF1",
      "KHDRBS3",
      "AREG",
      "ADCY2",
      "ADGRG7",
      "MTHFR",
      "CDX2",
      "CYP1A1",
      "GSTT1",
      "MTHFD1",
      "VENTXP7",
      "PTGS2",
      "WDR7",
      "KRAS",
      "SPARC",
      "CES1P1",
      "DPYD",
      "LMNTD1",
      "SIRPA",
      "MIR2054",
      "TYMP",
      "ZMIZ1",
      "ERCC2",
      "PPARD",
      "MTRR",
      "SHMT1",
      "APOBEC2",
      "XRCC1",
      "VEGFA",
      "SELE",
      "TK1",
      "COL6A3",
      "CES1",
      "CDA",
      "SLC19A1",
      "ARHGEF4",
      "ABCG2",
      "PTEN",
      "TP53",
      "CD96",
      "UMPS",
      "GSTM1",
      "MTR",
      "CYP19A1",
      "ABCC11",
      "CYP3A4",
      "C18orf56",
      "SPRY2",
      "CES2",
      "SSU72",
      "NSUN3",
      "MAN1A1",
      "TENM4",
      "ANK3",
      "CYP1B1",
      "UGT1A1",
      "CCDC70",
      "CYP3A5",
      "TMEM131L",
      "SLCO1B1",
      "MGAT4A",
      "DPYS",
      "FAT1",
      "SMAD7",
      "SLC22A7",
      "DLG5",
      "MIR27A",
      "CCDC77",
      "UPB1",
      "RRM1",
      "EXO1",
      "TYMS",
      "GSTP1",
      "NCOA7",
      "HLA-G",
      "MIR23A"
    ],
    "clinicalVariants": [
      {
        "variant": "rs17376848",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs2297595",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1801265",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1801160",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1801159",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1801158",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs67376798",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs3918290",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs55886062",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs56038477",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs75017182",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1048943",
        "gene": "CYP1A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs602950",
        "gene": "CDA",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs9936750",
        "gene": "",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs76387818",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs12022243",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs2741171",
        "gene": "ENOSF1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1047840",
        "gene": "EXO1",
        "level": "3",
        "phenotypes": "Metastatic neoplasm"
      },
      {
        "variant": "rs2291078",
        "gene": "UMPS",
        "level": "3",
        "phenotypes": "Metastatic neoplasm"
      },
      {
        "variant": "rs3772809",
        "gene": "UMPS",
        "level": "3",
        "phenotypes": "Metastatic neoplasm"
      },
      {
        "variant": "rs3772810",
        "gene": "UMPS",
        "level": "3",
        "phenotypes": "Metastatic neoplasm"
      },
      {
        "variant": "rs3218592",
        "gene": "REV3L",
        "level": "3",
        "phenotypes": "Metastatic neoplasm"
      },
      {
        "variant": "rs17160359",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Metastatic neoplasm"
      },
      {
        "variant": "rs2289310",
        "gene": "DLG5",
        "level": "3",
        "phenotypes": "Metastatic neoplasm"
      },
      {
        "variant": "rs17431184",
        "gene": "PTEN",
        "level": "3",
        "phenotypes": "Metastatic neoplasm"
      },
      {
        "variant": "rs2236722",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Metastatic neoplasm"
      },
      {
        "variant": "rs11942466",
        "gene": "AREG",
        "level": "3",
        "phenotypes": "Rectal Neoplasms"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Rectal Neoplasms"
      },
      {
        "variant": "rs699947",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms,Hand-foot syndrome"
      },
      {
        "variant": "rs371194629",
        "gene": "HLA-G",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs9380142",
        "gene": "HLA-G",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs17179108",
        "gene": "HLA-G",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs3917412",
        "gene": "SELE",
        "level": "3",
        "phenotypes": "Colonic Neoplasms"
      },
      {
        "variant": "rs183205964",
        "gene": "TYMS",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs12132152",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs885036",
        "gene": "MGAT4A",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs885036",
        "gene": "MGAT4A",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs5275",
        "gene": "PTGS2",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs2010963",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs2612091",
        "gene": "ENOSF1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs3217164",
        "gene": "CES1",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs2244614",
        "gene": "CES1",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs11861118",
        "gene": "CES1P1",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs7187684",
        "gene": "CES1P1",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs4678145",
        "gene": "UMPS",
        "level": "3",
        "phenotypes": "Asthenia,Neoplasms"
      },
      {
        "variant": "rs2270860",
        "gene": "SLC22A7",
        "level": "3",
        "phenotypes": "Drug Toxicity,Neoplasms"
      },
      {
        "variant": "rs4149178",
        "gene": "SLC22A7",
        "level": "3",
        "phenotypes": "Diarrhea,Neoplasms"
      },
      {
        "variant": "rs2853741",
        "gene": "TYMS",
        "level": "3",
        "phenotypes": "Diarrhea,Neoplasms"
      },
      {
        "variant": "rs1048977",
        "gene": "CDA",
        "level": "3",
        "phenotypes": "Hyperbilirubinemia,Neoplasms"
      },
      {
        "variant": "rs12119882",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Hyperbilirubinemia,Neoplasms"
      },
      {
        "variant": "rs2279199",
        "gene": "UMPS",
        "level": "3",
        "phenotypes": "Nausea,Vomiting"
      },
      {
        "variant": "rs699517",
        "gene": "TYMS",
        "level": "3",
        "phenotypes": "Asthenia,Nausea,Neoplasms,Vomiting"
      },
      {
        "variant": "rs11479",
        "gene": "TYMP",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs2072671",
        "gene": "CDA",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs3215400",
        "gene": "CDA",
        "level": "3",
        "phenotypes": "Hand-foot syndrome,Neoplasms"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs2244613",
        "gene": "CES1",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs367619008",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs755416212",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs143004875",
        "gene": "DPYS",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs2016520",
        "gene": "PPARD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs895819",
        "gene": "MIR27A",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs4702484",
        "gene": "ADCY2",
        "level": "4",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "4",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "4",
        "phenotypes": "Neoplasms"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for capecitabine and DPYD"
      },
      {
        "source": "EMA",
        "level": "Testing Recommended",
        "name": "Annotation of EMA Label for capecitabine and DPYD"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for capecitabine and DPYD"
      },
      {
        "source": "HCSC",
        "level": "Testing Recommended",
        "name": "Annotation of HCSC Label for capecitabine and DPYD"
      },
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for capecitabine and DPYD"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for capecitabine and ERBB2"
      }
    ],
    "guidelines": {
      "advice": "An Italian working group comprising the Italian Association of Medical Oncology (AIOM) and the Italian Society of Pharmacology (SIF) has published recommendations for the use of DPYD genotype when prescribing fluoropyrimidines (5-fluorouracil, capecitabine and tegafur).\n",
      "source": "AIOM"
    }
  },
  "carboplatin": {
    "genes": [
      "ERBB2",
      "ERCC1",
      "ATAT1",
      "ABCB1",
      "ACSS2",
      "OR4D6",
      "NRAS",
      "DDX53",
      "EGFR",
      "MTHFR",
      "GSTT1",
      "MAP3K1",
      "BARD1",
      "OPRM1",
      "ALDH1A1",
      "PIK3CA",
      "EIF3A",
      "DPYD",
      "SCN10A",
      "GSR",
      "DSCAM",
      "EIF4E2",
      "NRG3",
      "C6orf15",
      "TRIM5",
      "ALDH3A1",
      "DOCK8",
      "MSH5",
      "ERCC2",
      "SLCO1B3",
      "PSORS1C1",
      "BCL2",
      "XYLT2",
      "XRCC1",
      "LIG3",
      "ERBB3",
      "VEGFA",
      "RNF8",
      "RAF1",
      "MAD1L1",
      "NR1I2",
      "SLC19A1",
      "ABCG2",
      "PTEN",
      "AKT1",
      "MUCL3",
      "TP53",
      "GSTM1",
      "MTR",
      "FNTB",
      "C18orf56",
      "HCP5",
      "CDSN",
      "HLA-DRB1",
      "METTL3",
      "TNF",
      "PPP1R18",
      "CD274",
      "ATP7B",
      "PRRC2A",
      "CYP2C8",
      "HLA-C",
      "TIGD1",
      "UGT1A1",
      "CYP3A5",
      "AKT2",
      "ETS2",
      "SERPINC1",
      "SLC31A1",
      "GPX5",
      "MTOR",
      "RRM1",
      "TYMS",
      "SERPINA5",
      "GSTP1",
      "SOX10"
    ],
    "clinicalVariants": [
      {
        "variant": "rs9981861",
        "gene": "DSCAM",
        "level": "3",
        "phenotypes": "Neoplasms,Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1801368",
        "gene": "MAD1L1",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs1130214",
        "gene": "AKT1",
        "level": "3",
        "phenotypes": "Lung Neoplasms"
      },
      {
        "variant": "rs12659",
        "gene": "SLC19A1",
        "level": "3",
        "phenotypes": "Uterine Cervical Neoplasm"
      },
      {
        "variant": "rs3740556",
        "gene": "EIF3A",
        "level": "3",
        "phenotypes": "Lung Neoplasms"
      },
      {
        "variant": "rs544093",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs879207",
        "gene": "",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs2849380",
        "gene": "BCL2",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs139887",
        "gene": "SOX10",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs2494752",
        "gene": "AKT1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs7851395",
        "gene": "SLC31A1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs726501",
        "gene": "MAP3K1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6151031",
        "gene": "ALDH1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3594",
        "gene": "GSR",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs1801249",
        "gene": "ATP7B",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs9825762",
        "gene": "SCN10A",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs1061472",
        "gene": "ATP7B",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs1065634",
        "gene": "NRAS",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs11710163",
        "gene": "RAF1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs12118636",
        "gene": "",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs16886403",
        "gene": "MAP3K1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs17309872",
        "gene": "ACSS2",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs17661089",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs451774",
        "gene": "GPX5",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs7311358",
        "gene": "SLCO1B3",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs4149117",
        "gene": "SLCO1B3",
        "level": "3",
        "phenotypes": "Lung Neoplasms"
      },
      {
        "variant": "rs2699887",
        "gene": "PIK3CA",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2299939",
        "gene": "PTEN",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2498804",
        "gene": "",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs6900017",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs9369421",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs879825",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs11623866",
        "gene": "FNTB",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs9369421",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2070096",
        "gene": "BARD1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2229046",
        "gene": "ERBB3",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2284922",
        "gene": "RNF8",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs773123",
        "gene": "ERBB3",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1136201",
        "gene": "ERBB2",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1805087",
        "gene": "MTR",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs2233980",
        "gene": "C6orf15",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs5877",
        "gene": "SERPINC1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs9262132",
        "gene": "ATAT1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs886423",
        "gene": "",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs9262143",
        "gene": "PPP1R18",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs886424",
        "gene": "",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs3130985",
        "gene": "CDSN,PSORS1C1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs1049709",
        "gene": "HLA-C",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs3094086",
        "gene": "MUCL3",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs3130907",
        "gene": "HCP5",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs11229",
        "gene": "PRRC2A",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs1800629",
        "gene": "TNF",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs10885",
        "gene": "PRRC2A",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs3115672",
        "gene": "MSH5",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs10491684",
        "gene": "DOCK8",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs1058932",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs11572078",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs6119",
        "gene": "SERPINA5",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs6504649",
        "gene": "XYLT2",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs6113",
        "gene": "SERPINA5",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs6118",
        "gene": "SERPINA5",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs73450548",
        "gene": "ETS2",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Leukopenia,Neutropenia,Ovarian Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "docetaxel": {
    "genes": [
      "ERBB2",
      "ERCC1",
      "HNF4A",
      "RAB27A",
      "RRM2B",
      "IL6",
      "HLA-DQA1",
      "RPL13",
      "ABCB1",
      "ORM2",
      "ENOSF1",
      "ACSS2",
      "ATP7A",
      "MTHFR",
      "EGLN3",
      "CYP1A1",
      "GSTT1",
      "MAP3K1",
      "MDM4",
      "BARD1",
      "OPRM1",
      "PIK3CA",
      "TNFSF13B",
      "HLA-DQB1",
      "DPYD",
      "SPG7",
      "ESR2",
      "VAC14",
      "SNORD68",
      "AKR1C3",
      "TYMP",
      "PPCDC",
      "ERCC2",
      "PPARD",
      "SLCO1B3",
      "BCL2",
      "FGFR4",
      "XRCC1",
      "SULT1C4",
      "ERBB3",
      "SLC10A2",
      "EPHX1",
      "VEGFA",
      "SOD2",
      "RNF8",
      "RAF1",
      "CDA",
      "CHST3",
      "ABCC2",
      "NR1I2",
      "ABCG2",
      "TP53",
      "CYP4B1",
      "GSTM1",
      "MTR",
      "CCL2",
      "CYP3A4",
      "PGR",
      "XRCC3",
      "CYP24A1",
      "HLA-DRB1",
      "TNF",
      "CYP2C8",
      "ABCC6",
      "CYP1B1",
      "FLT1",
      "TANC1",
      "CYP3A5",
      "PIGB",
      "PRDX4",
      "SLCO1B1",
      "NAT2",
      "RXRA",
      "CYP2A6",
      "ABCC10",
      "XRCC4",
      "CASP7",
      "ABCC1",
      "RRM1",
      "TYMS",
      "EPAS1",
      "NR1I3",
      "ALDH2",
      "GSTP1",
      "ESR1",
      "SOX10"
    ],
    "clinicalVariants": [
      {
        "variant": "rs11045585",
        "gene": "SLCO1B3",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs4148945",
        "gene": "CHST3",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs4148943",
        "gene": "CHST3",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs870995",
        "gene": "PIK3CA",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs730720",
        "gene": "CHST3",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs6922548",
        "gene": "PPARD",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs2238472",
        "gene": "ABCC6",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs1883322",
        "gene": "PPARD",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs12418",
        "gene": "CHST3",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs7769719",
        "gene": "PPARD",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs4646487",
        "gene": "CYP4B1",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs4148950",
        "gene": "CHST3",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs4148947",
        "gene": "CHST3",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs3734254",
        "gene": "PPARD",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs2301159",
        "gene": "SLC10A2",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs2292954",
        "gene": "SPG7",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs2227291",
        "gene": "ATP7A",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs2016520",
        "gene": "PPARD",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs1799931",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs1402467",
        "gene": "SULT1C4",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs12960",
        "gene": "RPL13,SNORD68,SPG7",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs518329",
        "gene": "PRDX4",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2234922",
        "gene": "EPHX1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1382368",
        "gene": "XRCC4",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs7921977",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2227310",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs12415607",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs4353229",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1048943",
        "gene": "CYP1A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs544093",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs879207",
        "gene": "",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs2849380",
        "gene": "BCL2",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs139887",
        "gene": "SOX10",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs7311358",
        "gene": "SLCO1B3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs726501",
        "gene": "MAP3K1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs12762549",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2250242",
        "gene": "ORM2",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs35864111",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs13207351",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1570360",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs11710163",
        "gene": "RAF1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs16886403",
        "gene": "MAP3K1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs17309872",
        "gene": "ACSS2",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs17661089",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs875858",
        "gene": "VAC14",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs3732360",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": "Anemia,Nasopharyngeal Neoplasms"
      },
      {
        "variant": "rs11185648",
        "gene": "",
        "level": "3",
        "phenotypes": "Nasopharyngeal Neoplasms"
      },
      {
        "variant": "rs62576288",
        "gene": "RXRA",
        "level": "3",
        "phenotypes": "Nasopharyngeal Neoplasms"
      },
      {
        "variant": "rs1536475",
        "gene": "RXRA",
        "level": "3",
        "phenotypes": "Nasopharyngeal Neoplasms"
      },
      {
        "variant": "rs2273618",
        "gene": "HNF4A",
        "level": "3",
        "phenotypes": "Anemia,Nasopharyngeal Neoplasms"
      },
      {
        "variant": "rs3746574",
        "gene": "HNF4A",
        "level": "3",
        "phenotypes": "Anemia,Nasopharyngeal Neoplasms"
      },
      {
        "variant": "rs6413517",
        "gene": "RXRA",
        "level": "3",
        "phenotypes": "Anemia,Nasopharyngeal Neoplasms"
      },
      {
        "variant": "rs6130615",
        "gene": "HNF4A",
        "level": "3",
        "phenotypes": "Anemia,Nasopharyngeal Neoplasms"
      },
      {
        "variant": "rs9725457",
        "gene": "NR1I3",
        "level": "3",
        "phenotypes": "Anemia,Nasopharyngeal Neoplasms"
      },
      {
        "variant": "rs2502815",
        "gene": "NR1I3",
        "level": "3",
        "phenotypes": "Anemia,Nasopharyngeal Neoplasms"
      },
      {
        "variant": "rs2501873",
        "gene": "NR1I3",
        "level": "3",
        "phenotypes": "Anemia,Nasopharyngeal Neoplasms"
      },
      {
        "variant": "rs10538494",
        "gene": "NR1I3",
        "level": "3",
        "phenotypes": "Anemia,Nasopharyngeal Neoplasms"
      },
      {
        "variant": "rs75114882",
        "gene": "NR1I3",
        "level": "3",
        "phenotypes": "Nasopharyngeal Neoplasms,Neutropenia"
      },
      {
        "variant": "rs3732359",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": "Anemia,Nasopharyngeal Neoplasms"
      },
      {
        "variant": "rs3814058",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": "Anemia,Nasopharyngeal Neoplasms"
      },
      {
        "variant": "rs2234753",
        "gene": "RXRA",
        "level": "3",
        "phenotypes": "Anemia,Nasopharyngeal Neoplasms"
      },
      {
        "variant": "rs1563828",
        "gene": "MDM4",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1570360",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs3212986",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs11185647",
        "gene": "RXRA",
        "level": "3",
        "phenotypes": "Anemia,Nasopharyngeal Neoplasms,Neutropenia"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2740574",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs2070096",
        "gene": "BARD1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2229046",
        "gene": "ERBB3",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2284922",
        "gene": "RNF8",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs773123",
        "gene": "ERBB3",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1136201",
        "gene": "ERBB2",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs144854329",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs147451859",
        "gene": "PPCDC",
        "level": "3",
        "phenotypes": "Amenorrhea"
      },
      {
        "variant": "rs17587029",
        "gene": "",
        "level": "3",
        "phenotypes": "Amenorrhea"
      },
      {
        "variant": "rs1937840",
        "gene": "AKR1C3",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1871450",
        "gene": "CHST3",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs699947",
        "gene": "VEGFA",
        "level": "4",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs13181",
        "gene": "ERCC2",
        "level": "4",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Breast Neoplasms,Neoplasms"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for docetaxel and ESR1, ESR2, PGR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "paclitaxel": {
    "genes": [
      "ERBB2",
      "POR",
      "ERCC1",
      "TUBB2A",
      "SLC28A3",
      "FGD4",
      "ABCB1",
      "ACSS2",
      "EGFR",
      "CYP2D6",
      "MTHFR",
      "CYP1A1",
      "DAPK1",
      "GSTT1",
      "MAP3K1",
      "OPRM1",
      "DCK",
      "POLR1G",
      "DSCAM",
      "EIF4E2",
      "PPP1R13L",
      "NRG3",
      "TRIM5",
      "CYP17A1",
      "PDE4B",
      "ERCC2",
      "FZD3",
      "SLCO1B3",
      "IL17F",
      "BCL2",
      "AFG2A",
      "FGFR4",
      "LIG3",
      "VEGFA",
      "SOD2",
      "RAF1",
      "MAD1L1",
      "CDA",
      "ABCC2",
      "NR1I2",
      "EPHA5",
      "ABCG2",
      "EPHA8",
      "ABCG1",
      "TP53",
      "GSTM1",
      "MTR",
      "CYP2E1",
      "FNTB",
      "CYP3A4",
      "HLA-DRB1",
      "RARG",
      "EPHA6",
      "SPIDR",
      "RAC2",
      "MISP",
      "ARHGEF10",
      "FCGR2A",
      "CYP2C8",
      "CYP1B1",
      "TIGD1",
      "TANC1",
      "CMPK1",
      "CYP3A5",
      "SLCO1B1",
      "NAT2",
      "UGT1A6",
      "ETS2",
      "NCF4",
      "CASP7",
      "ABCC1",
      "RRM1",
      "TYMS",
      "GGT1",
      "GSTP1",
      "CBR3",
      "SLC29A1",
      "SOX10"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2229109",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs12721627",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Neoplasms,Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs11572080",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10509681",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs9981861",
        "gene": "DSCAM",
        "level": "3",
        "phenotypes": "Neoplasms,Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1113129",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs9282564",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs72552784",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1801368",
        "gene": "MAD1L1",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs7921977",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2227310",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs12415607",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs4353229",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1127687",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs544093",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs879207",
        "gene": "",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs2849380",
        "gene": "BCL2",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs139887",
        "gene": "SOX10",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs726501",
        "gene": "MAP3K1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs747199",
        "gene": "SLC29A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs10771973",
        "gene": "FGD4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Ovarian Neoplasms"
      },
      {
        "variant": "rs4880",
        "gene": "SOD2",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1113129",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs3212986",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs11710163",
        "gene": "RAF1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs16886403",
        "gene": "MAP3K1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs17309872",
        "gene": "ACSS2",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs17661089",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7311358",
        "gene": "SLCO1B3",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs4149117",
        "gene": "SLCO1B3",
        "level": "3",
        "phenotypes": "Lung Neoplasms"
      },
      {
        "variant": "rs11572080",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": "Drug Toxicity,Neurotoxicity Syndromes"
      },
      {
        "variant": "rs1056836",
        "gene": "CYP1B1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs11623866",
        "gene": "FNTB",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs7349683",
        "gene": "EPHA5",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Ovarian Neoplasms,Peripheral Nervous System Diseases"
      },
      {
        "variant": "rs2072671",
        "gene": "CDA",
        "level": "3",
        "phenotypes": "Nausea,Pancreatic Neoplasms"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Peripheral Nervous System Diseases"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Neoplasms,Neurotoxicity Syndromes"
      },
      {
        "variant": "CYP3A4*1, CYP3A4*8, CYP3A4*20, CYP3A4*22",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Ovarian Neoplasms"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Leukopenia,Neutropenia,Ovarian Neoplasms"
      },
      {
        "variant": "rs11572103",
        "gene": "CYP2C8",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs1934951",
        "gene": "CYP2C8",
        "level": "4",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Breast Neoplasms,Neoplasms"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Drug Toxicity,Neoplasms,Neutropenia,Peripheral Nervous System Diseases"
      },
      {
        "variant": "CYP2C8*1, CYP2C8*2, CYP2C8*3, CYP2C8*4",
        "gene": "CYP2C8",
        "level": "4",
        "phenotypes": "Drug Toxicity,Neutropenia,Peripheral Nervous System Diseases,Toxic liver disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for paclitaxel dosing based on CYP3A4 genotypes.\n",
      "source": "DPWG"
    }
  },
  "trastuzumab": {
    "genes": [
      "ERBB2",
      "ERCC1",
      "SLC28A3",
      "HLA-DQA1",
      "FCGR2B",
      "ABCB1",
      "ENOSF1",
      "MTHFR",
      "GSTT1",
      "BARD1",
      "PIK3CA",
      "HLA-DQB1",
      "FCGR3A",
      "DPYD",
      "ESR2",
      "TYMP",
      "PPCDC",
      "ERCC2",
      "ERBB3",
      "RNF8",
      "CDA",
      "GSTM1",
      "CYP3A4",
      "PGR",
      "HLA-DRB1",
      "RARG",
      "RAC2",
      "FCGR2A",
      "CYP3A5",
      "UGT1A6",
      "NCF4",
      "TYMS",
      "GSTP1",
      "CBR3",
      "ESR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1136201",
        "gene": "ERBB2",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Drug Toxicity"
      },
      {
        "variant": "rs2070096",
        "gene": "BARD1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2229046",
        "gene": "ERBB3",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2284922",
        "gene": "RNF8",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs773123",
        "gene": "ERBB3",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1136201",
        "gene": "ERBB2",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs147451859",
        "gene": "PPCDC",
        "level": "3",
        "phenotypes": "Amenorrhea"
      },
      {
        "variant": "rs17587029",
        "gene": "",
        "level": "3",
        "phenotypes": "Amenorrhea"
      },
      {
        "variant": "rs396991",
        "gene": "FCGR3A",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1801274",
        "gene": "FCGR2A",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for trastuzumab and ERBB2"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for trastuzumab and ERBB2"
      },
      {
        "source": "PMDA",
        "level": "Testing Required",
        "name": "Annotation of PMDA Label for trastuzumab and ERBB2"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for trastuzumab and ERBB2"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for trastuzumab and ESR1, ESR2, PGR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "aspirin": {
    "genes": [
      "HPGD",
      "EFR3A",
      "JMJD8",
      "CYP2C9",
      "IL6",
      "HLA-DQA1",
      "SLC6A12",
      "SLC30A9",
      "ABCB1",
      "CDH15",
      "AGAP3",
      "PLA2G4A",
      "GNB3",
      "CYP2D6",
      "TGFB1",
      "ITGA2",
      "PON1",
      "TMEM196",
      "TAPBP",
      "P2RY1",
      "CYP2C19",
      "PTGS2",
      "IL23R",
      "KRTAP10-4",
      "PAFAH1B2",
      "HLA-DQB1",
      "TSPEAR",
      "G6PD",
      "LPA",
      "ALOX15",
      "PTGIR",
      "CYP4F2",
      "GP1BA",
      "HNMT",
      "UGT1A9",
      "P2RY12",
      "ZBTB22",
      "WDR24",
      "LTC4S",
      "GP6",
      "MYOM2",
      "PTGER3",
      "CEP68",
      "IL4",
      "F2R",
      "TBXA2R",
      "TNFRSF11A",
      "NECAB1",
      "IL1A",
      "CES1",
      "B4GALT2",
      "PTGER2",
      "COL26A1",
      "ZDHHC3",
      "EYA1",
      "ODC1",
      "TBXAS1",
      "AGT",
      "IRS1",
      "FCER1G",
      "F13A1",
      "ECHS1",
      "CYP24A1",
      "HLA-DRB1",
      "PLCG1",
      "TNF",
      "HLA-DPB1",
      "CHIA",
      "ADORA1",
      "CDH13",
      "CYP2C8",
      "FCER1A",
      "HLA-DPB2",
      "TSC1",
      "TLR3",
      "PTGS1",
      "CYP3A5",
      "IL1B",
      "CYP4F11",
      "THRA",
      "NAT2",
      "UGT1A6",
      "NTRK1",
      "NCF4",
      "ACE",
      "ITGB3",
      "CYP1A2",
      "FSIP1",
      "IKBKB",
      "PPARG",
      "GSTP1",
      "NOS3",
      "PEAR1"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-DPB1*03:01",
        "gene": "HLA-DPB1",
        "level": "2B",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs20417",
        "gene": "PTGS2",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs1065776",
        "gene": "P2RY1",
        "level": "3",
        "phenotypes": "Myocardial Infarction"
      },
      {
        "variant": "rs7179742",
        "gene": "FSIP1",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs7572857",
        "gene": "CEP68",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs3856806",
        "gene": "PPARG",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs2243250",
        "gene": "IL4",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs2228079",
        "gene": "ADORA1",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs1613662",
        "gene": "GP6",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs11587213",
        "gene": "FCER1G",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs1143627",
        "gene": "IL1B",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1131882",
        "gene": "TBXA2R",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs1062535",
        "gene": "ITGA2",
        "level": "3",
        "phenotypes": "Myocardial Infarction"
      },
      {
        "variant": "rs2768759",
        "gene": "NTRK1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1050891",
        "gene": "HNMT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5985",
        "gene": "F13A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs12041331",
        "gene": "PEAR1",
        "level": "3",
        "phenotypes": "Myocardial Infarction"
      },
      {
        "variant": "G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham",
        "gene": "G6PD",
        "level": "3",
        "phenotypes": "Hemolysis"
      },
      {
        "variant": "rs4523",
        "gene": "TBXA2R",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "HLA-DPB1*04:01",
        "gene": "HLA-DPB1",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs3818822",
        "gene": "CHIA",
        "level": "3",
        "phenotypes": "Aspirin-induced asthma"
      },
      {
        "variant": "rs1047626",
        "gene": "SLC30A9",
        "level": "3",
        "phenotypes": "Aspirin-induced asthma"
      },
      {
        "variant": "rs3097671",
        "gene": "HLA-DPB1",
        "level": "3",
        "phenotypes": "Aspirin-induced asthma"
      },
      {
        "variant": "rs1042136",
        "gene": "HLA-DPB1",
        "level": "3",
        "phenotypes": "Aspirin-induced asthma,Asthma"
      },
      {
        "variant": "rs1042151",
        "gene": "HLA-DPB1",
        "level": "3",
        "phenotypes": "Aspirin-induced asthma,Asthma"
      },
      {
        "variant": "rs3129294",
        "gene": "HLA-DPB2",
        "level": "3",
        "phenotypes": "Aspirin-induced asthma,Asthma"
      },
      {
        "variant": "rs1074373",
        "gene": "",
        "level": "3",
        "phenotypes": "Aspirin-induced asthma,Asthma"
      },
      {
        "variant": "rs7862221",
        "gene": "TSC1",
        "level": "3",
        "phenotypes": "Aspirin-induced asthma,Asthma"
      },
      {
        "variant": "rs11819745",
        "gene": "THRA",
        "level": "3",
        "phenotypes": "Aspirin-induced asthma,Asthma"
      },
      {
        "variant": "rs1059288",
        "gene": "TAPBP",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs2071888",
        "gene": "TAPBP",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs1126510",
        "gene": "PTGIR",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs1353411",
        "gene": "PTGER2",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs2075797",
        "gene": "PTGER2",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs7551789",
        "gene": "PTGER3",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs4292",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs4291",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs3775291",
        "gene": "TLR3",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs5050",
        "gene": "AGT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10279545",
        "gene": "COL26A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs12746200",
        "gene": "PLA2G4A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1805034",
        "gene": "TNFRSF11A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2228246",
        "gene": "PLCG1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs1126643",
        "gene": "ITGA2",
        "level": "3",
        "phenotypes": "Coronary Artery Disease,Coronary Disease,Myocardial Infarction"
      },
      {
        "variant": "rs1062535",
        "gene": "ITGA2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10306114",
        "gene": "PTGS1",
        "level": "3",
        "phenotypes": "Myocardial Infarction"
      },
      {
        "variant": "rs12041331",
        "gene": "PEAR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2108622",
        "gene": "CYP4F2",
        "level": "3",
        "phenotypes": "Acute coronary syndrome"
      },
      {
        "variant": "rs4271002",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs6962291",
        "gene": "TBXAS1",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs16973225",
        "gene": "",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs557881",
        "gene": "SLC6A12",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs3130100",
        "gene": "ZBTB22",
        "level": "3",
        "phenotypes": "Aspirin-induced asthma,Asthma"
      },
      {
        "variant": "rs12042763",
        "gene": "PTGS2",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs16851030",
        "gene": "ADORA1",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs1800469",
        "gene": "TGFB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1131882",
        "gene": "TBXA2R",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs1105879",
        "gene": "UGT1A6",
        "level": "3",
        "phenotypes": "Colonic Neoplasms"
      },
      {
        "variant": "rs2070959",
        "gene": "UGT1A6",
        "level": "3",
        "phenotypes": "Colonic Neoplasms"
      },
      {
        "variant": "rs2965667",
        "gene": "",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs2768759",
        "gene": "NTRK1,PEAR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs12041331",
        "gene": "PEAR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6065",
        "gene": "GP1BA",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs730012",
        "gene": "LTC4S",
        "level": "3",
        "phenotypes": "Urticaria"
      },
      {
        "variant": "rs10306114",
        "gene": "PTGS1",
        "level": "3",
        "phenotypes": "Coronary Artery Disease,Myocardial Infarction"
      },
      {
        "variant": "rs115346678",
        "gene": "",
        "level": "3",
        "phenotypes": "adverse events"
      },
      {
        "variant": "rs12678747",
        "gene": "EYA1",
        "level": "3",
        "phenotypes": "Peptic Ulcer Disease"
      },
      {
        "variant": "rs11640115",
        "gene": "JMJD8,WDR24",
        "level": "3",
        "phenotypes": "Acute coronary syndrome,Major Adverse Cardiac Events (MACE)"
      },
      {
        "variant": "rs4736529",
        "gene": "EFR3A",
        "level": "3",
        "phenotypes": "Acute coronary syndrome,Major Adverse Cardiac Events (MACE)"
      },
      {
        "variant": "rs74569896",
        "gene": "NECAB1",
        "level": "3",
        "phenotypes": "Acute coronary syndrome,Major Adverse Cardiac Events (MACE)"
      },
      {
        "variant": "rs75750968",
        "gene": "AGAP3",
        "level": "3",
        "phenotypes": "Acute coronary syndrome,Major Adverse Cardiac Events (MACE)"
      },
      {
        "variant": "rs140410716",
        "gene": "ECHS1",
        "level": "3",
        "phenotypes": "Acute coronary syndrome,Major Adverse Cardiac Events (MACE)"
      },
      {
        "variant": "rs17064642",
        "gene": "MYOM2",
        "level": "3",
        "phenotypes": "Acute coronary syndrome,Major Adverse Cardiac Events (MACE)"
      },
      {
        "variant": "rs3749187",
        "gene": "ZDHHC3",
        "level": "3",
        "phenotypes": "Acute coronary syndrome,Major Adverse Cardiac Events (MACE)"
      },
      {
        "variant": "rs28360521",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1800629",
        "gene": "TNF",
        "level": "3",
        "phenotypes": "Migraine without Aura"
      },
      {
        "variant": "rs201441480",
        "gene": "KRTAP10-4,TSPEAR",
        "level": "3",
        "phenotypes": "Acute coronary syndrome,Major Adverse Cardiac Events (MACE)"
      },
      {
        "variant": "rs5918",
        "gene": "ITGB3",
        "level": "4",
        "phenotypes": "Acute coronary syndrome,Coronary Artery Disease"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for aspirin and G6PD"
      }
    ],
    "guidelines": {
      "advice": "There is no reason to avoid aspirin at doses of 1g/day in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), aspirin 1g/day should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. CPIC gives a 'no recommendation' for the use of G6PD genotype for prescribing aspirin at doses &gt;1g/day. In summary, CPIC either does not provide, or recommend changing, prescribing actions based on G6PD genotype for aspirin at any dose.\n",
      "source": "CPIC"
    }
  },
  "selective serotonin reuptake inhibitors": {
    "genes": [
      "REPS1",
      "RND1",
      "DRD2",
      "ABCB1",
      "HTR1A",
      "TPH1",
      "PTCHD1",
      "CYP2D6",
      "ADRA2A",
      "GRIK4",
      "DEAF1",
      "MTCL1",
      "STMN2",
      "CYP2C19",
      "BDNF",
      "TXNRD2",
      "SLC6A3",
      "FKBP5",
      "GAL",
      "OSMR",
      "BRD2",
      "ATF3",
      "SLC6A4",
      "HTR7",
      "BCR",
      "CSMD2",
      "ANGPT2",
      "HTR2A",
      "GABRP",
      "GRIA1",
      "TPH2",
      "APOE",
      "MIR7-2",
      "PHACTR1",
      "AFAP1L1",
      "PLCB1",
      "TH",
      "SLC6A2",
      "DGCR5",
      "CAP2",
      "MTMR12",
      "GRIA3",
      "GABRA6",
      "COMT",
      "SLC1A1",
      "LINC00478"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1992647",
        "gene": "GABRA6",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs10036156",
        "gene": "GABRP",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs3761555",
        "gene": "GRIA3",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs3761554",
        "gene": "GRIA3",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs502434",
        "gene": "GRIA3",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs948854",
        "gene": "GAL",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs6295",
        "gene": "HTR1A",
        "level": "3",
        "phenotypes": "Depressive Disorder,Major Depressive Disorder"
      },
      {
        "variant": "rs2734833",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs301434",
        "gene": "SLC1A1",
        "level": "3",
        "phenotypes": "Obsessive-Compulsive Disorder"
      },
      {
        "variant": "rs301435",
        "gene": "SLC1A1",
        "level": "3",
        "phenotypes": "Obsessive-Compulsive Disorder"
      },
      {
        "variant": "rs3087879",
        "gene": "SLC1A1",
        "level": "3",
        "phenotypes": "Obsessive-Compulsive Disorder"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs6108160",
        "gene": "PLCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs10514475",
        "gene": "",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs4460839",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1800544",
        "gene": "ADRA2A",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs7905446",
        "gene": "HTR7",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs4713916",
        "gene": "FKBP5",
        "level": "3",
        "phenotypes": "Depressive Disorder,Mood Disorder"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*4",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs13306278",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs6311",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "Diarrhea,Diminished ability to concentrate,Dizziness,Major Depressive Disorder,Tremor"
      },
      {
        "variant": "SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",
        "gene": "SLC6A4",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "thiazides, plain": {
    "genes": [
      "ADRB3",
      "NELFCD",
      "CSK",
      "ZNF652",
      "GNB3",
      "HS3ST4",
      "MTHFR",
      "ERCC6L2",
      "CSMD3",
      "CLCN6",
      "ADD1",
      "SH2B3",
      "PLCD3",
      "AGTR1",
      "PRKCA",
      "SLC12A3",
      "ACBD4",
      "SLCO2A1",
      "CNTNAP2",
      "ACE",
      "CABCOCO1",
      "FGF5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "atenolol": {
    "genes": [
      "ADRB3",
      "LDLR",
      "EDN1",
      "STN1",
      "CYP2C9",
      "ADRB1",
      "ABCB1",
      "NEDD4L",
      "PLA2G4A",
      "GNB3",
      "PPARA",
      "CYP2D6",
      "ADRA2A",
      "PTGS2",
      "SLC4A1",
      "CYP11B2",
      "MOV10",
      "ACE2",
      "SNX9",
      "CAPZA1",
      "XIRP2",
      "PRKCB",
      "NR1H3",
      "PLEKHH2",
      "RRP1B",
      "GALNT2",
      "HFE",
      "CACNA1C",
      "ARAP1",
      "LRRC15",
      "AGT",
      "ADD1",
      "OR10P1",
      "CHIC2",
      "AGTR1",
      "ADRB2",
      "GRK5",
      "KCNH2",
      "ALDH1A2",
      "ACY3",
      "ADRA2C",
      "PROX1",
      "PAH",
      "SLCO2B1",
      "TBX2",
      "FTO",
      "ZMAT4",
      "DPYS",
      "ACE",
      "SLC25A31",
      "GRK4",
      "FGF5"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1051375",
        "gene": "CACNA1C",
        "level": "3",
        "phenotypes": "Coronary Artery Disease,Hypertension"
      },
      {
        "variant": "rs688",
        "gene": "LDLR",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs11039149",
        "gene": "NR1H3",
        "level": "3",
        "phenotypes": "Coronary Artery Disease,Hypertension"
      },
      {
        "variant": "rs5370",
        "gene": "EDN1",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs5051",
        "gene": "AGT",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1800545",
        "gene": "ADRA2A",
        "level": "3",
        "phenotypes": "Hypertrophy, Left Ventricular"
      },
      {
        "variant": "rs4648287",
        "gene": "PTGS2",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs10157410",
        "gene": "PLA2G4A",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs2144297",
        "gene": "GALNT2",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs2144300",
        "gene": "GALNT2",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs3213619",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs10267099",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs12595985",
        "gene": "FTO",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs9940629",
        "gene": "FTO",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs12346562",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1104514",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs10739150",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs11313667",
        "gene": "LRRC15",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1042714",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs340874",
        "gene": "PROX1",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs11649514",
        "gene": "PRKCB",
        "level": "3",
        "phenotypes": "Hyperglycemia"
      },
      {
        "variant": "rs11124945",
        "gene": "PLEKHH2",
        "level": "3",
        "phenotypes": "Diabetes Mellitus,Hypertension"
      },
      {
        "variant": "rs2669429",
        "gene": "DPYS",
        "level": "3",
        "phenotypes": "Hyperglycemia,Hypertension"
      },
      {
        "variant": "rs35123024",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs261316",
        "gene": "ALDH1A2",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs7606603",
        "gene": "XIRP2",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs16872401",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs7184292",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs7184292",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs201279313",
        "gene": "SLC25A31",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1367094",
        "gene": "ZMAT4",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs45545233",
        "gene": "SLC4A1",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs294610",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Tachycardia"
      },
      {
        "variant": "rs1042714",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Tachycardia"
      },
      {
        "variant": "rs9306160",
        "gene": "RRP1B",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs4387287",
        "gene": "STN1",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs8068318",
        "gene": "TBX2",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs5443",
        "gene": "GNB3",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs2301339",
        "gene": "GNB3",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs11064426",
        "gene": "GNB3",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs699",
        "gene": "AGT",
        "level": "3",
        "phenotypes": "Hypertension,Hypertrophy, Left Ventricular"
      },
      {
        "variant": "rs1024323",
        "gene": "GRK4",
        "level": "3",
        "phenotypes": "Coronary Artery Disease,Hypertension"
      },
      {
        "variant": "rs1801253",
        "gene": "ADRB1",
        "level": "4",
        "phenotypes": "Atrial Fibrillation,Essential hypertension,Tachycardia"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of orally administered beta-blockers based on ADRB1, ADRA2C, GRK4 and/or GRK5 genotypes.\n",
      "source": "CPIC"
    }
  },
  "metoprolol": {
    "genes": [
      "ADRB3",
      "ADRB1",
      "GNB3",
      "PPARA",
      "CYP2D6",
      "CYP2C19",
      "SLC4A1",
      "SNX9",
      "LRRC15",
      "OR10P1",
      "ADRB2",
      "GRK5",
      "ADRA2C",
      "SEPTIN3",
      "UGT1A1",
      "ZMAT4",
      "SLC25A31",
      "GRK4"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*4",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*31, CYP2D6*35, CYP2D6*41",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1024323",
        "gene": "GRK4",
        "level": "3",
        "phenotypes": "Hypertension,Kidney Disorder,Nephrosclerosis"
      },
      {
        "variant": "rs5030655",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3892097",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11313667",
        "gene": "LRRC15",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1042714",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1801058",
        "gene": "GRK4",
        "level": "3",
        "phenotypes": "hypertensive nephrosclerosis"
      },
      {
        "variant": "rs1801252",
        "gene": "ADRB1",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs201279313",
        "gene": "SLC25A31",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs45545233",
        "gene": "SLC4A1",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs294610",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Tachycardia"
      },
      {
        "variant": "rs1042714",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Tachycardia"
      },
      {
        "variant": "rs1446468",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1801253",
        "gene": "ADRB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2D6*1, CYP2D6*45, CYP2D6*46",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Hypertension"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for metoprolol and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for metoprolol and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for metoprolol and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of orally administered beta-blockers based on ADRB1, ADRA2C, GRK4 and/or GRK5 genotypes.\n",
      "source": "CPIC"
    }
  },
  "fremanezumab": {
    "genes": [
      "CALCR",
      "CRCP",
      "CALCRL",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Migraine with Aura,Migraine without Aura"
      },
      {
        "variant": "rs12615320",
        "gene": "",
        "level": "3",
        "phenotypes": "Migraine with Aura,Migraine without Aura"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "galcanezumab": {
    "genes": [
      "CALCR",
      "CRCP",
      "CALCRL",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Migraine with Aura,Migraine without Aura"
      },
      {
        "variant": "rs12615320",
        "gene": "",
        "level": "3",
        "phenotypes": "Migraine with Aura,Migraine without Aura"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "erenumab": {
    "genes": [
      "CALCR",
      "RAMP1",
      "CRCP",
      "CALCRL",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Migraine with Aura,Migraine without Aura"
      },
      {
        "variant": "rs12615320",
        "gene": "",
        "level": "3",
        "phenotypes": "Migraine with Aura,Migraine without Aura"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "clopidogrel": {
    "genes": [
      "EFR3A",
      "ABCC3",
      "POR",
      "JMJD8",
      "CYP2C9",
      "TLN1",
      "KDR",
      "ABCB1",
      "CDH15",
      "CD80",
      "AGAP3",
      "PPARA",
      "MIR6076",
      "CYP2B6",
      "CYP2D6",
      "ITGA2",
      "CYP1A1",
      "PON1",
      "ITGA2B",
      "P2RY1",
      "ATP10A",
      "CYP2C19",
      "PIK3CA",
      "KRTAP10-4",
      "CYP2C18",
      "TSPEAR",
      "CES1P1",
      "RASGRP2",
      "CYP4F2",
      "GP1BA",
      "P2RY12",
      "APBB1IP",
      "WDR24",
      "GP6",
      "MYOM2",
      "FMO3",
      "F2R",
      "SLC14A2",
      "UGT2B7",
      "NECAB1",
      "CES1",
      "ABCC2",
      "B4GALT2",
      "ZDHHC3",
      "ARNT",
      "THSD7A",
      "IRS1",
      "CYP3A4",
      "F13A1",
      "ECHS1",
      "N6AMT1",
      "NOC3L",
      "UCP2",
      "CDH13",
      "CYP2C8",
      "SELP",
      "PTGS1",
      "CYP3A5",
      "ABCA1",
      "MED12L",
      "ZNF335",
      "ITGB3",
      "CYP1A2",
      "NOS3",
      "PEAR1"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",
        "gene": "CYP2C19",
        "level": "1A",
        "phenotypes": "Cardiovascular Disease"
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*10, CYP2C19*17, CYP2C19*19, CYP2C19*25, CYP2C19*26",
        "gene": "CYP2C19",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4, CYP2C19*5, CYP2C19*6, CYP2C19*8, CYP2C19*17",
        "gene": "CYP2C19",
        "level": "1A",
        "phenotypes": "Acute coronary syndrome,Cardiovascular Disease,Stroke,Transient Ischemic Attack"
      },
      {
        "variant": "rs71647871",
        "gene": "CES1",
        "level": "2B",
        "phenotypes": ""
      },
      {
        "variant": "rs71647871",
        "gene": "CES1",
        "level": "2B",
        "phenotypes": ""
      },
      {
        "variant": "CYP2B6*1, CYP2B6*5",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5918",
        "gene": "ITGB3",
        "level": "3",
        "phenotypes": "Coronary Artery Disease,Myocardial Infarction"
      },
      {
        "variant": "rs342293",
        "gene": "",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs762551",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6809699",
        "gene": "P2RY12",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs1126643",
        "gene": "ITGA2",
        "level": "3",
        "phenotypes": "Coronary Artery Disease,Coronary Disease,Myocardial Infarction"
      },
      {
        "variant": "rs6787801",
        "gene": "P2RY12",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1062535",
        "gene": "ITGA2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10306114",
        "gene": "PTGS1",
        "level": "3",
        "phenotypes": "Myocardial Infarction"
      },
      {
        "variant": "rs12041331",
        "gene": "PEAR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3785161",
        "gene": "CES1P1",
        "level": "3",
        "phenotypes": "Coronary Disease"
      },
      {
        "variant": "rs2108622",
        "gene": "CYP4F2",
        "level": "3",
        "phenotypes": "Acute coronary syndrome"
      },
      {
        "variant": "rs13431554",
        "gene": "IRS1",
        "level": "3",
        "phenotypes": "Coronary Artery Disease,Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs1061781",
        "gene": "B4GALT2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3732759",
        "gene": "P2RY12",
        "level": "3",
        "phenotypes": "Coronary Disease"
      },
      {
        "variant": "rs41273215",
        "gene": "PEAR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs57731889",
        "gene": "PEAR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Acute coronary syndrome,Myocardial Infarction"
      },
      {
        "variant": "rs2307240",
        "gene": "CES1",
        "level": "3",
        "phenotypes": "Acute coronary syndrome"
      },
      {
        "variant": "rs11568732",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Hemorrhage,Myocardial Infarction"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Coronary Disease,Hemorrhage"
      },
      {
        "variant": "rs12041331",
        "gene": "PEAR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs778068631",
        "gene": "CES1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C19*1, CYP2C19*14, CYP2C19*23",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C19*1, CYP2C19*17",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Acute coronary syndrome,Coronary Artery Disease,Hemorrhage,Myocardial Infarction"
      },
      {
        "variant": "rs11640115",
        "gene": "JMJD8,WDR24",
        "level": "3",
        "phenotypes": "Acute coronary syndrome,Major Adverse Cardiac Events (MACE)"
      },
      {
        "variant": "rs4736529",
        "gene": "EFR3A",
        "level": "3",
        "phenotypes": "Acute coronary syndrome,Major Adverse Cardiac Events (MACE)"
      },
      {
        "variant": "rs74569896",
        "gene": "NECAB1",
        "level": "3",
        "phenotypes": "Acute coronary syndrome,Major Adverse Cardiac Events (MACE)"
      },
      {
        "variant": "rs75750968",
        "gene": "AGAP3",
        "level": "3",
        "phenotypes": "Acute coronary syndrome,Major Adverse Cardiac Events (MACE)"
      },
      {
        "variant": "rs140410716",
        "gene": "ECHS1",
        "level": "3",
        "phenotypes": "Acute coronary syndrome,Major Adverse Cardiac Events (MACE)"
      },
      {
        "variant": "rs17064642",
        "gene": "MYOM2",
        "level": "3",
        "phenotypes": "Acute coronary syndrome,Major Adverse Cardiac Events (MACE)"
      },
      {
        "variant": "rs2254638",
        "gene": "N6AMT1",
        "level": "3",
        "phenotypes": "Major Adverse Cardiac Events (MACE)"
      },
      {
        "variant": "rs2046934",
        "gene": "P2RY12",
        "level": "3",
        "phenotypes": "Major Adverse Cardiac Events (MACE)"
      },
      {
        "variant": "rs1330344",
        "gene": "PTGS1",
        "level": "3",
        "phenotypes": "Major Adverse Cardiac Events (MACE)"
      },
      {
        "variant": "rs3749187",
        "gene": "ZDHHC3",
        "level": "3",
        "phenotypes": "Acute coronary syndrome,Major Adverse Cardiac Events (MACE)"
      },
      {
        "variant": "rs8192950",
        "gene": "CES1",
        "level": "3",
        "phenotypes": "Cerebrovascular Disorders,Stroke,Transient Ischemic Attack"
      },
      {
        "variant": "rs201441480",
        "gene": "KRTAP10-4,TSPEAR",
        "level": "3",
        "phenotypes": "Acute coronary syndrome,Major Adverse Cardiac Events (MACE)"
      },
      {
        "variant": "rs662",
        "gene": "PON1",
        "level": "4",
        "phenotypes": "Angina Pectoris,Coronary Artery Disease,Myocardial Infarction,Myocardial Ischemia,Thrombotic disease"
      },
      {
        "variant": "rs6785930",
        "gene": "P2RY12",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs2046934",
        "gene": "P2RY12",
        "level": "4",
        "phenotypes": "Acute coronary syndrome,Angina Pectoris"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "platelet reactivity"
      },
      {
        "variant": "rs2242480",
        "gene": "CYP3A4",
        "level": "4",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "4",
        "phenotypes": "Acute coronary syndrome,Coronary Artery Disease"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for clopidogrel and CYP2C19"
      },
      {
        "source": "EMA",
        "level": "Informative PGx",
        "name": "Annotation of EMA Label for clopidogrel and CYP2C19"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for clopidogrel and CYP2C19"
      },
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for clopidogrel and CYP2C19"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for clopidogrel and CYP2C19"
      }
    ],
    "guidelines": {
      "advice": "The American Heart Association has a statement of CYP2C19 and clopidogrel and testing before oral P2Y12 inhibitors are prescribed in patients with acute coronary syndromes or percutaneous coronary intervention.\n",
      "source": "AHA"
    }
  },
  "sodium oxybate": {
    "genes": [
      "ALDH5A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for sodium oxybate and ALDH5A1"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for sodium oxybate and ALDH5A1"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for sodium oxybate and ALDH5A1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "levetiracetam": {
    "genes": [
      "ALDH5A1",
      "HLA-DQB1",
      "HLA-A",
      "SCN1A",
      "HLA-DRB1"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-A*11:01",
        "gene": "HLA-A",
        "level": "3",
        "phenotypes": "adverse events,Epilepsy"
      },
      {
        "variant": "rs2298771",
        "gene": "SCN1A",
        "level": "4",
        "phenotypes": "Epilepsy"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "methadone": {
    "genes": [
      "ALDH5A1",
      "POR",
      "NPY5R",
      "CYP2C9",
      "KCNE1",
      "SLC22A1",
      "DAO",
      "DRD2",
      "ABCB1",
      "TPH1",
      "NR3C1",
      "GNB3",
      "KCNE2",
      "NGF",
      "CYP2B6",
      "CYP2D6",
      "CRY1",
      "ADRA2A",
      "PNOC",
      "OPRD1",
      "DRD1",
      "PDYN",
      "MYOCD",
      "OPRM1",
      "CYP2C19",
      "CCL11",
      "NPY1R",
      "BDNF",
      "TXNRD2",
      "SLC6A3",
      "OPRK1",
      "GRIN3B",
      "KCNJ6",
      "ARRB2",
      "SLC6A4",
      "DDC",
      "HTR2A",
      "BDNF-AS",
      "UGT2B7",
      "GAD1",
      "CRHBP",
      "TPH2",
      "CNR1",
      "ANKK1",
      "CYP2A7P1",
      "CYP3A4",
      "TH",
      "DBH",
      "OPRL1",
      "H2AX",
      "GRIN3A",
      "CYP3A5",
      "CDH2",
      "GRM6",
      "NTRK2",
      "NECTIN4",
      "GABRD",
      "CYP1A2",
      "GAD2",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2B6*1, CYP2B6*4, CYP2B6*6, CYP2B6*18",
        "gene": "CYP2B6",
        "level": "2A",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs7934165",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs1491850",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs2120266",
        "gene": "NTRK2",
        "level": "3",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs2289658",
        "gene": "NTRK2",
        "level": "3",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs4358872",
        "gene": "NTRK2",
        "level": "3",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs1948308",
        "gene": "NTRK2",
        "level": "3",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs2378676",
        "gene": "NTRK2",
        "level": "3",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs4877900",
        "gene": "NTRK2",
        "level": "3",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs7118900",
        "gene": "ANKK1",
        "level": "3",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs2283265",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs2239622",
        "gene": "NGF",
        "level": "3",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs10835210",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs2760118",
        "gene": "ALDH5A1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs2242480",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs1799978",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs3735451",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs4646440",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs4646437",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs2246709",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs6600879",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs6600880",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs4554144",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs11940316",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs7438135",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs7662029",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs7439366",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs4292394",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs6600893",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs5443",
        "gene": "GNB3",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs2070995",
        "gene": "KCNJ6",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs17180299",
        "gene": "",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs8094439",
        "gene": "CDH2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs17446819",
        "gene": "CDH2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs8192709",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3211371",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs9282564",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",
        "gene": "SLC6A4",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs3192723",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs1129844",
        "gene": "CCL11",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs678849",
        "gene": "OPRD1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs3749034",
        "gene": "GAD1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs3762556",
        "gene": "GAD1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs769404",
        "gene": "GAD1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs204047",
        "gene": "OPRD1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs797397",
        "gene": "OPRD1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs204047",
        "gene": "OPRD1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3802279",
        "gene": "OPRK1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs3802281",
        "gene": "OPRK1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs963549",
        "gene": "OPRK1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs933271",
        "gene": "COMT,TXNRD2",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs2279343",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Neonatal Abstinence Syndrome"
      },
      {
        "variant": "rs351776",
        "gene": "PNOC",
        "level": "3",
        "phenotypes": "Neonatal Abstinence Syndrome"
      },
      {
        "variant": "rs3745274",
        "gene": "CYP2A7P1,CYP2B6",
        "level": "3",
        "phenotypes": "Neonatal Abstinence Syndrome"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Neonatal Abstinence Syndrome"
      },
      {
        "variant": "rs4732636",
        "gene": "PNOC",
        "level": "3",
        "phenotypes": "Neonatal Abstinence Syndrome"
      },
      {
        "variant": "rs740603",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Neonatal Abstinence Syndrome"
      },
      {
        "variant": "CYP2B6*1, CYP2B6*6",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2B6*1, CYP2B6*6",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2075572",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders,Sleep Disorders"
      },
      {
        "variant": "rs558025",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Neonatal Abstinence Syndrome"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Neonatal Abstinence Syndrome"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*6",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs806368",
        "gene": "CNR1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs1386493",
        "gene": "TPH2",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs2229205",
        "gene": "OPRL1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs16974799",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs11265549",
        "gene": "NECTIN4",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders,Pruritus"
      },
      {
        "variant": "rs11265549",
        "gene": "NECTIN4",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs11265549",
        "gene": "NECTIN4",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs7668258",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs3762555",
        "gene": "GAD1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs6275",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs2279343",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs5326",
        "gene": "DRD1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs3745274",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs3745274",
        "gene": "CYP2A7P1,CYP2B6",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs73568641",
        "gene": "",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs10485058",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs55944529",
        "gene": "DAO",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs55944529",
        "gene": "DAO",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs55944529",
        "gene": "DAO",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7439366",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs6277",
        "gene": "DRD2",
        "level": "4",
        "phenotypes": "Substance-Related Disorders"
      },
      {
        "variant": "CYP2B6*1, CYP2B6*6",
        "gene": "CYP2B6",
        "level": "4",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3",
        "gene": "CYP2C19",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "CYP2D6*1, CYP2D6*2, CYP2D6*10, CYP2D6*87, CYP2D6*89, CYP2D6*90, CYP2D6*93, CYP2D6*95, CYP2D6*97, CYP2D6*98",
        "gene": "CYP2D6",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "4",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders,Substance-Related Disorders"
      },
      {
        "variant": "rs73568641",
        "gene": "",
        "level": "4",
        "phenotypes": "Opioid-Related Disorders"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "CPIC does not currently provide CYP2B6 genotype-based prescribing recommendations for methadone.\n",
      "source": "CPIC"
    }
  },
  "phenytoin": {
    "genes": [
      "ALDH5A1",
      "CYP2C9",
      "GABRB2",
      "DRD2",
      "ABCB1",
      "HTR2C",
      "PSORS1C3",
      "CYP2B6",
      "CYP2D6",
      "MTHFR",
      "CYP1A1",
      "CFHR4",
      "CYP2C19",
      "UGT1A4",
      "G6PD",
      "POU5F1",
      "UGT1A9",
      "GABRG2",
      "PSORS1C1",
      "SLC6A4",
      "HLA-A",
      "HTR2A",
      "EPHX1",
      "SCN2A",
      "CYCSP5",
      "CYP3A4",
      "HLA-B",
      "SCN1A",
      "HLA-DRB1",
      "UGT2B15",
      "GABRA1",
      "GABRA3",
      "HLA-C",
      "CYP3A5",
      "NAT2",
      "POLG",
      "UGT1A6",
      "GABRA6",
      "CYP1A2"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "1A",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*11, CYP2C9*13, CYP2C9*14, CYP2C9*16, CYP2C9*29, CYP2C9*31, CYP2C9*33, CYP2C9*37, CYP2C9*39, CYP2C9*42, CYP2C9*43, CYP2C9*45, CYP2C9*50, CYP2C9*52, CYP2C9*55",
        "gene": "CYP2C9",
        "level": "1A",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "HLA-B*15:02",
        "gene": "HLA-B",
        "level": "1A",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1051740",
        "gene": "EPHX1",
        "level": "3",
        "phenotypes": "Congenital Abnormalities,Disorder of facial skeleton"
      },
      {
        "variant": "rs2234922",
        "gene": "EPHX1",
        "level": "3",
        "phenotypes": "Congenital Abnormalities,Disorder of facial skeleton"
      },
      {
        "variant": "rs12782374",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs1934969",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "HLA-B*15:13",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "rs71486745",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2606345",
        "gene": "CYP1A1",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "HLA-C*08:01",
        "gene": "HLA-C",
        "level": "3",
        "phenotypes": "Maculopapular Exanthema,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "rs4986893",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "HLA-B*13:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "rs2279020",
        "gene": "GABRA1",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs544027339",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs1029359343",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "HLA-A*24:02",
        "gene": "HLA-A",
        "level": "3",
        "phenotypes": "Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "rs78239784",
        "gene": "CFHR4",
        "level": "3",
        "phenotypes": "Maculopapular Exanthema"
      },
      {
        "variant": "rs1041983",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Drug interaction with drug,Drug Toxicity"
      },
      {
        "variant": "rs1801280",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Drug interaction with drug,Drug Toxicity"
      },
      {
        "variant": "rs1799929",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Drug interaction with drug,Drug Toxicity"
      },
      {
        "variant": "rs1799930",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Drug interaction with drug,Drug Toxicity"
      },
      {
        "variant": "rs1208",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Drug interaction with drug,Drug Toxicity"
      },
      {
        "variant": "rs1799931",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Drug interaction with drug,Drug Toxicity"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Epilepsy,Psychotic Disorder"
      },
      {
        "variant": "rs780801862",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "CYP2C9*1, CYP2C9*19, CYP2C9*27, CYP2C9*36, CYP2C9*40, CYP2C9*41, CYP2C9*47, CYP2C9*49, CYP2C9*51, CYP2C9*53, CYP2C9*54, CYP2C9*56",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3812718",
        "gene": "SCN1A",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "HLA-B*56:02",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "rs2304016",
        "gene": "SCN2A",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "CYP2C9*1, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": "Stevens-Johnson Syndrome"
      },
      {
        "variant": "rs17183814",
        "gene": "SCN2A",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Epilepsy"
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Testing Recommended",
        "name": "Annotation of HCSC Label for phenytoin and HLA-B"
      },
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for phenytoin and CYP2C9, HLA-B"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for phenytoin and CYP2C9, HLA-B"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for phenytoin"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for phenytoin and CYP2C19"
      }
    ],
    "guidelines": {
      "advice": "Phenytoin should be avoided if possible in patients with the HLA-B*15:02 allele.\n",
      "source": "DPWG"
    }
  },
  "rosuvastatin": {
    "genes": [
      "LDLR",
      "CYP2C9",
      "HNF4A",
      "SCARB1",
      "CYP2D6",
      "CYP2C19",
      "SCAP",
      "SLC10A1",
      "LPA",
      "CETP",
      "APOA5",
      "NR1H4",
      "TPMT",
      "HNF1A",
      "FMO3",
      "CRP",
      "ABCC2",
      "APOE",
      "NR1I2",
      "ABCG2",
      "ABCB11",
      "CYP3A4",
      "HLA-DRB1",
      "RYR2",
      "KIF6",
      "CACNA1S",
      "CYP3A5",
      "ABCA1",
      "SLCO2B1",
      "FOXA3",
      "HMGCR",
      "SLCO1B1",
      "NAT2",
      "RXRA",
      "GATM",
      "COQ2",
      "LPL",
      "USP24"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": "statin-related myopathy"
      },
      {
        "variant": "SLCO1B1*1, SLCO1B1*5, SLCO1B1*9, SLCO1B1*14, SLCO1B1*15, SLCO1B1*37",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "1A",
        "phenotypes": "statin-related myopathy"
      },
      {
        "variant": "SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": "statin-related myopathy"
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "2A",
        "phenotypes": "Hypercholesterolemia,Myocardial Infarction"
      },
      {
        "variant": "rs6535454",
        "gene": "COQ2",
        "level": "3",
        "phenotypes": "Muscular Diseases"
      },
      {
        "variant": "rs4149081",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Coronary Disease"
      },
      {
        "variant": "rs1736557",
        "gene": "FMO3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1205",
        "gene": "CRP",
        "level": "3",
        "phenotypes": "Coronary Disease"
      },
      {
        "variant": "rs2808630",
        "gene": "",
        "level": "3",
        "phenotypes": "Coronary Disease"
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Myocardial Infarction"
      },
      {
        "variant": "HLA-DRB1*01:01, HLA-DRB1*04:06",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs20455",
        "gene": "KIF6",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs10455872",
        "gene": "LPA",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4693075",
        "gene": "COQ2",
        "level": "3",
        "phenotypes": "Muscular Diseases"
      },
      {
        "variant": "rs2230806",
        "gene": "ABCA1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2D6*1, CYP2D6*3, CYP2D6*4",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs708272",
        "gene": "CETP",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5882",
        "gene": "CETP",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs12422149",
        "gene": "SLCO2B1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2199936",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "4",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for rosuvastatin and LDLR"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for rosuvastatin and SLCO1B1"
      },
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for rosuvastatin and ABCG2, SLCO1B1"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for rosuvastatin and ABCG2, SLCO1B1"
      }
    ],
    "guidelines": {
      "advice": "Keep the rosuvastatin dose as low as possible (e.g. by adding ezetimibe) for patients with the SLCO1B1 521 CC or TC (rs4149056) genotype and with ADDITIONAL SIGNIFICANT RISK FACTORS for statin-induced myopathy. For patients without additional significant risk factors for statin-induced myopathy, advise the patients to contact their doctor in the event of muscle symptoms.\n",
      "source": "DPWG"
    }
  },
  "pitavastatin": {
    "genes": [
      "LDLR",
      "CYP2C9",
      "APOB",
      "ABCC2",
      "ABCG2",
      "PCSK9",
      "CYP3A4",
      "HLA-DRB1",
      "RYR2",
      "CYP3A5",
      "HMGCR",
      "SLCO1B1",
      "GATM"
    ],
    "clinicalVariants": [
      {
        "variant": "SLCO1B1*1, SLCO1B1*5, SLCO1B1*15, SLCO1B1*37",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs2306283",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for pitavastatin and SLCO1B1"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for pitavastatin"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for pitavastatin and APOB, LDLR, PCSK9"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for pitavastatin"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for atorvastatin, lovastatin, fluvastatin, pravastatin, pitavastatin, rosuvastatin and simvastatin dosing based on HMGCR, CYP3A4 or CYP3A5 genotypes.\n",
      "source": "CPIC"
    }
  },
  "peginterferon alfa-2a": {
    "genes": [
      "LDLR",
      "SCARB1",
      "IL6",
      "IL18",
      "ABCB1",
      "CTLA4",
      "EGFR",
      "ITPA",
      "OAS1",
      "APOH",
      "METTL1",
      "NT5C2",
      "CYP27B1",
      "HLA-A",
      "IDO1",
      "IFNL4",
      "ZHX2",
      "VDR",
      "HLA-B",
      "SOCS3",
      "DNAAF9",
      "CXCL10",
      "MICB",
      "DPP4",
      "IFNL3",
      "SLC29A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "1A",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "1A",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "1A",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs11322783",
        "gene": "IFNL4",
        "level": "1B",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs8099917",
        "gene": "IFNL3",
        "level": "1B",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs11881222",
        "gene": "IFNL3",
        "level": "2A",
        "phenotypes": "Hepatitis C virus infection,HIV infectious disease"
      },
      {
        "variant": "rs8099917",
        "gene": "IFNL3",
        "level": "2A",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs8103142",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "HLA-B*38:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "rs1544410",
        "gene": "VDR",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "rs3828913",
        "gene": "MICB",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs760370",
        "gene": "SLC29A1",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs4803219",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs28416813",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection,HIV infectious disease"
      },
      {
        "variant": "rs4803217",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection,HIV infectious disease"
      },
      {
        "variant": "rs14158",
        "gene": "LDLR",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection,HIV infectious disease"
      },
      {
        "variant": "rs12980275",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs8099917",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "rs56061981",
        "gene": "CXCL10",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs7248668",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs8105790",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs6051702",
        "gene": "ITPA",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "rs10846744",
        "gene": "SCARB1",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs11322783",
        "gene": "IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs117648444",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs4273729",
        "gene": "",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs11506105",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Myeloproliferative Disorder"
      },
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Hepatitis B, Chronic"
      },
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "IFNL3 (IL28B) variation (rs12979860) is the strongest baseline predictor of response to PEG-interferon-alpha-containing regimens in HCV genotype 1 patients.  Patients with the favorable response genotype (rs12979860 CC) have increased likelihood of response (higher SVR rate) to PEG-interferon-alpha-containing regimens as compared to patients with unfavorable response genotype (rs12979860 CT or TT). Consider implications before initiating PEG-IFN alpha and RBV containing regimens.\n",
      "source": "CPIC"
    }
  },
  "peginterferon alfa-2b": {
    "genes": [
      "LDLR",
      "IL6",
      "IL18",
      "CARD16",
      "CTLA4",
      "EGFR",
      "ITPA",
      "OAS1",
      "APOH",
      "TUT7",
      "IL21R",
      "IFIT1",
      "OASL",
      "CYP27B1",
      "SLC6A4",
      "HLA-A",
      "IDO1",
      "IFNL4",
      "HLA-DPA1",
      "VDR",
      "KIR2DS2",
      "HLA-B",
      "SOCS3",
      "DNAAF9",
      "CXCL10",
      "KLRK1",
      "HLA-C",
      "MICB",
      "UGT1A1",
      "CYP2R1",
      "DPP4",
      "SLC28A2",
      "IFNL3",
      "CASP1",
      "SLC29A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "1A",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "1A",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "1A",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs11322783",
        "gene": "IFNL4",
        "level": "1B",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs8099917",
        "gene": "IFNL3",
        "level": "1B",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs11881222",
        "gene": "IFNL3",
        "level": "2A",
        "phenotypes": "Hepatitis C virus infection,HIV infectious disease"
      },
      {
        "variant": "rs8099917",
        "gene": "IFNL3",
        "level": "2A",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs1127354",
        "gene": "ITPA",
        "level": "2B",
        "phenotypes": "Anemia,Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs7270101",
        "gene": "ITPA",
        "level": "2B",
        "phenotypes": "Anemia,Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs9657182",
        "gene": "IDO1",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs12819210",
        "gene": "OASL",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "rs8103142",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "HLA-B*38:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "rs3828913",
        "gene": "MICB",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs3077",
        "gene": "HLA-DPA1",
        "level": "3",
        "phenotypes": "Hepatitis B, Chronic"
      },
      {
        "variant": "rs760370",
        "gene": "SLC29A1",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs4803219",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs28416813",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection,HIV infectious disease"
      },
      {
        "variant": "rs10877012",
        "gene": "CYP27B1",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs8113007",
        "gene": "",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection,HIV infectious disease"
      },
      {
        "variant": "rs4803217",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection,HIV infectious disease"
      },
      {
        "variant": "rs10853728",
        "gene": "",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs11854484",
        "gene": "SLC28A2",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",
        "gene": "SLC6A4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs1800795",
        "gene": "IL6",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs14158",
        "gene": "LDLR",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection,HIV infectious disease"
      },
      {
        "variant": "rs12980275",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs8099917",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "rs56061981",
        "gene": "CXCL10",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs7248668",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs8105790",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs11322783",
        "gene": "IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs117648444",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs4273729",
        "gene": "",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs10741657",
        "gene": "CYP2R1",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs11506105",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "HLA-C*01:02, HLA-C*02:02, HLA-C*03:02, HLA-C*04:01, HLA-C*05:01, HLA-C*06:02, HLA-C*07:01, HLA-C*08:01, HLA-C*12:02, HLA-C*14:02, HLA-C*15:02, HLA-C*16:01, HLA-C*17:01",
        "gene": "HLA-C",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Myeloproliferative Disorder"
      },
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs2228570",
        "gene": "VDR",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for peginterferon alfa-2b and IFNL3"
      }
    ],
    "guidelines": {
      "advice": "IFNL3 (IL28B) variation (rs12979860) is the strongest baseline predictor of response to PEG-interferon-alpha-containing regimens in HCV genotype 1 patients.  Patients with the favorable response genotype (rs12979860 CC) have increased likelihood of response (higher SVR rate) to PEG-interferon-alpha-containing regimens as compared to patients with unfavorable response genotype (rs12979860 CT or TT). Consider implications before initiating PEG-IFN alpha and RBV containing regimens.\n",
      "source": "CPIC"
    }
  },
  "lomitapide": {
    "genes": [
      "LDLR",
      "APOB",
      "PCSK9"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for lomitapide and LDLR"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for lomitapide"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for lomitapide and APOB, LDLR, PCSK9"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mipomersen": {
    "genes": [
      "LDLR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for mipomersen and LDLR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "alirocumab": {
    "genes": [
      "LDLR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for alirocumab and LDLR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "evinacumab": {
    "genes": [
      "LDLR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for evinacumab and LDLR"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for evinacumab and LDLR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "inclisiran": {
    "genes": [
      "LDLR",
      "APOB",
      "PCSK9"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for inclisiran and APOB, LDLR, PCSK9"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for inclisiran and APOB, LDLR, PCSK9"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for inclisiran and APOB, LDLR, PCSK9"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "atorvastatin": {
    "genes": [
      "LDLR",
      "POR",
      "CAT",
      "LEPR",
      "APOC3",
      "UGT1A10",
      "CYP2C9",
      "FDPS",
      "SCARB1",
      "MTTP",
      "LPP",
      "ABCB1",
      "UGT1A3",
      "RYR1",
      "HTR2C",
      "MYLIP",
      "PPARA",
      "CYP2D6",
      "MTHFR",
      "PON1",
      "CYP2C19",
      "SCAP",
      "UGT1A4",
      "LPA",
      "PRDM16",
      "HTR1D",
      "CETP",
      "APOA5",
      "UGT1A9",
      "SLC6A4",
      "HTR7",
      "UGT1A8",
      "UGT1A5",
      "HTR2A",
      "IFNL4",
      "ABCC2",
      "APOE",
      "ABCG2",
      "AGT",
      "PCSK9",
      "HTR6",
      "CYP3A4",
      "AGTR1",
      "CLMN",
      "BDKRB2",
      "HLA-DRB1",
      "TNF",
      "RYR2",
      "HTR3A",
      "CYP7A1",
      "HTR5A",
      "KIF6",
      "SREBF1",
      "UGT1A1",
      "CACNA1S",
      "CYP3A5",
      "ABCA1",
      "SLCO2B1",
      "HMGCR",
      "SLCO1B1",
      "UGT1A6",
      "DRD3",
      "GATM",
      "UGT1A7",
      "COQ2",
      "HTR3B",
      "ACE",
      "IFNL3",
      "LPL",
      "CYP3A7",
      "NOS3",
      "ABCG8",
      "ESR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": "statin-related myopathy"
      },
      {
        "variant": "SLCO1B1*1, SLCO1B1*5, SLCO1B1*15, SLCO1B1*37",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs7412",
        "gene": "APOE",
        "level": "2B",
        "phenotypes": "Coronary Disease,Hyperlipidemias"
      },
      {
        "variant": "rs2276307",
        "gene": "HTR3B",
        "level": "3",
        "phenotypes": "Myalgia"
      },
      {
        "variant": "rs1935349",
        "gene": "HTR7",
        "level": "3",
        "phenotypes": "Myalgia"
      },
      {
        "variant": "rs6535454",
        "gene": "COQ2",
        "level": "3",
        "phenotypes": "Muscular Diseases"
      },
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "UGT1A3*1, UGT1A3*2",
        "gene": "UGT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1800591",
        "gene": "MTTP",
        "level": "3",
        "phenotypes": "Hyperlipoproteinemia Type II"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Coronary Artery Disease,Myalgia"
      },
      {
        "variant": "rs11887534",
        "gene": "ABCG8",
        "level": "3",
        "phenotypes": "Coronary Artery Disease,Hypercholesterolemia"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Myalgia"
      },
      {
        "variant": "rs17238540",
        "gene": "HMGCR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1800629",
        "gene": "TNF",
        "level": "3",
        "phenotypes": "Acute coronary syndrome"
      },
      {
        "variant": "rs12003906",
        "gene": "ABCA1",
        "level": "3",
        "phenotypes": "Hyperlipidemias"
      },
      {
        "variant": "rs5888",
        "gene": "SCARB1",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs9370867",
        "gene": "MYLIP",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs4149036",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1057868",
        "gene": "POR",
        "level": "3",
        "phenotypes": "Familial hypercholesterolemia"
      },
      {
        "variant": "rs2297480",
        "gene": "FDPS",
        "level": "3",
        "phenotypes": "Coronary Disease"
      },
      {
        "variant": "rs17671591",
        "gene": "HMGCR",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs662",
        "gene": "PON1",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs705379",
        "gene": "PON1",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs1805094",
        "gene": "LEPR",
        "level": "3",
        "phenotypes": "Acute coronary syndrome"
      },
      {
        "variant": "rs2740574",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs705379",
        "gene": "PON1",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11264359",
        "gene": "FDPS",
        "level": "3",
        "phenotypes": "Coronary Disease,Osteoporosis"
      },
      {
        "variant": "HLA-DRB1*01:01, HLA-DRB1*04:06",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2819742",
        "gene": "RYR2",
        "level": "3",
        "phenotypes": "Cardiovascular Disease"
      },
      {
        "variant": "rs5186",
        "gene": "AGTR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799722",
        "gene": "BDKRB2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs17161788",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs4693075",
        "gene": "COQ2",
        "level": "3",
        "phenotypes": "Muscular Diseases"
      },
      {
        "variant": "rs662799",
        "gene": "APOA5",
        "level": "3",
        "phenotypes": "Hyperlipidemias"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs2230806",
        "gene": "ABCA1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2D6*1, CYP2D6*3, CYP2D6*4",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs20455",
        "gene": "KIF6",
        "level": "3",
        "phenotypes": "Coronary Disease,Hypercholesterolemia,Myocardial Infarction"
      },
      {
        "variant": "rs2242480",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Hyperlipidemias"
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3808607",
        "gene": "CYP7A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs12487736",
        "gene": "SCAP",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs708272",
        "gene": "CETP",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs2306283",
        "gene": "SLCO1B1",
        "level": "4",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "4",
        "phenotypes": "Dyslipidaemia,Familial hypercholesterolemia,Hypercholesterolemia,Hyperlipidemias"
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for atorvastatin and LDLR"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for atorvastatin and LDLR"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for atorvastatin and SLCO1B1"
      },
      {
        "source": "PMDA",
        "level": "",
        "name": "Annotation of PMDA Label for atorvastatin and LDLR"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for atorvastatin, lovastatin, fluvastatin, pravastatin, pitavastatin, rosuvastatin and simvastatin dosing based on HMGCR, CYP3A4 or CYP3A5 genotypes.\n",
      "source": "CPIC"
    }
  },
  "fluvastatin": {
    "genes": [
      "LDLR",
      "CYP2C9",
      "ABCB1",
      "CYP2D6",
      "SCAP",
      "CETP",
      "LIPC",
      "APOE",
      "ABCG2",
      "CYP3A4",
      "HLA-DRB1",
      "RYR2",
      "SREBF1",
      "CYP3A5",
      "HMGCR",
      "SLCO1B1",
      "GATM",
      "COQ2",
      "ACE"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": "statin-related myopathy"
      },
      {
        "variant": "SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": "statin-related myopathy"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs11045819",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs60282872",
        "gene": "SREBF1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4783961",
        "gene": "CETP",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs1922242",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs5882",
        "gene": "CETP",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs17238540",
        "gene": "HMGCR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4986910",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1800588",
        "gene": "LIPC",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "HLA-DRB1*01:01, HLA-DRB1*04:06",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7412",
        "gene": "APOE",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2D6*1, CYP2D6*4",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "SLCO1B1*1, SLCO1B1*14",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for atorvastatin, lovastatin, fluvastatin, pravastatin, pitavastatin, rosuvastatin and simvastatin dosing based on HMGCR, CYP3A4 or CYP3A5 genotypes.\n",
      "source": "CPIC"
    }
  },
  "lovastatin": {
    "genes": [
      "LDLR",
      "PPARA",
      "CYP2D6",
      "CETP",
      "APOA5",
      "APOE",
      "ABCG2",
      "CYP3A4",
      "CYP3A5",
      "HMGCR",
      "SLCO1B1"
    ],
    "clinicalVariants": [
      {
        "variant": "SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": "statin-related myopathy"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": "statin-related myopathy"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs708272",
        "gene": "CETP",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs17238540",
        "gene": "HMGCR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2D6*1, CYP2D6*5, CYP2D6*10",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2291073",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Arteriosclerosis"
      },
      {
        "variant": "rs688",
        "gene": "LDLR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5925",
        "gene": "LDLR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs662799",
        "gene": "APOA5",
        "level": "3",
        "phenotypes": "Hyperlipidemias"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for atorvastatin, lovastatin, fluvastatin, pravastatin, pitavastatin, rosuvastatin and simvastatin dosing based on HMGCR, CYP3A4 or CYP3A5 genotypes.\n",
      "source": "CPIC"
    }
  },
  "pravastatin": {
    "genes": [
      "LDLR",
      "MTTP",
      "ABCB1",
      "HTR2C",
      "DLGAP1",
      "RHOA",
      "NLRP8",
      "MTHFR",
      "FCAR",
      "IL12B",
      "SLC10A1",
      "NPC1L1",
      "HTR1D",
      "CETP",
      "KYNU",
      "PPP1R1C",
      "ADAMTS14",
      "APOA1",
      "SLCO1B3",
      "SLC6A4",
      "HTR7",
      "LIPC",
      "IP6K2",
      "HTR2A",
      "ABCC2",
      "ITGBL1",
      "APOE",
      "ABCG2",
      "RNFT2",
      "ADAM12",
      "HTR6",
      "CYP3A4",
      "TLR4",
      "CLMN",
      "ANKRD55",
      "PPFIA1",
      "HLA-DRB1",
      "PDCD1LG2",
      "CMKLR2",
      "ADAMTS1",
      "PDE4C",
      "RYR2",
      "HTR3A",
      "MMP3",
      "HTR5A",
      "KIF6",
      "CACNA1S",
      "CYP3A5",
      "ABCA1",
      "IL1B",
      "HMGCR",
      "SLCO1B1",
      "ITGA9",
      "GATM",
      "COQ2",
      "HTR3B",
      "ACE",
      "LPL",
      "APBB1",
      "PPP2R5E"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": "statin-related myopathy"
      },
      {
        "variant": "SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": "statin-related myopathy"
      },
      {
        "variant": "SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs2276307",
        "gene": "HTR3B",
        "level": "3",
        "phenotypes": "Myalgia"
      },
      {
        "variant": "rs1935349",
        "gene": "HTR7",
        "level": "3",
        "phenotypes": "Myalgia"
      },
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4986790",
        "gene": "TLR4",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs1800591",
        "gene": "MTTP",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs17238540",
        "gene": "HMGCR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs17238540",
        "gene": "HMGCR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs17244841",
        "gene": "HMGCR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Coronary Artery Disease,Myocardial Infarction"
      },
      {
        "variant": "rs2230806",
        "gene": "ABCA1",
        "level": "3",
        "phenotypes": "Coronary Disease"
      },
      {
        "variant": "rs17655652",
        "gene": "NPC1L1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus,Hypertension,Vascular Diseases"
      },
      {
        "variant": "rs12003906",
        "gene": "ABCA1",
        "level": "3",
        "phenotypes": "Hyperlipidemias"
      },
      {
        "variant": "rs328",
        "gene": "LPL",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs16944",
        "gene": "IL1B",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs428785",
        "gene": "ADAMTS1",
        "level": "3",
        "phenotypes": "Coronary Disease,Myocardial Infarction"
      },
      {
        "variant": "rs1800588",
        "gene": "LIPC",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4341",
        "gene": "ACE",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs113646094",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11716445",
        "gene": "RHOA",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs1433099",
        "gene": "LDLR",
        "level": "3",
        "phenotypes": "Vascular Diseases"
      },
      {
        "variant": "rs2738466",
        "gene": "LDLR",
        "level": "3",
        "phenotypes": "Vascular Diseases"
      },
      {
        "variant": "HLA-DRB1*01:01, HLA-DRB1*04:06",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7412",
        "gene": "APOE",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs17244841",
        "gene": "HMGCR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4149015",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs708272",
        "gene": "CETP",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Acute coronary syndrome,Hyperlipoproteinemia Type II"
      },
      {
        "variant": "rs20455",
        "gene": "KIF6",
        "level": "3",
        "phenotypes": "Coronary Disease,Myocardial Infarction"
      },
      {
        "variant": "rs2306283",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs35068180",
        "gene": "MMP3",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs2306283",
        "gene": "SLCO1B1",
        "level": "4",
        "phenotypes": "Dyslipidaemia"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for pravastatin and APOE"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for pravastatin and LDLR"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for pravastatin dosing based on SLCO1B1 genotypes.\n",
      "source": "DPWG"
    }
  },
  "ribavirin": {
    "genes": [
      "LDLR",
      "SCARB1",
      "IL6",
      "IL18",
      "CARD16",
      "CTLA4",
      "EGFR",
      "ITPA",
      "OAS1",
      "APOH",
      "TUT7",
      "IL21R",
      "IFIT1",
      "OASL",
      "CYP27B1",
      "SLC6A4",
      "BCL2",
      "HLA-A",
      "IFNL4",
      "VDR",
      "HLA-B",
      "SOCS3",
      "DNAAF9",
      "KLRK1",
      "HLA-C",
      "MICB",
      "UGT1A1",
      "CYP2R1",
      "FTO",
      "SLC28A2",
      "IFNL3",
      "CASP1",
      "SLC29A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "1A",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "1A",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "1A",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs11322783",
        "gene": "IFNL4",
        "level": "1B",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs8099917",
        "gene": "IFNL3",
        "level": "1B",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs11881222",
        "gene": "IFNL3",
        "level": "2A",
        "phenotypes": "Hepatitis C virus infection,HIV infectious disease"
      },
      {
        "variant": "rs8099917",
        "gene": "IFNL3",
        "level": "2A",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs1127354",
        "gene": "ITPA",
        "level": "2B",
        "phenotypes": "Anemia,Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs7270101",
        "gene": "ITPA",
        "level": "2B",
        "phenotypes": "Anemia,Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs12819210",
        "gene": "OASL",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "rs8103142",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "HLA-B*38:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "rs9939609",
        "gene": "FTO",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection,HIV infectious disease"
      },
      {
        "variant": "rs1544410",
        "gene": "VDR",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "rs1800477",
        "gene": "BCL2",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "rs3828913",
        "gene": "MICB",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs760370",
        "gene": "SLC29A1",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs4803219",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs28416813",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection,HIV infectious disease"
      },
      {
        "variant": "rs10877012",
        "gene": "CYP27B1",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs8113007",
        "gene": "",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection,HIV infectious disease"
      },
      {
        "variant": "rs4803217",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection,HIV infectious disease"
      },
      {
        "variant": "rs10853728",
        "gene": "",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs11854484",
        "gene": "SLC28A2",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "rs1946518",
        "gene": "IL18",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs187238",
        "gene": "IL18",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",
        "gene": "SLC6A4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs1800795",
        "gene": "IL6",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs14158",
        "gene": "LDLR",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection,HIV infectious disease"
      },
      {
        "variant": "rs12980275",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs8099917",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "rs7248668",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs8105790",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs6051702",
        "gene": "ITPA",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "rs10846744",
        "gene": "SCARB1",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs11322783",
        "gene": "IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs117648444",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs4273729",
        "gene": "",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs10741657",
        "gene": "CYP2R1",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs11506105",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "HLA-C*01:02, HLA-C*02:02, HLA-C*03:02, HLA-C*04:01, HLA-C*05:01, HLA-C*06:02, HLA-C*07:01, HLA-C*08:01, HLA-C*12:02, HLA-C*14:02, HLA-C*15:02, HLA-C*16:01, HLA-C*17:01",
        "gene": "HLA-C",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "rs1127354",
        "gene": "ITPA",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs2228570",
        "gene": "VDR",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "HLA-B*44:02",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "IFNL3 (IL28B) variation (rs12979860) is the strongest baseline predictor of response to PEG-interferon-alpha-containing regimens in HCV genotype 1 patients.  Patients with the favorable response genotype (rs12979860 CC) have increased likelihood of response (higher SVR rate) to PEG-interferon-alpha-containing regimens as compared to patients with unfavorable response genotype (rs12979860 CT or TT). Consider implications before initiating PEG-IFN alpha and RBV containing regimens.\n",
      "source": "CPIC"
    }
  },
  "methylphenidate": {
    "genes": [
      "SPSB2",
      "GRIN2A",
      "DRD2",
      "CMTM8",
      "ABCB1",
      "HTR1B",
      "ZNF565",
      "CYP2D6",
      "ADRA2A",
      "DRD1",
      "CHURC1",
      "ETFDH",
      "ZDHHC7",
      "TRIB3",
      "ADGRL3",
      "BDNF",
      "PEBP4",
      "OPCML",
      "SLC6A3",
      "GRIN2B",
      "CORO7",
      "CDH23",
      "PURA",
      "MIR4278",
      "ARHGAP12",
      "SLC6A4",
      "RRP7A",
      "FXR2",
      "GRM7",
      "CES1",
      "TPH2",
      "CHRNA4",
      "GGH",
      "FARP2",
      "ZNF211",
      "STRBP",
      "NFIB",
      "SNAP25",
      "DRD4",
      "TH",
      "SENP3",
      "DBH",
      "ESYT2",
      "PYROXD2",
      "SLC6A2",
      "ELP5",
      "PDIA2",
      "ARHGEF28",
      "PIGM",
      "SYT1",
      "ARSA",
      "DRD3",
      "HTT",
      "COMT",
      "ALDH1L1",
      "ZNF134"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4532",
        "gene": "DRD1",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs6280",
        "gene": "DRD3",
        "level": "3",
        "phenotypes": "Autism Spectrum Disorder"
      },
      {
        "variant": "rs1947275",
        "gene": "ADGRL3",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs6813183",
        "gene": "ADGRL3",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs1355368",
        "gene": "ADGRL3",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs734644",
        "gene": "ADGRL3",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs17685420",
        "gene": "PEBP4",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs3210967",
        "gene": "ZDHHC7",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs10413455",
        "gene": "ZNF134",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs2071421",
        "gene": "ARSA",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs12302749",
        "gene": "SPSB2",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs10420097",
        "gene": "ZNF211",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs3810818",
        "gene": "CORO7",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs9901675",
        "gene": "FXR2",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs4805162",
        "gene": "ZNF565",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs4562",
        "gene": "ELP5",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs17712523",
        "gene": "CDH23",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs2799018",
        "gene": "ARHGAP12",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs12409352",
        "gene": "PIGM",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs4902333",
        "gene": "CHURC1",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs2295490",
        "gene": "TRIB3",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs4627790",
        "gene": "CMTM8",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs1048786",
        "gene": "PDIA2",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs751655",
        "gene": "OPCML",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs11559290",
        "gene": "ETFDH",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs7858",
        "gene": "NFIB",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs929740",
        "gene": "ARHGEF28",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs11552708",
        "gene": "SENP3",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs1061735",
        "gene": "ESYT2",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs11553441",
        "gene": "RRP7A",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs362272",
        "gene": "HTT",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs757978",
        "gene": "FARP2",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs17279558",
        "gene": "GGH",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs3761372",
        "gene": "",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs2013169",
        "gene": "PURA",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs2070762",
        "gene": "TH",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs2283265",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs28386840",
        "gene": "SLC6A2",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs2886059",
        "gene": "ALDH1L1",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs6551665",
        "gene": "ADGRL3",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs71647871",
        "gene": "CES1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs71647871",
        "gene": "CES1",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs9032",
        "gene": "STRBP",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs1061115",
        "gene": "PYROXD2",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "CYP2D6*2, CYP2D6*10",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "CYP2D6*4, CYP2D6*5",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5569",
        "gene": "SLC6A2",
        "level": "4",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs1800544",
        "gene": "ADRA2A",
        "level": "4",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "4",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no dosing recommendations for methylphenidate based on COMT genotype.\n",
      "source": "DPWG"
    }
  },
  "morphine-3-glucuronide": {
    "genes": [
      "ABCC3",
      "UGT2B7",
      "UGT1A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "busulfan": {
    "genes": [
      "ABCC3",
      "CYP2C9",
      "GSTA1",
      "CYP2B6",
      "MTHFR",
      "CYP2C19",
      "SLC7A8",
      "BCR",
      "SLC22A4",
      "GSTM1",
      "GSTA5",
      "CYP3A4",
      "CTH",
      "ABL1",
      "GSTP1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs3957357",
        "gene": "GSTA1",
        "level": "3",
        "phenotypes": "Transplantation"
      },
      {
        "variant": "rs3754446",
        "gene": "GSTM1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs1021737",
        "gene": "CTH",
        "level": "3",
        "phenotypes": "Hematopoietic stem cell transplantation"
      },
      {
        "variant": "rs1799853",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": "Hematopoietic stem cell transplantation"
      },
      {
        "variant": "rs12248560",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Hematopoietic stem cell transplantation"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for busulfan and ABL1, BCR"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for busulfan"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for busulfan"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fentanyl": {
    "genes": [
      "ABCC3",
      "IL6",
      "LAMB3",
      "ABCB1",
      "LY96",
      "STAT6",
      "P2RX7",
      "CYP2D6",
      "TGFB1",
      "OPRD1",
      "DRD1",
      "CACNA1E",
      "OPRM1",
      "CYP2C19",
      "SLC9A9",
      "SERP2",
      "PGAP6",
      "BDNF",
      "IL6R",
      "CALCA",
      "KCNJ6",
      "ARRB2",
      "MYD88",
      "RHBDF2",
      "TLR2",
      "UGT2B7",
      "CYP3A4",
      "ADRB2",
      "TNF",
      "IL10",
      "CASP5",
      "UGT1A1",
      "IL2",
      "CYP3A5",
      "CPPED1",
      "ASTN2",
      "CASP1",
      "ATF2",
      "ABCC1",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2242480",
        "gene": "CYP3A4",
        "level": "2A",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs12948783",
        "gene": "RHBDF2",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs11959113",
        "gene": "",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs2835859",
        "gene": "KCNJ6",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs1042718",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Hypotensive disorder"
      },
      {
        "variant": "rs4587017",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs10028494",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs7583431",
        "gene": "ATF2",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs13093031",
        "gene": "",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs6961071",
        "gene": "",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Neoplasms,Pain"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Pain,Pain, Postoperative"
      },
      {
        "variant": "rs1042718",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Neoplasms,Pain"
      },
      {
        "variant": "rs2242480",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs2234918",
        "gene": "OPRD1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders,Physiological sexual disorder"
      },
      {
        "variant": "rs1045280",
        "gene": "ARRB2",
        "level": "3",
        "phenotypes": "adverse events,Opioid-Related Disorders"
      },
      {
        "variant": "rs1718125",
        "gene": "P2RX7",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs6853",
        "gene": "MYD88",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3845446",
        "gene": "CACNA1E",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*9, CYP2D6*29",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7439366",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*10",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "adverse events,Opioid-Related Disorders"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Somnolence"
      },
      {
        "variant": "rs540825",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Vomiting"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Pain,Pain, Postoperative"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Exanthema,Opioid-Related Disorders"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Somnolence"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Pain,Pain, Postoperative"
      },
      {
        "variant": "rs79910351",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2740574",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7858836",
        "gene": "ASTN2",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs958804",
        "gene": "ASTN2",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3, CYP3A5*6",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Pain,Pain, Postoperative"
      },
      {
        "variant": "rs2952768",
        "gene": "",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "adverse events,Opioid-Related Disorders"
      },
      {
        "variant": "rs9397685",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Nausea,Pain, Postoperative,Vomiting"
      },
      {
        "variant": "rs2242480",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs145837941",
        "gene": "CALCA",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Hypoventilation,Pain, Postoperative"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Hypoventilation,Pain, Postoperative"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Hypoventilation,Pain, Postoperative"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Pain"
      },
      {
        "variant": "CYP3A4*1, CYP3A4*18",
        "gene": "CYP3A4",
        "level": "4",
        "phenotypes": "Pain, Postoperative"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of alfentanil, buprenorphine, codeine, fentanyl, hydrocodone, hydromorphone, levomethadone, naltrexone, remifentanil, sufentanil or tramadol based on OPRM1 or COMT genotypes.\n",
      "source": "CPIC"
    }
  },
  "lamivudine": {
    "genes": [
      "ABCC3",
      "ABCC4",
      "NT5C",
      "SLC22A1",
      "CHPT1",
      "ABCB1",
      "CYP2B6",
      "DCK",
      "SLC22A2",
      "PGK1",
      "ABCC2",
      "PCYT2",
      "ABCG2",
      "SLCO3A1",
      "CYP3A4",
      "HLA-B",
      "PCYT1A",
      "SLC22A3",
      "UGT1A1",
      "CMPK1",
      "NME1",
      "CYP2A6",
      "ABCC1",
      "NME2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs212091",
        "gene": "ABCC1",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "morphine": {
    "genes": [
      "ABCC3",
      "UGT1A10",
      "ARVCF",
      "SLC22A1",
      "DRD2",
      "IL6",
      "ABCB1",
      "UGT1A3",
      "CYP2D6",
      "OPRD1",
      "OPRM1",
      "CYP2C19",
      "UGT1A4",
      "CCL11",
      "BDNF",
      "TXNRD2",
      "METTL21A",
      "IL6R",
      "OPRK1",
      "UGT1A9",
      "KCNJ6",
      "SLC6A4",
      "UGT1A8",
      "RHBDF2",
      "UGT1A5",
      "HTR2A",
      "TLR2",
      "UGT2B7",
      "SULT1A4",
      "FAAH",
      "IL16",
      "UGT1A1",
      "IL2",
      "IL1B",
      "TAOK3",
      "UGT1A6",
      "UGT1A7",
      "SULT1A3",
      "COMT",
      "ESR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12948783",
        "gene": "RHBDF2",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs9282564",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7438135",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2295632",
        "gene": "FAAH",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4141964",
        "gene": "FAAH",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3766246",
        "gene": "FAAH",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7668282",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Sickle Cell Anemia"
      },
      {
        "variant": "rs767263838",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs757573592",
        "gene": "SULT1A3,SULT1A4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs762151655",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs553050853",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs751527244",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1293732453",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1328799050",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1143634",
        "gene": "IL1B",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs1143634",
        "gene": "IL1B",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs6517442",
        "gene": "KCNJ6",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs795484",
        "gene": "TAOK3",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs1277441",
        "gene": "TAOK3",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs7439366",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs7439366",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4793665",
        "gene": "ABCC3",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs1042173",
        "gene": "SLC6A4",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Neonatal Abstinence Syndrome"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Pain,Pain, Postoperative"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Sleep Apnea Syndromes"
      },
      {
        "variant": "rs1051660",
        "gene": "OPRK1",
        "level": "3",
        "phenotypes": "Neoplasms,Pain"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Pain,Pain, Postoperative"
      },
      {
        "variant": "rs6269",
        "gene": "COMT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3804100",
        "gene": "TLR2",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Pain,Pain, Postoperative"
      },
      {
        "variant": "rs324420",
        "gene": "FAAH",
        "level": "3",
        "phenotypes": "Constipation,Delirium,Lung Neoplasms,Nausea,Pain,Postoperative Nausea and Vomiting,Pruritus,Respiratory Insufficiency,Somnolence,Urinary Retention"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Pain,Pain, Postoperative"
      },
      {
        "variant": "rs7439366",
        "gene": "UGT2B7",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs6269",
        "gene": "COMT",
        "level": "4",
        "phenotypes": "Neoplasms,Pain,Pain, Postoperative"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "4",
        "phenotypes": "adverse events,Constipation,Delirium,Nausea,Pruritus,Somnolence,Urinary Retention"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "4",
        "phenotypes": "adverse events,Constipation,Delirium,Dizziness,Nausea,Pain, Postoperative,Postoperative Nausea and Vomiting,Pruritus,Respiratory Insufficiency,Somnolence,Urinary Retention,Vomiting"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of alfentanil, buprenorphine, codeine, fentanyl, hydrocodone, hydromorphone, levomethadone, naltrexone, remifentanil, sufentanil or tramadol based on OPRM1 or COMT genotypes.\n",
      "source": "CPIC"
    }
  },
  "vincristine": {
    "genes": [
      "ABCC3",
      "MIR202",
      "SLC28A3",
      "SNU13",
      "FGD4",
      "GSTA1",
      "CAPG",
      "NKAIN3",
      "MIR146A",
      "ABCB1",
      "MCM3AP",
      "CYBA",
      "GATA3",
      "NDRG1",
      "MIR6076",
      "CYP2B6",
      "CEP72",
      "MIR4481",
      "MTHFR",
      "CYP1A1",
      "TUBB1",
      "ASNS",
      "TNRC6B",
      "FCGR3A",
      "RAB7A",
      "BMP7",
      "NRG3",
      "MIR423",
      "MIR577",
      "SYNE2",
      "MRPL47",
      "CXCL12",
      "TPMT",
      "PNPLA3",
      "BCR",
      "BCL2",
      "MIR411",
      "MIR449B",
      "XRCC1",
      "GEMIN4",
      "PAPPA",
      "MIR2053",
      "ABCC2",
      "SLC5A7",
      "XPO5",
      "BPHL",
      "ATP5F1E",
      "METTL8",
      "SPDYA",
      "MTR",
      "ATF5",
      "NFIB",
      "CYP3A4",
      "C18orf56",
      "ACTG1",
      "SULF2",
      "MIR1206",
      "MIR1307",
      "CPT1A",
      "RALBP1",
      "METTL3",
      "MIR3117",
      "TNRC6A",
      "MIR4268",
      "RAC2",
      "MIR604",
      "MTNR1B",
      "GARS1",
      "AGO1",
      "DOK5",
      "BAHD1",
      "IL10",
      "LINC00251",
      "ARHGAP5",
      "MIR492",
      "UGT1A1",
      "MIR300",
      "CYP3A5",
      "C5orf22",
      "FBN2",
      "LRRTM3",
      "COCH",
      "KANSL1",
      "MAPT",
      "VTI1A",
      "ABCC10",
      "DDX20",
      "ABL1",
      "MIR618",
      "PDE4D",
      "ABCC1",
      "TYMS",
      "IGHMBP2",
      "CNOT1",
      "STIM1",
      "ZFAND3",
      "ACTN1",
      "GSTP1",
      "DROSHA",
      "TUBB3",
      "NOS3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Multiple Myeloma"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Multiple Myeloma"
      },
      {
        "variant": "rs4148416",
        "gene": "ABCC3",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs3824662",
        "gene": "GATA3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3770102",
        "gene": "CAPG",
        "level": "3",
        "phenotypes": "Drug Toxicity,Neurotoxicity Syndromes"
      },
      {
        "variant": "rs4728709",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs1135989",
        "gene": "ACTG1",
        "level": "3",
        "phenotypes": "Neurotoxicity Syndromes"
      },
      {
        "variant": "rs639174",
        "gene": "DROSHA",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs17021408",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs1891059",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs80223967",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs1801157",
        "gene": "CXCL12",
        "level": "3",
        "phenotypes": "Leukemia, Lymphocytic, Chronic, B-Cell"
      },
      {
        "variant": "rs2229109",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs2229109",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Non-Hodgkin Lymphoma"
      },
      {
        "variant": "rs117532069",
        "gene": "DOK5",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs79085477",
        "gene": "BMP7",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs141059755",
        "gene": "LINC00251",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs3957357",
        "gene": "GSTA1",
        "level": "3",
        "phenotypes": "Lymphoma, Large B-Cell, Diffuse"
      },
      {
        "variant": "rs4148737",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Osteosarcoma"
      },
      {
        "variant": "rs738409",
        "gene": "PNPLA3",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs924607",
        "gene": "CEP72",
        "level": "3",
        "phenotypes": "Peripheral Nervous System Diseases"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for vincristine and ABL1, BCR"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for vincristine"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for vincristine"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "morphine-6-glucuronide": {
    "genes": [
      "ABCC3",
      "OPRM1",
      "UGT2B7",
      "UGT1A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "voriconazole": {
    "genes": [
      "POR",
      "CYP2C9",
      "ABCB1",
      "CYP2C19",
      "CYP2C18",
      "SLCO1B3",
      "FMO3",
      "ABCC2",
      "NR1I2",
      "ABCG2",
      "CYP3A4",
      "CYP3A5",
      "SLCO2B1"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",
        "gene": "CYP2C19",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs4646437",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Fungal infectious disease"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3781727",
        "gene": "SLCO2B1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Informative PGx",
        "name": "Annotation of EMA Label for voriconazole and CYP2C19"
      },
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for voriconazole and CYP2C19"
      },
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for voriconazole and CYP2C19"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for voriconazole and CYP2C19"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for voriconazole and CYP2C19"
      }
    ],
    "guidelines": {
      "advice": "An alternative antifungal agent should be considered instead of voriconazole in patients who are known to be CYP2C19 ultrarapid metabolizers. CYP2C19 genotyping and use of an alternative antifungal agent is also recommended in patients with subtherapeutic voriconazole serum concentrations despite two dose adjustments.\n",
      "source": "AusNZ"
    }
  },
  "clobazam": {
    "genes": [
      "POR",
      "CYP2C19",
      "SCN1A"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3",
        "gene": "CYP2C19",
        "level": "2A",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2298771",
        "gene": "SCN1A",
        "level": "4",
        "phenotypes": "Epilepsy"
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for clobazam and CYP2C19"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for clobazam and CYP2C19"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sunitinib": {
    "genes": [
      "POR",
      "ABCC4",
      "KIT",
      "KDR",
      "ABCB1",
      "MET",
      "CYP1A1",
      "CYP4F2",
      "IL4R",
      "SLCO1B3",
      "FLT3",
      "PDGFRB",
      "GLP1R",
      "VEGFA",
      "PDGFRA",
      "NR1I2",
      "ABCG2",
      "IL13",
      "CYP3A4",
      "FLT4",
      "IL8",
      "FLT1",
      "CYP3A5",
      "SLC22A5",
      "RET",
      "FGFR2",
      "ZSCAN25",
      "NR1I3",
      "NOS3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs833061",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs699947",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Renal Cell Carcinoma"
      },
      {
        "variant": "rs307826",
        "gene": "FLT4",
        "level": "3",
        "phenotypes": "Renal Cell Carcinoma"
      },
      {
        "variant": "rs307821",
        "gene": "FLT4",
        "level": "3",
        "phenotypes": "Renal Cell Carcinoma"
      },
      {
        "variant": "rs1126647",
        "gene": "CXCL8",
        "level": "3",
        "phenotypes": "Renal Cell Carcinoma"
      },
      {
        "variant": "rs1800925",
        "gene": "IL13",
        "level": "3",
        "phenotypes": "Renal Cell Carcinoma"
      },
      {
        "variant": "rs6785049",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Renal Cell Carcinoma"
      },
      {
        "variant": "rs1057868",
        "gene": "POR",
        "level": "3",
        "phenotypes": "Gastrointestinal Stromal Tumors"
      },
      {
        "variant": "rs4149117",
        "gene": "SLCO1B3",
        "level": "3",
        "phenotypes": "Gastrointestinal Stromal Tumors"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Renal Cell Carcinoma"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Neutropenia,Renal Cell Carcinoma"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Renal Cell Carcinoma"
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1933437",
        "gene": "FLT3",
        "level": "3",
        "phenotypes": "Leukopenia,Myelosuppression,Neutropenia,Thrombocytopenia"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for sunitinib and CYP3A4"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "rivaroxaban": {
    "genes": [
      "POR",
      "CYP2J2",
      "PRF1",
      "BRD3",
      "GOT2",
      "ABCB1",
      "F5",
      "CYP2C19",
      "MMP13",
      "APOB",
      "CES1",
      "ABCG2",
      "SUSD3",
      "CYP3A4",
      "NCMAP",
      "PRKAG2",
      "CYP3A5",
      "CYP1A2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for rivaroxaban and F5"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dolutegravir": {
    "genes": [
      "POR",
      "ABCB1",
      "SLC22A2",
      "AADAC",
      "NR1I2",
      "ABCG2",
      "CYP3A4",
      "UGT1A1",
      "CYP3A5",
      "NAT2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs2472677",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": "adverse events,Discontinuation"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Informative PGx",
        "name": "Annotation of EMA Label for dolutegravir and UGT1A1"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for dolutegravir and UGT1A1"
      },
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for dolutegravir and CYP3A4, CYP3A5, NR1I2, UGT1A1"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for dolutegravir and UGT1A1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "edoxaban": {
    "genes": [
      "POR",
      "ABCB1",
      "APOB",
      "CES1",
      "CYP3A5",
      "SLCO1B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "alectinib": {
    "genes": [
      "POR",
      "PPARA",
      "ALK",
      "CYP3A4",
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for alectinib and ALK"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for alectinib and ALK"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for alectinib and ALK"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "apixaban": {
    "genes": [
      "POR",
      "SLC22A1",
      "ABCB1",
      "CYP4F2",
      "APOB",
      "CES1",
      "ABCC2",
      "APOE",
      "ABCG2",
      "CYP3A4",
      "SLC6A2",
      "CYP3A5",
      "ZSCAN25"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Atrial Fibrillation"
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Atrial Fibrillation"
      },
      {
        "variant": "rs4148738",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cyclosporine": {
    "genes": [
      "POR",
      "IL6",
      "TSPYL1",
      "ABCB1",
      "CTLA4",
      "PPARA",
      "CALM1",
      "TGFB1",
      "MTHFR",
      "ATIC",
      "CRTC2",
      "UMOD",
      "IMPDH2",
      "TPMT",
      "UGT1A8",
      "NFATC1",
      "ABCC2",
      "NR1I2",
      "SLC19A1",
      "TCF7L2",
      "PPP3R1",
      "LEP",
      "CYP3A4",
      "DHFR",
      "NFATC2",
      "TNF",
      "CYP2C8",
      "NOD2",
      "IL10",
      "IMPDH1",
      "IL2",
      "CYP3A5",
      "ABCC1",
      "CYP3A7",
      "SLC29A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Ulcerative Colitis"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs1800872",
        "gene": "IL10",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs28371759",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs4646437",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Transplantation"
      },
      {
        "variant": "rs1042597",
        "gene": "UGT1A8",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Kidney Transplantation,Myasthenia Gravis"
      },
      {
        "variant": "rs231775",
        "gene": "CTLA4",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs1800629",
        "gene": "TNF",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Liver transplantation"
      },
      {
        "variant": "rs1057868",
        "gene": "POR",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs35599367",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Organ Transplantation"
      },
      {
        "variant": "rs7903146",
        "gene": "TCF7L2",
        "level": "3",
        "phenotypes": "Kidney Transplantation,Liver transplantation"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Hematopoietic stem cell transplantation,Neurotoxicity Syndromes"
      },
      {
        "variant": "rs8450",
        "gene": "CRTC2",
        "level": "3",
        "phenotypes": "Transplantation"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs2740574",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs2740574",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Kidney Transplantation,Transplant rejection"
      },
      {
        "variant": "rs12885713",
        "gene": "CALM1",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs2874116",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11706052",
        "gene": "IMPDH2",
        "level": "4",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "4",
        "phenotypes": "Kidney Transplantation,Transplant rejection"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "donepezil": {
    "genes": [
      "POR",
      "KCNE1",
      "ABCB1",
      "KCNE2",
      "CYP2D6",
      "CHAT",
      "PRKCE",
      "SLC5A7",
      "APOE",
      "NR1I2",
      "ACHE",
      "CYP3A4",
      "BCHE",
      "CYP3A5",
      "CHRNA7",
      "CYP3A7"
    ],
    "clinicalVariants": [
      {
        "variant": "rs6494223",
        "gene": "CHRNA7",
        "level": "3",
        "phenotypes": "Alzheimer Disease"
      },
      {
        "variant": "rs3793790",
        "gene": "CHAT",
        "level": "3",
        "phenotypes": "Alzheimer Disease"
      },
      {
        "variant": "rs2177370",
        "gene": "CHAT",
        "level": "3",
        "phenotypes": "Alzheimer Disease"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Alzheimer Disease"
      },
      {
        "variant": "rs1803274",
        "gene": "BCHE",
        "level": "3",
        "phenotypes": "Alzheimer Disease,Cognitive disorder"
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for donepezil"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for donepezil and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "galantamine": {
    "genes": [
      "POR",
      "ABCB1",
      "CYP2D6",
      "CHAT",
      "PRKCE",
      "SLC5A7",
      "APOE",
      "ACHE",
      "CYP3A4",
      "CYP3A5",
      "CHRNA7"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*41",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Dementia"
      },
      {
        "variant": "rs6494223",
        "gene": "CHRNA7",
        "level": "3",
        "phenotypes": "Alzheimer Disease"
      },
      {
        "variant": "rs3793790",
        "gene": "CHAT",
        "level": "3",
        "phenotypes": "Alzheimer Disease"
      },
      {
        "variant": "rs2177370",
        "gene": "CHAT",
        "level": "3",
        "phenotypes": "Alzheimer Disease"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for galantamine and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for galantamine and CYP2D6"
      },
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for galantamine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "glimepiride": {
    "genes": [
      "POR",
      "CYP2C9",
      "G6PD",
      "ABCC8",
      "CDKAL1",
      "TCF7L2",
      "KCNJ11",
      "IRS1",
      "NOS1AP",
      "KCNQ1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs10494366",
        "gene": "NOS1AP",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2,Hypoglycemia"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for glimepiride and G6PD"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for glimepiride and G6PD"
      },
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for glimepiride, pioglitazone and G6PD"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for glimepiride and CYP2C9"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for glimepiride and G6PD"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of chlorpropamide, dabrafenib, gliclazide, glimepiride, glipizide, mepacrine (aka quinacrine), mesalazine, moxifloxacin, nicorandil, nitrofural (aka nitrofurazone), probenecid, sodium nitrate, sulfacetamide, tolazamide or trametinib based on G6PD genotype.\n",
      "source": "CPIC"
    }
  },
  "glipizide": {
    "genes": [
      "POR",
      "CYP2C9",
      "G6PD",
      "ABCC8",
      "CDKAL1",
      "TCF7L2",
      "KCNJ11",
      "IRS1",
      "NOS1AP",
      "KCNQ1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs10494366",
        "gene": "NOS1AP",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2,Hypoglycemia"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for glipizide and G6PD"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of chlorpropamide, dabrafenib, gliclazide, glimepiride, glipizide, mepacrine (aka quinacrine), mesalazine, moxifloxacin, nicorandil, nitrofural (aka nitrofurazone), probenecid, sodium nitrate, sulfacetamide, tolazamide or trametinib based on G6PD genotype.\n",
      "source": "CPIC"
    }
  },
  "glyburide": {
    "genes": [
      "POR",
      "CYP2C9",
      "FMO2",
      "SCNN1B",
      "G6PD",
      "ABCC8",
      "MAPK1",
      "SPINK5",
      "CDKAL1",
      "CYP51A1",
      "CHST13",
      "TCF7L2",
      "KCNJ11",
      "IRS1",
      "ABCB11",
      "ABCC5",
      "BDKRB2",
      "UGT2B15",
      "NOS1AP",
      "SLCO2B1",
      "KCNQ1",
      "ESR1"
    ],
    "clinicalVariants": [
      {
        "variant": "G6PD A- 202A_376G, G6PD B (reference)",
        "gene": "G6PD",
        "level": "3",
        "phenotypes": "Hemolytic Anemia"
      },
      {
        "variant": "rs5030868",
        "gene": "G6PD",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs889299",
        "gene": "SCNN1B",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs10494366",
        "gene": "NOS1AP",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2,Hypoglycemia"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for glyburide and G6PD"
      },
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for glyburide and G6PD"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for glyburide and G6PD"
      },
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for glyburide and G6PD"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for glyburide and CYP2C9"
      }
    ],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "midazolam": {
    "genes": [
      "POR",
      "ABCB1",
      "CYP2C19",
      "UGT1A4",
      "NR1I2",
      "VDR",
      "CYP3A4",
      "UGT1A1",
      "CYP3A5"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12721627",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1057868",
        "gene": "POR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs35599367",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs11568820",
        "gene": "VDR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1544410",
        "gene": "VDR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4516035",
        "gene": "VDR",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sirolimus": {
    "genes": [
      "POR",
      "ABCB1",
      "PPARA",
      "UGT1A8",
      "NR1I2",
      "TCF7L2",
      "CYP3A4",
      "TNF",
      "IL10",
      "CYP3A5"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs2740574",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs1042597",
        "gene": "UGT1A8",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs1057868",
        "gene": "POR",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs1800896",
        "gene": "IL10",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs3814055",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": "adverse events,Gastrointestinal toxicity,Myelosuppression,Urinary Bladder Neoplasms"
      },
      {
        "variant": "rs6785049",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": "Gastrointestinal toxicity,Myelosuppression,Urinary Bladder Neoplasms"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Hematopoietic stem cell transplantation,Kidney Transplantation,Urinary Bladder Neoplasms"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Urinary Bladder Neoplasms"
      },
      {
        "variant": "rs7903146",
        "gene": "TCF7L2",
        "level": "3",
        "phenotypes": "Kidney Transplantation,Liver transplantation"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Transplantation"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP3A4*1, CYP3A4*22",
        "gene": "CYP3A4",
        "level": "4",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for sirolimus and CYP3A4"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tacrolimus": {
    "genes": [
      "POR",
      "CYP2J2",
      "IL6",
      "IL3",
      "IL18",
      "ABCB1",
      "CTLA4",
      "CCDC22",
      "PPARA",
      "CYP2B6",
      "TGFB1",
      "CYP2C19",
      "SLC7A8",
      "FOXP3",
      "UGT1A4",
      "CRTC2",
      "ABCC8",
      "IL6R",
      "C6",
      "SLCO1B3",
      "MYD88",
      "UGT1A8",
      "FMO3",
      "TLR2",
      "CRP",
      "DUX1",
      "ABCC2",
      "NR1I2",
      "ABCG2",
      "TCF7L2",
      "KCNJ11",
      "LEP",
      "SULT1E1",
      "SLC2A2",
      "CYP2A7P1",
      "GSTM3",
      "CYP2E1",
      "VDR",
      "CYP3A4",
      "TLR4",
      "SUMO4",
      "CYP2C8",
      "PPP3CA",
      "NFATC4",
      "NOD2",
      "IL10",
      "IMPDH1",
      "IL2",
      "CYP3A5",
      "IL1B",
      "SLCO1B1",
      "CAPN10",
      "KCNQ1",
      "ACE",
      "HSD11B1",
      "CASP1",
      "ZSCAN25",
      "COMT",
      "CYP3A7",
      "NR1I3"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7",
        "gene": "CYP3A5",
        "level": "1A",
        "phenotypes": "Heart transplantation,Hematopoietic stem cell transplantation,Kidney Transplantation,Lung transplantation"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7",
        "gene": "CYP3A5",
        "level": "1A",
        "phenotypes": "Heart transplantation,Hematopoietic stem cell transplantation,Kidney Transplantation,Liver transplantation,Lung transplantation"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "1B",
        "phenotypes": "Liver transplantation"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "1B",
        "phenotypes": "Liver transplantation"
      },
      {
        "variant": "rs4646437",
        "gene": "CYP3A4",
        "level": "2A",
        "phenotypes": "Kidney Transplantation,Liver transplantation,Proteinuria"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "2A",
        "phenotypes": "Liver transplantation"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "2A",
        "phenotypes": "Liver transplantation"
      },
      {
        "variant": "CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22",
        "gene": "CYP3A4",
        "level": "2A",
        "phenotypes": "Kidney Transplantation,Organ Transplantation"
      },
      {
        "variant": "CYP3A4*1, CYP3A4*18, CYP3A4*20, CYP3A4*22",
        "gene": "CYP3A4",
        "level": "2A",
        "phenotypes": "Kidney Transplantation,Laparoscopic sleeve gastrectomy,Liver transplantation,Lung transplantation"
      },
      {
        "variant": "rs2242480",
        "gene": "CYP3A4",
        "level": "2A",
        "phenotypes": "Kidney Transplantation,Liver transplantation"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Organ Transplantation,Transplantation"
      },
      {
        "variant": "rs2066844",
        "gene": "NOD2",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs4823613",
        "gene": "PPARA",
        "level": "3",
        "phenotypes": "Organ Transplantation"
      },
      {
        "variant": "rs11265572",
        "gene": "",
        "level": "3",
        "phenotypes": "Liver transplantation"
      },
      {
        "variant": "rs2237895",
        "gene": "KCNQ1",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs1800896",
        "gene": "IL10",
        "level": "3",
        "phenotypes": "Liver transplantation"
      },
      {
        "variant": "rs1800872",
        "gene": "IL10",
        "level": "3",
        "phenotypes": "Liver transplantation"
      },
      {
        "variant": "rs1800871",
        "gene": "IL10",
        "level": "3",
        "phenotypes": "Liver transplantation"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Hyperlipidemias"
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Toxic liver disease"
      },
      {
        "variant": "rs846908",
        "gene": "HSD11B1",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs4844880",
        "gene": "HSD11B1",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs846910",
        "gene": "HSD11B1",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs1042597",
        "gene": "UGT1A8",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Kidney Failure"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Gastroesophageal Reflux,Transplantation"
      },
      {
        "variant": "rs5030952",
        "gene": "CAPN10",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Infectious disease"
      },
      {
        "variant": "rs3761548",
        "gene": "FOXP3",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Ulcerative Colitis"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Ulcerative Colitis"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Ulcerative Colitis"
      },
      {
        "variant": "rs1946518",
        "gene": "IL18",
        "level": "3",
        "phenotypes": "Kidney Transplantation,Lung transplantation"
      },
      {
        "variant": "rs5744247",
        "gene": "IL18",
        "level": "3",
        "phenotypes": "Transplantation"
      },
      {
        "variant": "rs4553808",
        "gene": "CTLA4",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs181781",
        "gene": "IL3",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs9200",
        "gene": "C6",
        "level": "3",
        "phenotypes": "Liver transplantation"
      },
      {
        "variant": "rs10052999",
        "gene": "C6",
        "level": "3",
        "phenotypes": "Liver transplantation"
      },
      {
        "variant": "rs237025",
        "gene": "SUMO4",
        "level": "3",
        "phenotypes": "Liver transplantation"
      },
      {
        "variant": "rs1927907",
        "gene": "TLR4",
        "level": "3",
        "phenotypes": "Organ Transplantation"
      },
      {
        "variant": "CYP3A7*1A, CYP3A7*1C",
        "gene": "CYP3A7",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs890293",
        "gene": "CYP2J2",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs3740066",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "CYP2C8*1, CYP2C8*3",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "CYP2C8*1, CYP2C8*3",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs4253728",
        "gene": "PPARA",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Nephrotic Syndrome"
      },
      {
        "variant": "rs15524",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Kidney Transplantation,Liver transplantation"
      },
      {
        "variant": "rs4646450",
        "gene": "CYP3A5,ZSCAN25",
        "level": "3",
        "phenotypes": "Kidney Transplantation,Liver transplantation"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs9282564",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Kidney Transplantation,Lung transplantation"
      },
      {
        "variant": "rs2229109",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs2276707",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs3814055",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Nephrotic Syndrome"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Nephrotic Syndrome"
      },
      {
        "variant": "rs5219",
        "gene": "KCNJ11",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs7903146",
        "gene": "TCF7L2",
        "level": "3",
        "phenotypes": "Kidney Transplantation,Liver transplantation"
      },
      {
        "variant": "rs290487",
        "gene": "TCF7L2",
        "level": "3",
        "phenotypes": "Liver transplantation"
      },
      {
        "variant": "rs1057868",
        "gene": "POR",
        "level": "3",
        "phenotypes": "Transplantation"
      },
      {
        "variant": "rs8450",
        "gene": "CRTC2",
        "level": "3",
        "phenotypes": "Transplantation"
      },
      {
        "variant": "rs2740574",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Kidney Transplantation,Transplant rejection"
      },
      {
        "variant": "rs1800871",
        "gene": "IL10",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs2242480",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Liver transplantation"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Ulcerative Colitis"
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5",
        "level": "4",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5",
        "level": "4",
        "phenotypes": "Neurotoxicity Syndromes"
      },
      {
        "variant": "rs1800896",
        "gene": "IL10",
        "level": "4",
        "phenotypes": "Transplantation"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Kidney Transplantation,Liver transplantation"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Transplantation"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "4",
        "phenotypes": "Kidney Transplantation,Transplant rejection"
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5",
        "level": "4",
        "phenotypes": "Transplant rejection"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "4",
        "phenotypes": "Hematopoietic stem cell transplantation,Kidney Transplantation,Transplant rejection"
      },
      {
        "variant": "rs1057868",
        "gene": "POR",
        "level": "4",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "4",
        "phenotypes": "Nephrotoxicity"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Organ Transplantation"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for tacrolimus and CYP3A4, CYP3A5"
      }
    ],
    "guidelines": {
      "advice": "Testing for the CYP3A5*3 and CYP3A4*22 alleles is recommended in patients receiving a kidney, heart or lung transplant. CYP3A extensive or intermediate meatbolizers (EMs or IMs) should be given an initial dose of tacrolimus 1.5-2 times higher than that recommended for CYP3A poor metabolizers (PMs), up to a maximum dose of 0.30 mg/kg/day.\n",
      "source": "RNPGx"
    }
  },
  "zidovudine": {
    "genes": [
      "POR",
      "ABCC4",
      "SLC28A1",
      "SLC28A3",
      "CYP2C9",
      "SLC22A1",
      "ABCB1",
      "CYP2B6",
      "SLC22A8",
      "TK1",
      "UGT2B7",
      "ABCG2",
      "SLC22A11",
      "ABCC5",
      "SLCO3A1",
      "CYP2E1",
      "CYP3A4",
      "SLC22A6",
      "UGT1A1",
      "NME1",
      "DTYMK",
      "CYP2A6",
      "SLC22A7",
      "ABCC1",
      "NME2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs28365062",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11568695",
        "gene": "ABCC4",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs212091",
        "gene": "ABCC1",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "acenocoumarol": {
    "genes": [
      "POR",
      "CYP2C9",
      "ABCB1",
      "STX4",
      "CYP2C19",
      "CYP2C18",
      "CYP4F2",
      "VKORC1",
      "APOE",
      "GATA4",
      "CYP3A4",
      "CALU",
      "GGCX"
    ],
    "clinicalVariants": [
      {
        "variant": "rs9923231",
        "gene": "VKORC1",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "1B",
        "phenotypes": "over-anticoagulation"
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "1B",
        "phenotypes": ""
      },
      {
        "variant": "rs9934438",
        "gene": "VKORC1",
        "level": "2A",
        "phenotypes": ""
      },
      {
        "variant": "rs2108622",
        "gene": "CYP4F2",
        "level": "2A",
        "phenotypes": "Atrial Fibrillation"
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "2A",
        "phenotypes": "Hemorrhage"
      },
      {
        "variant": "rs4086116",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7200749",
        "gene": "VKORC1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs61742245",
        "gene": "VKORC1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs55894764",
        "gene": "VKORC1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs17878544",
        "gene": "VKORC1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1043550",
        "gene": "CALU",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7294",
        "gene": "VKORC1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs429358",
        "gene": "APOE",
        "level": "3",
        "phenotypes": "Hemorrhage,Venous thromboembolism"
      },
      {
        "variant": "rs7294",
        "gene": "VKORC1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs9923231",
        "gene": "VKORC1",
        "level": "3",
        "phenotypes": "Hemorrhage"
      },
      {
        "variant": "rs11676382",
        "gene": "GGCX",
        "level": "4",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for acenocoumarol and CYP2C9"
      }
    ],
    "guidelines": {
      "advice": "Testing for VKORC1/CYP2C9 genotype is advisable to determine the optimal dose and to orient the prescription to an alternative therapeutic option such as a direct-action oral anticoagulant before initiating vitamin K antagonists (VKA) treatment. Testing is also advisable to explain an hemorrhagic event or VKA resistance after treatment initiation.\n",
      "source": "RNPGx"
    }
  },
  "diuretics": {
    "genes": [
      "NELFCD",
      "KCNE1",
      "ADRB1",
      "NEDD4L",
      "GNB3",
      "HS3ST4",
      "ERCC6L2",
      "CSMD3",
      "CACNA1C",
      "USP5",
      "CDCA3",
      "ADD1",
      "ADRB2",
      "PRKCA",
      "ADRA2C",
      "NOS1AP",
      "CYP4A11",
      "CNTNAP2",
      "ACE",
      "PDE4D",
      "NOS3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4961",
        "gene": "ADD1",
        "level": "3",
        "phenotypes": "Hypertension,Myocardial Infarction"
      },
      {
        "variant": "rs2070744",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs702553",
        "gene": "PDE4D",
        "level": "3",
        "phenotypes": "Nephrosclerosis"
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs1805128",
        "gene": "KCNE1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2273359",
        "gene": "NELFCD",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs4149601",
        "gene": "NEDD4L",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1801253",
        "gene": "ADRB1",
        "level": "3",
        "phenotypes": "Heart Failure"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "adefovir dipivoxil": {
    "genes": [
      "ABCC4",
      "SLC26A8",
      "ABCC2",
      "SLC22A6",
      "AK2",
      "NME1",
      "AK4",
      "NME2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs11568626",
        "gene": "SLC22A6",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs11568634",
        "gene": "SLC22A6",
        "level": "4",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tenofovir": {
    "genes": [
      "ABCC4",
      "UGT1A10",
      "SLC26A8",
      "GIMAP6",
      "ABCB1",
      "UGT1A3",
      "LST1",
      "CYP2B6",
      "MTHFR",
      "ATIC",
      "FCGR3A",
      "UGT1A4",
      "DPYD",
      "UGT1A9",
      "CCDC12",
      "FARP1",
      "RPE",
      "SLCO1B3",
      "UGT1A8",
      "UGT1A5",
      "STK24",
      "IFNL4",
      "VKORC1",
      "ABCC2",
      "APOE",
      "CLCN6",
      "SLC19A1",
      "ABCG2",
      "PRSS53",
      "SLC22A11",
      "CYP2A7P1",
      "LRIG3",
      "APOC1",
      "ADRB2",
      "SLC22A6",
      "OCRL",
      "AK2",
      "TNF",
      "LTA",
      "C1QTNF7",
      "KIF6",
      "UGT1A1",
      "NME1",
      "UGT1A6",
      "ABCC10",
      "SLC28A2",
      "UGT1A7",
      "IFNL3",
      "AK4",
      "NME2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs17222723",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs9349256",
        "gene": "ABCC10",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs113165732",
        "gene": "OCRL",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs8187707",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7917432",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs757639",
        "gene": "OCRL",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs3742106",
        "gene": "ABCC4",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs1059751",
        "gene": "ABCC4",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs2273697",
        "gene": "ABCC2",
        "level": "4",
        "phenotypes": "HIV infectious disease,Kidney Disorder"
      },
      {
        "variant": "rs11568626",
        "gene": "SLC22A6",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs8187710",
        "gene": "ABCC2",
        "level": "4",
        "phenotypes": "Fanconi renotubular syndrome,HIV infectious disease"
      },
      {
        "variant": "rs1751034",
        "gene": "ABCC4",
        "level": "4",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs899494",
        "gene": "ABCC4",
        "level": "4",
        "phenotypes": "Drug Toxicity,HIV infectious disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "valganciclovir": {
    "genes": [
      "ABCC4",
      "SLC28A3",
      "SLC22A1",
      "ABCB1",
      "ABCG2",
      "SLC28A2",
      "SLC29A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs11568658",
        "gene": "ABCC4",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs2229109",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "bisphosphonates": {
    "genes": [
      "ABCC4",
      "FDPS",
      "PHB2",
      "TAFA5",
      "CSRNP3",
      "TBC1D32",
      "RBMS3",
      "SFRP5",
      "KCNT2",
      "MARCHF1",
      "IGFBP7",
      "ALDH1A2",
      "CYP2C8",
      "IL1B",
      "PKLR",
      "MEX3C"
    ],
    "clinicalVariants": [
      {
        "variant": "rs16944",
        "gene": "IL1B",
        "level": "3",
        "phenotypes": "Osteitis Deformans"
      },
      {
        "variant": "rs17751934",
        "gene": "MEX3C",
        "level": "3",
        "phenotypes": "Osteonecrosis"
      },
      {
        "variant": "rs17024608",
        "gene": "RBMS3",
        "level": "3",
        "phenotypes": "Osteonecrosis"
      },
      {
        "variant": "rs1678387",
        "gene": "ABCC4",
        "level": "3",
        "phenotypes": "Osteonecrosis"
      },
      {
        "variant": "rs7588295",
        "gene": "CSRNP3",
        "level": "3",
        "phenotypes": "Osteonecrosis"
      },
      {
        "variant": "rs12903202",
        "gene": "ALDH1A2",
        "level": "3",
        "phenotypes": "Osteonecrosis"
      },
      {
        "variant": "rs11189381",
        "gene": "SFRP5",
        "level": "3",
        "phenotypes": "Osteonecrosis"
      },
      {
        "variant": "rs7740004",
        "gene": "TBC1D32",
        "level": "3",
        "phenotypes": "Osteonecrosis"
      },
      {
        "variant": "rs1886629",
        "gene": "KCNT2",
        "level": "3",
        "phenotypes": "Osteonecrosis"
      },
      {
        "variant": "rs11264359",
        "gene": "FDPS",
        "level": "3",
        "phenotypes": "Coronary Disease,Osteoporosis"
      },
      {
        "variant": "rs2297480",
        "gene": "FDPS",
        "level": "3",
        "phenotypes": "Osteoporosis,Osteoporosis, Postmenopausal"
      },
      {
        "variant": "rs2736308",
        "gene": "",
        "level": "3",
        "phenotypes": "Osteonecrosis of the jaw"
      },
      {
        "variant": "rs1934951",
        "gene": "CYP2C8",
        "level": "4",
        "phenotypes": "Multiple Myeloma,Osteonecrosis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "latanoprost": {
    "genes": [
      "ABCC4",
      "PTGFR",
      "PTGS1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs10306114",
        "gene": "PTGS1",
        "level": "3",
        "phenotypes": "Open-angle glaucoma"
      },
      {
        "variant": "rs11568658",
        "gene": "ABCC4",
        "level": "3",
        "phenotypes": "Open-angle glaucoma"
      },
      {
        "variant": "rs3766355",
        "gene": "PTGFR",
        "level": "3",
        "phenotypes": "Open-angle glaucoma"
      },
      {
        "variant": "rs3753380",
        "gene": "PTGFR",
        "level": "3",
        "phenotypes": "Open-angle glaucoma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "glucarpidase": {
    "genes": [
      "ABCC4",
      "GATA3",
      "SLCO1B1",
      "NTRK1",
      "ARID5B",
      "INSRR"
    ],
    "clinicalVariants": [
      {
        "variant": "rs10908521",
        "gene": "INSRR,NTRK1",
        "level": "3",
        "phenotypes": "Nephrotoxicity"
      },
      {
        "variant": "rs1353327",
        "gene": "",
        "level": "3",
        "phenotypes": "Nephrotoxicity"
      },
      {
        "variant": "rs9345389",
        "gene": "",
        "level": "3",
        "phenotypes": "Nephrotoxicity"
      },
      {
        "variant": "rs3824662",
        "gene": "GATA3",
        "level": "3",
        "phenotypes": "Nephrotoxicity"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Nephrotoxicity"
      },
      {
        "variant": "rs7317112",
        "gene": "ABCC4",
        "level": "3",
        "phenotypes": "Nephrotoxicity"
      },
      {
        "variant": "rs10821936",
        "gene": "ARID5B",
        "level": "3",
        "phenotypes": "Nephrotoxicity"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tenofovir disoproxil fumarate": {
    "genes": [
      "ABCC4",
      "HNF4A",
      "ABCB1",
      "CYP27B1",
      "ABCC2",
      "VDR",
      "SLC22A6",
      "CYP24A1",
      "ABCC10",
      "SLC28A2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs11854484",
        "gene": "SLC28A2",
        "level": "3",
        "phenotypes": "HIV infectious disease,Nephrotoxicity"
      },
      {
        "variant": "rs2248359",
        "gene": "CYP24A1",
        "level": "3",
        "phenotypes": "HIV infectious disease,Nephrotoxicity"
      },
      {
        "variant": "rs4646536",
        "gene": "CYP27B1",
        "level": "3",
        "phenotypes": "HIV infectious disease,Nephrotoxicity"
      },
      {
        "variant": "rs9349256",
        "gene": "ABCC10",
        "level": "3",
        "phenotypes": "HIV infectious disease,Nephrotoxicity"
      },
      {
        "variant": "rs3742106",
        "gene": "ABCC4",
        "level": "3",
        "phenotypes": "HIV infectious disease,Nephrotoxicity"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "17beta-estradiol glucuronide": {
    "genes": [
      "ABCC4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "azathioprine": {
    "genes": [
      "ABCC4",
      "HLA-DQA1",
      "ABCB1",
      "AOX1",
      "ITPA",
      "MTHFR",
      "GSTT1",
      "IL23R",
      "IMPDH2",
      "ADK",
      "UGT1A9",
      "CASP9",
      "SLCO1B3",
      "TPMT",
      "UGT1A8",
      "SUCLA2",
      "ABCC2",
      "PTPN2",
      "GSTM1",
      "XDH",
      "C18orf56",
      "DHFR",
      "MOCOS",
      "HLA-DRB1",
      "GMPS",
      "DDRGK1",
      "PACSIN2",
      "IMPDH1",
      "RAC1",
      "SLCO1B1",
      "FTO",
      "NUDT15",
      "MSH3",
      "ABCC1",
      "RRM1",
      "TYMS",
      "GSTP1",
      "SLC29A1"
    ],
    "clinicalVariants": [
      {
        "variant": "TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C",
        "gene": "TPMT",
        "level": "1A",
        "phenotypes": "Dose reduction"
      },
      {
        "variant": "rs116855232",
        "gene": "NUDT15",
        "level": "1A",
        "phenotypes": "Inflammatory Bowel Diseases,Myelosuppression"
      },
      {
        "variant": "TPMT*1, TPMT*3A, TPMT*3C",
        "gene": "TPMT",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*6",
        "gene": "TPMT",
        "level": "1A",
        "phenotypes": "Leukopenia,Myelosuppression"
      },
      {
        "variant": "rs55754655",
        "gene": "AOX1",
        "level": "3",
        "phenotypes": "Inflammatory Bowel Diseases"
      },
      {
        "variant": "TPMT*1, TPMT*2, TPMT*3A, TPMT*3C",
        "gene": "TPMT",
        "level": "3",
        "phenotypes": "Transplantation"
      },
      {
        "variant": "HLA-DRB1*07:01",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Drug Toxicity,Inflammatory Bowel Diseases,Pancreatitis"
      },
      {
        "variant": "HLA-DQA1*02:01",
        "gene": "HLA-DQA1",
        "level": "3",
        "phenotypes": "Drug Toxicity,Inflammatory Bowel Diseases,Pancreatitis"
      },
      {
        "variant": "rs2647087",
        "gene": "",
        "level": "3",
        "phenotypes": "Drug Toxicity,Inflammatory Bowel Diseases,Pancreatitis"
      },
      {
        "variant": "rs3765534",
        "gene": "ABCC4",
        "level": "3",
        "phenotypes": "Inflammatory Bowel Diseases"
      },
      {
        "variant": "rs79206939",
        "gene": "FTO",
        "level": "3",
        "phenotypes": "Irritable Bowel Syndrome,Leukopenia"
      },
      {
        "variant": "rs11969064",
        "gene": "",
        "level": "3",
        "phenotypes": "Inflammatory Bowel Diseases,Myelosuppression"
      },
      {
        "variant": "rs746071566",
        "gene": "NUDT15",
        "level": "3",
        "phenotypes": "Pancytopenia,Thrombocytopenia"
      },
      {
        "variant": "rs116855232",
        "gene": "NUDT15",
        "level": "3",
        "phenotypes": "Pancytopenia,Thrombocytopenia"
      },
      {
        "variant": "rs746071566",
        "gene": "NUDT15",
        "level": "3",
        "phenotypes": "Inflammatory Bowel Diseases,Myelosuppression"
      },
      {
        "variant": "rs16952570",
        "gene": "FTO",
        "level": "3",
        "phenotypes": "Crohn Disease,Irritable Bowel Syndrome,Leukopenia,Neutropenia,Ulcerative Colitis"
      },
      {
        "variant": "rs2413739",
        "gene": "PACSIN2",
        "level": "3",
        "phenotypes": "Irritable Bowel Syndrome"
      },
      {
        "variant": "rs1127354",
        "gene": "ITPA",
        "level": "3",
        "phenotypes": "Liver transplantation,Transplant rejection"
      },
      {
        "variant": "rs1127354",
        "gene": "ITPA",
        "level": "3",
        "phenotypes": "Systemic lupus erythematosus"
      },
      {
        "variant": "rs1127354",
        "gene": "DDRGK1,ITPA",
        "level": "3",
        "phenotypes": "Inflammatory Bowel Diseases"
      },
      {
        "variant": "rs7270101",
        "gene": "ITPA",
        "level": "4",
        "phenotypes": "Inflammatory Bowel Diseases"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for azathioprine and NUDT15, TPMT"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for azathioprine and TPMT"
      },
      {
        "source": "FDA",
        "level": "Testing Recommended",
        "name": "Annotation of FDA Label for azathioprine and NUDT15, TPMT"
      },
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for azathioprine and TPMT"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for azathioprine and NUDT15"
      }
    ],
    "guidelines": {
      "advice": "Testing for TPMT genotype and phenotype is recommended for patients who are receiving azathioprine as an immunosuppressant. A dose reduction should be considered for patients with intermediate TPMT activity, while a greater dose reduction or selection of an alternate drug should be considered for patients with low TPMT activity.\n",
      "source": "RNPGx"
    }
  },
  "efavirenz": {
    "genes": [
      "ABCC4",
      "HNF4A",
      "SLC22A1",
      "ABCB1",
      "CYP2B6",
      "CYP2C19",
      "HTR2A",
      "UGT2B7",
      "ABCC2",
      "TPH2",
      "ABCC9",
      "NR1I2",
      "ABCG2",
      "SLCO3A1",
      "CYP2A7P1",
      "CYP3A4",
      "HLA-DRB1",
      "HLA-C",
      "IL10",
      "UGT1A1",
      "CYP3A5",
      "SLCO1B1",
      "NAT2",
      "CYP2A6",
      "CYP1A2",
      "NR1I3"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2B6*1, CYP2B6*2, CYP2B6*6, CYP2B6*18, CYP2B6*38",
        "gene": "CYP2B6",
        "level": "1A",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs3745274",
        "gene": "CYP2B6",
        "level": "1A",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "CYP2B6*1, CYP2B6*4, CYP2B6*6, CYP2B6*9, CYP2B6*18, CYP2B6*28",
        "gene": "CYP2B6",
        "level": "1A",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "CYP2B6*1, CYP2B6*6, CYP2B6*26",
        "gene": "CYP2B6",
        "level": "1A",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs3745274",
        "gene": "CYP2B6",
        "level": "1A",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs2740574",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs6313",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs8192709",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1800896",
        "gene": "IL10",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs8192719",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "CYP2B6*27, CYP2B6*28",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2853826",
        "gene": "",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs36118214",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs2307424",
        "gene": "NR1I3",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs3003596",
        "gene": "NR1I3",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs1884613",
        "gene": "HNF4A",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs35303484",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs3842",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs28399433",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs4803419",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs2279345",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "HIV infectious disease,Tuberculosis"
      },
      {
        "variant": "rs7439366",
        "gene": "UGT2B7",
        "level": "4",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs8192726",
        "gene": "CYP2A6",
        "level": "4",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs28399454",
        "gene": "CYP2A6",
        "level": "4",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs28365062",
        "gene": "UGT2B7",
        "level": "4",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5",
        "level": "4",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs3211371",
        "gene": "CYP2B6",
        "level": "4",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for efavirenz and CYP2B6"
      },
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for efavirenz and CYP2B6"
      },
      {
        "source": "EMA",
        "level": "Informative PGx",
        "name": "Annotation of EMA Label for efavirenz and CYP2B6"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for efavirenz and CYP2B6"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for efavirenz and CYP2B6"
      }
    ],
    "guidelines": {
      "advice": "Adjust the initial efavirenz dose for patients with the CYP2B6 PM phenotype along with the consideration of age, weight and BMI and titrate the dose to plasma concentration if needed. For patients with the CYP2B6 IM phenotype, determine the efavirenz plasma concentration if side effects occur and reduce the dose if needed.\n",
      "source": "DPWG"
    }
  },
  "furosemide": {
    "genes": [
      "ABCC4",
      "GNB3",
      "CYP11B2",
      "SLC22A11",
      "ADD1",
      "SLC12A3",
      "SCNN1G",
      "SLCO1B1",
      "ACE",
      "NPPA-AS1",
      "SLC2A9"
    ],
    "clinicalVariants": [
      {
        "variant": "rs5063",
        "gene": "NPPA-AS1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5443",
        "gene": "GNB3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4961",
        "gene": "ADD1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1529927",
        "gene": "SLC12A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs17268282",
        "gene": "ABCC4",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4961",
        "gene": "ADD1",
        "level": "3",
        "phenotypes": "Liver Cirrhosis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "indinavir": {
    "genes": [
      "ABCC4",
      "CYP3A4",
      "UGT1A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4148323",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs2740574",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "UGT1A1*1, UGT1A1*28",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for indinavir and CYP3A4"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "irinotecan": {
    "genes": [
      "ABCC4",
      "ERCC1",
      "UGT1A10",
      "HNF4A",
      "TDP1",
      "IL6",
      "SMARCAD1",
      "ABCB1",
      "SYNE3",
      "NR3C1",
      "PPARA",
      "EGFR",
      "AREG",
      "ADCY2",
      "TGFB1",
      "CSPG4",
      "TGFBR2",
      "KRAS",
      "CES1P1",
      "STAT3",
      "DPYD",
      "DCBLD1",
      "UGT1A9",
      "PPARD",
      "MTRR",
      "SHMT1",
      "SLCO1B3",
      "UGT1A8",
      "XRCC1",
      "PDGFRB",
      "VEGFA",
      "CES1",
      "VKORC1",
      "ABCC2",
      "NR1I2",
      "SLC25A13",
      "SLC19A1",
      "ABCG2",
      "ABCG1",
      "NFKB1",
      "GSTM1",
      "ABCC5",
      "PLCB1",
      "KCNQ5",
      "KLC1",
      "VDR",
      "CYP3A4",
      "C18orf56",
      "ALOX5",
      "UGT1A",
      "RXRG",
      "HLA-B",
      "RGS5",
      "XRCC3",
      "C8orf34",
      "HLA-DRB1",
      "RALBP1",
      "TNF",
      "BCHE",
      "CES2",
      "TOP1",
      "UGT1A1",
      "CYP3A5",
      "PIN1",
      "TOMM40L",
      "SLCO1B1",
      "NAT2",
      "SEMA3C",
      "UGT1A6",
      "CYP2A6",
      "PDZRN3",
      "UBE2I",
      "ETFRF1",
      "SMAD7",
      "IFNG",
      "UGT1A7",
      "KCNQ1",
      "ABCC1",
      "TYMS",
      "HLA-DQB3",
      "SLC1A1",
      "NR1I3",
      "PPARG",
      "GSTP1"
    ],
    "clinicalVariants": [
      {
        "variant": "UGT1A1*1, UGT1A1*28",
        "gene": "UGT1A1",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "UGT1A1*1, UGT1A1*28",
        "gene": "UGT1A1",
        "level": "1A",
        "phenotypes": "Neutropenia"
      },
      {
        "variant": "UGT1A1*1, UGT1A1*6, UGT1A1*28",
        "gene": "UGT1A1",
        "level": "1B",
        "phenotypes": "Diarrhea"
      },
      {
        "variant": "UGT1A1*1, UGT1A1*6",
        "gene": "UGT1A1",
        "level": "1B",
        "phenotypes": "Neutropenia"
      },
      {
        "variant": "rs10929302",
        "gene": "UGT1A1",
        "level": "2A",
        "phenotypes": "Neutropenia"
      },
      {
        "variant": "rs1979277",
        "gene": "SHMT1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs4149015",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs3740066",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2231137",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs2273697",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs17574269",
        "gene": "DCBLD1",
        "level": "3",
        "phenotypes": "Small cell carcinoma"
      },
      {
        "variant": "rs16950650",
        "gene": "ABCC4",
        "level": "3",
        "phenotypes": "Small cell carcinoma"
      },
      {
        "variant": "rs1051266",
        "gene": "SLC19A1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs2306283",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs7186128",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6072262",
        "gene": "TOP1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs9351963",
        "gene": "KCNQ5",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1353295",
        "gene": "AREG",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs13104811",
        "gene": "AREG",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs9996584",
        "gene": "AREG",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs11942466",
        "gene": "AREG",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs712829",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "UGT1A1*60",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs2070959",
        "gene": "UGT1A6",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs11563250",
        "gene": "UGT1A",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs699947",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs10937158",
        "gene": "ABCC5",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs2292997",
        "gene": "",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs225440",
        "gene": "ABCG1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs3749438",
        "gene": "ABCC5",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs712830",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs11692021",
        "gene": "UGT1A9",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs10934498",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": "Colonic Neoplasms"
      },
      {
        "variant": "UGT1A7*3",
        "gene": "UGT1A7",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "UGT1A6*2a",
        "gene": "UGT1A6",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1056515",
        "gene": "RGS5",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs9597",
        "gene": "UBE2I",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1800469",
        "gene": "TGFB1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs3087465",
        "gene": "TGFBR2",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs17501331",
        "gene": "ABCC1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms,Neutropenia"
      },
      {
        "variant": "rs3743527",
        "gene": "ABCC1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs12720066",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms,Neutropenia"
      },
      {
        "variant": "rs7699188",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs2233678",
        "gene": "PIN1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs861539",
        "gene": "KLC1,XRCC3",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs7779029",
        "gene": "SEMA3C",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1517114",
        "gene": "C8orf34",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "UGT1A1*1, UGT1A1*6",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs45445694",
        "gene": "TYMS",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs11574077",
        "gene": "VDR",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs3832043",
        "gene": "UGT1A9",
        "level": "4",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2306283",
        "gene": "SLCO1B1",
        "level": "4",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs4124874",
        "gene": "UGT1A1",
        "level": "4",
        "phenotypes": "Lymphoma,Neoplasms"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for irinotecan and UGT1A1"
      },
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for irinotecan and UGT1A1"
      },
      {
        "source": "FDA",
        "level": "Testing Recommended",
        "name": "Annotation of FDA Label for irinotecan and UGT1A1"
      },
      {
        "source": "PMDA",
        "level": "Testing Recommended",
        "name": "Annotation of PMDA Label for irinotecan and UGT1A1"
      },
      {
        "source": "HCSC",
        "level": "Testing Recommended",
        "name": "Annotation of HCSC Label for irinotecan and UGT1A1"
      }
    ],
    "guidelines": {
      "advice": "An Italian working group comprising the Italian Association of Medical Oncology (AIOM) and the Italian Society of Pharmacology (SIF) has published recommendations for the use of UGT1A1*28 (TA7 repeats) genotype when prescribing irinotecan.\n",
      "source": "AIOM"
    }
  },
  "mercaptopurine": {
    "genes": [
      "ABCC4",
      "SLC28A3",
      "SLC22A1",
      "HLA-DQA1",
      "MIR146A",
      "AOX1",
      "CNNM2",
      "GATA3",
      "ITPA",
      "MTHFR",
      "MED4",
      "CYP1A1",
      "TNRC6B",
      "FOLH1",
      "IMPDH2",
      "MIR423",
      "MIR577",
      "NT5C2",
      "SHMT1",
      "TPMT",
      "PNPLA3",
      "GNAQ",
      "MIR449B",
      "XRCC1",
      "GEMIN4",
      "CYP2A7",
      "MIR2053",
      "SUCLA2",
      "XPO5",
      "SLC19A1",
      "PTPN2",
      "MTR",
      "XDH",
      "C18orf56",
      "DHFR",
      "MIR1206",
      "MIR1307",
      "CPT1A",
      "HLA-DRB1",
      "TNRC6A",
      "GMPS",
      "MIR604",
      "AGO1",
      "PACSIN2",
      "IL10",
      "MIR492",
      "UGT1A1",
      "MIR300",
      "IMPDH1",
      "C5orf22",
      "SLCO1B1",
      "FTO",
      "POLG",
      "DDX20",
      "NUDT15",
      "MIR618",
      "SLC28A2",
      "MSH3",
      "GNMT",
      "TYMS",
      "IGHMBP2",
      "CNOT1",
      "COMT",
      "GSTP1",
      "DROSHA",
      "SLC29A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs116855232",
        "gene": "NUDT15",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*4, TPMT*5, TPMT*6, TPMT*7, TPMT*8, TPMT*9, TPMT*12, TPMT*14, TPMT*15, TPMT*16, TPMT*23",
        "gene": "TPMT",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*9",
        "gene": "TPMT",
        "level": "1A",
        "phenotypes": "Dose reduction"
      },
      {
        "variant": "TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*4, TPMT*6, TPMT*9, TPMT*12",
        "gene": "TPMT",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "NUDT15*1, NUDT15*3",
        "gene": "NUDT15",
        "level": "1A",
        "phenotypes": "Leukopenia,Neutropenia"
      },
      {
        "variant": "NUDT15*1, NUDT15*3",
        "gene": "NUDT15",
        "level": "1A",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs3824662",
        "gene": "GATA3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "HLA-DRB1*07:01",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Drug Toxicity,Inflammatory Bowel Diseases,Pancreatitis"
      },
      {
        "variant": "HLA-DQA1*02:01",
        "gene": "HLA-DQA1",
        "level": "3",
        "phenotypes": "Drug Toxicity,Inflammatory Bowel Diseases,Pancreatitis"
      },
      {
        "variant": "rs2647087",
        "gene": "",
        "level": "3",
        "phenotypes": "Drug Toxicity,Inflammatory Bowel Diseases,Pancreatitis"
      },
      {
        "variant": "rs639174",
        "gene": "DROSHA",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs12201199",
        "gene": "TPMT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs17839843",
        "gene": "TPMT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3931660",
        "gene": "TPMT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2413739",
        "gene": "PACSIN2",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs61886492",
        "gene": "FOLH1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs10948059",
        "gene": "GNMT",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs3765534",
        "gene": "ABCC4",
        "level": "3",
        "phenotypes": "Inflammatory Bowel Diseases"
      },
      {
        "variant": "rs79206939",
        "gene": "FTO",
        "level": "3",
        "phenotypes": "Irritable Bowel Syndrome,Leukopenia"
      },
      {
        "variant": "rs766023281",
        "gene": "NUDT15",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs746071566",
        "gene": "NUDT15",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs1142345",
        "gene": "TPMT",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs7270101",
        "gene": "ITPA",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Leukopenia,Neutropenia"
      },
      {
        "variant": "rs11969064",
        "gene": "",
        "level": "3",
        "phenotypes": "Inflammatory Bowel Diseases,Myelosuppression"
      },
      {
        "variant": "rs746071566",
        "gene": "NUDT15",
        "level": "3",
        "phenotypes": "Pancytopenia,Thrombocytopenia"
      },
      {
        "variant": "rs116855232",
        "gene": "NUDT15",
        "level": "3",
        "phenotypes": "Pancytopenia,Thrombocytopenia"
      },
      {
        "variant": "rs746071566",
        "gene": "NUDT15",
        "level": "3",
        "phenotypes": "Inflammatory Bowel Diseases,Myelosuppression"
      },
      {
        "variant": "rs16952570",
        "gene": "FTO",
        "level": "3",
        "phenotypes": "Crohn Disease,Irritable Bowel Syndrome,Leukopenia,Neutropenia,Ulcerative Colitis"
      },
      {
        "variant": "rs2413739",
        "gene": "PACSIN2",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "NUDT15*1, NUDT15*4, NUDT15*5, NUDT15*6",
        "gene": "NUDT15",
        "level": "3",
        "phenotypes": "Leukopenia"
      },
      {
        "variant": "NUDT15*1, NUDT15*4, NUDT15*5, NUDT15*6",
        "gene": "NUDT15",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "NUDT15*1, NUDT15*6",
        "gene": "NUDT15",
        "level": "3",
        "phenotypes": "Neutropenia"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Drug Toxicity"
      },
      {
        "variant": "rs11045879",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Gastrointestinal toxicity"
      },
      {
        "variant": "TPMT*1, TPMT*21, TPMT*33, TPMT*34",
        "gene": "TPMT",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Neutropenia,Thrombocytopenia"
      },
      {
        "variant": "TPMT*1, TPMT*21, TPMT*33, TPMT*34",
        "gene": "TPMT",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "TPMT*1, TPMT*21, TPMT*24, TPMT*25, TPMT*32, TPMT*33, TPMT*34, TPMT*37",
        "gene": "TPMT",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Systemic lupus erythematosus"
      },
      {
        "variant": "rs73189762",
        "gene": "MED4,NUDT15",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "4",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs1127354",
        "gene": "ITPA",
        "level": "4",
        "phenotypes": "Acute lymphoblastic leukemia,Myelosuppression"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Recommended",
        "name": "Annotation of EMA Label for mercaptopurine and NUDT15, TPMT"
      },
      {
        "source": "FDA",
        "level": "Testing Recommended",
        "name": "Annotation of FDA Label for mercaptopurine and NUDT15, TPMT"
      },
      {
        "source": "HCSC",
        "level": "Testing Recommended",
        "name": "Annotation of HCSC Label for mercaptopurine and NUDT15, TPMT"
      },
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for mercaptopurine and NUDT15, TPMT"
      }
    ],
    "guidelines": {
      "advice": "The French National Network of Pharmacogenetics (Rseau national de pharmacogntique (RNPGx)) recommends testing for TPMT.\n",
      "source": "RNPGx"
    }
  },
  "misoprostol": {
    "genes": [
      "ABCC4",
      "SLCO1B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "thioguanine": {
    "genes": [
      "ABCC4",
      "SLC28A3",
      "GATA3",
      "NAT1",
      "BMP7",
      "TPMT",
      "PNPLA3",
      "XDH",
      "CPT1A",
      "DOK5",
      "LINC00251",
      "UGT1A1",
      "IMPDH1",
      "NUDT15",
      "IGHMBP2"
    ],
    "clinicalVariants": [
      {
        "variant": "TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9",
        "gene": "TPMT",
        "level": "1A",
        "phenotypes": "Acute lymphoblastic leukemia,Neoplasms,Neutropenia,Pancytopenia,Thrombocytopenia"
      },
      {
        "variant": "TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9",
        "gene": "TPMT",
        "level": "1A",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*7, TPMT*9, TPMT*10, TPMT*12, TPMT*13, TPMT*16, TPMT*17, TPMT*18, TPMT*23",
        "gene": "TPMT",
        "level": "1A",
        "phenotypes": "Crohn Disease"
      },
      {
        "variant": "rs3824662",
        "gene": "GATA3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs17021408",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs1891059",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs80223967",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs117532069",
        "gene": "DOK5",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs79085477",
        "gene": "BMP7",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs141059755",
        "gene": "LINC00251",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs11969064",
        "gene": "",
        "level": "3",
        "phenotypes": "Inflammatory Bowel Diseases,Myelosuppression"
      },
      {
        "variant": "rs746071566",
        "gene": "NUDT15",
        "level": "3",
        "phenotypes": "Inflammatory Bowel Diseases,Myelosuppression"
      },
      {
        "variant": "TPMT*1, TPMT*21, TPMT*33, TPMT*34",
        "gene": "TPMT",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Neutropenia,Thrombocytopenia"
      },
      {
        "variant": "TPMT*1, TPMT*21, TPMT*33, TPMT*34",
        "gene": "TPMT",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "TPMT*1, TPMT*19, TPMT*20, TPMT*21, TPMT*22, TPMT*30, TPMT*32, TPMT*33, TPMT*34",
        "gene": "TPMT",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for thioguanine and TPMT"
      },
      {
        "source": "HCSC",
        "level": "Testing Recommended",
        "name": "Annotation of HCSC Label for thioguanine and NUDT15, TPMT"
      },
      {
        "source": "FDA",
        "level": "Testing Recommended",
        "name": "Annotation of FDA Label for thioguanine and NUDT15, TPMT"
      }
    ],
    "guidelines": {
      "advice": "Select an alternative drug or reduce the initial dose of thioguanine for patients that are NUDT15 poor metabolizers and reduce initial dose for patients that are NUDT15 intermediate metabolizers.\n",
      "source": "DPWG"
    }
  },
  "purine analogues": {
    "genes": [
      "ABCC4",
      "FSTL5",
      "ITPA",
      "IL6ST",
      "TPMT",
      "PACSIN2",
      "RAC1",
      "NUDT15"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1127354",
        "gene": "ITPA",
        "level": "3",
        "phenotypes": "Systemic lupus erythematosus"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "platinum": {
    "genes": [
      "STMN1",
      "ERCC1",
      "CD74",
      "ABCB1",
      "KLC3",
      "AQP2",
      "POU2F2",
      "AQP9",
      "SLC2A1",
      "ERCC2",
      "HNF1B",
      "XRCC1",
      "RICTOR",
      "ERCC5",
      "TMEM205",
      "C18orf56",
      "LRP1",
      "TYMS",
      "GSTP1",
      "XRCC5"
    ],
    "clinicalVariants": [
      {
        "variant": "rs17655",
        "gene": "ERCC5",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs13181",
        "gene": "ERCC2,KLC3",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms,Neoplasm of esophagus,Osteosarcoma,Ovarian Neoplasms,Pancreatic Neoplasms"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vinorelbine": {
    "genes": [
      "STMN1",
      "MTHFR",
      "MTR",
      "CYP3A5",
      "CASP7",
      "TYMS"
    ],
    "clinicalVariants": [
      {
        "variant": "rs7921977",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2227310",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs12415607",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs4353229",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "palonosetron": {
    "genes": [
      "ERCC1",
      "ABCB1",
      "CYP2D6",
      "ABCG2",
      "HTR3D",
      "TACR1",
      "HTR3C",
      "HTR3B"
    ],
    "clinicalVariants": [
      {
        "variant": "rs3212986",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Nausea,Neoplasms,Vomiting"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for palonosetron and CYP2D6"
      },
      {
        "source": "EMA",
        "level": "No Clinical PGx",
        "name": "Annotation of EMA Label for palonosetron and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for palonosetron and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for palonosetron and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "bevacizumab": {
    "genes": [
      "ERCC1",
      "EDN1",
      "BAD",
      "KDR",
      "FHIT",
      "ENOSF1",
      "MTHFR",
      "IL7",
      "EGLN3",
      "CSPG4",
      "GSTT1",
      "MAPK14",
      "C3",
      "VEGFB",
      "DPYD",
      "GC",
      "CCT3",
      "ARMS2",
      "FZD4",
      "HTRA1",
      "EPO",
      "TYMP",
      "HSP90AB1",
      "ERCC2",
      "CXCL12",
      "SHMT1",
      "APOBEC2",
      "ANGPT2",
      "FGF2",
      "PDGFRB",
      "VEGFA",
      "INHBA",
      "CDA",
      "ANGPT1",
      "SLC19A1",
      "ARHGEF4",
      "KCNAB1",
      "MMP9",
      "CXCR2",
      "GGH",
      "GSTM1",
      "CYP3A4",
      "RGS5",
      "PRKCA",
      "HLA-DRB1",
      "SERPING1",
      "RALBP1",
      "IL8",
      "YBX1",
      "FLT1",
      "UGT1A1",
      "CFH",
      "CYP3A5",
      "MGAT4A",
      "CXCR4",
      "PROM1",
      "ANXA11",
      "VEGFC",
      "TYMS",
      "EPAS1",
      "CRHR1",
      "GSTP1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1979277",
        "gene": "SHMT1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs3025000",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Macular Degeneration"
      },
      {
        "variant": "rs1061170",
        "gene": "CFH",
        "level": "3",
        "phenotypes": "Macular Degeneration"
      },
      {
        "variant": "rs4073",
        "gene": "CXCL8",
        "level": "3",
        "phenotypes": "Macular Degeneration"
      },
      {
        "variant": "rs2010963",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Choroidal Neovascularization"
      },
      {
        "variant": "rs699947",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs10490924",
        "gene": "ARMS2",
        "level": "3",
        "phenotypes": "Macular Degeneration"
      },
      {
        "variant": "rs3780126",
        "gene": "GGH",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs800292",
        "gene": "CFH",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs885036",
        "gene": "MGAT4A",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs885036",
        "gene": "MGAT4A",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1056515",
        "gene": "RGS5",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs5370",
        "gene": "EDN1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs3025039",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2228014",
        "gene": "CXCR4",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs3025039",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Colorectal Neoplasms"
      },
      {
        "variant": "rs3734704",
        "gene": "HSP90AB1",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs6929249",
        "gene": "HSP90AB1",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs834576",
        "gene": "HSP90AB1",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs9381299",
        "gene": "PRKCA",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs6770663",
        "gene": "KCNAB1",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs11200638",
        "gene": "HTRA1",
        "level": "4",
        "phenotypes": "Macular Degeneration"
      },
      {
        "variant": "rs1061170",
        "gene": "CFH",
        "level": "4",
        "phenotypes": "Macular Degeneration"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "radiotherapy": {
    "genes": [
      "ERCC1",
      "HLA-DQA1",
      "KDR",
      "AREG",
      "ERCC4",
      "TGFB1",
      "GSTT1",
      "APEX1",
      "OGG1",
      "HLA-DQB1",
      "ATM",
      "OSMR",
      "ERCC2",
      "CDK1",
      "XRCC1",
      "EPHX1",
      "PRKCE",
      "WRN",
      "FEN1",
      "TP53",
      "ERCC5",
      "NFKB1",
      "GSTM1",
      "RAD51",
      "CACNA2D3",
      "XPC",
      "XRCC3",
      "HLA-DRB1",
      "TNF",
      "MUTYH",
      "IL8",
      "ATG10",
      "OSGEP",
      "TMEM167A",
      "TANC1",
      "MSH2",
      "CDH2",
      "XRCC4",
      "NEIL1",
      "MEG3",
      "MSH3",
      "GSTP1",
      "RIGI"
    ],
    "clinicalVariants": [
      {
        "variant": "rs264663",
        "gene": "TANC1",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs10711",
        "gene": "CDK1",
        "level": "3",
        "phenotypes": "Pneumonitis"
      },
      {
        "variant": "rs11125035",
        "gene": "PRKCE",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11942466",
        "gene": "AREG",
        "level": "3",
        "phenotypes": "Rectal Neoplasms"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Rectal Neoplasms"
      },
      {
        "variant": "rs73594404",
        "gene": "",
        "level": "3",
        "phenotypes": "Anemia,Dermatitis,Leukopenia,Mucositis,Myelosuppression,Neutropenia,Thrombocytopenia"
      },
      {
        "variant": "rs2027701",
        "gene": "",
        "level": "3",
        "phenotypes": "Anemia,Dermatitis,Leukopenia,Mucositis,Myelosuppression,Neutropenia,Thrombocytopenia"
      },
      {
        "variant": "rs2298881",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Stomach Neoplasms"
      },
      {
        "variant": "rs10040363",
        "gene": "XRCC4",
        "level": "3",
        "phenotypes": "Stomach Neoplasms"
      },
      {
        "variant": "rs1829346",
        "gene": "",
        "level": "3",
        "phenotypes": "Nasopharyngeal Neoplasms"
      },
      {
        "variant": "rs2075685",
        "gene": "TMEM167A,XRCC4",
        "level": "3",
        "phenotypes": "Stomach Neoplasms"
      },
      {
        "variant": "rs36080650",
        "gene": "",
        "level": "3",
        "phenotypes": "Nasopharyngeal Neoplasms"
      },
      {
        "variant": "rs10497203",
        "gene": "TANC1",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs7582141",
        "gene": "TANC1",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs6432512",
        "gene": "TANC1",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs264631",
        "gene": "TANC1",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs264588",
        "gene": "TANC1",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs264651",
        "gene": "TANC1",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs1760944",
        "gene": "APEX1,OSGEP",
        "level": "3",
        "phenotypes": "Carcinoma, Squamous Cell,Overall survival"
      },
      {
        "variant": "rs1799782",
        "gene": "XRCC1",
        "level": "3",
        "phenotypes": "Carcinoma, Squamous Cell,Overall survival"
      },
      {
        "variant": "rs3219489",
        "gene": "MUTYH",
        "level": "3",
        "phenotypes": "Carcinoma, Squamous Cell,Progression-free survival"
      },
      {
        "variant": "rs1059698",
        "gene": "",
        "level": "3",
        "phenotypes": "Anemia,Dermatitis,Mucositis,Myelosuppression,Nasopharyngeal Neoplasms,Neutropenia,Thrombocytopenia"
      },
      {
        "variant": "rs10132552",
        "gene": "MEG3",
        "level": "3",
        "phenotypes": "Anemia,Dermatitis,Leukopenia,Mucositis,Myelosuppression,Neutropenia,Thrombocytopenia"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "bleomycin": {
    "genes": [
      "ERCC1",
      "ABCB1",
      "GSTT1",
      "BLMH",
      "ERCC2",
      "GSTM1",
      "CYP3A4",
      "UGT1A1",
      "GSTP1"
    ],
    "clinicalVariants": [
      {
        "variant": "GSTM1 non-null, GSTM1 null",
        "gene": "GSTM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2229109",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Non-Hodgkin Lymphoma"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Testicular Neoplasms,Vomiting"
      },
      {
        "variant": "rs2740574",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Alopecia,Testicular Neoplasms"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Infectious disease,Nausea,Testicular Neoplasms"
      },
      {
        "variant": "rs1050565",
        "gene": "BLMH",
        "level": "3",
        "phenotypes": "Alopecia,Pain,Testicular Neoplasms"
      },
      {
        "variant": "rs13181",
        "gene": "ERCC2",
        "level": "3",
        "phenotypes": "Alopecia,Testicular Neoplasms"
      },
      {
        "variant": "rs1799793",
        "gene": "ERCC2",
        "level": "3",
        "phenotypes": "Anemia,Testicular Neoplasms"
      },
      {
        "variant": "rs238406",
        "gene": "ERCC2",
        "level": "3",
        "phenotypes": "Leukopenia,Testicular Neoplasms"
      },
      {
        "variant": "rs3212986",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Testicular Neoplasms,Vomiting"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Febrile neutropenia,Testicular Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dexamethasone": {
    "genes": [
      "ERCC1",
      "CHRM3",
      "KDR",
      "ABCB1",
      "CTLA4",
      "NR3C1",
      "GATA3",
      "LRP5",
      "MTHFR",
      "GSTT1",
      "CRISPLD2",
      "PTGDR",
      "BMP7",
      "POLR1G",
      "PPP1R13L",
      "SERPINE1",
      "F2RL1",
      "PTH1R",
      "VEGFA",
      "VDR",
      "CYP3A4",
      "ACP5",
      "CYP2C8",
      "PTH",
      "DOK5",
      "LINC00251",
      "UGT1A1",
      "BCL2L11",
      "BGLAP",
      "PYGL",
      "CTNNB1",
      "GSTP1",
      "ESR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Multiple Myeloma"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Multiple Myeloma"
      },
      {
        "variant": "rs4553808",
        "gene": "CTLA4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3824662",
        "gene": "GATA3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4135385",
        "gene": "CTNNB1",
        "level": "3",
        "phenotypes": "Multiple Myeloma"
      },
      {
        "variant": "rs7142143",
        "gene": "PYGL",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs17021408",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs1891059",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs80223967",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs6092",
        "gene": "SERPINE1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs117532069",
        "gene": "DOK5",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs79085477",
        "gene": "BMP7",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs141059755",
        "gene": "LINC00251",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs2229109",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Multiple Myeloma,Progression-free survival"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "diphenhydramine": {
    "genes": [
      "ERCC1",
      "ABCB1",
      "GSTT1",
      "POLR1G",
      "PPP1R13L",
      "CYP2C8",
      "GSTP1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "gemcitabine": {
    "genes": [
      "ERCC1",
      "SLC28A1",
      "ATAT1",
      "CAMK4",
      "HELB",
      "SLC28A3",
      "NT5C",
      "NT5C1A",
      "ABCB1",
      "KLC3",
      "ACSS2",
      "OR4D6",
      "NRAS",
      "DDX53",
      "ALOX5AP",
      "MTHFR",
      "TENT4A",
      "DAPK1",
      "CTDP1",
      "DCK",
      "SPARC",
      "BTRC",
      "POLR1G",
      "DCP1B",
      "PPP1R13L",
      "C6orf15",
      "ESR2",
      "FKBP5",
      "DOCK8",
      "POLR2A",
      "PDE4B",
      "MSH5",
      "PPCDC",
      "ERCC2",
      "NT5C2",
      "PSORS1C1",
      "IL17F",
      "XYLT2",
      "XRCC1",
      "MS4A2",
      "SH2D5",
      "BAZ2B",
      "RAF1",
      "CDA",
      "ABCC2",
      "ABCG2",
      "WWOX",
      "MUCL3",
      "PRB2",
      "SLC29A2",
      "GSTM1",
      "MTR",
      "POLA2",
      "FHL2",
      "CYP3A4",
      "C18orf56",
      "HCP5",
      "CDSN",
      "HLA-DRB1",
      "CDC5L",
      "TNF",
      "PPP1R18",
      "NT5C3A",
      "CDH4",
      "PRRC2A",
      "DCTD",
      "HIF1A",
      "CYP2C8",
      "ALG10",
      "HLA-C",
      "CYP1B1",
      "UBASH3B",
      "SLC29A3",
      "CMPK1",
      "CYP3A5",
      "SLCO1B1",
      "ETS2",
      "SERPINC1",
      "SLC28A2",
      "GPX5",
      "CASP7",
      "RRM1",
      "TYMS",
      "STIM1",
      "SERPINA5",
      "GSTP1",
      "SLC29A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs7921977",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2227310",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs12415607",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs4353229",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs1127687",
        "gene": "CASP7",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs66878317",
        "gene": "DCK",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs9394992",
        "gene": "SLC29A1",
        "level": "3",
        "phenotypes": "Pancreatic Neoplasms"
      },
      {
        "variant": "rs60369023",
        "gene": "CDA",
        "level": "3",
        "phenotypes": "Neoplasms,Neutropenia"
      },
      {
        "variant": "rs4694362",
        "gene": "DCK",
        "level": "3",
        "phenotypes": "Pancreatic Neoplasms"
      },
      {
        "variant": "rs7867504",
        "gene": "SLC28A3",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs747199",
        "gene": "SLC29A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs11141915",
        "gene": "DAPK1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs11211524",
        "gene": "CMPK1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1048977",
        "gene": "CDA",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs11030918",
        "gene": "RRM1",
        "level": "3",
        "phenotypes": "Mesothelioma"
      },
      {
        "variant": "rs1155463",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11719165",
        "gene": "",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs12806698",
        "gene": "RRM1",
        "level": "3",
        "phenotypes": "Mesothelioma"
      },
      {
        "variant": "rs1705772",
        "gene": "ALG10",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1901440",
        "gene": "",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs642990",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs760370",
        "gene": "SLC29A1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1060896",
        "gene": "SLC28A2",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1065634",
        "gene": "NRAS",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs11710163",
        "gene": "RAF1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs12118636",
        "gene": "",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs17309872",
        "gene": "ACSS2",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs451774",
        "gene": "GPX5",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs183484",
        "gene": "RRM1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs2242046",
        "gene": "SLC28A1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs73748206",
        "gene": "FKBP5",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs9937",
        "gene": "RRM1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1044457",
        "gene": "CMPK1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs3750117",
        "gene": "NT5C3A",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs10916852",
        "gene": "SH2D5",
        "level": "3",
        "phenotypes": "Pancreatic Neoplasms"
      },
      {
        "variant": "rs7543016",
        "gene": "CMPK1",
        "level": "3",
        "phenotypes": "Pancreatic Neoplasms"
      },
      {
        "variant": "rs274713",
        "gene": "TENT4A",
        "level": "3",
        "phenotypes": "Pancreatic Neoplasms"
      },
      {
        "variant": "rs35687416",
        "gene": "CMPK1",
        "level": "3",
        "phenotypes": "Pancreatic Neoplasms"
      },
      {
        "variant": "rs12507552",
        "gene": "DCTD",
        "level": "3",
        "phenotypes": "Pancreatic Neoplasms"
      },
      {
        "variant": "rs274717",
        "gene": "TENT4A",
        "level": "3",
        "phenotypes": "Pancreatic Neoplasms"
      },
      {
        "variant": "rs992160",
        "gene": "CDC5L",
        "level": "3",
        "phenotypes": "Pancreatic Neoplasms"
      },
      {
        "variant": "rs201045130",
        "gene": "NT5C1A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs374150125",
        "gene": "NT5C1A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs370457585",
        "gene": "NT5C1A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4492666",
        "gene": "CMPK1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2284449",
        "gene": "RRM1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs720106",
        "gene": "RRM1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs232043",
        "gene": "RRM1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs944050",
        "gene": "ESR2",
        "level": "3",
        "phenotypes": "Pancreatic Neoplasms"
      },
      {
        "variant": "rs1042927",
        "gene": "RRM1",
        "level": "3",
        "phenotypes": "Mesothelioma"
      },
      {
        "variant": "rs3212986",
        "gene": "ERCC1,POLR1G,PPP1R13L",
        "level": "3",
        "phenotypes": "Mesothelioma"
      },
      {
        "variant": "rs13181",
        "gene": "ERCC2,KLC3",
        "level": "3",
        "phenotypes": "Mesothelioma"
      },
      {
        "variant": "rs12806698",
        "gene": "RRM1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2228130",
        "gene": "POLR2A",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs471760",
        "gene": "CDA",
        "level": "3",
        "phenotypes": "Neutropenia,Pancreatic Neoplasms"
      },
      {
        "variant": "rs3825876",
        "gene": "SLC28A1",
        "level": "3",
        "phenotypes": "Neutropenia,Pancreatic Neoplasms"
      },
      {
        "variant": "rs12148896",
        "gene": "SLC28A1",
        "level": "3",
        "phenotypes": "Neutropenia,Pancreatic Neoplasms"
      },
      {
        "variant": "rs147451859",
        "gene": "PPCDC",
        "level": "3",
        "phenotypes": "Amenorrhea"
      },
      {
        "variant": "rs17587029",
        "gene": "",
        "level": "3",
        "phenotypes": "Amenorrhea"
      },
      {
        "variant": "rs2233980",
        "gene": "C6orf15",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs5877",
        "gene": "SERPINC1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs9262132",
        "gene": "ATAT1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs886423",
        "gene": "",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs9262143",
        "gene": "PPP1R18",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs886424",
        "gene": "",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs3130985",
        "gene": "CDSN,PSORS1C1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs1049709",
        "gene": "HLA-C",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs3094086",
        "gene": "MUCL3",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs3130907",
        "gene": "HCP5",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs11229",
        "gene": "PRRC2A",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs1800629",
        "gene": "TNF",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs10885",
        "gene": "PRRC2A",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs3115672",
        "gene": "MSH5",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs10491684",
        "gene": "DOCK8",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs1058932",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs11572078",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs6119",
        "gene": "SERPINA5",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs6504649",
        "gene": "XYLT2",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs6113",
        "gene": "SERPINA5",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs6118",
        "gene": "SERPINA5",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs73450548",
        "gene": "ETS2",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma,Thrombocytopenia"
      },
      {
        "variant": "rs11854484",
        "gene": "SLC28A2",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs2072671",
        "gene": "CDA",
        "level": "3",
        "phenotypes": "Mesothelioma,Non-Small Cell Lung Carcinoma,Pancreatic Neoplasms"
      },
      {
        "variant": "rs11598702",
        "gene": "NT5C2",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs2072671",
        "gene": "CDA",
        "level": "3",
        "phenotypes": "Nausea,Pancreatic Neoplasms"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs12046844",
        "gene": "",
        "level": "3",
        "phenotypes": "Leukopenia,Neoplasms"
      },
      {
        "variant": "rs1042858",
        "gene": "RRM1",
        "level": "4",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs780668",
        "gene": "SLC29A3",
        "level": "4",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "granisetron": {
    "genes": [
      "ERCC1",
      "ABCB1",
      "CYP2D6",
      "CYP1A1",
      "ABCG2",
      "HTR3D",
      "TACR1",
      "HTR3A",
      "HTR3C",
      "NOS1AP",
      "CYP3A5",
      "HTR3B"
    ],
    "clinicalVariants": [
      {
        "variant": "rs10494366",
        "gene": "NOS1AP",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP1A1*1, CYP1A1*2A",
        "gene": "CYP1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3212986",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Nausea,Neoplasms,Vomiting"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*1xN",
        "gene": "CYP2D6",
        "level": "4",
        "phenotypes": "Postoperative Nausea and Vomiting"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "leucovorin": {
    "genes": [
      "ERCC1",
      "HNF4A",
      "IL6",
      "ABCB1",
      "GATA3",
      "PPARA",
      "EGFR",
      "MTHFR",
      "CSPG4",
      "SPARC",
      "STAT3",
      "DPYD",
      "FASTKD3",
      "MSH6",
      "ERCC2",
      "PPARD",
      "MTRR",
      "SHMT1",
      "XRCC1",
      "PDGFRB",
      "VEGFA",
      "SELE",
      "UGT2B7",
      "ABCC2",
      "NR1I2",
      "SLC19A1",
      "ABCG2",
      "ABCG1",
      "NFKB1",
      "UMPS",
      "ABCC5",
      "KLC1",
      "VDR",
      "C18orf56",
      "RXRG",
      "RGS5",
      "XRCC3",
      "HLA-DRB1",
      "RALBP1",
      "TNF",
      "UGT1A1",
      "SLCO1B1",
      "IFNG",
      "AGXT",
      "ABCC1",
      "TYMS",
      "NR1I3",
      "PPARG",
      "GSTP1",
      "NOS3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs13181",
        "gene": "ERCC2",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1979277",
        "gene": "SHMT1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs3824662",
        "gene": "GATA3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs699947",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs10937158",
        "gene": "ABCC5",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs2292997",
        "gene": "",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs225440",
        "gene": "ABCG1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs3749438",
        "gene": "ABCC5",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs3917412",
        "gene": "SELE",
        "level": "3",
        "phenotypes": "Colonic Neoplasms"
      },
      {
        "variant": "rs712830",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Colonic Neoplasms"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1056515",
        "gene": "RGS5",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Colonic Neoplasms"
      },
      {
        "variant": "rs7699188",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs11615",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Colonic Neoplasms"
      },
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs861539",
        "gene": "KLC1,XRCC3",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "4",
        "phenotypes": "Colorectal Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ranitidine": {
    "genes": [
      "ERCC1",
      "SLC22A1",
      "ABCB1",
      "GSTT1",
      "SLC22A2",
      "POLR1G",
      "PPP1R13L",
      "CYP2C8",
      "GSTP1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "thalidomide": {
    "genes": [
      "ERCC1",
      "RPL13",
      "ATP7A",
      "GSTT1",
      "CYP2C19",
      "SPG7",
      "SNORD68",
      "PPARD",
      "SULT1C4",
      "FGF2",
      "SLC10A2",
      "VEGFA",
      "CHST3",
      "CYP4B1",
      "ABCC6",
      "NAT2",
      "CTNNB1",
      "XRCC5"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4148945",
        "gene": "CHST3",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs4148943",
        "gene": "CHST3",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs730720",
        "gene": "CHST3",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs6922548",
        "gene": "PPARD",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs2238472",
        "gene": "ABCC6",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs1883322",
        "gene": "PPARD",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs12418",
        "gene": "CHST3",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs7769719",
        "gene": "PPARD",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs4646487",
        "gene": "CYP4B1",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs4148950",
        "gene": "CHST3",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs4148947",
        "gene": "CHST3",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs3734254",
        "gene": "PPARD",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs2301159",
        "gene": "SLC10A2",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs2292954",
        "gene": "SPG7",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs2227291",
        "gene": "ATP7A",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs2016520",
        "gene": "PPARD",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs1799931",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs1402467",
        "gene": "SULT1C4",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs12960",
        "gene": "RPL13,SNORD68,SPG7",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs735482",
        "gene": "ERCC1",
        "level": "3",
        "phenotypes": "Multiple Myeloma"
      },
      {
        "variant": "rs1051685",
        "gene": "XRCC5",
        "level": "3",
        "phenotypes": "Multiple Myeloma"
      },
      {
        "variant": "rs4630",
        "gene": "GSTT1",
        "level": "3",
        "phenotypes": "Multiple Myeloma"
      },
      {
        "variant": "rs4135385",
        "gene": "CTNNB1",
        "level": "3",
        "phenotypes": "Multiple Myeloma"
      },
      {
        "variant": "rs4533622",
        "gene": "CTNNB1",
        "level": "3",
        "phenotypes": "Multiple Myeloma"
      },
      {
        "variant": "rs308395",
        "gene": "FGF2",
        "level": "3",
        "phenotypes": "Multiple Myeloma"
      },
      {
        "variant": "rs1871450",
        "gene": "CHST3",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "trans 4-hydroxypraziquantel": {
    "genes": [
      "CYP2J2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ebastine": {
    "genes": [
      "CYP2J2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "daunorubicin": {
    "genes": [
      "CYP2J2",
      "SLC28A1",
      "SETD4",
      "SLC28A3",
      "GPX3",
      "AKR7A2",
      "MIR146A",
      "ABCB1",
      "GATA3",
      "MTHFR",
      "GSTT1",
      "TNRC6B",
      "DCK",
      "SLC22A2",
      "ETFB",
      "G6PD",
      "BMP7",
      "CYP4F2",
      "SPG7",
      "COL1A2",
      "MIR423",
      "HNMT",
      "MIR577",
      "SLC22A17",
      "AKR1C3",
      "RAD50",
      "TPMT",
      "CBR1",
      "PNPLA3",
      "MIR449B",
      "GPR35",
      "SLCO6A1",
      "FMO3",
      "GEMIN4",
      "SLC10A2",
      "HFE",
      "SOD2",
      "MIR2053",
      "CDA",
      "ABCC2",
      "ABCC9",
      "XPO5",
      "ADH7",
      "SERPINA6",
      "GSTM1",
      "GSTA2",
      "ABCB11",
      "ABCC5",
      "XDH",
      "GSTM3",
      "ATF5",
      "C18orf56",
      "MIR1206",
      "MIR1307",
      "CPT1A",
      "RARG",
      "MIR3117",
      "SZRD1",
      "SLC13A3",
      "TNRC6A",
      "MIR4268",
      "ATP7B",
      "MIR604",
      "AGO1",
      "DOK5",
      "AKR1C4",
      "LINC00251",
      "SULT2B1",
      "MIR492",
      "UGT1A1",
      "MIR300",
      "C5orf22",
      "NRP2",
      "ABCA1",
      "SLCO1B1",
      "UGT1A6",
      "ABCC10",
      "DDX20",
      "SLC22A7",
      "ABCB4",
      "MIR618",
      "MAN1B1",
      "ABCC1",
      "TYMS",
      "IGHMBP2",
      "CNOT1",
      "GSTP1",
      "DROSHA",
      "SLCO4C1",
      "NOS3",
      "CBR3",
      "SLC15A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs7853758",
        "gene": "SLC28A3",
        "level": "2B",
        "phenotypes": "Cardiotoxicity"
      },
      {
        "variant": "rs10932125",
        "gene": "NRP2",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs3824662",
        "gene": "GATA3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs639174",
        "gene": "DROSHA",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs17021408",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs1891059",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs80223967",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs2291075",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs2291075",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs117532069",
        "gene": "DOK5",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs79085477",
        "gene": "BMP7",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs141059755",
        "gene": "LINC00251",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs738409",
        "gene": "PNPLA3",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs2229774",
        "gene": "RARG",
        "level": "3",
        "phenotypes": "Cardiotoxicity,Neoplasms"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "The Canadian Pharmacogenomics Network for Drug Safety (CPNDS) clinical recommendation group has published guidelines for the use of RARG , SLC28A3 , and UGT1A6 when prescribing anthracyclines for pediatric cancer patients. They recommend that pharmacogenomic testing of RARG rs2229774, SLC28A3 rs7853758, and UGT1A6 *4 (rs17863783) should be performed in all pediatric cancer patients who are treated with daunorubicin or doxorubicin because the association of those genetic variants with anthracycline associated cardiotoxicity (ACT).\n",
      "source": "CPNDS"
    }
  },
  "terfenadine": {
    "genes": [
      "CYP2J2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pegaspargase": {
    "genes": [
      "ARHGAP28",
      "APOC3",
      "HLA-DQA1",
      "GATA3",
      "MYBBP1A",
      "RGS6",
      "HLA-DQB1",
      "BMP7",
      "CNOT3",
      "APOA5",
      "TPMT",
      "PNPLA3",
      "GRIA1",
      "CCHCR1",
      "ULK2",
      "SPINK1",
      "RFXAP",
      "CPT1A",
      "HLA-DRB1",
      "NFATC2",
      "DOK5",
      "LINC00251",
      "UGT1A1",
      "IGHMBP2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs3824662",
        "gene": "GATA3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs17021408",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs1891059",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs80223967",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs117532069",
        "gene": "DOK5",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs79085477",
        "gene": "BMP7",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs141059755",
        "gene": "LINC00251",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs9958628",
        "gene": "ARHGAP28",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "HLA-DQB1*02:02",
        "gene": "HLA-DQB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "HLA-DRB1*07:01",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "irbesartan": {
    "genes": [
      "EDN1",
      "CYP2C9",
      "CYP11B2",
      "APOB",
      "AGT",
      "AGTR1",
      "KCNH2",
      "ACE"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1367117",
        "gene": "APOB",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs5370",
        "gene": "EDN1",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs1801701",
        "gene": "APOB",
        "level": "3",
        "phenotypes": "Hypertrophy, Left Ventricular"
      },
      {
        "variant": "rs1057910",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs72558187",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799853",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4762",
        "gene": "AGT",
        "level": "3",
        "phenotypes": "Hypertension,Hypertrophy, Left Ventricular"
      },
      {
        "variant": "rs699",
        "gene": "AGT",
        "level": "3",
        "phenotypes": "Hypertension,Hypertrophy, Left Ventricular"
      },
      {
        "variant": "rs5186",
        "gene": "AGTR1",
        "level": "3",
        "phenotypes": "Hypertension,Hypertrophy, Left Ventricular"
      },
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Hypertension,Hypertrophy, Left Ventricular"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ara-ctp": {
    "genes": [
      "SLC28A1",
      "SLC28A3",
      "CTPS1",
      "DCK",
      "CDA",
      "DCTD",
      "RRM1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "stavudine": {
    "genes": [
      "SLC28A1",
      "RRM2B",
      "CYP2B6",
      "MTHFR",
      "APOE",
      "SAMHD1",
      "HLA-B",
      "TNF"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1799964",
        "gene": "TNF",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs8124728",
        "gene": "SAMHD1",
        "level": "3",
        "phenotypes": "HIV infectious disease,Peripheral Nervous System Diseases"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "hydroxyurea": {
    "genes": [
      "CAT",
      "SLC14A1",
      "MAP3K5",
      "CYP2D6",
      "HBG2",
      "IFNL4",
      "SIN3A",
      "KLF4",
      "ASS1",
      "BCL11A",
      "IFNL3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs9376230",
        "gene": "MAP3K5",
        "level": "3",
        "phenotypes": "Beta-thalassemia and related diseases"
      },
      {
        "variant": "rs9483947",
        "gene": "MAP3K5",
        "level": "3",
        "phenotypes": "Beta-thalassemia and related diseases"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fenofibrate": {
    "genes": [
      "APOA4",
      "APOC3",
      "SCARB1",
      "IL6",
      "FABP1",
      "PPARA",
      "CETP",
      "APOA5",
      "APOB",
      "APOA1",
      "HLA-A",
      "CRP",
      "GCKR",
      "APOE",
      "ABCA1",
      "SLCO1B1",
      "LPL"
    ],
    "clinicalVariants": [
      {
        "variant": "rs135543",
        "gene": "PPARA",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs135550",
        "gene": "PPARA",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs964184",
        "gene": "APOA1",
        "level": "3",
        "phenotypes": "Hypertriglyceridemia"
      },
      {
        "variant": "rs4238001",
        "gene": "SCARB1",
        "level": "3",
        "phenotypes": "Hypertriglyceridemia"
      },
      {
        "variant": "rs3091244",
        "gene": "CRP",
        "level": "3",
        "phenotypes": "Metabolic Syndrome"
      },
      {
        "variant": "rs2230808",
        "gene": "ABCA1",
        "level": "3",
        "phenotypes": "Hypertriglyceridemia"
      },
      {
        "variant": "rs2230806",
        "gene": "ABCA1",
        "level": "3",
        "phenotypes": "Hypertriglyceridemia"
      },
      {
        "variant": "rs1417938",
        "gene": "CRP",
        "level": "3",
        "phenotypes": "Metabolic Syndrome"
      },
      {
        "variant": "rs4253778",
        "gene": "PPARA",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "rs1800795",
        "gene": "IL6",
        "level": "3",
        "phenotypes": "Cardiovascular Disease"
      },
      {
        "variant": "rs9626730",
        "gene": "PPARA",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2727786",
        "gene": "APOA1",
        "level": "3",
        "phenotypes": "Hypertriglyceridemia"
      },
      {
        "variant": "rs320",
        "gene": "LPL",
        "level": "3",
        "phenotypes": "Hypertriglyceridemia"
      },
      {
        "variant": "rs676210",
        "gene": "APOB",
        "level": "3",
        "phenotypes": "Hypertriglyceridemia"
      },
      {
        "variant": "rs7412",
        "gene": "APOE",
        "level": "3",
        "phenotypes": "Hypertriglyceridemia"
      },
      {
        "variant": "rs3135506",
        "gene": "APOA5",
        "level": "3",
        "phenotypes": "Hypertriglyceridemia"
      },
      {
        "variant": "rs2241883",
        "gene": "FABP1",
        "level": "4",
        "phenotypes": "Hypertriglyceridemia"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for fenofibrate, simvastatin and SLCO1B1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "candesartan": {
    "genes": [
      "KCNK3",
      "SULT1C3",
      "CYP11B2",
      "PLEKHJ1",
      "GPR83",
      "SH2B3",
      "AGTR1",
      "KCNH2",
      "ACE",
      "DOT1L"
    ],
    "clinicalVariants": [
      {
        "variant": "rs5186",
        "gene": "AGTR1",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs1799998",
        "gene": "CYP11B2",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs3758785",
        "gene": "GPR83",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs3184504",
        "gene": "SH2B3",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1275988",
        "gene": "KCNK3",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs6722745",
        "gene": "SULT1C3",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs740406",
        "gene": "DOT1L,PLEKHJ1",
        "level": "3",
        "phenotypes": "Hypertension"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sevoflurane": {
    "genes": [
      "KCNK3",
      "KCNE1",
      "ABCB1",
      "RYR1",
      "FASTKD3",
      "GRIN2B",
      "MTRR",
      "KCNK2",
      "DUX1",
      "CYP2E1",
      "ADRB2",
      "CACNA1S",
      "GABRA2",
      "GSTP1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs118192177",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192176",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922832",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922809",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192175",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922762",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192124",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922770",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922802",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs28933397",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922843",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs1801086",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs112563513",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922816",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922748",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192161",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918595",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918596",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922753",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918593",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs28933396",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922807",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192162",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922768",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918592",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922747",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192122",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192172",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192168",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918594",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922803",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922878",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922876",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922764",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922772",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922818",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192163",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs1800559",
        "gene": "CACNA1S",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs772226819",
        "gene": "CACNA1S",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs111888148",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192178",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs1042718",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Hypotensive disorder"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "tonsillectomy"
      },
      {
        "variant": "rs144336148",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs1801394",
        "gene": "FASTKD3,MTRR",
        "level": "3",
        "phenotypes": "sedation"
      },
      {
        "variant": "rs1801394",
        "gene": "FASTKD3,MTRR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs279858",
        "gene": "GABRA2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2307116",
        "gene": "FASTKD3,MTRR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1275988",
        "gene": "KCNK3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2031920",
        "gene": "CYP2E1,DUX1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3813867",
        "gene": "CYP2E1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6686529",
        "gene": "KCNK2",
        "level": "3",
        "phenotypes": "sedation"
      },
      {
        "variant": "rs1806201",
        "gene": "GRIN2B",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3733784",
        "gene": "FASTKD3,MTRR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2307116",
        "gene": "FASTKD3,MTRR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs63749869",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192116",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192167",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192170",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192178",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for sevoflurane and CACNA1S, RYR1"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for sevoflurane and CACNA1S, RYR1"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for sevoflurane"
      }
    ],
    "guidelines": {
      "advice": "The CPIC Dosing Guideline recommends that halogenated volatile anesthetics such as desflurane, enflurane, halothane, isoflurane, methoxyflurane, sevoflurane and the depolarizing muscle relaxants succinylcholine are relatively contraindicated in persons with malignant hyperthermia susceptibility (MHS). See full guideline for disclaimers, further details and supporting evidence. The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "hmg-coa reductase inhibitors": {
    "genes": [
      "ATP2B1",
      "CYP2C9",
      "SUGCT",
      "STAT4",
      "ABCB1",
      "UGT1A3",
      "RYR1",
      "GNB3",
      "PPARA",
      "TOMM40",
      "CYP2D6",
      "LILRB5",
      "CYP2C19",
      "NPC1L1",
      "LPA",
      "PRDM16",
      "CETP",
      "CHRNA1",
      "SLC22A8",
      "SIK3",
      "SLCO1B3",
      "HTR7",
      "CXCL5",
      "UGT2B7",
      "ABCC2",
      "SORT1",
      "APOE",
      "ABCG2",
      "CFAP44",
      "PCSK9",
      "ABCB11",
      "APOC1",
      "CYP19A1",
      "CYP3A4",
      "SLCO1A2",
      "SLC22A6",
      "DMPK",
      "HLA-DRB1",
      "ADAMTS1",
      "RYR2",
      "CDH13",
      "CYP2C8",
      "EYS",
      "KIF6",
      "SREBF1",
      "UGT1A1",
      "CYP3A5",
      "SLCO2B1",
      "HMGCR",
      "SLCO1B1",
      "COQ3",
      "GATM",
      "COQ2",
      "COQ5",
      "CELSR2",
      "NOS3",
      "HLA-G",
      "SLC15A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "2A",
        "phenotypes": "statin-related myopathy"
      },
      {
        "variant": "rs1935349",
        "gene": "HTR7",
        "level": "3",
        "phenotypes": "Myalgia"
      },
      {
        "variant": "rs6535454",
        "gene": "COQ2",
        "level": "3",
        "phenotypes": "Muscular Diseases"
      },
      {
        "variant": "rs17238540",
        "gene": "HMGCR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs352046",
        "gene": "CXCL5",
        "level": "3",
        "phenotypes": "Acute coronary syndrome"
      },
      {
        "variant": "rs12654264",
        "gene": "HMGCR",
        "level": "3",
        "phenotypes": "Colonic Neoplasms"
      },
      {
        "variant": "rs1063320",
        "gene": "HLA-G",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs646776",
        "gene": "CELSR2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2900478",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs445925",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs13064411",
        "gene": "CFAP44",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs402007",
        "gene": "ADAMTS1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs1062033",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Menopause"
      },
      {
        "variant": "rs11868035",
        "gene": "SREBF1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs247616",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "HLA-DRB1*01:01, HLA-DRB1*04:06",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1008805",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Menopause"
      },
      {
        "variant": "rs2306283",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Coronary Artery Disease,Diabetes Mellitus,Hypercholesterolemia"
      },
      {
        "variant": "rs1337512",
        "gene": "EYS",
        "level": "3",
        "phenotypes": "Rhabdomyolysis"
      },
      {
        "variant": "rs3857532",
        "gene": "EYS",
        "level": "3",
        "phenotypes": "Rhabdomyolysis"
      },
      {
        "variant": "rs429358",
        "gene": "APOE",
        "level": "3",
        "phenotypes": "Alzheimer Disease"
      },
      {
        "variant": "rs1532624",
        "gene": "CETP",
        "level": "3",
        "phenotypes": "Hyperlipidemias"
      },
      {
        "variant": "rs1719247",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4693075",
        "gene": "COQ2",
        "level": "3",
        "phenotypes": "Muscular Diseases"
      },
      {
        "variant": "rs10455872",
        "gene": "LPA",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs10455872",
        "gene": "LPA",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs118192172",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Muscular Diseases"
      },
      {
        "variant": "rs708272",
        "gene": "CETP",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5443",
        "gene": "GNB3",
        "level": "3",
        "phenotypes": "Hypercholesterolemia,Myocardial Infarction"
      },
      {
        "variant": "rs13210472",
        "gene": "",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs11045819",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2306283",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Cardiovascular Disease,Hyperlipidemias"
      },
      {
        "variant": "rs9806699",
        "gene": "GATM",
        "level": "4",
        "phenotypes": "Myocardial Infarction"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Testing for rs4149056 before starting statin treatment, or early after treatment onset (potentially useful test) is recommended in patients with one or more risk factors described (as a function of statin type and dose, co-medications, and the pathophysiological or genetic setting). If the genotype is not known early, the RNPGx considers that a polymorphism test is potentially useful in the event of muscle toxicity in patients treated with statins, in order to rule out or confirm a genetic cause.\n",
      "source": "RNPGx"
    }
  },
  "antihypertensives": {
    "genes": [
      "ATP2B1",
      "ADRB1",
      "NEDD4L",
      "PTPRD",
      "MMP9",
      "AGT",
      "ADD1",
      "NAMPT",
      "GRK5",
      "CYP3A5",
      "ADIPOQ",
      "ZSCAN25",
      "CLNK",
      "NOS3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2070744",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs2230345",
        "gene": "GRK5",
        "level": "3",
        "phenotypes": "Heart Diseases"
      },
      {
        "variant": "rs12817819",
        "gene": "ATP2B1",
        "level": "3",
        "phenotypes": "Coronary Artery Disease,Hypertension"
      },
      {
        "variant": "rs13144136",
        "gene": "CLNK",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs324498",
        "gene": "PTPRD",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs11749255",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs6487504",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "celecoxib": {
    "genes": [
      "CACNA2D1",
      "CYP2C9",
      "CACNA1G",
      "CYP2D6",
      "CDKN1B",
      "CACNA1E",
      "CDKN1A",
      "CYP2C19",
      "PTGS2",
      "IL23R",
      "CACNA2D2",
      "DDIT3",
      "CA12",
      "KCNQ4",
      "CASP9",
      "PTGER4",
      "PTGES",
      "CACNA1I",
      "CA9",
      "CACNB1",
      "VEGFA",
      "PDK1",
      "CACNA1C",
      "KCNQ3",
      "CACNA1H",
      "KCNQ2",
      "MMP9",
      "CACNA1F",
      "CACNA2D3",
      "KCNQ5",
      "CYP3A4",
      "BCAR1",
      "CACNB2",
      "CACNA1D",
      "CACNB3",
      "CACNA2D4",
      "CACNA1B",
      "ATP2A3",
      "CYP2C8",
      "ATP2A1",
      "CASP3",
      "ATP2A2",
      "CACNA1S",
      "PTGS1",
      "IGFBP3",
      "CACNB4",
      "CTNNB1",
      "KCNQ1",
      "CACNA1A",
      "ALOX12",
      "PPARG"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*13",
        "gene": "CYP2C9",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs11078659",
        "gene": "ALOX12",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs7518660",
        "gene": "IL23R",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs2302821",
        "gene": "PTGES",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs4133101",
        "gene": "PTGER4",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1057910",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for celecoxib and CYP2C9"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for celecoxib and CYP2C9"
      },
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for celecoxib and CYP2C9"
      },
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for celecoxib and CYP2C9"
      }
    ],
    "guidelines": {
      "advice": "The CPIC Dosing Guideline for celecoxib, flurbiprofen, ibuprofen and lornoxicam recommends initiating therapy with 25-50% of\nthe lowest recommended starting dose for CYP2C9 poor metabolizers and initiating therapy with lowest recommended starting dose for CYP2C9 intermediate metabolizers with activity score of 1. See full guideline for further details and supporting evidence.\n",
      "source": "CPIC"
    }
  },
  "apremilast": {
    "genes": [
      "LEPR",
      "ILF3",
      "P2RY11",
      "DOCK6",
      "PPAN-P2RY11",
      "CDKN2B-AS1",
      "TMEM130",
      "PDE4B",
      "TSPAN16",
      "CYP3A4",
      "CDKN2B",
      "LEPROT",
      "EIF3G",
      "PDE4D"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "setmelanotide": {
    "genes": [
      "LEPR",
      "PCSK1",
      "POMC"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for setmelanotide and LEPR, PCSK1, POMC"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for setmelanotide and LEPR, PCSK1, POMC"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for setmelanotide and LEPR, PCSK1, POMC"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "simvastatin": {
    "genes": [
      "LEPR",
      "CYP2C9",
      "ABCB1",
      "RYR1",
      "HTR2C",
      "RHOA",
      "CYBA",
      "PPARA",
      "CYP2D6",
      "ZNF542P",
      "PON1",
      "SCAP",
      "LPA",
      "PRDM16",
      "HTR1D",
      "CETP",
      "APOA5",
      "UGT1A9",
      "SLC6A4",
      "HTR7",
      "LIPC",
      "HTR2A",
      "SREBF2",
      "ABCC2",
      "APOE",
      "ABCG2",
      "HTR6",
      "CYP3A4",
      "CLMN",
      "HLA-DRB1",
      "RYR2",
      "HTR3A",
      "CYP2C8",
      "F3",
      "HTR5A",
      "KIF6",
      "SREBF1",
      "CACNA1S",
      "CYP3A5",
      "ABCA1",
      "SLCO2B1",
      "HMGCR",
      "SLCO1B1",
      "GATM",
      "COQ2",
      "HTR3B",
      "LPL",
      "HLA-G",
      "ABCG8"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": "statin-related myopathy"
      },
      {
        "variant": "SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": "statin-related myopathy"
      },
      {
        "variant": "rs2276307",
        "gene": "HTR3B",
        "level": "3",
        "phenotypes": "Myalgia"
      },
      {
        "variant": "rs1935349",
        "gene": "HTR7",
        "level": "3",
        "phenotypes": "Myalgia"
      },
      {
        "variant": "rs12487736",
        "gene": "SCAP",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Hypercholesterolemia,Myalgia"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Hypercholesterolemia,Myalgia"
      },
      {
        "variant": "CYP3A4*1, CYP3A4*4",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Hyperlipidemias"
      },
      {
        "variant": "rs4673",
        "gene": "CYBA",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs5882",
        "gene": "CETP",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs17238540",
        "gene": "HMGCR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs17238540",
        "gene": "HMGCR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs17244841",
        "gene": "HMGCR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3917643",
        "gene": "F3",
        "level": "3",
        "phenotypes": "Myocardial Ischemia"
      },
      {
        "variant": "rs12003906",
        "gene": "ABCA1",
        "level": "3",
        "phenotypes": "Hyperlipidemias"
      },
      {
        "variant": "rs4823613",
        "gene": "PPARA",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4253728",
        "gene": "PPARA",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2003569",
        "gene": "UGT1A9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4149081",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Coronary Disease"
      },
      {
        "variant": "rs1137101",
        "gene": "LEPR",
        "level": "3",
        "phenotypes": "Coronary Disease"
      },
      {
        "variant": "rs1137101",
        "gene": "LEPR",
        "level": "3",
        "phenotypes": "Hyperlipidemias"
      },
      {
        "variant": "rs1800588",
        "gene": "LIPC",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs662",
        "gene": "PON1",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs705379",
        "gene": "PON1",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs11716445",
        "gene": "RHOA",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs2740574",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "HLA-DRB1*01:01, HLA-DRB1*04:06",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2819742",
        "gene": "RYR2",
        "level": "3",
        "phenotypes": "Cardiovascular Disease"
      },
      {
        "variant": "rs20455",
        "gene": "KIF6",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs3846662",
        "gene": "HMGCR",
        "level": "3",
        "phenotypes": "Cardiovascular Disease"
      },
      {
        "variant": "rs6924995",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs429358",
        "gene": "APOE",
        "level": "3",
        "phenotypes": "Myocardial Infarction"
      },
      {
        "variant": "rs17244841",
        "gene": "HMGCR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs17244841",
        "gene": "HMGCR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1346268",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs662799",
        "gene": "APOA5",
        "level": "3",
        "phenotypes": "Hyperlipidemias"
      },
      {
        "variant": "rs2230806",
        "gene": "ABCA1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2D6*1, CYP2D6*3, CYP2D6*4",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs76103438",
        "gene": "",
        "level": "3",
        "phenotypes": "adverse events"
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP3A4*1, CYP3A4*22",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Hypercholesterolemia"
      },
      {
        "variant": "rs708272",
        "gene": "CETP",
        "level": "4",
        "phenotypes": "Hypercholesterolemia,Hyperlipoproteinemia Type II"
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5",
        "level": "4",
        "phenotypes": "Hypercholesterolemia,Myalgia"
      },
      {
        "variant": "rs9806699",
        "gene": "GATM",
        "level": "4",
        "phenotypes": "Myocardial Infarction"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs4363657",
        "gene": "SLCO1B1",
        "level": "4",
        "phenotypes": "Muscular Diseases"
      },
      {
        "variant": "rs2306283",
        "gene": "SLCO1B1",
        "level": "4",
        "phenotypes": "Coronary Disease,Dyslipidaemia,Hypercholesterolemia,Hyperlipidemias"
      },
      {
        "variant": "rs35599367",
        "gene": "CYP3A4",
        "level": "4",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Testing Recommended",
        "name": "Annotation of Swissmedic Label for simvastatin and SLCO1B1"
      },
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for fenofibrate, simvastatin and SLCO1B1"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for simvastatin and SLCO1B1"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for simvastatin and SLCO1B1"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for atorvastatin, lovastatin, fluvastatin, pravastatin, pitavastatin, rosuvastatin and simvastatin dosing based on HMGCR, CYP3A4 or CYP3A5 genotypes.\n",
      "source": "CPIC"
    }
  },
  "acetylcysteine": {
    "genes": [
      "MUC5B",
      "EPHX1",
      "TOLLIP"
    ],
    "clinicalVariants": [
      {
        "variant": "rs3750920",
        "gene": "TOLLIP",
        "level": "3",
        "phenotypes": "Pulmonary Fibrosis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "adalimumab": {
    "genes": [
      "TANK",
      "IL6",
      "HLA-DQA1",
      "IL2RB",
      "FCGR2B",
      "TNFRSF10A",
      "STAT4",
      "REV3L",
      "REL",
      "CTLA4",
      "TLR9",
      "TGFB1",
      "MACO1",
      "ALPL",
      "CCL21",
      "TAGAP",
      "IL23R",
      "CR1L",
      "HLA-E",
      "IL12B",
      "TNFAIP3",
      "FCGR3A",
      "ERAP1",
      "KLRC1",
      "EYA4",
      "TNFRSF1B",
      "IL6R",
      "CASP9",
      "RSRP1",
      "BLK",
      "ATG16L1",
      "PTGER4",
      "CD40",
      "PSORS1C1",
      "IL17F",
      "CERS6",
      "CD40LG",
      "ATG5",
      "TLR2",
      "SLCO1C1",
      "VEGFA",
      "CRP",
      "HFE",
      "MAP3K14",
      "PTPN22",
      "NFKBIA",
      "PTPRC",
      "NR1I2",
      "PTPN2",
      "KLRD1",
      "ATP5F1E",
      "IL13",
      "TRAF1",
      "ZNF816",
      "VDR",
      "SH3BP2",
      "CR1",
      "TLR4",
      "NCR3",
      "HLA-DRB1",
      "NFATC2",
      "TNF",
      "KCNH7",
      "CD28",
      "EMSY",
      "FCGR2A",
      "LTA",
      "PRKCQ",
      "IL2RA",
      "GAPDHP64",
      "IL27",
      "CCNY",
      "IL2",
      "PRDM1",
      "TNFRSF1A",
      "TRAF3IP2",
      "SLC9A8",
      "CD84",
      "TF",
      "IVL"
    ],
    "clinicalVariants": [
      {
        "variant": "rs767455",
        "gene": "TNFRSF1A",
        "level": "3",
        "phenotypes": "Arthritis, Psoriatic"
      },
      {
        "variant": "rs10919563",
        "gene": "PTPRC",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs3761847",
        "gene": "TRAF1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1800795",
        "gene": "IL6",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs10210302",
        "gene": "ATG16L1",
        "level": "3",
        "phenotypes": "Crohn Disease"
      },
      {
        "variant": "rs1801274",
        "gene": "FCGR2A",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1059150",
        "gene": "ATP5F1E",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1264457",
        "gene": "HLA-E",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs2071303",
        "gene": "HFE",
        "level": "3",
        "phenotypes": "Crohn Disease"
      },
      {
        "variant": "rs1799852",
        "gene": "TF",
        "level": "3",
        "phenotypes": "Crohn Disease"
      },
      {
        "variant": "rs1130864",
        "gene": "CRP",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs510432",
        "gene": "ATG5",
        "level": "3",
        "phenotypes": "Inflammatory Bowel Diseases"
      },
      {
        "variant": "rs2302489",
        "gene": "KLRD1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs7301582",
        "gene": "KLRC1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs396991",
        "gene": "FCGR3A",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs9373839",
        "gene": "ATG5",
        "level": "3",
        "phenotypes": "Inflammatory Bowel Diseases"
      },
      {
        "variant": "rs9828223",
        "gene": "",
        "level": "3",
        "phenotypes": "Crohn Disease"
      },
      {
        "variant": "rs1801274",
        "gene": "FCGR2A",
        "level": "4",
        "phenotypes": "Psoriasis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "desflurane": {
    "genes": [
      "ATP8B3",
      "RYR1",
      "CACNA1S"
    ],
    "clinicalVariants": [
      {
        "variant": "rs118192177",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192176",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922832",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922809",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192175",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922762",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192124",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922770",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922802",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs28933397",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922843",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs1801086",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs112563513",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922816",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922748",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192161",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918595",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918596",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922753",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918593",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs28933396",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922807",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192162",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922768",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918592",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922747",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192122",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192172",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192168",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918594",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922803",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922878",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922876",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922764",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922772",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922818",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192163",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs772226819",
        "gene": "CACNA1S",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs1800559",
        "gene": "CACNA1S",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs111888148",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192178",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs144336148",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs63749869",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192116",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192167",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192170",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192178",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for desflurane and CACNA1S, RYR1"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for desflurane and CACNA1S, RYR1"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for desflurane"
      }
    ],
    "guidelines": {
      "advice": "The CPIC Dosing Guideline recommends that halogenated volatile anesthetics such as desflurane, enflurane, halothane, isoflurane, methoxyflurane, sevoflurane and the depolarizing muscle relaxants succinylcholine are relatively contraindicated in persons with malignant hyperthermia susceptibility (MHS). See full guideline for disclaimers, further details and supporting evidence. The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "propofol": {
    "genes": [
      "ATP8B3",
      "CYP2C9",
      "KCNE1",
      "DRD2",
      "ABCB1",
      "RYR1",
      "KCNE2",
      "CYP2B6",
      "SCN9A",
      "UGT1A9",
      "HTR2A",
      "ADRB2",
      "GABRA1",
      "GABRA2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs58597806",
        "gene": "UGT1A9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3745274",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1042718",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Hypotensive disorder"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2279343",
        "gene": "CYP2B6",
        "level": "4",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "emapalumab": {
    "genes": [
      "PRF1",
      "RAB27A",
      "STX11",
      "SH2D1A",
      "STXBP2",
      "XIAP",
      "UNC13D"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for emapalumab and PRF1, RAB27A, SH2D1A, STX11, STXBP2, UNC13D, XIAP"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "bezafibrate": {
    "genes": [
      "APOC3",
      "APOE"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "antivirals for treatment of hiv infections, combinations": {
    "genes": [
      "APOC3",
      "ABCB1",
      "TOMM40",
      "CYP2B6",
      "GSTT1",
      "APOA5",
      "SIK3",
      "APOE",
      "GSTM1",
      "APOC1",
      "UGT1A1",
      "NAT2",
      "GSTP1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "protease inhibitors": {
    "genes": [
      "APOC3",
      "ITPA",
      "SLC28A2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs11854484",
        "gene": "SLC28A2",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ritonavir": {
    "genes": [
      "APOC3",
      "SLC22A1",
      "ABCB1",
      "UGT1A3",
      "TOMM40",
      "CYP2B6",
      "CYP2D6",
      "ABCC2",
      "APOE",
      "NR1I2",
      "APOC1",
      "CYP3A4",
      "SLC22A6",
      "UGT1A1",
      "CYP3A5",
      "SLCO1B1",
      "UGT1A7",
      "ABCC1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs7412",
        "gene": "APOE",
        "level": "3",
        "phenotypes": "HIV infectious disease,Hypertriglyceridemia"
      },
      {
        "variant": "rs5128",
        "gene": "APOC3",
        "level": "3",
        "phenotypes": "HIV infectious disease,Hyperlipidemias"
      },
      {
        "variant": "rs212091",
        "gene": "ABCC1",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs2853826",
        "gene": "",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs2854116",
        "gene": "APOC3",
        "level": "3",
        "phenotypes": "HIV infectious disease,Hyperlipidemias"
      },
      {
        "variant": "rs2854117",
        "gene": "APOC3",
        "level": "3",
        "phenotypes": "HIV infectious disease,Hyperlipidemias"
      },
      {
        "variant": "rs1042640",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "HIV infectious disease,Nephrolithiasis"
      },
      {
        "variant": "rs7586110",
        "gene": "UGT1A7",
        "level": "3",
        "phenotypes": "HIV infectious disease,Hyperbilirubinemia"
      },
      {
        "variant": "rs17868323",
        "gene": "UGT1A7",
        "level": "3",
        "phenotypes": "HIV infectious disease,Hyperbilirubinemia"
      },
      {
        "variant": "rs17863778",
        "gene": "UGT1A7",
        "level": "3",
        "phenotypes": "HIV infectious disease,Hyperbilirubinemia"
      },
      {
        "variant": "rs3806596",
        "gene": "UGT1A3",
        "level": "3",
        "phenotypes": "HIV infectious disease,Hyperbilirubinemia"
      },
      {
        "variant": "rs10929303",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "HIV infectious disease,Nephrolithiasis"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs8330",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "HIV infectious disease,Nephrolithiasis"
      },
      {
        "variant": "rs429358",
        "gene": "APOE",
        "level": "3",
        "phenotypes": "HIV infectious disease,Hyperlipidemias"
      },
      {
        "variant": "rs7412",
        "gene": "APOE",
        "level": "3",
        "phenotypes": "HIV infectious disease,Hyperlipidemias,Hypertriglyceridemia"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "HIV infectious disease"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for ritonavir and CYP2D6, CYP3A4"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pazopanib": {
    "genes": [
      "SCGB3A1",
      "KDR",
      "VEGFA",
      "HFE",
      "NR1I2",
      "ABCG2",
      "CYP3A4",
      "HLA-B",
      "FLT4",
      "IL8",
      "HIF1A",
      "CYP2C8",
      "UGT1A1",
      "FGFR2"
    ],
    "clinicalVariants": [
      {
        "variant": "UGT1A1*1, UGT1A1*6, UGT1A1*28, UGT1A1*37",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "Renal Cell Carcinoma"
      },
      {
        "variant": "rs34231037",
        "gene": "KDR",
        "level": "3",
        "phenotypes": "Kidney Neoplasms"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for pazopanib and HLA-B"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for pazopanib and HLA-B"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for pazopanib and HLA-B, UGT1A1"
      },
      {
        "source": "EMA",
        "level": "Informative PGx",
        "name": "Annotation of EMA Label for pazopanib and HLA-B"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ace inhibitors, plain": {
    "genes": [
      "MME",
      "ADRB1",
      "SH2B1",
      "F5",
      "GABRG2",
      "KCNMA1",
      "MBOAT1",
      "PTGER3",
      "CES1",
      "AGT",
      "CLASP1",
      "AGTR1",
      "ADRB2",
      "PRKCA",
      "BDKRB2",
      "KCNIP4",
      "XPNPEP2",
      "ADRA2C",
      "PRKCQ",
      "RBFOX3",
      "CYP4A11",
      "ETV6",
      "ACE",
      "ABO",
      "NOS3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "metformin": {
    "genes": [
      "PPARGC1A",
      "HNF4A",
      "SLC22A1",
      "NBEA",
      "PRKAG1",
      "PPARA",
      "PRKAB2",
      "PPARGC1B",
      "GCK",
      "AMHR2",
      "PRKAB1",
      "FMO5",
      "SLC47A2",
      "C11orf65",
      "SLC29A4",
      "SLC22A2",
      "MEF2A",
      "FKBP1A",
      "BDNF",
      "PRKAA2",
      "ALDH3A2",
      "PCK1",
      "ABCC8",
      "MEF2D",
      "ATM",
      "SLC30A8",
      "HNF1B",
      "HNF1A",
      "SLC22A4",
      "CPA6",
      "FMO1",
      "PRKAA1",
      "NR1I2",
      "SNORA59B",
      "TCF7L2",
      "KCNJ11",
      "GCG",
      "PRPF31",
      "SLC2A2",
      "CBARP",
      "CSMD1",
      "SRR",
      "PRKAG3",
      "SLC19A3",
      "SLC22A3",
      "PRKAG2",
      "IL1B",
      "STK11",
      "SP1",
      "CAPN10",
      "ITLN2",
      "ADIPOR2",
      "SLC47A1",
      "PKLR",
      "PPARG",
      "ARFGEF3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs72552763",
        "gene": "SLC22A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3792269",
        "gene": "CAPN10",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "rs10747673",
        "gene": "",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "rs2683511",
        "gene": "SP1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "rs149711321",
        "gene": "PPARA",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "rs578427",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs34834489",
        "gene": "SLC47A2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs36056065",
        "gene": "SLC22A1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs2076828",
        "gene": "SLC22A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs316019",
        "gene": "SLC22A2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7541245",
        "gene": "FMO5",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "rs8187725",
        "gene": "SLC22A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs594709",
        "gene": "SLC22A1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs622342",
        "gene": "SLC22A1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "rs8192675",
        "gene": "SLC2A2",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "rs2282143",
        "gene": "SLC22A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2252281",
        "gene": "SLC47A1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2,Polycystic Ovary Syndrome"
      },
      {
        "variant": "rs12943590",
        "gene": "SLC47A2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2289669",
        "gene": "SLC47A1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2,Polycystic Ovary Syndrome"
      },
      {
        "variant": "rs12943590",
        "gene": "SLC47A2",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "rs5219",
        "gene": "KCNJ11",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs12208357",
        "gene": "SLC22A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs784888",
        "gene": "SP1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs784892",
        "gene": "AMHR2",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "rs2162145",
        "gene": "CPA6",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs57081354",
        "gene": "NBEA",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs254271",
        "gene": "PRPF31",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs628031",
        "gene": "SLC22A1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs628031",
        "gene": "SLC22A1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2,Gastrointestinal toxicity"
      },
      {
        "variant": "rs11212617",
        "gene": "ATM,C11orf65",
        "level": "4",
        "phenotypes": "Diabetes Mellitus, Type 2"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "rosiglitazone": {
    "genes": [
      "PPARGC1A",
      "CYP2C9",
      "PAX4",
      "PLIN1",
      "LPIN1",
      "CYP2C8",
      "SLCO1B1",
      "PPARG"
    ],
    "clinicalVariants": [
      {
        "variant": "rs10192566",
        "gene": "LPIN1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs6467136",
        "gene": "PAX4",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs894160",
        "gene": "PLIN1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2,Weight gain"
      },
      {
        "variant": "CYP2C8*1, CYP2C8*3",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C8*1, CYP2C8*3",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C8*1, CYP2C8*3",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "zoledronate": {
    "genes": [
      "MMP2",
      "FDPS",
      "PPCDC",
      "TNFRSF11A",
      "COL1A1",
      "TNFRSF11B",
      "VDR",
      "SPP1",
      "CYP2C8",
      "SIRT1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2297480",
        "gene": "FDPS",
        "level": "3",
        "phenotypes": "Neoplasms,Osteonecrosis"
      },
      {
        "variant": "rs147451859",
        "gene": "PPCDC",
        "level": "3",
        "phenotypes": "Amenorrhea"
      },
      {
        "variant": "rs17587029",
        "gene": "",
        "level": "3",
        "phenotypes": "Amenorrhea"
      },
      {
        "variant": "rs1934951",
        "gene": "CYP2C8",
        "level": "4",
        "phenotypes": "Multiple Myeloma,Osteonecrosis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ulinastatin": {
    "genes": [
      "MMP2",
      "MMP9"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pamidronate": {
    "genes": [
      "MMP2",
      "TNFRSF11A",
      "COL1A1",
      "TNFRSF11B",
      "SPP1",
      "CYP2C8"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1934951",
        "gene": "CYP2C8",
        "level": "4",
        "phenotypes": "Multiple Myeloma,Osteonecrosis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lithium": {
    "genes": [
      "CACNG2",
      "CLOCK",
      "DRD2",
      "ABCB1",
      "HTR2C",
      "TPH1",
      "SH2B1",
      "OR52E2",
      "HTR1B",
      "GADL1",
      "ADCY2",
      "CRY1",
      "DRD1",
      "FYN",
      "SCN8A",
      "EPHX2",
      "LECT2",
      "NR1D1",
      "BDNF",
      "GSK3B",
      "OR52J2P",
      "FAM178B",
      "GRIN2B",
      "BMAL1",
      "FKBP5",
      "IMPA2",
      "CREB1",
      "ASIC2",
      "BCR",
      "GRAMD1B",
      "NBAS",
      "HTR2A",
      "BDNF-AS",
      "CNKSR3",
      "TMCC1",
      "ZNF804A",
      "MMP9",
      "ANKK1",
      "MYO1H",
      "ADCY1",
      "PER3",
      "THRA",
      "OR52J3",
      "NTRK2",
      "DRD3",
      "PDLIM5",
      "FAM177A1",
      "COMT",
      "DGKH",
      "RABEP1",
      "PER2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2284017",
        "gene": "CACNG2",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs8192440",
        "gene": "CRY1",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs4532",
        "gene": "DRD1",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs334558",
        "gene": "GSK3B",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs2826494",
        "gene": "",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs2499984",
        "gene": "OR52J2P,OR52J3",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs2284018",
        "gene": "CACNG2",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs2314339",
        "gene": "NR1D1,THRA",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs2769605",
        "gene": "",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs6438552",
        "gene": "GSK3B",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs1800532",
        "gene": "TPH1",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs2071427",
        "gene": "NR1D1,THRA",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs130058",
        "gene": "HTR1B",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs1360780",
        "gene": "FKBP5",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs16909440",
        "gene": "OR52E2",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs11869731",
        "gene": "ASIC2",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs16973410",
        "gene": "",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs79663003",
        "gene": "",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs75222709",
        "gene": "",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs3888190",
        "gene": "SH2B1",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depressive Disorder,Psychotic Disorder,Schizoaffective disorder"
      },
      {
        "variant": "rs1000940",
        "gene": "RABEP1",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depressive Disorder,Psychotic Disorder,Schizoaffective disorder"
      },
      {
        "variant": "rs324899",
        "gene": "",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs6942227",
        "gene": "",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs1611259",
        "gene": "",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs59724122",
        "gene": "EPHX2",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs61123830",
        "gene": "GRAMD1B",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs7959663",
        "gene": "MYO1H",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs66486766",
        "gene": "",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs7405404",
        "gene": "",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs6728642",
        "gene": "FAM178B",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs62200793",
        "gene": "ZNF804A",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs7588746",
        "gene": "",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs3919583",
        "gene": "",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs1611255",
        "gene": "",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs209474",
        "gene": "",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs1521470",
        "gene": "ADCY1",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs79403677",
        "gene": "FAM177A1",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs78015114",
        "gene": "",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs74795342",
        "gene": "",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs1801260",
        "gene": "CLOCK",
        "level": "4",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs1387923",
        "gene": "NTRK2",
        "level": "4",
        "phenotypes": "Bipolar Disorder"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "benazepril": {
    "genes": [
      "PRCP",
      "MTHFR",
      "CYP11B2",
      "AGT",
      "ADD1",
      "MTR",
      "SPTA1",
      "AGTR1",
      "ADRB2",
      "ACE"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1805087",
        "gene": "MTR",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs2229437",
        "gene": "PRCP",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1799998",
        "gene": "CYP11B2",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs7079",
        "gene": "AGT",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs5051",
        "gene": "AGT",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "4",
        "phenotypes": "Essential hypertension"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fluticasone / salmeterol": {
    "genes": [
      "ZNF432",
      "CHRM2",
      "IL10",
      "IL17A",
      "CRHR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "budesonide": {
    "genes": [
      "ZNF432",
      "FCER2",
      "GLCCI1",
      "ADRB2",
      "SUMF1",
      "IL10",
      "CYP3A5",
      "IL17A",
      "CRHR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs37973",
        "gene": "GLCCI1",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs2392165",
        "gene": "",
        "level": "3",
        "phenotypes": "Asthma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fluticasone propionate": {
    "genes": [
      "ZNF432",
      "CD14",
      "GLCCI1",
      "CA10",
      "ORMDL3",
      "TMCO6",
      "CYP3A4",
      "ADRB2",
      "CYP3A5",
      "CRHR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs37973",
        "gene": "GLCCI1",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs1786929",
        "gene": "",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs967676",
        "gene": "CA10",
        "level": "3",
        "phenotypes": "Asthma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "aripiprazole": {
    "genes": [
      "CYP3A43",
      "CYP2C9",
      "DRD2",
      "DTNBP1",
      "ABCB1",
      "HTR2C",
      "SH2B1",
      "CYP2B6",
      "CYP2D6",
      "MC4R",
      "CYP2C19",
      "UGT1A4",
      "SLC6A4",
      "RELN",
      "HLA-A",
      "HTR2A",
      "APOE",
      "CNR1",
      "DAOA",
      "AGT",
      "ANKK1",
      "FAAH",
      "CYP3A4",
      "HLA-B",
      "CYP3A5",
      "POLG",
      "TAAR6",
      "FAT1",
      "DRD3",
      "ACE",
      "CYP1A2",
      "RABEP1"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Psychotic Disorder,Schizoaffective disorder,Schizophrenia"
      },
      {
        "variant": "rs324420",
        "gene": "FAAH",
        "level": "3",
        "phenotypes": "Psychotic Disorder"
      },
      {
        "variant": "rs4305746",
        "gene": "TAAR6",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs3888190",
        "gene": "SH2B1",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depressive Disorder,Psychotic Disorder,Schizoaffective disorder"
      },
      {
        "variant": "rs1000940",
        "gene": "RABEP1",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depressive Disorder,Psychotic Disorder,Schizoaffective disorder"
      },
      {
        "variant": "rs6277",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2514218",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Psychotic Disorder,Schizoaffective disorder,Schizophrenia"
      },
      {
        "variant": "rs2514218",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Psychomotor Agitation"
      },
      {
        "variant": "rs489693",
        "gene": "MC4R",
        "level": "3",
        "phenotypes": "Weight gain"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1800497",
        "gene": "ANKK1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for aripiprazole and CYP2D6"
      },
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for aripiprazole and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for aripiprazole and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for aripiprazole and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "The Royal Dutch Pharmacists Association - Pharmacogenetics Working Group (DPWG) recommends reducing maximum dose of aripiprazole for patients carrying poor metabolizer alleles of CYP2D6.\n",
      "source": "DPWG"
    }
  },
  "ticagrelor": {
    "genes": [
      "CYP3A43",
      "CYP2C9",
      "NUP153",
      "ABCB1",
      "CYP2B6",
      "CYP2C19",
      "CYP4F2",
      "P2RY12",
      "UGT2B7",
      "SVEP1",
      "CYP3A4",
      "CYP3A5",
      "SLCO1B1",
      "PEAR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs61361928",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Acute coronary syndrome"
      },
      {
        "variant": "rs56324128",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Acute coronary syndrome"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Acute coronary syndrome"
      },
      {
        "variant": "rs62471956",
        "gene": "CYP3A43",
        "level": "3",
        "phenotypes": "Acute coronary syndrome"
      },
      {
        "variant": "rs113681054",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Acute coronary syndrome"
      },
      {
        "variant": "rs12041331",
        "gene": "PEAR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4661012",
        "gene": "PEAR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs12566888",
        "gene": "PEAR1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Informative PGx",
        "name": "Annotation of EMA Label for ticagrelor and CYP2C19"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for ticagrelor and CYP2C19"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for ticagrelor and CYP2C19"
      }
    ],
    "guidelines": {
      "advice": "There are currently no dosing recommendations for ticagrelor based on CYP2C19 genotypes.\n",
      "source": "DPWG"
    }
  },
  "haloperidol": {
    "genes": [
      "CYP3A43",
      "GRIN2A",
      "KCNE1",
      "DRD2",
      "DTNBP1",
      "ABCB1",
      "RYR1",
      "HTR2C",
      "KCNE2",
      "CYP2D6",
      "HTR3E",
      "MTHFR",
      "GRIK4",
      "DRD1",
      "MC4R",
      "IL1RN",
      "SLC6A5",
      "PLEKHA6",
      "SLC6A3",
      "GRIN2B",
      "AKAP13",
      "SLC6A4",
      "HOMER1",
      "DPP6",
      "EPM2A",
      "ABCB5",
      "GRIA1",
      "CACNA1C",
      "UGT2B7",
      "TOR1A",
      "NKX6-1",
      "CNR1",
      "GRIN1",
      "ANKK1",
      "FAAH",
      "CYP3A4",
      "ZIC4",
      "RTKN2",
      "EIF2AK4",
      "HTR3A",
      "HSPG2",
      "CYP3A5",
      "RGS2",
      "NTS",
      "ARID5B",
      "CYP1A2",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*17",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs909706",
        "gene": "DTNBP1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2298826",
        "gene": "SLC6A5",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs7912580",
        "gene": "",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2412459",
        "gene": "EIF2AK4",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs17143212",
        "gene": "ABCB5",
        "level": "3",
        "phenotypes": "Psychotic Disorder"
      },
      {
        "variant": "rs324420",
        "gene": "FAAH",
        "level": "3",
        "phenotypes": "Psychotic Disorder"
      },
      {
        "variant": "rs1415744",
        "gene": "EPM2A",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs489693",
        "gene": "MC4R",
        "level": "3",
        "phenotypes": "Hypertriglyceridemia,Schizoaffective disorder,Schizophrenia,Weight gain"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "The recommendation for CYP2D6 poor metabolizers is to use 60% of the normal dose of haloperidol and for CYP2D6 ultrarapid metabolizers to use 1.5 times the normal dose or to choose an alternative to haloperidol.\n",
      "source": "DPWG"
    }
  },
  "ziprasidone": {
    "genes": [
      "CYP3A43",
      "CYP2C9",
      "DRD2",
      "HTR2C",
      "RGS4",
      "CYP2B6",
      "CYP2D6",
      "MC4R",
      "CYP2C19",
      "UGT1A4",
      "SV2C",
      "SLC6A4",
      "NALCN",
      "HLA-A",
      "HTR2A",
      "APOE",
      "LYN",
      "AGT",
      "CYP3A4",
      "EHF",
      "HLA-B",
      "EIF2AK4",
      "CDH4",
      "CYP3A5",
      "POLG",
      "CNTN4",
      "ACE",
      "CYP1A2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs951439",
        "gene": "RGS4",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs7912580",
        "gene": "",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs2412459",
        "gene": "EIF2AK4",
        "level": "3",
        "phenotypes": "Schizophrenia"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mycophenolic acid": {
    "genes": [
      "UGT1A10",
      "HPRT1",
      "IMPDH2",
      "UGT1A9",
      "SLCO1B3",
      "UGT1A8",
      "NFATC1",
      "UGT2B7",
      "CES1",
      "ABCC2",
      "CYP3A4",
      "CES2",
      "CYP2C8",
      "UGT1A1",
      "IMPDH1",
      "CYP3A5",
      "SLCO1B1",
      "UGT1A7"
    ],
    "clinicalVariants": [
      {
        "variant": "rs3832043",
        "gene": "UGT1A9",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs3740066",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Organ Transplantation"
      },
      {
        "variant": "rs2306283",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs4149117",
        "gene": "SLCO1B3",
        "level": "3",
        "phenotypes": "Lung transplantation,Overall survival"
      },
      {
        "variant": "rs4149117",
        "gene": "SLCO1B3",
        "level": "3",
        "phenotypes": "Chronic lung allograft dysfunction,Lung transplantation"
      },
      {
        "variant": "rs7311358",
        "gene": "SLCO1B3",
        "level": "3",
        "phenotypes": "Lung transplantation,Overall survival"
      },
      {
        "variant": "rs4149117",
        "gene": "SLCO1B3",
        "level": "3",
        "phenotypes": "Lung transplantation,Transplant rejection"
      },
      {
        "variant": "rs7311358",
        "gene": "SLCO1B3",
        "level": "3",
        "phenotypes": "Lung transplantation,Transplant rejection"
      },
      {
        "variant": "rs7311358",
        "gene": "SLCO1B3",
        "level": "3",
        "phenotypes": "Chronic lung allograft dysfunction,Lung transplantation"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs11706052",
        "gene": "IMPDH2",
        "level": "4",
        "phenotypes": "Kidney Transplantation"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for mycophenolic acid and HPRT1"
      },
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for mycophenolic acid and HPRT1"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for mycophenolic acid and HPRT1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "axitinib": {
    "genes": [
      "UGT1A10",
      "KDR",
      "ABCB1",
      "CYP2C19",
      "UGT1A9",
      "UGT1A8",
      "OR2B11",
      "ABCG2",
      "HIF1A",
      "FLT1",
      "UGT1A1",
      "CYP3A5",
      "SLCO1B1",
      "UGT1A7"
    ],
    "clinicalVariants": [
      {
        "variant": "rs11549465",
        "gene": "HIF1A",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "No Clinical PGx",
        "name": "Annotation of EMA Label for axitinib and CYP2C19, UGT1A1"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for axitinib and CYP2C19, UGT1A1"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for axitinib and CYP2C19, UGT1A1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sn-38": {
    "genes": [
      "UGT1A10",
      "ABCB1",
      "UGT1A3",
      "UGT1A4",
      "UGT1A9",
      "UGT1A8",
      "CES1",
      "ABCC2",
      "ABCG2",
      "BCHE",
      "CES2",
      "TOP1",
      "UGT1A1",
      "SLCO1B1",
      "UGT1A6",
      "ABCC1"
    ],
    "clinicalVariants": [
      {
        "variant": "UGT1A1*1, UGT1A1*6, UGT1A1*28",
        "gene": "UGT1A1",
        "level": "1B",
        "phenotypes": ""
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      },
      {
        "variant": "rs3806598",
        "gene": "UGT1A9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2741049",
        "gene": "UGT1A9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs72551344",
        "gene": "UGT1A9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs34993780",
        "gene": "UGT1A9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs35350960",
        "gene": "UGT1A9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6498588",
        "gene": "ABCC1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs35621",
        "gene": "ABCC1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs3832043",
        "gene": "UGT1A9",
        "level": "3",
        "phenotypes": "Non-Small Cell Lung Carcinoma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fesoterodine": {
    "genes": [
      "UGT1A10",
      "UGT1A3",
      "CYP2D6",
      "UGT1A4",
      "UGT1A9",
      "UGT1A8",
      "UGT1A5",
      "CES1",
      "CYP3A4",
      "UGT1A1",
      "UGT1A6",
      "UGT1A7"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for fesoterodine and CYP2D6"
      },
      {
        "source": "EMA",
        "level": "Informative PGx",
        "name": "Annotation of EMA Label for fesoterodine and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for fesoterodine and CYP2D6"
      },
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for fesoterodine and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for fesoterodine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "febuxostat": {
    "genes": [
      "UGT1A10",
      "AOX1",
      "UGT1A3",
      "UGT1A4",
      "UGT1A9",
      "UGT1A8",
      "UGT1A5",
      "XDH",
      "UGT1A1",
      "UGT1A6",
      "UGT1A7"
    ],
    "clinicalVariants": [
      {
        "variant": "rs34650714",
        "gene": "UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A5,UGT1A6,UGT1A7,UGT1A8,UGT1A9",
        "level": "3",
        "phenotypes": "Gout"
      },
      {
        "variant": "rs75995567",
        "gene": "AOX1",
        "level": "3",
        "phenotypes": "Gout"
      },
      {
        "variant": "rs3731722",
        "gene": "AOX1",
        "level": "3",
        "phenotypes": "Gout"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "acetaminophen glucuronide": {
    "genes": [
      "UGT1A10",
      "UGT1A3",
      "UGT1A4",
      "UGT1A9",
      "UGT1A8",
      "UGT1A5",
      "MROH2A",
      "UGT1A",
      "UGT1A1",
      "UGT1A6",
      "UGT1A7"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "n-desmethylclozapine": {
    "genes": [
      "UGT1A10",
      "ABCB1",
      "CYP2D6",
      "CYP1A1",
      "CYP2C19",
      "UGT1A4",
      "UGT1A9",
      "SLC6A4",
      "UGT1A8",
      "UGT1A5",
      "UGT2B7",
      "CYP3A4",
      "SLCO1B1",
      "UGT1A6",
      "UGT1A7",
      "CYP1A2",
      "UGT2B10"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "folfiri": {
    "genes": [
      "UGT1A10",
      "ABCB1",
      "MTHFR",
      "CES1P1",
      "DPYD",
      "UGT1A8",
      "CES1",
      "ABCC2",
      "ABCG2",
      "BRAF",
      "UGT1A1",
      "DPYS",
      "ABCC1",
      "TYMS"
    ],
    "clinicalVariants": [
      {
        "variant": "UGT1A1*1, UGT1A1*28",
        "gene": "UGT1A1",
        "level": "1A",
        "phenotypes": "Neutropenia"
      },
      {
        "variant": "UGT1A1*1, UGT1A1*6, UGT1A1*28",
        "gene": "UGT1A1",
        "level": "1B",
        "phenotypes": "Diarrhea"
      },
      {
        "variant": "UGT1A1*1, UGT1A1*6",
        "gene": "UGT1A1",
        "level": "1B",
        "phenotypes": "Neutropenia"
      },
      {
        "variant": "rs45445694",
        "gene": "TYMS",
        "level": "3",
        "phenotypes": "Overall survival,Progression-free survival"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "acetaminophen": {
    "genes": [
      "UGT1A10",
      "SULT1A1",
      "UGT1A3",
      "PLA2G4A",
      "CD44",
      "SULT2A1",
      "CYP2D6",
      "OPRD1",
      "OPRM1",
      "HLA-DQB1",
      "UGT1A4",
      "G6PD",
      "UGT1A9",
      "UGT1A8",
      "HLA-A",
      "UGT1A5",
      "TNFRSF11A",
      "SULT1A4",
      "ABCG2",
      "SULT1E1",
      "CYP2E1",
      "CYP3A4",
      "UGT1A",
      "HLA-B",
      "TLR4",
      "HLA-DRB1",
      "PLCG1",
      "UGT2B15",
      "HLA-C",
      "TRPV1",
      "UGT1A1",
      "CYP3A5",
      "UGT1A6",
      "CYP2A6",
      "NPIPB8",
      "UGT1A7",
      "SULT1A3",
      "CYP1A2",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "rs10929303",
        "gene": "UGT1A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10929303",
        "gene": "UGT1A",
        "level": "3",
        "phenotypes": "Liver Failure, Acute"
      },
      {
        "variant": "rs1042640",
        "gene": "UGT1A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1042640",
        "gene": "UGT1A",
        "level": "3",
        "phenotypes": "Liver Failure, Acute"
      },
      {
        "variant": "rs8330",
        "gene": "UGT1A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs8330",
        "gene": "UGT1A,UGT1A9",
        "level": "3",
        "phenotypes": "Liver Failure, Acute"
      },
      {
        "variant": "rs12746200",
        "gene": "PLA2G4A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1805034",
        "gene": "TNFRSF11A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2228246",
        "gene": "PLCG1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs9933632",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6500265",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs767263838",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs757573592",
        "gene": "SULT1A3,SULT1A4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs776817009",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs762151655",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs750575779",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs553050853",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs751527244",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1293732453",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1328799050",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs224534",
        "gene": "TRPV1",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs1902023",
        "gene": "UGT2B15",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs765399160",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs28374453",
        "gene": "NPIPB8,SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1042028",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs72547527",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1042008",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs767487725",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs758145522",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs544820732",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs552524124",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1042028",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Neuropathic pain"
      },
      {
        "variant": "HLA-DQB1*02:02",
        "gene": "HLA-DQB1",
        "level": "3",
        "phenotypes": "Severe Cutaneous Adverse Reactions"
      },
      {
        "variant": "HLA-C*14:03",
        "gene": "HLA-C",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for acetaminophen, tramadol and CYP2D6"
      },
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for acetaminophen, acetaminophen / tramadol and G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "allopurinol": {
    "genes": [
      "UGT1A10",
      "AOX1",
      "UGT1A3",
      "PDZK1",
      "PSORS1C3",
      "TBL1XR1",
      "HLA-DQB1",
      "UGT1A4",
      "POU5F1",
      "SLC17A1",
      "GREM2",
      "UGT1A9",
      "NTNG1",
      "PSORS1C1",
      "UGT1A8",
      "HLA-A",
      "UGT1A5",
      "CCHCR1",
      "ABCG2",
      "SLC22A11",
      "CYCSP5",
      "XDH",
      "HLA-B",
      "MOCOS",
      "PKD2",
      "TRIB2",
      "HLA-DRB1",
      "TSHZ2",
      "HLA-C",
      "MYT1L",
      "UGT1A1",
      "UGT1A6",
      "CFLAR",
      "NOTCH4",
      "PSORS1C2",
      "SLC22A12",
      "UGT1A7",
      "SLC2A9"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "1A",
        "phenotypes": "Gout"
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "1A",
        "phenotypes": "Gout"
      },
      {
        "variant": "HLA-B*58:01",
        "gene": "HLA-B",
        "level": "1A",
        "phenotypes": "Drug Hypersensitivity,Drug Reaction with Eosinophilia and Systemic Symptoms,Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-C*03:02",
        "gene": "HLA-C",
        "level": "2B",
        "phenotypes": "Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-A*33:03",
        "gene": "HLA-A",
        "level": "2B",
        "phenotypes": "Drug Hypersensitivity,Stevens-Johnson Syndrome"
      },
      {
        "variant": "HLA-DRB1*14:01",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Drug Hypersensitivity"
      },
      {
        "variant": "HLA-DRB1*09:01",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Drug Hypersensitivity"
      },
      {
        "variant": "HLA-DRB1*03:01",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Severe Cutaneous Adverse Reactions"
      },
      {
        "variant": "HLA-C*03:02",
        "gene": "HLA-C",
        "level": "3",
        "phenotypes": "Exanthema"
      },
      {
        "variant": "HLA-DRB1*15:02",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Severe Cutaneous Adverse Reactions"
      },
      {
        "variant": "HLA-DRB1*13:02",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Severe Cutaneous Adverse Reactions"
      },
      {
        "variant": "rs2844665",
        "gene": "",
        "level": "3",
        "phenotypes": "Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "rs3094188",
        "gene": "PSORS1C3",
        "level": "3",
        "phenotypes": "Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "rs3130501",
        "gene": "POU5F1",
        "level": "3",
        "phenotypes": "Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "rs3130931",
        "gene": "POU5F1",
        "level": "3",
        "phenotypes": "Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-A*02:01",
        "gene": "HLA-A",
        "level": "3",
        "phenotypes": "Severe Cutaneous Adverse Reactions"
      },
      {
        "variant": "HLA-B*48:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Hypersensitivity"
      },
      {
        "variant": "HLA-C*08:01",
        "gene": "HLA-C",
        "level": "3",
        "phenotypes": "Drug Hypersensitivity,Stevens-Johnson Syndrome"
      },
      {
        "variant": "HLA-DQB1*05:02",
        "gene": "HLA-DQB1",
        "level": "3",
        "phenotypes": "Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "rs9469003",
        "gene": "CYCSP5",
        "level": "3",
        "phenotypes": "Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "rs34650714",
        "gene": "UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A5,UGT1A6,UGT1A7,UGT1A8,UGT1A9",
        "level": "3",
        "phenotypes": "Gout"
      },
      {
        "variant": "rs75995567",
        "gene": "AOX1",
        "level": "3",
        "phenotypes": "Gout"
      },
      {
        "variant": "rs3731722",
        "gene": "AOX1",
        "level": "3",
        "phenotypes": "Gout"
      },
      {
        "variant": "rs367398",
        "gene": "NOTCH4",
        "level": "3",
        "phenotypes": "Severe Cutaneous Adverse Reactions"
      },
      {
        "variant": "rs3131003",
        "gene": "PSORS1C1",
        "level": "3",
        "phenotypes": "Severe Cutaneous Adverse Reactions"
      },
      {
        "variant": "rs9263726",
        "gene": "PSORS1C1",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome"
      },
      {
        "variant": "rs3099844",
        "gene": "CYCSP5",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome"
      },
      {
        "variant": "rs2734583",
        "gene": "",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome"
      },
      {
        "variant": "rs61816456",
        "gene": "NTNG1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs77567654",
        "gene": "GREM2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10802887",
        "gene": "GREM2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1934341",
        "gene": "GREM2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4659982",
        "gene": "GREM2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs79663562",
        "gene": "MYT1L",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10193126",
        "gene": "TRIB2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs57449396",
        "gene": "TBL1XR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2725215",
        "gene": "PKD2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4148157",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs76979899",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4148155",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs9366772",
        "gene": "HLA-C",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3815087",
        "gene": "PSORS1C1",
        "level": "4",
        "phenotypes": "Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "rs10011796",
        "gene": "ABCG2",
        "level": "4",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "PMDA",
        "level": "Informative PGx",
        "name": "Annotation of PMDA Label for allopurinol and HLA-B"
      },
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for allopurinol and HLA-B"
      },
      {
        "source": "FDA",
        "level": "Testing Recommended",
        "name": "Annotation of FDA Label for allopurinol and HLA-B"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for allopurinol"
      },
      {
        "source": "HCSC",
        "level": "Testing Recommended",
        "name": "Annotation of HCSC Label for allopurinol and HLA-B"
      }
    ],
    "guidelines": {
      "advice": "The Socit Francophone d'Histocompatibilit et d'Immunogntique (SFHI) has established national guidelines around testing for HLA-B*58:01 prior to prescription of allopurinol to avoid severe cutaneous adverse reactions (SCARs).\n",
      "source": "RNPGx"
    }
  },
  "ketamine": {
    "genes": [
      "UGT1A10",
      "UGT1A3",
      "CYP2B6",
      "OPRM1",
      "UGT1A4",
      "GRIN2B",
      "UGT1A9",
      "UGT1A8",
      "UGT1A5",
      "UGT1A1",
      "UGT1A6",
      "UGT1A7"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2B6*1, CYP2B6*6",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Neoplasms,Pain"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ondansetron": {
    "genes": [
      "UGT1A10",
      "KCNE1",
      "ABCB1",
      "UGT1A3",
      "KCNE2",
      "CYP2D6",
      "UGT1A4",
      "UGT1A9",
      "SLC6A4",
      "UGT1A8",
      "UGT1A5",
      "CYP3A4",
      "UGT1A1",
      "CYP3A5",
      "UGT1A6",
      "UGT1A7"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*35xN",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Vomiting"
      },
      {
        "variant": "rs1042173",
        "gene": "SLC6A4",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",
        "gene": "SLC6A4",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Postoperative Nausea and Vomiting,Vomiting"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Postoperative Nausea and Vomiting,Vomiting"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for ondansetron and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for ondansetron and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for ondansetron and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "The CPIC dosing guideline for ondansetron recommends selecting an alternate drug for CYP2D6 ultrarapid metabolizers.  It is recommended that the alternate drug not be predominantly metabolized by CYP2D6 (eg. granisetron). The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "oxcarbazepine": {
    "genes": [
      "UGT1A10",
      "CYP2C9",
      "HNF4A",
      "DRD2",
      "ABCB1",
      "HTR2C",
      "CYP2B6",
      "CYP2D6",
      "CYP2C19",
      "UGT1A4",
      "UGT1A9",
      "SLC6A4",
      "UGT1A8",
      "HLA-A",
      "HTR2A",
      "UGT2B7",
      "ABCC2",
      "SCN2A",
      "CYP3A4",
      "HLA-B",
      "SCN1A",
      "HLA-DRB1",
      "UGT2B15",
      "GABRA1",
      "GABRA3",
      "CYP3A5",
      "POLG",
      "UGT1A6",
      "UGT1A7",
      "CYP1A2"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-B*15:02",
        "gene": "HLA-B",
        "level": "1A",
        "phenotypes": "Stevens-Johnson Syndrome"
      },
      {
        "variant": "HLA-B*13:02",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Maculopapular Exanthema"
      },
      {
        "variant": "HLA-B*15:19",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Maculopapular Exanthema"
      },
      {
        "variant": "HLA-B*15:27",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Maculopapular Exanthema"
      },
      {
        "variant": "HLA-B*27:09",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Maculopapular Exanthema"
      },
      {
        "variant": "HLA-B*38:02",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Maculopapular Exanthema"
      },
      {
        "variant": "HLA-B*48:04",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Maculopapular Exanthema"
      },
      {
        "variant": "HLA-B*40:02",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "HLA-B*15:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "HLA-DRB1*04:03",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2741049",
        "gene": "UGT1A10,UGT1A7,UGT1A8,UGT1A9",
        "level": "3",
        "phenotypes": "Epilepsy,Seizures"
      },
      {
        "variant": "rs7439366",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "HLA-A*31:01",
        "gene": "HLA-A",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms"
      },
      {
        "variant": "rs2304016",
        "gene": "SCN2A",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "HLA-B*15:18, HLA-B*40:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Stevens-Johnson Syndrome"
      },
      {
        "variant": "rs2273697",
        "gene": "ABCC2",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2298771",
        "gene": "SCN1A",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2298771",
        "gene": "SCN1A",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "HLA-B*15:02",
        "gene": "HLA-B",
        "level": "4",
        "phenotypes": "Maculopapular Exanthema"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Testing Required",
        "name": "Annotation of Swissmedic Label for oxcarbazepine and HLA-B"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for oxcarbazepine and HLA-A"
      },
      {
        "source": "FDA",
        "level": "Testing Recommended",
        "name": "Annotation of FDA Label for oxcarbazepine and HLA-B"
      },
      {
        "source": "HCSC",
        "level": "Testing Recommended",
        "name": "Annotation of HCSC Label for oxcarbazepine and HLA-B"
      }
    ],
    "guidelines": {
      "advice": "The Socit Francophone d'Histocompatibilit et d'Immunogntique (SFHI) has guidance about carbamazepine and oxcarbazepine toxicity and HLA-B*15:02 and HLA-A*31:01.\n",
      "source": "RNPGx"
    }
  },
  "topiramate": {
    "genes": [
      "UGT1A10",
      "ABCB1",
      "UGT1A3",
      "CYP2D6",
      "GRIK1-AS2",
      "OPRM1",
      "CYP2C19",
      "GRIK1",
      "UGT1A4",
      "CA12",
      "UGT1A9",
      "UGT1A8",
      "UGT1A5",
      "SCN2A",
      "GABRA1",
      "GABRA3",
      "UGT1A1",
      "UGT1A6",
      "INSR",
      "UGT1A7"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2832407",
        "gene": "GRIK1",
        "level": "3",
        "phenotypes": "Alcohol-Related Disorders"
      },
      {
        "variant": "rs4984241",
        "gene": "CA12",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2306719",
        "gene": "CA12",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2396185",
        "gene": "INSR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2304016",
        "gene": "SCN2A",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Migraine with Aura,Migraine without Aura"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "salbutamol": {
    "genes": [
      "THRB",
      "SPATS2L",
      "CLOCK",
      "PRKG1",
      "COL22A1",
      "IGF2R",
      "NCOA3",
      "PAPPA2",
      "SLC24A4",
      "COL2A1",
      "ADCY9",
      "DUSP1",
      "VEGFA",
      "CRHR2",
      "ADRB2",
      "NOS3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs9552679",
        "gene": "",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs1522113",
        "gene": "CLOCK",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs1423515",
        "gene": "",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs11252394",
        "gene": "",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs17701271",
        "gene": "",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs17495520",
        "gene": "",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs1419555",
        "gene": "",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs1663330",
        "gene": "",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs1663332",
        "gene": "",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs518350",
        "gene": "",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs6002674",
        "gene": "",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs881152",
        "gene": "DUSP1",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs2267715",
        "gene": "CRHR2",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs1800888",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10511905",
        "gene": "",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs7793837",
        "gene": "CRHR2",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs6988229",
        "gene": "COL22A1",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs255100",
        "gene": "CRHR2",
        "level": "4",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs2284220",
        "gene": "CRHR2",
        "level": "4",
        "phenotypes": "Asthma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "gemcitabine triphosphate": {
    "genes": [
      "SLC28A3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "prednisolone": {
    "genes": [
      "SLC28A3",
      "TSPYL1",
      "ABCB1",
      "CYBA",
      "GATA3",
      "MTHFR",
      "FCGR3A",
      "CD40",
      "PNPLA3",
      "DSE",
      "TLR4",
      "RAC2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs2229109",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs738409",
        "gene": "PNPLA3",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs3828743",
        "gene": "DSE,TSPYL1",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "midostaurin": {
    "genes": [
      "KIT",
      "FLT3",
      "NPM1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for midostaurin and FLT3"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for midostaurin and KIT, NPM1"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for midostaurin and FLT3"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for midostaurin and FLT3"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "avapritinib": {
    "genes": [
      "KIT",
      "PDGFRA"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for avapritinib and PDGFRA"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for avapritinib and PDGFRA"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for avapritinib and KIT, PDGFRA"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sorafenib": {
    "genes": [
      "KIT",
      "CYP2C9",
      "SLC22A1",
      "MAPK11",
      "KDR",
      "ABCB1",
      "EGFR",
      "CYP2B6",
      "MAPK3",
      "MAPK12",
      "ADAMTS18",
      "MAPK14",
      "VEGFB",
      "GALNT14",
      "FGFR1",
      "PIK3R5",
      "UGT1A9",
      "MAPK1",
      "FLT3",
      "SLC15A2",
      "PDGFRB",
      "VEGFA",
      "PRKCE",
      "RAF1",
      "ABCC2",
      "NR1I2",
      "ABCG2",
      "WWOX",
      "CYP3A4",
      "BRAF",
      "FLT4",
      "TNF",
      "MAPK7",
      "MAPK9",
      "CDH13",
      "HIF1A",
      "CYP2C8",
      "MAP2K6",
      "FLT1",
      "MAPK10",
      "UGT1A1",
      "CYP3A5",
      "ARAF",
      "MAPK8",
      "SLCO1B1",
      "MAPK4",
      "RET",
      "MAPK13",
      "MAPK6",
      "EPAS1",
      "NOS3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs17868320",
        "gene": "UGT1A9",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1570360",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Renal Cell Carcinoma"
      },
      {
        "variant": "rs2239702",
        "gene": "KDR",
        "level": "3",
        "phenotypes": "Renal Cell Carcinoma"
      },
      {
        "variant": "rs2010963",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Hand-foot syndrome,Renal Cell Carcinoma"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Hypertension,Renal Cell Carcinoma"
      },
      {
        "variant": "rs2010963",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Hepatocellular Carcinoma"
      },
      {
        "variant": "rs4604006",
        "gene": "",
        "level": "3",
        "phenotypes": "Hepatocellular Carcinoma"
      },
      {
        "variant": "rs2070744",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Hepatocellular Carcinoma"
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Hepatocellular Carcinoma"
      },
      {
        "variant": "rs11549465",
        "gene": "HIF1A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1870377",
        "gene": "KDR",
        "level": "3",
        "phenotypes": "Hepatocellular Carcinoma"
      },
      {
        "variant": "rs7574296",
        "gene": "UGT1A9",
        "level": "3",
        "phenotypes": "Hand-foot syndrome,Hepatocellular Carcinoma"
      },
      {
        "variant": "rs3025040",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Hand-foot syndrome,Hepatocellular Carcinoma"
      },
      {
        "variant": "rs2306283",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Diarrhea"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Thrombocytopenia"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Exanthema"
      },
      {
        "variant": "rs1870377",
        "gene": "KDR",
        "level": "3",
        "phenotypes": "Hand-foot syndrome,Hypertension"
      },
      {
        "variant": "rs2257212",
        "gene": "SLC15A2",
        "level": "3",
        "phenotypes": "Hepatocellular Carcinoma"
      },
      {
        "variant": "rs9679162",
        "gene": "GALNT14",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection,Liver cancer"
      },
      {
        "variant": "UGT1A1*1, UGT1A1*28",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "Hepatocellular Carcinoma,Hyperbilirubinemia"
      },
      {
        "variant": "rs2071559",
        "gene": "KDR",
        "level": "3",
        "phenotypes": "Hepatocellular Carcinoma,Renal Cell Carcinoma"
      },
      {
        "variant": "rs1800629",
        "gene": "TNF",
        "level": "3",
        "phenotypes": "Hand-foot syndrome,Hepatocellular Carcinoma"
      },
      {
        "variant": "rs444904",
        "gene": "PIK3R5",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs917881",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Diarrhea"
      },
      {
        "variant": "rs12366035",
        "gene": "VEGFB",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs4035887",
        "gene": "EPAS1",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs4864950",
        "gene": "KDR",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs10958704",
        "gene": "",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs1868089",
        "gene": "EPAS1",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs11125039",
        "gene": "PRKCE",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1346563",
        "gene": "ADAMTS18",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs2330951",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs11651488",
        "gene": "MAP2K6",
        "level": "3",
        "phenotypes": "Diarrhea"
      },
      {
        "variant": "rs17682789",
        "gene": "CDH13",
        "level": "3",
        "phenotypes": "Diarrhea"
      },
      {
        "variant": "rs9927200",
        "gene": "WWOX",
        "level": "3",
        "phenotypes": "Diarrhea"
      },
      {
        "variant": "rs917881",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Diarrhea"
      },
      {
        "variant": "rs12948059",
        "gene": "MAP2K6",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs315498",
        "gene": "",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs9973653",
        "gene": "EPAS1",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs7557402",
        "gene": "EPAS1",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nintedanib": {
    "genes": [
      "DSP",
      "HLA-C"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fosdenopterin": {
    "genes": [
      "MOCS1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for fosdenopterin and MOCS1"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for fosdenopterin and MOCS1"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for fosdenopterin"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "bosentan": {
    "genes": [
      "CYP2C9",
      "SLCO1B3",
      "ABCB11",
      "SLCO1B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "duloxetine": {
    "genes": [
      "CYP2C9",
      "TEX10",
      "DRD2",
      "IL6",
      "HTR2C",
      "CYP2B6",
      "CYP2D6",
      "ATP10A",
      "CYP2C19",
      "UGT1A4",
      "ANO2",
      "FCN2",
      "BDNF",
      "KMT2E",
      "SLC6A4",
      "HTR7",
      "ZNF385D",
      "HLA-A",
      "HTR2A",
      "MIEF2",
      "NCAM1",
      "TREML4",
      "NRXN1",
      "CYP3A4",
      "HLA-B",
      "INVS",
      "CYP3A5",
      "POLG",
      "DRD3",
      "CYP1A2",
      "COMT",
      "SKIC3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs963468",
        "gene": "DRD3",
        "level": "3",
        "phenotypes": "Anxiety Disorders"
      },
      {
        "variant": "rs324026",
        "gene": "DRD3",
        "level": "3",
        "phenotypes": "Anxiety Disorders"
      },
      {
        "variant": "rs324023",
        "gene": "DRD3",
        "level": "3",
        "phenotypes": "Anxiety Disorders"
      },
      {
        "variant": "rs167770",
        "gene": "DRD3",
        "level": "3",
        "phenotypes": "Anxiety Disorders"
      },
      {
        "variant": "rs6700741",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4971678",
        "gene": "NRXN1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs9873889",
        "gene": "ZNF385D",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs9879065",
        "gene": "ZNF385D",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4437856",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2419128",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs12094644",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs9310658",
        "gene": "ZNF385D",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs7616119",
        "gene": "ZNF385D",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs7653345",
        "gene": "ZNF385D",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs9819548",
        "gene": "ZNF385D",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs13093500",
        "gene": "ZNF385D",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs12630569",
        "gene": "ZNF385D",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs9824595",
        "gene": "ZNF385D",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4334661",
        "gene": "ZNF385D",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs7625956",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4858478",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs12502866",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs61692318",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs10007051",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs11933890",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs62319299",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs56229625",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs55881666",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs12657120",
        "gene": "SKIC3",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4639250",
        "gene": "SKIC3",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs13204353",
        "gene": "TREML4",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs10123866",
        "gene": "INVS",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs7472",
        "gene": "TEX10",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs10124893",
        "gene": "TEX10",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs6479008",
        "gene": "TEX10",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs10989064",
        "gene": "TEX10",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs3124955",
        "gene": "FCN2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs3128624",
        "gene": "FCN2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs61908402",
        "gene": "ANO2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs61908403",
        "gene": "ANO2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs61908404",
        "gene": "ANO2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs61908405",
        "gene": "ANO2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs17724452",
        "gene": "ANO2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs17724464",
        "gene": "ANO2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs17786394",
        "gene": "ANO2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs17786400",
        "gene": "ANO2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs61908406",
        "gene": "ANO2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs17786412",
        "gene": "ANO2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs61908407",
        "gene": "ANO2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs61908408",
        "gene": "ANO2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs61908409",
        "gene": "ANO2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs61908410",
        "gene": "ANO2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs78482393",
        "gene": "ANO2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs78615940",
        "gene": "ANO2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs17724494",
        "gene": "ANO2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs61908411",
        "gene": "ANO2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs7316769",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs7306991",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs10771997",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs10771998",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs10771999",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs12595802",
        "gene": "ATP10A",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs3889402",
        "gene": "MIEF2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs12603700",
        "gene": "MIEF2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs56355515",
        "gene": "MIEF2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs58042962",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2933304",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs9310657",
        "gene": "ZNF385D",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs9369266",
        "gene": "TREML4",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs7035619",
        "gene": "TEX10",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4261893",
        "gene": "ZNF385D",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs117986340",
        "gene": "KMT2E",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2303377",
        "gene": "NCAM1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for duloxetine and CYP2D6"
      },
      {
        "source": "EMA",
        "level": "Informative PGx",
        "name": "Annotation of EMA Label for duloxetine and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for duloxetine and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for duloxetine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of escitalopram, citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, duloxetine, venlafaxine, desvenlafaxine, vilazodone, vortioxetine, levomilnacipran, or milnacipran based on SLC6A4 genotypes.\n",
      "source": "CPIC"
    }
  },
  "escitalopram": {
    "genes": [
      "CYP2C9",
      "KCNE1",
      "DRD2",
      "ABCB1",
      "HTR1A",
      "TSPAN5",
      "HTR2C",
      "TPH1",
      "GNB3",
      "KCNE2",
      "HTR1B",
      "CYP2B6",
      "CYP2D6",
      "IL11",
      "CYP2C19",
      "CYP2C18",
      "UGT1A4",
      "SLITRK5",
      "ERICH3",
      "RFK",
      "BDNF",
      "FKBP5",
      "SLC6A4",
      "HTR7",
      "HLA-A",
      "HTR2A",
      "BDNF-AS",
      "FAIM2",
      "CYP3A4",
      "HLA-B",
      "GRK5",
      "KCNH2",
      "BMP5",
      "RPP30",
      "CYP3A5",
      "POLG",
      "CYP1A2",
      "COMT",
      "GLDC"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",
        "gene": "CYP2C19",
        "level": "1A",
        "phenotypes": "Major Depressive Disorder,Mental Disorders"
      },
      {
        "variant": "rs962369",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs352428",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs9380524",
        "gene": "FKBP5",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2069521",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2069526",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4646425",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4646427",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs915120",
        "gene": "GRK5",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs11144870",
        "gene": "RFK",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs41271330",
        "gene": "BMP5",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1126757",
        "gene": "IL11",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs11568817",
        "gene": "HTR1B",
        "level": "3",
        "phenotypes": "Anxiety Disorders"
      },
      {
        "variant": "rs10975641",
        "gene": "GLDC",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs696692",
        "gene": "ERICH3",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs7905446",
        "gene": "HTR7,RPP30",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs6318",
        "gene": "HTR2C",
        "level": "3",
        "phenotypes": "Neuropathic pain"
      },
      {
        "variant": "rs6311",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "Anxiety Disorders,Major Depressive Disorder"
      },
      {
        "variant": "rs9316233",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs1065852",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs12054895",
        "gene": "",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs11947402",
        "gene": "TSPAN5",
        "level": "4",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs1800532",
        "gene": "TPH1",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs6313",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs6311",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs7997012",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",
        "gene": "SLC6A4",
        "level": "4",
        "phenotypes": "Depression,Depressive Disorder"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for escitalopram and CYP2D6"
      },
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for escitalopram and CYP2C19, CYP2D6"
      },
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for escitalopram and CYP2C19"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for escitalopram and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for escitalopram and CYP2C19"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for escitalopram"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for escitalopram and CYP2C19"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of escitalopram, citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, duloxetine, venlafaxine, desvenlafaxine, vilazodone, vortioxetine, levomilnacipran, or milnacipran based on SLC6A4 genotypes.\n",
      "source": "CPIC"
    }
  },
  "sulfonamides, urea derivatives": {
    "genes": [
      "CYP2C9",
      "SLC22A1",
      "CYP2C19",
      "SLC22A2",
      "ABCC8",
      "CDKAL1",
      "TCF7L2",
      "KCNJ11",
      "IRS1",
      "CYP2C8",
      "NOS1AP",
      "SLC47A1",
      "KCNQ1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sulfamethoxazole / trimethoprim": {
    "genes": [
      "CYP2C9",
      "KCNE1",
      "CYB5R3",
      "G6PD",
      "HLA-A",
      "GSTM1",
      "CYB5A",
      "HLA-B",
      "HLA-C",
      "NAT2"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-B*13:01, HLA-B*15:02, HLA-B*38:02",
        "gene": "HLA-B",
        "level": "2A",
        "phenotypes": "Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-C*06:02, HLA-C*07:27, HLA-C*08:01",
        "gene": "HLA-C",
        "level": "2B",
        "phenotypes": "Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "GSTM1 non-null, GSTM1 null",
        "gene": "GSTM1",
        "level": "3",
        "phenotypes": "Acquired Immunodeficiency Syndrome"
      },
      {
        "variant": "rs1799931",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "adverse events,Hypersensitivity"
      },
      {
        "variant": "rs1799930",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "adverse events,Hypersensitivity"
      },
      {
        "variant": "NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "adverse events,Hypersensitivity,Severe Cutaneous Adverse Reactions"
      },
      {
        "variant": "HLA-B*07:02",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Respiratory Insufficiency"
      },
      {
        "variant": "HLA-C*07:02",
        "gene": "HLA-C",
        "level": "3",
        "phenotypes": "Respiratory Insufficiency"
      },
      {
        "variant": "G6PD B (reference), G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like",
        "gene": "G6PD",
        "level": "4",
        "phenotypes": "Hemolysis,Hemolytic Anemia"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for sulfamethoxazole / trimethoprim and G6PD"
      },
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for sulfamethoxazole / trimethoprim and G6PD"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for sulfamethoxazole / trimethoprim and G6PD"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for sulfamethoxazole / trimethoprim and G6PD, NAT2"
      }
    ],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "gliclazide": {
    "genes": [
      "CYP2C9",
      "CYP2C19",
      "G6PD",
      "ABCC8",
      "KCNJ11",
      "KCNQ1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs5219",
        "gene": "KCNJ11",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for gliclazide and G6PD"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of chlorpropamide, dabrafenib, gliclazide, glimepiride, glipizide, mepacrine (aka quinacrine), mesalazine, moxifloxacin, nicorandil, nitrofural (aka nitrofurazone), probenecid, sodium nitrate, sulfacetamide, tolazamide or trametinib based on G6PD genotype.\n",
      "source": "CPIC"
    }
  },
  "tenoxicam": {
    "genes": [
      "CYP2C9"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "1A",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "The CPIC Dosing Guideline for tenoxicam recommends that CYP2C9 poor metabolizers and intermediate metabolizers with activity score of 1 should choose an alternative therapy not metabolized by CYP2C9 or not significantly impacted by CYP2C9 genetic variants in vivo or choose an NSAID metabolized by CYP2C9 but with a shorter half-life. See full guideline for further details and supporting evidence.\n",
      "source": "CPIC"
    }
  },
  "benzbromarone": {
    "genes": [
      "CYP2C9"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "prasugrel": {
    "genes": [
      "CYP2C9",
      "CYP2B6",
      "CYP2C19",
      "P2RY12",
      "CYP3A4",
      "CYP3A5",
      "ABCA1",
      "NTRK1",
      "ZNF335",
      "CYP1A2",
      "PEAR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4244285",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Acute coronary syndrome"
      },
      {
        "variant": "rs12407843",
        "gene": "PEAR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs77235035",
        "gene": "PEAR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3737224",
        "gene": "PEAR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs41273215",
        "gene": "PEAR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs822441",
        "gene": "PEAR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs822442",
        "gene": "PEAR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2768759",
        "gene": "NTRK1,PEAR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs12041331",
        "gene": "PEAR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C19*1, CYP2C19*17",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Acute coronary syndrome"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "No Clinical PGx",
        "name": "Annotation of EMA Label for prasugrel and CYP2B6, CYP2C19, CYP2C9, CYP3A5"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for prasugrel and CYP2B6, CYP2C19, CYP2C9, CYP3A5"
      },
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for prasugrel and CYP2B6, CYP2C19, CYP2C9, CYP3A5"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for prasugrel and CYP2B6, CYP2C19, CYP2C9, CYP3A5"
      }
    ],
    "guidelines": {
      "advice": "There are currently no dosing recommendations for prasugrel based on CYP2C19 genotypes.\n",
      "source": "DPWG"
    }
  },
  "antiinflammatory agents, non-steroids": {
    "genes": [
      "CYP2C9",
      "IL22RA2",
      "DRD2",
      "CTLA4",
      "OPRD1",
      "HRH2",
      "OPRM1",
      "PTGS2",
      "CDKN2B-AS1",
      "MMP10",
      "MMP1",
      "ALOX15",
      "BDNF",
      "HLA-A",
      "IL4",
      "HTR2A",
      "CRP",
      "VKORC1",
      "AGT",
      "HLA-B",
      "DBH",
      "HRH1",
      "HLA-DRB1",
      "CYP2C8",
      "IL10",
      "PTGS1",
      "HRH4",
      "COMT",
      "KL"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vitamin k and analogues": {
    "genes": [
      "CYP2C9",
      "G6PD",
      "CYP4F2",
      "VKORC1",
      "AIFM2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2108622",
        "gene": "CYP4F2",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "vitamin k antagonists": {
    "genes": [
      "CYP2C9",
      "CYP4F2",
      "VKORC1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "gliquidone": {
    "genes": [
      "CYP2C9",
      "ABCC8",
      "KCNJ11"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fosphenytoin": {
    "genes": [
      "CYP2C9",
      "HLA-B"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for fosphenytoin and HLA-B"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for fosphenytoin and CYP2C9"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for fosphenytoin and CYP2C9, HLA-B"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for fosphenytoin"
      }
    ],
    "guidelines": {
      "advice": "Phenytoin/fosphenytoin is contraindicated in individuals with the HLA-B*15:02 variant allele (&quot;HLA-B*15:02-positive&quot;) due to significantly increased risk of phenytoin-induced cutaneous adverse reactions of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).  Additionally, patients with the CYP2C9 poor metabolizer phenotype or with a CYP2C9 activity score of 1 may require reduced doses of phenytoin/fosphenytoin.\n",
      "source": "CPIC"
    }
  },
  "sitagliptin": {
    "genes": [
      "CYP2C9",
      "IL6",
      "WFS1",
      "CTRB1",
      "CDKAL1",
      "GLP1R",
      "GIPR",
      "TCF7L2",
      "KCNJ11",
      "PRKD1",
      "CTRB2",
      "HLA-DRB1",
      "DPP4",
      "KCNQ1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs6923761",
        "gene": "GLP1R",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs3765467",
        "gene": "GLP1R",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs2285676",
        "gene": "KCNJ11",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs163184",
        "gene": "KCNQ1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs7202877",
        "gene": "CTRB1,CTRB2",
        "level": "4",
        "phenotypes": "Diabetes Mellitus, Type 2"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "praziquantel": {
    "genes": [
      "CYP2C9",
      "CYP2D6",
      "CYP2C19",
      "CYP3A4",
      "CYP3A5",
      "CYP1A2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lumiracoxib": {
    "genes": [
      "CYP2C9",
      "HLA-DQA1",
      "HLA-DQB1",
      "HLA-DRB1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of aceclofenac, aspirin, diclofenac, indomethacin, lumiracoxib, metamizole, nabumetone and naproxen based on CYP2C9 genotypes.\n",
      "source": "CPIC"
    }
  },
  "divalproex sodium": {
    "genes": [
      "CYP2C9",
      "DRD2",
      "HTR2C",
      "CYP2B6",
      "CYP2D6",
      "CYP2C19",
      "UGT1A4",
      "SLC6A4",
      "HLA-A",
      "HTR2A",
      "CYP3A4",
      "HLA-B",
      "CYP3A5",
      "POLG",
      "CYP1A2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for divalproex sodium and POLG"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for divalproex sodium and POLG"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ethambutol": {
    "genes": [
      "CYP2C9",
      "IL6",
      "UGT1A3",
      "CYP2B6",
      "CYP2D6",
      "CYP1A1",
      "GSTT1",
      "CYP2C19",
      "STAT3",
      "ALAS1",
      "HSPA1L",
      "NR1I2",
      "GSTM1",
      "CYP2E1",
      "CYP3A4",
      "TNF",
      "ATP7B",
      "FECH",
      "UGT1A1",
      "SLCO1B1",
      "NAT2",
      "GSTP1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4646244",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "CYP2B6*1, CYP2B6*6",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "rs1800629",
        "gene": "TNF",
        "level": "3",
        "phenotypes": "Toxic liver disease,Tuberculosis"
      },
      {
        "variant": "rs9332096",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": "Maculopapular Exanthema,Tuberculosis"
      },
      {
        "variant": "rs4986893",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Maculopapular Exanthema,Tuberculosis"
      },
      {
        "variant": "rs1041983",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Toxic liver disease,Tuberculosis"
      },
      {
        "variant": "GSTM1 non-null, GSTM1 null",
        "gene": "GSTM1",
        "level": "4",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "GSTT1 non-null, GSTT1 null",
        "gene": "GSTT1",
        "level": "4",
        "phenotypes": "Tuberculosis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dabigatran": {
    "genes": [
      "CYP2C9",
      "SLC22A1",
      "ABCB1",
      "CYP2B6",
      "CYP2D6",
      "CYP2C19",
      "CYP4F2",
      "APOB",
      "CES1",
      "ABCC2",
      "CYP3A4",
      "CYP2C8",
      "UGT1A1",
      "CYP3A5",
      "SLCO1B1",
      "CYP2A6",
      "CYP1A2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4148738",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Atrial Fibrillation"
      },
      {
        "variant": "rs2244613",
        "gene": "CES1",
        "level": "3",
        "phenotypes": "Atrial Fibrillation"
      },
      {
        "variant": "rs8192935",
        "gene": "CES1",
        "level": "3",
        "phenotypes": "Atrial Fibrillation"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "noscapine": {
    "genes": [
      "CYP2C9"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "hydroxyphenytoin": {
    "genes": [
      "CYP2C9"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lornoxicam": {
    "genes": [
      "CYP2C9"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C9*1, CYP2C9*3, CYP2C9*13",
        "gene": "CYP2C9",
        "level": "1A",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "The CPIC Dosing Guideline for celecoxib, flurbiprofen, ibuprofen and lornoxicam recommends initiating therapy with 25-50% of\nthe lowest recommended starting dose for CYP2C9 poor metabolizers and initiating therapy with lowest recommended starting dose for CYP2C9 intermediate metabolizers with activity score of 1. See full guideline for further details and supporting evidence.\n",
      "source": "CPIC"
    }
  },
  "fluindione": {
    "genes": [
      "CYP2C9",
      "CYP4F2",
      "EPHX1",
      "VKORC1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs9934438",
        "gene": "VKORC1",
        "level": "3",
        "phenotypes": "Thromboembolism"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Testing for VKORC1/CYP2C9 genotype is advisable to determine the optimal dose and to orient the prescription to an alternative therapeutic option such as a direct-action oral anticoagulant before initiating vitamin K antagonists (VKA) treatment. Testing is also advisable to explain an hemorrhagic event or VKA resistance after treatment initiation.\n",
      "source": "RNPGx"
    }
  },
  "aceclofenac": {
    "genes": [
      "CYP2C9"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of aceclofenac, aspirin, diclofenac, indomethacin, lumiracoxib, metamizole, nabumetone and naproxen based on CYP2C9 genotypes.\n",
      "source": "CPIC"
    }
  },
  "endoxifen": {
    "genes": [
      "CYP2C9",
      "SULT1A2",
      "CYP2D6",
      "CYP2C19",
      "TCF20",
      "SREBF2",
      "NDUFA6",
      "CYP3A4",
      "SEPTIN3",
      "CYP3A5",
      "WBP2NL",
      "CYP2D7"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4386686",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "n-desmethyltamoxifen": {
    "genes": [
      "CYP2C9",
      "CYP2D6",
      "CYP2C19",
      "SMIM45",
      "TCF20",
      "SREBF2",
      "CENPM",
      "ABCG2",
      "CYP3A4",
      "SEPTIN3",
      "CYP3A5",
      "WBP2NL"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*12, CYP2D6*14, CYP2D6*17, CYP2D6*18, CYP2D6*22, CYP2D6*23, CYP2D6*24, CYP2D6*25, CYP2D6*26, CYP2D6*27, CYP2D6*28, CYP2D6*29, CYP2D6*30, CYP2D6*31, CYP2D6*32, CYP2D6*33, CYP2D6*36, CYP2D6*37, CYP2D6*40, CYP2D6*43, CYP2D6*45, CYP2D6*46, CYP2D6*47, CYP2D6*49, CYP2D6*50, CYP2D6*51, CYP2D6*52, CYP2D6*54, CYP2D6*55, CYP2D6*61, CYP2D6*62, CYP2D6*63, CYP2D6*64, CYP2D6*65, CYP2D6*70, CYP2D6*71, CYP2D6*114",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2D6*1, CYP2D6*24",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "4-hydroxytamoxifen": {
    "genes": [
      "CYP2C9",
      "SULT1A2",
      "CYP2D6",
      "CYP2C19",
      "CYP3A4",
      "CYP3A5",
      "WBP2NL"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dipyrone": {
    "genes": [
      "CYP2C9",
      "CYP2C19",
      "NAT2"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C19*1, CYP2C19*2",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C9*1, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of aceclofenac, aspirin, diclofenac, indomethacin, lumiracoxib, metamizole, nabumetone and naproxen based on CYP2C9 genotypes.\n",
      "source": "CPIC"
    }
  },
  "losartan e-3174": {
    "genes": [
      "CYP2C9",
      "ZNF703",
      "FBXW12",
      "SLC17A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "7-hydroxy r-warfarin": {
    "genes": [
      "CYP2C9"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "7-hydroxy s-warfarin": {
    "genes": [
      "CYP2C9"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "carboxycelecoxib": {
    "genes": [
      "CYP2C9"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "osimertinib": {
    "genes": [
      "CYP2C9",
      "IL6",
      "ABCB1",
      "EGFR",
      "F5",
      "STAT3",
      "LZTR1",
      "ABCG2",
      "HLA-B",
      "CYP2A6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for osimertinib and EGFR"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for osimertinib and EGFR"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for osimertinib and EGFR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "flibanserin": {
    "genes": [
      "CYP2C9",
      "CYP2D6",
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for flibanserin and CYP2C19"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for flibanserin and CYP2C9, CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for flibanserin and CYP2C9, CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for flibanserin and CYP2C19"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for flibanserin"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "brivaracetam": {
    "genes": [
      "CYP2C9",
      "CYP2C19"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for brivaracetam and CYP2C19"
      },
      {
        "source": "EMA",
        "level": "Informative PGx",
        "name": "Annotation of EMA Label for brivaracetam and CYP2C19"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for brivaracetam and CYP2C19"
      },
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for brivaracetam and CYP2C19, CYP2C9"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lesinurad": {
    "genes": [
      "CYP2C9"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for lesinurad and CYP2C9"
      },
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for lesinurad and CYP2C9"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for lesinurad and CYP2C9"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ar-c124910xx": {
    "genes": [
      "CYP2C9",
      "CYP2B6",
      "CYP2C19",
      "UGT2B7",
      "CYP3A4",
      "CYP3A5",
      "SLCO1B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "uric acid": {
    "genes": [
      "CYP2C9",
      "PADI4",
      "BRINP3",
      "VEGFC"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "avatrombopag": {
    "genes": [
      "CYP2C9",
      "ABCB1",
      "CTLA4",
      "F5",
      "F2",
      "PROC",
      "CYP3A5",
      "PROS1",
      "SERPINC1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for avatrombopag and CYP2C9"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for avatrombopag and F2, F5, PROC, PROS1, SERPINC1"
      },
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for avatrombopag and CYP2C9, F2, F5, PROC, PROS1, SERPINC1"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for avatrombopag and CYP2C9, F2, F5, PROC, PROS1, SERPINC1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "erdafitinib": {
    "genes": [
      "CYP2C9",
      "FGFR3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for erdafitinib and FGFR3"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for erdafitinib and CYP2C9"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for erdafitinib and FGFR3"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for erdafitinib and CYP2C9"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for erdafitinib and FGFR3"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "siponimod": {
    "genes": [
      "CYP2C9"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "1A",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for siponimod and CYP2C9"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for siponimod and CYP2C9"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for siponimod and CYP2C9"
      }
    ],
    "guidelines": {
      "advice": "The Dutch Pharmacogenetics Working Group Guideline for siponimod recommends decreasing the dose for CYP2C9 *1/*3, *2/*3 genotypes or CYP2C9 intermediate metabolizer (not including *2 and *3) and to avoid siponimod for the CYP2C9 *3/*3 genotype or CYP2C9 poor metabolizer (two alleles with no/decreased enzyme activity, of which at least one other than *2 or *3).\n",
      "source": "DPWG"
    }
  },
  "ospemifene": {
    "genes": [
      "CYP2C9",
      "CYP2B6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for ospemifene and CYP2B6, CYP2C9"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for ospemifene and CYP2B6, CYP2C9"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for ospemifene and CYP2B6, CYP2C9"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "rimegepant": {
    "genes": [
      "CYP2C9"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "No Clinical PGx",
        "name": "Annotation of EMA Label for rimegepant and CYP2C9"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for rimegepant and CYP2C9"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for rimegepant and CYP2C9"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "macitentan": {
    "genes": [
      "CYP2C9",
      "CYP3A4",
      "CYP2C8"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "abrocitinib": {
    "genes": [
      "CYP2C9",
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for abrocitinib and CYP2C19"
      },
      {
        "source": "EMA",
        "level": "No Clinical PGx",
        "name": "Annotation of EMA Label for abrocitinib and CYP2C19, CYP2C9"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for abrocitinib and CYP2C19, CYP2C9"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "selexipag": {
    "genes": [
      "CYP2C9",
      "CYP2C8"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "apatinib": {
    "genes": [
      "CYP2C9",
      "KDR",
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "apatinib metabolite m1-1": {
    "genes": [
      "CYP2C9",
      "CYP2D6",
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "apatinib metabolite m1-2": {
    "genes": [
      "CYP2C9",
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "etrasimod": {
    "genes": [
      "CYP2C9"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for etrasimod and CYP2C9"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for etrasimod and CYP2C9"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for etrasimod and CYP2C9"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "deuruxolitinib": {
    "genes": [
      "CYP2C9"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Recommended",
        "name": "Annotation of FDA Label for deuruxolitinib and CYP2C9"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "seladelpar": {
    "genes": [
      "CYP2C9"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Informative PGx",
        "name": "Annotation of EMA Label for seladelpar and CYP2C9"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for seladelpar and CYP2C9"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dimolegin": {
    "genes": [
      "CYP2C9",
      "ABCB1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "amitriptyline": {
    "genes": [
      "CYP2C9",
      "DRD2",
      "ABCB1",
      "HTR2C",
      "CYP2B6",
      "CYP2D6",
      "CYP2C19",
      "UGT1A4",
      "BDNF",
      "SLC6A4",
      "HLA-A",
      "HTR2A",
      "CYP3A4",
      "HLA-B",
      "CYP3A5",
      "POLG",
      "CYP1A2"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Depressive Disorder,Mental Disorders"
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",
        "gene": "CYP2C19",
        "level": "1A",
        "phenotypes": "Major Depressive Disorder,Mental Disorders"
      },
      {
        "variant": "rs7787082",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs10280101",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs10248420",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs11983225",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs12720067",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs2235040",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs4148740",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2235067",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4148739",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression,Major Depressive Disorder"
      },
      {
        "variant": "rs2032583",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression,Depressive Disorder,Major Depressive Disorder"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2235015",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression,Depressive Disorder,Major Depressive Disorder"
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for amitriptyline and CYP2C19, CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for amitriptyline and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "There are currently no dosing recommendations for amitriptyline based on CYP2C19 genotype.\n",
      "source": "DPWG"
    }
  },
  "anastrozole": {
    "genes": [
      "CYP2C9",
      "PRKG1",
      "ABCB1",
      "DLGAP1",
      "TNFSF11",
      "MAP4K4",
      "DLG2",
      "TUBB1",
      "SLC37A1",
      "DGKI",
      "UGT1A4",
      "ESR2",
      "CCDC148",
      "FLT3",
      "ZNF613",
      "TNFRSF11A",
      "PPP1R14C",
      "CLDN11",
      "CYP19A1",
      "TNFRSF11B",
      "CYP3A4",
      "DNAH12",
      "PGR",
      "CSMD1",
      "DOCK4",
      "TCL1A",
      "ESR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2234693",
        "gene": "ESR1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs6901146",
        "gene": "",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs3732219",
        "gene": "UGT1A4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3732218",
        "gene": "UGT1A4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7984870",
        "gene": "TNFSF11",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2073618",
        "gene": "TNFRSF11B",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs4550690",
        "gene": "MAP4K4",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs10485828",
        "gene": "TUBB1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs6493497",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Arthralgia,Breast Neoplasms"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs727479",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs9340799",
        "gene": "ESR1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1008805",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs6990851",
        "gene": "CSMD1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2449598",
        "gene": "DLG2",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs6981827",
        "gene": "CSMD1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1437153",
        "gene": "",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for anastrozole and ESR1, ESR2, PGR"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for anastrozole and ESR1, ESR2, PGR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "buprenorphine": {
    "genes": [
      "CYP2C9",
      "DRD2",
      "ABCB1",
      "CYP2B6",
      "CYP2D6",
      "ADRA2A",
      "PNOC",
      "OPRD1",
      "OPRM1",
      "CYP2C19",
      "SLC6A3",
      "OPRK1",
      "ARRB2",
      "SLC6A4",
      "HTR2A",
      "UGT2B7",
      "SLC39A10",
      "CYP3A4",
      "ADAMTSL2",
      "CYP1A2",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "rs529520",
        "gene": "OPRD1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",
        "gene": "SLC6A4",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs2234918",
        "gene": "OPRD1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders,Physiological sexual disorder"
      },
      {
        "variant": "rs1045280",
        "gene": "ARRB2",
        "level": "3",
        "phenotypes": "adverse events,Opioid-Related Disorders"
      },
      {
        "variant": "rs351776",
        "gene": "PNOC",
        "level": "3",
        "phenotypes": "Neonatal Abstinence Syndrome"
      },
      {
        "variant": "rs4732636",
        "gene": "PNOC",
        "level": "3",
        "phenotypes": "Neonatal Abstinence Syndrome"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "adverse events,Opioid-Related Disorders"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Exanthema,Opioid-Related Disorders"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Neonatal Abstinence Syndrome"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Neonatal Abstinence Syndrome"
      },
      {
        "variant": "rs740603",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Neonatal Abstinence Syndrome"
      },
      {
        "variant": "rs2740574",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs62368105",
        "gene": "",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs6973474",
        "gene": "",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs13169373",
        "gene": "",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs11782370",
        "gene": "",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs7205113",
        "gene": "",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs756770",
        "gene": "ADAMTSL2",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs678849",
        "gene": "OPRD1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "adverse events,Opioid-Related Disorders"
      },
      {
        "variant": "rs2740574",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs581111",
        "gene": "OPRD1",
        "level": "4",
        "phenotypes": "Opioid-Related Disorders"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of alfentanil, buprenorphine, codeine, fentanyl, hydrocodone, hydromorphone, levomethadone, naltrexone, remifentanil, sufentanil or tramadol based on OPRM1 or COMT genotypes.\n",
      "source": "CPIC"
    }
  },
  "buspirone": {
    "genes": [
      "CYP2C9",
      "DRD2",
      "HTR2C",
      "CYP2B6",
      "CYP2D6",
      "CYP2C19",
      "UGT1A4",
      "SLC6A4",
      "HLA-A",
      "HTR2A",
      "CYP3A4",
      "HLA-B",
      "CYP3A5",
      "POLG",
      "CYP1A2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "carbamazepine": {
    "genes": [
      "CYP2C9",
      "GABRB2",
      "HNF4A",
      "DRD2",
      "HLA-DQA1",
      "ABCB1",
      "HTR2C",
      "PSORS1C3",
      "CYP2B6",
      "CYP2D6",
      "MICA",
      "CYP1A1",
      "CYP2C19",
      "HLA-DQB1",
      "UGT1A4",
      "POU5F1",
      "GABRG2",
      "HSPA1L",
      "PSORS1C1",
      "SLC6A4",
      "MLN",
      "HLA-A",
      "HTR2A",
      "ALK",
      "EPHX1",
      "UGT2B7",
      "ABCC2",
      "NR1I2",
      "BAG6",
      "SCN2A",
      "CYCSP5",
      "CYP3A4",
      "HLA-B",
      "SCN1A",
      "HLA-DRB1",
      "RALBP1",
      "TNF",
      "HSPA1A",
      "GABRA1",
      "PRRC2A",
      "CYP2C8",
      "GABRA3",
      "LTA",
      "HLA-C",
      "ZNRD1-AS1",
      "CYP3A5",
      "POLG",
      "UGT1A6",
      "GABRA6",
      "CYP1A2",
      "NR1I3"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-B*15:02, HLA-B*15:11",
        "gene": "HLA-B",
        "level": "1A",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Maculopapular Exanthema,Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-A*31:01",
        "gene": "HLA-A",
        "level": "1A",
        "phenotypes": "Drug Hypersensitivity,Drug Reaction with Eosinophilia and Systemic Symptoms,Maculopapular Exanthema,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*40:01",
        "gene": "HLA-B",
        "level": "2A",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "rs3812718",
        "gene": "SCN1A",
        "level": "2B",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs750332",
        "gene": "BAG6,PRRC2A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2290732",
        "gene": "GABRA1",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "HLA-B*15:18",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Stevens-Johnson Syndrome"
      },
      {
        "variant": "HLA-B*59:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Stevens-Johnson Syndrome"
      },
      {
        "variant": "rs2273697",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "HLA-B*51:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Hypersensitivity"
      },
      {
        "variant": "rs3740066",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs4688040",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs3814055",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2461817",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs7643645",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs28365063",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs4148740",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs4148739",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2740574",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs4148386",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs1043620",
        "gene": "HSPA1A,HSPA1L",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1800629",
        "gene": "LTA,TNF",
        "level": "3",
        "phenotypes": "Hypersensitivity"
      },
      {
        "variant": "rs2227956",
        "gene": "HSPA1L",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2242480",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs15524",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2606345",
        "gene": "CYP1A1",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "HLA-C*08:01",
        "gene": "HLA-C",
        "level": "3",
        "phenotypes": "Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "rs2279020",
        "gene": "GABRA1",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs1051740",
        "gene": "EPHX1",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs1051740",
        "gene": "EPHX1",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs3812718",
        "gene": "SCN1A",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2234922",
        "gene": "EPHX1",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2304016",
        "gene": "SCN2A",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "HLA-B*46:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*15:21",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-A*24:02",
        "gene": "HLA-A",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-DRB1*03:01",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Maculopapular Exanthema"
      },
      {
        "variant": "HLA-A*11:01",
        "gene": "HLA-A",
        "level": "3",
        "phenotypes": "Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "rs762551",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs17183814",
        "gene": "SCN2A",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2273697",
        "gene": "ABCC2",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2071197",
        "gene": "HNF4A",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2298771",
        "gene": "SCN1A",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2298771",
        "gene": "SCN1A",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "HLA-B*58:01",
        "gene": "HLA-B",
        "level": "4",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Maculopapular Exanthema,Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-A*02:01",
        "gene": "HLA-A",
        "level": "4",
        "phenotypes": "Drug Hypersensitivity,Drug Reaction with Eosinophilia and Systemic Symptoms,Maculopapular Exanthema,Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Testing Required",
        "name": "Annotation of Swissmedic Label for carbamazepine and HLA-B"
      },
      {
        "source": "Swissmedic",
        "level": "Testing Recommended",
        "name": "Annotation of Swissmedic Label for carbamazepine and HLA-A"
      },
      {
        "source": "HCSC",
        "level": "Testing Recommended",
        "name": "Annotation of HCSC Label for carbamazepine and HLA-A, HLA-B"
      },
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for carbamazepine and HLA-A, HLA-B"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for carbamazepine and HLA-B"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for carbamazepine and HLA-A"
      }
    ],
    "guidelines": {
      "advice": "The Socit Francophone d'Histocompatibilit et d'Immunogntique (SFHI) has guidance about carbamazepine and oxcarbazepine toxicity and HLA-B*15:02 and HLA-A*31:01.\n",
      "source": "RNPGx"
    }
  },
  "carvedilol": {
    "genes": [
      "CYP2C9",
      "ADRB1",
      "PPARA",
      "CYP2D6",
      "CYP2C19",
      "UGT2B7",
      "ADRB2",
      "GRK5",
      "ADRA2C",
      "UGT1A1",
      "SLCO1B1",
      "GRK4"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4148323",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "Angina Pectoris,Heart Failure"
      },
      {
        "variant": "rs1042714",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs1801252",
        "gene": "ADRB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1801253",
        "gene": "ADRB1",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*10",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Heart Diseases"
      },
      {
        "variant": "UGT1A1*1, UGT1A1*28",
        "gene": "UGT1A1",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs1801253",
        "gene": "ADRB1",
        "level": "4",
        "phenotypes": "Heart Failure"
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for carvedilol and CYP2D6"
      },
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for carvedilol and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for carvedilol and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of carvedilol, labetalol, nadolol, pindolol, propranolol or sotalol based on ADRB2 genotypes.\n",
      "source": "CPIC"
    }
  },
  "citalopram": {
    "genes": [
      "CYP2C9",
      "KCNE1",
      "DRD2",
      "ADRB1",
      "DTNBP1",
      "ABCB1",
      "HTR1A",
      "DISP1",
      "TSPAN5",
      "HTR2C",
      "TPH1",
      "NEDD4L",
      "KCNE2",
      "HTR1B",
      "CYP2B6",
      "CYP2D6",
      "GRIK4",
      "IL11",
      "PAPLN",
      "REEP5",
      "CYP2C19",
      "UGT1A4",
      "SRP19",
      "SLITRK5",
      "ERICH3",
      "RFK",
      "BDNF",
      "GSK3B",
      "METTL21A",
      "FKBP5",
      "CREB1",
      "SLC6A4",
      "HLA-A",
      "SERPINE1",
      "HTR2A",
      "BDNF-AS",
      "FAIM2",
      "CACNA1C",
      "TPH2",
      "RORA",
      "COL26A1",
      "ABCG1",
      "CRHR2",
      "HES6",
      "HTR6",
      "CYP3A4",
      "HLA-B",
      "GRK5",
      "GRIK2",
      "ABCB6",
      "CYP3A5",
      "SLC18A2",
      "POLG",
      "GRIA3",
      "CYP1A2",
      "GLDC"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",
        "gene": "CYP2C19",
        "level": "1A",
        "phenotypes": "Depressive Disorder,Major Depressive Disorder"
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4",
        "gene": "CYP2C19",
        "level": "1A",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs2227631",
        "gene": "SERPINE1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1799889",
        "gene": "SERPINE1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs334558",
        "gene": "GSK3B",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs7787082",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs352428",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs9380524",
        "gene": "FKBP5",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs17135437",
        "gene": "COL26A1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2235040",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10280101",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs10248420",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs11983225",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs12720067",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs2235040",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs495794",
        "gene": "SRP19",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs153560",
        "gene": "REEP5",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs153549",
        "gene": "REEP5",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4148740",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2235067",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs16965962",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs915120",
        "gene": "GRK5",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs11144870",
        "gene": "RFK",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs28401781",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4148739",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression,Major Depressive Disorder"
      },
      {
        "variant": "rs7124442",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs520210",
        "gene": "NEDD4L",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs11628713",
        "gene": "PAPLN",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4570625",
        "gene": "TPH2",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs1006737",
        "gene": "CACNA1C",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs809736",
        "gene": "RORA",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs760761",
        "gene": "DTNBP1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs10848635",
        "gene": "CACNA1C",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs10975641",
        "gene": "GLDC",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2270007",
        "gene": "CRHR2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs585719",
        "gene": "",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs6127921",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs6966038",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4675690",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4825476",
        "gene": "GRIA3",
        "level": "3",
        "phenotypes": "Depression,Suicide"
      },
      {
        "variant": "rs1360780",
        "gene": "FKBP5",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs696692",
        "gene": "ERICH3",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs7569963",
        "gene": "CREB1,METTL21A",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs6296",
        "gene": "HTR1B",
        "level": "3",
        "phenotypes": "Anxiety Disorders,Major Depressive Disorder"
      },
      {
        "variant": "rs2032583",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression,Depressive Disorder,Major Depressive Disorder"
      },
      {
        "variant": "rs6265",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*4, CYP2D6*10",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2D6*1, CYP2D6*4",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7997012",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "Depression,Depressive Disorder"
      },
      {
        "variant": "rs6311",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "Major Depressive Disorder,Nausea,Vomiting"
      },
      {
        "variant": "rs6313",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "Major Depressive Disorder,Physiological sexual disorder"
      },
      {
        "variant": "rs2235015",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression,Depressive Disorder,Major Depressive Disorder"
      },
      {
        "variant": "rs12054895",
        "gene": "",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs11947402",
        "gene": "TSPAN5",
        "level": "4",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs7103411",
        "gene": "BDNF",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1800532",
        "gene": "TPH1",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*17, CYP2D6*41",
        "gene": "CYP2D6",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",
        "gene": "CYP2C19",
        "level": "4",
        "phenotypes": "Major Depressive Disorder,Obsessive-Compulsive Disorder"
      },
      {
        "variant": "rs6311",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs6313",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",
        "gene": "SLC6A4",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs25531",
        "gene": "SLC6A4",
        "level": "4",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for citalopram and CYP2C19"
      },
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for citalopram and CYP2C19, CYP2D6"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for citalopram and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for citalopram and CYP2C19"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of escitalopram, citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, duloxetine, venlafaxine, desvenlafaxine, vilazodone, vortioxetine, levomilnacipran, or milnacipran based on SLC6A4 genotypes.\n",
      "source": "CPIC"
    }
  },
  "dapsone": {
    "genes": [
      "CYP2C9",
      "CYB5R3",
      "G6PD",
      "HLA-A",
      "HLA-B",
      "HLA-DRB1",
      "NAT2"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-B*13:01",
        "gene": "HLA-B",
        "level": "2A",
        "phenotypes": "Drug Hypersensitivity,Drug Reaction with Eosinophilia and Systemic Symptoms,Leprosy,Maculopapular Exanthema,Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome"
      },
      {
        "variant": "rs701829",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Drug Hypersensitivity"
      },
      {
        "variant": "rs201929247",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Drug Hypersensitivity"
      },
      {
        "variant": "rs17211071",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Drug Hypersensitivity"
      },
      {
        "variant": "HLA-DRB1*15:01, HLA-DRB1*16:02",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Drug Hypersensitivity"
      },
      {
        "variant": "HLA-A*24:02",
        "gene": "HLA-A",
        "level": "3",
        "phenotypes": "Drug Hypersensitivity"
      },
      {
        "variant": "HLA-B*15:02",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome"
      },
      {
        "variant": "rs1050828",
        "gene": "G6PD",
        "level": "4",
        "phenotypes": "Malaria"
      }
    ],
    "fdaLabels": [
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for dapsone and G6PD"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for dapsone and CYB5R3"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for dapsone and G6PD"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for dapsone and G6PD"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for dapsone and CYB5R3"
      }
    ],
    "guidelines": {
      "advice": "High risk drugs should be avoided in G6PD deficient patients with or without chronic non-spherocytic hemolytic anemia (CNSHA). In patients with a G6PD variable or indeterminate phenotype an enzyme activity test should be carried out before initiating drug therapy.\nThe G6PD gene is located on the X chromosome. Therefore, some patients will only have one copy, whereas others will have two copies. See full guideline for disclaimers, further details and supporting evidence.\n",
      "source": "CPIC"
    }
  },
  "diazepam": {
    "genes": [
      "CYP2C9",
      "DRD2",
      "ABCB1",
      "HTR2C",
      "CYP2B6",
      "CYP2D6",
      "CYP2C19",
      "UGT1A4",
      "SLC6A4",
      "HLA-A",
      "HTR2A",
      "ABCG2",
      "CYP3A4",
      "HLA-B",
      "CYP3A5",
      "NAT2",
      "POLG",
      "CYP1A2"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for diazepam and CYP2C19, CYP3A4"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for diazepam and CYP2C19, CYP3A4"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "diclofenac": {
    "genes": [
      "CYP2C9",
      "IL6",
      "PLA2G4A",
      "LST1",
      "UGT2B7",
      "TNFRSF11A",
      "IL1A",
      "ABCC2",
      "PLCG1",
      "TNF",
      "CYP2C8",
      "LTA",
      "IL1B",
      "UGT2B17",
      "SLC22A7",
      "PPARG"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12746200",
        "gene": "PLA2G4A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1805034",
        "gene": "TNFRSF11A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2228246",
        "gene": "PLCG1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C8*1, CYP2C8*3, CYP2C8*4",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1057910",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*8, CYP2C9*13, CYP2C9*36, CYP2C9*37, CYP2C9*38, CYP2C9*39, CYP2C9*40, CYP2C9*42, CYP2C9*43, CYP2C9*44, CYP2C9*45, CYP2C9*46, CYP2C9*47, CYP2C9*48, CYP2C9*50, CYP2C9*52, CYP2C9*53, CYP2C9*54, CYP2C9*55, CYP2C9*59, CYP2C9*60, CYP2C9*62",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1800629",
        "gene": "LST1,LTA,TNF",
        "level": "3",
        "phenotypes": "Migraine without Aura"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of aceclofenac, aspirin, diclofenac, indomethacin, lumiracoxib, metamizole, nabumetone and naproxen based on CYP2C9 genotypes.\n",
      "source": "CPIC"
    }
  },
  "doxepin": {
    "genes": [
      "CYP2C9",
      "CYP2D6",
      "CYP2C19",
      "CYP3A4",
      "CYP1A2"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2",
        "gene": "CYP2C19",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C9*1, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for doxepin and CYP2C19, CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for doxepin and CYP2C19, CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "There are currently no dosing recommendations for doxepin based on CYP2C19 genotype.\n",
      "source": "DPWG"
    }
  },
  "dronabinol": {
    "genes": [
      "CYP2C9",
      "COMT"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for dronabinol"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for dronabinol and CYP2C9"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fluconazole": {
    "genes": [
      "CYP2C9",
      "KCNE1",
      "KCNE2",
      "CYP2C19",
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fluoxetine": {
    "genes": [
      "CYP2C9",
      "DRD2",
      "ABCB1",
      "HTR1A",
      "DISP1",
      "HTR2C",
      "TPH1",
      "HTR1B",
      "CYP2B6",
      "CYP2D6",
      "REEP5",
      "CYP2C19",
      "UGT1A4",
      "SRP19",
      "SLITRK5",
      "BDNF",
      "GSK3B",
      "FKBP5",
      "SLC6A4",
      "HTR7",
      "HLA-A",
      "SERPINE1",
      "HTR2A",
      "FAIM2",
      "TPH2",
      "ABCG1",
      "HES6",
      "HTR6",
      "CYP3A4",
      "HLA-B",
      "ABCB6",
      "CYP3A5",
      "SLCO1B1",
      "POLG",
      "PDLIM5",
      "ACE",
      "CYP1A2",
      "COMT",
      "CRHR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2227631",
        "gene": "SERPINE1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs61888800",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": "Depression,Major Depressive Disorder"
      },
      {
        "variant": "rs1799889",
        "gene": "SERPINE1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs334558",
        "gene": "GSK3B",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs242941",
        "gene": "CRHR1",
        "level": "3",
        "phenotypes": "Anxiety Disorders,Major Depressive Disorder"
      },
      {
        "variant": "rs495794",
        "gene": "SRP19",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs153560",
        "gene": "REEP5",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs153549",
        "gene": "REEP5",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs28401781",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4148739",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression,Major Depressive Disorder"
      },
      {
        "variant": "rs6295",
        "gene": "HTR1A",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs2433320",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs9361233",
        "gene": "HTR1B",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4713916",
        "gene": "FKBP5",
        "level": "3",
        "phenotypes": "Mood Disorder"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Major Depressive Disorder,Mental Disorders"
      },
      {
        "variant": "SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",
        "gene": "SLC6A4",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs57098334",
        "gene": "SLC6A4",
        "level": "3",
        "phenotypes": "Depression,Major Depressive Disorder"
      },
      {
        "variant": "rs6265",
        "gene": "BDNF",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1800532",
        "gene": "TPH1",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs6313",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs6311",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs7997012",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs6311",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs25531",
        "gene": "SLC6A4",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",
        "gene": "SLC6A4",
        "level": "4",
        "phenotypes": "Major Depressive Disorder,Obsessive-Compulsive Disorder"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for fluoxetine and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for fluoxetine and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for fluoxetine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of escitalopram, citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, duloxetine, venlafaxine, desvenlafaxine, vilazodone, vortioxetine, levomilnacipran, or milnacipran based on SLC6A4 genotypes.\n",
      "source": "CPIC"
    }
  },
  "flurbiprofen": {
    "genes": [
      "CYP2C9",
      "UGT2B7",
      "UGT1A1"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*29",
        "gene": "CYP2C9",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs780801862",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for flurbiprofen and CYP2C9"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for flurbiprofen and CYP2C9"
      }
    ],
    "guidelines": {
      "advice": "The CPIC Dosing Guideline for celecoxib, flurbiprofen, ibuprofen and lornoxicam recommends initiating therapy with 25-50% of\nthe lowest recommended starting dose for CYP2C9 poor metabolizers and initiating therapy with lowest recommended starting dose for CYP2C9 intermediate metabolizers with activity score of 1. See full guideline for further details and supporting evidence.\n",
      "source": "CPIC"
    }
  },
  "ibuprofen": {
    "genes": [
      "CYP2C9",
      "IL6",
      "UGT1A3",
      "LST1",
      "CYP2B6",
      "CYP2D6",
      "NOS2",
      "CYP2C19",
      "NOS1",
      "PTGS2",
      "UGT1A9",
      "UGT2B4",
      "UGT2B7",
      "IL1A",
      "FAAH",
      "CYP2A7P1",
      "CYP3A4",
      "TNF",
      "AMACR",
      "CYP2C8",
      "LTA",
      "PTGS1",
      "CYP3A5",
      "IL1B",
      "UGT2B17",
      "COMT",
      "NOS3"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs9933632",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6500265",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C8*1, CYP2C8*3",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C8*1, CYP2C8*3",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs20417",
        "gene": "PTGS2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1800629",
        "gene": "LST1,LTA,TNF",
        "level": "3",
        "phenotypes": "Migraine without Aura"
      },
      {
        "variant": "CYP2C8*1, CYP2C8*2, CYP2C8*3, CYP2C8*4",
        "gene": "CYP2C8",
        "level": "4",
        "phenotypes": "Pain, Postoperative"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for NSAIDs dosing based on CYP2C8 genotypes.\n",
      "source": "CPIC"
    }
  },
  "indomethacin": {
    "genes": [
      "CYP2C9",
      "IL6",
      "LST1",
      "IL1A",
      "TFAP2B",
      "TNF",
      "LTA",
      "IL1B",
      "EPAS1"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C9*1, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1800629",
        "gene": "LST1,LTA,TNF",
        "level": "3",
        "phenotypes": "Migraine without Aura"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of aceclofenac, aspirin, diclofenac, indomethacin, lumiracoxib, metamizole, nabumetone and naproxen based on CYP2C9 genotypes.\n",
      "source": "CPIC"
    }
  },
  "isoniazid": {
    "genes": [
      "CYP2C9",
      "IL6",
      "HLA-DQA1",
      "ABCB1",
      "UGT1A3",
      "CYP2B6",
      "CYP2D6",
      "NOS2",
      "CYP1A1",
      "GSTT1",
      "CYP2C19",
      "HLA-DQB1",
      "STAT3",
      "G6PD",
      "HSPA1L",
      "HLA-A",
      "XPO1",
      "SOD2",
      "DUX1",
      "CES1",
      "NR1I2",
      "GSTM1",
      "CYP2E1",
      "HLA-B",
      "TNF",
      "HLA-DPB1",
      "BACH1",
      "UGT1A1",
      "SLCO1B1",
      "NAT2",
      "ASTN2",
      "MAFK",
      "GSTP1"
    ],
    "clinicalVariants": [
      {
        "variant": "NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16",
        "gene": "NAT2",
        "level": "1B",
        "phenotypes": "Drug-induced liver injury,Toxic liver disease,Tuberculosis"
      },
      {
        "variant": "NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G, NAT2*14, NAT2*16, NAT2*39",
        "gene": "NAT2",
        "level": "2A",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "rs4646244",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "CYP2B6*1, CYP2B6*6",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "rs1800629",
        "gene": "TNF",
        "level": "3",
        "phenotypes": "Toxic liver disease,Tuberculosis"
      },
      {
        "variant": "rs2070401",
        "gene": "BACH1",
        "level": "3",
        "phenotypes": "Drug-induced liver injury,Toxic liver disease"
      },
      {
        "variant": "rs11125883",
        "gene": "XPO1",
        "level": "3",
        "phenotypes": "Drug-induced liver injury,Toxic liver disease"
      },
      {
        "variant": "rs4720833",
        "gene": "MAFK",
        "level": "3",
        "phenotypes": "Drug-induced liver injury,Toxic liver disease"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Drug-induced liver injury,Tuberculosis"
      },
      {
        "variant": "rs1041983",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Drug interaction with drug,Drug Toxicity"
      },
      {
        "variant": "rs1801280",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Drug interaction with drug,Drug Toxicity"
      },
      {
        "variant": "rs1799929",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Drug interaction with drug,Drug Toxicity"
      },
      {
        "variant": "rs1799930",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Drug interaction with drug,Drug Toxicity"
      },
      {
        "variant": "rs1208",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Drug interaction with drug,Drug Toxicity"
      },
      {
        "variant": "rs1799931",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Drug interaction with drug,Drug Toxicity"
      },
      {
        "variant": "rs9332096",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": "Maculopapular Exanthema,Tuberculosis"
      },
      {
        "variant": "rs4986893",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Maculopapular Exanthema,Tuberculosis"
      },
      {
        "variant": "rs11080344",
        "gene": "NOS2",
        "level": "3",
        "phenotypes": "Toxic liver disease,Tuberculosis"
      },
      {
        "variant": "rs1041983",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Toxic liver disease,Tuberculosis"
      },
      {
        "variant": "rs1041983",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Toxic liver disease,Tuberculosis"
      },
      {
        "variant": "GSTM1 non-null, GSTM1 null",
        "gene": "GSTM1",
        "level": "4",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "GSTT1 non-null, GSTT1 null",
        "gene": "GSTT1",
        "level": "4",
        "phenotypes": "Tuberculosis"
      }
    ],
    "fdaLabels": [
      {
        "source": "PMDA",
        "level": "Informative PGx",
        "name": "Annotation of PMDA Label for isoniazid and NAT2"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for isoniazid and NAT2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ketoprofen": {
    "genes": [
      "CYP2C9",
      "CYP2D6",
      "PTGS2",
      "PTGS1"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": "Dyspepsia,Pain, Postoperative"
      },
      {
        "variant": "CYP2C9*1, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ketorolac": {
    "genes": [
      "CYP2C9",
      "IL6",
      "LST1",
      "CYP2D6",
      "IL1A",
      "TNF",
      "LTA",
      "IL1B"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2562456",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs1800629",
        "gene": "LST1,LTA,TNF",
        "level": "3",
        "phenotypes": "Migraine without Aura"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lamotrigine": {
    "genes": [
      "CYP2C9",
      "HNF4A",
      "SLC22A1",
      "DRD2",
      "ABCB1",
      "HTR2C",
      "CYP2B6",
      "CYP2D6",
      "CYP2C19",
      "HLA-DQB1",
      "UGT1A4",
      "SLC6A4",
      "HLA-A",
      "HTR2A",
      "UGT2B7",
      "ABCC2",
      "CACNA1H",
      "NR1I2",
      "ABCG2",
      "SCN2A",
      "CYP3A4",
      "HLA-B",
      "SCN1A",
      "HLA-DRB1",
      "UGT2B15",
      "GABRA1",
      "GABRA3",
      "HLA-C",
      "CYP3A5",
      "POLG",
      "CYP1A2"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-B*15:02",
        "gene": "HLA-B",
        "level": "1A",
        "phenotypes": "Epilepsy,Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*38:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-A*02:07",
        "gene": "HLA-A",
        "level": "3",
        "phenotypes": "Maculopapular Exanthema,Severe Cutaneous Adverse Reactions,Stevens-Johnson Syndrome"
      },
      {
        "variant": "HLA-A*33:03",
        "gene": "HLA-A",
        "level": "3",
        "phenotypes": "Maculopapular Exanthema"
      },
      {
        "variant": "HLA-B*44:03",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Maculopapular Exanthema"
      },
      {
        "variant": "HLA-B*58:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Severe Cutaneous Adverse Reactions"
      },
      {
        "variant": "rs2011425",
        "gene": "UGT1A4",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs3114020",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs628031",
        "gene": "SLC22A1",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "UGT1A4*1a, UGT1A4*1b, UGT1A4*2",
        "gene": "UGT1A4",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs7668258",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs7668258",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2304016",
        "gene": "SCN2A",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2071197",
        "gene": "HNF4A",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs2298771",
        "gene": "SCN1A",
        "level": "4",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs28365063",
        "gene": "UGT2B7",
        "level": "4",
        "phenotypes": "Epilepsy"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Avoid lamotrigine in patients with HLA-B*15:02 if an alternative is available. If avoidance is not possible, advise to report any rash immediately.\n",
      "source": "DPWG"
    }
  },
  "losartan": {
    "genes": [
      "CYP2C9",
      "ABCB1",
      "ZNF703",
      "STK39",
      "CAMK1D",
      "FBXW12",
      "NPHS1",
      "UGT2B7",
      "AGT",
      "CYP3A4",
      "AGTR1",
      "UGT1A1",
      "KIRREL2",
      "SLC17A4",
      "SLC22A12",
      "ACE"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1057910",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs12721226",
        "gene": "AGTR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6749447",
        "gene": "STK39",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5186",
        "gene": "AGTR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5186",
        "gene": "AGTR1",
        "level": "3",
        "phenotypes": "Liver Cirrhosis"
      },
      {
        "variant": "rs3814995",
        "gene": "NPHS1",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*13, CYP2C9*59, CYP2C9*62",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1934969",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10737062",
        "gene": "CAMK1D",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs10752271",
        "gene": "CAMK1D",
        "level": "3",
        "phenotypes": "Essential hypertension"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for losartan and CYP2C9, CYP3A4"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "meloxicam": {
    "genes": [
      "CYP2C9",
      "CYB5R3",
      "G6PD"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*13",
        "gene": "CYP2C9",
        "level": "1A",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for meloxicam and CYP2C9"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for meloxicam and CYP2C9"
      }
    ],
    "guidelines": {
      "advice": "The CPIC Dosing Guideline for meloxicam recommends alternative therapy for CYP2C9 poor metabolizers due to markedly prolonged half-life, and initiating therapy with 50% of the lowest recommended starting dose or choose an alternative therapy for CYP2C9 intermediate metabolizers with activity score of 1. See full guideline for further details and supporting evidence.\n",
      "source": "CPIC"
    }
  },
  "mirtazapine": {
    "genes": [
      "CYP2C9",
      "DRD2",
      "HTR2C",
      "SH2B1",
      "CYP2B6",
      "CYP2D6",
      "CYP2C19",
      "UGT1A4",
      "BDNF",
      "FKBP5",
      "GAL",
      "SLC6A4",
      "HLA-A",
      "HTR2A",
      "TPH2",
      "CYP3A4",
      "HLA-B",
      "CYP3A5",
      "POLG",
      "CYP1A2",
      "RABEP1"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6",
        "gene": "CYP2D6",
        "level": "2A",
        "phenotypes": ""
      },
      {
        "variant": "rs10879346",
        "gene": "TPH2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1487278",
        "gene": "TPH2",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs948854",
        "gene": "GAL",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*7",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*7",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs3888190",
        "gene": "SH2B1",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depressive Disorder,Psychotic Disorder,Schizoaffective disorder"
      },
      {
        "variant": "rs1000940",
        "gene": "RABEP1",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depressive Disorder,Psychotic Disorder,Schizoaffective disorder"
      },
      {
        "variant": "SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",
        "gene": "SLC6A4",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4713916",
        "gene": "FKBP5",
        "level": "3",
        "phenotypes": "Mood Disorder"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no dosing recommendations for mirtazapine based on CYP2C19 genotypes.\n",
      "source": "DPWG"
    }
  },
  "modafinil": {
    "genes": [
      "CYP2C9",
      "DRD2",
      "ABCB1",
      "HTR2C",
      "CYP2B6",
      "CYP2D6",
      "OPRM1",
      "CYP2C19",
      "UGT1A4",
      "BDNF",
      "SLC6A4",
      "HLA-A",
      "HTR2A",
      "CYP3A4",
      "HLA-B",
      "CYP3A5",
      "POLG",
      "CYP1A2",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Narcolepsy"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Narcolepsy"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Narcolepsy"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Methamphetamine dependence"
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for modafinil and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for modafinil and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nabumetone": {
    "genes": [
      "CYP2C9"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of aceclofenac, aspirin, diclofenac, indomethacin, lumiracoxib, metamizole, nabumetone and naproxen based on CYP2C9 genotypes.\n",
      "source": "CPIC"
    }
  },
  "naproxen": {
    "genes": [
      "CYP2C9",
      "IL6",
      "ABCB1",
      "LST1",
      "IL1A",
      "TNF",
      "LTA",
      "IL1B"
    ],
    "clinicalVariants": [
      {
        "variant": "rs780801862",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1800629",
        "gene": "LST1,LTA,TNF",
        "level": "3",
        "phenotypes": "Migraine without Aura"
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*29",
        "gene": "CYP2C9",
        "level": "4",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of aceclofenac, aspirin, diclofenac, indomethacin, lumiracoxib, metamizole, nabumetone and naproxen based on CYP2C9 genotypes.\n",
      "source": "CPIC"
    }
  },
  "nateglinide": {
    "genes": [
      "CYP2C9",
      "CYP3A4",
      "SLCO1B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for nateglinide and CYP2C9"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for nateglinide"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for nateglinide and CYP2C9"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nevirapine": {
    "genes": [
      "CYP2C9",
      "SLC22A1",
      "ABCB1",
      "CYP2B6",
      "CYP2D6",
      "CYP2B7P1",
      "GSTT1",
      "CYP2C19",
      "HLA-DQB1",
      "PSORS1C1",
      "TCF19",
      "HLA-A",
      "NR1I2",
      "CCHCR1",
      "CYCSP5",
      "GSTM1",
      "SLCO3A1",
      "POLR3G",
      "CYP3A4",
      "HLA-B",
      "HCP5",
      "HLA-DRB1",
      "HLA-C",
      "CYP3A5",
      "NAT2",
      "CYP2A6",
      "ABCC10",
      "TRAF3IP2",
      "CYP1A2",
      "NR1I3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs3745274",
        "gene": "CYP2B6",
        "level": "2A",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs28399499",
        "gene": "CYP2B6",
        "level": "2A",
        "phenotypes": "Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-DRB1*01:01",
        "gene": "HLA-DRB1",
        "level": "2B",
        "phenotypes": ""
      },
      {
        "variant": "HLA-C*04:01",
        "gene": "HLA-C",
        "level": "2B",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Exanthema,Hypersensitivity,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "rs9461684",
        "gene": "HLA-C",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs2054675",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs3786547",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs76228616",
        "gene": "TRAF3IP2",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs12768009",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs2125739",
        "gene": "ABCC10",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs1265112",
        "gene": "CCHCR1",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs130072",
        "gene": "CCHCR1",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs2073724",
        "gene": "TCF19",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs2562519",
        "gene": "POLR3G",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs6545803",
        "gene": "",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs28371706",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs12721646",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "GSTM1 non-null, GSTM1 null",
        "gene": "GSTM1",
        "level": "3",
        "phenotypes": "HIV infectious disease,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*35:05",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Exanthema"
      },
      {
        "variant": "HLA-B*39:10",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*51:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*51:02",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*54:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*55:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*55:02",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*56:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*56:06",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*78:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*13:02",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*38:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*39:05",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*39:06",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*39:09",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*15:12",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*15:24",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*15:25",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*15:27",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*15:32",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*15:35",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*52:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*35:10",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-C*04:03",
        "gene": "HLA-C",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-DRB1*01:02",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-DRB1*10:01",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-DRB1*08:01",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-DRB1*04:04",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-DRB1*01:03",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-C*04:06",
        "gene": "HLA-C",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-C*04:07",
        "gene": "HLA-C",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-C*05:01",
        "gene": "HLA-C",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-C*05:09",
        "gene": "HLA-C",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-C*18:01",
        "gene": "HLA-C",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "rs3099844",
        "gene": "CYCSP5",
        "level": "3",
        "phenotypes": "Acquired Immunodeficiency Syndrome"
      },
      {
        "variant": "HLA-B*57:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "rs28399499",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs746647",
        "gene": "CCHCR1",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "HLA-B*35:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Hypersensitivity"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "HIV infectious disease,Toxic liver disease"
      },
      {
        "variant": "HLA-B*67:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-B*39:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-DQB1*05:01",
        "gene": "HLA-DQB1",
        "level": "3",
        "phenotypes": "Drug Hypersensitivity"
      },
      {
        "variant": "HLA-B*15:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "rs58425034",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5",
        "level": "4",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "HLA-B*38:02",
        "gene": "HLA-B",
        "level": "4",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "rs3745274",
        "gene": "CYP2B6",
        "level": "4",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms,HIV infectious disease,Stevens-Johnson Syndrome,Toxic liver disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nortriptyline": {
    "genes": [
      "CYP2C9",
      "KCNE1",
      "DRD2",
      "ABCB1",
      "HTR2C",
      "GNB3",
      "CYP2B6",
      "CYP2D6",
      "ADRA2A",
      "OPRM1",
      "CYP2C19",
      "UGT1A4",
      "BDNF",
      "SLC6A4",
      "HTR7",
      "HLA-A",
      "HTR2A",
      "UST",
      "PPM1A",
      "CYP3A4",
      "HLA-B",
      "SLC39A14",
      "CYP3A5",
      "POLG",
      "CYP1A2",
      "NOS3"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs962369",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression,Depressive Disorder,Hypotensive disorder,Major Depressive Disorder"
      },
      {
        "variant": "rs2500535",
        "gene": "UST",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs17060812",
        "gene": "SLC39A14",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs5443",
        "gene": "GNB3",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Migraine with Aura,Migraine without Aura"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for nortriptyline and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for nortriptyline and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "The CPIC Dosing Guideline update for nortriptyline recommends a 25% dose reduction for CYP2D6 intermediate metabolizers. For CYP2D6 ultrarapid or poor metabolizers, an alternative drug should be considered. If nortriptyline is warranted, consider a 50% dose reduction in CYP2D6 poor metabolizers. The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "paroxetine": {
    "genes": [
      "CYP2C9",
      "DRD2",
      "ABCB1",
      "HTR1A",
      "GDNF",
      "DISP1",
      "HTR2C",
      "TPH1",
      "HTR1B",
      "CYP2B6",
      "CYP2D6",
      "REEP5",
      "CYP2C19",
      "UGT1A4",
      "SRP19",
      "SLITRK5",
      "BDNF",
      "FKBP5",
      "SLC6A4",
      "HTR7",
      "HLA-A",
      "HTR2A",
      "FAIM2",
      "TPH2",
      "ABCG1",
      "MDGA2",
      "HES6",
      "HTR6",
      "CYP3A4",
      "HLA-B",
      "ADM",
      "HTR3A",
      "ABCB6",
      "RPP30",
      "CYP3A5",
      "POLG",
      "DRD3",
      "HTR3B",
      "CYP1A2",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*14, CYP2D6*41",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs10042486",
        "gene": "HTR1A",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs11042725",
        "gene": "ADM",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs7787082",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs762551",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs6265",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs1364043",
        "gene": "HTR1A",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs130058",
        "gene": "HTR1B",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs2235040",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2470890",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2472304",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4646425",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4646427",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs6295",
        "gene": "HTR1A",
        "level": "3",
        "phenotypes": "Depressive Disorder,Major Depressive Disorder"
      },
      {
        "variant": "rs10280101",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs10248420",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs11983225",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs12720067",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs2235040",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs6280",
        "gene": "DRD3",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs495794",
        "gene": "SRP19",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs153560",
        "gene": "REEP5",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs153549",
        "gene": "REEP5",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4148740",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2235067",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1360780",
        "gene": "FKBP5",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs28401781",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4148739",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression,Major Depressive Disorder"
      },
      {
        "variant": "rs2216711",
        "gene": "GDNF",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2973049",
        "gene": "GDNF",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1360780",
        "gene": "FKBP5",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs2032583",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression,Depressive Disorder,Major Depressive Disorder"
      },
      {
        "variant": "rs1160351",
        "gene": "MDGA2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs6265",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs7905446",
        "gene": "HTR7,RPP30",
        "level": "3",
        "phenotypes": "Bipolar Disorder"
      },
      {
        "variant": "rs6295",
        "gene": "HTR1A",
        "level": "3",
        "phenotypes": "Panic Disorder"
      },
      {
        "variant": "rs6311",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "Depression,Major Depressive Disorder"
      },
      {
        "variant": "rs6313",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs57098334",
        "gene": "SLC6A4",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",
        "gene": "SLC6A4",
        "level": "3",
        "phenotypes": "Major Depressive Disorder,Mood Disorder,Panic Disorder"
      },
      {
        "variant": "rs2235015",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression,Depressive Disorder,Major Depressive Disorder"
      },
      {
        "variant": "rs1176744",
        "gene": "HTR3B",
        "level": "4",
        "phenotypes": "Mental Disorders"
      },
      {
        "variant": "rs1800532",
        "gene": "TPH1",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs6313",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs6311",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": "Major Depressive Disorder,Obsessive-Compulsive Disorder"
      },
      {
        "variant": "rs7997012",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for paroxetine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of escitalopram, citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, duloxetine, venlafaxine, desvenlafaxine, vilazodone, vortioxetine, levomilnacipran, or milnacipran based on SLC6A4 genotypes.\n",
      "source": "CPIC"
    }
  },
  "phenprocoumon": {
    "genes": [
      "CYP2C9",
      "STX4",
      "PPARA",
      "CYP2C19",
      "CYP4F2",
      "EPHX1",
      "VKORC1",
      "GATA4",
      "CYP3A4",
      "CALU",
      "PROC",
      "CYP3A5",
      "F7",
      "GGCX"
    ],
    "clinicalVariants": [
      {
        "variant": "rs9923231",
        "gene": "VKORC1",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs9934438",
        "gene": "VKORC1",
        "level": "2A",
        "phenotypes": ""
      },
      {
        "variant": "rs9923231",
        "gene": "VKORC1",
        "level": "2A",
        "phenotypes": "Hemorrhage,over-anticoagulation,time above therapeutic range"
      },
      {
        "variant": "rs4253728",
        "gene": "PPARA",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10871454",
        "gene": "STX4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4086116",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1051740",
        "gene": "EPHX1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799808",
        "gene": "PROC",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7294",
        "gene": "VKORC1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2108622",
        "gene": "CYP4F2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for phenprocoumon dosing based on CYP2C9 genotypes.\n",
      "source": "DPWG"
    }
  },
  "pioglitazone": {
    "genes": [
      "CYP2C9",
      "CYP2D6",
      "G6PD",
      "PTPRD",
      "CYP2C8",
      "CYP3A5",
      "SLCO1B1",
      "ADIPOQ",
      "LPL",
      "PPARG"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2241766",
        "gene": "ADIPOQ",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "CYP2C8*1, CYP2C8*2, CYP2C8*3",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1801282",
        "gene": "PPARG",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs17584499",
        "gene": "PTPRD",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for glimepiride, pioglitazone and G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "piroxicam": {
    "genes": [
      "CYP2C9",
      "CYP2C8"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "1A",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for piroxicam and CYP2C9"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for piroxicam"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for piroxicam and CYP2C9"
      }
    ],
    "guidelines": {
      "advice": "The CPIC Dosing Guideline for piroxicam recommends that CYP2C9 poor metabolizers and intermediate metabolizers with activity score of 1 should choose an alternative therapy not metabolized by CYP2C9 or not significantly impacted by CYP2C9 genetic variants in vivo or choose an NSAID metabolized by CYP2C9 but with a shorter half-life. See full guideline for further details and supporting evidence.\n",
      "source": "CPIC"
    }
  },
  "primidone": {
    "genes": [
      "CYP2C9",
      "CYP2D6",
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "progesterone": {
    "genes": [
      "CYP2C9",
      "CYP2C19"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*17",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pyrazinamide": {
    "genes": [
      "CYP2C9",
      "IL6",
      "HLA-DQA1",
      "ABCB1",
      "AOX1",
      "UGT1A3",
      "CYP2B6",
      "CYP2D6",
      "CYP1A1",
      "GSTT1",
      "CYP2C19",
      "HLA-DQB1",
      "STAT3",
      "HSPA1L",
      "GSTM1",
      "CYP2E1",
      "TNF",
      "UGT1A1",
      "SLCO1B1",
      "NAT2",
      "GSTP1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4646244",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "CYP2B6*1, CYP2B6*6",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "rs1800629",
        "gene": "TNF",
        "level": "3",
        "phenotypes": "Toxic liver disease,Tuberculosis"
      },
      {
        "variant": "rs9332096",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": "Maculopapular Exanthema,Tuberculosis"
      },
      {
        "variant": "rs4986893",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Maculopapular Exanthema,Tuberculosis"
      },
      {
        "variant": "rs1041983",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Toxic liver disease,Tuberculosis"
      },
      {
        "variant": "rs1041983",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Toxic liver disease,Tuberculosis"
      },
      {
        "variant": "GSTM1 non-null, GSTM1 null",
        "gene": "GSTM1",
        "level": "4",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "GSTT1 non-null, GSTT1 null",
        "gene": "GSTT1",
        "level": "4",
        "phenotypes": "Tuberculosis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "rifampin": {
    "genes": [
      "CYP2C9",
      "IL6",
      "HLA-DQA1",
      "ABCB1",
      "UGT1A3",
      "CYP2B6",
      "CYP2D6",
      "NOS2",
      "CYP1A1",
      "GSTT1",
      "CYP2C19",
      "HLA-DQB1",
      "STAT3",
      "AADAC",
      "HSPA1L",
      "CUX2",
      "CYP27B1",
      "HLA-A",
      "XPO1",
      "RIPOR2",
      "DUX1",
      "NR1I2",
      "GSTM1",
      "CYP2E1",
      "VDR",
      "CYP3A4",
      "AGBL4",
      "TNF",
      "HLA-DPB1",
      "BACH1",
      "UGT1A1",
      "SLCO1B1",
      "NAT2",
      "MAFK",
      "GSTP1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2472677",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4149032",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4646244",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "rs11045819",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2306283",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7958375",
        "gene": "CUX2",
        "level": "3",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "rs10946739",
        "gene": "RIPOR2",
        "level": "3",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "rs320003",
        "gene": "AGBL4",
        "level": "3",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "rs319952",
        "gene": "AGBL4",
        "level": "3",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "rs393994",
        "gene": "AGBL4",
        "level": "3",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "CYP2B6*1, CYP2B6*6",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "rs1800629",
        "gene": "TNF",
        "level": "3",
        "phenotypes": "Toxic liver disease,Tuberculosis"
      },
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Drug-induced liver injury,Tuberculosis"
      },
      {
        "variant": "rs10946737",
        "gene": "RIPOR2",
        "level": "3",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "SLCO1B1*1, SLCO1B1*15",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Drug-induced liver injury"
      },
      {
        "variant": "rs9332096",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": "Maculopapular Exanthema,Tuberculosis"
      },
      {
        "variant": "rs4986893",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Maculopapular Exanthema,Tuberculosis"
      },
      {
        "variant": "rs11080344",
        "gene": "NOS2",
        "level": "3",
        "phenotypes": "Toxic liver disease,Tuberculosis"
      },
      {
        "variant": "rs1041983",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Toxic liver disease,Tuberculosis"
      },
      {
        "variant": "rs1041983",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Toxic liver disease,Tuberculosis"
      },
      {
        "variant": "rs1803155",
        "gene": "AADAC",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "GSTM1 non-null, GSTM1 null",
        "gene": "GSTM1",
        "level": "4",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "GSTT1 non-null, GSTT1 null",
        "gene": "GSTT1",
        "level": "4",
        "phenotypes": "Tuberculosis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sertraline": {
    "genes": [
      "CYP2C9",
      "DRD2",
      "ABCB1",
      "HTR1A",
      "DISP1",
      "HTR2C",
      "GNB3",
      "HTR1B",
      "CYP2B6",
      "CYP2D6",
      "REEP5",
      "CYP2C19",
      "CYP2C18",
      "UGT1A4",
      "SRP19",
      "SLITRK5",
      "P3H3",
      "BDNF",
      "SLC6A4",
      "HLA-A",
      "HTR2A",
      "BDNF-AS",
      "FAIM2",
      "ABCG1",
      "CYP3A4",
      "HLA-B",
      "ABCB6",
      "CYP3A5",
      "POLG",
      "DRD3",
      "ACE",
      "CYP1A2"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",
        "gene": "CYP2C19",
        "level": "1A",
        "phenotypes": "Mental Disorders"
      },
      {
        "variant": "CYP2B6*1, CYP2B6*4, CYP2B6*6, CYP2B6*9",
        "gene": "CYP2B6",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs2235040",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6295",
        "gene": "HTR1A",
        "level": "3",
        "phenotypes": "Depressive Disorder,Major Depressive Disorder"
      },
      {
        "variant": "rs495794",
        "gene": "SRP19",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs153560",
        "gene": "REEP5",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs153549",
        "gene": "REEP5",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs13432159",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs28401781",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4148739",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression,Major Depressive Disorder"
      },
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs2032583",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression,Depressive Disorder,Major Depressive Disorder"
      },
      {
        "variant": "rs5441",
        "gene": "GNB3,P3H3",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*4",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs6313",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": "Anxiety Disorders,Depression"
      },
      {
        "variant": "rs6311",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": "Major Depressive Disorder,Physiological sexual disorder"
      },
      {
        "variant": "rs6311",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs6313",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": "Major Depressive Disorder,Physiological sexual disorder"
      },
      {
        "variant": "rs7997012",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": "Anxiety Disorders,Depression"
      },
      {
        "variant": "rs57098334",
        "gene": "SLC6A4",
        "level": "4",
        "phenotypes": "Major Depressive Disorder,Panic Disorder"
      },
      {
        "variant": "SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",
        "gene": "SLC6A4",
        "level": "4",
        "phenotypes": "Major Depressive Disorder,Panic Disorder"
      },
      {
        "variant": "SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",
        "gene": "SLC6A4",
        "level": "4",
        "phenotypes": "Anxiety Disorders,Major Depressive Disorder"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of escitalopram, citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, duloxetine, venlafaxine, desvenlafaxine, vilazodone, vortioxetine, levomilnacipran, or milnacipran based on SLC6A4 genotypes.\n",
      "source": "CPIC"
    }
  },
  "sildenafil": {
    "genes": [
      "CYP2C9",
      "GNB3",
      "ARG1",
      "VEGFA",
      "ARG2",
      "CYP3A4",
      "CYP3A5",
      "ACE",
      "NOS3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4343",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Erectile Dysfunction"
      },
      {
        "variant": "rs699947",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Erectile Dysfunction"
      },
      {
        "variant": "rs2070744",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Erectile Dysfunction"
      },
      {
        "variant": "CYP3A4*1, CYP3A4*22",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs5443",
        "gene": "GNB3",
        "level": "3",
        "phenotypes": "Erectile Dysfunction"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for sildenafil"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sulfamethoxazole": {
    "genes": [
      "CYP2C9",
      "GCLC",
      "G6PD",
      "HLA-B",
      "NAT2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs761142",
        "gene": "GCLC",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "G6PD B (reference), G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like",
        "gene": "G6PD",
        "level": "3",
        "phenotypes": "Hemolysis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "tamoxifen": {
    "genes": [
      "CYP2C9",
      "SULT1A1",
      "HLA-DQA1",
      "ZNF423",
      "LPP",
      "ABCB1",
      "IGF1",
      "CYP2B6",
      "CYP2D6",
      "C1QTNF6",
      "LRMDA",
      "F5",
      "NCOA1",
      "CYP2C19",
      "HLA-DQB1",
      "UGT1A4",
      "ESR2",
      "ZNF613",
      "FMO3",
      "FMO1",
      "UGT2B7",
      "ABCC2",
      "E2F7",
      "IRS1",
      "HS6ST3",
      "CYP19A1",
      "IGF1R",
      "CYP3A4",
      "SLCO1A2",
      "PGR",
      "RRAS2",
      "HLA-DRB1",
      "F2",
      "UGT2B15",
      "CCNA2",
      "CYP3A5",
      "SLCO2B1",
      "SLCO1B1",
      "IGFBP3",
      "WBP2NL",
      "CYP1A2",
      "ESR1"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*10x2, CYP2D6*11, CYP2D6*17, CYP2D6*21, CYP2D6*36, CYP2D6*41",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs4986938",
        "gene": "ESR2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs9340799",
        "gene": "ESR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10030044",
        "gene": "",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs8060157",
        "gene": "ZNF423",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs478437",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs310786",
        "gene": "E2F7",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs310786",
        "gene": "E2F7",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs11023197",
        "gene": "RRAS2",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs3740065",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2740574",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*17",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1804645",
        "gene": "NCOA1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs10509373",
        "gene": "LRMDA",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2011425",
        "gene": "UGT1A4",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs4646",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Menopause"
      },
      {
        "variant": "rs4646",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*87, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*95, CYP2D6*98",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for tamoxifen and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for tamoxifen and F2, F5"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for tamoxifen and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for tamoxifen and ESR1, ESR2, PGR"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for tamoxifen and ESR1, ESR2, PGR"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for tamoxifen and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "The French National Network of Pharmacogenetics (Rseau national de pharmacogntique (RNPGx)) states that there is no recommendation\nfor genotyping CYP2D6 in all patients starting a tamoxifen regimen.\n",
      "source": "RNPGx"
    }
  },
  "tolbutamide": {
    "genes": [
      "CYP2C9",
      "CYP2C19",
      "G6PD",
      "KCNJ11"
    ],
    "clinicalVariants": [
      {
        "variant": "rs9332239",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs762081829",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs761895497",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*62",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs771237265",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for tolbutamide and G6PD"
      }
    ],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "trazodone": {
    "genes": [
      "CYP2C9",
      "DRD2",
      "ABCB1",
      "HTR2C",
      "CYP2B6",
      "CYP2D6",
      "CYP2C19",
      "UGT1A4",
      "SLC6A4",
      "HLA-A",
      "HTR2A",
      "CYP3A4",
      "HLA-B",
      "CYP3A5",
      "POLG",
      "CYP1A2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "trimipramine": {
    "genes": [
      "CYP2C9",
      "ABCB1",
      "CYP2D6",
      "CYP2C19"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Mental Disorders"
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2",
        "gene": "CYP2C19",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C9*1, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for trimipramine and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for trimipramine"
      }
    ],
    "guidelines": {
      "advice": "Tricyclic antidepressants have comparable pharmacokinetic properties, it may be reasonable to apply the CPIC Dosing Guideline for amitriptyline and CYP2C19, CYP2D6 to other tricyclics including trimipramine. The CPIC Dosing Guideline update for amitriptyline recommends an alternative drug for CYP2D6 ultrarapid or poor metabolizers and CYP2C19 ultrarapid, rapid or poor metabolizers. If amitriptyline is warranted, consider a 50% dose reduction in CYP2D6 or CYP2C19 poor metabolizers. For CYP2D6 intermediate metabolizers, a 25% dose reduction should be considered. The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "venlafaxine": {
    "genes": [
      "CYP2C9",
      "KCNE1",
      "DRD2",
      "ABCB1",
      "HTR1A",
      "HTR2C",
      "TPH1",
      "HTR1B",
      "CYP2B6",
      "CYP2D6",
      "GRIK4",
      "OPRM1",
      "CYP2C19",
      "UGT1A4",
      "BDNF",
      "SLC6A3",
      "FKBP5",
      "SLC6A4",
      "HTR7",
      "HLA-A",
      "HTR2A",
      "GABRP",
      "TPH2",
      "CYP3A4",
      "HLA-B",
      "SLC6A2",
      "CYP3A5",
      "GABRQ",
      "POLG",
      "GRIA3",
      "GABRA6",
      "CYP1A2",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Depressive Disorder,Obsessive-Compulsive Disorder"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*81",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Agitation,Alcohol-Related Disorders,Cardiotoxicity,Depression,Depressive Disorder,Drug Toxicity,dysphoria,Edema,Major Depressive Disorder,Nausea,Obsessive-Compulsive Disorder,Tachycardia,Vomiting"
      },
      {
        "variant": "rs10879346",
        "gene": "TPH2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs3810651",
        "gene": "GABRQ",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1487278",
        "gene": "TPH2",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs1992647",
        "gene": "GABRA6",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs10036156",
        "gene": "GABRP",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs3761555",
        "gene": "GRIA3",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs3761554",
        "gene": "GRIA3",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs502434",
        "gene": "GRIA3",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs7787082",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs2235040",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10280101",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs10248420",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs11983225",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs12720067",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs2235040",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs130058",
        "gene": "HTR1B",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs4148740",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2235067",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1360780",
        "gene": "FKBP5",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs4148739",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression,Major Depressive Disorder"
      },
      {
        "variant": "rs4244285",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs1360780",
        "gene": "FKBP5",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depressive Disorder,Narcolepsy"
      },
      {
        "variant": "rs2032583",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression,Depressive Disorder,Major Depressive Disorder"
      },
      {
        "variant": "rs2242446",
        "gene": "SLC6A2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Anxiety Disorders,Depressive Disorder"
      },
      {
        "variant": "CYP2C19*2",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7997012",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "Anxiety Disorders"
      },
      {
        "variant": "rs2235015",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression,Depressive Disorder,Major Depressive Disorder"
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2",
        "gene": "CYP2C19",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs6313",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs6311",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",
        "gene": "SLC6A4",
        "level": "4",
        "phenotypes": "Anxiety Disorders,Depression"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for venlafaxine and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for venlafaxine and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for venlafaxine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of escitalopram, citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, duloxetine, venlafaxine, desvenlafaxine, vilazodone, vortioxetine, levomilnacipran, or milnacipran based on SLC6A4 genotypes.\n",
      "source": "CPIC"
    }
  },
  "zafirlukast": {
    "genes": [
      "CYP2C9",
      "CYSLTR1"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C9*1, CYP2C9*3, CYP2C9*13",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "hormonal contraceptives for systemic use": {
    "genes": [
      "CYP2C9",
      "SUGCT",
      "MTHFR",
      "FGG",
      "F5",
      "PROCR",
      "F2",
      "F11",
      "KNG1",
      "ABO"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1799963",
        "gene": "F2",
        "level": "2B",
        "phenotypes": "Stroke,Venous Thrombosis"
      },
      {
        "variant": "rs6025",
        "gene": "F5",
        "level": "2B",
        "phenotypes": "Thrombotic disease"
      },
      {
        "variant": "rs2289252",
        "gene": "F11",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs710446",
        "gene": "KNG1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4379368",
        "gene": "SUGCT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs56392308",
        "gene": "ABO",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs8176719",
        "gene": "ABO",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799853",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "arsenic trioxide": {
    "genes": [
      "MT1A",
      "PML",
      "AS3MT",
      "RARA"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for arsenic trioxide and PML, RARA"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for arsenic trioxide and PML, RARA"
      },
      {
        "source": "PMDA",
        "level": "Testing Required",
        "name": "Annotation of PMDA Label for arsenic trioxide and PML, RARA"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for arsenic trioxide and PML, RARA"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "desloratadine": {
    "genes": [
      "HDC",
      "ORAI1",
      "HRH1",
      "FCER1A"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2298805",
        "gene": "FCER1A",
        "level": "3",
        "phenotypes": "Urticaria"
      },
      {
        "variant": "rs901865",
        "gene": "HRH1",
        "level": "3",
        "phenotypes": "sedation,Urticaria"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for desloratadine"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "phenobarbital": {
    "genes": [
      "GABRB2",
      "ABCB1",
      "MTHFR",
      "CYP1A1",
      "CYP2C19",
      "UGT1A9",
      "GABRG2",
      "HLA-A",
      "SCN2A",
      "HLA-B",
      "HLA-DRB1",
      "UGT2B15",
      "GABRA1",
      "UGT1A6",
      "GABRA6"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "HLA-B*51:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Stevens-Johnson Syndrome"
      },
      {
        "variant": "rs2606345",
        "gene": "CYP1A1",
        "level": "3",
        "phenotypes": "Epilepsy"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Epilepsy,Psychotic Disorder"
      },
      {
        "variant": "rs17183814",
        "gene": "SCN2A",
        "level": "4",
        "phenotypes": "Epilepsy"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "corticosteroids for systemic use": {
    "genes": [
      "HDAC1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "o-desmethyltramadol": {
    "genes": [
      "HCN1",
      "SLC22A1",
      "ABCB1",
      "CYP2D6",
      "ICA1",
      "UGT1A8",
      "RFPL4B",
      "ABCC2",
      "RGL4",
      "SULT1A3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs767263838",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs757573592",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs776817009",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs762151655",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs750575779",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs553050853",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs751527244",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1293732453",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1328799050",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs72732317",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs184199168",
        "gene": "RGL4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs62435418",
        "gene": "ICA1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs79983226",
        "gene": "HCN1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs9384825",
        "gene": "RFPL4B",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tramadol": {
    "genes": [
      "HCN1",
      "SLC22A1",
      "ABCB1",
      "CYP2B6",
      "CYP2D6",
      "OPRD1",
      "ICA1",
      "OPRM1",
      "ARRB2",
      "RFPL4B",
      "UGT2B7",
      "CYP2A7P1",
      "CYP3A4",
      "CYP1B1",
      "SEPTIN3",
      "CYP3A5",
      "WBP2NL",
      "RGL4",
      "SULT1A3",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Pain,Pain, Postoperative"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Cardiotoxicity,Drug Toxicity"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10",
        "gene": "CYP2D6",
        "level": "2A",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs34130495",
        "gene": "SLC22A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs35167514",
        "gene": "SLC22A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs767263838",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs757573592",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs776817009",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs762151655",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs750575779",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs553050853",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs751527244",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1293732453",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1328799050",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2234918",
        "gene": "OPRD1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders,Physiological sexual disorder"
      },
      {
        "variant": "rs1045280",
        "gene": "ARRB2",
        "level": "3",
        "phenotypes": "adverse events,Opioid-Related Disorders"
      },
      {
        "variant": "rs72732317",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs184199168",
        "gene": "RGL4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs62435418",
        "gene": "ICA1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs79983226",
        "gene": "HCN1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs9384825",
        "gene": "RFPL4B",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "adverse events,Opioid-Related Disorders"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Neuropathic pain"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Exanthema,Opioid-Related Disorders"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Fractures, Bone,Pain,Pain, Postoperative"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Fractures, Bone,Pain,Pain, Postoperative"
      },
      {
        "variant": "rs3745274",
        "gene": "CYP2A7P1,CYP2B6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs12208357",
        "gene": "SLC22A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs62436463",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "adverse events"
      },
      {
        "variant": "rs739296",
        "gene": "SEPTIN3,WBP2NL",
        "level": "3",
        "phenotypes": "adverse events"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "adverse events,Opioid-Related Disorders"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for tramadol and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for acetaminophen, tramadol and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for tramadol and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Alternate non-codeine analgesics are recommended for CYP2D6 ultrarapid and poor metabolizers. A label recommended age- or weight-specific dose of tramadol is warranted for CYP2D6 normal and intermediate metabolizers.\n",
      "source": "CPIC"
    }
  },
  "qt-prolonging drugs": {
    "genes": [
      "KCNE1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1805128",
        "gene": "KCNE1",
        "level": "3",
        "phenotypes": "Acquired Long QT Syndrome (aLQTS)"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dronedarone": {
    "genes": [
      "KCNE1",
      "KCNE2",
      "CYP2D6",
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Informative PGx",
        "name": "Annotation of EMA Label for dronedarone and CYP2D6, CYP3A4"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "papaverine": {
    "genes": [
      "KCNE1",
      "KCNE2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cilostazol": {
    "genes": [
      "KCNE1",
      "KCNE2",
      "CYP2C19",
      "CYP3A5"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "hydroxychloroquine": {
    "genes": [
      "KCNE1",
      "KCNE2",
      "CYP2D6",
      "MTHFR",
      "ATIC",
      "HLA-DQB1",
      "G6PD",
      "SHMT1",
      "HLA-A",
      "SLC19A1",
      "MTR",
      "CYP3A4",
      "C18orf56",
      "DHFR",
      "HLA-B",
      "HLA-DRB1",
      "CYP2C8",
      "HLA-C",
      "CYP3A5",
      "TYMS"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1805087",
        "gene": "MTR",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for hydroxychloroquine and G6PD"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for hydroxychloroquine and G6PD"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for hydroxychloroquine and G6PD"
      }
    ],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "amiodarone": {
    "genes": [
      "KCNE1",
      "KCNE2",
      "CYP2D6",
      "CACNA1C",
      "CYP3A4",
      "HLA-DRB1",
      "KCNH2",
      "NOS1AP"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12720441",
        "gene": "KCNH2",
        "level": "3",
        "phenotypes": "Torsades de Pointes"
      },
      {
        "variant": "rs10919035",
        "gene": "NOS1AP",
        "level": "3",
        "phenotypes": "Long QT Syndrome"
      },
      {
        "variant": "rs10800397",
        "gene": "NOS1AP",
        "level": "3",
        "phenotypes": "Long QT Syndrome"
      },
      {
        "variant": "rs1805128",
        "gene": "KCNE1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no dosing recommendations for amiodarone based on CYP2D6 genotype.\n",
      "source": "DPWG"
    }
  },
  "azithromycin": {
    "genes": [
      "KCNE1",
      "ABCB1",
      "KCNE2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "chlorpromazine": {
    "genes": [
      "KCNE1",
      "DRD2",
      "KCNE2",
      "MTHFR",
      "EPM2A"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1415744",
        "gene": "EPM2A",
        "level": "3",
        "phenotypes": "Schizophrenia"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ciprofloxacin": {
    "genes": [
      "KCNE1",
      "KCNE2",
      "CYP2D6",
      "G6PD",
      "UGT2B7",
      "HLA-B",
      "CYP1A2"
    ],
    "clinicalVariants": [
      {
        "variant": "G6PD B (reference), G6PD Mediterranean Haplotype, G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham",
        "gene": "G6PD",
        "level": "3",
        "phenotypes": "Hemolytic Anemia"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for ciprofloxacin and G6PD"
      }
    ],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "clarithromycin": {
    "genes": [
      "KCNE1",
      "KCNE2",
      "CYP2C19",
      "VDR",
      "CYP3A4",
      "KCNH2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dofetilide": {
    "genes": [
      "KCNE1",
      "KCNE2",
      "KCNH2",
      "C18orf21"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "erythromycin": {
    "genes": [
      "KCNE1",
      "ABCB1",
      "KCNE2",
      "ABCC2",
      "CYP3A4",
      "CYP3A5",
      "SLCO1B1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs35599367",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "flecainide": {
    "genes": [
      "KCNE1",
      "ADRB1",
      "KCNE2",
      "CYP2D6",
      "SCN4A",
      "CYP3A5",
      "CYP1A2"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Cardiac rhythm disease"
      },
      {
        "variant": "rs1567817380",
        "gene": "SCN4A",
        "level": "3",
        "phenotypes": "Myotonic Disorders"
      },
      {
        "variant": "rs80338792",
        "gene": "SCN4A",
        "level": "3",
        "phenotypes": "Myotonia"
      },
      {
        "variant": "rs121908547",
        "gene": "SCN4A",
        "level": "3",
        "phenotypes": "Myotonic Disorders"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Reduce flecainide dose by 50% for CYP2D6 poor metabolizer (PM) and record an ECG and monitor the plasma concentration. Reduce flecainide dose to 75% of the standard dose for CYP2D6 intermediate metabolizer (IM) patients with indications other than diagnosis of Brugada syndrome and record an ECG and monitor the plasma concentration.\n",
      "source": "DPWG"
    }
  },
  "hydroxyzine": {
    "genes": [
      "KCNE1",
      "KCNH2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "levofloxacin": {
    "genes": [
      "KCNE1",
      "ABCB1",
      "KCNE2",
      "ABCG2",
      "HLA-B"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "metoclopramide": {
    "genes": [
      "KCNE1",
      "CYB5R3",
      "CYP2D6",
      "CYB5R4",
      "G6PD",
      "CYB5R2",
      "CYB5R1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for metoclopramide and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for metoclopramide and CYB5R1, CYB5R2, CYB5R3, CYB5R4, G6PD"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for metoclopramide and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for metoclopramide and CYB5R1, CYB5R2, CYB5R3, CYB5R4, G6PD"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for metoclopramide"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "moxifloxacin": {
    "genes": [
      "KCNE1",
      "ABCB1",
      "KCNE2",
      "G6PD",
      "HLA-B",
      "UGT1A1",
      "SLCO1B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for moxifloxacin and G6PD"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of chlorpropamide, dabrafenib, gliclazide, glimepiride, glipizide, mepacrine (aka quinacrine), mesalazine, moxifloxacin, nicorandil, nitrofural (aka nitrofurazone), probenecid, sodium nitrate, sulfacetamide, tolazamide or trametinib based on G6PD genotype.\n",
      "source": "CPIC"
    }
  },
  "pentamidine": {
    "genes": [
      "KCNE1",
      "KCNE2",
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "procainamide": {
    "genes": [
      "KCNE1",
      "KCNE2",
      "NAT2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for procainamide and NAT2"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for procainamide"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for procainamide"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "prochlorperazine": {
    "genes": [
      "KCNE1",
      "DRD2",
      "CYP2D6",
      "OPRM1",
      "ANKK1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1800497",
        "gene": "ANKK1,DRD2",
        "level": "3",
        "phenotypes": "Nausea"
      },
      {
        "variant": "rs1079597",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Nausea"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "promethazine": {
    "genes": [
      "KCNE1",
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "quinidine": {
    "genes": [
      "KCNE1",
      "KCNE2",
      "CYP2D6",
      "CACNA1C",
      "CYP3A4",
      "KCNH2",
      "C18orf21"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1805128",
        "gene": "KCNE1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs104894021",
        "gene": "KCNH2",
        "level": "3",
        "phenotypes": "short qt syndrome 1"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for quinidine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "There are currently no dosing recommendations for quinidine based on CYP2D6 genotypes.\n",
      "source": "DPWG"
    }
  },
  "sotalol": {
    "genes": [
      "KCNE1",
      "ADRB1",
      "KCNE2",
      "CYP2D6",
      "CACNA1C",
      "ADRB2",
      "GRK5",
      "ADRA2C",
      "C18orf21",
      "NOS1AP",
      "GRK4"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1805128",
        "gene": "KCNE1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of carvedilol, labetalol, nadolol, pindolol, propranolol or sotalol based on ADRB2 genotypes.\n",
      "source": "CPIC"
    }
  },
  "tizanidine": {
    "genes": [
      "KCNE1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "trifluoperazine": {
    "genes": [
      "KCNE1",
      "EPM2A"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1415744",
        "gene": "EPM2A",
        "level": "3",
        "phenotypes": "Schizophrenia"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "antiarrhythmics, class i and iii": {
    "genes": [
      "KCNE1",
      "KCNH2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "abt-751": {
    "genes": [
      "SULT1A2",
      "SULT1A1",
      "UGT1A4",
      "UGT1A8",
      "UGT2B7",
      "UGT1A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs6755571",
        "gene": "UGT1A4",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs6431558",
        "gene": "UGT1A8",
        "level": "3",
        "phenotypes": "Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "brostallicin": {
    "genes": [
      "GSTA1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "prednisone": {
    "genes": [
      "GSTA1",
      "RAPGEF5",
      "MIR146A",
      "ABCB1",
      "CTLA4",
      "NR3C1",
      "CYBA",
      "GATA3",
      "CYP1A1",
      "ASNS",
      "TNRC6B",
      "BMP7",
      "MIR423",
      "MIR577",
      "CXCL12",
      "TPMT",
      "MIR449B",
      "XRCC1",
      "NFATC1",
      "GEMIN4",
      "MIR2053",
      "CCHCR1",
      "XPO5",
      "SLC19A1",
      "ATF5",
      "C18orf56",
      "RFXAP",
      "MIR1206",
      "MIR1307",
      "EDNRA",
      "MIR3117",
      "TNRC6A",
      "MIR4268",
      "MIR604",
      "AGO1",
      "DOK5",
      "LINC00251",
      "MIR492",
      "MIR300",
      "CYP3A5",
      "C5orf22",
      "DDX20",
      "MIR618",
      "TYMS",
      "CNOT1",
      "GSTP1",
      "DROSHA",
      "NOS3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Organ Transplantation,Transplantation"
      },
      {
        "variant": "rs4553808",
        "gene": "CTLA4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3824662",
        "gene": "GATA3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs639174",
        "gene": "DROSHA",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs17021408",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs1891059",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs80223967",
        "gene": "",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs1801157",
        "gene": "CXCL12",
        "level": "3",
        "phenotypes": "Leukemia, Lymphocytic, Chronic, B-Cell"
      },
      {
        "variant": "rs2229109",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Non-Hodgkin Lymphoma"
      },
      {
        "variant": "rs117532069",
        "gene": "DOK5",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs79085477",
        "gene": "BMP7",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs141059755",
        "gene": "LINC00251",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Osteonecrosis"
      },
      {
        "variant": "rs3957357",
        "gene": "GSTA1",
        "level": "3",
        "phenotypes": "Lymphoma, Large B-Cell, Diffuse"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "rituximab": {
    "genes": [
      "GSTA1",
      "IL6",
      "TNFRSF10A",
      "STAT4",
      "ABCB1",
      "CTLA4",
      "CYBA",
      "TGFB1",
      "NOS1",
      "TNFAIP3",
      "FCGR3A",
      "CXCL13",
      "TNFRSF1B",
      "CXCL12",
      "MS4A1",
      "PTPN22",
      "ABCC2",
      "ABCG2",
      "TRAF1",
      "TNFSF10",
      "HLA-B",
      "TNF",
      "CIDEA",
      "FCGR2A",
      "LTA",
      "IL10",
      "IL2",
      "SLC35F4",
      "NCF4",
      "CBR3",
      "OXNAD1",
      "TNIP3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs396991",
        "gene": "FCGR3A",
        "level": "2B",
        "phenotypes": "Neuromyelitis Optica,Rheumatoid arthritis"
      },
      {
        "variant": "rs1800471",
        "gene": "TGFB1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs6822844",
        "gene": "IL2",
        "level": "3",
        "phenotypes": "Systemic lupus erythematosus"
      },
      {
        "variant": "rs1800470",
        "gene": "TGFB1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1801157",
        "gene": "CXCL12",
        "level": "3",
        "phenotypes": "Leukemia, Lymphocytic, Chronic, B-Cell"
      },
      {
        "variant": "rs2229109",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Non-Hodgkin Lymphoma"
      },
      {
        "variant": "rs3759467",
        "gene": "",
        "level": "3",
        "phenotypes": "Vasculitis"
      },
      {
        "variant": "rs3957357",
        "gene": "GSTA1",
        "level": "3",
        "phenotypes": "Lymphoma, Large B-Cell, Diffuse"
      },
      {
        "variant": "rs1801274",
        "gene": "FCGR2A",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs396991",
        "gene": "FCGR3A",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for rituximab and MS4A1"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for rituximab and MS4A1"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for rituximab and MS4A1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cladribine": {
    "genes": [
      "NT5C1A",
      "RRM2B",
      "RRM2",
      "RRM1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs5030743",
        "gene": "RRM2",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs1265138",
        "gene": "RRM2B",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs2898950",
        "gene": "RRM1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs1561876",
        "gene": "RRM1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs1042919",
        "gene": "RRM1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs201045130",
        "gene": "NT5C1A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs374150125",
        "gene": "NT5C1A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs370457585",
        "gene": "NT5C1A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1130609",
        "gene": "RRM2",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "bortezomib": {
    "genes": [
      "PKNOX1",
      "CTLA4",
      "CBS"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4553808",
        "gene": "CTLA4",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fenoterol": {
    "genes": [
      "SLC22A1",
      "ADRB2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tropisetron": {
    "genes": [
      "SLC22A1",
      "CYP2D6"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Vomiting"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "The CPIC dosing guideline for tropisetron recommends selecting an alternate drug for CYP2D6 ultrarapid metabolizers.  It is recommended that the alternate drug not be predominantly metabolized by CYP2D6 (eg. granisetron). The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "anticholinergics": {
    "genes": [
      "SLC22A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs622342",
        "gene": "SLC22A1",
        "level": "3",
        "phenotypes": "Parkinson Disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "antiemetics and antinauseants": {
    "genes": [
      "SLC22A1",
      "SLC6A3",
      "SDK1",
      "HTR3A",
      "HTR3B"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dopamine agonists": {
    "genes": [
      "SLC22A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs622342",
        "gene": "SLC22A1",
        "level": "3",
        "phenotypes": "Parkinson Disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "olmesartan": {
    "genes": [
      "SLC22A1",
      "SLCO1B1"
    ],
    "clinicalVariants": [
      {
        "variant": "SLCO1B1*15, SLCO1B1*37",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "rasagiline": {
    "genes": [
      "SLC22A1",
      "DRD2",
      "ABCB1",
      "ABCC2",
      "CYP1A2",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1076560",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Parkinson Disease"
      },
      {
        "variant": "rs2283265",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Parkinson Disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cycloguanil": {
    "genes": [
      "SLC22A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "berberine": {
    "genes": [
      "SLC22A1",
      "CYP2D6",
      "SLC6A4"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*10",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nilotinib": {
    "genes": [
      "SLC22A1",
      "ABCB1",
      "CYP1A1",
      "BCR",
      "ABCG2",
      "CYP3A4",
      "UGT1A1",
      "ABL1",
      "GSTP1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs41282401",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1061018",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2231137",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "UGT1A1*1, UGT1A1*6, UGT1A1*27, UGT1A1*28",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "Hyperbilirubinemia"
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for nilotinib and UGT1A1"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for nilotinib and ABL1, BCR"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for nilotinib and ABL1, BCR"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for nilotinib and ABL1, BCR"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for nilotinib and UGT1A1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "n-desmethyltramadol": {
    "genes": [
      "SLC22A1",
      "CYP2D6",
      "UGT1A8",
      "ABCC2",
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "amantadine": {
    "genes": [
      "SLC22A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs622342",
        "gene": "SLC22A1",
        "level": "3",
        "phenotypes": "Parkinson Disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "codeine": {
    "genes": [
      "SLC22A1",
      "ABCB1",
      "CYP2D6",
      "OPRM1",
      "UGT2B7",
      "CYP1B1",
      "SEPTIN3",
      "WBP2NL",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Pain"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*17, CYP2D6*40",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Pain"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*36, CYP2D6*41",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs7439366",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2D6*1, CYP2D6*3, CYP2D6*4",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs9620007",
        "gene": "WBP2NL",
        "level": "3",
        "phenotypes": "adverse events"
      },
      {
        "variant": "rs62436463",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "adverse events"
      },
      {
        "variant": "rs739296",
        "gene": "SEPTIN3,WBP2NL",
        "level": "3",
        "phenotypes": "adverse events"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*24",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for codeine and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for codeine and CYP2D6"
      },
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for codeine and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for codeine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of alfentanil, buprenorphine, codeine, fentanyl, hydrocodone, hydromorphone, levomethadone, naltrexone, remifentanil, sufentanil or tramadol based on OPRM1 or COMT genotypes.\n",
      "source": "CPIC"
    }
  },
  "levodopa": {
    "genes": [
      "SLC22A1",
      "DRD2",
      "DRD1",
      "MAOB",
      "G6PD",
      "SLC6A3",
      "ADORA2A",
      "HOMER1",
      "DBH",
      "DRD3",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4704559",
        "gene": "HOMER1",
        "level": "3",
        "phenotypes": "Parkinson Disease"
      },
      {
        "variant": "rs1611115",
        "gene": "DBH",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs622342",
        "gene": "SLC22A1",
        "level": "3",
        "phenotypes": "Parkinson Disease"
      },
      {
        "variant": "rs1799732",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Parkinson Disease"
      },
      {
        "variant": "rs3836790",
        "gene": "SLC6A3",
        "level": "3",
        "phenotypes": "Parkinson Disease"
      },
      {
        "variant": "rs6280",
        "gene": "DRD3",
        "level": "3",
        "phenotypes": "Gastrointestinal toxicity,Hallucinations,Parkinson Disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lopinavir": {
    "genes": [
      "SLC22A1",
      "ABCB1",
      "CYP2B6",
      "ABCC2",
      "CYP3A4",
      "SLC22A6",
      "CYP3A5",
      "SLCO1B1",
      "ABCC1",
      "ZSCAN25"
    ],
    "clinicalVariants": [
      {
        "variant": "rs8187710",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs8187710",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs212091",
        "gene": "ABCC1",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs2853826",
        "gene": "",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5,ZSCAN25",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "CYP3A4*1, CYP3A4*22",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "naratriptan": {
    "genes": [
      "SLC22A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "proguanil": {
    "genes": [
      "SLC22A1",
      "CYP2C19",
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "rizatriptan": {
    "genes": [
      "SLC22A1",
      "DRD2",
      "IL6",
      "HTR1B",
      "MAOA",
      "SLC6A4",
      "GRIA1",
      "IL1A",
      "TNF",
      "IL1B"
    ],
    "clinicalVariants": [
      {
        "variant": "rs6275",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Migraine without Aura"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "selegiline": {
    "genes": [
      "SLC22A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs622342",
        "gene": "SLC22A1",
        "level": "3",
        "phenotypes": "Parkinson Disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sumatriptan": {
    "genes": [
      "SLC22A1",
      "DRD2",
      "IL6",
      "GNB3",
      "HTR1B",
      "OPRM1",
      "BDNF",
      "HTR2A",
      "GRIA1",
      "IL1A",
      "DBH",
      "TNF",
      "IL1B",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "rs5443",
        "gene": "GNB3",
        "level": "3",
        "phenotypes": "Cluster Headache"
      },
      {
        "variant": "rs6305",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1611115",
        "gene": "DBH",
        "level": "3",
        "phenotypes": "Substance Withdrawal Syndrome"
      },
      {
        "variant": "rs6265",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6275",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Substance Withdrawal Syndrome"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs130060",
        "gene": "HTR1B",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "zolmitriptan": {
    "genes": [
      "SLC22A1",
      "IL6",
      "GRIA1",
      "IL1A",
      "TNF",
      "IL1B"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nemonapride": {
    "genes": [
      "DRD2",
      "ANKK1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1800497",
        "gene": "ANKK1",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs1799732",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "analgesics": {
    "genes": [
      "DRD2",
      "OPRM1",
      "BDNF",
      "KCNJ6",
      "HTR2A",
      "DBH",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "rs6305",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1611115",
        "gene": "DBH",
        "level": "3",
        "phenotypes": "Substance Withdrawal Syndrome"
      },
      {
        "variant": "rs6265",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6275",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2070995",
        "gene": "KCNJ6",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Substance Withdrawal Syndrome"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ergot alkaloids": {
    "genes": [
      "DRD2",
      "OPRM1",
      "BDNF",
      "HTR2A",
      "DBH",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "rs6305",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1611115",
        "gene": "DBH",
        "level": "3",
        "phenotypes": "Substance Withdrawal Syndrome"
      },
      {
        "variant": "rs6265",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6275",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Substance Withdrawal Syndrome"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "botulinum toxin type a": {
    "genes": [
      "DRD2",
      "WFS1",
      "KCNS1",
      "HTR2C",
      "P2RX7",
      "SCN9A",
      "MEF2D",
      "TRPV3",
      "CALCA",
      "TRPM8",
      "SLC1A2",
      "GABRE",
      "GRIK3",
      "LRP1",
      "GABRA3",
      "TRPV1",
      "GABRQ"
    ],
    "clinicalVariants": [
      {
        "variant": "rs222749",
        "gene": "TRPV1",
        "level": "3",
        "phenotypes": "Migraine disorder"
      },
      {
        "variant": "rs3781719",
        "gene": "CALCA",
        "level": "3",
        "phenotypes": "Migraine disorder"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "bromperidol": {
    "genes": [
      "DRD2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1799732",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "amphetamine": {
    "genes": [
      "DRD2",
      "CYP2D6",
      "OPRM1",
      "SLC6A3",
      "KAT2B",
      "CDH13"
    ],
    "clinicalVariants": [
      {
        "variant": "rs510769",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2281617",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs12364283",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs9829896",
        "gene": "KAT2B",
        "level": "3",
        "phenotypes": "Substance-Related Disorders"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for amphetamine"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for amphetamine and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for amphetamine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "caffeine": {
    "genes": [
      "DRD2",
      "RYR1",
      "AHR",
      "CYP1A1",
      "SPECC1L",
      "ADORA2A",
      "CYP2E1",
      "ACTR3B",
      "CYP3A4",
      "ADORA1",
      "CACNA1S",
      "NAT2",
      "CYP2A6",
      "CYP1A2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs762551",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": "Myocardial Infarction"
      },
      {
        "variant": "rs2069514",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs186983396",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs762551",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": "Insomnia"
      },
      {
        "variant": "rs3761422",
        "gene": "ADORA2A",
        "level": "3",
        "phenotypes": "Anxiety Disorders"
      },
      {
        "variant": "rs5751876",
        "gene": "ADORA2A",
        "level": "3",
        "phenotypes": "Anxiety Disorders"
      },
      {
        "variant": "rs2298383",
        "gene": "ADORA2A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs762551",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs762551",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": "Abortion, Spontaneous"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "disulfiram": {
    "genes": [
      "DRD2",
      "ADRA1A",
      "MTHFR",
      "OPRD1",
      "SLC6A3",
      "SLC6A4",
      "TPH2",
      "ANKK1",
      "DBH",
      "ALDH2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2283265",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs1800497",
        "gene": "ANKK1",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs28363170",
        "gene": "SLC6A3",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      },
      {
        "variant": "rs678849",
        "gene": "OPRD1",
        "level": "3",
        "phenotypes": "Cocaine dependence"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "methamphetamine": {
    "genes": [
      "DRD2",
      "DTNBP1",
      "HTR1A",
      "CYP2D6",
      "OPRM1",
      "NRG1",
      "BDNF",
      "SLC6A9",
      "ARRB2",
      "ANKS1B",
      "GRIN1",
      "AKT1",
      "DAOA",
      "ANKK1",
      "FAAH",
      "DRD4",
      "CSNK1E",
      "PICK1",
      "DRD3",
      "GAD2",
      "COMT",
      "ESR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2619538",
        "gene": "DTNBP1",
        "level": "3",
        "phenotypes": "Psychotic Disorder"
      },
      {
        "variant": "rs2076369",
        "gene": "PICK1",
        "level": "3",
        "phenotypes": "Psychotic Disorder,Substance-Related Disorders"
      },
      {
        "variant": "rs3213207",
        "gene": "DTNBP1",
        "level": "3",
        "phenotypes": "Psychotic Disorder"
      },
      {
        "variant": "rs1126442",
        "gene": "GRIN1",
        "level": "3",
        "phenotypes": "Psychotic Disorder"
      },
      {
        "variant": "rs1045280",
        "gene": "ARRB2",
        "level": "3",
        "phenotypes": "Substance-Related Disorders"
      },
      {
        "variant": "rs778293",
        "gene": "DAOA",
        "level": "3",
        "phenotypes": "Psychotic Disorder"
      },
      {
        "variant": "rs878567",
        "gene": "HTR1A",
        "level": "3",
        "phenotypes": "Substance-Related Disorders"
      },
      {
        "variant": "rs2036657",
        "gene": "ARRB2",
        "level": "3",
        "phenotypes": "Substance-Related Disorders"
      },
      {
        "variant": "rs713729",
        "gene": "PICK1",
        "level": "3",
        "phenotypes": "Substance-Related Disorders"
      },
      {
        "variant": "rs6280",
        "gene": "DRD3",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs2234693",
        "gene": "ESR1",
        "level": "3",
        "phenotypes": "Psychotic Disorder"
      },
      {
        "variant": "rs4790694",
        "gene": "ARRB2",
        "level": "3",
        "phenotypes": "Substance-Related Disorders"
      },
      {
        "variant": "rs2075572",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Methamphetamine dependence"
      },
      {
        "variant": "rs6265",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": "Methamphetamine dependence"
      },
      {
        "variant": "rs2133896",
        "gene": "ANKS1B",
        "level": "3",
        "phenotypes": "Methamphetamine dependence"
      },
      {
        "variant": "rs324420",
        "gene": "FAAH",
        "level": "3",
        "phenotypes": "Substance-Related Disorders"
      },
      {
        "variant": "rs6265",
        "gene": "BDNF",
        "level": "4",
        "phenotypes": "Substance-Related Disorders"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "naltrexone": {
    "genes": [
      "DRD2",
      "OPRD1",
      "GRIK1-AS2",
      "OPRM1",
      "GRIK1",
      "ADH1B",
      "OPRK1",
      "ANKK1",
      "DBH",
      "AKR1C4",
      "COMT",
      "ADH1C",
      "ALDH2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4654327",
        "gene": "OPRD1",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs1611115",
        "gene": "DBH",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs1800497",
        "gene": "ANKK1,DRD2",
        "level": "3",
        "phenotypes": "Obesity"
      },
      {
        "variant": "rs12749274",
        "gene": "",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs698",
        "gene": "ADH1C",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs2066702",
        "gene": "ADH1B",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs671",
        "gene": "ALDH2",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs17134592",
        "gene": "AKR1C4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3829125",
        "gene": "AKR1C4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "4",
        "phenotypes": "Alcohol abuse,Amplification of sexual behavior,Tobacco Use Disorder"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of alfentanil, buprenorphine, codeine, fentanyl, hydrocodone, hydromorphone, levomethadone, naltrexone, remifentanil, sufentanil or tramadol based on OPRM1 or COMT genotypes.\n",
      "source": "CPIC"
    }
  },
  "oxycodone": {
    "genes": [
      "DRD2",
      "ABCB1",
      "CYP2D6",
      "OPRD1",
      "OPRM1",
      "CYP2C19",
      "OPRK1",
      "KCNJ6",
      "RHBDF2",
      "UGT2B7",
      "FAAH",
      "MACROD2",
      "CYP3A4",
      "SEPTIN3",
      "CYP3A5",
      "WBP2NL",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7",
        "gene": "CYP2D6",
        "level": "2A",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs12948783",
        "gene": "RHBDF2",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs7439366",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs581111",
        "gene": "OPRD1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6848893",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2D6*1, CYP2D6*3, CYP2D6*4",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs62436463",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "adverse events"
      },
      {
        "variant": "rs739296",
        "gene": "SEPTIN3,WBP2NL",
        "level": "3",
        "phenotypes": "adverse events"
      },
      {
        "variant": "CYP3A4*1, CYP3A4*2, CYP3A4*3, CYP3A4*4, CYP3A4*5, CYP3A4*6, CYP3A4*7, CYP3A4*8, CYP3A4*9, CYP3A4*10, CYP3A4*11, CYP3A4*12, CYP3A4*13, CYP3A4*14, CYP3A4*15, CYP3A4*16, CYP3A4*17, CYP3A4*18, CYP3A4*19, CYP3A4*20, CYP3A4*21, CYP3A4*22, CYP3A4*23, CYP3A4*24, CYP3A4*26, CYP3A4*28, CYP3A4*29, CYP3A4*30, CYP3A4*31, CYP3A4*32, CYP3A4*33, CYP3A4*34",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Pain,Pain, Postoperative"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Erythema"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Vomiting"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Erythema"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6",
        "gene": "CYP2D6",
        "level": "4",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "4",
        "phenotypes": "adverse events,Constipation,Delirium,Nausea,Pruritus,Somnolence,Urinary Retention"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "4",
        "phenotypes": "adverse events,Constipation,Delirium,Nausea,Pruritus,Somnolence,Urinary Retention"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6",
        "gene": "CYP2D6",
        "level": "4",
        "phenotypes": "CNS depression,Drug Toxicity"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for oxycodone and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of methadone or oxycodone based on CYP2D6, OPRM1 or COMT genotypes.\n",
      "source": "CPIC"
    }
  },
  "perphenazine": {
    "genes": [
      "DRD2",
      "RGS4",
      "CYP2D6",
      "MCPH1",
      "RELN",
      "PRKCE",
      "MAML3",
      "CDH13",
      "SKOR2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2842030",
        "gene": "RGS4",
        "level": "3",
        "phenotypes": "Schizophrenia"
      },
      {
        "variant": "rs951439",
        "gene": "RGS4",
        "level": "3",
        "phenotypes": "Schizophrenia"
      }
    ],
    "fdaLabels": [
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for perphenazine and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for perphenazine"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for perphenazine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "opioids": {
    "genes": [
      "DRD2",
      "IL6",
      "ABCB1",
      "HTR1A",
      "GNAZ",
      "GNB3",
      "STAT6",
      "CYP2B6",
      "CYP2D6",
      "HTR3E",
      "ADRA2A",
      "OPRD1",
      "PDYN",
      "PDE3A",
      "OPRM1",
      "CYP2C19",
      "CLCC1",
      "SCN9A",
      "BDNF",
      "TXNRD2",
      "TNFRSF1B",
      "OPRK1",
      "GAL",
      "KCNJ6",
      "ARRB2",
      "RSPH14",
      "ENPP2",
      "TACR3",
      "ZNF165",
      "GPR98",
      "HNF1A",
      "MUC16",
      "MCOLN1",
      "RHBDF2",
      "HTR2A",
      "BDNF-AS",
      "CNIH3",
      "UGT2B7",
      "TGFB2",
      "EXOC4",
      "CNR1",
      "ZNF804A",
      "KAT2B",
      "HTR3D",
      "RGS19",
      "ANKK1",
      "GCH1",
      "TACR1",
      "CRYBG2",
      "FAAH",
      "CYP2A7P1",
      "CYP3A4",
      "SLCO1A2",
      "TH",
      "TLR5",
      "DBH",
      "HRH1",
      "GABRB3",
      "HINT1",
      "TNF",
      "MC1R",
      "HTR3A",
      "POM121L2",
      "OPRL1",
      "HTR4",
      "GABBR2",
      "HTR3C",
      "IL2",
      "CYP3A5",
      "IL1B",
      "TAOK3",
      "SLCO1B1",
      "SLC18A2",
      "IL17A",
      "GRK3",
      "ZNF568",
      "DRD3",
      "HTR3B",
      "LKAAEAR1",
      "CYP1A2",
      "ZSCAN25",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12948783",
        "gene": "RHBDF2",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs4633",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs6269",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs4818",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs2236861",
        "gene": "OPRD1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs948854",
        "gene": "GAL",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs9479757",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs6305",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1611115",
        "gene": "DBH",
        "level": "3",
        "phenotypes": "Substance Withdrawal Syndrome"
      },
      {
        "variant": "rs6265",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6275",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs2295632",
        "gene": "FAAH",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1611131",
        "gene": "DBH",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs6090041",
        "gene": "OPRL1,RGS19",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs6090043",
        "gene": "LKAAEAR1,OPRL1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Substance Withdrawal Syndrome"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2275913",
        "gene": "IL17A",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs3778156",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs609148",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs548646",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs648893",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Cardiac Arrest,Overdose,Respiratory Insufficiency"
      },
      {
        "variant": "rs1800497",
        "gene": "ANKK1,DRD2",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs3823010",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs524731",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs511435",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs9829896",
        "gene": "KAT2B",
        "level": "3",
        "phenotypes": "Substance-Related Disorders"
      },
      {
        "variant": "rs1277441",
        "gene": "TAOK3",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs1277441",
        "gene": "TAOK3",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs795484",
        "gene": "TAOK3",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs795484",
        "gene": "TAOK3",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Pain,Pain, Postoperative"
      },
      {
        "variant": "rs1076560",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs114077267",
        "gene": "MCOLN1",
        "level": "3",
        "phenotypes": "Overdose"
      },
      {
        "variant": "rs115208233",
        "gene": "MCOLN1",
        "level": "3",
        "phenotypes": "Overdose"
      },
      {
        "variant": "rs116181528",
        "gene": "MCOLN1",
        "level": "3",
        "phenotypes": "Overdose"
      },
      {
        "variant": "rs910080",
        "gene": "PDYN",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs1997794",
        "gene": "PDYN",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs1022563",
        "gene": "PDYN",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs4633",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Dizziness"
      },
      {
        "variant": "rs4633",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Physiological sexual disorder"
      },
      {
        "variant": "rs2366929",
        "gene": "ADGRV1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs10457090",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs589046",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs36024412",
        "gene": "CRYBG2",
        "level": "3",
        "phenotypes": "Nausea,Vomiting"
      },
      {
        "variant": "rs168107",
        "gene": "CLCC1",
        "level": "3",
        "phenotypes": "Nausea,Vomiting"
      },
      {
        "variant": "rs41269255",
        "gene": "POM121L2",
        "level": "3",
        "phenotypes": "Nausea,Vomiting"
      },
      {
        "variant": "rs9393888",
        "gene": "ZNF165",
        "level": "3",
        "phenotypes": "Nausea,Vomiting"
      },
      {
        "variant": "rs11882256",
        "gene": "MUC16",
        "level": "3",
        "phenotypes": "Nausea,Vomiting"
      },
      {
        "variant": "rs12305038",
        "gene": "PDE3A",
        "level": "3",
        "phenotypes": "Nausea,Vomiting"
      },
      {
        "variant": "rs10405238",
        "gene": "ZNF568",
        "level": "3",
        "phenotypes": "Nausea,Vomiting"
      },
      {
        "variant": "rs2070762",
        "gene": "TH",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs10770141",
        "gene": "TH",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs10770140",
        "gene": "TH",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Hyperalgesia"
      },
      {
        "variant": "rs9282564",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Death,Opioid-Related Disorders"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Death,Opioid-Related Disorders"
      },
      {
        "variant": "rs495491",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "adverse events,Nausea,Vomiting"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Pain,Pain, Postoperative"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Pain,Pain, Postoperative"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Sleep Disorders"
      },
      {
        "variant": "rs6517442",
        "gene": "KCNJ6",
        "level": "3",
        "phenotypes": "Low Back Pain"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Low Back Pain"
      },
      {
        "variant": "rs11030096",
        "gene": "BDNF-AS",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs4906902",
        "gene": "GABRB3",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs1079596",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs1125394",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs9288993",
        "gene": "DRD3",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs735668",
        "gene": "TACR1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs7597593",
        "gene": "ZNF804A",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs2023239",
        "gene": "CNR1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs510769",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs6928499",
        "gene": "CNR1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs3745274",
        "gene": "CYP2A7P1,CYP2B6",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs6280",
        "gene": "DRD3",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs1065852",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs718656",
        "gene": "EXOC4",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs1384401",
        "gene": "TACR3",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs4530637",
        "gene": "",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs10799590",
        "gene": "CNIH3",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs997917",
        "gene": "OPRK1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs2952768",
        "gene": "",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5,ZSCAN25",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs2069514",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs324029",
        "gene": "DRD3",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs15524",
        "gene": "CYP3A5,ZSCAN25",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs2654754",
        "gene": "DRD3",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs2740574",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs1799972",
        "gene": "OPRM1",
        "level": "4",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "4",
        "phenotypes": "Substance-Related Disorders"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "4",
        "phenotypes": "Opioid-Related Disorders"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "heroin": {
    "genes": [
      "DRD2",
      "GRM3",
      "OPRD1",
      "OPRM1",
      "BDNF",
      "SLC6A3",
      "OPRK1",
      "GAL",
      "ANKS1B",
      "DDC",
      "BDNF-AS",
      "SOD2",
      "CES1",
      "ANKK1",
      "XPC",
      "TH",
      "DBH",
      "CSNK1E",
      "DRD3",
      "HTR3B",
      "ALDH2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs274618",
        "gene": "GRM3",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs1990040",
        "gene": "GRM3",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs13242038",
        "gene": "GRM3",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs724226",
        "gene": "GRM3",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs2189814",
        "gene": "GRM3",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs274622",
        "gene": "GRM3",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs5746136",
        "gene": "SOD2",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs62638690",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Cocaine dependence,Heroin Dependence"
      },
      {
        "variant": "rs2075572",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs9479757",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs1051660",
        "gene": "OPRK1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs694066",
        "gene": "GAL",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs3758987",
        "gene": "HTR3B",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs6473797",
        "gene": "OPRK1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs1534891",
        "gene": "CSNK1E",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs9479757",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs2298897",
        "gene": "OPRD1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs2236855",
        "gene": "OPRD1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs3778150",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs9384169",
        "gene": "",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs562859",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs3823010",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs9478495",
        "gene": "",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs524731",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs511435",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Heroin Dependence,Opioid-Related Disorders"
      },
      {
        "variant": "rs508448",
        "gene": "OPRD1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs3778151",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs16917234",
        "gene": "BDNF,BDNF-AS",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs4654327",
        "gene": "OPRD1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs12364283",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs2133896",
        "gene": "ANKS1B",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs495491",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs2236857",
        "gene": "OPRD1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs510769",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs3766951",
        "gene": "OPRD1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs671",
        "gene": "ALDH2",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs71647871",
        "gene": "CES1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1611114",
        "gene": "DBH",
        "level": "3",
        "phenotypes": "Heroin Dependence,Memory impairment"
      },
      {
        "variant": "rs2236861",
        "gene": "OPRD1",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs2758339",
        "gene": "SOD2",
        "level": "3",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "4",
        "phenotypes": "Heroin Dependence"
      },
      {
        "variant": "rs6265",
        "gene": "BDNF",
        "level": "4",
        "phenotypes": "Substance-Related Disorders"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "telbivudine": {
    "genes": [
      "RRM2B",
      "TK2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ranibizumab": {
    "genes": [
      "SCARB1",
      "BAD",
      "KDR",
      "SYN3",
      "FHIT",
      "LRP5",
      "C2",
      "MAPK14",
      "C3",
      "ANO2",
      "CCT3",
      "ARMS2",
      "FZD4",
      "HTRA1",
      "CFI",
      "VEGFA",
      "INHBA",
      "APOE",
      "SERPINF1",
      "SKIC2",
      "RGS5",
      "CFB",
      "IL8",
      "YBX1",
      "NRP1",
      "FLT1",
      "CFH",
      "EPAS1",
      "CRHR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs3025000",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Macular Degeneration"
      },
      {
        "variant": "rs2010963",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Choroidal Neovascularization"
      },
      {
        "variant": "rs2070296",
        "gene": "NRP1",
        "level": "3",
        "phenotypes": "Macular Degeneration"
      },
      {
        "variant": "rs833069",
        "gene": "VEGFA",
        "level": "4",
        "phenotypes": "Macular Degeneration"
      },
      {
        "variant": "rs699947",
        "gene": "VEGFA",
        "level": "4",
        "phenotypes": "Macular Degeneration"
      },
      {
        "variant": "rs11200638",
        "gene": "HTRA1",
        "level": "4",
        "phenotypes": "Macular Degeneration"
      },
      {
        "variant": "rs1061170",
        "gene": "CFH",
        "level": "4",
        "phenotypes": "Macular Degeneration"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "beta blocking agents": {
    "genes": [
      "CSK",
      "ADRB1",
      "ZNF652",
      "GNB3",
      "PPARA",
      "CYP2D6",
      "MTHFR",
      "CLCN6",
      "USP5",
      "SH2B3",
      "PLCD3",
      "ADRB2",
      "PRKCA",
      "GRK5",
      "ACBD4",
      "ADRA2C",
      "CYP4A11",
      "ACE",
      "CABCOCO1",
      "KL",
      "NOS3",
      "FGF5"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4253778",
        "gene": "PPARA",
        "level": "3",
        "phenotypes": "Coronary Disease"
      },
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Headache Disorders,Migraine with Aura,Migraine without Aura"
      },
      {
        "variant": "rs2230345",
        "gene": "GRK5",
        "level": "3",
        "phenotypes": "Heart Diseases"
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs5443",
        "gene": "GNB3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs1801252",
        "gene": "ADRB1",
        "level": "3",
        "phenotypes": "Major Adverse Cardiac Events (MACE)"
      },
      {
        "variant": "rs36217263",
        "gene": "KL",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs28404156",
        "gene": "BST1",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1801253",
        "gene": "ADRB1",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs139945292",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs139945292",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs61767072",
        "gene": "ADRA2C",
        "level": "3",
        "phenotypes": "Cardiomyopathy, Dilated,Death"
      },
      {
        "variant": "rs10787959",
        "gene": "GRK5",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs3740563",
        "gene": "GRK5",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs11198893",
        "gene": "GRK5",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs4752292",
        "gene": "GRK5",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs1801253",
        "gene": "ADRB1",
        "level": "4",
        "phenotypes": "Cardiomyopathy, Dilated,Heart Failure"
      },
      {
        "variant": "rs2230345",
        "gene": "GRK5",
        "level": "4",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "4",
        "phenotypes": "Cardiomyopathy, Dilated,Heart Failure"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "diltiazem": {
    "genes": [
      "CSK",
      "ADRB1",
      "NEDD4L",
      "ZNF652",
      "MTHFR",
      "CLCN6",
      "SH2B3",
      "PLCD3",
      "SLCO1B1",
      "CABCOCO1",
      "FGF5"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12946454",
        "gene": "PLCD3",
        "level": "3",
        "phenotypes": "Hypertension"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "repaglinide": {
    "genes": [
      "PAX4",
      "NEUROD1",
      "SLC30A8",
      "NR1I2",
      "TCF7L2",
      "KCNJ11",
      "IGF2BP2",
      "CYP3A4",
      "CYP2C8",
      "NOS1AP",
      "SLCO1B1",
      "KCNQ1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2306283",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs290487",
        "gene": "TCF7L2",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs10509681",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11572080",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1801262",
        "gene": "NEUROD1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "rs114202595",
        "gene": "PAX4",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "rs2237895",
        "gene": "KCNQ1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs2237892",
        "gene": "KCNQ1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs13266634",
        "gene": "SLC30A8",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs2276706",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3814058",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10494366",
        "gene": "NOS1AP",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs4402960",
        "gene": "IGF2BP2",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs1470579",
        "gene": "IGF2BP2",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs5219",
        "gene": "KCNJ11",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "SLCO1B1*1, SLCO1B1*5, SLCO1B1*15, SLCO1B1*37",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "exemestane": {
    "genes": [
      "PRKG1",
      "AKR7A2",
      "DLGAP1",
      "MAP4K4",
      "CYP1A1",
      "TUBB1",
      "SLC37A1",
      "DGKI",
      "ESR2",
      "CCDC148",
      "AKR1C3",
      "FLT3",
      "PPP1R14C",
      "CYP19A1",
      "CYP3A4",
      "DNAH12",
      "PGR",
      "DOCK4",
      "AKR1C4",
      "CYP1B1",
      "CYP4A11",
      "UGT2B17",
      "TCL1A",
      "ESR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs934635",
        "gene": "",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs16964189",
        "gene": "",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs6901146",
        "gene": "",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs9322335",
        "gene": "ESR1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs6493497",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2813543",
        "gene": "ESR1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs62621365",
        "gene": "AKR1C3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11253043",
        "gene": "AKR1C4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4550690",
        "gene": "MAP4K4",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs10485828",
        "gene": "TUBB1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs6493497",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs7176005",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "CYP3A4*1, CYP3A4*22",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for exemestane and ESR1, ESR2"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for exemestane and ESR1, ESR2, PGR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "abacavir": {
    "genes": [
      "LSM2",
      "LST1",
      "LTB",
      "HLA-DQB1",
      "ADH1B",
      "ADK",
      "DDX39B",
      "HSPA1L",
      "HLA-B",
      "HCP5",
      "HLA-DRB1",
      "TNF",
      "HSPA1A",
      "LTA",
      "ADH1A",
      "ADH1C"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-B*57:01",
        "gene": "HLA-B",
        "level": "1A",
        "phenotypes": "Drug Hypersensitivity,HIV infectious disease"
      },
      {
        "variant": "rs3093726",
        "gene": "LST1,LTA,LTB",
        "level": "3",
        "phenotypes": "Drug Hypersensitivity"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for abacavir and HLA-B"
      },
      {
        "source": "Swissmedic",
        "level": "Testing Required",
        "name": "Annotation of Swissmedic Label for abacavir and HLA-B"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for abacavir and HLA-B"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for abacavir and HLA-B"
      },
      {
        "source": "PMDA",
        "level": "Informative PGx",
        "name": "Annotation of PMDA Label for abacavir and HLA-B"
      }
    ],
    "guidelines": {
      "advice": "The Socit Francophone d'Histocompatibilit et d'Immunogntique (SFHI) has established national guidelines and requires mandatory HLA testing prior to prescribing abacavir and abacavir is contraindicated in patients where the HLA-B*57:01 is present.\n",
      "source": "RNPGx"
    }
  },
  "antidepressants": {
    "genes": [
      "RAPGEF5",
      "NBEA",
      "ABCB1",
      "HTR1A",
      "FHIT",
      "TPH1",
      "NR3C1",
      "GNB3",
      "CYP2D6",
      "GRIK4",
      "CTNNA3",
      "TGFBR3",
      "OPRM1",
      "CYP2C19",
      "ERICH3",
      "BDNF",
      "METTL21A",
      "MAPK1",
      "FKBP5",
      "GAL",
      "CUX1",
      "MAOA",
      "MTRF1L",
      "NGFR",
      "CREB1",
      "SLC6A4",
      "HTR7",
      "SERPINE1",
      "HTR2A",
      "BDNF-AS",
      "ADCY9",
      "GABRP",
      "PON2",
      "TPH2",
      "NAV2",
      "CRH",
      "RGS17",
      "HTR6",
      "SLC6A2",
      "SLC22A3",
      "ACSS3",
      "RPP30",
      "CHL1",
      "GRIA3",
      "GABRA6",
      "NTRK2",
      "ACE",
      "CYP1A2",
      "CACNA1A",
      "COMT",
      "CRHR1",
      "PARP11"
    ],
    "clinicalVariants": [
      {
        "variant": "rs10879346",
        "gene": "TPH2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2227631",
        "gene": "SERPINE1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs61888800",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": "Depression,Major Depressive Disorder"
      },
      {
        "variant": "rs1799889",
        "gene": "SERPINE1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs3800373",
        "gene": "FKBP5",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs1992647",
        "gene": "GABRA6",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs10036156",
        "gene": "GABRP",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs3761555",
        "gene": "GRIA3",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs3761554",
        "gene": "GRIA3",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs502434",
        "gene": "GRIA3",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs948854",
        "gene": "GAL",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs12800734",
        "gene": "GRIK4",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs2235040",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6295",
        "gene": "HTR1A",
        "level": "3",
        "phenotypes": "Depressive Disorder,Major Depressive Disorder"
      },
      {
        "variant": "rs12082710",
        "gene": "TGFBR3",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Headache Disorders,Migraine with Aura,Migraine without Aura"
      },
      {
        "variant": "rs889895",
        "gene": "CREB1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs28364032",
        "gene": "CRHR1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1360780",
        "gene": "FKBP5",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs6314",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs521093",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs49411",
        "gene": "FHIT",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs766127",
        "gene": "MTRF1L",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs672170",
        "gene": "RGS17",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2299267",
        "gene": "PON2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs10997242",
        "gene": "CTNNA3",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2112460",
        "gene": "CACNA1A",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2831440",
        "gene": "",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs7569963",
        "gene": "CREB1,METTL21A",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs16873129",
        "gene": "RAPGEF5",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4737771",
        "gene": "CRH",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2532560",
        "gene": "PARP11",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs9315310",
        "gene": "NBEA",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2032583",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression,Depressive Disorder,Major Depressive Disorder"
      },
      {
        "variant": "rs1439050",
        "gene": "NTRK2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs6265",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Cardiac Arrest,Overdose,Respiratory Insufficiency"
      },
      {
        "variant": "rs7905446",
        "gene": "HTR7,RPP30",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs4713916",
        "gene": "FKBP5",
        "level": "3",
        "phenotypes": "Depressive Disorder,Mood Disorder"
      },
      {
        "variant": "rs1954787",
        "gene": "GRIK4",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs6313",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "adverse events,Bipolar Disorder,Depression,Major Depressive Disorder"
      },
      {
        "variant": "rs6311",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "adverse events,Bipolar Disorder,Depression,Major Depressive Disorder"
      },
      {
        "variant": "rs7997012",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depression,Major Depressive Disorder"
      },
      {
        "variant": "rs57098334",
        "gene": "SLC6A4",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs11580409",
        "gene": "ERICH3",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2235015",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression,Depressive Disorder,Major Depressive Disorder"
      },
      {
        "variant": "rs5443",
        "gene": "GNB3",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1800532",
        "gene": "TPH1",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs6311",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": "Bipolar Disorder,Depression,Major Depressive Disorder"
      },
      {
        "variant": "rs6313",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": "Bipolar Disorder,Depression,Major Depressive Disorder"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "The French National Network of Pharmacogenetics (Rseau national de pharmacogntique (RNPGx)) recommends CYP2D6 and CYP2C19 genotyping before initiating an antidepressant treatment, especially in patients with a high risk of toxicity.\n",
      "source": "RNPGx"
    }
  },
  "almotriptan": {
    "genes": [
      "IL6",
      "GRIA1",
      "IL1A",
      "TNF",
      "IL1B"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "eletriptan": {
    "genes": [
      "IL6",
      "CYP2D6",
      "GRIA1",
      "IL1A",
      "TNF",
      "IL1B"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for eletriptan and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dipeptidyl peptidase 4 (dpp-4) inhibitors": {
    "genes": [
      "IL6",
      "HLA-DQA1",
      "ABCB1",
      "HLA-DQB1",
      "PNPLA3",
      "CTRB1",
      "CDKAL1",
      "GLP1R",
      "TCF7L2",
      "KCNJ11",
      "PRKD1",
      "CTRB2",
      "NAT2",
      "DPP4",
      "KCNQ1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs7756992",
        "gene": "CDKAL1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "rs7754840",
        "gene": "CDKAL1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tumor necrosis factor alpha (tnf-alpha) inhibitors": {
    "genes": [
      "IL6",
      "IL18",
      "HLA-DQA1",
      "IL2RB",
      "FCGR2B",
      "TAP1",
      "TNFRSF10A",
      "STAT4",
      "PGLYRP4",
      "REL",
      "CTLA4",
      "TLR9",
      "IL9",
      "MAFB",
      "LY96",
      "CST5",
      "MICA",
      "PON1",
      "ALPL",
      "CTNNA2",
      "CCL21",
      "MAP3K1",
      "CD14",
      "TAGAP",
      "IL23R",
      "IL12B",
      "TNFAIP3",
      "FCGR3A",
      "IL1RN",
      "IL5",
      "EYA4",
      "IFNGR2",
      "TNFRSF1B",
      "IL6R",
      "BLK",
      "CD40",
      "KLRC4",
      "SLC12A8",
      "MOB3B",
      "CERS6",
      "IFNGR1",
      "TLR2",
      "CDKAL1",
      "SLCO1C1",
      "PTPN22",
      "PADI4",
      "CSRP3",
      "C9orf72",
      "PTPRC",
      "TRAF1",
      "FBXL19",
      "NLRP3",
      "ZNF816",
      "SH3BP2",
      "TLR4",
      "TLR5",
      "NCR3",
      "GBP6",
      "TNF",
      "CD28",
      "FCGR2A",
      "IL17RA",
      "PRKCQ",
      "HLA-C",
      "IL2RA",
      "CNPY4",
      "GAPDHP64",
      "IL2",
      "PRDM1",
      "IL1B",
      "CNTN5",
      "CHUK",
      "IL17A",
      "TNFRSF1A",
      "ARAP2",
      "IFNG",
      "TBX21",
      "JAK2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs983332",
        "gene": "CSRP3",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs437943",
        "gene": "ARAP2",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs6138150",
        "gene": "CST5",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs6028945",
        "gene": "MAFB",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs6071980",
        "gene": "MAFB",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs868856",
        "gene": "MOB3B",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs774359",
        "gene": "C9orf72",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs3849942",
        "gene": "C9orf72",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs2814707",
        "gene": "MOB3B",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs928655",
        "gene": "GBP6",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs10919563",
        "gene": "PTPRC",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs7046653",
        "gene": "MOB3B",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs20575",
        "gene": "TNFRSF10A",
        "level": "3",
        "phenotypes": "Arthritis"
      },
      {
        "variant": "rs4848306",
        "gene": "IL1B",
        "level": "3",
        "phenotypes": "Inflammatory Bowel Diseases,Ulcerative Colitis"
      },
      {
        "variant": "rs4251961",
        "gene": "IL1RN",
        "level": "3",
        "phenotypes": "Ulcerative Colitis"
      },
      {
        "variant": "rs352139",
        "gene": "TLR9",
        "level": "3",
        "phenotypes": "Crohn Disease,Inflammatory Bowel Diseases"
      },
      {
        "variant": "rs4696480",
        "gene": "TLR2",
        "level": "3",
        "phenotypes": "Ulcerative Colitis"
      },
      {
        "variant": "rs1816702",
        "gene": "TLR2",
        "level": "3",
        "phenotypes": "Crohn Disease"
      },
      {
        "variant": "rs3804099",
        "gene": "TLR2",
        "level": "3",
        "phenotypes": "Inflammatory Bowel Diseases"
      },
      {
        "variant": "rs2569190",
        "gene": "CD14",
        "level": "3",
        "phenotypes": "Ulcerative Colitis"
      },
      {
        "variant": "rs2275913",
        "gene": "IL17A",
        "level": "3",
        "phenotypes": "Inflammatory Bowel Diseases,Ulcerative Colitis"
      },
      {
        "variant": "rs6927172",
        "gene": "TNFAIP3",
        "level": "3",
        "phenotypes": "Inflammatory Bowel Diseases,Ulcerative Colitis"
      },
      {
        "variant": "rs10499563",
        "gene": "IL6",
        "level": "3",
        "phenotypes": "Inflammatory Bowel Diseases,Ulcerative Colitis"
      },
      {
        "variant": "rs5030728",
        "gene": "TLR4",
        "level": "3",
        "phenotypes": "Inflammatory Bowel Diseases"
      },
      {
        "variant": "rs1554973",
        "gene": "CNPY4",
        "level": "3",
        "phenotypes": "Inflammatory Bowel Diseases"
      },
      {
        "variant": "rs4149570",
        "gene": "TNFRSF1A",
        "level": "3",
        "phenotypes": "Crohn Disease,Inflammatory Bowel Diseases"
      },
      {
        "variant": "rs2430561",
        "gene": "IFNG",
        "level": "3",
        "phenotypes": "Crohn Disease,Inflammatory Bowel Diseases"
      },
      {
        "variant": "rs3761847",
        "gene": "TRAF1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1799964",
        "gene": "TNF",
        "level": "3",
        "phenotypes": "Spondylitis, Ankylosing"
      },
      {
        "variant": "rs3397",
        "gene": "TNFRSF1B",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1061631",
        "gene": "TNFRSF1B",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs767455",
        "gene": "TNFRSF1A",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1061622",
        "gene": "TNFRSF1B",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs10945919",
        "gene": "",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs13393173",
        "gene": "CERS6",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs854547",
        "gene": "PON1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs854548",
        "gene": "PON1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs854555",
        "gene": "PON1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs11209026",
        "gene": "IL23R",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs3087243",
        "gene": "CTLA4",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs651630",
        "gene": "SLC12A8",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs10782001",
        "gene": "FBXL19",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs2916205",
        "gene": "PGLYRP4",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs11126740",
        "gene": "CTNNA2",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs96844",
        "gene": "MAP3K1",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs2546890",
        "gene": "IL12B",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs6908425",
        "gene": "CDKAL1",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs12191877",
        "gene": "HLA-C",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs9304742",
        "gene": "ZNF816",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs4819554",
        "gene": "IL17RA",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs11938228",
        "gene": "TLR2",
        "level": "3",
        "phenotypes": "Inflammatory Bowel Diseases,Psoriasis"
      },
      {
        "variant": "rs1143627",
        "gene": "IL1B",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs1143623",
        "gene": "IL1B",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs352139",
        "gene": "TLR9",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs4696480",
        "gene": "TLR2",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs11465996",
        "gene": "LY96",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs1800795",
        "gene": "IL6",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs610604",
        "gene": "TNFAIP3",
        "level": "3",
        "phenotypes": "Arthritis, Psoriatic,Psoriasis"
      },
      {
        "variant": "rs6920220",
        "gene": "SH3BP2,TNFAIP3",
        "level": "3",
        "phenotypes": "Arthritis, Psoriatic,Psoriasis"
      },
      {
        "variant": "rs3794271",
        "gene": "SLCO1C1",
        "level": "3",
        "phenotypes": "Arthritis, Psoriatic,Rheumatoid arthritis"
      },
      {
        "variant": "rs1800629",
        "gene": "TNF",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1051792",
        "gene": "MICA",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "HLA-DQA1*05",
        "gene": "HLA-DQA1",
        "level": "3",
        "phenotypes": "Inflammatory Bowel Diseases"
      },
      {
        "variant": "rs1799724",
        "gene": "TNF",
        "level": "4",
        "phenotypes": "Crohn Disease,Psoriasis,Rheumatoid arthritis,Spondylitis, Ankylosing"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "frovatriptan": {
    "genes": [
      "IL6",
      "GRIA1",
      "IL1A",
      "TNF",
      "IL1B"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tocilizumab": {
    "genes": [
      "IL6",
      "FCGR3A",
      "IL6R",
      "GALNT18",
      "KCNMB1",
      "CD69",
      "CLEC2D",
      "HLA-DRB1",
      "FCGR2A"
    ],
    "clinicalVariants": [
      {
        "variant": "rs11052877",
        "gene": "CD69",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs4910008",
        "gene": "GALNT18",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs12083537",
        "gene": "IL6R",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs11265618",
        "gene": "IL6R",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs396991",
        "gene": "FCGR3A",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs4329505",
        "gene": "IL6R",
        "level": "4",
        "phenotypes": "Rheumatoid arthritis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vildagliptin": {
    "genes": [
      "IL6",
      "WFS1",
      "CTRB1",
      "GLP1R",
      "GIPR",
      "TCF7L2",
      "KCNJ11",
      "PRKD1",
      "CTRB2",
      "DPP4",
      "KCNQ1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs6923761",
        "gene": "GLP1R",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs7202877",
        "gene": "CTRB1,CTRB2",
        "level": "4",
        "phenotypes": "Diabetes Mellitus, Type 2"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "teneligliptin": {
    "genes": [
      "IL6",
      "FMO3",
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "linagliptin": {
    "genes": [
      "IL6",
      "WFS1",
      "GLP1R",
      "TCF7L2",
      "KCNJ11",
      "PRKD1",
      "DPP4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "alogliptin": {
    "genes": [
      "IL6",
      "PNPLA3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "etanercept": {
    "genes": [
      "IL6",
      "IL2RB",
      "FCGR2B",
      "TNFRSF10A",
      "STAT4",
      "REV3L",
      "REL",
      "CTLA4",
      "TLR9",
      "TGFB1",
      "MACO1",
      "ALPL",
      "CCL21",
      "MAP3K1",
      "TAGAP",
      "IL23R",
      "CR1L",
      "PTTG1",
      "HLA-E",
      "IL12B",
      "TNFAIP3",
      "FCGR3A",
      "ERAP1",
      "KLRC1",
      "EYA4",
      "TNFRSF1B",
      "IL6R",
      "RSRP1",
      "BLK",
      "CD40",
      "PSORS1C1",
      "IL17F",
      "CERS6",
      "SLCO1C1",
      "PTPN22",
      "NFKBIA",
      "PTPRC",
      "PTPN2",
      "KLRD1",
      "ATP5F1E",
      "TRAF1",
      "NLRP3",
      "NFKB1",
      "ZNF816",
      "VDR",
      "SH3BP2",
      "CR1",
      "HLA-B",
      "NCR3",
      "GBP6",
      "HLA-DRB1",
      "NFATC2",
      "TNF",
      "KCNH7",
      "CD28",
      "FCGR2A",
      "LTA",
      "PRKCQ",
      "IL10",
      "IL2RA",
      "GAPDHP64",
      "IL2",
      "PRDM1",
      "TNFRSF1A",
      "CARD8",
      "TRAF3IP2",
      "CD84"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1800629",
        "gene": "TNF",
        "level": "2B",
        "phenotypes": "Arthritis, Psoriatic,Crohn Disease,Inflammation,Psoriasis,Rheumatoid arthritis,Spondylitis, Ankylosing"
      },
      {
        "variant": "rs767455",
        "gene": "TNFRSF1A",
        "level": "3",
        "phenotypes": "Arthritis, Psoriatic"
      },
      {
        "variant": "rs10919563",
        "gene": "PTPRC",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs3761847",
        "gene": "TRAF1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1800795",
        "gene": "IL6",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1059150",
        "gene": "ATP5F1E",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1264457",
        "gene": "HLA-E",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs6427528",
        "gene": "CD84",
        "level": "3",
        "phenotypes": "Psoriasis,Rheumatoid arthritis"
      },
      {
        "variant": "rs2302489",
        "gene": "KLRD1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs7301582",
        "gene": "KLRC1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs396991",
        "gene": "FCGR3A",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs7574865",
        "gene": "STAT4",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs2233945",
        "gene": "PSORS1C1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1061622",
        "gene": "TNFRSF1B",
        "level": "3",
        "phenotypes": "Spondylitis, Ankylosing"
      },
      {
        "variant": "rs1801274",
        "gene": "FCGR2A",
        "level": "4",
        "phenotypes": "Psoriasis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "streptomycin": {
    "genes": [
      "IL6",
      "MT-RNR1",
      "CYP1A1",
      "GSTT1",
      "STAT3",
      "G6PD",
      "HSPA1L",
      "GSTM1",
      "CYP2E1",
      "NAT2",
      "GSTP1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs267606617",
        "gene": "MT-RNR1",
        "level": "1A",
        "phenotypes": "Ototoxicity"
      },
      {
        "variant": "rs267606619",
        "gene": "MT-RNR1",
        "level": "1A",
        "phenotypes": "Ototoxicity"
      },
      {
        "variant": "rs267606618",
        "gene": "MT-RNR1",
        "level": "1A",
        "phenotypes": "Ototoxicity"
      },
      {
        "variant": "rs28358569",
        "gene": "MT-RNR1",
        "level": "3",
        "phenotypes": "Ototoxicity"
      },
      {
        "variant": "rs1556422499",
        "gene": "MT-RNR1",
        "level": "3",
        "phenotypes": "Ototoxicity"
      },
      {
        "variant": "rs28358571",
        "gene": "",
        "level": "3",
        "phenotypes": "Ototoxicity"
      },
      {
        "variant": "GSTM1 non-null, GSTM1 null",
        "gene": "GSTM1",
        "level": "4",
        "phenotypes": "Tuberculosis"
      },
      {
        "variant": "GSTT1 non-null, GSTT1 null",
        "gene": "GSTT1",
        "level": "4",
        "phenotypes": "Tuberculosis"
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for streptomycin"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for streptomycin and MT-RNR1"
      }
    ],
    "guidelines": {
      "advice": "Administration of aminoglycoside antibiotics should be avoided in patients carrying certain MT-RNR1 variants due to the increased risk of developing aminoglycoside-induced hearing loss (AIHL). The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "infliximab": {
    "genes": [
      "IL6",
      "HLA-DQA1",
      "IL2RB",
      "FCGR2B",
      "TNFRSF10A",
      "STAT4",
      "REL",
      "CTLA4",
      "TLR9",
      "TGFB1",
      "MACO1",
      "ALPL",
      "CCL21",
      "TAGAP",
      "IL23R",
      "CR1L",
      "HLA-E",
      "IL12B",
      "HLA-DQB1",
      "FCGR3A",
      "KLRC1",
      "EYA4",
      "TNFRSF1B",
      "IL6R",
      "RSRP1",
      "BLK",
      "CD40",
      "IL17F",
      "CERS6",
      "TLR2",
      "SLCO1C1",
      "MAP3K14",
      "PTPN22",
      "NFKBIA",
      "PTPRC",
      "KLRD1",
      "ATP5F1E",
      "TRAF1",
      "NLRP3",
      "ZNF816",
      "VDR",
      "SH3BP2",
      "CR1",
      "HLA-B",
      "TLR4",
      "NCR3",
      "HLA-DRB1",
      "NFATC2",
      "TNF",
      "HLA-DPB1",
      "CD28",
      "FCGR2A",
      "ADAM17",
      "LTA",
      "PRKCQ",
      "HLA-C",
      "IL2RA",
      "GAPDHP64",
      "IL2",
      "PRDM1",
      "IL1B",
      "TNFRSF1A",
      "CARD8",
      "SLC9A8",
      "IVL"
    ],
    "clinicalVariants": [
      {
        "variant": "rs767455",
        "gene": "TNFRSF1A",
        "level": "3",
        "phenotypes": "Arthritis, Psoriatic"
      },
      {
        "variant": "rs10919563",
        "gene": "PTPRC",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs3761847",
        "gene": "TRAF1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1800795",
        "gene": "IL6",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1801274",
        "gene": "FCGR2A",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs396991",
        "gene": "FCGR3A",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs361525",
        "gene": "TNF",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1059150",
        "gene": "ATP5F1E",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1264457",
        "gene": "HLA-E",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1061622",
        "gene": "TNFRSF1B",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1143634",
        "gene": "IL1B",
        "level": "3",
        "phenotypes": "Crohn Disease"
      },
      {
        "variant": "rs2302489",
        "gene": "KLRD1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs7301582",
        "gene": "KLRC1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs396991",
        "gene": "FCGR3A",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "HLA-B*08:01, HLA-B*39:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug-induced liver injury"
      },
      {
        "variant": "HLA-C*12:03",
        "gene": "HLA-C",
        "level": "3",
        "phenotypes": "Drug-induced liver injury"
      },
      {
        "variant": "HLA-DQB1*02:01",
        "gene": "HLA-DQB1",
        "level": "3",
        "phenotypes": "Drug-induced liver injury"
      },
      {
        "variant": "HLA-DPB1*10:01",
        "gene": "HLA-DPB1",
        "level": "3",
        "phenotypes": "Drug-induced liver injury"
      },
      {
        "variant": "HLA-DRB1*03:01, HLA-DRB1*04:04",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Drug-induced liver injury"
      },
      {
        "variant": "rs2097432",
        "gene": "",
        "level": "3",
        "phenotypes": "Inflammatory Bowel Diseases"
      },
      {
        "variant": "rs1801274",
        "gene": "FCGR2A",
        "level": "4",
        "phenotypes": "Psoriasis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "rasburicase": {
    "genes": [
      "CYB5R3",
      "CYB5R4",
      "G6PD",
      "CYB5R2",
      "CYB5R1"
    ],
    "clinicalVariants": [
      {
        "variant": "G6PD A- 202A_376G, G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham",
        "gene": "G6PD",
        "level": "1A",
        "phenotypes": "Hemolysis,Methemoglobinemia"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for rasburicase and G6PD"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for rasburicase and G6PD"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for rasburicase and CYB5R1, CYB5R2, CYB5R3, CYB5R4"
      },
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for rasburicase and G6PD"
      },
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for rasburicase and G6PD"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for rasburicase and G6PD"
      }
    ],
    "guidelines": {
      "advice": "High risk drugs should be avoided in G6PD deficient patients with or without chronic non-spherocytic hemolytic anemia (CNSHA). In patients with a G6PD variable or indeterminate phenotype an enzyme activity test should be carried out before initiating drug therapy.\nThe G6PD gene is located on the X chromosome. Therefore, some patients will only have one copy, whereas others will have two copies. See full guideline for disclaimers, further details and supporting evidence.\n",
      "source": "CPIC"
    }
  },
  "bupivacaine": {
    "genes": [
      "CYB5R3",
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for bupivacaine and CYB5R3, G6PD"
      },
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for bupivacaine and CYB5R3, G6PD"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for bupivacaine"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sodium nitrite": {
    "genes": [
      "CYB5R3",
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for sodium nitrite and G6PD"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for sodium nitrite and CYB5R3, G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lidocaine / prilocaine": {
    "genes": [
      "CYB5R3",
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for lidocaine / prilocaine and CYB5R3, G6PD"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for lidocaine / prilocaine and CYB5R3, G6PD"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for lidocaine / prilocaine and CYB5R3, G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lidocaine and tetracaine": {
    "genes": [
      "CYB5R3",
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for lidocaine and tetracaine and CYB5R3, G6PD"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for lidocaine and tetracaine and G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "articaine / epinephrine": {
    "genes": [
      "CYB5R3",
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for articaine / epinephrine and CYB5R3, G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "oxymetazoline and tetracaine": {
    "genes": [
      "CYB5R3",
      "G6PD",
      "BCHE"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for oxymetazoline and tetracaine and BCHE, CYB5R3, G6PD"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for oxymetazoline and tetracaine"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for oxymetazoline and tetracaine"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ceftriaxone": {
    "genes": [
      "CYB5R3",
      "ABCB1",
      "G6PD",
      "HLA-A",
      "ABCC2",
      "ABCG2",
      "ABCB11",
      "SLCO1A2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs13120400",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Central Nervous System Infectious Disorder"
      },
      {
        "variant": "rs2273697",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Central Nervous System Infectious Disorder"
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for ceftriaxone"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for ceftriaxone and CYB5R3, G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "chloroprocaine": {
    "genes": [
      "CYB5R3",
      "G6PD",
      "BCHE"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for chloroprocaine and BCHE"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for chloroprocaine and CYB5R3, G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "isosorbide dinitrate": {
    "genes": [
      "CYB5R3",
      "CYB5R4",
      "CYB5R2",
      "CYB5R1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for isosorbide dinitrate and CYB5R1, CYB5R2, CYB5R3, CYB5R4"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "isosorbide mononitrate": {
    "genes": [
      "CYB5R3",
      "CYB5R4",
      "CYB5R2",
      "CYB5R1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for isosorbide mononitrate and CYB5R1, CYB5R2, CYB5R3, CYB5R4"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "primaquine": {
    "genes": [
      "CYB5R3",
      "CYP2D6",
      "CYB5R4",
      "G6PD",
      "CYB5R2",
      "MAOA",
      "SLCO2B1",
      "CYB5R1",
      "IKBKG"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1050828",
        "gene": "G6PD,IKBKG",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for primaquine and CYB5R1, CYB5R2, CYB5R3, CYB5R4, CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for primaquine and G6PD"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for primaquine and CYB5R1, CYB5R2, CYB5R3, CYB5R4"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for primaquine and G6PD"
      }
    ],
    "guidelines": {
      "advice": "Primaquine should be avoided in G6PD deficient patients with or without chronic non-spherocytic hemolytic anemia (CNSHA) in most cases, with some exceptions for G6PD deficient patients without CNSHA. In patients with a G6PD variable or indeterminate phenotype an enzyme activity test should be carried out before initiating drug therapy.\nThe G6PD gene is located on the X chromosome. Therefore, some patients will only have one copy, whereas others will have two copies. See full guideline for disclaimers, further details and supporting evidence.\n",
      "source": "CPIC"
    }
  },
  "ropivacaine": {
    "genes": [
      "CYB5R3",
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for ropivacaine"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for ropivacaine and CYB5R3, G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "regadenoson": {
    "genes": [
      "AMPD1",
      "ADORA2A",
      "ADORA2A-AS1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs17602729",
        "gene": "AMPD1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "folic acid": {
    "genes": [
      "AMPD1",
      "ABCB1",
      "ITPA",
      "MTHFR",
      "MTHFD1",
      "ATIC",
      "MTRR",
      "SHMT1",
      "SLC19A1",
      "MTR",
      "C18orf56",
      "DHFR",
      "TLR4",
      "TYMS"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4986790",
        "gene": "TLR4",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1801394",
        "gene": "MTRR",
        "level": "3",
        "phenotypes": "Migraine with Aura"
      },
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs1805087",
        "gene": "MTR",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for folic acid dosing based on MTHFR rs1801133 genotypes.\n",
      "source": "DPWG"
    }
  },
  "conjugated estrogens": {
    "genes": [
      "SULT1A1",
      "VDR",
      "SLCO1B1",
      "ABCC1",
      "ESR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs9340799",
        "gene": "ESR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1544410",
        "gene": "VDR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1042028",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": "Endometrial Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "desmethylnaproxen": {
    "genes": [
      "SULT1A1",
      "NPIPB8"
    ],
    "clinicalVariants": [
      {
        "variant": "rs765399160",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs28374453",
        "gene": "NPIPB8,SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1042028",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs72547527",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1042008",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs767487725",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs758145522",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs544820732",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs552524124",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tapentadol": {
    "genes": [
      "SULT1A1",
      "OPRM1",
      "NPIPB8",
      "SULT1A3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs767263838",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs757573592",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs776817009",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs762151655",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs750575779",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs553050853",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs751527244",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1293732453",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1328799050",
        "gene": "SULT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs28374453",
        "gene": "NPIPB8,SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1042028",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs72547527",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1042008",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs767487725",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs758145522",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs544820732",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs552524124",
        "gene": "SULT1A1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "interferon alfa-2a, recombinant": {
    "genes": [
      "IL18",
      "TLR7",
      "IDO1",
      "IFNL4",
      "HLA-B",
      "FTO",
      "IFNL3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "interferon alfa-2b, recombinant": {
    "genes": [
      "IL18",
      "ITPA",
      "IFNL4",
      "FTO",
      "IFNL3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "interferons": {
    "genes": [
      "IL18",
      "STAT3",
      "BCL2",
      "IFNL4",
      "VDR",
      "IFNL3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs8099917",
        "gene": "IFNL3",
        "level": "1B",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs1800477",
        "gene": "BCL2",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "rs4796793",
        "gene": "STAT3",
        "level": "3",
        "phenotypes": "Renal Cell Carcinoma"
      },
      {
        "variant": "rs1946518",
        "gene": "IL18",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs187238",
        "gene": "IL18",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "catecholamines": {
    "genes": [
      "ADRB1",
      "SLC22A3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1801253",
        "gene": "ADRB1",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs8187725",
        "gene": "SLC22A3",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nebivolol": {
    "genes": [
      "ADRB1",
      "CYP2D6",
      "CYP2C19",
      "GRK5",
      "ADRA2C",
      "GRK4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for nebivolol and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for nebivolol and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for nebivolol and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of orally administered beta-blockers based on ADRB1, ADRA2C, GRK4 and/or GRK5 genotypes.\n",
      "source": "CPIC"
    }
  },
  "angiotensin ii antagonists": {
    "genes": [
      "ADRB1",
      "CYP2D6",
      "F5",
      "ADRB2",
      "PRKCA",
      "ADRA2C",
      "CYP4A11",
      "MMP16",
      "ACE",
      "NOS3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs1801253",
        "gene": "ADRB1",
        "level": "3",
        "phenotypes": "Heart Failure"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "beta blocking agents, non-selective": {
    "genes": [
      "ADRB1",
      "ADRB2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "beta blocking agents, selective": {
    "genes": [
      "ADRB1",
      "NEDD4L",
      "BST1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "labetalol": {
    "genes": [
      "ADRB1",
      "ABCB1",
      "CYP2D6",
      "CYP2C19",
      "UGT2B7",
      "ADRB2",
      "GRK5",
      "ADRA2C",
      "UGT1A1",
      "GRK4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of carvedilol, labetalol, nadolol, pindolol, propranolol or sotalol based on ADRB2 genotypes.\n",
      "source": "CPIC"
    }
  },
  "bucindolol": {
    "genes": [
      "ADRB1",
      "ADRA2C"
    ],
    "clinicalVariants": [
      {
        "variant": "rs61767072",
        "gene": "ADRA2C",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs1801253",
        "gene": "ADRB1",
        "level": "3",
        "phenotypes": "Heart Failure"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "acebutolol": {
    "genes": [
      "ADRB1",
      "CYP2D6",
      "GRK5",
      "ADRA2C",
      "GRK4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of orally administered beta-blockers based on ADRB1, ADRA2C, GRK4 and/or GRK5 genotypes.\n",
      "source": "CPIC"
    }
  },
  "betaxolol": {
    "genes": [
      "ADRB1",
      "CYP2D6",
      "GRK5",
      "ADRA2C",
      "GRK4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of orally administered beta-blockers based on ADRB1, ADRA2C, GRK4 and/or GRK5 genotypes.\n",
      "source": "CPIC"
    }
  },
  "bisoprolol": {
    "genes": [
      "ADRB1",
      "CYP2D6",
      "GRK5",
      "KCNH2",
      "ACY3",
      "ADRA2C",
      "CYP3A5",
      "GRK4"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12346562",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs2514036",
        "gene": "ACY3",
        "level": "3",
        "phenotypes": "Hypertension"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of orally administered beta-blockers based on ADRB1, ADRA2C, GRK4 and/or GRK5 genotypes.\n",
      "source": "CPIC"
    }
  },
  "digoxin": {
    "genes": [
      "ADRB1",
      "ABCB1",
      "ADRB2",
      "ADRA2C",
      "NOS1AP",
      "CYP4A11",
      "ACE",
      "NOS3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1801253",
        "gene": "ADRB1",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs10494366",
        "gene": "NOS1AP",
        "level": "3",
        "phenotypes": "Shortened QT interval"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dobutamine": {
    "genes": [
      "ADRB1",
      "GNAS"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1801253",
        "gene": "ADRB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs62205366",
        "gene": "GNAS",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "esmolol": {
    "genes": [
      "ADRB1",
      "GRK5",
      "ADRA2C",
      "GRK4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of orally administered beta-blockers based on ADRB1, ADRA2C, GRK4 and/or GRK5 genotypes.\n",
      "source": "CPIC"
    }
  },
  "isoproterenol": {
    "genes": [
      "ADRB1",
      "ADRA1A",
      "ADRA2A",
      "ADRA1B",
      "ADRA2B",
      "ADRB2",
      "ADRA2C",
      "ADRA1D"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nadolol": {
    "genes": [
      "ADRB1",
      "SLCO1A2",
      "ADRB2",
      "GRK5",
      "ADRA2C",
      "SLCO2B1",
      "GRK4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of carvedilol, labetalol, nadolol, pindolol, propranolol or sotalol based on ADRB2 genotypes.\n",
      "source": "CPIC"
    }
  },
  "pindolol": {
    "genes": [
      "ADRB1",
      "CYP2D6",
      "SLC6A4",
      "ADRB2",
      "GRK5",
      "ADRA2C",
      "GRK4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of carvedilol, labetalol, nadolol, pindolol, propranolol or sotalol based on ADRB2 genotypes.\n",
      "source": "CPIC"
    }
  },
  "propranolol": {
    "genes": [
      "ADRB1",
      "ABCB1",
      "HTR1B",
      "CYP2D6",
      "CYP2C19",
      "ADRB2",
      "GRK5",
      "ADRA2C",
      "CYP1A2",
      "COMT",
      "GRK4"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Liver Cirrhosis"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Temporomandibular joint dysfunction syndrome"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*10",
        "gene": "CYP2D6",
        "level": "4",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "No Clinical PGx",
        "name": "Annotation of EMA Label for propranolol and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for propranolol and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for propranolol and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of carvedilol, labetalol, nadolol, pindolol, propranolol or sotalol based on ADRB2 genotypes.\n",
      "source": "CPIC"
    }
  },
  "spironolactone": {
    "genes": [
      "ADRB1",
      "CYP11B2",
      "ADD1",
      "ADRB2",
      "ADRA2C",
      "CYP4A11",
      "ACE",
      "NOS3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs4343",
        "gene": "ACE",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs1126742",
        "gene": "CYP4A11",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs3890011",
        "gene": "CYP4A11",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs4961",
        "gene": "ADD1",
        "level": "3",
        "phenotypes": "Liver Cirrhosis"
      },
      {
        "variant": "rs1801253",
        "gene": "ADRB1",
        "level": "3",
        "phenotypes": "Heart Failure"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sufentanil": {
    "genes": [
      "ADRB1",
      "ABCB1",
      "REL",
      "CYP2D6",
      "OPRM1",
      "IL1RN",
      "IL1A",
      "NFKBIA",
      "NFKB1",
      "CYP3A4",
      "TNF",
      "IL8",
      "IL10",
      "CYP3A5",
      "IL1B",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1323040",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Pain,Pain, Postoperative"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs696",
        "gene": "NFKBIA",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2242480",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2242480",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2242480",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs2242480",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Hypoventilation"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "4",
        "phenotypes": "adverse events,Pain, Postoperative"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of alfentanil, buprenorphine, codeine, fentanyl, hydrocodone, hydromorphone, levomethadone, naltrexone, remifentanil, sufentanil or tramadol based on OPRM1 or COMT genotypes.\n",
      "source": "CPIC"
    }
  },
  "timolol": {
    "genes": [
      "ADRB1",
      "CYP2D6"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs16947",
        "gene": "",
        "level": "3",
        "phenotypes": "Bradycardia"
      },
      {
        "variant": "rs1801252",
        "gene": "ADRB1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for timolol and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "verapamil": {
    "genes": [
      "ADRB1",
      "ABCB1",
      "PCDHB8",
      "ITGAL",
      "PTPRD",
      "NR1H3",
      "PLEKHH2",
      "CACNA1C",
      "KCNMB1",
      "ADD1",
      "CYP3A4",
      "CACNB2",
      "GRK5",
      "KCNIP1",
      "PCDHB6",
      "NOS1AP",
      "CYP3A5",
      "ACE",
      "GRK4"
    ],
    "clinicalVariants": [
      {
        "variant": "rs10918594",
        "gene": "NOS1AP",
        "level": "3",
        "phenotypes": "Acquired Long QT Syndrome (aLQTS)"
      },
      {
        "variant": "rs10494366",
        "gene": "NOS1AP",
        "level": "3",
        "phenotypes": "Acquired Long QT Syndrome (aLQTS)"
      },
      {
        "variant": "rs11739136",
        "gene": "KCNIP1,KCNMB1",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1051375",
        "gene": "CACNA1C",
        "level": "3",
        "phenotypes": "Coronary Artery Disease,Hypertension"
      },
      {
        "variant": "rs2301149",
        "gene": "KCNIP1,KCNMB1",
        "level": "3",
        "phenotypes": "Coronary Artery Disease,Hypertension"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11039149",
        "gene": "NR1H3",
        "level": "3",
        "phenotypes": "Coronary Artery Disease,Hypertension"
      },
      {
        "variant": "rs12221497",
        "gene": "NR1H3",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs2279238",
        "gene": "NR1H3",
        "level": "3",
        "phenotypes": "Coronary Artery Disease,Hypertension"
      },
      {
        "variant": "rs4742610",
        "gene": "PTPRD",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs11124945",
        "gene": "PLEKHH2",
        "level": "3",
        "phenotypes": "Diabetes Mellitus,Hypertension"
      },
      {
        "variant": "rs1024323",
        "gene": "GRK4",
        "level": "3",
        "phenotypes": "Coronary Artery Disease,Hypertension"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "measles vaccines": {
    "genes": [
      "HLA-DQA1",
      "HLA-B",
      "HLA-DRB1",
      "TLR3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs3775291",
        "gene": "TLR3",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "flucloxacillin": {
    "genes": [
      "HLA-DQA1",
      "HLA-DQB1",
      "HLA-A",
      "NR1I2",
      "HLA-DRA",
      "HLA-B",
      "HLA-DRB1",
      "HLA-C",
      "ST6GAL1"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-B*57:01",
        "gene": "HLA-B",
        "level": "1A",
        "phenotypes": "Drug-induced liver injury"
      },
      {
        "variant": "rs3814055",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": "Toxic liver disease"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for flucloxacillin and HLA-B"
      }
    ],
    "guidelines": {
      "advice": "Monitor for liver function and select an alternative drug instead of flucloxacillin if liver enzymes or bilirubin is elevated, for patients that are HLA-B*57:01.\n",
      "source": "DPWG"
    }
  },
  "ustekinumab": {
    "genes": [
      "HLA-DQA1",
      "STAT4",
      "REV3L",
      "IL23R",
      "IL12B",
      "TNFAIP3",
      "ERAP1",
      "TNFRSF1B",
      "IL12A",
      "IL17F",
      "SLC22A4",
      "HTR2A",
      "NFKBIA",
      "C9orf72",
      "IL13",
      "IL23A",
      "ZNF816",
      "TLR5",
      "AGBL4",
      "ADAM33",
      "KCNH7",
      "HLA-C",
      "IL1B",
      "CHUK",
      "TIRAP",
      "CD84"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-C*06:02",
        "gene": "HLA-C",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs3213094",
        "gene": "IL12B",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs8177374",
        "gene": "TIRAP",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs5744174",
        "gene": "TLR5",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs1143627",
        "gene": "IL1B",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs1143623",
        "gene": "IL1B",
        "level": "3",
        "phenotypes": "Psoriasis"
      },
      {
        "variant": "rs610604",
        "gene": "TNFAIP3",
        "level": "4",
        "phenotypes": "Psoriasis"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for ustekinumab and IL12A, IL12B, IL23A"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mepolizumab": {
    "genes": [
      "HLA-DQA1",
      "FIP1L1",
      "PDGFRA",
      "ADRB2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for mepolizumab and FIP1L1, PDGFRA"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "letrozole": {
    "genes": [
      "HLA-DQA1",
      "TNFSF11",
      "ESR2",
      "CCDC148",
      "ZNF613",
      "TNFRSF11A",
      "PPP1R14C",
      "CYP19A1",
      "TNFRSF11B",
      "PGR",
      "CYP2A6",
      "ESR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2234693",
        "gene": "ESR1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs7984870",
        "gene": "TNFSF11",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs2073618",
        "gene": "TNFRSF11B",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs3759811",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Menopause"
      },
      {
        "variant": "rs4775936",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Menopause"
      },
      {
        "variant": "rs749292",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Menopause"
      },
      {
        "variant": "rs700518",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Menopause"
      },
      {
        "variant": "rs1062033",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Menopause"
      },
      {
        "variant": "rs9322335",
        "gene": "ESR1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs4870061",
        "gene": "ESR1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs6493497",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs10140457",
        "gene": "ESR2",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs6493497",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs1008805",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Menopause"
      },
      {
        "variant": "rs2289105",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Menopause"
      },
      {
        "variant": "rs10046",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Menopause"
      },
      {
        "variant": "rs4646",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Menopause"
      },
      {
        "variant": "rs9340799",
        "gene": "ESR1",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35, CYP2A6*46",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      }
    ],
    "fdaLabels": [
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for letrozole and CYP2A6"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for letrozole and ESR1, ESR2, PGR"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for letrozole and ESR1, ESR2, PGR"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for letrozole"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "abiraterone": {
    "genes": [
      "TSPYL1",
      "CYP17A1",
      "AKR1C3",
      "DSE",
      "SRD5A2",
      "YBX1",
      "SLCO2B1",
      "HSD3B1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs523349",
        "gene": "SRD5A2",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      },
      {
        "variant": "rs3828743",
        "gene": "DSE,TSPYL1",
        "level": "3",
        "phenotypes": "Prostatic Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "raloxifene": {
    "genes": [
      "ZNF423",
      "CYP2D6",
      "ESR2",
      "UGT1A8",
      "VDR",
      "UGT1A1",
      "COMT",
      "ESR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs10030044",
        "gene": "",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs8060157",
        "gene": "ZNF423",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs11543791",
        "gene": "ESR1",
        "level": "3",
        "phenotypes": "Menopause,Schizophrenia"
      },
      {
        "variant": "rs1042597",
        "gene": "UGT1A8",
        "level": "3",
        "phenotypes": "Menopause,Schizophrenia"
      },
      {
        "variant": "UGT1A1*1, UGT1A1*28",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "bone density"
      },
      {
        "variant": "UGT1A1*1, UGT1A1*28",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "Osteoporosis"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for raloxifene and ESR1, ESR2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lenalidomide": {
    "genes": [
      "KDR",
      "ABCB1",
      "FGF2",
      "VEGFA",
      "CTNNB1",
      "NCF4",
      "CRBN",
      "GSTP1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4135385",
        "gene": "CTNNB1",
        "level": "3",
        "phenotypes": "Multiple Myeloma"
      },
      {
        "variant": "rs4533622",
        "gene": "CTNNB1",
        "level": "3",
        "phenotypes": "Multiple Myeloma"
      },
      {
        "variant": "rs308395",
        "gene": "FGF2",
        "level": "3",
        "phenotypes": "Multiple Myeloma"
      },
      {
        "variant": "rs2229109",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Multiple Myeloma,Progression-free survival"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for lenalidomide"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for lenalidomide"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for lenalidomide"
      },
      {
        "source": "PMDA",
        "level": "",
        "name": "Annotation of PMDA Label for lenalidomide"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "brivanib": {
    "genes": [
      "KDR",
      "FGFR3P1",
      "FGFR3",
      "FGFR1",
      "FGFR4",
      "FGFR1OP2",
      "FGFR2",
      "FGFRL1",
      "CEP43"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "regorafenib": {
    "genes": [
      "KDR",
      "KRAS",
      "CYP3A4",
      "HLA-B",
      "HLA-C",
      "RORC",
      "IL12RB2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4864950",
        "gene": "KDR",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Informative PGx",
        "name": "Annotation of EMA Label for regorafenib and KRAS"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for regorafenib and KRAS"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for regorafenib and KRAS"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "motesanib": {
    "genes": [
      "KDR",
      "FLT1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vandetanib": {
    "genes": [
      "KDR",
      "CYP3A4",
      "RET"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for vandetanib and RET"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "carfilzomib": {
    "genes": [
      "KDR",
      "VEGFA",
      "TMSB10"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "anlotinib": {
    "genes": [
      "KDR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pranlukast": {
    "genes": [
      "CYSLTR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "montelukast": {
    "genes": [
      "CYSLTR1",
      "UGT1A3",
      "LTA4H",
      "LTC4S",
      "CA10",
      "ABCC9",
      "GALNT17",
      "ALOX5",
      "ADRB2",
      "CYP2C8",
      "SLCO2B1",
      "MLLT3",
      "ABCC1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2115819",
        "gene": "ALOX5",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs2660845",
        "gene": "LTA4H",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs119774",
        "gene": "ABCC1",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs12422149",
        "gene": "SLCO2B1",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs1786929",
        "gene": "",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs967676",
        "gene": "CA10",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs1364805",
        "gene": "",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs7794356",
        "gene": "GALNT17",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs6475448",
        "gene": "MLLT3",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs953977",
        "gene": "",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs730012",
        "gene": "LTC4S",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs7604115",
        "gene": "UGT1A3",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "UGT1A3*1, UGT1A3*2",
        "gene": "UGT1A3",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs704212",
        "gene": "ABCC9",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "CYP2C8*1, CYP2C8*3, CYP2C8*4",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": "Asthma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "levothyroxine": {
    "genes": [
      "DIO1",
      "TBL1X",
      "NOX3",
      "PAX8",
      "MROH2A",
      "DIO2",
      "UGT1A",
      "SLCO1B1",
      "IRS4",
      "TSHB",
      "NKX2-5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for levothyroxine and IRS4, NKX2-5, PAX8, TBL1X, TSHB"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for levothyroxine"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "atorvastatin lactone": {
    "genes": [
      "LPP",
      "CYP3A4",
      "UGT1A1",
      "SLCO1B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "2-hydroxyatorvastatin": {
    "genes": [
      "LPP",
      "UGT1A3",
      "NR3C1",
      "PPARA",
      "CYP3A4",
      "PGRMC2",
      "SLCO1B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "4-hydroxyatorvastatin": {
    "genes": [
      "LPP",
      "UGT1A3",
      "SLCO2B1",
      "SLCO1B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "methotrexate polyglutamate": {
    "genes": [
      "FSTL5",
      "CEP72",
      "ATG16L1",
      "SLCO1B3",
      "IMPDH1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pirtobrutinib": {
    "genes": [
      "IGH",
      "BTK",
      "TP53"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for pirtobrutinib"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for pirtobrutinib and BTK, IGH, TP53"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for pirtobrutinib and BTK"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "curcumin": {
    "genes": [
      "CFTR"
    ],
    "clinicalVariants": [
      {
        "variant": "rs77010898",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "genistein": {
    "genes": [
      "CFTR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "roflumilast": {
    "genes": [
      "CFTR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ivacaftor": {
    "genes": [
      "CFTR",
      "HTR2C",
      "SLC26A9"
    ],
    "clinicalVariants": [
      {
        "variant": "rs397508602",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs1800100",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs1800111",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs77409459",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs35516286",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs186089140",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs75039782",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs1800076",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs80224560",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs397508572",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs397508573",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs121908755",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs74551128",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs397508537",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs113993958",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs77834169",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs75527207",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs78769542",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs186045772",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs397508256",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs75541969",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs121908757",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs368505753",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs115545701",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs11971167",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs193922525",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs121908753",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs121909041",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs267606723",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs397508513",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs78655421",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs121909005",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs121909020",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs202179988",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs121909013",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs397508759",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs397508442",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs141033578",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs150212784",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs121908752",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs74503330",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs80282562",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs397508288",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs77932196",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs7512462",
        "gene": "SLC26A9",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs397508453",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs75527207",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs121909011",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs77010898",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs397508328",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs121909019",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs397508510",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs397508139",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs34911792",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs397508435",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs121909047",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs77010898",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs113993960",
        "gene": "CFTR",
        "level": "4",
        "phenotypes": "Cystic Fibrosis"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for ivacaftor and CFTR"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for ivacaftor and CFTR"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for ivacaftor and CFTR"
      }
    ],
    "guidelines": {
      "advice": "Ivacaftor is suggested for some cystic fibrosis patients with specific CFTR gating mutations, including the R117H or G551D variants.\nNote that the guideline also suggests that ivacaftor should not be used in patients with at least one R117H mutation who are aged under 6 years or aged 12-17 years and with ppFEV1 greater than 90% predicted.\n",
      "source": "CFF"
    }
  },
  "lumacaftor": {
    "genes": [
      "CFTR"
    ],
    "clinicalVariants": [
      {
        "variant": "rs113993960",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs121909047",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ataluren": {
    "genes": [
      "CFTR"
    ],
    "clinicalVariants": [
      {
        "variant": "rs77010898",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs75039782",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs113993959",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ivacaftor / lumacaftor": {
    "genes": [
      "CFTR"
    ],
    "clinicalVariants": [
      {
        "variant": "rs113993960",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs113993960",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs74551128",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs121909011",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for ivacaftor / lumacaftor and CFTR"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for ivacaftor / lumacaftor and CFTR"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for ivacaftor / lumacaftor and CFTR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "latonduine a": {
    "genes": [
      "CFTR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "corr-4a": {
    "genes": [
      "CFTR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nppb": {
    "genes": [
      "CFTR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cavosonstat": {
    "genes": [
      "CFTR"
    ],
    "clinicalVariants": [
      {
        "variant": "rs113993960",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tezacaftor": {
    "genes": [
      "CFTR"
    ],
    "clinicalVariants": [
      {
        "variant": "rs75527207",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ivacaftor / tezacaftor": {
    "genes": [
      "CFTR"
    ],
    "clinicalVariants": [
      {
        "variant": "rs113993960",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for ivacaftor / tezacaftor and CFTR"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for ivacaftor / tezacaftor and CFTR"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for ivacaftor / tezacaftor and CFTR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "elexacaftor": {
    "genes": [
      "CFTR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "elexacaftor / tezacaftor / ivacaftor": {
    "genes": [
      "CFTR",
      "SERPINA1",
      "UGT1A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs121908751",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs35516286",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs186089140",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs75039782",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs1800076",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs80224560",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs397508572",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs397508573",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs36210737",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs77932196",
        "gene": "CFTR",
        "level": "1A",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs121909019",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs75549581",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs121909047",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs121909011",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs80034486",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      },
      {
        "variant": "rs75961395",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for elexacaftor / tezacaftor / ivacaftor and CFTR"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for elexacaftor / tezacaftor / ivacaftor and CFTR"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for elexacaftor / tezacaftor / ivacaftor and CFTR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vanzacaftor / tezacaftor / deutivacaftor": {
    "genes": [
      "CFTR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for vanzacaftor / tezacaftor / deutivacaftor and CFTR"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for vanzacaftor / tezacaftor / deutivacaftor and CFTR"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for vanzacaftor / tezacaftor / deutivacaftor and CFTR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cysteamine": {
    "genes": [
      "CFTR"
    ],
    "clinicalVariants": [
      {
        "variant": "rs113993960",
        "gene": "CFTR",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "asparaginase": {
    "genes": [
      "MIR146A",
      "GATA3",
      "MYBBP1A",
      "MTHFR",
      "CYP1A1",
      "F5",
      "ASNS",
      "TNRC6B",
      "CPA2",
      "MIR423",
      "MIR577",
      "PNPLA3",
      "MIR449B",
      "XRCC1",
      "GEMIN4",
      "GRIA1",
      "SOD2",
      "MIR2053",
      "CCHCR1",
      "XPO5",
      "ATL2",
      "ATF5",
      "SPINK1",
      "C18orf56",
      "RFXAP",
      "MIR1206",
      "MIR1307",
      "HLA-DRB1",
      "NFATC2",
      "MIR3117",
      "TNRC6A",
      "MIR4268",
      "MIR604",
      "AGO1",
      "IL10",
      "IL16",
      "MIR492",
      "MIR300",
      "C5orf22",
      "PYGL",
      "DDX20",
      "MIR618",
      "TYMS",
      "CNOT1",
      "GSTP1",
      "DROSHA"
    ],
    "clinicalVariants": [
      {
        "variant": "rs3824662",
        "gene": "GATA3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs17885382",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs6021191",
        "gene": "NFATC2",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs4880",
        "gene": "SOD2",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs7142143",
        "gene": "PYGL",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs199695765",
        "gene": "CPA2",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia,Pancreatitis"
      },
      {
        "variant": "rs4958381",
        "gene": "GRIA1",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      },
      {
        "variant": "rs738409",
        "gene": "PNPLA3",
        "level": "3",
        "phenotypes": "Acute lymphoblastic leukemia"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "esomeprazole": {
    "genes": [
      "ABCB1",
      "STAT6",
      "CYP2C19"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1059513",
        "gene": "STAT6",
        "level": "3",
        "phenotypes": "eosinophilic esophagitis"
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Gastroesophageal Reflux,Helicobacter Infections"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for esomeprazole and CYP2C19"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for esomeprazole and CYP2C19"
      },
      {
        "source": "EMA",
        "level": "No Clinical PGx",
        "name": "Annotation of EMA Label for esomeprazole and CYP2C19"
      }
    ],
    "guidelines": {
      "advice": "The CPIC Dosing Guideline for CYP2C19 and Proton Pump Inhibitor Dosing states that inconsistent findings regarding the effect of CYP2C19 genotype on the pharmacokinetics and therapeutic response to esomeprazole and rabeprazole preclude making recommendations for these proton pump inhibitors.\n",
      "source": "CPIC"
    }
  },
  "vindesine": {
    "genes": [
      "ABCB1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2229109",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Non-Hodgkin Lymphoma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "atazanavir": {
    "genes": [
      "ABCB1",
      "UGT1A3",
      "CYP2C19",
      "G6PD",
      "ABCC2",
      "TPH2",
      "NR1I2",
      "CYP3A4",
      "SLC22A6",
      "SORCS2",
      "UGT1A1",
      "CYP3A5",
      "SLCO1B1",
      "UGT1A7"
    ],
    "clinicalVariants": [
      {
        "variant": "UGT1A1*1, UGT1A1*6, UGT1A1*28, UGT1A1*36, UGT1A1*37",
        "gene": "UGT1A1",
        "level": "1A",
        "phenotypes": "HIV infectious disease,Hyperbilirubinemia"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1042640",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "HIV infectious disease,Nephrolithiasis"
      },
      {
        "variant": "rs7586110",
        "gene": "UGT1A7",
        "level": "3",
        "phenotypes": "HIV infectious disease,Hyperbilirubinemia"
      },
      {
        "variant": "rs17868323",
        "gene": "UGT1A7",
        "level": "3",
        "phenotypes": "HIV infectious disease,Hyperbilirubinemia"
      },
      {
        "variant": "rs17863778",
        "gene": "UGT1A7",
        "level": "3",
        "phenotypes": "HIV infectious disease,Hyperbilirubinemia"
      },
      {
        "variant": "rs3806596",
        "gene": "UGT1A3",
        "level": "3",
        "phenotypes": "HIV infectious disease,Hyperbilirubinemia"
      },
      {
        "variant": "rs10929303",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "HIV infectious disease,Nephrolithiasis"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs2740574",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2472677",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": "Acquired Immunodeficiency Syndrome,HIV infectious disease,Nephrolithiasis"
      },
      {
        "variant": "rs8330",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "HIV infectious disease,Nephrolithiasis"
      },
      {
        "variant": "rs73208473",
        "gene": "SORCS2",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs887829",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "HIV infectious disease"
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for atazanavir and CYP2C19"
      },
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for atazanavir and CYP2C19"
      },
      {
        "source": "EMA",
        "level": "Informative PGx",
        "name": "Annotation of EMA Label for atazanavir and CYP2C19"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for atazanavir and CYP2C19"
      }
    ],
    "guidelines": {
      "advice": "For patients who are UGT1A1 *28/*28, avoidance of atazanavir is recommended if there is a suitable alternative.\n",
      "source": "DPWG"
    }
  },
  "ezetimibe": {
    "genes": [
      "ABCB1",
      "ABCG5",
      "ABCC2",
      "SLCO1B1",
      "ABCG8"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cannabinoids": {
    "genes": [
      "ABCB1",
      "OPRM1",
      "UGT2B7",
      "KAT2B",
      "FAAH",
      "TRPV1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs324420",
        "gene": "FAAH",
        "level": "3",
        "phenotypes": "Substance-Related Disorders"
      },
      {
        "variant": "rs9829896",
        "gene": "KAT2B",
        "level": "3",
        "phenotypes": "Substance-Related Disorders"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Marijuana Abuse"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "4",
        "phenotypes": "Substance-Related Disorders"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "calcein": {
    "genes": [
      "ABCB1",
      "ABCC2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs8187710",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "desmethylcitalopram": {
    "genes": [
      "ABCB1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "aliskiren": {
    "genes": [
      "ABCB1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "bisantrene": {
    "genes": [
      "ABCB1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "forskolin": {
    "genes": [
      "ABCB1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "talinolol": {
    "genes": [
      "ABCB1",
      "ABCB5",
      "ABCC2",
      "ABCG2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2273697",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "taxanes": {
    "genes": [
      "ABCB1",
      "EGLN3",
      "SCN10A",
      "GSR",
      "CYP4X1",
      "VEGFA",
      "UGT2B7",
      "NR1I2",
      "GSTM1",
      "ATP7B",
      "FLT1",
      "EPAS1",
      "NR1I3",
      "GSTP1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs3594",
        "gene": "GSR",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs1801249",
        "gene": "ATP7B",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs9825762",
        "gene": "SCN10A",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs1061472",
        "gene": "ATP7B",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs6900017",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs9369421",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs879825",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      },
      {
        "variant": "rs9369421",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs74497159",
        "gene": "",
        "level": "3",
        "phenotypes": "Peripheral Nervous System Diseases"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dactinomycin": {
    "genes": [
      "ABCB1",
      "CYP2B6",
      "MTHFR",
      "MTR",
      "C18orf56",
      "TYMS"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "posaconazole": {
    "genes": [
      "ABCB1",
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for posaconazole and CYP3A4"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "paliperidone": {
    "genes": [
      "ABCB1",
      "HTR2C",
      "SH2B1",
      "CYP2D6",
      "MC4R",
      "NFIB",
      "ERBB4",
      "RABEP1",
      "ADCK1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs3888190",
        "gene": "SH2B1",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depressive Disorder,Psychotic Disorder,Schizoaffective disorder"
      },
      {
        "variant": "rs1000940",
        "gene": "RABEP1",
        "level": "3",
        "phenotypes": "Bipolar Disorder,Depressive Disorder,Psychotic Disorder,Schizoaffective disorder"
      },
      {
        "variant": "rs489693",
        "gene": "MC4R",
        "level": "3",
        "phenotypes": "Weight gain"
      },
      {
        "variant": "rs17782313",
        "gene": "MC4R",
        "level": "3",
        "phenotypes": "Weight gain"
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for paliperidone and CYP2D6"
      },
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for paliperidone and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for paliperidone and CYP2D6"
      },
      {
        "source": "EMA",
        "level": "No Clinical PGx",
        "name": "Annotation of EMA Label for paliperidone and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "melatonin receptor agonists": {
    "genes": [
      "ABCB1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "proton pump inhibitors": {
    "genes": [
      "ABCB1",
      "STAT6",
      "CYP2C19",
      "TRPM6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ranolazine": {
    "genes": [
      "ABCB1",
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for ranolazine and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for ranolazine"
      },
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for ranolazine and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for ranolazine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mitotane": {
    "genes": [
      "ABCB1",
      "CYP2B6"
    ],
    "clinicalVariants": [
      {
        "variant": "rs3745274",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "Adrenocortical Carcinoma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "temsirolimus": {
    "genes": [
      "ABCB1",
      "NR1I2",
      "CYP3A5"
    ],
    "clinicalVariants": [
      {
        "variant": "rs3814055",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": "adverse events,Gastrointestinal toxicity,Myelosuppression,Urinary Bladder Neoplasms"
      },
      {
        "variant": "rs6785049",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": "Gastrointestinal toxicity,Myelosuppression,Urinary Bladder Neoplasms"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Hematopoietic stem cell transplantation,Kidney Transplantation,Urinary Bladder Neoplasms"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Urinary Bladder Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dicloxacillin": {
    "genes": [
      "ABCB1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Cystic Fibrosis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "rocuronium": {
    "genes": [
      "ABCB1",
      "RYR1",
      "CYP2D6",
      "IAPP",
      "CYP3A4",
      "SLCO1A2",
      "SLCO1B1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2306283",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3834939",
        "gene": "SLCO1A2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs7967354",
        "gene": "SLCO1A2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11045995",
        "gene": "IAPP,SLCO1A2",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "daptomycin": {
    "genes": [
      "ABCB1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "l-asparagine": {
    "genes": [
      "ABCB1",
      "ASNS",
      "CNOT3",
      "GRIA1",
      "NFATC2",
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "liothyronine": {
    "genes": [
      "ABCB1",
      "HTR1B",
      "FKBP5"
    ],
    "clinicalVariants": [
      {
        "variant": "rs130058",
        "gene": "HTR1B",
        "level": "3",
        "phenotypes": "Depression"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "rifapentine": {
    "genes": [
      "ABCB1",
      "NAT2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "raltegravir": {
    "genes": [
      "ABCB1",
      "UGT1A9",
      "ABCC2",
      "SLCO1A2",
      "HLA-B",
      "SLC22A6",
      "UGT1A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "No Clinical PGx",
        "name": "Annotation of EMA Label for raltegravir and UGT1A1"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for raltegravir and UGT1A1"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for raltegravir and UGT1A1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "celiprolol": {
    "genes": [
      "ABCB1",
      "CYP2D6",
      "SLCO1A2",
      "KCNH2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "rhodamine 123": {
    "genes": [
      "ABCB1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tipifarnib": {
    "genes": [
      "ABCB1",
      "CYP3A4",
      "UGT1A1",
      "CYP3A5"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lumefantrine": {
    "genes": [
      "ABCB1",
      "CYP2B6",
      "ABCC2",
      "CYP3A4",
      "CYP3A5",
      "ZSCAN25"
    ],
    "clinicalVariants": [
      {
        "variant": "rs10264272",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Malaria"
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5,ZSCAN25",
        "level": "3",
        "phenotypes": "Malaria"
      },
      {
        "variant": "rs2740574",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Malaria"
      },
      {
        "variant": "rs41303343",
        "gene": "CYP3A5",
        "level": "4",
        "phenotypes": "Malaria"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "crizotinib": {
    "genes": [
      "ABCB1",
      "MET",
      "ROS1",
      "ALK"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for crizotinib and ALK, ROS1"
      },
      {
        "source": "PMDA",
        "level": "Testing Required",
        "name": "Annotation of PMDA Label for crizotinib and ALK"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for crizotinib and ALK, ROS1"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for crizotinib and ALK, ROS1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vemurafenib": {
    "genes": [
      "ABCB1",
      "NRAS",
      "HRAS",
      "KRAS",
      "CYP3A4",
      "BRAF",
      "CYP1A2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "PMDA",
        "level": "Testing Required",
        "name": "Annotation of PMDA Label for vemurafenib and BRAF"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for vemurafenib and BRAF"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for vemurafenib and HRAS, KRAS, NRAS"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for vemurafenib and BRAF"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for vemurafenib and BRAF"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "boceprevir": {
    "genes": [
      "ABCB1",
      "ITPA",
      "APOH",
      "IFNL4",
      "VDR",
      "SLC28A2",
      "IFNL3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "1A",
        "phenotypes": "Chronic hepatitis C virus infection"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "No Clinical PGx",
        "name": "Annotation of EMA Label for boceprevir and IFNL3"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for boceprevir and IFNL3"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for boceprevir and IFNL3"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "trabectedin": {
    "genes": [
      "ABCB1",
      "ABCC2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "agomelatine": {
    "genes": [
      "ABCB1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cabazitaxel": {
    "genes": [
      "ABCB1",
      "TUBB1",
      "CYP3A4",
      "CYP2C8",
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for cabazitaxel and CYP3A4"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dexlansoprazole": {
    "genes": [
      "ABCB1",
      "CYP2C19"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3",
        "gene": "CYP2C19",
        "level": "1A",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for dexlansoprazole and CYP2C19"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for dexlansoprazole and CYP2C19"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for dexlansoprazole and CYP2C19"
      }
    ],
    "guidelines": {
      "advice": "The CPIC Dosing Guideline recommendations for dexlansoprazole are based on the similarity in its metabolism and lansoprazole and extrapolated from the first-generation PPIs. The guideline recommends to increase the starting daily dose and to monitor efficacy in CYP2C19 ultrarapid metabolizer. For CYP2C19 rapid and normal metabolizers in the treatment of H. pylori infection and erosive esophagitis increasing the dose might be considered after initiation with the standard starting daily dose. The recommendations for intermediate and poor metabolizers for chronic therapy (&gt;12 weeks) and efficacy achieved is to consider 50% reduction in daily dose. See full guideline for further details and supporting evidence.\n",
      "source": "CPIC"
    }
  },
  "bilirubin": {
    "genes": [
      "ABCB1",
      "SLCO1B7",
      "SLCO1B3",
      "SOD2",
      "UGT1A",
      "UGT1A1",
      "SLCO1B1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs11563250",
        "gene": "UGT1A",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "silibinin": {
    "genes": [
      "ABCB1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "clopidogrel thiol metabolite h4": {
    "genes": [
      "ABCB1",
      "CYP2C19",
      "RAD18",
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "venetoclax": {
    "genes": [
      "ABCB1",
      "CYP2C19",
      "SLCO1B3",
      "FLT3",
      "IDH1",
      "ABCG2",
      "TP53",
      "CYP3A4",
      "CYP3A5",
      "SLCO1B1",
      "NPM1",
      "IDH2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for venetoclax and FLT3, IDH1, IDH2, NPM1, TP53"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for venetoclax and FLT3, IDH1, IDH2, NPM1, TP53"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for venetoclax and FLT3, IDH1, IDH2, NPM1, TP53"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "romidepsin": {
    "genes": [
      "ABCB1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dehydroaripiprazole": {
    "genes": [
      "ABCB1",
      "CYP2D6",
      "CYP1A2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dihydrocodeine": {
    "genes": [
      "ABCB1",
      "CYP2D6",
      "OPRM1",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*4",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "highly active antiretroviral therapy (haart)": {
    "genes": [
      "ABCB1",
      "OPRM1",
      "IFNL4",
      "IFNL3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs671531",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "s-eddp": {
    "genes": [
      "ABCB1",
      "CYP2B6",
      "CYP2D6",
      "CYP2C19",
      "UGT2B7",
      "CYP3A5"
    ],
    "clinicalVariants": [
      {
        "variant": "rs7439366",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "iguratimod": {
    "genes": [
      "ABCB1",
      "CYP2C19",
      "ABCG2",
      "NAT2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "clopidogrel carboxylic acid": {
    "genes": [
      "ABCB1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "folfox": {
    "genes": [
      "ABCB1",
      "MTHFR",
      "CDX2",
      "DPYD",
      "BRAF",
      "DPYS",
      "SMAD7",
      "TYMS",
      "GSTP1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs11280056",
        "gene": "TYMS",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs45445694",
        "gene": "TYMS",
        "level": "3",
        "phenotypes": "Overall survival,Progression-free survival"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "xelox": {
    "genes": [
      "ABCB1",
      "MTHFR",
      "DPYD",
      "ABCG5",
      "BRAF",
      "ABCA2",
      "TYMS",
      "GSTP1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs367619008",
        "gene": "DPYD",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "piritramide": {
    "genes": [
      "ABCB1",
      "OPRM1",
      "COMT"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tilidine": {
    "genes": [
      "ABCB1",
      "OPRM1",
      "COMT"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "levomethadone": {
    "genes": [
      "ABCB1",
      "CYP2B6",
      "CYP2D6",
      "OPRM1",
      "UGT2B7",
      "COMT",
      "NR1I3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs7439366",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of alfentanil, buprenorphine, codeine, fentanyl, hydrocodone, hydromorphone, levomethadone, naltrexone, remifentanil, sufentanil or tramadol based on OPRM1 or COMT genotypes.\n",
      "source": "CPIC"
    }
  },
  "tenofovir alafenamide": {
    "genes": [
      "ABCB1",
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "amlodipine": {
    "genes": [
      "ABCB1",
      "NPPA",
      "GNB3",
      "RYR3",
      "CACNA1C",
      "AGT",
      "CYP3A4",
      "CACNA1D",
      "NOS1AP",
      "CYP3A5",
      "ACE"
    ],
    "clinicalVariants": [
      {
        "variant": "rs5065",
        "gene": "NPPA",
        "level": "3",
        "phenotypes": "Cardiovascular Disease,Coronary Disease,Stroke"
      },
      {
        "variant": "rs4291",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs11122576",
        "gene": "AGT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11122576",
        "gene": "AGT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs12143842",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs200148",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2740574",
        "gene": "CYP3A4",
        "level": "4",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs2246709",
        "gene": "CYP3A4",
        "level": "4",
        "phenotypes": "Hypertension"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "clomipramine": {
    "genes": [
      "ABCB1",
      "DISP1",
      "HTR1B",
      "CYP2D6",
      "CYP2C19",
      "SLITRK5",
      "BDNF",
      "FKBP5",
      "SLC6A4",
      "HTR2A",
      "CYP3A4",
      "SLC6A2",
      "CYP3A5",
      "CYP1A2"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Major Depressive Disorder,Mental Disorders"
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",
        "gene": "CYP2C19",
        "level": "1A",
        "phenotypes": "Mental Disorders"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs130058",
        "gene": "HTR1B",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs1360780",
        "gene": "FKBP5",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",
        "gene": "SLC6A4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1360780",
        "gene": "FKBP5",
        "level": "3",
        "phenotypes": "Depression"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for clomipramine and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for clomipramine and CYP2C19, CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for clomipramine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "The Royal Dutch Pharmacists Association - Pharmacogenetics Working Group (DPWG) recommends to avoid clomipramine in CYP2C19 ultrarapid metabolizer (UM) for Indication OBSESSIVE COMPULSIVE DISORDER or ANXIETY DISORDERS.\n",
      "source": "DPWG"
    }
  },
  "colchicine": {
    "genes": [
      "ABCB1",
      "CYP2D6",
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dexrazoxane": {
    "genes": [
      "ABCB1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fexofenadine": {
    "genes": [
      "ABCB1",
      "SLCO2B1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2306168",
        "gene": "SLCO2B1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fluvoxamine": {
    "genes": [
      "ABCB1",
      "HTR1A",
      "DISP1",
      "HTR1B",
      "CYP2D6",
      "CYP2C19",
      "SLITRK5",
      "BDNF",
      "SLC6A4",
      "FGF2",
      "HTR2A",
      "FAIM2",
      "MDGA2",
      "HTR3A",
      "HTR3B",
      "CYP1A2",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*14",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs10042486",
        "gene": "HTR1A",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1364043",
        "gene": "HTR1A",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2235040",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6295",
        "gene": "HTR1A",
        "level": "3",
        "phenotypes": "Depressive Disorder,Major Depressive Disorder"
      },
      {
        "variant": "rs1449683",
        "gene": "FGF2",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs2032583",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression,Depressive Disorder,Major Depressive Disorder"
      },
      {
        "variant": "rs1160351",
        "gene": "MDGA2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",
        "gene": "SLC6A4",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs6313",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs6311",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs6311",
        "gene": "HTR2A",
        "level": "4",
        "phenotypes": "Major Depressive Disorder"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for fluvoxamine and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for fluvoxamine and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for fluvoxamine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of escitalopram, citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, duloxetine, venlafaxine, desvenlafaxine, vilazodone, vortioxetine, levomilnacipran, or milnacipran based on SLC6A4 genotypes.\n",
      "source": "CPIC"
    }
  },
  "hydromorphone": {
    "genes": [
      "ABCB1",
      "CYP2D6",
      "OPRM1",
      "CYP2C19",
      "UGT2B7",
      "COMT"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of alfentanil, buprenorphine, codeine, fentanyl, hydrocodone, hydromorphone, levomethadone, naltrexone, remifentanil, sufentanil or tramadol based on OPRM1 or COMT genotypes.\n",
      "source": "CPIC"
    }
  },
  "ifosfamide": {
    "genes": [
      "ABCB1",
      "KLC3",
      "ALDH1A1",
      "ERCC2",
      "ABCG2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ivermectin": {
    "genes": [
      "ABCB1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lansoprazole": {
    "genes": [
      "ABCB1",
      "CYP2C19",
      "CYP2C18",
      "SLC22A8",
      "SLC22A6",
      "TNF",
      "IL1B",
      "SLCO1B1"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9, CYP2C19*17",
        "gene": "CYP2C19",
        "level": "1A",
        "phenotypes": "Gastroesophageal Reflux"
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3",
        "gene": "CYP2C19",
        "level": "1A",
        "phenotypes": "Gastroesophageal Reflux,Helicobacter Infections"
      },
      {
        "variant": "rs16944",
        "gene": "IL1B",
        "level": "3",
        "phenotypes": "Helicobacter Infections"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Gastroesophageal Reflux,Transplantation"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for lansoprazole and CYP2C19"
      },
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for lansoprazole and CYP2C19"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for lansoprazole and CYP2C19"
      }
    ],
    "guidelines": {
      "advice": "The CPIC Dosing Guideline for omeprazole, lansoprazole, pantoprazole recommends to increase the starting daily dose and to monitor efficacy in CYP2C19 ultrarapid metabolizer. For CYP2C19 rapid and normal metabolizers in the treatment of H. pylori infection and erosive esophagitis increasing the dose might be considered after initiation with the standard starting daily dose. The recommendations for intermediate and poor metabolizer for chronic therapy (&gt;12 weeks) and efficacy achieved is to consider 50% reduction in daily dose. See full guideline for further details and supporting evidence.\n",
      "source": "CPIC"
    }
  },
  "loperamide": {
    "genes": [
      "ABCB1",
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "methylprednisolone": {
    "genes": [
      "ABCB1",
      "SERPINE1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mitoxantrone": {
    "genes": [
      "ABCB1",
      "MECP2",
      "C10orf67",
      "DCK",
      "GALNT14",
      "WWOX",
      "SLCO1B1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2291075",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs2291075",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs12613732",
        "gene": "GALNT14",
        "level": "3",
        "phenotypes": "Hepatocellular Carcinoma"
      },
      {
        "variant": "rs6025211",
        "gene": "",
        "level": "3",
        "phenotypes": "Liver cancer"
      },
      {
        "variant": "rs9679162",
        "gene": "GALNT14",
        "level": "3",
        "phenotypes": "Hepatocellular Carcinoma,Liver cancer"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mycophenolate mofetil": {
    "genes": [
      "ABCB1",
      "TGFB1",
      "HUS1",
      "IMPDH2",
      "UGT1A9",
      "IL12A",
      "SLCO1B3",
      "UGT1A8",
      "UGT2B7",
      "CES1",
      "ABCC2",
      "CYP3A4",
      "TNF",
      "CES2",
      "CYP2C8",
      "IL10",
      "IMPDH1",
      "IL2",
      "CYP3A5",
      "SLCO1B1",
      "UGT1A7"
    ],
    "clinicalVariants": [
      {
        "variant": "rs568408",
        "gene": "IL12A",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs2278294",
        "gene": "IMPDH1",
        "level": "3",
        "phenotypes": "Kidney Transplantation,Organ Transplantation"
      },
      {
        "variant": "rs2278294",
        "gene": "IMPDH1",
        "level": "3",
        "phenotypes": "Leukopenia"
      },
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs72551330",
        "gene": "UGT1A9",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs1800872",
        "gene": "IL10",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs7311358",
        "gene": "SLCO1B3",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs11572076",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs7438135",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs1042597",
        "gene": "UGT1A8",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs3832043",
        "gene": "UGT1A9",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs4149117",
        "gene": "SLCO1B3",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs2228075",
        "gene": "IMPDH1",
        "level": "3",
        "phenotypes": "Organ Transplantation"
      },
      {
        "variant": "rs1800629",
        "gene": "TNF",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs11706052",
        "gene": "IMPDH2",
        "level": "4",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs17868320",
        "gene": "UGT1A9",
        "level": "4",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs11706052",
        "gene": "IMPDH2",
        "level": "4",
        "phenotypes": "Kidney Transplantation"
      },
      {
        "variant": "rs2278293",
        "gene": "IMPDH1",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs6714486",
        "gene": "UGT1A9",
        "level": "4",
        "phenotypes": "Kidney Transplantation"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nefazodone": {
    "genes": [
      "ABCB1",
      "HTR1B",
      "CYP2D6",
      "FKBP5"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2032582",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs130058",
        "gene": "HTR1B",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs1360780",
        "gene": "FKBP5",
        "level": "3",
        "phenotypes": "Depression"
      },
      {
        "variant": "rs1360780",
        "gene": "FKBP5",
        "level": "3",
        "phenotypes": "Depression"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for nefazodone and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nelfinavir": {
    "genes": [
      "ABCB1",
      "CYP2C19",
      "CYP3A4",
      "CYP3A5"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs4244285",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "HIV infectious disease,Pancreatic Neoplasms"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for nelfinavir and CYP2C19, CYP3A4, CYP3A5"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for nelfinavir and CYP3A4"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nimodipine": {
    "genes": [
      "ABCB1",
      "CACNA1C",
      "CACNA1B",
      "CYP3A5"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2239128",
        "gene": "CACNA1C",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2239050",
        "gene": "CACNA1C",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "omeprazole": {
    "genes": [
      "ABCB1",
      "AHR",
      "CYP2C19",
      "SLC22A8",
      "VDR",
      "SLC22A6",
      "TNF",
      "IL1B"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3",
        "gene": "CYP2C19",
        "level": "1A",
        "phenotypes": "Esophagitis,Gastroesophageal Reflux,Helicobacter Infections,Peptic Ulcer Disease"
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*9, CYP2C19*10, CYP2C19*17, CYP2C19*24, CYP2C19*26",
        "gene": "CYP2C19",
        "level": "1A",
        "phenotypes": "Gastroesophageal Reflux"
      },
      {
        "variant": "rs16944",
        "gene": "IL1B",
        "level": "3",
        "phenotypes": "Helicobacter Infections"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Gastroesophageal Reflux"
      },
      {
        "variant": "CYP2C19*1, CYP2C19*23, CYP2C19*29, CYP2C19*30, CYP2C19*31, CYP2C19*33",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for omeprazole and CYP2C19"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for omeprazole and CYP2C19"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for omeprazole and CYP2C19"
      },
      {
        "source": "PMDA",
        "level": "Informative PGx",
        "name": "Annotation of PMDA Label for omeprazole and CYP2C19"
      }
    ],
    "guidelines": {
      "advice": "The CPIC Dosing Guideline for omeprazole, lansoprazole, pantoprazole recommends to increase the starting daily dose and to monitor efficacy in CYP2C19 ultrarapid metabolizer. For CYP2C19 rapid and normal metabolizers in the treatment of H. pylori infection and erosive esophagitis increasing the dose might be considered after initiation with the standard starting daily dose. The recommendations for intermediate and poor metabolizer for chronic therapy (&gt;12 weeks) and efficacy achieved is to consider 50% reduction in daily dose. See full guideline for further details and supporting evidence.\n",
      "source": "CPIC"
    }
  },
  "oseltamivir": {
    "genes": [
      "ABCB1",
      "NEU2",
      "CES1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs200707504",
        "gene": "CES1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pantoprazole": {
    "genes": [
      "ABCB1",
      "CYP2C19",
      "CYP2C18",
      "SLC22A8",
      "CYP3A4",
      "SLC22A6",
      "IL1B"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",
        "gene": "CYP2C19",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3",
        "gene": "CYP2C19",
        "level": "1A",
        "phenotypes": "Helicobacter Infections,Ulcer"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "4",
        "phenotypes": "Helicobacter Infections"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for pantoprazole and CYP2C19"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for pantoprazole"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for pantoprazole and CYP2C19"
      }
    ],
    "guidelines": {
      "advice": "The CPIC Dosing Guideline for omeprazole, lansoprazole, pantoprazole recommends to increase the starting daily dose and to monitor efficacy in CYP2C19 ultrarapid metabolizer. For CYP2C19 rapid and normal metabolizers in the treatment of H. pylori infection and erosive esophagitis increasing the dose might be considered after initiation with the standard starting daily dose. The recommendations for intermediate and poor metabolizer for chronic therapy (&gt;12 weeks) and efficacy achieved is to consider 50% reduction in daily dose. See full guideline for further details and supporting evidence.\n",
      "source": "CPIC"
    }
  },
  "prazosin": {
    "genes": [
      "ABCB1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "probenecid": {
    "genes": [
      "ABCB1",
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for probenecid and G6PD"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of chlorpropamide, dabrafenib, gliclazide, glimepiride, glipizide, mepacrine (aka quinacrine), mesalazine, moxifloxacin, nicorandil, nitrofural (aka nitrofurazone), probenecid, sodium nitrate, sulfacetamide, tolazamide or trametinib based on G6PD genotype.\n",
      "source": "CPIC"
    }
  },
  "remifentanil": {
    "genes": [
      "ABCB1",
      "ADRA2A",
      "OPRM1",
      "CACNA2D2",
      "SLC9A9",
      "PGAP6",
      "KCNJ6",
      "ADRB2",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1042718",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Hypotensive disorder"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "tonsillectomy"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs79910351",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of alfentanil, buprenorphine, codeine, fentanyl, hydrocodone, hydromorphone, levomethadone, naltrexone, remifentanil, sufentanil or tramadol based on OPRM1 or COMT genotypes.\n",
      "source": "CPIC"
    }
  },
  "temozolomide": {
    "genes": [
      "ABCB1",
      "HDAC4",
      "MGMT",
      "GSTP1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2229109",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Glioma"
      },
      {
        "variant": "rs1128503",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "Glioma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vinblastine": {
    "genes": [
      "ABCB1",
      "GSTT1",
      "GSTM1"
    ],
    "clinicalVariants": [
      {
        "variant": "GSTM1 non-null, GSTM1 null",
        "gene": "GSTM1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "glucocorticoids": {
    "genes": [
      "ABCB1",
      "NR3C1",
      "NLRP1",
      "HLA-E",
      "KLRC1",
      "FKBP5",
      "CYP17A1",
      "GLCCI1",
      "KLRD1",
      "ATP5F1E",
      "TNF",
      "CDH2",
      "HSD3B1",
      "CRHR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs37973",
        "gene": "GLCCI1",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs1059150",
        "gene": "ATP5F1E",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1264457",
        "gene": "HLA-E",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs2302489",
        "gene": "KLRD1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs7301582",
        "gene": "KLRC1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1047303",
        "gene": "HSD3B1",
        "level": "3",
        "phenotypes": "Asthma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mecasermin": {
    "genes": [
      "GH1",
      "IGF1",
      "GHR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for mecasermin and GH1, GHR, IGF1"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for mecasermin and GH1, IGF1"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for mecasermin and IGF1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "chlorthalidone": {
    "genes": [
      "NPPA",
      "AGT",
      "MMP3",
      "ACE"
    ],
    "clinicalVariants": [
      {
        "variant": "rs5065",
        "gene": "NPPA",
        "level": "3",
        "phenotypes": "Cardiovascular Disease,Coronary Disease,Stroke"
      },
      {
        "variant": "rs4291",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs11122576",
        "gene": "AGT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11122576",
        "gene": "AGT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs12143842",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs200148",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs35068180",
        "gene": "MMP3",
        "level": "3",
        "phenotypes": "Hypertension"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "milnacipran": {
    "genes": [
      "HTR1A",
      "ADRA2A",
      "BDNF",
      "SLC6A4",
      "HTR2A",
      "MDGA2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs10042486",
        "gene": "HTR1A",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1364043",
        "gene": "HTR1A",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1800544",
        "gene": "ADRA2A",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs6295",
        "gene": "HTR1A",
        "level": "3",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "rs1160351",
        "gene": "MDGA2",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of escitalopram, citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, duloxetine, venlafaxine, desvenlafaxine, vilazodone, vortioxetine, levomilnacipran, or milnacipran based on SLC6A4 genotypes.\n",
      "source": "CPIC"
    }
  },
  "lurasidone": {
    "genes": [
      "HTR1A",
      "CYP3A4"
    ],
    "clinicalVariants": [
      {
        "variant": "rs6295",
        "gene": "HTR1A",
        "level": "3",
        "phenotypes": "Schizophrenia"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "xk469": {
    "genes": [
      "AOX1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs10931910",
        "gene": "AOX1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "deferasirox": {
    "genes": [
      "UGT1A3",
      "CYP2D6",
      "CYP1A1",
      "GC",
      "CYP27B1",
      "ABCC2",
      "ABCG2",
      "VDR",
      "CYP24A1",
      "UGT1A1",
      "CYP1A2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2273697",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Beta-thalassemia and related diseases"
      },
      {
        "variant": "rs8187710",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Beta-thalassemia and related diseases"
      },
      {
        "variant": "rs717620",
        "gene": "ABCC2",
        "level": "3",
        "phenotypes": "Beta-thalassemia and related diseases"
      },
      {
        "variant": "rs2470890",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": "Beta-thalassemia and related diseases"
      },
      {
        "variant": "rs2606345",
        "gene": "CYP1A1",
        "level": "3",
        "phenotypes": "Beta-thalassemia and related diseases"
      },
      {
        "variant": "rs762551",
        "gene": "CYP1A2",
        "level": "3",
        "phenotypes": "Beta-thalassemia and related diseases"
      },
      {
        "variant": "rs13120400",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Beta-thalassemia and related diseases"
      },
      {
        "variant": "rs3806596",
        "gene": "UGT1A3",
        "level": "3",
        "phenotypes": "Beta-thalassemia and related diseases"
      },
      {
        "variant": "rs927650",
        "gene": "CYP24A1",
        "level": "3",
        "phenotypes": "Beta-thalassemia and related diseases"
      },
      {
        "variant": "rs2585428",
        "gene": "CYP24A1",
        "level": "3",
        "phenotypes": "Beta-thalassemia and related diseases"
      },
      {
        "variant": "rs2248359",
        "gene": "CYP24A1",
        "level": "3",
        "phenotypes": "Beta-thalassemia and related diseases"
      },
      {
        "variant": "rs10877012",
        "gene": "CYP27B1",
        "level": "3",
        "phenotypes": "Beta-thalassemia and related diseases"
      },
      {
        "variant": "rs887829",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "Beta-thalassemia and related diseases"
      },
      {
        "variant": "rs7041",
        "gene": "GC",
        "level": "3",
        "phenotypes": "Beta-thalassemia and related diseases"
      },
      {
        "variant": "rs1983023",
        "gene": "UGT1A3",
        "level": "3",
        "phenotypes": "Beta-thalassemia and related diseases"
      },
      {
        "variant": "rs731236",
        "gene": "VDR",
        "level": "3",
        "phenotypes": "Beta-thalassemia and related diseases"
      },
      {
        "variant": "rs1544410",
        "gene": "VDR",
        "level": "3",
        "phenotypes": "Beta-thalassemia and related diseases"
      },
      {
        "variant": "rs887829",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "Beta-thalassemia and related diseases"
      },
      {
        "variant": "rs4124874",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "Beta-thalassemia and related diseases,Drug Toxicity"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fiboflapon": {
    "genes": [
      "UGT1A3",
      "UGT1A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mirabegron": {
    "genes": [
      "UGT1A3",
      "CYP2D6",
      "UGT1A4",
      "SLC19A1",
      "CYP3A4",
      "SLC6A2",
      "SLCO1B1",
      "NAT2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "No Clinical PGx",
        "name": "Annotation of EMA Label for mirabegron and CYP2D6"
      },
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for mirabegron and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for mirabegron and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for mirabegron and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "telmisartan": {
    "genes": [
      "UGT1A3",
      "GNB3",
      "SLCO1B3",
      "ABCG2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs5443",
        "gene": "GNB3",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "UGT1A3*1, UGT1A3*2, UGT1A3*3",
        "gene": "UGT1A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs60140950",
        "gene": "SLCO1B3",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "glp-1 receptor agonists": {
    "genes": [
      "WFS1",
      "ARRB1",
      "GLP1R",
      "CNR1",
      "TCF7L2",
      "SORCS1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "darapladib": {
    "genes": [
      "FHIT",
      "HEATR4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "calcium": {
    "genes": [
      "RYR1",
      "VDR"
    ],
    "clinicalVariants": [
      {
        "variant": "rs731236",
        "gene": "VDR",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "anesthetics": {
    "genes": [
      "RYR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "chlorocresol": {
    "genes": [
      "RYR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs186983396",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "volatile anesthetics": {
    "genes": [
      "RYR1",
      "OPRM1",
      "ABCG2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs118204423",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ryanodine": {
    "genes": [
      "RYR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "remimazolam": {
    "genes": [
      "RYR1",
      "CES1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "enflurane": {
    "genes": [
      "RYR1",
      "CACNA1S"
    ],
    "clinicalVariants": [
      {
        "variant": "rs118192177",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192176",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922832",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922809",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192175",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922762",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192124",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922770",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922802",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs28933397",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922843",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs1801086",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs112563513",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922816",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922748",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192161",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918595",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918596",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922753",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918593",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs28933396",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922807",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192162",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922768",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918592",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922747",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192122",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192172",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192168",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918594",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922803",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922878",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922876",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922764",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922772",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922818",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192163",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs1800559",
        "gene": "CACNA1S",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs772226819",
        "gene": "CACNA1S",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs111888148",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192178",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs144336148",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs63749869",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192116",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192167",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192170",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192178",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for enflurane"
      }
    ],
    "guidelines": {
      "advice": "The CPIC Dosing Guideline recommends that halogenated volatile anesthetics such as desflurane, enflurane, halothane, isoflurane, methoxyflurane, sevoflurane and the depolarizing muscle relaxants succinylcholine are relatively contraindicated in persons with malignant hyperthermia susceptibility (MHS). See full guideline for disclaimers, further details and supporting evidence. The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "halothane": {
    "genes": [
      "RYR1",
      "CACNA1S"
    ],
    "clinicalVariants": [
      {
        "variant": "rs118192177",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192176",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922832",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922809",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192175",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922762",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192124",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922770",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922802",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs28933397",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922843",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs1801086",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs112563513",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922816",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922748",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192161",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918595",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918596",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922753",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918593",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs28933396",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922807",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192162",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922768",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918592",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922747",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192122",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192172",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192168",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918594",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922803",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922878",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922876",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922764",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922772",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922818",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192163",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs1800559",
        "gene": "CACNA1S",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs772226819",
        "gene": "CACNA1S",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs111888148",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192178",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs144336148",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs63749869",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192116",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192167",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192170",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192178",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "The CPIC Dosing Guideline recommends that halogenated volatile anesthetics such as desflurane, enflurane, halothane, isoflurane, methoxyflurane, sevoflurane and the depolarizing muscle relaxants succinylcholine are relatively contraindicated in persons with malignant hyperthermia susceptibility (MHS). See full guideline for disclaimers, further details and supporting evidence. The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "isoflurane": {
    "genes": [
      "RYR1",
      "CYP2E1",
      "MC1R",
      "CACNA1S"
    ],
    "clinicalVariants": [
      {
        "variant": "rs118192177",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192176",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922832",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922809",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192175",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922762",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192124",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922770",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922802",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs28933397",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922843",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs1801086",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs112563513",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922816",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922748",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192161",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918595",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918596",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922753",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918593",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs28933396",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922807",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192162",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922768",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918592",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922747",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192122",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192172",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192168",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918594",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922803",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922878",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922876",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922764",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922772",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922818",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192163",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs1800559",
        "gene": "CACNA1S",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs772226819",
        "gene": "CACNA1S",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs111888148",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192178",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs144336148",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs63749869",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192116",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192167",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192170",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192178",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for isoflurane and CACNA1S, RYR1"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for isoflurane and CACNA1S, RYR1"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for isoflurane"
      }
    ],
    "guidelines": {
      "advice": "The CPIC Dosing Guideline recommends that halogenated volatile anesthetics such as desflurane, enflurane, halothane, isoflurane, methoxyflurane, sevoflurane and the depolarizing muscle relaxants succinylcholine are relatively contraindicated in persons with malignant hyperthermia susceptibility (MHS). See full guideline for disclaimers, further details and supporting evidence. The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "methoxyflurane": {
    "genes": [
      "RYR1",
      "CACNA1S"
    ],
    "clinicalVariants": [
      {
        "variant": "rs118192177",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192176",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922832",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922809",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192175",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922762",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192124",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922770",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922802",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs28933397",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922843",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs1801086",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs112563513",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922816",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922748",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192161",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918595",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918596",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922753",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918593",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs28933396",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922807",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192162",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922768",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918592",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922747",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192122",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192172",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192168",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918594",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922803",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922878",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922876",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922764",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922772",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922818",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192163",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs772226819",
        "gene": "CACNA1S",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs1800559",
        "gene": "CACNA1S",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs111888148",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192178",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs144336148",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs63749869",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192116",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192167",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192170",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192178",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "The CPIC Dosing Guideline recommends that halogenated volatile anesthetics such as desflurane, enflurane, halothane, isoflurane, methoxyflurane, sevoflurane and the depolarizing muscle relaxants succinylcholine are relatively contraindicated in persons with malignant hyperthermia susceptibility (MHS). See full guideline for disclaimers, further details and supporting evidence. The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "succinylcholine": {
    "genes": [
      "RYR1",
      "BCHE",
      "CACNA1S"
    ],
    "clinicalVariants": [
      {
        "variant": "rs118192177",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192176",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922832",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922809",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192175",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922762",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192124",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922770",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922802",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs28933397",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922843",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs1801086",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs112563513",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922816",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922748",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192161",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918595",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918596",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922753",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918593",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs28933396",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922807",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192162",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922768",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918592",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922747",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192122",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192172",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192168",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs121918594",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922803",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922878",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922876",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922764",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922772",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs193922818",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192163",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs772226819",
        "gene": "CACNA1S",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs1800559",
        "gene": "CACNA1S",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs111888148",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192178",
        "gene": "RYR1",
        "level": "1A",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs28933389",
        "gene": "BCHE",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs745364489",
        "gene": "BCHE",
        "level": "3",
        "phenotypes": "Apnea"
      },
      {
        "variant": "rs1799807",
        "gene": "BCHE",
        "level": "3",
        "phenotypes": "Butyrylcholinesterase deficiency"
      },
      {
        "variant": "rs1803274",
        "gene": "BCHE",
        "level": "3",
        "phenotypes": "Butyrylcholinesterase deficiency"
      },
      {
        "variant": "rs774072493",
        "gene": "BCHE",
        "level": "3",
        "phenotypes": "Apnea"
      },
      {
        "variant": "rs568724445",
        "gene": "BCHE",
        "level": "3",
        "phenotypes": "Apnea"
      },
      {
        "variant": "rs764841347",
        "gene": "BCHE",
        "level": "3",
        "phenotypes": "Apnea"
      },
      {
        "variant": "rs1560022535",
        "gene": "BCHE",
        "level": "3",
        "phenotypes": "Apnea"
      },
      {
        "variant": "rs531738678",
        "gene": "BCHE",
        "level": "3",
        "phenotypes": "Apnea"
      },
      {
        "variant": "rs201820739",
        "gene": "BCHE",
        "level": "3",
        "phenotypes": "Apnea"
      },
      {
        "variant": "rs28933390",
        "gene": "BCHE",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs144336148",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs63749869",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192116",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192167",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192170",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118192178",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      },
      {
        "variant": "rs118204423",
        "gene": "RYR1",
        "level": "3",
        "phenotypes": "Malignant Hyperthermia"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for succinylcholine and BCHE, CACNA1S, RYR1"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for succinylcholine"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for succinylcholine and BCHE, CACNA1S, RYR1"
      }
    ],
    "guidelines": {
      "advice": "The CPIC Dosing Guideline recommends that halogenated volatile anesthetics such as desflurane, enflurane, halothane, isoflurane, methoxyflurane, sevoflurane and the depolarizing muscle relaxants succinylcholine are relatively contraindicated in persons with malignant hyperthermia susceptibility (MHS). See full guideline for disclaimers, further details and supporting evidence. The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "serotonin": {
    "genes": [
      "TSPAN5",
      "MAOB",
      "ERICH3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "enalapril": {
    "genes": [
      "PCGF3",
      "VEGFA",
      "CES1",
      "NR3C2",
      "CLASP1",
      "ADRB2",
      "BDKRB2",
      "SLCO1B1",
      "PNPT1",
      "ACE",
      "ABO",
      "NOS3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1042714",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Hypertrophy, Left Ventricular"
      },
      {
        "variant": "rs5522",
        "gene": "NR3C2",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1799722",
        "gene": "BDKRB2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799722",
        "gene": "BDKRB2",
        "level": "3",
        "phenotypes": "Cough,Essential hypertension"
      },
      {
        "variant": "rs495828",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs2070744",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs699947",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs71647871",
        "gene": "CES1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Arteriosclerosis,Coronary Disease,Essential hypertension,Glomerulonephritis, IGA,Kidney Disorder"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "iloperidone": {
    "genes": [
      "HTR2C",
      "CYP2D6",
      "CERKL",
      "NRG3",
      "ZFP91-CNTF",
      "NUBPL",
      "CELF4",
      "CNTF"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4933824",
        "gene": "NRG3",
        "level": "3",
        "phenotypes": "Acquired Long QT Syndrome (aLQTS)"
      },
      {
        "variant": "rs7142881",
        "gene": "NUBPL",
        "level": "3",
        "phenotypes": "Acquired Long QT Syndrome (aLQTS)"
      },
      {
        "variant": "rs4799915",
        "gene": "CELF4",
        "level": "3",
        "phenotypes": "Acquired Long QT Syndrome (aLQTS)"
      },
      {
        "variant": "rs993648",
        "gene": "CERKL",
        "level": "3",
        "phenotypes": "Acquired Long QT Syndrome (aLQTS)"
      },
      {
        "variant": "rs1065852",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Schizophrenia"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for iloperidone and CYP2D6"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for iloperidone"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "hydroxymethyl ivacaftor": {
    "genes": [
      "HTR2C"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "atrasentan": {
    "genes": [
      "ORM2",
      "SLCO1B1"
    ],
    "clinicalVariants": [
      {
        "variant": "SLCO1B1*1, SLCO1B1*5, SLCO1B1*9, SLCO1B1*14, SLCO1B1*15, SLCO1B1*37",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "eltrombopag": {
    "genes": [
      "CTLA4",
      "F5",
      "ABCG2",
      "UGT1A1",
      "SERPINC1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for eltrombopag and F5, SERPINC1"
      },
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for eltrombopag and SERPINC1"
      },
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for eltrombopag and F5, SERPINC1"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for eltrombopag and F5, SERPINC1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "glatiramer acetate": {
    "genes": [
      "CTLA4",
      "TGFB1",
      "PVT1",
      "CLEC16A",
      "EOMES",
      "HLA-DRB1",
      "CCR5",
      "IFNAR1",
      "IFNG",
      "IFNB1",
      "IL7R"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12459996",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1056854",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs75041078",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "melphalan": {
    "genes": [
      "CTLA4",
      "SLC7A5",
      "POLR1G"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4553808",
        "gene": "CTLA4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4240803",
        "gene": "SLC7A5",
        "level": "3",
        "phenotypes": "Multiple Myeloma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "chlorothiazide": {
    "genes": [
      "HMGCS2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs9943291",
        "gene": "HMGCS2",
        "level": "3",
        "phenotypes": "Hyperglycemia,Hypertension"
      },
      {
        "variant": "rs61824877",
        "gene": "",
        "level": "3",
        "phenotypes": "Hyperglycemia,Hypertension"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "timbetasin": {
    "genes": [
      "TMSB4X"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "afatinib": {
    "genes": [
      "UHRF1",
      "EGFR",
      "ARF1",
      "NUP62",
      "DVL2",
      "NR1I2",
      "AKT1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for afatinib and EGFR"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for afatinib and EGFR"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for afatinib and EGFR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "l-ornithine": {
    "genes": [
      "NPC2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "arimoclomol": {
    "genes": [
      "NPC2",
      "NPC1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for arimoclomol"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for arimoclomol and NPC1, NPC2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "levacetylleucine": {
    "genes": [
      "NPC2",
      "NPC1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for levacetylleucine and NPC1, NPC2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cysteine-s-sulfate": {
    "genes": [
      "NPC2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "1,7-dimethylxanthine": {
    "genes": [
      "AHR",
      "CYP1A1",
      "ACTR3B",
      "CYP2A6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "xenobiotics": {
    "genes": [
      "AHR",
      "CYP1A2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cholic acid": {
    "genes": [
      "DHCR7",
      "HSD3B7",
      "HSD3B2",
      "AMACR",
      "CYP7A1",
      "AKR1D1",
      "CYP27A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for cholic acid and AKR1D1, HSD3B7"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for cholic acid and AKR1D1, AMACR, CYP27A1, CYP7A1, DHCR7, HSD3B2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "aldosterone antagonists": {
    "genes": [
      "NEDD4L"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "amiloride": {
    "genes": [
      "NEDD4L",
      "SCNN1B",
      "SCNN1A",
      "SCNN1G",
      "CYP4A11"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1126742",
        "gene": "CYP4A11",
        "level": "3",
        "phenotypes": "Hypertension"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "thiazolidinediones": {
    "genes": [
      "AQP2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs296766",
        "gene": "AQP2",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "carglumic acid": {
    "genes": [
      "NAGS"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for carglumic acid and NAGS"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for carglumic acid and NAGS"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for carglumic acid and NAGS"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sodium benzoate / sodium phenylacetate": {
    "genes": [
      "NAGS",
      "ARG1",
      "ASL",
      "CPS1",
      "OTC",
      "ASS1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for sodium benzoate / sodium phenylacetate and ARG1, ASL, ASS1, CPS1, NAGS, OTC"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "glycerol phenylbutyrate": {
    "genes": [
      "NAGS",
      "ARG1",
      "ASL",
      "CPS1",
      "OTC",
      "ASS1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for glycerol phenylbutyrate and ARG1, ASL, ASS1, CPS1, OTC"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for glycerol phenylbutyrate and NAGS"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for glycerol phenylbutyrate and ASS1, CPS1, OTC"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for glycerol phenylbutyrate and ARG1, ASL, ASS1, CPS1, OTC"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "trofinetide": {
    "genes": [
      "MECP2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for trofinetide and MECP2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cetuximab": {
    "genes": [
      "NRG2",
      "NRAS",
      "EGFR",
      "AREG",
      "EREG",
      "PTGS2",
      "WWTR1",
      "KRAS",
      "NRG1",
      "FCGR3A",
      "GC",
      "NRG3",
      "APOBEC2",
      "EGF",
      "VEGFA",
      "RASSF1",
      "ARHGEF4",
      "CCND1",
      "TGFA",
      "HBEGF",
      "BRAF",
      "IL8",
      "FCGR2A",
      "BTC",
      "MGAT4A",
      "LATS2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs9344",
        "gene": "CCND1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1353295",
        "gene": "AREG",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs13104811",
        "gene": "AREG",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs9996584",
        "gene": "AREG",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs11942466",
        "gene": "AREG",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs712829",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs712830",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs885036",
        "gene": "MGAT4A",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs2227983",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Head and Neck Neoplasms"
      },
      {
        "variant": "rs61764370",
        "gene": "KRAS",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs2236947",
        "gene": "RASSF1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1801274",
        "gene": "FCGR2A",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms,Head and Neck Neoplasms"
      },
      {
        "variant": "rs396991",
        "gene": "FCGR3A",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs4444903",
        "gene": "EGF",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms,Rectal Neoplasms"
      },
      {
        "variant": "rs112445441",
        "gene": "KRAS",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for cetuximab and BRAF, EGFR, KRAS, NRAS"
      },
      {
        "source": "PMDA",
        "level": "Testing Required",
        "name": "Annotation of PMDA Label for cetuximab and EGFR, KRAS"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for cetuximab and EGFR, KRAS, NRAS"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for cetuximab and EGFR, KRAS, NRAS"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "panitumumab": {
    "genes": [
      "NRG2",
      "NRAS",
      "EGFR",
      "AREG",
      "EREG",
      "PTGS2",
      "KRAS",
      "NRG1",
      "FCGR3A",
      "NRG3",
      "EGF",
      "VEGFA",
      "CCND1",
      "TGFA",
      "HBEGF",
      "IL8",
      "FCGR2A",
      "BTC"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1353295",
        "gene": "AREG",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs13104811",
        "gene": "AREG",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs9996584",
        "gene": "AREG",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs11942466",
        "gene": "AREG",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs712829",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs61764370",
        "gene": "KRAS",
        "level": "3",
        "phenotypes": "Neoplasms"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for panitumumab and KRAS, NRAS"
      },
      {
        "source": "PMDA",
        "level": "Testing Required",
        "name": "Annotation of PMDA Label for panitumumab and KRAS"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for panitumumab and KRAS, NRAS"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for panitumumab and KRAS, NRAS"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for panitumumab and EGFR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pyrazolones": {
    "genes": [
      "PLA2G4A",
      "TNFRSF11A",
      "PLCG1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12746200",
        "gene": "PLA2G4A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1805034",
        "gene": "TNFRSF11A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2228246",
        "gene": "PLCG1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "propionic acid derivatives": {
    "genes": [
      "PLA2G4A",
      "TNFRSF11A",
      "PLCG1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12746200",
        "gene": "PLA2G4A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1805034",
        "gene": "TNFRSF11A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2228246",
        "gene": "PLCG1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "leukotriene receptor antagonists": {
    "genes": [
      "CYSLTR2",
      "LTA4H",
      "LTC4S",
      "ALOX5",
      "ADRB2",
      "SLCO2B1",
      "PRORP",
      "MLLT3",
      "ABCC1",
      "GLT1D1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "low density lipoprotein": {
    "genes": [
      "SH2B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dabrafenib": {
    "genes": [
      "NRAS",
      "HRAS",
      "KRAS",
      "G6PD",
      "BRAF",
      "HLA-DRB1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for dabrafenib and G6PD"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for dabrafenib and BRAF"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for dabrafenib and HRAS, KRAS, NRAS"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for dabrafenib and BRAF"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for dabrafenib and BRAF"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for dabrafenib and HRAS, KRAS, NRAS"
      },
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for dabrafenib and HRAS, KRAS, NRAS"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of chlorpropamide, dabrafenib, gliclazide, glimepiride, glipizide, mepacrine (aka quinacrine), mesalazine, moxifloxacin, nicorandil, nitrofural (aka nitrofurazone), probenecid, sodium nitrate, sulfacetamide, tolazamide or trametinib based on G6PD genotype.\n",
      "source": "CPIC"
    }
  },
  "trametinib": {
    "genes": [
      "NRAS",
      "HRAS",
      "KRAS",
      "G6PD",
      "BRAF"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for trametinib and G6PD"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for trametinib and BRAF"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for trametinib and BRAF"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for trametinib and HRAS, KRAS, NRAS"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for trametinib and BRAF"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of chlorpropamide, dabrafenib, gliclazide, glimepiride, glipizide, mepacrine (aka quinacrine), mesalazine, moxifloxacin, nicorandil, nitrofural (aka nitrofurazone), probenecid, sodium nitrate, sulfacetamide, tolazamide or trametinib based on G6PD genotype.\n",
      "source": "CPIC"
    }
  },
  "encorafenib": {
    "genes": [
      "NRAS",
      "HRAS",
      "KRAS",
      "BRAF"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for encorafenib and HRAS, KRAS, NRAS"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for encorafenib and HRAS, KRAS, NRAS"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for encorafenib and BRAF"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for encorafenib and BRAF"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for encorafenib and HRAS, KRAS, NRAS"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for encorafenib and BRAF"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "azacitidine": {
    "genes": [
      "NRAS",
      "MTHFR",
      "KRAS",
      "PTPN11",
      "XRCC1",
      "CDA",
      "CBL",
      "TYMS"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for azacitidine and KRAS, NRAS, PTPN11"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for azacitidine and CBL, KRAS, NRAS, PTPN11"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for azacitidine"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vancomycin": {
    "genes": [
      "GJA1",
      "G6PD",
      "MIA3",
      "HLA-A",
      "PLEKHN1",
      "AIDA"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2789047",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "HLA-A*32:01",
        "gene": "HLA-A",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "hydralazine / isosorbide dinitrate": {
    "genes": [
      "GNB3",
      "CYP11B2",
      "NAT2",
      "NOS3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs5443",
        "gene": "GNB3",
        "level": "3",
        "phenotypes": "Heart Failure"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for hydralazine / isosorbide dinitrate and NAT2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "bumetanide": {
    "genes": [
      "GNB3",
      "SLC17A3",
      "ADD1",
      "SLC12A3",
      "SCNN1G",
      "ACE",
      "NPPA-AS1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs5063",
        "gene": "NPPA-AS1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5443",
        "gene": "GNB3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4961",
        "gene": "ADD1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1529927",
        "gene": "SLC12A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "clonidine": {
    "genes": [
      "GNB3",
      "CYP2D6",
      "ADRA2A",
      "ADRA2B",
      "ADRA2C"
    ],
    "clinicalVariants": [
      {
        "variant": "rs5443",
        "gene": "GNB3",
        "level": "3",
        "phenotypes": "Liver Cirrhosis"
      },
      {
        "variant": "rs11269124",
        "gene": "ADRA2C",
        "level": "3",
        "phenotypes": "Liver Cirrhosis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no dosing recommendations for clonidine based on CYP2D6 genotype and DPWG suggest clonidine as possible alternative for atomoxetine in variant CYP2D6 metabolisers.\n",
      "source": "DPWG"
    }
  },
  "sibutramine": {
    "genes": [
      "GNB3",
      "CYP2B6"
    ],
    "clinicalVariants": [
      {
        "variant": "rs5443",
        "gene": "GNB3",
        "level": "3",
        "phenotypes": "Obesity"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "torasemide": {
    "genes": [
      "GNB3",
      "ADD1",
      "SLC12A3",
      "SCNN1G",
      "ACE",
      "NPPA-AS1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs5063",
        "gene": "NPPA-AS1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5443",
        "gene": "GNB3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4961",
        "gene": "ADD1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1529927",
        "gene": "SLC12A3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "risedronate": {
    "genes": [
      "LRP5",
      "SIRT1",
      "IL1B"
    ],
    "clinicalVariants": [
      {
        "variant": "rs16944",
        "gene": "IL1B",
        "level": "3",
        "phenotypes": "Osteitis Deformans"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "teniposide": {
    "genes": [
      "NUP50",
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "migalastat": {
    "genes": [
      "GLA",
      "HNRNPH2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs869312136",
        "gene": "GLA,HNRNPH2",
        "level": "3",
        "phenotypes": "Fabry Disease"
      },
      {
        "variant": "rs28935195",
        "gene": "GLA",
        "level": "3",
        "phenotypes": "Fabry Disease"
      },
      {
        "variant": "rs1569304898",
        "gene": "GLA",
        "level": "3",
        "phenotypes": "Fabry Disease"
      },
      {
        "variant": "rs398123212",
        "gene": "GLA",
        "level": "3",
        "phenotypes": "Fabry Disease"
      },
      {
        "variant": "rs104894827",
        "gene": "GLA",
        "level": "3",
        "phenotypes": "Fabry Disease"
      },
      {
        "variant": "rs372966991",
        "gene": "GLA",
        "level": "3",
        "phenotypes": "Fabry Disease"
      },
      {
        "variant": "rs869312146",
        "gene": "GLA",
        "level": "3",
        "phenotypes": "Fabry Disease"
      },
      {
        "variant": "rs397515870",
        "gene": "GLA",
        "level": "3",
        "phenotypes": "Fabry Disease"
      },
      {
        "variant": "rs398123223",
        "gene": "GLA",
        "level": "3",
        "phenotypes": "Fabry Disease"
      },
      {
        "variant": "rs28935490",
        "gene": "GLA",
        "level": "3",
        "phenotypes": "Fabry Disease"
      },
      {
        "variant": "rs869312138",
        "gene": "GLA,HNRNPH2",
        "level": "3",
        "phenotypes": "Fabry Disease"
      },
      {
        "variant": "rs398123217",
        "gene": "GLA",
        "level": "3",
        "phenotypes": "Fabry Disease"
      },
      {
        "variant": "rs397515874",
        "gene": "GLA",
        "level": "3",
        "phenotypes": "Fabry Disease"
      },
      {
        "variant": "rs727505292",
        "gene": "GLA",
        "level": "3",
        "phenotypes": "Fabry Disease"
      },
      {
        "variant": "rs869312399",
        "gene": "GLA",
        "level": "3",
        "phenotypes": "Fabry Disease"
      },
      {
        "variant": "rs104894828",
        "gene": "GLA",
        "level": "3",
        "phenotypes": "Fabry Disease"
      },
      {
        "variant": "rs398123226",
        "gene": "GLA",
        "level": "3",
        "phenotypes": "Fabry Disease"
      },
      {
        "variant": "rs727504348",
        "gene": "GLA",
        "level": "3",
        "phenotypes": "Fabry Disease"
      },
      {
        "variant": "rs190347120",
        "gene": "GLA",
        "level": "3",
        "phenotypes": "Fabry Disease"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for migalastat and GLA"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for migalastat and GLA"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for migalastat and GLA"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lovastatin acid": {
    "genes": [
      "PPARA",
      "SLCO1B1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "chiglitazar": {
    "genes": [
      "PPARA"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ketanserin": {
    "genes": [
      "HTR1B"
    ],
    "clinicalVariants": [
      {
        "variant": "rs130060",
        "gene": "HTR1B",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dihydroergotamine": {
    "genes": [
      "HTR1B"
    ],
    "clinicalVariants": [
      {
        "variant": "rs130060",
        "gene": "HTR1B",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "methysergide": {
    "genes": [
      "HTR1B"
    ],
    "clinicalVariants": [
      {
        "variant": "rs130060",
        "gene": "HTR1B",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "topoisomerase i inhibitors": {
    "genes": [
      "EGFR",
      "SLFN11"
    ],
    "clinicalVariants": [
      {
        "variant": "rs712829",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "geldanamycin": {
    "genes": [
      "EGFR"
    ],
    "clinicalVariants": [
      {
        "variant": "rs712829",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "egfr inhibitors": {
    "genes": [
      "EGFR",
      "PIK3CA",
      "HLA-A",
      "PIK3R1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2227983",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms,Neoplasms,Non-Small Cell Lung Carcinoma,Pancreatic Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "alkylating agents": {
    "genes": [
      "EGFR",
      "ESR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs712829",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs2207396",
        "gene": "ESR1",
        "level": "3",
        "phenotypes": "Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "atezolizumab": {
    "genes": [
      "EGFR",
      "IL7",
      "SMAD3",
      "SEMA5A",
      "HLA-A",
      "ALK",
      "GABRP",
      "BRAF",
      "CD274",
      "SLCO1B1",
      "EDIL3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for atezolizumab and ALK, CD274, EGFR"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for atezolizumab and ALK, CD274, EGFR"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for atezolizumab and ALK, BRAF, CD274, EGFR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "durvalumab": {
    "genes": [
      "EGFR",
      "PDCD1",
      "SMAD3",
      "SEMA5A",
      "HLA-A",
      "ALK",
      "GABRP",
      "CD274",
      "SLCO1B1",
      "EDIL3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for durvalumab and ALK, CD274, EGFR, PDCD1"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for durvalumab and CD274"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for durvalumab and ALK, CD274, EGFR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dacomitinib": {
    "genes": [
      "EGFR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for dacomitinib and EGFR"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for dacomitinib and EGFR"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for dacomitinib and EGFR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ipilimumab": {
    "genes": [
      "EGFR",
      "IL7",
      "SMAD3",
      "KRAS",
      "SEMA5A",
      "HLA-A",
      "ALK",
      "GABRP",
      "CD274",
      "SLCO1B1",
      "EDIL3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for ipilimumab and ALK, CD274, EGFR"
      },
      {
        "source": "EMA",
        "level": "No Clinical PGx",
        "name": "Annotation of EMA Label for ipilimumab and HLA-A"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for ipilimumab and ALK, CD274, EGFR"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for ipilimumab and ALK, CD274, EGFR"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for ipilimumab and HLA-A"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ramucirumab": {
    "genes": [
      "EGFR",
      "KRAS",
      "ALK"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for ramucirumab"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for ramucirumab and KRAS"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for ramucirumab and EGFR"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for ramucirumab and ALK, EGFR"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for ramucirumab and KRAS"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tepotinib": {
    "genes": [
      "EGFR",
      "MET",
      "ALK"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for tepotinib and MET"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for tepotinib and MET"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for tepotinib and ALK, EGFR"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for tepotinib and MET"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cemiplimab-rwlc": {
    "genes": [
      "EGFR",
      "ROS1",
      "ALK",
      "CD274"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for cemiplimab-rwlc and ALK, CD274, EGFR, ROS1"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for cemiplimab-rwlc and ALK, CD274, EGFR, ROS1"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for cemiplimab-rwlc and ALK, CD274, EGFR, ROS1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mobocertinib": {
    "genes": [
      "EGFR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for mobocertinib and EGFR"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for mobocertinib"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for mobocertinib"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tremelimumab": {
    "genes": [
      "EGFR",
      "ALK",
      "CD274"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for tremelimumab and ALK, EGFR"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for tremelimumab"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for tremelimumab and ALK, EGFR"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for tremelimumab and CD274"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lazertinib": {
    "genes": [
      "EGFR",
      "GSTM1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for lazertinib and GSTM1"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for lazertinib and EGFR"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for lazertinib and EGFR"
      },
      {
        "source": "EMA",
        "level": "No Clinical PGx",
        "name": "Annotation of EMA Label for lazertinib and GSTM1"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for lazertinib and EGFR"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for lazertinib and GSTM1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "amivantamab": {
    "genes": [
      "EGFR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for amivantamab and EGFR"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for amivantamab and EGFR"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for amivantamab and EGFR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tegafur": {
    "genes": [
      "EGFR",
      "CDX2",
      "DPYD",
      "FASTKD3",
      "MTRR",
      "CDA",
      "UMPS",
      "C18orf56",
      "CYP2A6",
      "SMAD7",
      "TYMS"
    ],
    "clinicalVariants": [
      {
        "variant": "rs67376798",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs3918290",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs55886062",
        "gene": "DPYD",
        "level": "1A",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs183205964",
        "gene": "TYMS",
        "level": "3",
        "phenotypes": "Neoplasms"
      },
      {
        "variant": "rs712830",
        "gene": "EGFR",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs8192725",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs28399433",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs8192720",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1801019",
        "gene": "UMPS",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10, CYP2A6*11, CYP2A6*18, CYP2A6*19, CYP2A6*46",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": "Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "An Italian working group comprising the Italian Association of Medical Oncology (AIOM) and the Italian Society of Pharmacology (SIF) has published recommendations for the use of DPYD genotype when prescribing fluoropyrimidines (5-fluorouracil, capecitabine and tegafur).\n",
      "source": "AIOM"
    }
  },
  "cannabidiol": {
    "genes": [
      "AOC1",
      "ABCC5",
      "SLC15A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "protein kinase inhibitors": {
    "genes": [
      "STAT6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "3,4-methylenedioxymethamphetamine": {
    "genes": [
      "CYP2B6",
      "CYP2D6",
      "OPRM1",
      "CYP2C19",
      "SLC6A2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "non-nucleoside reverse transcriptase inhibitors": {
    "genes": [
      "CYP2B6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "artemisinin": {
    "genes": [
      "CYP2B6",
      "G6PD",
      "CYP3A4",
      "CYP2A6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "artemether": {
    "genes": [
      "CYP2B6",
      "CYP3A4",
      "CYP3A5"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2B6*1, CYP2B6*6",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "arteether": {
    "genes": [
      "CYP2B6",
      "CYP3A4",
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dihydroartemisinin": {
    "genes": [
      "CYP2B6",
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "efavirenz / emtricitabine / tenofovir disoproxil": {
    "genes": [
      "CYP2B6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for efavirenz / emtricitabine / tenofovir disoproxil and CYP2B6"
      },
      {
        "source": "EMA",
        "level": "Informative PGx",
        "name": "Annotation of EMA Label for efavirenz / emtricitabine / tenofovir disoproxil and CYP2B6"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for efavirenz / emtricitabine / tenofovir disoproxil and CYP2B6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "s-methadone": {
    "genes": [
      "CYP2B6",
      "CYP2D6",
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "hydroxybupropion": {
    "genes": [
      "CYP2B6",
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "r-eddp": {
    "genes": [
      "CYP2B6",
      "CYP2D6",
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "desbutyl lumefantrine": {
    "genes": [
      "CYP2B6",
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "chlorambucil": {
    "genes": [
      "CYP2B6",
      "CXCL12"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1801157",
        "gene": "CXCL12",
        "level": "3",
        "phenotypes": "Leukemia, Lymphocytic, Chronic, B-Cell"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fludarabine": {
    "genes": [
      "CYP2B6",
      "CXCL12",
      "CYP2E1",
      "SULT2B1",
      "SLCO1B1",
      "SLC22A12",
      "ADH1A"
    ],
    "clinicalVariants": [
      {
        "variant": "rs11231825",
        "gene": "SLC22A12",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs2070673",
        "gene": "CYP2E1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs2302948",
        "gene": "SULT2B1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs2515641",
        "gene": "CYP2E1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs1801157",
        "gene": "CXCL12",
        "level": "3",
        "phenotypes": "Leukemia, Lymphocytic, Chronic, B-Cell"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "levonorgestrel": {
    "genes": [
      "CYP2B6",
      "ADAMTS10",
      "TP53",
      "UGT1A1",
      "NAT2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "medroxyprogesterone": {
    "genes": [
      "CYP2B6",
      "ESR2",
      "VDR",
      "NAT2",
      "ESR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs9340799",
        "gene": "ESR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1544410",
        "gene": "VDR",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for medroxyprogesterone"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for medroxyprogesterone and ESR1, ESR2"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for medroxyprogesterone"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "eplerenone": {
    "genes": [
      "ATP1A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "capmatinib": {
    "genes": [
      "MET"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for capmatinib and MET"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for capmatinib and MET"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for capmatinib and MET"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "alpha-adrenoreceptor antagonists": {
    "genes": [
      "ADRA1A",
      "ADRA1B",
      "ADRA1D"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dihydropyridine derivatives": {
    "genes": [
      "ADRA1A",
      "RYR3",
      "APCDD1",
      "NUMA1",
      "NOS1AP",
      "CYP3A5"
    ],
    "clinicalVariants": [
      {
        "variant": "rs10494366",
        "gene": "NOS1AP",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dopamine": {
    "genes": [
      "ADRA1A",
      "ADRA2A",
      "ADRA1B",
      "ADRA2B",
      "ADRA2C",
      "ADRA1D"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "epinephrine": {
    "genes": [
      "ADRA1A",
      "ADRA2A",
      "ADRA1B",
      "ADRA2B",
      "ADRB2",
      "ADRA2C",
      "ADRA1D"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "methoxamine": {
    "genes": [
      "ADRA1A",
      "ADRA1B",
      "ADRA1D"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nifedipine": {
    "genes": [
      "ADRA1A",
      "ACE2",
      "SLC14A2",
      "CACNA1C",
      "MMP9",
      "CYP3A4",
      "ADRB2",
      "NOS1AP",
      "CYP3A5",
      "ADIPOQ",
      "ACE"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1123617",
        "gene": "SLC14A2",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs3745009",
        "gene": "SLC14A2",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs776746",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "Pregnancy"
      },
      {
        "variant": "rs1048101",
        "gene": "ADRA1A",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "CYP3A4*1, CYP3A4*17",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "norepinephrine": {
    "genes": [
      "ADRA1A",
      "ADRA2A",
      "ADRA1B",
      "ADRA2B",
      "ADRA2C",
      "ACE",
      "ADRA1D"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "phenylephrine": {
    "genes": [
      "ADRA1A",
      "ADRA1B",
      "ADRB2",
      "ADRA1D"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dextromethorphan": {
    "genes": [
      "PHETA2",
      "CYP2D6",
      "TCF20",
      "SMDT1",
      "IP6K2",
      "NFIB",
      "CYP3A4",
      "SEPTIN3",
      "WBP2NL",
      "CYP2D7"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*4x2, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*10x2, CYP2D6*13, CYP2D6*14, CYP2D6*15, CYP2D6*17, CYP2D6*18, CYP2D6*21, CYP2D6*29, CYP2D6*31, CYP2D6*36, CYP2D6*40, CYP2D6*41, CYP2D6*42, CYP2D6*44, CYP2D6*49, CYP2D6*52, CYP2D6*55, CYP2D6*56, CYP2D6*59, CYP2D6*69, CYP2D6*84, CYP2D6*100, CYP2D6*101",
        "gene": "CYP2D6",
        "level": "1B",
        "phenotypes": ""
      },
      {
        "variant": "rs777560972",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs750996195",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs745746329",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs371793722",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs138417770",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2D6*1, CYP2D6*7, CYP2D6*12, CYP2D6*26, CYP2D6*37, CYP2D6*47, CYP2D6*50, CYP2D6*51, CYP2D6*54, CYP2D6*62, CYP2D6*64, CYP2D6*71, CYP2D6*72, CYP2D6*75, CYP2D6*87, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*92, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*96, CYP2D6*97, CYP2D6*98, CYP2D6*114, CYP2D6*134, CYP2D6*153, CYP2D6*169",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for dextromethorphan and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "eteplirsen": {
    "genes": [
      "DMD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for eteplirsen and DMD"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for eteplirsen"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for eteplirsen"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "golodirsen": {
    "genes": [
      "DMD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for golodirsen and DMD"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for golodirsen"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for golodirsen"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "viltolarsen": {
    "genes": [
      "DMD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for viltolarsen and DMD"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for viltolarsen"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for viltolarsen"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "casimersen": {
    "genes": [
      "DMD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for casimersen and DMD"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for casimersen"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for casimersen"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "bromazepam": {
    "genes": [
      "CYP2D6",
      "CYP1A2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "flupenthixol": {
    "genes": [
      "CYP2D6",
      "NFKB1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no dosing recommendations for flupenthixol based on CYP2D6 genotype.\n",
      "source": "DPWG"
    }
  },
  "oxprenolol": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "formoterol": {
    "genes": [
      "CYP2D6",
      "CYP2C19",
      "ADRB2",
      "IL10",
      "IL17A"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for formoterol and CYP2C19, CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mianserin": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*5, CYP2D6*10",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Depression"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "levomepromazine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "atomoxetine": {
    "genes": [
      "CYP2D6",
      "CYP2C19",
      "HTR7",
      "SLC6A2"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*10, CYP2D6*17, CYP2D6*92, CYP2D6*96",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs3785143",
        "gene": "SLC6A2",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "rs12708954",
        "gene": "SLC6A2",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2D6*4, CYP2D6*5",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for atomoxetine and CYP2D6"
      },
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for atomoxetine and CYP2D6"
      },
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for atomoxetine and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for atomoxetine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "The CPIC Dosing Guideline for atomoxetine provides therapeutic recommendations for CYP2D6 ultrarapid, normal, intermediate, and poor metabolizer, which includes guidance for plasma drug concentration testing, as a means to estimate atomoxetine exposure, if no clinical response and in the absence of adverse events after 2 weeks of therapy. The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "tetrabenazine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Testing Required",
        "name": "Annotation of Swissmedic Label for tetrabenazine and CYP2D6"
      },
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for tetrabenazine and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for tetrabenazine and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for tetrabenazine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "opipramol": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*4",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Depression"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "anticholinergic agents": {
    "genes": [
      "CYP2D6",
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "enzyme inhibitors": {
    "genes": [
      "CYP2D6",
      "CYP19A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "opium derivatives and expectorants": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for Opium derivatives and expectorants and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "bevantolol": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "arformoterol": {
    "genes": [
      "CYP2D6",
      "UGT1A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for arformoterol and CYP2D6, UGT1A1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lofexidine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for lofexidine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tolterodine": {
    "genes": [
      "CYP2D6",
      "CYP3A4"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*10, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*92, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*96, CYP2D6*97, CYP2D6*98",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for tolterodine and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for tolterodine and CYP2D6"
      },
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for tolterodine and CYP2D6, CYP3A4"
      },
      {
        "source": "PMDA",
        "level": "Informative PGx",
        "name": "Annotation of PMDA Label for tolterodine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lisdexamfetamine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "penbutolol": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cevimeline": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for cevimeline and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "bepridil": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pregabalin": {
    "genes": [
      "CYP2D6",
      "SLC7A5",
      "NAT2",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4240803",
        "gene": "SLC7A5",
        "level": "3",
        "phenotypes": "adverse events,Neuropathic pain"
      },
      {
        "variant": "rs4240803",
        "gene": "SLC7A5",
        "level": "3",
        "phenotypes": "Neuropathic pain"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tiotropium": {
    "genes": [
      "CYP2D6",
      "ADRB2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Asthma"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for tiotropium and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "darifenacin": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for darifenacin and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for darifenacin and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for darifenacin and CYP2D6"
      },
      {
        "source": "EMA",
        "level": "Informative PGx",
        "name": "Annotation of EMA Label for darifenacin and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sertindole": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for sertindole and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "hydroxyamitriptyline": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "desvenlafaxine": {
    "genes": [
      "CYP2D6",
      "CYP2C19",
      "SLC6A4",
      "HTR7",
      "HTR2A",
      "UGT1A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for desvenlafaxine"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for desvenlafaxine and CYP2D6"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for desvenlafaxine"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of escitalopram, citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, duloxetine, venlafaxine, desvenlafaxine, vilazodone, vortioxetine, levomilnacipran, or milnacipran based on SLC6A4 genotypes.\n",
      "source": "CPIC"
    }
  },
  "bufuralol": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [
      {
        "variant": "rs777560972",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs750996195",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs745746329",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs371793722",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs138417770",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2D6*1, CYP2D6*7, CYP2D6*10, CYP2D6*12, CYP2D6*14, CYP2D6*17, CYP2D6*18, CYP2D6*27, CYP2D6*29, CYP2D6*36, CYP2D6*37, CYP2D6*39, CYP2D6*40, CYP2D6*47, CYP2D6*48, CYP2D6*49, CYP2D6*50, CYP2D6*51, CYP2D6*53, CYP2D6*54, CYP2D6*55, CYP2D6*62, CYP2D6*71, CYP2D6*72, CYP2D6*75, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*92, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*96, CYP2D6*97, CYP2D6*98, CYP2D6*114",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pridopidine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tafenoquine": {
    "genes": [
      "CYP2D6",
      "G6PD"
    ],
    "clinicalVariants": [
      {
        "variant": "rs62103056",
        "gene": "",
        "level": "3",
        "phenotypes": "Malaria"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for tafenoquine and G6PD"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for tafenoquine"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for tafenoquine"
      }
    ],
    "guidelines": {
      "advice": "High risk drugs should be avoided in G6PD deficient patients with or without chronic non-spherocytic hemolytic anemia (CNSHA). In patients with a G6PD variable or indeterminate phenotype an enzyme activity test should be carried out before initiating drug therapy.\nThe G6PD gene is located on the X chromosome. Therefore, some patients will only have one copy, whereas others will have two copies. See full guideline for disclaimers, further details and supporting evidence.\n",
      "source": "CPIC"
    }
  },
  "ibrutinib": {
    "genes": [
      "CYP2D6",
      "BTK",
      "MYD88",
      "ABCG2",
      "CYP3A4",
      "KCNQ1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for ibrutinib and CYP2D6"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for ibrutinib"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for ibrutinib"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for ibrutinib"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for ibrutinib and MYD88"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vortioxetine": {
    "genes": [
      "CYP2D6",
      "SLC6A4",
      "HTR2A"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*4, CYP2D6*10",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for vortioxetine and CYP2D6"
      },
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for vortioxetine and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for vortioxetine and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for vortioxetine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of escitalopram, citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, duloxetine, venlafaxine, desvenlafaxine, vilazodone, vortioxetine, levomilnacipran, or milnacipran based on SLC6A4 genotypes.\n",
      "source": "CPIC"
    }
  },
  "eliglustat": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "PMDA",
        "level": "Testing Required",
        "name": "Annotation of PMDA Label for eliglustat and CYP2D6"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for eliglustat and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for eliglustat and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for eliglustat and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "The Dutch Pharmacogenetics Working Group Guideline for eliglustat recommends to use an alternative in CYP2D6 ultrarapid metabolizer. For CYP2D6 poor metabolizer in combination with CYP3A inhibitors and strong inducers, the guideline recommends to choose an alternative if possible. For intermediate metabolizers recommendations are provided for renal and hepatic impairment.\n",
      "source": "DPWG"
    }
  },
  "casopitant": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "s-norfluoxetine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "noroxycodone": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "r-norfluoxetine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "n,n-didesmethyltramadol": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "n,o-didesmethyltramadol": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "desmethyl clomipramine": {
    "genes": [
      "CYP2D6",
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "noroxymorphone": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dapoxetine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*10, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for dapoxetine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tolperisone": {
    "genes": [
      "CYP2D6",
      "CYP2C19"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*4, CYP2D6*5",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for tolperisone and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "coptisine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*10",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "brexpiprazole": {
    "genes": [
      "CYP2D6",
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for brexpiprazole and CYP2D6"
      },
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for brexpiprazole and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for brexpiprazole and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for brexpiprazole and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "The Royal Dutch Pharmacists Association - Pharmacogenetics Working Group (DPWG) recommends to use half of the normal dose of brexpiprazole for poor metabolizers of CYP2D6.\n",
      "source": "DPWG"
    }
  },
  "aripiprazole lauroxil": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for aripiprazole lauroxil and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "paramethoxymethamphetamine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "rucaparib": {
    "genes": [
      "CYP2D6",
      "BRCA1",
      "BRCA2",
      "CYP1A2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for rucaparib and BRCA1, BRCA2"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for rucaparib and BRCA1, BRCA2"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for rucaparib and CYP1A2, CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for rucaparib"
      },
      {
        "source": "EMA",
        "level": "No Clinical PGx",
        "name": "Annotation of EMA Label for rucaparib and CYP1A2, CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "2-hydroxymethyl olanzapine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "deutetrabenazine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for deutetrabenazine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "valbenazine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for valbenazine"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for valbenazine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ritalinic acid": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dextromethorphan / quinidine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Informative PGx",
        "name": "Annotation of EMA Label for dextromethorphan / quinidine and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for dextromethorphan / quinidine"
      },
      {
        "source": "FDA",
        "level": "Testing Recommended",
        "name": "Annotation of FDA Label for dextromethorphan / quinidine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fluoxetine / olanzapine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for fluoxetine / olanzapine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cariprazine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for cariprazine and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for cariprazine and CYP2D6"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for cariprazine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "umeclidinium": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "No Clinical PGx",
        "name": "Annotation of EMA Label for umeclidinium and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for umeclidinium and CYP2D6"
      },
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for umeclidinium and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for umeclidinium and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "alpha-hydroxymetoprolol": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dextropropoxyphene": {
    "genes": [
      "CYP2D6",
      "CYP3A5"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP3A5*1, CYP3A5*3",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nordextropropoxyphene": {
    "genes": [
      "CYP2D6",
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "acetaminophen / codeine": {
    "genes": [
      "CYP2D6",
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for acetaminophen / codeine and G6PD"
      },
      {
        "source": "Swissmedic",
        "level": "Testing Required",
        "name": "Annotation of Swissmedic Label for acetaminophen / codeine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vernakalant": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for vernakalant and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "umeclidinium / vilanterol": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for umeclidinium / vilanterol and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "paracetamol, combinations excl. psycholeptics (vicks medinait sirup)": {
    "genes": [
      "CYP2D6",
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for paracetamol, combinations excl. Psycholeptics (Vicks MediNait Sirup) and CYP2D6, G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mephedrone": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pitolisant": {
    "genes": [
      "CYP2D6",
      "HRH3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for pitolisant and CYP2D6"
      },
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for pitolisant and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for pitolisant and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "upadacitinib": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for upadacitinib and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for upadacitinib and CYP2D6"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for upadacitinib and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "desethyl hydroxychloroquine": {
    "genes": [
      "CYP2D6",
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "desethylchloroquine": {
    "genes": [
      "CYP2D6",
      "CYP2C8"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dihydromorphine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ethylmorphine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*4",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ketobemidone": {
    "genes": [
      "CYP2D6",
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "oliceridine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for oliceridine and CYP2D6"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for oliceridine"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for oliceridine"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "acetaminophen / caffeine / dihydrocodeine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for acetaminophen / caffeine / dihydrocodeine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "beta-dihydrodeutetrabenazine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "alpha-dihydrodeutetrabenazine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "viloxazine": {
    "genes": [
      "CYP2D6",
      "SLCO1B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for viloxazine and SLCO1B1"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for viloxazine and CYP2D6"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for viloxazine"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for viloxazine"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "norquetiapine": {
    "genes": [
      "CYP2D6",
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dextromethorphan hydrobromide / bupropion hydrochloride": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for dextromethorphan hydrobromide / bupropion hydrochloride"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for dextromethorphan hydrobromide / bupropion hydrochloride"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for dextromethorphan hydrobromide / bupropion hydrochloride and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "solanidine": {
    "genes": [
      "CYP2D6",
      "NFIB"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "apatinib-25-n-oxide": {
    "genes": [
      "CYP2D6",
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pyrantel": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ulotaront": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "primaquine 5,6-orthoquinone": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ibogaine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "xanomeline / trospium": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for xanomeline / trospium and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "iloperidone metabolite p88": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "4-hydroxysolanidine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "amoxapine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for amoxapine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cimetidine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "desipramine": {
    "genes": [
      "CYP2D6",
      "CYP2C19",
      "BDNF",
      "CYP3A4",
      "SLC6A2",
      "MC1R",
      "CYP1A2"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Major Depressive Disorder,Mental Disorders"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Depressive Disorder,Major Depressive Disorder"
      },
      {
        "variant": "rs61888800",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": "Depression,Major Depressive Disorder"
      },
      {
        "variant": "rs2228479",
        "gene": "MC1R",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs2228478",
        "gene": "MC1R",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for desipramine and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for desipramine"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for desipramine"
      }
    ],
    "guidelines": {
      "advice": "Tricyclic antidepressants have comparable pharmacokinetic properties, it may be reasonable to apply the CPIC Dosing Guideline for amitriptyline/nortriptyline and CYP2C19, CYP2D6 to other tricyclics including desipramine. The CPIC Dosing Guideline update for nortriptyline recommends a 25% dose reduction for CYP2D6 intermediate metabolizers. For CYP2D6 ultrarapid or poor metabolizers, an alternative drug should be considered. If nortriptyline is warranted, consider a 50% dose reduction in CYP2D6 poor metabolizers. The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "dexmedetomidine": {
    "genes": [
      "CYP2D6",
      "ADRA2A",
      "CACNA2D2",
      "KCNMA1",
      "PRKCB",
      "ADRA2B",
      "KCNMB1",
      "ABCC9",
      "NR1I2",
      "ABCG2",
      "KCNA3",
      "ADRB2",
      "CACNB2",
      "CYP2A6",
      "GABRA2",
      "WBP2NL",
      "CYP1A2",
      "UGT2B10"
    ],
    "clinicalVariants": [
      {
        "variant": "rs9922316",
        "gene": "PRKCB",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1800544",
        "gene": "ADRA2A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1800035",
        "gene": "ADRA2A",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs201376588",
        "gene": "ADRA2A",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      },
      {
        "variant": "rs775887911",
        "gene": "ADRA2A",
        "level": "3",
        "phenotypes": "Pain, Postoperative"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "disopyramide": {
    "genes": [
      "CYP2D6",
      "KCNH2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs104894021",
        "gene": "KCNH2",
        "level": "3",
        "phenotypes": "short qt syndrome 1"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no dosing recommendations for disopyramide based on CYP2D6 genotype.\n",
      "source": "DPWG"
    }
  },
  "dolasetron": {
    "genes": [
      "CYP2D6",
      "NOS1AP"
    ],
    "clinicalVariants": [
      {
        "variant": "rs10494366",
        "gene": "NOS1AP",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2D6*1, CYP2D6*1xN",
        "gene": "CYP2D6",
        "level": "4",
        "phenotypes": "Postoperative Nausea and Vomiting"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fluphenazine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "hydrocodone": {
    "genes": [
      "CYP2D6",
      "OPRM1",
      "MACROD2",
      "SEPTIN3",
      "WBP2NL",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*17, CYP2D6*41",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "CYP2D6*5, CYP2D6*17",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Pain"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*3, CYP2D6*4",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*2xN",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Constipation,Dry mouth,Respiratory Insufficiency"
      },
      {
        "variant": "rs62436463",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "adverse events"
      },
      {
        "variant": "rs739296",
        "gene": "SEPTIN3,WBP2NL",
        "level": "3",
        "phenotypes": "adverse events"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "CYP2D6 intermediate and poor metabolizers should initiate hydrocodone therapy using the label recommended age- or weight-specific dosing. However, if there is no response to hydrocodone in these patients, an alternative analgesic should be considered.\nThere is insufficient evidence to provide a dosing recommendation for hydrocodone in CYP2D6 ultrarapid metabolizers.\n",
      "source": "CPIC"
    }
  },
  "imipramine": {
    "genes": [
      "CYP2D6",
      "CYP2C19",
      "UGT1A4",
      "BDNF",
      "CYP3A4",
      "CYP1A2"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN, CYP2D6*4, CYP2D6*5",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Depressive Disorder"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Major Depressive Disorder,Mental Disorders"
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",
        "gene": "CYP2C19",
        "level": "1A",
        "phenotypes": "Depressive Disorder,Major Depressive Disorder"
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for imipramine and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for imipramine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Tricyclic antidepressants have comparable pharmacokinetic properties, it may be reasonable to apply the CPIC Dosing Guideline for amitriptyline and CYP2C19, CYP2D6 to other tricyclics including imipramine. The CPIC Dosing Guideline update for amitriptyline recommends an alternative drug for CYP2D6 ultrarapid or poor metabolizers and CYP2C19 ultrarapid, rapid or poor metabolizers. If amitriptyline is warranted, consider a 50% dose reduction in CYP2D6 or CYP2C19 poor metabolizers. For CYP2D6 intermediate metabolizers, a 25% dose reduction should be considered. The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "leuprolide": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "loratadine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "maprotiline": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*4",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Depression"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "meclizine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for meclizine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mexiletine": {
    "genes": [
      "CYP2D6",
      "SCN4A"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1567817380",
        "gene": "SCN4A",
        "level": "3",
        "phenotypes": "Myotonic Disorders"
      },
      {
        "variant": "rs121908560",
        "gene": "SCN4A",
        "level": "3",
        "phenotypes": "Myotonic Disorders"
      },
      {
        "variant": "rs886043595",
        "gene": "SCN4A",
        "level": "3",
        "phenotypes": "Myotonic Disorders"
      },
      {
        "variant": "rs80338792",
        "gene": "SCN4A",
        "level": "3",
        "phenotypes": "Myotonia"
      },
      {
        "variant": "rs121908547",
        "gene": "SCN4A",
        "level": "3",
        "phenotypes": "Myotonic Disorders"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "oxymorphone": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pimozide": {
    "genes": [
      "CYP2D6",
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for pimozide and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for pimozide and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Patients who are CYP2D6 intermediate metabolizers should be given no more than 80% of the standard maximum dose of pimozide while patients who are CYP2D6 poor metabolizers should be given no more than 50% of the standard maximum dose.\n",
      "source": "DPWG"
    }
  },
  "propafenone": {
    "genes": [
      "CYP2D6",
      "SCN4A",
      "SCN5A"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*36",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Cardiac rhythm disease,Tachycardia"
      },
      {
        "variant": "CYP2D6*1, CYP2D6*10",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": "Cardiac rhythm disease"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for propafenone and CYP2D6"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for propafenone and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for propafenone and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Reduce the dose of propafenone by 70% for CYP2D6 poor metabolizers, and monitor propafenone plasma concentrations or use an alternative drug for CYP2D6 intermediate and ultrarapid metabolizers.\n",
      "source": "DPWG"
    }
  },
  "protriptyline": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for protriptyline and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "quinine": {
    "genes": [
      "CYP2D6",
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for quinine and G6PD"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for quinine and G6PD"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for quinine and G6PD"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for quinine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "sulfasalazine": {
    "genes": [
      "CYP2D6",
      "MTHFR",
      "ATIC",
      "HLA-DQB1",
      "G6PD",
      "SHMT1",
      "HLA-A",
      "SLC19A1",
      "ABCG2",
      "MTR",
      "C18orf56",
      "DHFR",
      "HLA-B",
      "HLA-DRB1",
      "SLCO2B1",
      "NAT2",
      "TYMS"
    ],
    "clinicalVariants": [
      {
        "variant": "G6PD A- 202A_376G, G6PD B (reference)",
        "gene": "G6PD",
        "level": "3",
        "phenotypes": "Hemolysis"
      },
      {
        "variant": "HLA-B*39:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms"
      },
      {
        "variant": "HLA-B*13:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms"
      },
      {
        "variant": "HLA-B*15:05",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Reaction with Eosinophilia and Systemic Symptoms"
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs72552713",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1805087",
        "gene": "MTR",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for sulfasalazine and G6PD"
      },
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for sulfasalazine and G6PD"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for sulfasalazine and G6PD"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for sulfasalazine and G6PD"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for sulfasalazine and NAT2"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for sulfasalazine and NAT2"
      }
    ],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "tamsulosin": {
    "genes": [
      "CYP2D6",
      "CYP3A4",
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for tamsulosin and CYP2D6, CYP3A4"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for tamsulosin and CYP2D6"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for tamsulosin and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "terbinafine": {
    "genes": [
      "CYP2D6",
      "HLA-A"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for terbinafine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "thioridazine": {
    "genes": [
      "CYP2D6",
      "CYP2C19"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1080985",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for thioridazine and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "toremifene": {
    "genes": [
      "CYP2D6",
      "ESR2",
      "ESR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for toremifene and ESR1, ESR2"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for toremifene and ESR1, ESR2"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for toremifene"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sparteine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*8, CYP2D6*10, CYP2D6*11, CYP2D6*12, CYP2D6*18, CYP2D6*35xN, CYP2D6*41, CYP2D6*59, CYP2D6*62",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "debrisoquine": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*8, CYP2D6*9, CYP2D6*10, CYP2D6*15, CYP2D6*17, CYP2D6*18, CYP2D6*21, CYP2D6*29, CYP2D6*36xN, CYP2D6*38",
        "gene": "CYP2D6",
        "level": "2A",
        "phenotypes": ""
      },
      {
        "variant": "rs1080985",
        "gene": "CYP2D6",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "zuclopenthixol": {
    "genes": [
      "CYP2D6"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2D6*1, CYP2D6*3, CYP2D6*4",
        "gene": "CYP2D6",
        "level": "1A",
        "phenotypes": "Schizophrenia"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "",
        "name": "Annotation of Swissmedic Label for zuclopenthixol and CYP2D6"
      }
    ],
    "guidelines": {
      "advice": "For CYP2D6 poor and intermediate metabolizers, reduce zuclopenthixol dose. For ultrarapid metabolizers, if the effectiveness is insufficient a dose increase not exceeding 1.5x normal dose is suggested.\n",
      "source": "DPWG"
    }
  },
  "meperidine": {
    "genes": [
      "FIP1L1",
      "SERINC5",
      "CYP2C19",
      "UGT1A1",
      "CYP3A5"
    ],
    "clinicalVariants": [
      {
        "variant": "rs113100019",
        "gene": "FIP1L1",
        "level": "3",
        "phenotypes": "adverse events"
      },
      {
        "variant": "rs11049274",
        "gene": "",
        "level": "3",
        "phenotypes": "adverse events"
      },
      {
        "variant": "rs185462714",
        "gene": "SERINC5",
        "level": "3",
        "phenotypes": "adverse events"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "brimonidine": {
    "genes": [
      "ADRA2A",
      "ADRA2B",
      "ADRA2C"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "doxazosin": {
    "genes": [
      "ADRA2A",
      "ADRA1B",
      "KCNH2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "phenoxybenzamine": {
    "genes": [
      "ADRA2A",
      "ADRA1B"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "yohimbine": {
    "genes": [
      "ADRA2A",
      "ADRA2B",
      "ADRA2C"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "amikacin": {
    "genes": [
      "MT-RNR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs267606617",
        "gene": "MT-RNR1",
        "level": "1A",
        "phenotypes": "Ototoxicity"
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for amikacin"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for amikacin and MT-RNR1"
      }
    ],
    "guidelines": {
      "advice": "Administration of aminoglycoside antibiotics should be avoided in patients carrying certain MT-RNR1 variants due to the increased risk of developing aminoglycoside-induced hearing loss (AIHL). The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "netilmicin": {
    "genes": [
      "MT-RNR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Administration of aminoglycoside antibiotics should be avoided in patients carrying certain MT-RNR1 variants due to the increased risk of developing aminoglycoside-induced hearing loss (AIHL). The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "paromomycin": {
    "genes": [
      "MT-RNR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Administration of aminoglycoside antibiotics should be avoided in patients carrying certain MT-RNR1 variants due to the increased risk of developing aminoglycoside-induced hearing loss (AIHL). The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "plazomicin": {
    "genes": [
      "MT-RNR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for plazomicin and MT-RNR1"
      }
    ],
    "guidelines": {
      "advice": "Administration of aminoglycoside antibiotics should be avoided in patients carrying certain MT-RNR1 variants due to the increased risk of developing aminoglycoside-induced hearing loss (AIHL). The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "isepamicin": {
    "genes": [
      "MT-RNR1",
      "MT-ND1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs267606617",
        "gene": "MT-ND1,MT-RNR1",
        "level": "3",
        "phenotypes": "Ototoxicity"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "micronomicin": {
    "genes": [
      "MT-RNR1",
      "MT-ND1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs267606619",
        "gene": "MT-ND1,MT-RNR1",
        "level": "3",
        "phenotypes": "Ototoxicity"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "hygromycin b": {
    "genes": [
      "MT-RNR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dihydrostreptomycin": {
    "genes": [
      "MT-RNR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1556422499",
        "gene": "MT-RNR1",
        "level": "3",
        "phenotypes": "Ototoxicity"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dibekacin": {
    "genes": [
      "MT-RNR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Administration of aminoglycoside antibiotics should be avoided in patients carrying certain MT-RNR1 variants due to the increased risk of developing aminoglycoside-induced hearing loss (AIHL). The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "ribostamycin": {
    "genes": [
      "MT-RNR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Administration of aminoglycoside antibiotics should be avoided in patients carrying certain MT-RNR1 variants due to the increased risk of developing aminoglycoside-induced hearing loss (AIHL). The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "gentamicin": {
    "genes": [
      "MT-RNR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs267606619",
        "gene": "MT-RNR1",
        "level": "1A",
        "phenotypes": "Ototoxicity"
      },
      {
        "variant": "rs267606618",
        "gene": "MT-RNR1",
        "level": "1A",
        "phenotypes": "Ototoxicity"
      },
      {
        "variant": "rs267606617",
        "gene": "MT-RNR1",
        "level": "1A",
        "phenotypes": "Ototoxicity"
      },
      {
        "variant": "rs28358569",
        "gene": "MT-RNR1",
        "level": "3",
        "phenotypes": "Ototoxicity"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for gentamicin and MT-RNR1"
      }
    ],
    "guidelines": {
      "advice": "Administration of aminoglycoside antibiotics should be avoided in patients carrying certain MT-RNR1 variants due to the increased risk of developing aminoglycoside-induced hearing loss (AIHL). The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "kanamycin": {
    "genes": [
      "MT-RNR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs267606617",
        "gene": "MT-RNR1",
        "level": "1A",
        "phenotypes": "Ototoxicity"
      },
      {
        "variant": "rs267606619",
        "gene": "MT-RNR1",
        "level": "1A",
        "phenotypes": "Ototoxicity"
      },
      {
        "variant": "rs267606618",
        "gene": "MT-RNR1",
        "level": "1A",
        "phenotypes": "Ototoxicity"
      },
      {
        "variant": "rs28358571",
        "gene": "",
        "level": "3",
        "phenotypes": "Ototoxicity"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Administration of aminoglycoside antibiotics should be avoided in patients carrying certain MT-RNR1 variants due to the increased risk of developing aminoglycoside-induced hearing loss (AIHL). The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "neomycin": {
    "genes": [
      "MT-RNR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs267606617",
        "gene": "MT-RNR1",
        "level": "1A",
        "phenotypes": "Ototoxicity"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for neomycin and MT-RNR1"
      }
    ],
    "guidelines": {
      "advice": "Administration of aminoglycoside antibiotics should be avoided in patients carrying certain MT-RNR1 variants due to the increased risk of developing aminoglycoside-induced hearing loss (AIHL). The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "tobramycin": {
    "genes": [
      "MT-RNR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs267606617",
        "gene": "MT-RNR1",
        "level": "1A",
        "phenotypes": "Ototoxicity"
      },
      {
        "variant": "rs267606619",
        "gene": "MT-RNR1",
        "level": "1A",
        "phenotypes": "Ototoxicity"
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for tobramycin and MT-RNR1"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for tobramycin and MT-RNR1"
      }
    ],
    "guidelines": {
      "advice": "Administration of aminoglycoside antibiotics should be avoided in patients carrying certain MT-RNR1 variants due to the increased risk of developing aminoglycoside-induced hearing loss (AIHL). The guideline has been updated since its original publication. Please see the guideline annotation for more information.\n",
      "source": "CPIC"
    }
  },
  "aminoglycoside antibacterials": {
    "genes": [
      "MT-RNR1",
      "GSTT1",
      "MT-ND1",
      "GSTM1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs267606617",
        "gene": "MT-RNR1",
        "level": "1A",
        "phenotypes": "Ototoxicity"
      },
      {
        "variant": "rs267606619",
        "gene": "MT-RNR1",
        "level": "1A",
        "phenotypes": "Ototoxicity"
      },
      {
        "variant": "rs267606618",
        "gene": "MT-RNR1",
        "level": "1A",
        "phenotypes": "Ototoxicity"
      },
      {
        "variant": "rs1556422499",
        "gene": "MT-RNR1",
        "level": "3",
        "phenotypes": "Ototoxicity"
      },
      {
        "variant": "rs1603218569",
        "gene": "MT-ND1,MT-RNR1",
        "level": "3",
        "phenotypes": "Ototoxicity"
      },
      {
        "variant": "rs28358572",
        "gene": "",
        "level": "3",
        "phenotypes": "Ototoxicity"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mesalazine": {
    "genes": [
      "NAT1",
      "G6PD",
      "TPMT"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of chlorpropamide, dabrafenib, gliclazide, glimepiride, glipizide, mepacrine (aka quinacrine), mesalazine, moxifloxacin, nicorandil, nitrofural (aka nitrofurazone), probenecid, sodium nitrate, sulfacetamide, tolazamide or trametinib based on G6PD genotype.\n",
      "source": "CPIC"
    }
  },
  "telaprevir": {
    "genes": [
      "ITPA",
      "APOH",
      "IFNL4",
      "CYP24A1",
      "IFNL3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "1A",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs8099917",
        "gene": "IFNL3",
        "level": "2A",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs2585428",
        "gene": "CYP24A1",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Informative PGx",
        "name": "Annotation of EMA Label for telaprevir and IFNL3"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for telaprevir and IFNL3"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "simeprevir": {
    "genes": [
      "ITPA",
      "IFNL4",
      "IFNL3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs8099917",
        "gene": "IFNL3",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      },
      {
        "variant": "rs11322783",
        "gene": "IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for simeprevir and IFNL3"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for simeprevir and IFNL3"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sofosbuvir": {
    "genes": [
      "ITPA",
      "IFNL4",
      "CES1",
      "HINT1",
      "NME1",
      "IFNL3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection,Recurrence"
      },
      {
        "variant": "rs8099917",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs11322783",
        "gene": "IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for sofosbuvir and IFNL3, IFNL4"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for sofosbuvir and IFNL3"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "thioguanosine monophosphate": {
    "genes": [
      "ITPA",
      "TPMT"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "thioguanosine diphosphate": {
    "genes": [
      "ITPA",
      "TPMT"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "thioguanosine triphosphate": {
    "genes": [
      "ITPA",
      "TPMT",
      "PACSIN2",
      "NUDT15"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "iodine (131i) compounds": {
    "genes": [
      "TGFB1",
      "ATM",
      "NFKB1",
      "TNF",
      "ATG10"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vitamin b-complex, plain": {
    "genes": [
      "MTHFR",
      "MTRR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pyrimidine analogues": {
    "genes": [
      "MTHFR",
      "DPYD",
      "MIR27A"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vitamin b-complex, incl. combinations": {
    "genes": [
      "MTHFR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "aprepitant": {
    "genes": [
      "MTHFR",
      "UGT2B7",
      "HTR3C",
      "HTR3B"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ethinyl estradiol / norelgestromin": {
    "genes": [
      "MTHFR",
      "F5",
      "F2",
      "PROC",
      "PROS1",
      "SERPINC1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for ethinyl estradiol / norelgestromin and F2, F5, MTHFR, PROC, PROS1, SERPINC1"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for ethinyl estradiol / norelgestromin and F5, PROC, PROS1, SERPINC1"
      },
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for ethinyl estradiol / norelgestromin and F5, PROC, PROS1, SERPINC1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "levomefolic acid": {
    "genes": [
      "MTHFR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "l-methylfolate": {
    "genes": [
      "MTHFR"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "betaine": {
    "genes": [
      "MTHFR",
      "MMADHC",
      "CBS"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for betaine and CBS, MMADHC, MTHFR"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for betaine and CBS, MMADHC, MTHFR"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for betaine and CBS, MMADHC, MTHFR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vitamin b12 and folic acid": {
    "genes": [
      "MTHFR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nitrous oxide": {
    "genes": [
      "MTHFR"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cyanocobalamin": {
    "genes": [
      "MTHFR"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors": {
    "genes": [
      "IL7",
      "IL22RA1",
      "FTO",
      "IFNL3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs16906115",
        "gene": "IL7",
        "level": "3",
        "phenotypes": "adverse events"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "acetaldehyde": {
    "genes": [
      "SRPRB",
      "ADH1B",
      "PGM1",
      "ADH1A",
      "ALDH2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1229976",
        "gene": "ADH1A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1229984",
        "gene": "ADH1B",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4643",
        "gene": "PGM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs671",
        "gene": "ALDH2",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nalmefene": {
    "genes": [
      "OPRD1",
      "OPRM1",
      "OPRK1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "buprenorphine / naloxone": {
    "genes": [
      "OPRD1",
      "OPRM1",
      "UGT2B7"
    ],
    "clinicalVariants": [
      {
        "variant": "rs7662029",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      },
      {
        "variant": "rs7439366",
        "gene": "UGT2B7",
        "level": "3",
        "phenotypes": "Opioid-Related Disorders"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "norbuprenorphine": {
    "genes": [
      "OPRD1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "selective beta-2-adrenoreceptor agonists": {
    "genes": [
      "ARG1",
      "CRHR2",
      "VDR",
      "ADRB2",
      "ADAM33"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1540339",
        "gene": "VDR",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs2239179",
        "gene": "VDR",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs2781659",
        "gene": "ARG1",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs2267715",
        "gene": "CRHR2",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs255100",
        "gene": "CRHR2",
        "level": "4",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs2284220",
        "gene": "CRHR2",
        "level": "4",
        "phenotypes": "Asthma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "bosutinib": {
    "genes": [
      "CAMK2G",
      "BCR",
      "ABL1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for bosutinib and ABL1, BCR"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for bosutinib and ABL1, BCR"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for bosutinib and ABL1, BCR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "drotrecogin alfa": {
    "genes": [
      "DRD1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dextroamphetamine": {
    "genes": [
      "DRD1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4532",
        "gene": "DRD1",
        "level": "3",
        "phenotypes": "Attention Deficit Disorder with Hyperactivity"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "belimumab": {
    "genes": [
      "ANO3",
      "TNFSF13B"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for belimumab and TNFSF13B"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for belimumab and TNFSF13B"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for belimumab and TNFSF13B"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "amodiaquine": {
    "genes": [
      "CYP1A1",
      "G6PD",
      "CYP2C8",
      "CYP1B1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1050828",
        "gene": "G6PD",
        "level": "3",
        "phenotypes": "Malaria,Malaria, Falciparum"
      },
      {
        "variant": "rs11572080",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10509681",
        "gene": "CYP2C8",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dacarbazine": {
    "genes": [
      "CYP1A1",
      "GSTT1",
      "GSTM1",
      "EPM2AIP1",
      "CYP1A2"
    ],
    "clinicalVariants": [
      {
        "variant": "GSTM1 non-null, GSTM1 null",
        "gene": "GSTM1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "insulins and analogues": {
    "genes": [
      "SCNN1B"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "insulin recombinant": {
    "genes": [
      "SCNN1B",
      "G6PD",
      "SLC30A8"
    ],
    "clinicalVariants": [
      {
        "variant": "rs13266634",
        "gene": "SLC30A8",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "aldosterone": {
    "genes": [
      "SCNN1B"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "farglitazar": {
    "genes": [
      "SCNN1B"
    ],
    "clinicalVariants": [
      {
        "variant": "rs889299",
        "gene": "SCNN1B",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "triamterene": {
    "genes": [
      "SCNN1B",
      "SCNN1A",
      "SCNN1G"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "niraparib": {
    "genes": [
      "BRCA1",
      "BRCA2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for niraparib and BRCA1, BRCA2"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for niraparib and BRCA1, BRCA2"
      },
      {
        "source": "EMA",
        "level": "Informative PGx",
        "name": "Annotation of EMA Label for niraparib and BRCA1, BRCA2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "leflunomide": {
    "genes": [
      "PON1",
      "CYP2C19",
      "DHODH",
      "ESR2",
      "PTPN22",
      "ABCG2",
      "CYB5A",
      "CYP1A2",
      "ESR1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs9340799",
        "gene": "ESR1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs2234693",
        "gene": "ESR1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs3213422",
        "gene": "DHODH",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs762551",
        "gene": "CYP1A2",
        "level": "4",
        "phenotypes": "Rheumatoid arthritis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "certolizumab pegol": {
    "genes": [
      "ALPL",
      "HLA-E",
      "KLRC1",
      "EYA4",
      "CERS6",
      "KLRD1",
      "ATP5F1E",
      "VDR",
      "NCR3",
      "TNF"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1059150",
        "gene": "ATP5F1E",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs1264457",
        "gene": "HLA-E",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs2302489",
        "gene": "KLRD1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      },
      {
        "variant": "rs7301582",
        "gene": "KLRC1",
        "level": "3",
        "phenotypes": "Rheumatoid arthritis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "givosiran": {
    "genes": [
      "CPOX",
      "PPOX",
      "HMBS"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for givosiran and CPOX, HMBS, PPOX"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for givosiran and CPOX, HMBS, PPOX"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for givosiran and CPOX, HMBS, PPOX"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "direct thrombin inhibitors": {
    "genes": [
      "FGG",
      "F2",
      "FGA"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "direct factor xa inhibitors": {
    "genes": [
      "FGG",
      "F2",
      "FGA"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "abciximab": {
    "genes": [
      "FGG",
      "ITGA2B",
      "FGB",
      "ITGB3",
      "FGA"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "eptifibatide": {
    "genes": [
      "FGG",
      "ITGA2B",
      "FGB",
      "ITGB3",
      "FGA"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tirofiban": {
    "genes": [
      "FGG",
      "ITGA2B",
      "FGB",
      "ITGB3",
      "FGA"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "drospirenone / ethinyl estradiol": {
    "genes": [
      "F5",
      "CYP2C19",
      "PROC",
      "PROS1",
      "SERPINC1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for drospirenone / ethinyl estradiol and F5, PROC, PROS1, SERPINC1"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for drospirenone / ethinyl estradiol and CYP2C19"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lusutrombopag": {
    "genes": [
      "F5",
      "F2",
      "PROC",
      "PROS1",
      "SERPINC1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for lusutrombopag and F2, F5, PROC, PROS1, SERPINC1"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for lusutrombopag and F2, F5, PROC, PROS1, SERPINC1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "relugolix / estradiol / norethindrone acetate": {
    "genes": [
      "F5",
      "PROC",
      "PROS1",
      "SERPINC1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for relugolix / estradiol / norethindrone acetate and F5, PROC, PROS1, SERPINC1"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for relugolix / estradiol / norethindrone acetate and F5, PROC, PROS1, SERPINC1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "antithrombotic agents": {
    "genes": [
      "F5",
      "G6PD",
      "F2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for antithrombotic agents and G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "immunosuppressants": {
    "genes": [
      "GSTT1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "gabapentin": {
    "genes": [
      "SLC7A5",
      "GABRA1",
      "GABRA3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4240803",
        "gene": "SLC7A5",
        "level": "3",
        "phenotypes": "adverse events,Neuropathic pain"
      },
      {
        "variant": "rs4240803",
        "gene": "SLC7A5",
        "level": "3",
        "phenotypes": "Neuropathic pain"
      },
      {
        "variant": "rs4240803",
        "gene": "SLC7A5",
        "level": "3",
        "phenotypes": "Neuropathic pain"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "alpha-msh": {
    "genes": [
      "POMC"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "5-hydroxyindole-3-acetic acid": {
    "genes": [
      "MAOB"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "flunitrazepam": {
    "genes": [
      "GABRG1",
      "CYP2C19",
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "benzodiazepine derivatives": {
    "genes": [
      "OPRM1",
      "GAL"
    ],
    "clinicalVariants": [
      {
        "variant": "rs948854",
        "gene": "GAL",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Cardiac Arrest,Overdose,Respiratory Insufficiency"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "opioid anesthetics": {
    "genes": [
      "OPRM1",
      "ABCG2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "other general anesthetics": {
    "genes": [
      "OPRM1",
      "ABCG2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2231142",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sympathomimetics": {
    "genes": [
      "OPRM1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Cardiac Arrest,Overdose,Respiratory Insufficiency"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "butorphanol": {
    "genes": [
      "OPRM1",
      "OPRK1",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "rs702764",
        "gene": "OPRK1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4633",
        "gene": "COMT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6269",
        "gene": "COMT",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "acetaminophen / tramadol": {
    "genes": [
      "OPRM1",
      "G6PD",
      "MIR23B",
      "MIR107"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for acetaminophen, acetaminophen / tramadol and G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tianeptine": {
    "genes": [
      "OPRM1",
      "OPRK1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Major Depressive Disorder,suicidal ideation"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "alfentanil": {
    "genes": [
      "OPRM1",
      "CYP3A5",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Pain"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Pain"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of alfentanil, buprenorphine, codeine, fentanyl, hydrocodone, hydromorphone, levomethadone, naltrexone, remifentanil, sufentanil or tramadol based on OPRM1 or COMT genotypes.\n",
      "source": "CPIC"
    }
  },
  "naloxone": {
    "genes": [
      "OPRM1",
      "UGT2B7",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Erythema"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Vomiting"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Erythema"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "thiotepa": {
    "genes": [
      "ALDH1A1",
      "ALDH3A1",
      "GSTP1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs6151031",
        "gene": "ALDH1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1138272",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "platelet aggregation inhibitors excl. heparin": {
    "genes": [
      "CYP2C19",
      "GP1BA",
      "PEAR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "respiratory system": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ambrisentan": {
    "genes": [
      "CYP2C19",
      "CYP3A4",
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "etravirine": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4244285",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lafutidine": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "icotinib": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ginkgo biloba extract": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "3-cyano-7-ethoxycoumarin": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "selumetinib": {
    "genes": [
      "CYP2C19",
      "ABCG2",
      "BRAF",
      "UGT1A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lacosamide": {
    "genes": [
      "CYP2C19",
      "ABCC2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "No Clinical PGx",
        "name": "Annotation of EMA Label for lacosamide and CYP2C19"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for lacosamide and CYP2C19"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for lacosamide and CYP2C19"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "rilpivirine": {
    "genes": [
      "CYP2C19",
      "CYP3A4",
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "norclobazam": {
    "genes": [
      "CYP2C19",
      "GABRA2"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3",
        "gene": "CYP2C19",
        "level": "2A",
        "phenotypes": "Epilepsy"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "androstenedione": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "phenazepam": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12248560",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "normeperidine": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "belzutifan": {
    "genes": [
      "CYP2C19",
      "VHL",
      "UGT2B17"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for belzutifan and VHL"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for belzutifan and VHL"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for belzutifan and CYP2C19, UGT2B17"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for belzutifan and CYP2C19, UGT2B17"
      },
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for belzutifan and CYP2C19, UGT2B17"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for belzutifan and VHL"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mavacamten": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for mavacamten and CYP2C19"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for mavacamten and CYP2C19"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for mavacamten and CYP2C19"
      }
    ],
    "guidelines": {
      "advice": "The Dutch Pharmacogenetics Working Group Guideline for mavacamten recommends a lower dose for CYP2C19 poor metabolizers and to avoid mavacamten in CYP2C19 poor metabolizers with strong CYP3A4 inhibitor as co-medication.\n",
      "source": "DPWG"
    }
  },
  "6beta-hydroxytestosterone": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "16alpha-hydroxytestosterone": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "11alpha-hydroxytestosterone": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "16alpha-hydroxyprogesterone": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "11a-hydroxyprogesterone": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "6beta-hydroxyprogesterone": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "desoxycortone": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dt-678": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sulforidazine": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "amoxicillin": {
    "genes": [
      "CYP2C19",
      "HLA-DQB1",
      "ERAP1",
      "HLA-DRB5",
      "HLA-A",
      "PTPN22",
      "HLA-DRA",
      "VDR",
      "HLA-B",
      "HLA-DRB1",
      "ERAP2",
      "HLA-DPB1",
      "HLA-C"
    ],
    "clinicalVariants": [
      {
        "variant": "rs9274407",
        "gene": "HLA-DQB1",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "HLA-B*18:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "carisoprodol": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C19*1, CYP2C19*2",
        "gene": "CYP2C19",
        "level": "4",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for carisoprodol and CYP2C19"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for carisoprodol"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for carisoprodol"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "famotidine": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "hydroxyprogesterone": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ketoconazole": {
    "genes": [
      "CYP2C19",
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mephenytoin": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [
      {
        "variant": "rs11188072",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs12248560",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*5, CYP2C19*6, CYP2C19*7, CYP2C19*8",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs28399504",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C19*1, CYP2C19*5, CYP2C19*6, CYP2C19*8, CYP2C19*9, CYP2C19*10, CYP2C19*11, CYP2C19*13, CYP2C19*14, CYP2C19*15, CYP2C19*16, CYP2C19*18, CYP2C19*19, CYP2C19*22, CYP2C19*23, CYP2C19*24, CYP2C19*25, CYP2C19*26",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs61311738",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs145119820",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1187513719",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs144928727",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs183701923",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "methylphenobarbital": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*16",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mesoridazine": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "oxazepam": {
    "genes": [
      "CYP2C19",
      "UGT1A9",
      "UGT2B7",
      "CYP3A4",
      "UGT2B15",
      "UGT1A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1976391",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1902023",
        "gene": "UGT2B15",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "rabeprazole": {
    "genes": [
      "CYP2C19",
      "TNF",
      "IL1B"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3",
        "gene": "CYP2C19",
        "level": "2A",
        "phenotypes": ""
      },
      {
        "variant": "rs16944",
        "gene": "IL1B",
        "level": "3",
        "phenotypes": "Helicobacter Infections"
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Gastroesophageal Reflux,Helicobacter Infections,Peptic Ulcer Disease"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for rabeprazole and CYP2C19"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for rabeprazole and CYP2C19"
      },
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for rabeprazole and CYP2C19"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for rabeprazole and CYP2C19"
      }
    ],
    "guidelines": {
      "advice": "The CPIC Dosing Guideline for CYP2C19 and Proton Pump Inhibitor Dosing states that inconsistent findings regarding the effect of CYP2C19 genotype on the pharmacokinetics and therapeutic response to esomeprazole and rabeprazole preclude making recommendations for these proton pump inhibitors.\n",
      "source": "CPIC"
    }
  },
  "temazepam": {
    "genes": [
      "CYP2C19",
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ticlopidine": {
    "genes": [
      "CYP2C19",
      "HLA-DQB1",
      "P2RY12",
      "HLA-A",
      "HLA-B",
      "HLA-DRB1",
      "HLA-C"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-B*44:03",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "HLA-C*14:03",
        "gene": "HLA-C",
        "level": "3",
        "phenotypes": "Toxic liver disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tranylcypromine": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "troglitazone": {
    "genes": [
      "CYP2C19"
    ],
    "clinicalVariants": [
      {
        "variant": "rs10811661",
        "gene": "",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "moclobemide": {
    "genes": [
      "CYP2C19",
      "HTR2A"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for moclobemide and CYP2C19"
      }
    ],
    "guidelines": {
      "advice": "No action is needed for this gene-drug interaction.\n",
      "source": "DPWG"
    }
  },
  "chop": {
    "genes": [
      "NOS1",
      "ABCC2",
      "ABCG2",
      "CIDEA",
      "IL10",
      "SLC35F4",
      "NCF4",
      "CBR3",
      "OXNAD1",
      "TNIP3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nimesulide": {
    "genes": [
      "PTGS2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "coxibs": {
    "genes": [
      "PTGS2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "omega-3 polyunsaturated fatty acids": {
    "genes": [
      "PTGS2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "rofecoxib": {
    "genes": [
      "PTGS2",
      "PTGS1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs20417",
        "gene": "PTGS2",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "isatuximab": {
    "genes": [
      "CD38"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for isatuximab and CD38"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for isatuximab"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for isatuximab"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "maralixibat": {
    "genes": [
      "JAG1",
      "MYO5B",
      "ABCB11",
      "ATP8B1",
      "TJP2",
      "ABCB4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for maralixibat and ABCB11, ABCB4, ATP8B1, MYO5B, TJP2"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for maralixibat and JAG1"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for maralixibat and ABCB11, ABCB4, ATP8B1, MYO5B, TJP2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "odevixibat": {
    "genes": [
      "JAG1",
      "NOTCH2",
      "ABCB11",
      "ATP8B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for odevixibat and ABCB11, ATP8B1"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for odevixibat and JAG1, NOTCH2"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for odevixibat and ABCB11"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for odevixibat and ABCB11"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "epidermal growth factor receptor (egfr) tyrosine kinase inhibitors": {
    "genes": [
      "KIR3DL2",
      "CTBP2",
      "HLA-DRB5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "laropiprant": {
    "genes": [
      "PTGDR",
      "NR1H3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "avelumab": {
    "genes": [
      "SMAD3",
      "SEMA5A",
      "GABRP",
      "CD274",
      "SLCO1B1",
      "EDIL3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for avelumab and CD274"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for avelumab and CD274"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for avelumab and CD274"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "indapamide": {
    "genes": [
      "TRIB3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "perindopril": {
    "genes": [
      "TRIB3",
      "G6PD",
      "BDKRB1",
      "AGTR1",
      "BDKRB2",
      "ACE"
    ],
    "clinicalVariants": [
      {
        "variant": "rs5186",
        "gene": "AGTR1",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs275651",
        "gene": "AGTR1",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs12050217",
        "gene": "BDKRB1",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs5182",
        "gene": "AGTR1",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for perindopril and G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "adagrasib": {
    "genes": [
      "KRAS"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for adagrasib and KRAS"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for adagrasib and KRAS"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for adagrasib"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sotorasib": {
    "genes": [
      "KRAS"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for sotorasib and KRAS"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for sotorasib and KRAS"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for sotorasib and KRAS"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fruquintinib": {
    "genes": [
      "KRAS"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for fruquintinib and KRAS"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for fruquintinib and KRAS"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for fruquintinib and KRAS"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "aflibercept": {
    "genes": [
      "VEGFB",
      "ANO2",
      "VEGFA",
      "VEGFC"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "alendronate": {
    "genes": [
      "MVK",
      "ESR2",
      "SOST",
      "TNFRSF11A",
      "VDR",
      "DKK1",
      "SIRT1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs10161126",
        "gene": "MVK",
        "level": "3",
        "phenotypes": "Bone Diseases"
      },
      {
        "variant": "rs1544410",
        "gene": "VDR",
        "level": "3",
        "phenotypes": "Osteoporosis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vegf/vegfr (vascular endothelial growth factor) inhibitors": {
    "genes": [
      "TRIB1",
      "VEGFA"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "acamprosate": {
    "genes": [
      "CHDH",
      "GRIN2B",
      "GLRB",
      "IL17RB"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2058878",
        "gene": "GRIN2B",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      },
      {
        "variant": "rs77583603",
        "gene": "",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "first-generation cephalosporins": {
    "genes": [
      "HLA-DQB1",
      "HLA-B",
      "HLA-C"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fourth-generation cephalosporins": {
    "genes": [
      "HLA-DQB1",
      "HLA-B",
      "HLA-C"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "influenza vaccines": {
    "genes": [
      "HLA-DQB1",
      "HLA-DRB1"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-DQB1*06:02",
        "gene": "HLA-DQB1",
        "level": "3",
        "phenotypes": "Narcolepsy"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "other cephalosporins": {
    "genes": [
      "HLA-DQB1",
      "HLA-B",
      "HLA-C"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "third-generation cephalosporins": {
    "genes": [
      "HLA-DQB1",
      "HLA-B",
      "HLA-C"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "clavulanate": {
    "genes": [
      "HLA-DQB1",
      "ERAP1",
      "HLA-DRB5",
      "HLA-A",
      "PTPN22",
      "HLA-DRA",
      "HLA-B",
      "HLA-DRB1",
      "ERAP2",
      "HLA-C"
    ],
    "clinicalVariants": [
      {
        "variant": "rs9274407",
        "gene": "HLA-DQB1",
        "level": "3",
        "phenotypes": "Drug Toxicity"
      },
      {
        "variant": "HLA-B*18:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "bucillamine": {
    "genes": [
      "HLA-DQB1",
      "HLA-DRB1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "flupirtine": {
    "genes": [
      "HLA-DQB1",
      "HLA-DRB1"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-DRB1*16:01",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Drug-induced liver injury"
      },
      {
        "variant": "HLA-DQB1*05:02",
        "gene": "HLA-DQB1",
        "level": "3",
        "phenotypes": "Drug-induced liver injury"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "beta-lactam antibacterials, penicillins": {
    "genes": [
      "HLA-DQB1",
      "HLA-A",
      "HLA-DRB1",
      "HLA-C"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "other beta-lactam antibacterials": {
    "genes": [
      "HLA-DQB1",
      "HLA-A",
      "HLA-DRB1",
      "HLA-C"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "imidapril": {
    "genes": [
      "CYP11B2",
      "AGT",
      "BDKRB2",
      "KCNH2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1799998",
        "gene": "CYP11B2",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs5051",
        "gene": "AGT",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1799722",
        "gene": "BDKRB2",
        "level": "3",
        "phenotypes": "Cough,Essential hypertension"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "zenocutuzumab": {
    "genes": [
      "NRG1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for zenocutuzumab and NRG1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tildrakizumab": {
    "genes": [
      "TNFAIP3",
      "ATG5",
      "IL17RC",
      "PDE4D"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "l-tryptophan": {
    "genes": [
      "SLC22A2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs316019",
        "gene": "SLC22A2",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fampridine": {
    "genes": [
      "SLC22A2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for fampridine and SLC22A2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tipiracil hydrochloride": {
    "genes": [
      "SLC22A2",
      "SLC47A1",
      "SLC29A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs760370",
        "gene": "SLC29A1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs9394992",
        "gene": "SLC29A1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "trifluridine": {
    "genes": [
      "SLC22A2",
      "SLC47A1",
      "SLC29A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs760370",
        "gene": "SLC29A1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs9394992",
        "gene": "SLC29A1",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "trimethoprim": {
    "genes": [
      "SLC22A2",
      "G6PD",
      "SLC47A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "antithymocyte globulin": {
    "genes": [
      "FCGR3A"
    ],
    "clinicalVariants": [
      {
        "variant": "rs396991",
        "gene": "FCGR3A",
        "level": "3",
        "phenotypes": "Kidney Transplantation"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tamoxifen-n-glucuronide": {
    "genes": [
      "UGT1A4",
      "UGT2B7",
      "UGT2B15"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "clozapine 5-n-glucuronide": {
    "genes": [
      "UGT1A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "desmethylclozapine glucuronide": {
    "genes": [
      "UGT1A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pexidartinib": {
    "genes": [
      "UGT1A4",
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "testosterone": {
    "genes": [
      "UGT1A4",
      "CYP3A4",
      "CYP3A5"
    ],
    "clinicalVariants": [
      {
        "variant": "UGT1A4*1a, UGT1A4*3a",
        "gene": "UGT1A4",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "leniolisib": {
    "genes": [
      "PIK3CD",
      "PIK3R1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for leniolisib and PIK3CD, PIK3R1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lutetium (177lu) vipivotide tetraxetan": {
    "genes": [
      "FOLH1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for lutetium (177Lu) vipivotide tetraxetan and FOLH1"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for lutetium (177Lu) vipivotide tetraxetan and FOLH1"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for lutetium (177Lu) vipivotide tetraxetan and FOLH1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "anakinra": {
    "genes": [
      "IL1RN",
      "NLRP3",
      "HLA-DRB1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for anakinra and IL1RN"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for anakinra and NLRP3"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for anakinra and NLRP3"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for anakinra and NLRP3"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "canakinumab": {
    "genes": [
      "IL1RN",
      "HLA-DRB1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "heparin": {
    "genes": [
      "IL1RN",
      "HLA-DRB3"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-DRB3*01:01",
        "gene": "HLA-DRB3",
        "level": "3",
        "phenotypes": "Heparin-induced thrombocytopenia"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "folfirinox": {
    "genes": [
      "CES1P1",
      "DPYD",
      "ABCG2",
      "UGT1A1",
      "DPYS"
    ],
    "clinicalVariants": [
      {
        "variant": "UGT1A1*1, UGT1A1*28",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "Pancreatic Neoplasms,Thrombocytopenia"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "trandolapril": {
    "genes": [
      "CES1P1",
      "PTPRD",
      "CES1",
      "GRK5"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4742610",
        "gene": "PTPRD",
        "level": "3",
        "phenotypes": "Hypertension"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tegafur / gimeracil / oteracil": {
    "genes": [
      "DPYD",
      "HLA-DRB1",
      "UGT1A1",
      "UGT1A6",
      "CYP2A6",
      "UGT1A7"
    ],
    "clinicalVariants": [
      {
        "variant": "UGT1A7*3",
        "gene": "UGT1A7",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "UGT1A6*2a",
        "gene": "UGT1A6",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Recommended",
        "name": "Annotation of EMA Label for tegafur / gimeracil / oteracil and DPYD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fluorouracil / salicylic acid": {
    "genes": [
      "DPYD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Testing Recommended",
        "name": "Annotation of Swissmedic Label for fluorouracil / salicylic acid and DPYD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "uracil": {
    "genes": [
      "DPYD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "3-aminoisobutyrate": {
    "genes": [
      "DPYD",
      "AGXT2",
      "UPB1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "flucytosine": {
    "genes": [
      "DPYD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Testing Recommended",
        "name": "Annotation of Swissmedic Label for flucytosine and DPYD"
      }
    ],
    "guidelines": {
      "advice": "The Dutch Pharmacogenetics Working Group Guideline for flucytosine states that patients with a DPYD activity score of 0 should avoid flucytosine. Patients with a DPYD activity score of 1 or 1.5 should be alert to the occurrence of severe side effects and flucytosine should be stopped if severe side effects occur.\n",
      "source": "DPWG"
    }
  },
  "artemisinin and derivatives": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ascorbic acid (vitamin c), combinations": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for Ascorbic acid (vitamin C), combinations, Ascorbic acid (vitamin C), plain, sodium ascorbate and G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ascorbic acid (vitamin c), plain": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for Ascorbic acid (vitamin C), plain"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for Ascorbic acid (vitamin C), plain"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for Ascorbic acid (vitamin C), combinations, Ascorbic acid (vitamin C), plain, sodium ascorbate and G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "quinolone antibacterials": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vitamin b-complex with vitamin c": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for Vitamin B-complex with vitamin C and G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "quinacrine": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of chlorpropamide, dabrafenib, gliclazide, glimepiride, glipizide, mepacrine (aka quinacrine), mesalazine, moxifloxacin, nicorandil, nitrofural (aka nitrofurazone), probenecid, sodium nitrate, sulfacetamide, tolazamide or trametinib based on G6PD genotype.\n",
      "source": "CPIC"
    }
  },
  "nalidixic acid": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for nalidixic acid and G6PD"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for nalidixic acid and G6PD"
      }
    ],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "furazolidone": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "phenazopyridine": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [
      {
        "variant": "G6PD B (reference), G6PD Mediterranean Haplotype",
        "gene": "G6PD",
        "level": "3",
        "phenotypes": "Hemolysis,Hemolytic Anemia"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "trihexyphenidyl": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sulfametopyrazine": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [
      {
        "variant": "G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham",
        "gene": "G6PD",
        "level": "4",
        "phenotypes": "Hemolysis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mepivacaine": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for mepivacaine and G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sulfisoxazole": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "nitrofurazone": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of chlorpropamide, dabrafenib, gliclazide, glimepiride, glipizide, mepacrine (aka quinacrine), mesalazine, moxifloxacin, nicorandil, nitrofural (aka nitrofurazone), probenecid, sodium nitrate, sulfacetamide, tolazamide or trametinib based on G6PD genotype.\n",
      "source": "CPIC"
    }
  },
  "tolazamide": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for tolazamide and G6PD"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of chlorpropamide, dabrafenib, gliclazide, glimepiride, glipizide, mepacrine (aka quinacrine), mesalazine, moxifloxacin, nicorandil, nitrofural (aka nitrofurazone), probenecid, sodium nitrate, sulfacetamide, tolazamide or trametinib based on G6PD genotype.\n",
      "source": "CPIC"
    }
  },
  "artesunate": {
    "genes": [
      "G6PD",
      "CYP2C8",
      "CYP2A6",
      "IKBKG"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1050828",
        "gene": "G6PD,IKBKG",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1050828",
        "gene": "G6PD",
        "level": "4",
        "phenotypes": "Malaria"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "chlorproguanil": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1050828",
        "gene": "G6PD",
        "level": "4",
        "phenotypes": "Malaria"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dimercaprol": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [
      {
        "variant": "G6PD A- 202A_376G, G6PD B (reference)",
        "gene": "G6PD",
        "level": "3",
        "phenotypes": "Hemolysis,Lead Poisoning"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "pegloticase": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [
      {
        "variant": "G6PD A- 202A_376G",
        "gene": "G6PD",
        "level": "3",
        "phenotypes": "Hemolysis,Methemoglobinemia"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for pegloticase and G6PD"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for pegloticase and G6PD"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for pegloticase"
      }
    ],
    "guidelines": {
      "advice": "High risk drugs should be avoided in G6PD deficient patients with or without chronic non-spherocytic hemolytic anemia (CNSHA). In patients with a G6PD variable or indeterminate phenotype an enzyme activity test should be carried out before initiating drug therapy.\nThe G6PD gene is located on the X chromosome. Therefore, some patients will only have one copy, whereas others will have two copies. See full guideline for disclaimers, further details and supporting evidence.\n",
      "source": "CPIC"
    }
  },
  "mafenide": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for mafenide and G6PD"
      }
    ],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "pamaquine": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sitamaquine": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "menadione sodium bisulfite": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "moviprep": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for moviprep and G6PD"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for moviprep and G6PD"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for moviprep and G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sodium ascorbate": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for Ascorbic acid (vitamin C), combinations, Ascorbic acid (vitamin C), plain, sodium ascorbate and G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "erythromycin ethylsuccinate / sulfisoxazole acetyl": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for erythromycin ethylsuccinate / sulfisoxazole acetyl and G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "amlodipine / atorvastatin / perindopril arginine": {
    "genes": [
      "G6PD",
      "SLCO1B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for amlodipine / atorvastatin / perindopril arginine and G6PD, SLCO1B1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "metabutethamine": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for metabutethamine and G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "bisoprolol fumarate / perindopril arginine": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for bisoprolol fumarate / perindopril arginine and G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "carbasalate calcium": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for carbasalate calcium and G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nicorandil": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for nicorandil and G6PD"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of chlorpropamide, dabrafenib, gliclazide, glimepiride, glipizide, mepacrine (aka quinacrine), mesalazine, moxifloxacin, nicorandil, nitrofural (aka nitrofurazone), probenecid, sodium nitrate, sulfacetamide, tolazamide or trametinib based on G6PD genotype.\n",
      "source": "CPIC"
    }
  },
  "toluidine blue": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "High risk drugs should be avoided in G6PD deficient patients with or without chronic non-spherocytic hemolytic anemia (CNSHA). In patients with a G6PD variable or indeterminate phenotype an enzyme activity test should be carried out before initiating drug therapy.\nThe G6PD gene is located on the X chromosome. Therefore, some patients will only have one copy, whereas others will have two copies. See full guideline for disclaimers, further details and supporting evidence.\n",
      "source": "CPIC"
    }
  },
  "sodium nitrate": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of chlorpropamide, dabrafenib, gliclazide, glimepiride, glipizide, mepacrine (aka quinacrine), mesalazine, moxifloxacin, nicorandil, nitrofural (aka nitrofurazone), probenecid, sodium nitrate, sulfacetamide, tolazamide or trametinib based on G6PD genotype.\n",
      "source": "CPIC"
    }
  },
  "carboxyprimaquine": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "primaquine n-carbamoyl glucuronide": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "aminosalicylic acid": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "atovaquone": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "chloramphenicol": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [
      {
        "variant": "G6PD A- 202A_376G, G6PD B (reference)",
        "gene": "G6PD",
        "level": "3",
        "phenotypes": "Hemolysis,Hemolytic Anemia"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "chloroquine": {
    "genes": [
      "G6PD",
      "SLCO2B1"
    ],
    "clinicalVariants": [
      {
        "variant": "G6PD A- 202A_376G, G6PD B (reference), G6PD Mediterranean Haplotype, G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham",
        "gene": "G6PD",
        "level": "4",
        "phenotypes": "Hemolytic Anemia"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for chloroquine and G6PD"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for chloroquine and G6PD"
      }
    ],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "chlorpropamide": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for chlorpropamide and G6PD"
      }
    ],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of chlorpropamide, dabrafenib, gliclazide, glimepiride, glipizide, mepacrine (aka quinacrine), mesalazine, moxifloxacin, nicorandil, nitrofural (aka nitrofurazone), probenecid, sodium nitrate, sulfacetamide, tolazamide or trametinib based on G6PD genotype.\n",
      "source": "CPIC"
    }
  },
  "doxycycline": {
    "genes": [
      "G6PD",
      "ESR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "flutamide": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for flutamide"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for flutamide and G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ganciclovir": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mefloquine": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [
      {
        "variant": "G6PD A- 202A_376G, G6PD B (reference)",
        "gene": "G6PD",
        "level": "4",
        "phenotypes": "Malaria"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for mefloquine and G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "methylene blue": {
    "genes": [
      "G6PD",
      "BLVRB"
    ],
    "clinicalVariants": [
      {
        "variant": "G6PD A- 202A_376G, G6PD B (reference)",
        "gene": "G6PD",
        "level": "3",
        "phenotypes": "Hemolysis,Hemolytic Anemia,Protein Deficiency"
      }
    ],
    "fdaLabels": [
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for methylene blue and BLVRB, G6PD"
      },
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for methylene blue and BLVRB, G6PD"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for methylene blue and G6PD"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for methylene blue and G6PD"
      }
    ],
    "guidelines": {
      "advice": "High risk drugs should be avoided in G6PD deficient patients with or without chronic non-spherocytic hemolytic anemia (CNSHA). In patients with a G6PD variable or indeterminate phenotype an enzyme activity test should be carried out before initiating drug therapy.\nThe G6PD gene is located on the X chromosome. Therefore, some patients will only have one copy, whereas others will have two copies. See full guideline for disclaimers, further details and supporting evidence.\n",
      "source": "CPIC"
    }
  },
  "nitrofurantoin": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [
      {
        "variant": "G6PD A- 202A_376G, G6PD B (reference)",
        "gene": "G6PD",
        "level": "3",
        "phenotypes": "Hemolysis,Hemolytic Anemia"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for nitrofurantoin and G6PD"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for nitrofurantoin and G6PD"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for nitrofurantoin and G6PD"
      }
    ],
    "guidelines": {
      "advice": "Nitrofurantoin should be use with caution in G6PD deficient patients without chronic non-spherocytic hemolytic anemia (CNSHA) and completely avoided by G6PD deficient patients with CNSHA. In patients with a G6PD variable or indeterminate phenotype an enzyme activity test should be carried out before initiating drug therapy.\nThe G6PD gene is located on the X chromosome. Therefore, some patients will only have one copy, whereas others will have two copies. See full guideline for disclaimers, further details and supporting evidence.\n",
      "source": "CPIC"
    }
  },
  "nitroglycerin": {
    "genes": [
      "G6PD",
      "ALDH2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for nitroglycerin and G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "norfloxacin": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for norfloxacin and G6PD"
      },
      {
        "source": "HCSC",
        "level": "Informative PGx",
        "name": "Annotation of HCSC Label for norfloxacin and G6PD"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for norfloxacin and G6PD"
      }
    ],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "ofloxacin": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for ofloxacin and G6PD"
      }
    ],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "phenylbutazone": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "prilocaine": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for prilocaine and G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pyrimethamine": {
    "genes": [
      "G6PD",
      "IKBKG"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1050828",
        "gene": "G6PD,IKBKG",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1050828",
        "gene": "G6PD",
        "level": "3",
        "phenotypes": "Malaria,Malaria, Falciparum"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "succimer": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for succimer and G6PD"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sulfacetamide": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of chlorpropamide, dabrafenib, gliclazide, glimepiride, glipizide, mepacrine (aka quinacrine), mesalazine, moxifloxacin, nicorandil, nitrofural (aka nitrofurazone), probenecid, sodium nitrate, sulfacetamide, tolazamide or trametinib based on G6PD genotype.\n",
      "source": "CPIC"
    }
  },
  "sulfadiazine": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for sulfadiazine and G6PD"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for sulfadiazine and G6PD"
      },
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for sulfadiazine and G6PD"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for sulfadiazine and G6PD"
      }
    ],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "sulfadoxine": {
    "genes": [
      "G6PD",
      "IKBKG"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1050828",
        "gene": "G6PD,IKBKG",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1050828",
        "gene": "G6PD",
        "level": "3",
        "phenotypes": "Malaria,Malaria, Falciparum"
      },
      {
        "variant": "G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham",
        "gene": "G6PD",
        "level": "3",
        "phenotypes": "Hemolysis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sulfamethazine": {
    "genes": [
      "G6PD",
      "NAT2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "sulfanilamide": {
    "genes": [
      "G6PD"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "vitamin c": {
    "genes": [
      "G6PD",
      "TXNRD1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for vitamin c and G6PD"
      }
    ],
    "guidelines": {
      "advice": "There is no reason to avoid low-to-no risk drugs in patients with the G6PD deficient or G6PD variable phenotypes. In patients who are G6PD deficient with chronic non-spherocytic hemolytic anemia (CNSHA), low-to-no risk drugs should be used with caution and close monitoring for acute exacerbation of chronic hemolysis is recommended. However, CPIC does not recommend changing prescribing actions based on G6PD genotype for low-to-no risk drugs.\n",
      "source": "CPIC"
    }
  },
  "ritodrine": {
    "genes": [
      "KCNMB2",
      "PDE4B",
      "CACNA1C",
      "ADRB2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs10774053",
        "gene": "CACNA1C",
        "level": "3",
        "phenotypes": "adverse events,Premature Birth"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pemigatinib": {
    "genes": [
      "FGFR1",
      "FGFR2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for pemigatinib and FGFR2"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for pemigatinib and FGFR2"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for pemigatinib and FGFR1, FGFR2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "selective serotonin (5ht1) agonists": {
    "genes": [
      "PRDM16",
      "PHACTR1",
      "LRP1",
      "ASTN2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "hdl cholesterol": {
    "genes": [
      "CRTC2",
      "CYP19A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2289105",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Menopause"
      },
      {
        "variant": "rs10046",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Menopause"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "glucose": {
    "genes": [
      "CRTC2",
      "SLCO1B1",
      "COMT",
      "RABEP1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vorinostat": {
    "genes": [
      "CHD4",
      "UGT2B17"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "calcineurin inhibitors": {
    "genes": [
      "IMPDH2",
      "CYP2C8",
      "IMPDH1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "empagliflozin": {
    "genes": [
      "BDNF",
      "ATP2A2",
      "SLC5A2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "arachidonic acid": {
    "genes": [
      "CYP4F2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vitamin k1": {
    "genes": [
      "CYP4F2"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP4F2*1, CYP4F2*3",
        "gene": "CYP4F2",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "brincidofovir": {
    "genes": [
      "CYP4F2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vitamin e": {
    "genes": [
      "CYP4F2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2108622",
        "gene": "CYP4F2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3093105",
        "gene": "CYP4F2",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "methacholine": {
    "genes": [
      "RUNX1",
      "ADRB2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Asthma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "photodynamic therapy": {
    "genes": [
      "ARMS2",
      "F13A1",
      "CFH"
    ],
    "clinicalVariants": [
      {
        "variant": "rs5985",
        "gene": "F13A1",
        "level": "3",
        "phenotypes": "Choroidal Neovascularization"
      },
      {
        "variant": "rs1061170",
        "gene": "CFH",
        "level": "4",
        "phenotypes": "Macular Degeneration"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "somatropin recombinant": {
    "genes": [
      "CDK4",
      "COL1A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1800012",
        "gene": "COL1A1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2069502",
        "gene": "CDK4",
        "level": "3",
        "phenotypes": "Turner Syndrome"
      },
      {
        "variant": "rs2270777",
        "gene": "CDK4",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "hepatitis vaccines": {
    "genes": [
      "IL4R",
      "IL13",
      "HLA-DRB1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1295686",
        "gene": "IL13",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1805015",
        "gene": "IL4R",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pitrakinra": {
    "genes": [
      "IL4R"
    ],
    "clinicalVariants": [
      {
        "variant": "rs8832",
        "gene": "IL4R",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs1110470",
        "gene": "IL4R",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs3024530",
        "gene": "IL4R",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs1805010",
        "gene": "IL4R",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs2239347",
        "gene": "IL4R",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs1029489",
        "gene": "IL4R",
        "level": "3",
        "phenotypes": "Asthma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "zonisamide": {
    "genes": [
      "CA12",
      "HLA-A",
      "CYP3A4",
      "HLA-B",
      "HLA-DRB1"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-A*02:07",
        "gene": "HLA-A",
        "level": "3",
        "phenotypes": "Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "rs4984241",
        "gene": "CA12",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2306719",
        "gene": "CA12",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for zonisamide and CYP3A4"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cefaclor": {
    "genes": [
      "TPSAB1",
      "HLA-DRB5",
      "LIMD1",
      "HLA-DRB1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "captopril": {
    "genes": [
      "ACE2",
      "AGT",
      "AGTR1",
      "ACE"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "2A",
        "phenotypes": "Chronic Obstructive Pulmonary Disease,Diabetes Mellitus, Type 2,Heart Failure"
      },
      {
        "variant": "rs2106809",
        "gene": "ACE2",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs5186",
        "gene": "AGTR1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs4291",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Alzheimer Disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "goserelin": {
    "genes": [
      "ESR2",
      "PGR",
      "SLCO1B1",
      "ESR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for goserelin and ESR1, ESR2, PGR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "alglucosidase alfa": {
    "genes": [
      "GAA"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for alglucosidase alfa and GAA"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for alglucosidase alfa and GAA"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for alglucosidase alfa and GAA"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sarilumab": {
    "genes": [
      "IL6R"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "satralizumab": {
    "genes": [
      "IL6R",
      "AQP4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for satralizumab and AQP4, IL6R"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for satralizumab and AQP4"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for satralizumab and AQP4"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fructose": {
    "genes": [
      "KHK"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "isoniazid / pyrazinamide / rifampin": {
    "genes": [
      "ALAS1",
      "NR1I2",
      "CYP2E1",
      "CYP3A4",
      "ATP7B",
      "FECH",
      "NAT2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for isoniazid / pyrazinamide / rifampin and NAT2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "entacapone": {
    "genes": [
      "UGT1A9",
      "COMT"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": "Parkinson Disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mycophenolic acid glucuronide": {
    "genes": [
      "UGT1A9",
      "UGT1A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cotinine glucuronide": {
    "genes": [
      "UGT1A9"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12471326",
        "gene": "UGT1A9",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ertugliflozin": {
    "genes": [
      "UGT1A9"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "canagliflozin": {
    "genes": [
      "UGT1A9"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sulfinpyrazone": {
    "genes": [
      "UGT1A9"
    ],
    "clinicalVariants": [
      {
        "variant": "rs72551330",
        "gene": "UGT1A9",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tolcapone": {
    "genes": [
      "UGT1A9",
      "COMT"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cangrelor": {
    "genes": [
      "P2RY12"
    ],
    "clinicalVariants": [
      {
        "variant": "rs9859552",
        "gene": "P2RY12",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6787801",
        "gene": "P2RY12",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "inebilizumab": {
    "genes": [
      "AQP4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for inebilizumab and AQP4"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for inebilizumab and AQP4"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "metreleptin": {
    "genes": [
      "BSCL2",
      "LEP",
      "LMNB2",
      "AGPAT2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for metreleptin and AGPAT2, BSCL2, LEP"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for metreleptin and AGPAT2, BSCL2, LEP, LMNB2"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for metreleptin and AGPAT2, BSCL2, LEP, LMNB2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "imiquimod": {
    "genes": [
      "TLR7"
    ],
    "clinicalVariants": [
      {
        "variant": "rs179008",
        "gene": "TLR7",
        "level": "3",
        "phenotypes": "Basal Cell Carcinoma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "methimazole": {
    "genes": [
      "NOX3",
      "KLRC4",
      "HLA-B",
      "HLA-DRB1"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-B*38:02",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Graves Disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "propylthiouracil": {
    "genes": [
      "NOX3",
      "KLRC4",
      "HLA-B",
      "HLA-DRB1"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-B*38:02",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Agranulocytosis,Graves Disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "immunoglobulins": {
    "genes": [
      "COQ8B",
      "PRIMPOL",
      "CASP3",
      "ITPKC"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "triheptanoin": {
    "genes": [
      "HADHB",
      "CPT2",
      "ACADVL",
      "HADHA"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for triheptanoin and ACADVL, CPT2, HADHA, HADHB"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for triheptanoin"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for triheptanoin and ACADVL, CPT2, HADHA, HADHB"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lorlatinib": {
    "genes": [
      "ROS1",
      "ALK"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for lorlatinib and ALK"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for lorlatinib and ALK"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for lorlatinib and ROS1"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for lorlatinib and ALK"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "entrectinib": {
    "genes": [
      "ROS1",
      "NTRK2",
      "NTRK1",
      "NTRK3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for entrectinib and NTRK1, NTRK2, NTRK3, ROS1"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for entrectinib and NTRK1, NTRK2, NTRK3, ROS1"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for entrectinib and NTRK1, NTRK2, NTRK3, ROS1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "repotrectinib": {
    "genes": [
      "ROS1",
      "NTRK2",
      "NTRK1",
      "NTRK3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for repotrectinib and NTRK1, NTRK2, NTRK3, ROS1"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for repotrectinib and NTRK1, NTRK2, NTRK3, ROS1"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for repotrectinib"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sodium phenylbutyrate": {
    "genes": [
      "CPS1",
      "OTC",
      "ASS1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for sodium phenylbutyrate and ASS1, CPS1, OTC"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for sodium phenylbutyrate and ASS1, CPS1, OTC"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for sodium phenylbutyrate and ASS1, CPS1, OTC"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "methionine": {
    "genes": [
      "CPS1",
      "PSPH",
      "CBS",
      "GNMT",
      "ALDH1L1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "zinc acetate": {
    "genes": [
      "SLC30A8"
    ],
    "clinicalVariants": [
      {
        "variant": "rs13266634",
        "gene": "SLC30A8",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dichloroacetic acid": {
    "genes": [
      "POMT2",
      "GSTZ1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cefotaxime": {
    "genes": [
      "SLC22A8"
    ],
    "clinicalVariants": [
      {
        "variant": "rs11568482",
        "gene": "SLC22A8",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "antiandrogens": {
    "genes": [
      "AKR1C3",
      "CYP19A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "eslicarbazepine acetate": {
    "genes": [
      "AADAC"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "adenosine": {
    "genes": [
      "ADORA2A"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dextrorphan": {
    "genes": [
      "TCF20",
      "IP6K2",
      "NFIB"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "alemtuzumab": {
    "genes": [
      "CXCL12"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1801157",
        "gene": "CXCL12",
        "level": "3",
        "phenotypes": "Leukemia, Lymphocytic, Chronic, B-Cell"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ethosuximide": {
    "genes": [
      "CACNA1I",
      "CACNA1H",
      "SCN1A"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2298771",
        "gene": "SCN1A",
        "level": "4",
        "phenotypes": "Epilepsy"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "didanosine": {
    "genes": [
      "NT5C2",
      "XDH"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1594160",
        "gene": "XDH",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs1429376",
        "gene": "XDH",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs11191561",
        "gene": "NT5C2",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      },
      {
        "variant": "rs11598702",
        "gene": "NT5C2",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lutetium (177lu) dotatate": {
    "genes": [
      "SSTR3",
      "SSTR5",
      "SSTR1",
      "SSTR4",
      "SSTR2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for lutetium (177Lu) dotatate and SSTR1, SSTR2, SSTR3, SSTR4, SSTR5"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for lutetium (177Lu) dotatate and SSTR1, SSTR2, SSTR3, SSTR4, SSTR5"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for lutetium (177Lu) dotatate and SSTR1, SSTR2, SSTR3, SSTR4, SSTR5"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "gilteritinib": {
    "genes": [
      "FLT3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for gilteritinib and FLT3"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for gilteritinib and FLT3"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for gilteritinib and FLT3"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "quizartinib": {
    "genes": [
      "FLT3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for quizartinib and FLT3"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for quizartinib and FLT3"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for quizartinib and FLT3"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "evodiamine": {
    "genes": [
      "SLC6A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vilazodone": {
    "genes": [
      "SLC6A4",
      "HTR2A",
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of escitalopram, citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, duloxetine, venlafaxine, desvenlafaxine, vilazodone, vortioxetine, levomilnacipran, or milnacipran based on SLC6A4 genotypes.\n",
      "source": "CPIC"
    }
  },
  "levomilnacipran": {
    "genes": [
      "SLC6A4",
      "HTR2A"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "There are currently no recommendations for dosing of escitalopram, citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, duloxetine, venlafaxine, desvenlafaxine, vilazodone, vortioxetine, levomilnacipran, or milnacipran based on SLC6A4 genotypes.\n",
      "source": "CPIC"
    }
  },
  "clozapine n+ glucuronide": {
    "genes": [
      "UGT2B@"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "rivastigmine": {
    "genes": [
      "CHAT",
      "PRKCE",
      "SLC5A7",
      "APOE",
      "ACHE",
      "BCHE",
      "CHRNA7"
    ],
    "clinicalVariants": [
      {
        "variant": "rs6494223",
        "gene": "CHRNA7",
        "level": "3",
        "phenotypes": "Alzheimer Disease"
      },
      {
        "variant": "rs3793790",
        "gene": "CHAT",
        "level": "3",
        "phenotypes": "Alzheimer Disease"
      },
      {
        "variant": "rs2177370",
        "gene": "CHAT",
        "level": "3",
        "phenotypes": "Alzheimer Disease"
      },
      {
        "variant": "rs1803274",
        "gene": "BCHE",
        "level": "3",
        "phenotypes": "Alzheimer Disease,Lewy Body Disease"
      },
      {
        "variant": "rs2571598",
        "gene": "ACHE",
        "level": "3",
        "phenotypes": "Alzheimer Disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "zanubrutinib": {
    "genes": [
      "MYD88",
      "TP53"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for zanubrutinib and MYD88, TP53"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for zanubrutinib and MYD88"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for zanubrutinib and MYD88"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ivosidenib": {
    "genes": [
      "IDH1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for ivosidenib and IDH1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "olutasidenib": {
    "genes": [
      "IDH1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for olutasidenib and IDH1"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for olutasidenib"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for olutasidenib"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vorasidenib": {
    "genes": [
      "IDH1",
      "IDH2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for vorasidenib and IDH1, IDH2"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for vorasidenib and IDH1, IDH2"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for vorasidenib and IDH1, IDH2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "s-adenosylmethionine": {
    "genes": [
      "TPMT"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "methylmercaptopurine": {
    "genes": [
      "TPMT",
      "XDH"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "deoxy-thioguanosine triphosphate": {
    "genes": [
      "TPMT",
      "PACSIN2",
      "NUDT15"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "carbidopa": {
    "genes": [
      "DDC"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "doxorubicinol": {
    "genes": [
      "CBR1",
      "SLC22A16",
      "AKR1A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs714368",
        "gene": "SLC22A16",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      },
      {
        "variant": "rs20572",
        "gene": "CBR1",
        "level": "3",
        "phenotypes": "Breast Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dasatinib": {
    "genes": [
      "BCR",
      "ABCG2",
      "ABL1",
      "NQO2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs45605536",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs58818712",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs41282401",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1061018",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2231137",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for dasatinib and ABL1, BCR"
      },
      {
        "source": "PMDA",
        "level": "Testing Required",
        "name": "Annotation of PMDA Label for dasatinib and ABL1, BCR"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for dasatinib and ABL1, BCR"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for dasatinib and ABL1, BCR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ponatinib": {
    "genes": [
      "BCR",
      "ABL1",
      "ABCC1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for ponatinib and ABL1, BCR"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for ponatinib and ABL1, BCR"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for ponatinib and ABL1, BCR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "omacetaxine": {
    "genes": [
      "BCR",
      "ABL1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for omacetaxine and ABL1, BCR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "blinatumomab": {
    "genes": [
      "BCR",
      "CD19",
      "ABL1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for blinatumomab and ABL1, BCR"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for blinatumomab and CD19"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for blinatumomab and CD19"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for blinatumomab and CD19"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for blinatumomab and ABL1, BCR"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for blinatumomab and ABL1, BCR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "inotuzumab ozogamicin": {
    "genes": [
      "BCR",
      "ABL1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for inotuzumab ozogamicin and ABL1, BCR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "asciminib": {
    "genes": [
      "BCR",
      "ABL1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for asciminib and ABL1, BCR"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for asciminib and ABL1, BCR"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for asciminib and ABL1, BCR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "polatuzumab vedotin": {
    "genes": [
      "BCL2",
      "MYC",
      "BCL6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for polatuzumab vedotin and BCL2, BCL6, MYC"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "flunisolide": {
    "genes": [
      "GLCCI1",
      "TBXT"
    ],
    "clinicalVariants": [
      {
        "variant": "rs37973",
        "gene": "GLCCI1",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs2305089",
        "gene": "TBXT",
        "level": "3",
        "phenotypes": "Asthma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nedocromil": {
    "genes": [
      "GLCCI1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs37973",
        "gene": "GLCCI1",
        "level": "3",
        "phenotypes": "Asthma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "triamcinolone": {
    "genes": [
      "GLCCI1",
      "HCG22"
    ],
    "clinicalVariants": [
      {
        "variant": "rs37973",
        "gene": "GLCCI1",
        "level": "3",
        "phenotypes": "Asthma"
      },
      {
        "variant": "rs3873352",
        "gene": "HCG22",
        "level": "3",
        "phenotypes": "Retinal Diseases"
      },
      {
        "variant": "rs2523864",
        "gene": "HCG22",
        "level": "3",
        "phenotypes": "Retinal Diseases"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "colistimethate": {
    "genes": [
      "SLC15A2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "niacin": {
    "genes": [
      "HCAR2",
      "NR1H3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "creatine": {
    "genes": [
      "MOBP",
      "UNC13A"
    ],
    "clinicalVariants": [
      {
        "variant": "rs616147",
        "gene": "MOBP",
        "level": "3",
        "phenotypes": "Amyotrophic Lateral Sclerosis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tretinoin": {
    "genes": [
      "PML",
      "RARA"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for tretinoin and PML, RARA"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for tretinoin and PML, RARA"
      },
      {
        "source": "PMDA",
        "level": "",
        "name": "Annotation of PMDA Label for tretinoin and PML, RARA"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for tretinoin"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "bacampicillin": {
    "genes": [
      "HLA-A"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cefdinir": {
    "genes": [
      "HLA-A"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "benznidazole": {
    "genes": [
      "HLA-A"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tebentafusp": {
    "genes": [
      "HLA-A"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for tebentafusp and HLA-A"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for tebentafusp and HLA-A"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for tebentafusp and HLA-A"
      }
    ],
    "guidelines": {
      "advice": "The Socit Francophone d'Histocompatibilit et d'Immunogntique (SFHI) requires testing for HLA-A*02:01 to select patients with metastatic uveal melanoma suitable for treatment with tebentafusp.\n",
      "source": "RNPGx"
    }
  },
  "bcr-abl tyrosine kinase inhibitors": {
    "genes": [
      "HLA-A",
      "HLA-B"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ampicillin": {
    "genes": [
      "HLA-A"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cefazolin": {
    "genes": [
      "HLA-A"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cefuroxime": {
    "genes": [
      "HLA-A"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cephalexin": {
    "genes": [
      "HLA-A"
    ],
    "clinicalVariants": [
      {
        "variant": "rs34545984",
        "gene": "",
        "level": "3",
        "phenotypes": "adverse events"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "methazolamide": {
    "genes": [
      "HLA-A",
      "HLA-B",
      "HLA-C"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-B*59:01",
        "gene": "HLA-B",
        "level": "2A",
        "phenotypes": "Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      },
      {
        "variant": "HLA-C*01:02",
        "gene": "HLA-C",
        "level": "2B",
        "phenotypes": "Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tetanus antitoxin": {
    "genes": [
      "HLA-A"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "semaglutide": {
    "genes": [
      "CTRB1",
      "GLP1R",
      "TCF7L2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "6-hydroxy s-warfarin": {
    "genes": [
      "GRID2",
      "PARP14"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "6-hydroxy r-warfarin": {
    "genes": [
      "GRID2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "bimatoprost": {
    "genes": [
      "PTGFR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "itopride": {
    "genes": [
      "FMO3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2266782",
        "gene": "FMO3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2266780",
        "gene": "FMO3",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "olanzapine 10-n-glucuronide": {
    "genes": [
      "FMO3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sulindac": {
    "genes": [
      "FMO3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2266782",
        "gene": "FMO3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2266780",
        "gene": "FMO3",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "5'-deoxy-5-fluorouridine": {
    "genes": [
      "ABCG5",
      "UGT1A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ivacaftor carboxylate": {
    "genes": [
      "HTR2A"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dutasteride": {
    "genes": [
      "SRD5A2",
      "HSD3B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nivasorexant": {
    "genes": [
      "HCRTR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "brentuximab vedotin": {
    "genes": [
      "ALK",
      "TNFRSF8"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for brentuximab vedotin and TNFRSF8"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for brentuximab vedotin and TNFRSF8"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for brentuximab vedotin and TNFRSF8"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for brentuximab vedotin and ALK"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ceritinib": {
    "genes": [
      "ALK"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for ceritinib and ALK"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for ceritinib and ALK"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for ceritinib and ALK"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "brigatinib": {
    "genes": [
      "ALK"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for brigatinib and ALK"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for brigatinib and ALK"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for brigatinib and ALK"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ensartinib": {
    "genes": [
      "ALK"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for ensartinib and ALK"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dalcetrapib": {
    "genes": [
      "ADCY9"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1967309",
        "gene": "ADCY9",
        "level": "3",
        "phenotypes": "Acute coronary syndrome"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "albiglutide": {
    "genes": [
      "ARRB1",
      "GLP1R"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dulaglutide": {
    "genes": [
      "ARRB1",
      "GLP1R",
      "SLCO1B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "8-oxo-dgtp": {
    "genes": [
      "NUDT1",
      "NUDT15"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tositumomab": {
    "genes": [
      "MS4A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ibritumomab": {
    "genes": [
      "MS4A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for ibritumomab and MS4A1"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for ibritumomab and MS4A1"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for ibritumomab and MS4A1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ofatumumab": {
    "genes": [
      "MS4A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for ofatumumab and MS4A1"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for ofatumumab and MS4A1"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for ofatumumab and MS4A1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "obinutuzumab": {
    "genes": [
      "MS4A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for obinutuzumab and MS4A1"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for obinutuzumab and MS4A1"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for obinutuzumab and MS4A1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "exenatide": {
    "genes": [
      "GLP1R",
      "TCF7L2",
      "SORCS1",
      "KCNQ1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs3765467",
        "gene": "GLP1R",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "saxagliptin": {
    "genes": [
      "GLP1R",
      "PRKD1",
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "liraglutide": {
    "genes": [
      "GLP1R",
      "CNR1",
      "TCF7L2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs6923761",
        "gene": "GLP1R",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10305420",
        "gene": "GLP1R",
        "level": "4",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "gemigliptin": {
    "genes": [
      "GLP1R"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "topotecan": {
    "genes": [
      "DDO",
      "ABCG2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4148157",
        "gene": "ABCG2",
        "level": "3",
        "phenotypes": "Brain Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pegaptanib": {
    "genes": [
      "VEGFA"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2010963",
        "gene": "VEGFA",
        "level": "3",
        "phenotypes": "Choroidal Neovascularization"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "erythropoietin": {
    "genes": [
      "HFE",
      "ORAI1",
      "STIM1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "iron": {
    "genes": [
      "HFE"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nirogacestat": {
    "genes": [
      "APC",
      "CTNNB1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for nirogacestat and APC, CTNNB1"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for nirogacestat and APC, CTNNB1"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for nirogacestat and APC, CTNNB1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "olaratumab": {
    "genes": [
      "PDGFRA"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for olaratumab and PDGFRA"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "gemtuzumab ozogamicin": {
    "genes": [
      "CD33",
      "CYP2E1",
      "SULT2B1",
      "SLCO1B1",
      "SLC22A12",
      "ADH1A"
    ],
    "clinicalVariants": [
      {
        "variant": "rs11231825",
        "gene": "SLC22A12",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs2070673",
        "gene": "CYP2E1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs2302948",
        "gene": "SULT2B1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs2515641",
        "gene": "CYP2E1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      },
      {
        "variant": "rs35112940",
        "gene": "CD33",
        "level": "3",
        "phenotypes": "Leukemia, Myeloid, Acute"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for gemtuzumab ozogamicin and CD33"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for gemtuzumab ozogamicin and CD33"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for gemtuzumab ozogamicin and CD33"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "calcium channel blockers": {
    "genes": [
      "CACNA1C",
      "PICALM",
      "NUMA1",
      "TANC2",
      "KCNH2",
      "ACE"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1137617",
        "gene": "KCNH2",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Headache Disorders,Migraine with Aura,Migraine without Aura"
      },
      {
        "variant": "rs2429427",
        "gene": "TANC2",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs10898815",
        "gene": "NUMA1",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs588076",
        "gene": "PICALM",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs2238032",
        "gene": "CACNA1C",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs2239128",
        "gene": "CACNA1C",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs2239050",
        "gene": "CACNA1C",
        "level": "3",
        "phenotypes": "Hypertension"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nitrendipine": {
    "genes": [
      "CACNA1C",
      "AGTR1",
      "KCNH2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1137617",
        "gene": "KCNH2",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs5186",
        "gene": "AGTR1",
        "level": "3",
        "phenotypes": "Hypertension"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lacidipine": {
    "genes": [
      "CACNA1C"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "felodipine": {
    "genes": [
      "CACNA1C",
      "ABCG2",
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "silodosin": {
    "genes": [
      "UGT2B7",
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mycophenolic acid acyl glucuronide": {
    "genes": [
      "UGT2B7"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "diclofenac acyl glucuronide": {
    "genes": [
      "UGT2B7",
      "CYP2C8"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "letrozole carbinol": {
    "genes": [
      "UGT2B7"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "letrozole carbinol glucuronide": {
    "genes": [
      "UGT2B7"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lorazepam": {
    "genes": [
      "UGT2B7",
      "UGT2B15",
      "SLCO1B1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1902023",
        "gene": "UGT2B15",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ecallantide": {
    "genes": [
      "KLKB1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "interferon alfa-n1": {
    "genes": [
      "IFNL4",
      "IFNL3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "deleobuvir": {
    "genes": [
      "IFNL4",
      "IFNL3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "faldaprevir": {
    "genes": [
      "IFNL4",
      "IFNL3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ledipasvir": {
    "genes": [
      "IFNL4",
      "IFNL3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection,Recurrence"
      },
      {
        "variant": "rs8099917",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "daclatasvir": {
    "genes": [
      "IFNL4",
      "VDR",
      "CYP24A1",
      "HINT1",
      "NME1",
      "IFNL3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      }
    ],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for daclatasvir and IFNL3"
      },
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for daclatasvir and IFNL3"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "asunaprevir": {
    "genes": [
      "IFNL4",
      "IFNL3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ombitasvir / paritaprevir / ritonavir": {
    "genes": [
      "IFNL4",
      "IFNL3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for ombitasvir / paritaprevir / ritonavir and IFNL3"
      },
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for ombitasvir / paritaprevir / ritonavir and IFNL3, IFNL4"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "velpatasvir": {
    "genes": [
      "IFNL4",
      "IFNL3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ledipasvir / sofosbuvir": {
    "genes": [
      "IFNL4",
      "IFNL3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for ledipasvir / sofosbuvir and IFNL3"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "elbasvir / grazoprevir": {
    "genes": [
      "IFNL4",
      "SLCO1B1",
      "IFNL3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for elbasvir / grazoprevir and IFNL3"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "voxilaprevir": {
    "genes": [
      "IFNL4",
      "IFNL3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12979860",
        "gene": "IFNL3,IFNL4",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "direct acting antivirals": {
    "genes": [
      "IFNL4",
      "IFNL3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs11322783",
        "gene": "IFNL4",
        "level": "3",
        "phenotypes": "Sustained virological response (SVR)"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pirfenidone": {
    "genes": [
      "TOLLIP",
      "CYP1A2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "2-oxo-clopidogrel": {
    "genes": [
      "CES1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sacubitril": {
    "genes": [
      "CES1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs71647871",
        "gene": "CES1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "quinapril": {
    "genes": [
      "CES1",
      "AGT",
      "AGTR1",
      "ACE"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs699",
        "gene": "AGT",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "difluorodeoxyuridine": {
    "genes": [
      "CDA"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4655226",
        "gene": "CDA",
        "level": "3",
        "phenotypes": "Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lonafarnib": {
    "genes": [
      "ZMPSTE24",
      "FNTB",
      "CYP3A4",
      "LMNA"
    ],
    "clinicalVariants": [
      {
        "variant": "rs11623866",
        "gene": "FNTB",
        "level": "3",
        "phenotypes": "Ovarian Neoplasms"
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Actionable PGx",
        "name": "Annotation of EMA Label for lonafarnib and CYP3A4"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for lonafarnib and LMNA, ZMPSTE24"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for lonafarnib"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for lonafarnib and LMNA, ZMPSTE24"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "emtricitabine": {
    "genes": [
      "ABCC2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "10-monohydroxy oxcarbazepine": {
    "genes": [
      "ABCC2",
      "INSR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cholesterol": {
    "genes": [
      "APOE"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lecanemab": {
    "genes": [
      "APOE"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for lecanemab"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for lecanemab and APOE"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "aducanumab": {
    "genes": [
      "APOE"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for aducanumab and APOE"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for aducanumab"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for aducanumab"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "donanemab": {
    "genes": [
      "APOE"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for donanemab and APOE"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for donanemab and APOE"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "acitretin": {
    "genes": [
      "APOE",
      "APOC1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dinutuximab": {
    "genes": [
      "MYCN"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for dinutuximab and MYCN"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "eflornithine": {
    "genes": [
      "MYCN"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for eflornithine"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for eflornithine"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for eflornithine and MYCN"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "memantine": {
    "genes": [
      "NR1I2",
      "BCHE"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1523130",
        "gene": "NR1I2",
        "level": "3",
        "phenotypes": "Dementia"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "etonogestrel": {
    "genes": [
      "NR1I2",
      "PGR",
      "CYP3A7"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "etidronic acid": {
    "genes": [
      "COL1A1",
      "VDR",
      "IL1B"
    ],
    "clinicalVariants": [
      {
        "variant": "rs16944",
        "gene": "IL1B",
        "level": "3",
        "phenotypes": "Osteitis Deformans"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "diflomotecan": {
    "genes": [
      "ABCG2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lenvatinib": {
    "genes": [
      "ABCG2",
      "CYP3A4",
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for lenvatinib"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for lenvatinib"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for lenvatinib"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "n-desethyl sunitinib": {
    "genes": [
      "ABCG2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "letermovir": {
    "genes": [
      "ABCG2",
      "UGT1A1",
      "SLCO1B1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4149032",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4148323",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for letermovir and SLCO1B1, UGT1A1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ezetimibe / rosuvastatin": {
    "genes": [
      "ABCG2",
      "SLCO1B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for ezetimibe / rosuvastatin and ABCG2, SLCO1B1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "resmetirom": {
    "genes": [
      "ABCG2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for resmetirom"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for resmetirom and ABCG2"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for resmetirom and ABCG2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ramipril": {
    "genes": [
      "ABCG2",
      "ADRB2",
      "UGT1A1",
      "SLCO1B1",
      "ACE"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4344",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs4359",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Hypertension"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "crizanlizumab-tmca": {
    "genes": [
      "HBB",
      "SELP"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for crizanlizumab-tmca and HBB"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for crizanlizumab-tmca"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for crizanlizumab-tmca and HBB, SELP"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "voxelotor": {
    "genes": [
      "HBB"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for voxelotor and HBB"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for voxelotor and HBB"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for voxelotor"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "luspatercept": {
    "genes": [
      "HBB"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for luspatercept and HBB"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "drugs used in alcohol dependence": {
    "genes": [
      "GATA4"
    ],
    "clinicalVariants": [
      {
        "variant": "rs13273672",
        "gene": "GATA4",
        "level": "3",
        "phenotypes": "Alcohol abuse"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sacrosidase": {
    "genes": [
      "SI"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for sacrosidase and SI"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "methyldopa": {
    "genes": [
      "MMP9",
      "ARG2",
      "ADIPOQ"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "hydralazine": {
    "genes": [
      "MMP9",
      "HLA-DRB1",
      "NAT2",
      "ADIPOQ"
    ],
    "clinicalVariants": [
      {
        "variant": "NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*16",
        "gene": "NAT2",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "NAT2*6, NAT2*7, NAT2*14, NAT2*16",
        "gene": "NAT2",
        "level": "1A",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "NAT2*1, NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16",
        "gene": "NAT2",
        "level": "1A",
        "phenotypes": "Hypertension"
      }
    ],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for hydralazine and NAT2"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for hydralazine and NAT2"
      }
    ],
    "guidelines": {
      "advice": "Consider a starting total daily dose of hydralazine of at least 75 mg. for patients who are NAT2 rapid metabolizers and NAT2 intermediate metabolizers and titrate up to 300 mg as tolerated. For patients who are NAT2 poor metabolizers, initiate therapy at a total daily dose of hydralazine of 40 to 75 mg and carefully titrate upwards; use caution with total daily hydralazine doses of 200 mg or more.\n",
      "source": "CPIC"
    }
  },
  "lisinopril": {
    "genes": [
      "AGT",
      "BDKRB2",
      "MMP3",
      "ACE"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4291",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1799722",
        "gene": "BDKRB2",
        "level": "3",
        "phenotypes": "Cough,Essential hypertension"
      },
      {
        "variant": "rs11122576",
        "gene": "AGT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs11122576",
        "gene": "AGT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs12143842",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs200148",
        "gene": "",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs35068180",
        "gene": "MMP3",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "4",
        "phenotypes": "Diabetes Mellitus, Type 1,Heart Failure"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "valsartan": {
    "genes": [
      "AGT"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "drugs used in diabetes": {
    "genes": [
      "IRS1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1801278",
        "gene": "IRS1",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sulfonamides, plain": {
    "genes": [
      "SLC12A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mirvetuximab soravtansine": {
    "genes": [
      "FOLR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for mirvetuximab soravtansine and FOLR1"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for mirvetuximab soravtansine and FOLR1"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for mirvetuximab soravtansine"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "antineoplastic and immunomodulating agents": {
    "genes": [
      "ABCC5",
      "SLC22A6",
      "ABCC1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "darunavir": {
    "genes": [
      "SLCO3A1",
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for darunavir and CYP3A4"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "thioxanthine": {
    "genes": [
      "XDH"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "triglycerides": {
    "genes": [
      "CYP19A1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2289105",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Menopause"
      },
      {
        "variant": "rs10046",
        "gene": "CYP19A1",
        "level": "3",
        "phenotypes": "Breast Neoplasms,Menopause"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "hydrocortisone": {
    "genes": [
      "ATF5",
      "MIR3117",
      "MIR4268"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nitric oxide": {
    "genes": [
      "NAMPT"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pyridoxal phosphate": {
    "genes": [
      "CYP2E1",
      "NAT2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "acetaminophen sulfate": {
    "genes": [
      "CYP2E1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "theophylline": {
    "genes": [
      "CYP2E1",
      "CYP1A2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "clodronate": {
    "genes": [
      "VDR",
      "IL1B"
    ],
    "clinicalVariants": [
      {
        "variant": "rs16944",
        "gene": "IL1B",
        "level": "3",
        "phenotypes": "Osteitis Deformans"
      },
      {
        "variant": "rs731236",
        "gene": "VDR",
        "level": "3",
        "phenotypes": "Osteitis Deformans"
      },
      {
        "variant": "rs1544410",
        "gene": "VDR",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "golimumab": {
    "genes": [
      "VDR",
      "TNF"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "calcitriol": {
    "genes": [
      "VDR",
      "CYP24A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fosamprenavir": {
    "genes": [
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for fosamprenavir and CYP3A4"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "telithromycin": {
    "genes": [
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tipranavir": {
    "genes": [
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for tipranavir and CYP3A4"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cabozantinib": {
    "genes": [
      "CYP3A4",
      "RET"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for cabozantinib and RET"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lurbinectedin": {
    "genes": [
      "CYP3A4",
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ruxolitinib": {
    "genes": [
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for ruxolitinib and CYP3A4"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ivabradine": {
    "genes": [
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for ivabradine and CYP3A4"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "1-hydroxymidazolam": {
    "genes": [
      "CYP3A4",
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "clozapine n-oxide": {
    "genes": [
      "CYP3A4",
      "CYP1A2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "4-beta-hydroxycholesterol": {
    "genes": [
      "CYP3A4",
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "norfentanyl": {
    "genes": [
      "CYP3A4",
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "umifenovir": {
    "genes": [
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "acalabrutinib": {
    "genes": [
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "perampanel": {
    "genes": [
      "CYP3A4",
      "CYP3A5",
      "ZSCAN25"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ripretinib": {
    "genes": [
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "blonanserin": {
    "genes": [
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "omaveloxolone": {
    "genes": [
      "CYP3A4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "alprazolam": {
    "genes": [
      "CYP3A4",
      "CYP3A5"
    ],
    "clinicalVariants": [
      {
        "variant": "rs35599367",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP3A4*1, CYP3A4*22",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "adverse events,Alcohol abuse,Anxiety Disorders"
      },
      {
        "variant": "CYP3A4*1, CYP3A4*22",
        "gene": "CYP3A4",
        "level": "3",
        "phenotypes": "Alcohol abuse,Anxiety Disorders"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "clindamycin": {
    "genes": [
      "CYP3A4",
      "HLA-B"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-B*51:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "HLA-B*15:27",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lidocaine": {
    "genes": [
      "CYP3A4",
      "SCN5A"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "triazolam": {
    "genes": [
      "CYP3A4",
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "zileuton": {
    "genes": [
      "ALOX5",
      "PRORP"
    ],
    "clinicalVariants": [
      {
        "variant": "rs12436663",
        "gene": "PRORP",
        "level": "3",
        "phenotypes": "Asthma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cobimetinib": {
    "genes": [
      "BRAF"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for cobimetinib and BRAF"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for cobimetinib and BRAF"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for cobimetinib and BRAF"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "binimetinib": {
    "genes": [
      "BRAF",
      "UGT1A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for binimetinib and BRAF"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for binimetinib and BRAF"
      },
      {
        "source": "EMA",
        "level": "No Clinical PGx",
        "name": "Annotation of EMA Label for binimetinib and UGT1A1"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for binimetinib and UGT1A1"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for binimetinib and UGT1A1"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for binimetinib and BRAF"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nivolumab / relatlimab": {
    "genes": [
      "BRAF",
      "CD274",
      "LAG3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for nivolumab / relatlimab and BRAF, CD274, LAG3"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tovorafenib": {
    "genes": [
      "BRAF"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for tovorafenib"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for tovorafenib"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for tovorafenib and BRAF"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "multivitamins, plain": {
    "genes": [
      "DHFR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "metyrosine": {
    "genes": [
      "TH"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "rubella vaccines": {
    "genes": [
      "HLA-B",
      "HLA-C"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sulfonamides and trimethoprim": {
    "genes": [
      "HLA-B"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "carbimazole": {
    "genes": [
      "HLA-B",
      "HLA-DRB1"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-B*38:02",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Graves Disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "penicillin v": {
    "genes": [
      "HLA-B"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-B*55:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Hypersensitivity"
      },
      {
        "variant": "rs115200108",
        "gene": "",
        "level": "3",
        "phenotypes": "adverse events"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "trichloroethylene": {
    "genes": [
      "HLA-B"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-B*13:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Hypersensitivity"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lamivudine / abacavir": {
    "genes": [
      "HLA-B"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Testing Required",
        "name": "Annotation of Swissmedic Label for lamivudine / abacavir and HLA-B"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "zidovudine / lamivudine / abacavir": {
    "genes": [
      "HLA-B"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Testing Required",
        "name": "Annotation of Swissmedic Label for zidovudine / lamivudine / abacavir and HLA-B"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dolutegravir / abacavir / lamivudine": {
    "genes": [
      "HLA-B"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Testing Required",
        "name": "Annotation of Swissmedic Label for dolutegravir / abacavir / lamivudine and HLA-B"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cabotegravir / rilpivirine": {
    "genes": [
      "HLA-B",
      "UGT1A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for cabotegravir / rilpivirine and UGT1A1"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for cabotegravir / rilpivirine and UGT1A1"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for cabotegravir / rilpivirine and HLA-B"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for cabotegravir / rilpivirine"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "acetazolamide": {
    "genes": [
      "HLA-B"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-B*59:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Stevens-Johnson Syndrome"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ceftazidime": {
    "genes": [
      "HLA-B"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "minocycline": {
    "genes": [
      "HLA-B"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-B*35:02",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug-induced liver injury"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "penicillin g": {
    "genes": [
      "HLA-B",
      "HLA-DPB1",
      "IFNG"
    ],
    "clinicalVariants": [
      {
        "variant": "HLA-B*55:01",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Drug Hypersensitivity"
      },
      {
        "variant": "rs115200108",
        "gene": "",
        "level": "3",
        "phenotypes": "adverse events"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pertussis vaccines": {
    "genes": [
      "TLR4"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2770150",
        "gene": "TLR4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4986790",
        "gene": "TLR4",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "angiotensin ii": {
    "genes": [
      "AGTR1",
      "ACE"
    ],
    "clinicalVariants": [
      {
        "variant": "rs5186",
        "gene": "AGTR1",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "drugs for obstructive airway diseases": {
    "genes": [
      "ADRB2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "indacaterol": {
    "genes": [
      "ADRB2",
      "UGT1A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Informative PGx",
        "name": "Annotation of Swissmedic Label for indacaterol and UGT1A1"
      },
      {
        "source": "PMDA",
        "level": "Actionable PGx",
        "name": "Annotation of PMDA Label for indacaterol and UGT1A1"
      },
      {
        "source": "EMA",
        "level": "Informative PGx",
        "name": "Annotation of EMA Label for indacaterol and UGT1A1"
      },
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for indacaterol and UGT1A1"
      },
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for indacaterol and UGT1A1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ephedrine": {
    "genes": [
      "ADRB2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "orciprenaline": {
    "genes": [
      "ADRB2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "salmeterol": {
    "genes": [
      "ADRB2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "2A",
        "phenotypes": "Asthma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "terbutaline": {
    "genes": [
      "ADRB2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1042714",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "aminohippurate": {
    "genes": [
      "SLC22A6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cidofovir": {
    "genes": [
      "SLC22A6"
    ],
    "clinicalVariants": [
      {
        "variant": "rs11568626",
        "gene": "SLC22A6",
        "level": "4",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "thyrotropin alfa": {
    "genes": [
      "FSHR"
    ],
    "clinicalVariants": [
      {
        "variant": "rs6166",
        "gene": "FSHR",
        "level": "3",
        "phenotypes": "Infertility, Female,Ovarian hyperstimulation syndrome"
      },
      {
        "variant": "rs6166",
        "gene": "FSHR",
        "level": "3",
        "phenotypes": "Infertility disorder"
      },
      {
        "variant": "rs6166",
        "gene": "FSHR",
        "level": "3",
        "phenotypes": "Infertility disorder"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "menotropins": {
    "genes": [
      "FSHR"
    ],
    "clinicalVariants": [
      {
        "variant": "rs6166",
        "gene": "FSHR",
        "level": "3",
        "phenotypes": "Infertility disorder"
      },
      {
        "variant": "rs6166",
        "gene": "FSHR",
        "level": "3",
        "phenotypes": "Infertility disorder"
      },
      {
        "variant": "rs6166",
        "gene": "FSHR",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "follitropin beta": {
    "genes": [
      "FSHR"
    ],
    "clinicalVariants": [
      {
        "variant": "rs6166",
        "gene": "FSHR",
        "level": "3",
        "phenotypes": "Infertility, Female,Ovarian hyperstimulation syndrome"
      },
      {
        "variant": "rs6166",
        "gene": "FSHR",
        "level": "3",
        "phenotypes": "Infertility disorder"
      },
      {
        "variant": "rs6166",
        "gene": "FSHR",
        "level": "3",
        "phenotypes": "Infertility disorder"
      },
      {
        "variant": "rs6166",
        "gene": "FSHR",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "chorionic gonadotropin": {
    "genes": [
      "FSHR"
    ],
    "clinicalVariants": [
      {
        "variant": "rs6166",
        "gene": "FSHR",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "urofollitropin": {
    "genes": [
      "FSHR"
    ],
    "clinicalVariants": [
      {
        "variant": "rs6166",
        "gene": "FSHR",
        "level": "3",
        "phenotypes": "Infertility, Female,Ovarian hyperstimulation syndrome"
      },
      {
        "variant": "rs6166",
        "gene": "FSHR",
        "level": "3",
        "phenotypes": "Infertility disorder"
      },
      {
        "variant": "rs6166",
        "gene": "FSHR",
        "level": "3",
        "phenotypes": "Infertility disorder"
      },
      {
        "variant": "rs6166",
        "gene": "FSHR",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "4-ene valproic acid": {
    "genes": [
      "CPT1A"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "2-aminoheptanoate": {
    "genes": [
      "ACAD11"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "2-hydroxylaurate": {
    "genes": [
      "ACAD11"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "2-aminooctanoic acid": {
    "genes": [
      "ACAD11"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "bicalutamide": {
    "genes": [
      "HLA-DRB1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "abatacept": {
    "genes": [
      "HLA-DRB1",
      "FCGR2A"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "rilonacept": {
    "genes": [
      "HLA-DRB1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nutlin-3": {
    "genes": [
      "MDM2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "secukinumab": {
    "genes": [
      "ERAP2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lomustine": {
    "genes": [
      "METTL3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cerivastatin": {
    "genes": [
      "RYR2",
      "CYP2C8",
      "HMGCR",
      "SLCO1B1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2819742",
        "gene": "RYR2",
        "level": "3",
        "phenotypes": "Rhabdomyolysis"
      },
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "Rhabdomyolysis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tislelizumab": {
    "genes": [
      "CD274"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for tislelizumab and CD274"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for tislelizumab"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for tislelizumab and CD274"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cosibelimab": {
    "genes": [
      "CD274"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for cosibelimab and CD274"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cisapride": {
    "genes": [
      "KCNH2",
      "SCN5A"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mivacurium": {
    "genes": [
      "BCHE"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for mivacurium and BCHE"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for mivacurium and BCHE"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for mivacurium"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sipoglitazar": {
    "genes": [
      "UGT2B15"
    ],
    "clinicalVariants": [
      {
        "variant": "UGT2B15*1, UGT2B15*2",
        "gene": "UGT2B15",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dabigatran glucuronide": {
    "genes": [
      "UGT2B15"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "revumenib": {
    "genes": [
      "KMT2A"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for revumenib and KMT2A"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "arsenic compounds": {
    "genes": [
      "AS3MT",
      "CBS"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nicardipine": {
    "genes": [
      "CACNA1B"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "avacopan": {
    "genes": [
      "C5AR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "coumarin": {
    "genes": [
      "CYP2A13",
      "CYP2A6"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1801272",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs28399433",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2A6*1, CYP2A6*4, CYP2A6*5, CYP2A6*6, CYP2A6*7, CYP2A6*9, CYP2A6*10, CYP2A6*12, CYP2A6*17, CYP2A6*18, CYP2A6*19, CYP2A6*20",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ursodeoxycholic acid": {
    "genes": [
      "MGAT5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "estradiol / progesterone": {
    "genes": [
      "PROC",
      "PROS1",
      "SERPINC1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for estradiol / progesterone"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for estradiol / progesterone and PROC, PROS1, SERPINC1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "synthetic conjugated estrogens, a": {
    "genes": [
      "PROC",
      "PROS1",
      "SERPINC1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for synthetic conjugated estrogens, A and PROC, PROS1, SERPINC1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "velaglucerase alfa": {
    "genes": [
      "GBA1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for velaglucerase alfa and GBA1"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for velaglucerase alfa and GBA1"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for velaglucerase alfa and GBA1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "inotersen": {
    "genes": [
      "TTR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for inotersen and TTR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "patisiran": {
    "genes": [
      "TTR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for patisiran and TTR"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for patisiran and TTR"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for patisiran and TTR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tafamidis": {
    "genes": [
      "TTR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for tafamidis and TTR"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for tafamidis and TTR"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for tafamidis and TTR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vutrisiran": {
    "genes": [
      "TTR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for vutrisiran and TTR"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for vutrisiran and TTR"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for vutrisiran and TTR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "eplontersen": {
    "genes": [
      "TTR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for eplontersen and TTR"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for eplontersen and TTR"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for eplontersen and TTR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "maraviroc": {
    "genes": [
      "CCR5",
      "CYP3A5"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      }
    ],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for maraviroc and CYP3A5"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for maraviroc and CCR5"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ibandronate": {
    "genes": [
      "SIRT1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "carbocisteine": {
    "genes": [
      "PAH"
    ],
    "clinicalVariants": [
      {
        "variant": "rs75193786",
        "gene": "PAH",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5030843",
        "gene": "PAH",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs76394784",
        "gene": "PAH",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs138809906",
        "gene": "PAH",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5030849",
        "gene": "PAH",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs62516101",
        "gene": "PAH",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5030858",
        "gene": "PAH",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5030860",
        "gene": "PAH",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "l-phenylalanine": {
    "genes": [
      "PAH"
    ],
    "clinicalVariants": [
      {
        "variant": "rs5030843",
        "gene": "PAH",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs138809906",
        "gene": "PAH",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5030849",
        "gene": "PAH",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs62516101",
        "gene": "PAH",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5030858",
        "gene": "PAH",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5030860",
        "gene": "PAH",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs76394784",
        "gene": "PAH",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ibutilide": {
    "genes": [
      "C18orf21"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "4-hydroxyestradiol": {
    "genes": [
      "CYP1B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nusinersen": {
    "genes": [
      "SMN2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for nusinersen and SMN2"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for nusinersen and SMN2"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for nusinersen and SMN2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "risdiplam": {
    "genes": [
      "SMN2",
      "SMN1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for risdiplam and SMN1, SMN2"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for risdiplam and SMN1, SMN2"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for risdiplam and SMN1, SMN2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mizolastine": {
    "genes": [
      "FCER1A"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2298805",
        "gene": "FCER1A",
        "level": "3",
        "phenotypes": "Urticaria"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cerliponase alfa": {
    "genes": [
      "TPP1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for cerliponase alfa and TPP1"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for cerliponase alfa and TPP1"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for cerliponase alfa and TPP1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "omalizumab": {
    "genes": [
      "IL10",
      "IL17A"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "parathyroid hormones and analogues": {
    "genes": [
      "CASR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for Parathyroid Hormones And Analogues and CASR"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cinacalcet": {
    "genes": [
      "CASR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "denileukin diftitox": {
    "genes": [
      "IL2RA"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for denileukin diftitox and IL2RA"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for denileukin diftitox"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for denileukin diftitox"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pregnenolone": {
    "genes": [
      "SULT2B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "hmg coa reductase inhibitors, other combinations": {
    "genes": [
      "EYS"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "raltitrexed": {
    "genes": [
      "UGT1A1",
      "TYMS"
    ],
    "clinicalVariants": [
      {
        "variant": "rs45445694",
        "gene": "TYMS",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tranilast": {
    "genes": [
      "UGT1A1"
    ],
    "clinicalVariants": [
      {
        "variant": "UGT1A1*1, UGT1A1*28",
        "gene": "UGT1A1",
        "level": "3",
        "phenotypes": "Hyperbilirubinemia"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "belinostat": {
    "genes": [
      "UGT1A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for belinostat"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for belinostat"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for belinostat and UGT1A1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "atazanavir / ritonavir": {
    "genes": [
      "UGT1A1",
      "CYP3A5",
      "SLCO1B1"
    ],
    "clinicalVariants": [
      {
        "variant": "UGT1A1*1, UGT1A1*6, UGT1A1*28, UGT1A1*36, UGT1A1*37",
        "gene": "UGT1A1",
        "level": "1A",
        "phenotypes": "HIV infectious disease,Hyperbilirubinemia"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "raloxifene-4-glucuronide": {
    "genes": [
      "UGT1A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "raloxifene 6-glucuronide": {
    "genes": [
      "UGT1A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "2-hydroxyatorvastatin lactone": {
    "genes": [
      "UGT1A1",
      "SLCO1B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "4-hydroxyatorvastatin lactone": {
    "genes": [
      "UGT1A1",
      "SLCO2B1",
      "SLCO1B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vardenafil": {
    "genes": [
      "CYP3A5"
    ],
    "clinicalVariants": [
      {
        "variant": "rs776746",
        "gene": "CYP3A5",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for vardenafil"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "simvastatin acid": {
    "genes": [
      "CYP3A5",
      "SLCO1B1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": ""
      },
      {
        "variant": "SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",
        "gene": "SLCO1B1",
        "level": "1A",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "4-hydroxycyclophosphamide": {
    "genes": [
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "6beta-hydroxycortisol": {
    "genes": [
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "fluticasone": {
    "genes": [
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "3,4-dehydrocilostazol": {
    "genes": [
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "naldemedine": {
    "genes": [
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "beclomethasone dipropionate": {
    "genes": [
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "isavuconazole": {
    "genes": [
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "amprenavir": {
    "genes": [
      "CYP3A5",
      "SLCO1B1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs4149056",
        "gene": "SLCO1B1",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "beclomethasone": {
    "genes": [
      "CYP3A5",
      "CRHR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "itraconazole": {
    "genes": [
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mometasone": {
    "genes": [
      "CYP3A5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "saquinavir": {
    "genes": [
      "CYP3A5",
      "SLCO1B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "calcidiol": {
    "genes": [
      "CYP2R1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "anifrolumab": {
    "genes": [
      "IFNAR1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for anifrolumab and IFNAR1"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for anifrolumab and IFNAR1"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for anifrolumab and IFNAR1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tiludronate": {
    "genes": [
      "IL1B"
    ],
    "clinicalVariants": [
      {
        "variant": "rs16944",
        "gene": "IL1B",
        "level": "3",
        "phenotypes": "Osteitis Deformans"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "estrone sulfate": {
    "genes": [
      "SLCO2B1",
      "SLCO1B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "grazoprevir": {
    "genes": [
      "SLCO1B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "elagolix": {
    "genes": [
      "SLCO1B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "No Clinical PGx",
        "name": "Annotation of HCSC Label for elagolix and SLCO1B1"
      },
      {
        "source": "FDA",
        "level": "Informative PGx",
        "name": "Annotation of FDA Label for elagolix and SLCO1B1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ezetimibe / simvastatin": {
    "genes": [
      "SLCO1B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Testing Recommended",
        "name": "Annotation of Swissmedic Label for ezetimibe / simvastatin and SLCO1B1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pitavastatin lactone": {
    "genes": [
      "SLCO1B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "estrone": {
    "genes": [
      "SLCO1B1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sulfapyridine": {
    "genes": [
      "NAT2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "daniquidone": {
    "genes": [
      "NAT2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "acetylisoniazid": {
    "genes": [
      "NAT2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "solithromycin": {
    "genes": [
      "NAT2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "amifampridine phosphate": {
    "genes": [
      "NAT2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for amifampridine phosphate and NAT2"
      },
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for amifampridine phosphate and NAT2"
      },
      {
        "source": "EMA",
        "level": "Informative PGx",
        "name": "Annotation of EMA Label for amifampridine phosphate and NAT2"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for amifampridine phosphate and NAT2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "amifampridine": {
    "genes": [
      "NAT2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Actionable PGx",
        "name": "Annotation of HCSC Label for amifampridine and NAT2"
      },
      {
        "source": "FDA",
        "level": "Actionable PGx",
        "name": "Annotation of FDA Label for amifampridine and NAT2"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for amifampridine"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "clonazepam": {
    "genes": [
      "NAT2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "deferiprone": {
    "genes": [
      "UGT1A6"
    ],
    "clinicalVariants": [
      {
        "variant": "rs6759892",
        "gene": "UGT1A6",
        "level": "3",
        "phenotypes": "Beta-thalassemia and related diseases"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "3-hydroxycotinine glucuronide": {
    "genes": [
      "CYP2A6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "methoxsalen": {
    "genes": [
      "CYP2A6"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2A6*1, CYP2A6*15, CYP2A6*21, CYP2A6*22",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "metronidazole": {
    "genes": [
      "CYP2A6"
    ],
    "clinicalVariants": [
      {
        "variant": "CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*17",
        "gene": "CYP2A6",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pilocarpine": {
    "genes": [
      "CYP2A6"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "elosulfase alfa": {
    "genes": [
      "GALNS"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for elosulfase alfa and GALNS"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for elosulfase alfa and GALNS"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for elosulfase alfa and GALNS"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mavorixafor": {
    "genes": [
      "CXCR4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for mavorixafor"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for mavorixafor"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for mavorixafor and CXCR4"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "procarbazine": {
    "genes": [
      "EPM2AIP1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "larotrectinib": {
    "genes": [
      "NTRK2",
      "NTRK1",
      "NTRK3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for larotrectinib and NTRK1, NTRK2, NTRK3"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for larotrectinib and NTRK1, NTRK2, NTRK3"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for larotrectinib and NTRK1, NTRK2, NTRK3"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "selpercatinib": {
    "genes": [
      "RET"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for selpercatinib and RET"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for selpercatinib and RET"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for selpercatinib and RET"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pralsetinib": {
    "genes": [
      "RET"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for pralsetinib and RET"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for pralsetinib and RET"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for pralsetinib and RET"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "mitapivat": {
    "genes": [
      "PKLR"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for mitapivat and PKLR"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for mitapivat and PKLR"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for mitapivat"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "infigratinib": {
    "genes": [
      "FGFR2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "futibatinib": {
    "genes": [
      "FGFR2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for futibatinib and FGFR2"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for futibatinib and FGFR2"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for futibatinib"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pramipexole": {
    "genes": [
      "DRD3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs6280",
        "gene": "DRD3",
        "level": "3",
        "phenotypes": "Parkinson Disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lumasiran": {
    "genes": [
      "AGXT"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for lumasiran and AGXT"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for lumasiran and AGXT"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for lumasiran and AGXT"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nedosiran": {
    "genes": [
      "AGXT"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for nedosiran and AGXT"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for nedosiran and AGXT"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for nedosiran and AGXT"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "lasmiditan": {
    "genes": [
      "HTR1F"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "estradiol": {
    "genes": [
      "TCL1A",
      "NFE2L2"
    ],
    "clinicalVariants": [
      {
        "variant": "rs11849538",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "enzymes": {
    "genes": [
      "A2M",
      "F12"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1801020",
        "gene": "F12",
        "level": "3",
        "phenotypes": "Stroke"
      },
      {
        "variant": "rs669",
        "gene": "A2M",
        "level": "3",
        "phenotypes": "Stroke"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "5,6-dihydrothymine": {
    "genes": [
      "UPB1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "bradykinin": {
    "genes": [
      "ACE"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "salvianolic acid b": {
    "genes": [
      "ACE",
      "NOS3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Coronary Disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "acetylcholine": {
    "genes": [
      "ACE"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nitroprusside": {
    "genes": [
      "ACE"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dasabuvir / ombitasvir / paritaprevir / ritonavir": {
    "genes": [
      "IFNL3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for dasabuvir / ombitasvir / paritaprevir / ritonavir and IFNL3"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dasabuvir": {
    "genes": [
      "IFNL3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "Swissmedic",
        "level": "Actionable PGx",
        "name": "Annotation of Swissmedic Label for dasabuvir and IFNL3"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sofosbuvir / velpatasvir": {
    "genes": [
      "IFNL3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for sofosbuvir / velpatasvir and IFNL3"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sofosbuvir / velpatasvir / voxilaprevir": {
    "genes": [
      "IFNL3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for sofosbuvir / velpatasvir / voxilaprevir and IFNL3"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "enfortumab vedotin": {
    "genes": [
      "NECTIN4"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for enfortumab vedotin and NECTIN4"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for enfortumab vedotin and NECTIN4"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for enfortumab vedotin and NECTIN4"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "daunorubicinol": {
    "genes": [
      "AKR1A1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ropeginterferon alfa-2b": {
    "genes": [
      "JAK2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "No Clinical PGx",
        "name": "Annotation of FDA Label for ropeginterferon alfa-2b and JAK2"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for ropeginterferon alfa-2b"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for ropeginterferon alfa-2b and JAK2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "desmethyl olanzapine": {
    "genes": [
      "CYP1A2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "olezarsen": {
    "genes": [
      "LPL"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for olezarsen and LPL"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for olezarsen and LPL"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "desmopressin": {
    "genes": [
      "F8"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for desmopressin and F8"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for desmopressin and F8"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for desmopressin"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "enasidenib": {
    "genes": [
      "IDH2"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for enasidenib"
      },
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for enasidenib and IDH2"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "pilsicainide": {
    "genes": [
      "SCN5A"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "tofersen": {
    "genes": [
      "SOD1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for tofersen and SOD1"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "cortisone acetate": {
    "genes": [
      "CYP3A7"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dimethyl fumarate": {
    "genes": [
      "GSTP1"
    ],
    "clinicalVariants": [
      {
        "variant": "rs1695",
        "gene": "GSTP1",
        "level": "3",
        "phenotypes": "Psoriasis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "levamisole": {
    "genes": [
      "GSTP1"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ganaxolone": {
    "genes": [
      "CDKL5"
    ],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for ganaxolone and CDKL5"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for ganaxolone and CDKL5"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for ganaxolone"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "antihypertensives and diuretics in combination": {
    "genes": [
      "NOS3"
    ],
    "clinicalVariants": [
      {
        "variant": "rs2070744",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2070744",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Hypertension"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "l-arginine": {
    "genes": [
      "NOS3"
    ],
    "clinicalVariants": [],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "ace inhibitors": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs11209716",
        "gene": "PTGER3",
        "level": "3",
        "phenotypes": "Cough,Hypertension"
      },
      {
        "variant": "rs2016848",
        "gene": "MME",
        "level": "3",
        "phenotypes": "Cough,Hypertension"
      },
      {
        "variant": "rs8012552",
        "gene": "BDKRB2",
        "level": "3",
        "phenotypes": "Cough,Hypertension"
      },
      {
        "variant": "rs8016905",
        "gene": "BDKRB2",
        "level": "3",
        "phenotypes": "Cough"
      },
      {
        "variant": "rs5186",
        "gene": "AGTR1",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs495828",
        "gene": "ABO",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4459610",
        "gene": "",
        "level": "3",
        "phenotypes": "Cough"
      },
      {
        "variant": "rs4267385",
        "gene": "",
        "level": "3",
        "phenotypes": "Cough"
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5182",
        "gene": "AGTR1",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs6838116",
        "gene": "KCNIP4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs699",
        "gene": "AGT",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs145489027",
        "gene": "KCNIP4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1495509",
        "gene": "KCNIP4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2253201",
        "gene": "KCNMA1",
        "level": "3",
        "phenotypes": "Angioedema"
      },
      {
        "variant": "rs1801253",
        "gene": "ADRB1",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs3788853",
        "gene": "XPNPEP2",
        "level": "3",
        "phenotypes": "Angioedema"
      },
      {
        "variant": "rs16870989",
        "gene": "KCNIP4",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs7661530",
        "gene": "KCNIP4",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs7675300",
        "gene": "KCNIP4",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs1799722",
        "gene": "BDKRB2",
        "level": "4",
        "phenotypes": "Cough"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "plain": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs11209716",
        "gene": "PTGER3",
        "level": "3",
        "phenotypes": "Cough,Hypertension"
      },
      {
        "variant": "rs2016848",
        "gene": "MME",
        "level": "3",
        "phenotypes": "Cough,Hypertension"
      },
      {
        "variant": "rs8012552",
        "gene": "BDKRB2",
        "level": "3",
        "phenotypes": "Cough,Hypertension"
      },
      {
        "variant": "rs8016905",
        "gene": "BDKRB2",
        "level": "3",
        "phenotypes": "Cough"
      },
      {
        "variant": "rs5186",
        "gene": "AGTR1",
        "level": "3",
        "phenotypes": "Coronary Artery Disease"
      },
      {
        "variant": "rs495828",
        "gene": "ABO",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs4459610",
        "gene": "",
        "level": "3",
        "phenotypes": "Cough"
      },
      {
        "variant": "rs4267385",
        "gene": "",
        "level": "3",
        "phenotypes": "Cough"
      },
      {
        "variant": "rs1801394",
        "gene": "MTRR",
        "level": "3",
        "phenotypes": "Migraine with Aura"
      },
      {
        "variant": "rs13306673",
        "gene": "SLC12A3",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs1799983",
        "gene": "NOS3",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs1799752",
        "gene": "ACE",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5182",
        "gene": "AGTR1",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs6838116",
        "gene": "KCNIP4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1042713",
        "gene": "ADRB2",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs699",
        "gene": "AGT",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs4341",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "rs5186",
        "gene": "AGTR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5443",
        "gene": "GNB3",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "rs145489027",
        "gene": "KCNIP4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1495509",
        "gene": "KCNIP4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2273359",
        "gene": "NELFCD",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs2253201",
        "gene": "KCNMA1",
        "level": "3",
        "phenotypes": "Angioedema"
      },
      {
        "variant": "rs1801253",
        "gene": "ADRB1",
        "level": "3",
        "phenotypes": "Heart Failure"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs3788853",
        "gene": "XPNPEP2",
        "level": "3",
        "phenotypes": "Angioedema"
      },
      {
        "variant": "rs34550074",
        "gene": "SLCO2A1",
        "level": "3",
        "phenotypes": "Hypertension,Hyponatremia"
      },
      {
        "variant": "rs16870989",
        "gene": "KCNIP4",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs7661530",
        "gene": "KCNIP4",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs7675300",
        "gene": "KCNIP4",
        "level": "4",
        "phenotypes": ""
      },
      {
        "variant": "rs1799722",
        "gene": "BDKRB2",
        "level": "4",
        "phenotypes": "Cough"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "antivirals for treatment of hiv infections": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs7412",
        "gene": "APOE",
        "level": "3",
        "phenotypes": "HIV infectious disease,Hypertriglyceridemia"
      },
      {
        "variant": "rs3745274",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "HIV infectious disease,Tuberculosis"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "HIV infectious disease,Tuberculosis"
      },
      {
        "variant": "rs429358",
        "gene": "APOE",
        "level": "3",
        "phenotypes": "HIV infectious disease,Hyperlipidemias"
      },
      {
        "variant": "rs7412",
        "gene": "APOE",
        "level": "3",
        "phenotypes": "HIV infectious disease,Hyperlipidemias,Hypertriglyceridemia"
      },
      {
        "variant": "NAT2*1, NAT2*4, NAT2*6, NAT2*7, NAT2*16",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Drug-induced liver injury,HIV infectious disease,Tuberculosis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "combinations": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs7412",
        "gene": "APOE",
        "level": "3",
        "phenotypes": "HIV infectious disease,Hypertriglyceridemia"
      },
      {
        "variant": "rs3745274",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": "HIV infectious disease,Tuberculosis"
      },
      {
        "variant": "rs1045642",
        "gene": "ABCB1",
        "level": "3",
        "phenotypes": "HIV infectious disease,Tuberculosis"
      },
      {
        "variant": "rs429358",
        "gene": "APOE",
        "level": "3",
        "phenotypes": "HIV infectious disease,Hyperlipidemias"
      },
      {
        "variant": "rs7412",
        "gene": "APOE",
        "level": "3",
        "phenotypes": "HIV infectious disease,Hyperlipidemias,Hypertriglyceridemia"
      },
      {
        "variant": "NAT2*1, NAT2*4, NAT2*6, NAT2*7, NAT2*16",
        "gene": "NAT2",
        "level": "3",
        "phenotypes": "Drug-induced liver injury,HIV infectious disease,Tuberculosis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "sulfonamides": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs12255372",
        "gene": "TCF7L2",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs5219",
        "gene": "KCNJ11",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs5219",
        "gene": "KCNJ11",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs757110",
        "gene": "ABCC8,KCNJ11",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "rs7903146",
        "gene": "TCF7L2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5219",
        "gene": "KCNJ11",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "urea derivatives": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs12255372",
        "gene": "TCF7L2",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs5219",
        "gene": "KCNJ11",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs5219",
        "gene": "KCNJ11",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      },
      {
        "variant": "rs757110",
        "gene": "ABCC8,KCNJ11",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "rs7903146",
        "gene": "TCF7L2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5219",
        "gene": "KCNJ11",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "CYP2C9*1, CYP2C9*2, CYP2C9*3",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*3",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": "Diabetes Mellitus, Type 2"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "interferon alfa-2a": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs9657182",
        "gene": "IDO1",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs9939609",
        "gene": "FTO",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection,HIV infectious disease"
      },
      {
        "variant": "HLA-B*44:02",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "recombinant": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs9657182",
        "gene": "IDO1",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "rs9939609",
        "gene": "FTO",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection,HIV infectious disease"
      },
      {
        "variant": "rs9939609",
        "gene": "FTO",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection,HIV infectious disease"
      },
      {
        "variant": "rs1127354",
        "gene": "ITPA",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      },
      {
        "variant": "HLA-B*44:02",
        "gene": "HLA-B",
        "level": "3",
        "phenotypes": "Hepatitis C virus infection"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "antiinflammatory agents": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs943580",
        "gene": "AGT",
        "level": "3",
        "phenotypes": "Acute coronary syndrome"
      },
      {
        "variant": "rs10757274",
        "gene": "CDKN2B-AS1",
        "level": "3",
        "phenotypes": "Acute coronary syndrome"
      },
      {
        "variant": "rs699",
        "gene": "AGT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6305",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1611115",
        "gene": "DBH",
        "level": "3",
        "phenotypes": "Substance Withdrawal Syndrome"
      },
      {
        "variant": "rs6265",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6275",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10306135",
        "gene": "PTGS1",
        "level": "3",
        "phenotypes": "Acute coronary syndrome"
      },
      {
        "variant": "rs16973225",
        "gene": "",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1800896",
        "gene": "IL10",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs231775",
        "gene": "CTLA4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2965667",
        "gene": "",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Substance Withdrawal Syndrome"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1057910",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "HLA-DRB1*11:01",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Anaphylaxis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "non-steroids": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs943580",
        "gene": "AGT",
        "level": "3",
        "phenotypes": "Acute coronary syndrome"
      },
      {
        "variant": "rs10757274",
        "gene": "CDKN2B-AS1",
        "level": "3",
        "phenotypes": "Acute coronary syndrome"
      },
      {
        "variant": "rs699",
        "gene": "AGT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6305",
        "gene": "HTR2A",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1611115",
        "gene": "DBH",
        "level": "3",
        "phenotypes": "Substance Withdrawal Syndrome"
      },
      {
        "variant": "rs6265",
        "gene": "BDNF",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6275",
        "gene": "DRD2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs10306135",
        "gene": "PTGS1",
        "level": "3",
        "phenotypes": "Acute coronary syndrome"
      },
      {
        "variant": "rs16973225",
        "gene": "",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1800896",
        "gene": "IL10",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs231775",
        "gene": "CTLA4",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2965667",
        "gene": "",
        "level": "3",
        "phenotypes": "Colorectal Neoplasms"
      },
      {
        "variant": "rs1799971",
        "gene": "OPRM1",
        "level": "3",
        "phenotypes": "Substance Withdrawal Syndrome"
      },
      {
        "variant": "rs4680",
        "gene": "COMT",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1057910",
        "gene": "CYP2C9",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "HLA-DRB1*11:01",
        "gene": "HLA-DRB1",
        "level": "3",
        "phenotypes": "Anaphylaxis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "vitamin b-complex": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs1801394",
        "gene": "MTRR",
        "level": "3",
        "phenotypes": "Migraine with Aura"
      },
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "thiazides": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs13306673",
        "gene": "SLC12A3",
        "level": "3",
        "phenotypes": "Essential hypertension"
      },
      {
        "variant": "rs4341",
        "gene": "ACE",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "rs5186",
        "gene": "AGTR1",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs5443",
        "gene": "GNB3",
        "level": "3",
        "phenotypes": "Diabetes Mellitus"
      },
      {
        "variant": "rs2273359",
        "gene": "NELFCD",
        "level": "3",
        "phenotypes": "Hypertension"
      },
      {
        "variant": "rs34550074",
        "gene": "SLCO2A1",
        "level": "3",
        "phenotypes": "Hypertension,Hyponatremia"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "interferon alfa-2b": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs9939609",
        "gene": "FTO",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection,HIV infectious disease"
      },
      {
        "variant": "rs1127354",
        "gene": "ITPA",
        "level": "3",
        "phenotypes": "Chronic hepatitis C virus infection"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "adrenergics": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs34548976",
        "gene": "",
        "level": "3",
        "phenotypes": "Asthma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "inhalants": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs34548976",
        "gene": "",
        "level": "3",
        "phenotypes": "Asthma"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "nucleoside and nucleotide reverse transcriptase inhibitors": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs2853826",
        "gene": "",
        "level": "3",
        "phenotypes": "HIV infectious disease"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "4-methylenedioxymethamphetamine": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs3745274",
        "gene": "CYP2B6",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs2242446",
        "gene": "SLC6A2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs36029",
        "gene": "SLC6A2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs1861647",
        "gene": "SLC6A2",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*17",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "CYP2C19*1, CYP2C19*2, CYP2C19*17",
        "gene": "CYP2C19",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "loxoprofen": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs9933632",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6500265",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "salicylamide": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs9933632",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      },
      {
        "variant": "rs6500265",
        "gene": "",
        "level": "3",
        "phenotypes": ""
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "hmg coa reductase inhibitors": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs9342288",
        "gene": "EYS",
        "level": "3",
        "phenotypes": "Cardiovascular Disease,Rhabdomyolysis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "other combinations": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs9342288",
        "gene": "EYS",
        "level": "3",
        "phenotypes": "Cardiovascular Disease,Rhabdomyolysis"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "incl. combinations": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs1801131",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      },
      {
        "variant": "rs1801133",
        "gene": "MTHFR",
        "level": "3",
        "phenotypes": "Major Depressive Disorder"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "selective": {
    "genes": [],
    "clinicalVariants": [
      {
        "variant": "rs28404156",
        "gene": "BST1",
        "level": "3",
        "phenotypes": "Hypertension"
      }
    ],
    "fdaLabels": [],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "bempedoic acid / ezetimibe": {
    "genes": [],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for bempedoic acid / ezetimibe"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for bempedoic acid / ezetimibe"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for bempedoic acid / ezetimibe"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "evolocumab": {
    "genes": [],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for evolocumab"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for evolocumab"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for evolocumab"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "teclistamab": {
    "genes": [],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for teclistamab"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for teclistamab"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for teclistamab"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "estradiol valerate": {
    "genes": [],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for estradiol valerate"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for estradiol valerate"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "dostarlimab": {
    "genes": [],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "Testing Required",
        "name": "Annotation of FDA Label for dostarlimab"
      },
      {
        "source": "EMA",
        "level": "Testing Required",
        "name": "Annotation of EMA Label for dostarlimab"
      },
      {
        "source": "HCSC",
        "level": "Testing Required",
        "name": "Annotation of HCSC Label for dostarlimab"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "duvelisib": {
    "genes": [],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for duvelisib"
      },
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for duvelisib"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for duvelisib"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  },
  "elranatamab": {
    "genes": [],
    "clinicalVariants": [],
    "fdaLabels": [
      {
        "source": "EMA",
        "level": "",
        "name": "Annotation of EMA Label for elranatamab"
      },
      {
        "source": "HCSC",
        "level": "",
        "name": "Annotation of HCSC Label for elranatamab"
      },
      {
        "source": "FDA",
        "level": "",
        "name": "Annotation of FDA Label for elranatamab"
      }
    ],
    "guidelines": {
      "advice": "Follow standard protocol.",
      "source": "General"
    }
  }
}